Citrus Sinensis ID: 010078
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 518 | 2.2.26 [Sep-21-2011] | |||||||
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.420 | 0.558 | 0.452 | 6e-56 | |
| Q55GU0 | 916 | Probable serine/threonine | yes | no | 0.418 | 0.236 | 0.440 | 3e-52 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.416 | 0.336 | 0.450 | 8e-50 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.459 | 0.289 | 0.429 | 7e-49 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.416 | 0.313 | 0.436 | 5e-48 | |
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.424 | 0.235 | 0.442 | 6e-47 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.469 | 0.146 | 0.398 | 9e-47 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.416 | 0.133 | 0.433 | 9e-47 | |
| P09560 | 638 | RAF proto-oncogene serine | N/A | no | 0.469 | 0.380 | 0.385 | 1e-45 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.413 | 0.166 | 0.414 | 5e-45 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 219 bits (557), Expect = 6e-56, Method: Compositional matrix adjust.
Identities = 101/223 (45%), Positives = 150/223 (67%), Gaps = 5/223 (2%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLK----PERINSDMQKEFAQEVFI 342
W D L G+K ASG++ +YRG Y + VA+K+++ E + ++++F EV +
Sbjct: 79 WTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTHKEETRAKLEQQFKSEVAL 138
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSK 401
+ ++ H N+VQFI AC KPP CI+TE+MS G++ YL+K + + ++L++A+D+S+
Sbjct: 139 LSRLFHPNIVQFIAACKKPPVYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDISR 198
Query: 402 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI 461
GM YLH +IHRDLK+ NLL+++ VKVADFG + ++ Q GTYRWMAPE+I
Sbjct: 199 GMEYLHSQGVIHRDLKSNNLLLNDEMRVKVADFGTSCLETQCREAKGNMGTYRWMAPEMI 258
Query: 462 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504
+ KPY K DV+SFGIVLWEL T LP++ +TP+QAA V +K
Sbjct: 259 KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 301
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 206 bits (525), Expect = 3e-52, Method: Compositional matrix adjust.
Identities = 96/218 (44%), Positives = 148/218 (67%), Gaps = 1/218 (0%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLK-PERINSDMQKEFAQEVFIMRKV 346
EI LK SK+ G++G +Y+G + VAIK +K E +N+ + +EF +E+ I+ ++
Sbjct: 656 EISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTILSRL 715
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
RH N+V + ACT PP+LC +TE++ GGS+YD LH K + K+AI +++GMNYL
Sbjct: 716 RHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQGMNYL 775
Query: 407 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 466
H + +IHRD+K+ NLL+DE+ VK+ DFG++++K++S MT G+ WM+PE++ + Y
Sbjct: 776 HLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKSIGSPIWMSPELLMGEDY 835
Query: 467 DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504
K DV++FGI+LWEL TG+LPY L +Q A+ V K
Sbjct: 836 TEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTK 873
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 198 bits (504), Expect = 8e-50, Method: Compositional matrix adjust.
Identities = 100/222 (45%), Positives = 141/222 (63%), Gaps = 6/222 (2%)
Query: 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 341
DG D ID +K G ++ G+YG++Y GT+ VA+K L IN ++ KEF +E+
Sbjct: 365 DGKD---IDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREIN 421
Query: 342 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 401
+M+ +RH NV+QF+G+C PP +CI TE+M GS+Y LH + L+K+ ID +K
Sbjct: 422 LMKNLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAK 481
Query: 402 GMNYLHQNN--IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 459
G+ YLH + I+HRDLK+ NLL+DEN VKVADFG++ ++ Q MTA GT W +PE
Sbjct: 482 GVIYLHNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGATMTA-CGTPCWTSPE 540
Query: 460 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV 501
V+ + Y KADV+SFGI+LWE T + PY + P Q V
Sbjct: 541 VLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAV 582
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 195 bits (496), Expect = 7e-49, Method: Compositional matrix adjust.
Identities = 109/254 (42%), Positives = 159/254 (62%), Gaps = 16/254 (6%)
Query: 266 EDTGMKSHPYHLKIPN--------DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD 317
E M + P +PN DG D+ +I L K+ +GS+G ++R + D
Sbjct: 516 EAAPMNAPPISQPVPNRANRELGLDGDDM-DIPWCDLNIKEKIGAGSFGTVHRAEWHGSD 574
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
VA+K+L + +++ EF +EV IM+++RH N+V F+GA T+PP+L IVTE++S GS+Y
Sbjct: 575 VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY 634
Query: 378 DYLHKLKGVFKLPSL--LKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVKVAD 433
LHK +L L +A DV+KGMNYLH N I+HRDLK+ NLL+D+ VKV D
Sbjct: 635 RLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCD 694
Query: 434 FGVARVKAQSGVMT-AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL 492
FG++R+KA + + + + GT WMAPEV+ +P + K+DV+SFG++LWEL T + P+ L
Sbjct: 695 FGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 754
Query: 493 TPLQ--AAVGVVQK 504
P Q AAVG K
Sbjct: 755 NPAQVVAAVGFKCK 768
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 192 bits (488), Expect = 5e-48, Method: Compositional matrix adjust.
Identities = 97/222 (43%), Positives = 140/222 (63%), Gaps = 6/222 (2%)
Query: 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 341
DG D ID + +K G ++ G++G++Y GT+ VA+K L IN ++ KEF +E+
Sbjct: 382 DGKD---IDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREIN 438
Query: 342 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 401
+M+ +RH NV+QF+G+C P +CI TE+M GS+Y LH K + ++ ID +K
Sbjct: 439 LMKNLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAK 498
Query: 402 GMNYLHQNN--IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 459
G+ YLH + I+HRDLK+ NLL+DEN VKVADFG++ ++ Q MTA GT W +PE
Sbjct: 499 GIIYLHGSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGATMTA-CGTPCWTSPE 557
Query: 460 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV 501
V+ + Y KADV+SFGI+LWE T + PY + P Q V
Sbjct: 558 VLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAV 599
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 189 bits (479), Expect = 6e-47, Method: Compositional matrix adjust.
Identities = 100/226 (44%), Positives = 141/226 (62%), Gaps = 6/226 (2%)
Query: 282 DGTDV--WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQE 339
D DV EI L ++ GSYG++Y + +VA+K + + EF E
Sbjct: 655 DDADVGECEIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSE 714
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
V IMR++RH NVV F+GA T+PP+L IVTEF+ GS+Y LH+ K +K+A+DV
Sbjct: 715 VRIMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDV 774
Query: 400 SKGMNYLHQN--NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET-GTYRWM 456
+ GMN LH + I+HRDLK NLL+D N VKV DFG++R+K + + + T GT WM
Sbjct: 775 AMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWM 834
Query: 457 APEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 502
APEV+ ++P + K DV+SFG++LWEL T +LP+ + P+Q VG V
Sbjct: 835 APEVLRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQ-VVGAV 879
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 188 bits (477), Expect = 9e-47, Method: Compositional matrix adjust.
Identities = 100/251 (39%), Positives = 160/251 (63%), Gaps = 8/251 (3%)
Query: 275 YHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPER-INSDMQ 333
+ L+ +D WEID L+ G ++ +G++G++++GT+ +VA+K++ P++ I D++
Sbjct: 767 FSLRFRKGISDDWEIDFHELELGEQLGTGAFGEVHKGTWRGTEVAVKMISPDKTITKDIE 826
Query: 334 KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL 393
+ F EV +M +RH NVV F+ A TKPP +CIV EFM+ GS++D L K + + +P L
Sbjct: 827 RNFKDEVRVMTTLRHPNVVLFMAASTKPPKMCIVMEFMALGSLHDLL-KNELIPDIPFAL 885
Query: 394 KVAI--DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-- 449
KV I SKGM++LH + I HRDLK+ NLL+D VKV+DFG+ + K+ + E
Sbjct: 886 KVKIAYQASKGMHFLHSSGITHRDLKSLNLLLDIKWNVKVSDFGLTKFKSDVKSINPEKF 945
Query: 450 TGTYRWMAPEVI-EHKPYDH-KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHH 507
GT +W APE++ E + D+ +DV+SFGI++WEL+T PY ++P AV V++ +
Sbjct: 946 AGTIQWTAPEILSEDREVDYILSDVYSFGIIMWELITRDQPYFGMSPAAIAVSVIRDNYR 1005
Query: 508 SFLEQRLRKSV 518
+ +LR V
Sbjct: 1006 PVISDQLRSEV 1016
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 188 bits (477), Expect = 9e-47, Method: Compositional matrix adjust.
Identities = 97/224 (43%), Positives = 147/224 (65%), Gaps = 8/224 (3%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
WEID L+ G + +G YG++Y+ + +VA+K++ + ++ DM++ F +EV IM +
Sbjct: 779 WEIDFSELEIGETLGTGGYGEVYKSIWKGTEVAVKLISSKHVSKDMERSFFEEVKIMTSL 838
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKV--AIDVSKGMN 404
RH NVV F+ A TK P++CIV EFMS GS+YD L + + ++P LK+ A SKGM+
Sbjct: 839 RHPNVVLFMAASTKSPNMCIVMEFMSLGSLYDLLGN-ELIPEIPYALKIKMAYQASKGMH 897
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE---TGTYRWMAPEVI 461
+LH + I+HRDLK+ NLL+D VKV+DFG+ +VK++ GT W+APE++
Sbjct: 898 FLHSSGIVHRDLKSLNLLLDSKWNVKVSDFGLTKVKSELDKKKTNDNIIGTIHWIAPEIL 957
Query: 462 -EHKPYDH-KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503
+ D+ ADV+SFGI+LWELLT + PY+ +TP AV V++
Sbjct: 958 NDSTEVDYILADVYSFGIILWELLTREQPYKGMTPAAIAVSVIR 1001
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P09560|RAF1_XENLA RAF proto-oncogene serine/threonine-protein kinase OS=Xenopus laevis GN=raf1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 184 bits (468), Expect = 1e-45, Method: Compositional matrix adjust.
Identities = 98/254 (38%), Positives = 154/254 (60%), Gaps = 11/254 (4%)
Query: 248 LERQGWPSHRSSSPT---SEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGS 304
L GW + ++ +PT TG + + + D + WEI + S++ SGS
Sbjct: 291 LSPTGWSNAKAPAPTHREKAASSTGQEKNKIRARGQRDSSYYWEIIASEVMLSSRIGSGS 350
Query: 305 YGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364
+G +Y+G + DVA+K+LK + + F EV ++RK RH N++ F+G TK +L
Sbjct: 351 FGTVYKGKW-HGDVAVKILKVTDPTPEQLQAFRNEVAVLRKTRHVNILLFMGYMTKD-NL 408
Query: 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD 424
IVT++ G S+Y +LH L F++ L+ +A ++GM+YLH NIIHRD+K+ N+ +
Sbjct: 409 AIVTQWCEGSSLYYHLHVLDTKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH 468
Query: 425 ENEVVKVADFGVARVKAQ-SGVMTAE--TGTYRWMAPEVI---EHKPYDHKADVFSFGIV 478
E VK+ DFG+A VK + SG E TG+ WMAPEVI ++ P+ ++DV+S+GIV
Sbjct: 469 EGLTVKIGDFGLATVKTRWSGSQQVEQLTGSILWMAPEVIRMQDNNPFSFQSDVYSYGIV 528
Query: 479 LWELLTGKLPYEYL 492
L+EL+TG+LPY ++
Sbjct: 529 LYELMTGELPYSHI 542
|
Serine/threonine-protein kinase that acts as a regulatory link between the membrane-associated Ras GTPases and the MAPK/ERK cascade, and this critical regulatory link functions as a switch determining cell fate decisions. RAF1 activation initiates a mitogen-activated protein kinase (MAPK) cascade that comprises a sequential phosphorylation of the dual-specific MAPK kinases (MAP2K1/MEK1 and MAP2K2/MEK2) and the extracellular signal-regulated kinases (MAPK3/ERK1 and MAPK1/ERK2). Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 182 bits (463), Expect = 5e-45, Method: Compositional matrix adjust.
Identities = 90/217 (41%), Positives = 135/217 (62%), Gaps = 3/217 (1%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
WE+ + G+++ G YG ++RG++ +VA+K+L + +N + + +EV ++ K+
Sbjct: 844 WEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKMLFNDNVNLKLISDLRKEVDLLCKL 903
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
RH N+V F+GACT+P S CIVTE++S GS+ + L L++ D ++GM YL
Sbjct: 904 RHPNIVLFMGACTEPSSPCIVTEYLSRGSLANILLDESIEMDWGLRLQLGFDCARGMTYL 963
Query: 407 HQNN--IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 464
H N IIHRDLK NLL+D++ VKVADFG+A VK+ + T GT W+APEV+ +
Sbjct: 964 HSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATVKSHTFAKTM-CGTTGWVAPEVLAEE 1022
Query: 465 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV 501
Y KADV+S+ IVLWELLT +PY +Q +
Sbjct: 1023 GYTEKADVYSYAIVLWELLTRLIPYAGKNTMQVVRSI 1059
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 518 | ||||||
| 297744550 | 580 | unnamed protein product [Vitis vinifera] | 0.957 | 0.855 | 0.799 | 0.0 | |
| 449454245 | 573 | PREDICTED: protein-tyrosine kinase 2-bet | 0.949 | 0.858 | 0.801 | 0.0 | |
| 359474826 | 1515 | PREDICTED: uncharacterized mscS family p | 0.951 | 0.325 | 0.753 | 0.0 | |
| 283132359 | 578 | ACT-domain-containing protein kinase [Lo | 0.942 | 0.844 | 0.772 | 0.0 | |
| 255560441 | 558 | protein kinase, putative [Ricinus commun | 0.930 | 0.863 | 0.777 | 0.0 | |
| 357444821 | 771 | Protein kinase like protein [Medicago tr | 0.955 | 0.642 | 0.751 | 0.0 | |
| 356574129 | 581 | PREDICTED: uncharacterized protein LOC10 | 0.963 | 0.858 | 0.746 | 0.0 | |
| 18420244 | 575 | ACT-like protein tyrosine kinase family | 0.947 | 0.853 | 0.742 | 0.0 | |
| 297797832 | 565 | kinase family protein [Arabidopsis lyrat | 0.934 | 0.856 | 0.748 | 0.0 | |
| 217074650 | 538 | unknown [Medicago truncatula] | 0.949 | 0.914 | 0.701 | 0.0 |
| >gi|297744550|emb|CBI37812.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 835 bits (2156), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/518 (79%), Positives = 451/518 (87%), Gaps = 22/518 (4%)
Query: 1 MVMEENNNESCGSRASDTSSTSSPPPQHQSRQHRQKLGVYNEVLGRLKESNNDEAIQPRF 60
MVME +NESC SR D+SS + QSRQ RQKL VYNEVL RLK+S+N+EA +P F
Sbjct: 1 MVME--DNESCSSRVHDSSSPA------QSRQQRQKLEVYNEVLRRLKDSDNEEAFEPGF 52
Query: 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDR- 119
D+ELW HF RLPTRYALDVNVERAEDVL HKRLLHLAHDP NRPAIEVRLVQVHP+SD
Sbjct: 53 DEELWAHFVRLPTRYALDVNVERAEDVLTHKRLLHLAHDPTNRPAIEVRLVQVHPISDGI 112
Query: 120 NSAVSSLLDSEVP-----------AQRQSIHPPPAFGSSPNLEALAIEANNSH--NLDGD 166
+ ++ + S P + +QSI PPPAFGSSPNLEALAIEANNSH + DGD
Sbjct: 113 HGNIADSIHSNSPTIGPAHGSPKYSSKQSILPPPAFGSSPNLEALAIEANNSHVQDGDGD 172
Query: 167 NSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV 226
+SVHA+ Q+SRPMHEITFS+DDKPKLLSQLT LL+++ LNIQEAHAFSTVDGYSLDVFVV
Sbjct: 173 DSVHASSQYSRPMHEITFSSDDKPKLLSQLTCLLSELELNIQEAHAFSTVDGYSLDVFVV 232
Query: 227 DGWPYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDV 286
DGWPYEETEQLR ALEKEV K+E+Q WP+H S SPT E E+TG+K + IPNDGTDV
Sbjct: 233 DGWPYEETEQLRTALEKEVFKIEKQSWPNHHSLSPTGEQEETGIKCESDFVTIPNDGTDV 292
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
WEID + LKF +KVASGSYGDLY+GTYCSQ+VAIKVLKPER+NSDMQKEFAQEVFIMRKV
Sbjct: 293 WEIDVRQLKFENKVASGSYGDLYKGTYCSQEVAIKVLKPERLNSDMQKEFAQEVFIMRKV 352
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
RHKNVVQFIGACT+PPSL IVTEFMSGGSVYDYLHK KGVFKLP+LLKV+IDVSKGMNYL
Sbjct: 353 RHKNVVQFIGACTRPPSLYIVTEFMSGGSVYDYLHKQKGVFKLPALLKVSIDVSKGMNYL 412
Query: 407 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 466
HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY
Sbjct: 413 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 472
Query: 467 DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504
DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK
Sbjct: 473 DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 510
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449454245|ref|XP_004144866.1| PREDICTED: protein-tyrosine kinase 2-beta-like [Cucumis sativus] gi|449528766|ref|XP_004171374.1| PREDICTED: protein-tyrosine kinase 2-beta-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 832 bits (2149), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/515 (80%), Positives = 444/515 (86%), Gaps = 23/515 (4%)
Query: 1 MVMEENNNESCGSRASDTSSTSSPPPQHQSRQHRQKLGVYNEVLGRLKESNNDEAIQPRF 60
MVME +NESCGSRA D S + QSRQ RQK VYNEVL RLK+SNN+EAIQP F
Sbjct: 1 MVME--DNESCGSRAYDLLSPA------QSRQQRQKFEVYNEVLRRLKDSNNEEAIQPGF 52
Query: 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRN 120
DDELW HFNRLPTRYALDVNVERAEDVLMHKRLL AHDP NRPAIEVRLVQV VSD +
Sbjct: 53 DDELWVHFNRLPTRYALDVNVERAEDVLMHKRLLQFAHDPANRPAIEVRLVQVQAVSDEH 112
Query: 121 SAVSSLLDSEVPAQ-----------RQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSV 169
SA DS P + RQS+HPPPAFGSSPNLEALA+EANN+ +L+ D SV
Sbjct: 113 SA--DFADS-CPVKDTDHNSSNCLSRQSMHPPPAFGSSPNLEALALEANNTQDLEVDQSV 169
Query: 170 HANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGW 229
HA QF RPMHEITFSTDDKPKLLSQLT+LLA+IGLNIQEAHAFSTVDGYSLDVFVVDGW
Sbjct: 170 HARTQFFRPMHEITFSTDDKPKLLSQLTSLLAEIGLNIQEAHAFSTVDGYSLDVFVVDGW 229
Query: 230 PYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEI 289
PYEETE+L+ ALE EVL +ER+GWP+ +SSSP E + T K ++IP DGTDVWEI
Sbjct: 230 PYEETERLKTALESEVLLVERRGWPNQKSSSPVGELDITA-KCESDRVEIPTDGTDVWEI 288
Query: 290 DPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 349
+P+HLKF KVASGSYGDLY+GTYCSQ+VAIKVLK ER+N+DMQ EFAQEV+IMRKVRHK
Sbjct: 289 NPRHLKFEHKVASGSYGDLYKGTYCSQEVAIKVLKTERVNTDMQSEFAQEVYIMRKVRHK 348
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHK KG F+LPSLLKVAIDVSKGMNYLHQN
Sbjct: 349 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKQKGTFRLPSLLKVAIDVSKGMNYLHQN 408
Query: 410 NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK 469
NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK
Sbjct: 409 NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK 468
Query: 470 ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504
ADVFSFGIVLWELLTGKLPYE+LTPLQAAVGVVQK
Sbjct: 469 ADVFSFGIVLWELLTGKLPYEFLTPLQAAVGVVQK 503
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474826|ref|XP_002280985.2| PREDICTED: uncharacterized mscS family protein At1g78610-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 810 bits (2091), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/547 (75%), Positives = 449/547 (82%), Gaps = 54/547 (9%)
Query: 1 MVMEENNNESCGSRASDTSSTSSPPPQHQSRQHRQKLGVYNEVLGRLKESNNDEAIQPRF 60
MVME +NESC SR D+SS + QSRQ RQKL VYNEVL RLK+S+N+EA +P F
Sbjct: 1 MVME--DNESCSSRVHDSSSPA------QSRQQRQKLEVYNEVLRRLKDSDNEEAFEPGF 52
Query: 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQ-------- 112
D+ELW HF RLPTRYALDVNVERAEDVL HKRLLHLAHDP NRPAIEVRLVQ
Sbjct: 53 DEELWAHFVRLPTRYALDVNVERAEDVLTHKRLLHLAHDPTNRPAIEVRLVQFGKFDVSH 112
Query: 113 ---------------------VHPVSDR-NSAVSSLLDSEVP-----------AQRQSIH 139
VHP+SD + ++ + S P + +QSI
Sbjct: 113 KRYVRCGWALRQGKRNIISLTVHPISDGIHGNIADSIHSNSPTIGPAHGSPKYSSKQSIL 172
Query: 140 PPPAFGSSPNLEALAIEANNSH--NLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLT 197
PPPAFGSSPNLEALAIEANNSH + DGD+SVHA+ S+PMHEITFS+DDKPKLLSQLT
Sbjct: 173 PPPAFGSSPNLEALAIEANNSHVQDGDGDDSVHAS---SQPMHEITFSSDDKPKLLSQLT 229
Query: 198 ALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLKLERQGWPSHR 257
LL+++ LNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLR ALEKEV K+E+Q WP+H
Sbjct: 230 CLLSELELNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRTALEKEVFKIEKQSWPNHH 289
Query: 258 SSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD 317
S SPT E E+TG+K + IPNDGTDVWEID + LKF +KVASGSYGDLY+GTYCSQ+
Sbjct: 290 SLSPTGEQEETGIKCESDFVTIPNDGTDVWEIDVRQLKFENKVASGSYGDLYKGTYCSQE 349
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
VAIKVLKPER+NSDMQKEFAQEVFIMRKVRHKNVVQFIGACT+PPSL IVTEFMSGGSVY
Sbjct: 350 VAIKVLKPERLNSDMQKEFAQEVFIMRKVRHKNVVQFIGACTRPPSLYIVTEFMSGGSVY 409
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437
DYLHK KGVFKLP+LLKV+IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA
Sbjct: 410 DYLHKQKGVFKLPALLKVSIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 469
Query: 438 RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 497
RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA
Sbjct: 470 RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 529
Query: 498 AVGVVQK 504
AVGVVQK
Sbjct: 530 AVGVVQK 536
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|283132359|dbj|BAI63585.1| ACT-domain-containing protein kinase [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 787 bits (2033), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/501 (77%), Positives = 429/501 (85%), Gaps = 13/501 (2%)
Query: 16 SDTSSTS---SPPPQHQSRQHRQKLGVYNEVLGRLKESNNDEAIQPRFDDELWTHFNRLP 72
+DTS TS + P Q+RQHR K+ VYNE+L RL +S N EA+QP F D+LW HFNRLP
Sbjct: 9 NDTSGTSNHRATPSPSQTRQHRHKVEVYNEILRRLNDSGNPEALQPGFHDQLWAHFNRLP 68
Query: 73 TRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRNSAVSSLLDS--- 129
RYALDVNVERA DVLMHKRLLHLAHDP NRP+IEVRLVQVHP SD NSA S DS
Sbjct: 69 ARYALDVNVERAADVLMHKRLLHLAHDPANRPSIEVRLVQVHPTSDGNSADSFHSDSPGT 128
Query: 130 ------EVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEIT 183
+ RQSIHPPPAFGSSPNLEALA+E NNS ++D + SVHA+VQ+SRPMHEIT
Sbjct: 129 ESGQSSSKYSSRQSIHPPPAFGSSPNLEALALEENNSEDID-ERSVHASVQYSRPMHEIT 187
Query: 184 FSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEK 243
FST+DKPKLLSQLTALLA+IGLNIQEAHAFST DGYSLDVFVVDGWPYEETE+L+ ALEK
Sbjct: 188 FSTEDKPKLLSQLTALLAEIGLNIQEAHAFSTSDGYSLDVFVVDGWPYEETEKLKVALEK 247
Query: 244 EVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASG 303
E+LK+ERQ + +S S EP+ MK HL IPNDGTDVWEID KHL +G+++ASG
Sbjct: 248 EILKIERQARSNQQSVSSADEPDQARMKHEQDHLTIPNDGTDVWEIDAKHLTYGNQIASG 307
Query: 304 SYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363
SYG+L++GTYCSQ+VAIKVLK E +N++MQ+EF QEV+IMRKVRHKNVVQFIGACTKPP
Sbjct: 308 SYGELFKGTYCSQEVAIKVLKGEHVNAEMQREFVQEVYIMRKVRHKNVVQFIGACTKPPR 367
Query: 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
LCI+TEFMSGGSVYDYLHK KG FK PSLLKVAIDVSKGMNYLHQ+NIIHRDLK ANLLM
Sbjct: 368 LCIITEFMSGGSVYDYLHKQKGFFKFPSLLKVAIDVSKGMNYLHQHNIIHRDLKGANLLM 427
Query: 424 DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELL 483
DEN VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFG+VLWELL
Sbjct: 428 DENGVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGVVLWELL 487
Query: 484 TGKLPYEYLTPLQAAVGVVQK 504
TGKLPYEYLTPLQAA+GVVQK
Sbjct: 488 TGKLPYEYLTPLQAAIGVVQK 508
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255560441|ref|XP_002521235.1| protein kinase, putative [Ricinus communis] gi|223539503|gb|EEF41091.1| protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 777 bits (2007), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/509 (77%), Positives = 431/509 (84%), Gaps = 27/509 (5%)
Query: 1 MVMEENNNESCGSRASDTSSTSSPPPQHQSRQHRQKLGVYNEVLGRLKESNNDEAIQPRF 60
MV+ NESCGSR D++++S P H R RQKL VYNEVL RLKESNN+EA QP F
Sbjct: 1 MVVMMEENESCGSRVQDSTTSSPSP-SHAGRNQRQKLEVYNEVLRRLKESNNEEANQPGF 59
Query: 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRN 120
DDELW+HF+RLPTRYALDVNVERAEDVLMHKRLL LAHDP NRPAIE+RLVQV PVSD N
Sbjct: 60 DDELWSHFHRLPTRYALDVNVERAEDVLMHKRLLQLAHDPDNRPAIEIRLVQVPPVSDGN 119
Query: 121 SAVSSLLDS----EVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLD-GDNSVHANVQF 175
SA S L S + + R+SIHPPPAFGSSPNLEALA+EA N G++ + ++Q
Sbjct: 120 SADSDLSGSPRKGDTQSNRKSIHPPPAFGSSPNLEALALEAINPKMXXLGNSDLLYHLQ- 178
Query: 176 SRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETE 235
PMHEITFSTDDKPKLLSQLT+LLA+IGLNIQEAHAFSTVDGYSLDVFVVDGWPYE
Sbjct: 179 --PMHEITFSTDDKPKLLSQLTSLLAEIGLNIQEAHAFSTVDGYSLDVFVVDGWPYE--- 233
Query: 236 QLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLK 295
+ WP+ S SP+SE + T +K P H+ IPNDGTDVWEIDPK+LK
Sbjct: 234 --------------KHTWPT-LSLSPSSEHKQTKIKCDPDHVTIPNDGTDVWEIDPKNLK 278
Query: 296 FGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 355
F +KVASGSYGDLY+GTYCSQ+VAIK+LKPERINSD++KEFAQEVFIMRKVRHKNVVQFI
Sbjct: 279 FENKVASGSYGDLYKGTYCSQEVAIKILKPERINSDLEKEFAQEVFIMRKVRHKNVVQFI 338
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
GACTKPPSLCIVTEFMSGGSVYDYLHK KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD
Sbjct: 339 GACTKPPSLCIVTEFMSGGSVYDYLHKQKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 398
Query: 416 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 475
LKAANLLMDENEVVKVADFGVARVKAQ+GVMTAETGTYRWMAPEVIEHKPYDHKAD+FSF
Sbjct: 399 LKAANLLMDENEVVKVADFGVARVKAQTGVMTAETGTYRWMAPEVIEHKPYDHKADIFSF 458
Query: 476 GIVLWELLTGKLPYEYLTPLQAAVGVVQK 504
IVLWELLTGKLPYEYLTPLQAAVGVVQK
Sbjct: 459 AIVLWELLTGKLPYEYLTPLQAAVGVVQK 487
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357444821|ref|XP_003592688.1| Protein kinase like protein [Medicago truncatula] gi|355481736|gb|AES62939.1| Protein kinase like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 777 bits (2006), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/507 (75%), Positives = 433/507 (85%), Gaps = 12/507 (2%)
Query: 7 NNESCGSRASDTSSTSSPPPQHQSRQHRQKLGVYNEVLGRLKESNNDEAIQPRFDDELWT 66
+NESCGS +S+S P QSRQ RQK+ VYNE+L RLK+S N+EA+QP FDD+LW
Sbjct: 8 DNESCGSGIHHRTSSSIPA---QSRQQRQKVEVYNEILRRLKDSGNEEAMQPGFDDQLWN 64
Query: 67 HFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRNSA---- 122
HFNRLP+RYALDVNVERAEDVLMHKRLLHLAHDP NRP+IEV LVQ+HP SD NSA
Sbjct: 65 HFNRLPSRYALDVNVERAEDVLMHKRLLHLAHDPANRPSIEVHLVQLHPSSDGNSADSFQ 124
Query: 123 -----VSSLLDSEVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSR 177
V S S + +Q I PPPAFGSSPNLEALA+E N+S +L+ + SVHA+VQ+SR
Sbjct: 125 SCAPGVDSGQSSSKYSSKQGILPPPAFGSSPNLEALALEENDSEDLEEEQSVHASVQYSR 184
Query: 178 PMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQL 237
PMHEIT STDDKPKLLSQLTALLA++GLNIQEAHAFST DG+SLDVFVV+GWPYEETE+L
Sbjct: 185 PMHEITVSTDDKPKLLSQLTALLAEVGLNIQEAHAFSTTDGFSLDVFVVEGWPYEETEKL 244
Query: 238 RAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFG 297
+ LEKEVLK+ER S +S S E + + MK+ IPNDGTDVWEIDPKHLK+G
Sbjct: 245 KETLEKEVLKIERGERSSQQSVSSVDECDQSRMKNELDRFTIPNDGTDVWEIDPKHLKYG 304
Query: 298 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357
+++AS SYG+LY+G YCSQ+VAIKVLK E ++S+MQKEFAQEV+IMRKVRHKNVVQF+GA
Sbjct: 305 TQIASASYGELYKGIYCSQEVAIKVLKAEHVSSEMQKEFAQEVYIMRKVRHKNVVQFMGA 364
Query: 358 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 417
CT+PP LCIVTEFMSGGSVYDYLHK KG FK P++LKVAIDVSKGMNYLHQ+NIIHRDLK
Sbjct: 365 CTQPPRLCIVTEFMSGGSVYDYLHKQKGFFKFPTVLKVAIDVSKGMNYLHQHNIIHRDLK 424
Query: 418 AANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGI 477
AANLLMDEN VVKVADFGVARV+AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFG+
Sbjct: 425 AANLLMDENGVVKVADFGVARVRAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGV 484
Query: 478 VLWELLTGKLPYEYLTPLQAAVGVVQK 504
VLWELLTGKLPYE+LTPLQAA+GVVQK
Sbjct: 485 VLWELLTGKLPYEFLTPLQAAIGVVQK 511
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574129|ref|XP_003555204.1| PREDICTED: uncharacterized protein LOC100804170 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 768 bits (1984), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/516 (74%), Positives = 435/516 (84%), Gaps = 17/516 (3%)
Query: 2 VMEENNNESCGSRAS-DTSSTSSPPPQHQSRQHRQKLGVYNEVLGRLKESNNDEAIQPRF 60
++ E NN SCGS + +TSS QSR RQKL VYNE+L RLK+S N+EA+QP F
Sbjct: 1 MLTEGNNSSCGSGSGVQHHTTSSSSSPAQSRLQRQKLEVYNEILRRLKDSGNEEAMQPGF 60
Query: 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRN 120
D+LW HFNRLPT YALDVNVERA DVLMHKRLLHLAHDP NRP+IEVRLVQVHP S+ N
Sbjct: 61 HDQLWAHFNRLPTWYALDVNVERAADVLMHKRLLHLAHDPANRPSIEVRLVQVHPTSNGN 120
Query: 121 SAVSSLLDSEVPA-----------QRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSV 169
SA +S+ P RQSIHPPPAFGSSPNLEALA+EANNS +++ + S
Sbjct: 121 SA--DTFESDDPGIESGQSSSKYSSRQSIHPPPAFGSSPNLEALALEANNSEDIEEEQSA 178
Query: 170 HANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGW 229
HANVQ+SR MHEIT STDDKPKLLSQLTALL++IGLNIQEAHAFST DG+SLDVFVV+GW
Sbjct: 179 HANVQYSRHMHEITISTDDKPKLLSQLTALLSEIGLNIQEAHAFSTTDGFSLDVFVVEGW 238
Query: 230 PYEETEQLRAALEKEVL-KLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWE 288
P+EETE+L+AALE+ VL K+E + P +S S +P+ MKS +L IP DGTDVWE
Sbjct: 239 PHEETEKLKAALERGVLKKIEVKSSP--QSVSSVDKPDQAKMKSELDYLTIPTDGTDVWE 296
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 348
IDPKHLK+G+++ASGSYG+L++G YCSQ+VAIKVLK + +NS++Q+EFAQEV+IMRKVRH
Sbjct: 297 IDPKHLKYGTQIASGSYGELFKGVYCSQEVAIKVLKADHVNSELQREFAQEVYIMRKVRH 356
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
KNVVQFIGACTKPP LCIVTEFMSGGSVYDYLHK KG FK P+LLKVAIDVSKGMNYLHQ
Sbjct: 357 KNVVQFIGACTKPPGLCIVTEFMSGGSVYDYLHKQKGFFKFPTLLKVAIDVSKGMNYLHQ 416
Query: 409 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 468
+NIIHRDLKAANLLMDEN VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH
Sbjct: 417 HNIIHRDLKAANLLMDENCTVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 476
Query: 469 KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504
KADVFSFGIVLWELLTGKLPYEYLTPLQAA+GVVQK
Sbjct: 477 KADVFSFGIVLWELLTGKLPYEYLTPLQAAIGVVQK 512
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18420244|ref|NP_568041.1| ACT-like protein tyrosine kinase family protein [Arabidopsis thaliana] gi|332661531|gb|AEE86931.1| ACT-like protein tyrosine kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 748 bits (1931), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/513 (74%), Positives = 428/513 (83%), Gaps = 22/513 (4%)
Query: 1 MVMEENNNESCGSRA-SDTSSTSSPPPQHQSRQHRQKLGVYNEVLGRLKESNNDEAIQPR 59
MVME +NESC SR D TS R+ R K+ V++EVL RL++S+ ++A P
Sbjct: 1 MVME--DNESCASRVIFDALPTSQAT---MDRRERIKMEVFDEVLRRLRQSDIEDAHLPG 55
Query: 60 FDDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDR 119
F+D+LW HFNRLP RYALDVNVERAEDVLMHKRLLH A+DP+NRPAIEV LVQV P
Sbjct: 56 FEDDLWNHFNRLPARYALDVNVERAEDVLMHKRLLHSAYDPQNRPAIEVHLVQVQP---- 111
Query: 120 NSAVSSLLDS------EVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANV 173
+ +S+ LDS R+SIHPPPAFGSSPNLEALA+ A+ S + D DNSVH N
Sbjct: 112 -AGISADLDSTSNDAGHSSPTRKSIHPPPAFGSSPNLEALALAASLSQDEDADNSVHNNS 170
Query: 174 QFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEE 233
+SRP+HEITFST+DKPKLL QLTALLA++GLNIQEAHAFST DGYSLDVFVVDGWPYEE
Sbjct: 171 LYSRPLHEITFSTEDKPKLLFQLTALLAELGLNIQEAHAFSTTDGYSLDVFVVDGWPYEE 230
Query: 234 TEQLRAALEKEVLKLE--RQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDP 291
TE+LR +LEKE K+E Q WP +S SP E TG ++H + IPNDGTDVWEI+
Sbjct: 231 TERLRISLEKEAAKIELQSQSWPMQQSFSPEKENGQTGARTH---VPIPNDGTDVWEINL 287
Query: 292 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 351
KHLKFG K+ASGSYGDLY+GTYCSQ+VAIKVLKPER++SD++KEFAQEVFIMRKVRHKNV
Sbjct: 288 KHLKFGHKIASGSYGDLYKGTYCSQEVAIKVLKPERLDSDLEKEFAQEVFIMRKVRHKNV 347
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
VQFIGACTKPP LCIVTEFM GGSVYDYLHK KGVFKLP+L KVAID+ KGM+YLHQNNI
Sbjct: 348 VQFIGACTKPPHLCIVTEFMPGGSVYDYLHKQKGVFKLPTLFKVAIDICKGMSYLHQNNI 407
Query: 412 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKAD 471
IHRDLKAANLLMDENEVVKVADFGVARVKAQ+GVMTAETGTYRWMAPEVIEHKPYDHKAD
Sbjct: 408 IHRDLKAANLLMDENEVVKVADFGVARVKAQTGVMTAETGTYRWMAPEVIEHKPYDHKAD 467
Query: 472 VFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504
VFS+GIVLWELLTGKLPYEY+TPLQAAVGVVQK
Sbjct: 468 VFSYGIVLWELLTGKLPYEYMTPLQAAVGVVQK 500
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297797832|ref|XP_002866800.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297312636|gb|EFH43059.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 740 bits (1911), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/501 (74%), Positives = 422/501 (84%), Gaps = 17/501 (3%)
Query: 8 NESCGSRASDTSSTSSPPPQHQSRQHRQKLGVYNEVLGRLKESNNDEAIQPRFDDELWTH 67
NESC SR +S S R+ R K+ V++EVL RL++S+ +A P F+DELWTH
Sbjct: 3 NESCASRLILDASQSKAT---MDRRERIKMEVFDEVLRRLRQSDIQDAHLPGFEDELWTH 59
Query: 68 FNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSD--RNSAVSS 125
FNRLP RYALDVNVERAEDVLMHKRLLH A+DP+NRPAI+V LVQV P ++A+SS
Sbjct: 60 FNRLPARYALDVNVERAEDVLMHKRLLHSAYDPQNRPAIDVHLVQVQPADSPTYDAALSS 119
Query: 126 LLDSEVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFS 185
R+SIHPPPAFGSSPNLEALA+ A+ S + DGDNSVH N +SRP+HEITFS
Sbjct: 120 -------PTRKSIHPPPAFGSSPNLEALALAASISQDHDGDNSVHNNSLYSRPLHEITFS 172
Query: 186 TDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEV 245
T DKPKLL QLTALLA++GLNIQEAHAFST DGYSLDVFVVDGWPYEET++LR +LEKE
Sbjct: 173 TQDKPKLLLQLTALLAELGLNIQEAHAFSTTDGYSLDVFVVDGWPYEETDRLRISLEKEA 232
Query: 246 LKLE--RQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASG 303
K+E Q WP +S SP E TG ++H + IPNDGTDVWEI+ KHLKFG K+ASG
Sbjct: 233 AKIELQSQSWPMQQSFSPEKENGQTGARTH---VPIPNDGTDVWEINLKHLKFGHKIASG 289
Query: 304 SYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363
SYGDLY+GTYCSQ+VAIKVLKPER++S+++KEFAQEVFIMRKVRHKNVVQFIGACTKPP
Sbjct: 290 SYGDLYKGTYCSQEVAIKVLKPERLDSELEKEFAQEVFIMRKVRHKNVVQFIGACTKPPH 349
Query: 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
LCIVTEFM GGSVYDYLHK KGVFKLP+L KVAID+ KGM+YLHQNNIIHRDLKAANLLM
Sbjct: 350 LCIVTEFMPGGSVYDYLHKQKGVFKLPTLFKVAIDICKGMSYLHQNNIIHRDLKAANLLM 409
Query: 424 DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELL 483
DENEVVKVADFGVARVKAQ+GVMTAETGTYRWMAPEVIEHKPYDHKADVFS+GIVLWELL
Sbjct: 410 DENEVVKVADFGVARVKAQTGVMTAETGTYRWMAPEVIEHKPYDHKADVFSYGIVLWELL 469
Query: 484 TGKLPYEYLTPLQAAVGVVQK 504
TGKLPYEY+TPLQAAVGVVQK
Sbjct: 470 TGKLPYEYMTPLQAAVGVVQK 490
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|217074650|gb|ACJ85685.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 725 bits (1872), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 358/510 (70%), Positives = 416/510 (81%), Gaps = 18/510 (3%)
Query: 5 ENNNESCGSRASDTSSTSSPPPQHQSRQHRQKLGVYNEVLGRLKESNNDEAIQPRFDDEL 64
EN+ ESCGSRA S ++P R HRQKL VYNEVL R+++S+ ++A+ P FDD+L
Sbjct: 4 ENDIESCGSRA--VQSHANP------RHHRQKLEVYNEVLRRIQDSDCEDALVPGFDDQL 55
Query: 65 WTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRN---S 121
W HFNRLP RYALDVNVERAEDVL HKRLL LA DP NRPA +VRLVQV+P + N S
Sbjct: 56 WLHFNRLPARYALDVNVERAEDVLAHKRLLELAEDPANRPAFQVRLVQVYPFAGANHNDS 115
Query: 122 AVSSLLDSEVPAQ-------RQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQ 174
+V S + AQ +Q IHPPP FGSS NLEALA+ N ++ DGDN++
Sbjct: 116 SVHSDPSEKDDAQSSLNYSLKQGIHPPPTFGSSSNLEALALHTNKNNIEDGDNTMGVTPN 175
Query: 175 FSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEET 234
F+RPMHEITFST DKPKLLSQLT++L +IGLNIQEAHAFST DG+SLDVFVV+GWP EET
Sbjct: 176 FNRPMHEITFSTIDKPKLLSQLTSILGEIGLNIQEAHAFSTSDGFSLDVFVVEGWPNEET 235
Query: 235 EQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHL 294
E+L+ LEKE+LK++ Q + + +++ T M+S P ++IP DG DVWEIDP L
Sbjct: 236 EELKGVLEKEILKVKDQYLSNQGTLYSSNDQYQTRMESSPDCIQIPFDGADVWEIDPSQL 295
Query: 295 KFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 354
K+ +KV SGS+GDL+RG+YCSQDVAIKVLKPERI++DM KEFAQEV+IMRK+RHKNVVQF
Sbjct: 296 KYENKVGSGSFGDLFRGSYCSQDVAIKVLKPERISTDMLKEFAQEVYIMRKIRHKNVVQF 355
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
IGACT+PP+LCIVTEFMS GS+YD+LH+ KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR
Sbjct: 356 IGACTRPPNLCIVTEFMSRGSLYDFLHRQKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 415
Query: 415 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 474
DLK ANLLMDENE+VKVADFGVARV+ QSGVMTAETGTYRWMAPEVIEHKPYD KADVFS
Sbjct: 416 DLKTANLLMDENELVKVADFGVARVQTQSGVMTAETGTYRWMAPEVIEHKPYDQKADVFS 475
Query: 475 FGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504
FGI LWELLTG+LPY YLTPLQAAVGVVQK
Sbjct: 476 FGIALWELLTGELPYSYLTPLQAAVGVVQK 505
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 518 | ||||||
| TAIR|locus:2121154 | 575 | STY46 "serine/threonine/tyrosi | 0.957 | 0.862 | 0.738 | 2.9e-197 | |
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.957 | 0.870 | 0.658 | 7.2e-171 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.947 | 0.899 | 0.647 | 3.1e-163 | |
| TAIR|locus:2126311 | 412 | AT4G31170 [Arabidopsis thalian | 0.434 | 0.546 | 0.497 | 1.1e-57 | |
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.438 | 0.552 | 0.489 | 1.4e-57 | |
| DICTYBASE|DDB_G0267514 | 916 | DDB_G0267514 "protein kinase, | 0.424 | 0.240 | 0.436 | 1.7e-51 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.498 | 0.337 | 0.410 | 2.6e-50 | |
| TAIR|locus:2180992 | 333 | AT5G01850 [Arabidopsis thalian | 0.440 | 0.684 | 0.454 | 5.2e-49 | |
| TAIR|locus:2084314 | 773 | AT3G06620 [Arabidopsis thalian | 0.492 | 0.329 | 0.404 | 7.4e-49 | |
| TAIR|locus:2154573 | 525 | AT5G58950 [Arabidopsis thalian | 0.430 | 0.424 | 0.413 | 8.5e-49 |
| TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1910 (677.4 bits), Expect = 2.9e-197, P = 2.9e-197
Identities = 375/508 (73%), Positives = 421/508 (82%)
Query: 1 MVMEENNNESCGSRASDXXXXXXXXXXXXXXXXXXKLGVYNEVLGRLKESNNDEAIQPRF 60
MVME+N ESC SR K+ V++EVL RL++S+ ++A P F
Sbjct: 1 MVMEDN--ESCASRV--IFDALPTSQATMDRRERIKMEVFDEVLRRLRQSDIEDAHLPGF 56
Query: 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHP--VSD 118
+D+LW HFNRLP RYALDVNVERAEDVLMHKRLLH A+DP+NRPAIEV LVQV P +S
Sbjct: 57 EDDLWNHFNRLPARYALDVNVERAEDVLMHKRLLHSAYDPQNRPAIEVHLVQVQPAGISA 116
Query: 119 RNSAVSSLLDSEVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRP 178
+ S+ P R+SIHPPPAFGSSPNLEALA+ A+ S + D DNSVH N +SRP
Sbjct: 117 DLDSTSNDAGHSSPT-RKSIHPPPAFGSSPNLEALALAASLSQDEDADNSVHNNSLYSRP 175
Query: 179 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLR 238
+HEITFST+DKPKLL QLTALLA++GLNIQEAHAFST DGYSLDVFVVDGWPYEETE+LR
Sbjct: 176 LHEITFSTEDKPKLLFQLTALLAELGLNIQEAHAFSTTDGYSLDVFVVDGWPYEETERLR 235
Query: 239 AALEKEVLKLE--RQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKF 296
+LEKE K+E Q WP +S SP E TG ++H + IPNDGTDVWEI+ KHLKF
Sbjct: 236 ISLEKEAAKIELQSQSWPMQQSFSPEKENGQTGARTH---VPIPNDGTDVWEINLKHLKF 292
Query: 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
G K+ASGSYGDLY+GTYCSQ+VAIKVLKPER++SD++KEFAQEVFIMRKVRHKNVVQFIG
Sbjct: 293 GHKIASGSYGDLYKGTYCSQEVAIKVLKPERLDSDLEKEFAQEVFIMRKVRHKNVVQFIG 352
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
ACTKPP LCIVTEFM GGSVYDYLHK KGVFKLP+L KVAID+ KGM+YLHQNNIIHRDL
Sbjct: 353 ACTKPPHLCIVTEFMPGGSVYDYLHKQKGVFKLPTLFKVAIDICKGMSYLHQNNIIHRDL 412
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFG 476
KAANLLMDENEVVKVADFGVARVKAQ+GVMTAETGTYRWMAPEVIEHKPYDHKADVFS+G
Sbjct: 413 KAANLLMDENEVVKVADFGVARVKAQTGVMTAETGTYRWMAPEVIEHKPYDHKADVFSYG 472
Query: 477 IVLWELLTGKLPYEYLTPLQAAVGVVQK 504
IVLWELLTGKLPYEY+TPLQAAVGVVQK
Sbjct: 473 IVLWELLTGKLPYEYMTPLQAAVGVVQK 500
|
|
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1661 (589.8 bits), Expect = 7.2e-171, P = 7.2e-171
Identities = 336/510 (65%), Positives = 385/510 (75%)
Query: 1 MVMEENNNESCGSRASDXXXXXXXXXXXXXXXXXXKLGVYNEVLGRLKESNNDEAIQPRF 60
M ++E ESCGSRA KL VY EVL R++ESN +EA P F
Sbjct: 1 MAIKEETEESCGSRA-----VVASITKESPRQHRMKLEVYGEVLQRIQESNYEEANFPGF 55
Query: 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRN 120
DD LW HFNRLP RYALDVNVERAEDVL H+RLL LA DP RP EVR VQV P + N
Sbjct: 56 DDLLWLHFNRLPARYALDVNVERAEDVLTHQRLLKLAEDPATRPVFEVRCVQVSPTLNGN 115
Query: 121 SAVSSLLDSEVPAQRQSIH-----PPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQF 175
S D V QS + PP FGSSPN EAL +A H D D++V+A +
Sbjct: 116 SGDVDPSDPAVNEDAQSSYNSRSLAPPTFGSSPNFEALT-QAYKDHAQDDDSAVNAQLPN 174
Query: 176 SRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETE 235
SRPMHEITFST D+PKLLSQLT++L ++GLNIQEAHAFST DG+SLDVFVVDGW EETE
Sbjct: 175 SRPMHEITFSTIDRPKLLSQLTSMLGELGLNIQEAHAFSTADGFSLDVFVVDGWSQEETE 234
Query: 236 QLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSH-PYHLKIPNDGTDVWEIDPKHL 294
L+ AL+KE+ K + Q P + S T D P ++IP DGTD WEID K L
Sbjct: 235 GLKDALKKEIRKFKDQ--PCSKQKSITFFEHDKSTNELLPACVEIPTDGTDEWEIDMKQL 292
Query: 295 KFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 354
K KVA GSYG+L+RGTYCSQ+VAIK+LKPER+N++M +EF+QEV+IMRKVRHKNVVQF
Sbjct: 293 KIEKKVACGSYGELFRGTYCSQEVAIKILKPERVNAEMLREFSQEVYIMRKVRHKNVVQF 352
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
IGACT+ P+LCIVTEFM+ GS+YD+LHK KGVFK+ SLLKVA+DVSKGMNYLHQNNIIHR
Sbjct: 353 IGACTRSPNLCIVTEFMTRGSIYDFLHKHKGVFKIQSLLKVALDVSKGMNYLHQNNIIHR 412
Query: 415 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 474
DLK ANLLMDE+EVVKVADFGVARV+ +SGVMTAETGTYRWMAPEVIEHKPYDH+ADVFS
Sbjct: 413 DLKTANLLMDEHEVVKVADFGVARVQTESGVMTAETGTYRWMAPEVIEHKPYDHRADVFS 472
Query: 475 FGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504
+ IVLWELLTG+LPY YLTPLQAAVGVVQK
Sbjct: 473 YAIVLWELLTGELPYSYLTPLQAAVGVVQK 502
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1589 (564.4 bits), Expect = 3.1e-163, P = 3.1e-163
Identities = 325/502 (64%), Positives = 381/502 (75%)
Query: 5 ENNNESCGSRASDXXXXXXXXXXXXXXXXXXKLGVYNEVLGRLKESNNDEAIQPRFDDEL 64
++ +ESCGSRA KL VY+EVL RL+ESN +EA P F+D+L
Sbjct: 4 KDESESCGSRA-----VVASPSQENPRHYRMKLDVYSEVLQRLQESNYEEATLPDFEDQL 58
Query: 65 WTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHP-VS-DRNSA 122
W HFNRLP RYALDV VERAEDVL H+RLL LA DP RP EVR VQV P +S D + A
Sbjct: 59 WLHFNRLPARYALDVKVERAEDVLTHQRLLKLAADPATRPVFEVRSVQVSPRISADSDPA 118
Query: 123 VSSLLDSEVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEI 182
V S + PP FGSSPN EA I + D D+ V+A + +RPMHEI
Sbjct: 119 VEEDAQSSHQPSGPGVLAPPTFGSSPNFEA--ITQGSKIVEDVDSVVNATLS-TRPMHEI 175
Query: 183 TFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALE 242
TFST DKPKLLSQLT+LL ++GLNIQEAHAFSTVDG+SLDVFVVDGW EET+ LR AL
Sbjct: 176 TFSTIDKPKLLSQLTSLLGELGLNIQEAHAFSTVDGFSLDVFVVDGWSQEETDGLRDALS 235
Query: 243 KEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVAS 302
KE+LKL+ Q +S S E + + + P ++IP DGTD WEID LK KVAS
Sbjct: 236 KEILKLKDQPGSKQKSIS-FFEHDKSSNELIPACIEIPTDGTDEWEIDVTQLKIEKKVAS 294
Query: 303 GSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362
GSYGDL+RGTYCSQ+VAIK LKP+R+N++M +EF+QEVFIMRKVRHKNVVQF+GACT+ P
Sbjct: 295 GSYGDLHRGTYCSQEVAIKFLKPDRVNNEMLREFSQEVFIMRKVRHKNVVQFLGACTRSP 354
Query: 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 422
+LCIVTEFM+ GS+YD+LHK K FKL +LLKVA+DV+KGM+YLHQNNIIHRDLK ANLL
Sbjct: 355 TLCIVTEFMARGSIYDFLHKQKCAFKLQTLLKVALDVAKGMSYLHQNNIIHRDLKTANLL 414
Query: 423 MDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWEL 482
MDE+ +VKVADFGVARV+ +SGVMTAETGTYRWMAPEVIEHKPY+HKADVFS+ IVLWEL
Sbjct: 415 MDEHGLVKVADFGVARVQIESGVMTAETGTYRWMAPEVIEHKPYNHKADVFSYAIVLWEL 474
Query: 483 LTGKLPYEYLTPLQAAVGVVQK 504
LTG +PY +LTPLQAAVGVVQK
Sbjct: 475 LTGDIPYAFLTPLQAAVGVVQK 496
|
|
| TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 593 (213.8 bits), Expect = 1.1e-57, P = 1.1e-57
Identities = 118/237 (49%), Positives = 165/237 (69%)
Query: 278 KIPNDGT---DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLK-----PERIN 329
K P +G + W ID + L G A G++G LYRGTY +DVAIK+L+ PE+
Sbjct: 112 KYPTEGLVNYEEWTIDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLERSDSNPEKAQ 171
Query: 330 SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL 389
+ ++++F QEV ++ ++H N+V+FIGAC KP CIVTE+ GGSV +L K + +
Sbjct: 172 A-LEQQFQQEVSMLAFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNR-AV 229
Query: 390 PSLLKV--AIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT 447
P L V A+DV++GM Y+H+ N IHRDLK+ NLL+ + +K+ADFGVAR++ Q+ MT
Sbjct: 230 PLKLAVMQALDVARGMAYVHERNFIHRDLKSDNLLISADRSIKIADFGVARIEVQTEGMT 289
Query: 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504
ETGTYRWMAPE+I+H+PY K DV+SFGIVLWEL+TG LP++ +T +QAA VV +
Sbjct: 290 PETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNR 346
|
|
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 592 (213.5 bits), Expect = 1.4e-57, P = 1.4e-57
Identities = 115/235 (48%), Positives = 162/235 (68%)
Query: 278 KIPNDGT---DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVL-KPERINSD-- 331
+ P +G D W ID + L G A G++G LY+GTY +DVAIK+L +PE
Sbjct: 111 RYPTEGLTNYDEWTIDLRKLNMGPAFAQGAFGKLYKGTYNGEDVAIKILERPENSPEKAQ 170
Query: 332 -MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKL 389
M+++F QEV ++ ++H N+V+FIGAC KP CIVTE+ GGSV +L + + L
Sbjct: 171 FMEQQFQQEVSMLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 230
Query: 390 PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 449
+K A+DV++GM Y+H N IHRDLK+ NLL+ ++ +K+ADFGVAR++ Q+ MT E
Sbjct: 231 KLAVKQALDVARGMAYVHGRNFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE 290
Query: 450 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504
TGTYRWMAPE+I+H+ Y+ K DV+SFGIVLWEL+TG LP++ +T +QAA VV +
Sbjct: 291 TGTYRWMAPEMIQHRAYNQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNR 345
|
|
| DICTYBASE|DDB_G0267514 DDB_G0267514 "protein kinase, TKL group" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 518 (187.4 bits), Expect = 1.7e-51, Sum P(2) = 1.7e-51
Identities = 97/222 (43%), Positives = 151/222 (68%)
Query: 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLK-PERINSDMQKEFAQEVFI 342
+D+ EI LK SK+ G++G +Y+G + VAIK +K E +N+ + +EF +E+ I
Sbjct: 653 SDI-EISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTI 711
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
+ ++RH N+V + ACT PP+LC +TE++ GGS+YD LH K + K+AI +++G
Sbjct: 712 LSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQG 771
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE 462
MNYLH + +IHRD+K+ NLL+DE+ VK+ DFG++++K++S MT G+ WM+PE++
Sbjct: 772 MNYLHLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKSIGSPIWMSPELLM 831
Query: 463 HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504
+ Y K DV++FGI+LWEL TG+LPY L +Q A+ V K
Sbjct: 832 GEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTK 873
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 502 (181.8 bits), Expect = 2.6e-50, Sum P(2) = 2.6e-50
Identities = 110/268 (41%), Positives = 164/268 (61%)
Query: 249 ERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDL 308
E G + S+S S T S + + +D D +EI + L G ++ GS G +
Sbjct: 444 ENMGSVNVNSASSASSCGSTS-SSVMNKVDMDSDCLD-YEILWEDLTIGEQIGQGSCGTV 501
Query: 309 YRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368
Y G + DVA+KV + + ++ F QEV +M+++RH NV+ F+GA P LCIVT
Sbjct: 502 YHGLWFGSDVAVKVFSKQEYSEEIITSFKQEVSLMKRLRHPNVLLFMGAVASPQRLCIVT 561
Query: 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDEN 426
EF+ GS++ L + K L + +A D+++GMNYLH + IIHRDLK++NLL+D N
Sbjct: 562 EFLPRGSLFRLLQRNKSKLDLRRRIHMASDIARGMNYLHHCSPPIIHRDLKSSNLLVDRN 621
Query: 427 EVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK 486
VKVADFG++R+K ++ + T GT +WMAPEV+ ++ D K+DV+SFG+VLWEL+T K
Sbjct: 622 WTVKVADFGLSRIKHETYLTTNGRGTPQWMAPEVLRNEAADEKSDVYSFGVVLWELVTEK 681
Query: 487 LPYEYLTPLQAAVGVVQKVHHSFLEQRL 514
+P+E L +Q +G V F+ QRL
Sbjct: 682 IPWENLNAMQV-IGAV-----GFMNQRL 703
|
|
| TAIR|locus:2180992 AT5G01850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 511 (184.9 bits), Expect = 5.2e-49, P = 5.2e-49
Identities = 111/244 (45%), Positives = 161/244 (65%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVL----KPERINSDMQKEFAQEVFIMR 344
+DPK L GSK+ G++G +Y+G Y Q VAIKV+ KP++ S ++ F +EV +M
Sbjct: 13 VDPKLLFIGSKIGEGAHGKVYQGRYGRQIVAIKVVNRGSKPDQ-QSSLESRFVREVNMMS 71
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGM 403
+V+H N+V+FIGAC K P + IVTE + G S+ YL ++ + LP L A+D+++ +
Sbjct: 72 RVQHHNLVKFIGAC-KDPLMVIVTELLPGMSLRKYLTSIRPQLLHLPLALSFALDIARAL 130
Query: 404 NYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI- 461
+ LH N IIHRDLK NLL+ EN + VK+ADFG+AR ++ + +MTAETGTYRWMAPE+
Sbjct: 131 HCLHANGIIHRDLKPDNLLLTENHKSVKLADFGLAREESVTEMMTAETGTYRWMAPELYS 190
Query: 462 -------EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSFLEQRL 514
E K Y++K DV+SFGIVLWELLT ++P+E ++ LQAA K + + +
Sbjct: 191 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQERPVMPEGI 250
Query: 515 RKSV 518
S+
Sbjct: 251 SPSL 254
|
|
| TAIR|locus:2084314 AT3G06620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 513 (185.6 bits), Expect = 7.4e-49, P = 7.4e-49
Identities = 108/267 (40%), Positives = 168/267 (62%)
Query: 253 WPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDV-WEIDPKHLKFGSKVASGSYGDLYRG 311
W S +++ TS G S K+ D + +EI L G +V GS G +Y G
Sbjct: 452 WSSPINANSTSSASSCGSTSSSVMNKVDTDSEGLEYEILWDDLTIGEQVGQGSCGTVYHG 511
Query: 312 TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371
+ DVA+KV + ++++ + F QEV +M+++RH NV+ F+GA T P LCIV+EF+
Sbjct: 512 LWFGSDVAVKVFSKQEYSAEVIESFKQEVLLMKRLRHPNVLLFMGAVTSPQRLCIVSEFL 571
Query: 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVV 429
GS++ L K + +A+D+++GMNYLH + IIHRDLK++NLL+D+N V
Sbjct: 572 PRGSLFRLLQKSTSKLDWRRRIHMALDIARGMNYLHHCSPPIIHRDLKSSNLLVDKNWTV 631
Query: 430 KVADFGVARVKAQSGVMTAETG--TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKL 487
KVADFG++R+K ++ +T+++G T +WMAPEV+ ++ D K+D++SFG+VLWEL T K+
Sbjct: 632 KVADFGLSRIKHET-YLTSKSGKGTPQWMAPEVLRNESADEKSDIYSFGVVLWELATEKI 690
Query: 488 PYEYLTPLQAAVGVVQKVHHSFLEQRL 514
P+E L +Q +G V F++QRL
Sbjct: 691 PWETLNSMQV-IGAV-----GFMDQRL 711
|
|
| TAIR|locus:2154573 AT5G58950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 509 (184.2 bits), Expect = 8.5e-49, P = 8.5e-49
Identities = 95/230 (41%), Positives = 151/230 (65%)
Query: 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLK-PER-----INSDMQKE 335
+ ++ + +D L FG K A G Y LY G Y + VA+K++ P+ + + ++K+
Sbjct: 195 EASEEFRVDMSKLFFGLKFAHGLYSRLYHGKYEDKAVAVKLITVPDDDDNGCLGARLEKQ 254
Query: 336 FAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLK 394
F +EV ++ ++ H NV++F+GA PP C++T+++ GS+ +LHK + L L++
Sbjct: 255 FTKEVTLLSRLTHPNVIKFVGAYKDPPVYCVLTQYLPEGSLRSFLHKPENRSLPLKKLIE 314
Query: 395 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 454
AID+++GM Y+H IIHRDLK N+L+DE +K+ADFG+A + ++ + GTYR
Sbjct: 315 FAIDIARGMEYIHSRRIIHRDLKPENVLIDEEFHLKIADFGIACEEEYCDMLADDPGTYR 374
Query: 455 WMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504
WMAPE+I+ KP+ KADV+SFG+VLWE++ G +PYE + P+QAA VV K
Sbjct: 375 WMAPEMIKRKPHGRKADVYSFGLVLWEMVAGAIPYEDMNPIQAAFAVVHK 424
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00036186001 | SubName- Full=Chromosome chr3 scaffold_8, whole genome shotgun sequence; (580 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 518 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-76 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-76 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-75 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-67 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-67 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-66 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-60 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-60 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-57 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-56 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-56 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-56 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-53 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-51 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-49 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-49 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-48 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-47 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-47 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-47 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-45 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-45 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-45 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-44 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-44 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-44 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-43 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-43 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-43 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-43 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-42 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-42 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-41 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-41 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-41 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-40 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-40 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-40 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-40 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-39 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-39 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-39 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-39 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-38 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-38 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-37 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-37 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-36 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-36 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-36 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-36 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-36 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-36 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-35 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-35 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-34 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-34 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-34 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-34 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-34 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-33 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-33 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-33 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-32 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-32 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-32 | |
| cd04928 | 68 | cd04928, ACT_TyrKc, Uncharacterized, N-terminal AC | 5e-32 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-32 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-32 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-31 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-31 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-31 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-31 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-31 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-31 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-31 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-31 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-31 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-31 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-30 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-30 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-30 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-30 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-30 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-30 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-29 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-29 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-29 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-29 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-29 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-29 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-29 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-29 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-29 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-28 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-28 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-28 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-28 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-28 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-28 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-28 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-27 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-27 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-27 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-27 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-27 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-27 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-27 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-27 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-27 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-26 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-26 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-26 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-26 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-26 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-26 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-26 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-26 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-26 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-26 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-26 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-26 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-26 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-26 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-26 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-26 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-25 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-25 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-25 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-25 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-25 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-25 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-25 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-25 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-25 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-25 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-24 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-24 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-24 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-24 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-24 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-24 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-24 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-24 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-24 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-24 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-24 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-24 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-23 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-23 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-23 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-23 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-23 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-23 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-23 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-23 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-22 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-22 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-22 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-22 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-21 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-21 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-21 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-21 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-21 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-21 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-20 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-20 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-20 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-20 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-20 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-20 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-20 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-20 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-20 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-19 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-19 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-19 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-19 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-19 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-19 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-19 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-19 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-18 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-18 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-18 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-18 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-18 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-18 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-18 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-18 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-18 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-18 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-18 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-18 | |
| cd04900 | 73 | cd04900, ACT_UUR-like_1, ACT domain family, ACT_UU | 5e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-18 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-18 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-17 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-17 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-17 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-17 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-17 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-17 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-17 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-17 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-17 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-17 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-17 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-16 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-16 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-16 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-16 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-16 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-16 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-16 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-16 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-15 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-15 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-15 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-15 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-14 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-14 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-14 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-14 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-14 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-14 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-14 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-14 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-14 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 8e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-14 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-13 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-12 | |
| cd04873 | 70 | cd04873, ACT_UUR-ACR-like, ACT domains of the bact | 8e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-11 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-11 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-10 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-09 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 9e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-08 | |
| PRK05092 | 931 | PRK05092, PRK05092, PII uridylyl-transferase; Prov | 1e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-06 | |
| cd02116 | 60 | cd02116, ACT, ACT domains are commonly involved in | 1e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-06 | |
| COG2844 | 867 | COG2844, GlnD, UTP:GlnB (protein PII) uridylyltran | 3e-06 | |
| pfam01842 | 66 | pfam01842, ACT, ACT domain | 5e-06 | |
| cd04899 | 70 | cd04899, ACT_ACR-UUR-like_2, C-terminal ACT domain | 6e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-05 | |
| TIGR01693 | 850 | TIGR01693, UTase_glnD, [Protein-PII] uridylyltrans | 3e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-05 | |
| PRK05007 | 884 | PRK05007, PRK05007, PII uridylyl-transferase; Prov | 2e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-04 | |
| PRK00275 | 895 | PRK00275, glnD, PII uridylyl-transferase; Provisio | 8e-04 | |
| PRK03381 | 774 | PRK03381, PRK03381, PII uridylyl-transferase; Prov | 0.002 | |
| PRK03381 | 774 | PRK03381, PRK03381, PII uridylyl-transferase; Prov | 0.002 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.003 | |
| PRK05092 | 931 | PRK05092, PRK05092, PII uridylyl-transferase; Prov | 0.004 | |
| COG2844 | 867 | COG2844, GlnD, UTP:GlnB (protein PII) uridylyltran | 0.004 | |
| TIGR01693 | 850 | TIGR01693, UTase_glnD, [Protein-PII] uridylyltrans | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 241 bits (617), Expect = 1e-76
Identities = 83/221 (37%), Positives = 126/221 (57%), Gaps = 14/221 (6%)
Query: 294 LKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
L G K+ G++G++Y+G +VA+K LK + + +EF +E IMRK+
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-SEQQIEEFLREARIMRKLD 59
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H NVV+ +G CT+ L IV E+M GG + YL K + L LL A+ +++GM YL
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG--TYRWMAPEVIEHKP 465
N IHRDL A N L+ EN VVK++DFG++R G RWMAPE ++
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179
Query: 466 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKV 505
+ K+DV+SFG++LWE+ T G+ PY ++ + V++ +
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE----VLEYL 216
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 240 bits (615), Expect = 3e-76
Identities = 81/214 (37%), Positives = 128/214 (59%), Gaps = 11/214 (5%)
Query: 294 LKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
L+ G K+ G++G++Y+GT VA+K LK + + ++EF +E IM+K+
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEG-ASEEEREEFLEEASIMKKLS 59
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H N+V+ +G CT+ L IVTE+M GG + D+L K L LL++A+ ++KGM YL
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHK 464
N +HRDL A N L+ EN VVK++DFG++R + G +WMAPE ++
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDG 179
Query: 465 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 497
+ K+DV+SFG++LWE+ T G+ PY ++ +
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEV 213
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 237 bits (608), Expect = 3e-75
Identities = 83/214 (38%), Positives = 125/214 (58%), Gaps = 11/214 (5%)
Query: 294 LKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
L G K+ G++G++Y+GT +VA+K LK + + +EF +E IMRK+
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKED-ASEQQIEEFLREARIMRKLD 59
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYL 406
H N+V+ +G CT+ L IV E+M GG + DYL K + L LL A+ +++GM YL
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 407 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG--TYRWMAPEVIEHK 464
N IHRDL A N L+ EN VVK++DFG++R + G RWMAPE ++
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179
Query: 465 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 497
+ K+DV+SFG++LWE+ T G+ PY ++ +
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEV 213
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 217 bits (554), Expect = 3e-67
Identities = 70/198 (35%), Positives = 110/198 (55%), Gaps = 4/198 (2%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ K+ GS+G +Y + VAIKV+K ++I D ++ +E+ I++K++H N+V
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD-RERILREIKILKKLKHPNIV 60
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
+ L +V E+ GG ++D L K +G + + YLH I+
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLHSKGIV 119
Query: 413 HRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADV 472
HRDLK N+L+DE+ VK+ADFG+AR +T GT +MAPEV+ K Y D+
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDI 179
Query: 473 FSFGIVLWELLTGKLPYE 490
+S G++L+ELLTGK P+
Sbjct: 180 WSLGVILYELLTGKPPFP 197
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 216 bits (553), Expect = 5e-67
Identities = 79/200 (39%), Positives = 120/200 (60%), Gaps = 5/200 (2%)
Query: 294 LKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 351
+ K+ SGS+G +Y+ + + VA+K+LK S + +E+ I+R++ H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
V+ I A L +V E+ GG ++DYL + G K+A+ + +G+ YLH N I
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR-GGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 412 IHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVI-EHKPYDHK 469
IHRDLK N+L+DEN VVK+ADFG+A+ +S +T GT +MAPEV+ Y K
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179
Query: 470 ADVFSFGIVLWELLTGKLPY 489
DV+S G++L+ELLTGK P+
Sbjct: 180 VDVWSLGVILYELLTGKPPF 199
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 215 bits (551), Expect = 1e-66
Identities = 80/206 (38%), Positives = 121/206 (58%), Gaps = 18/206 (8%)
Query: 302 SGSYGDLYRGTY-----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
G++G++Y+G + +VA+K LK E + + +K+F +E +M+K+ H NVV+ +G
Sbjct: 5 EGAFGEVYKGKLKGKDGKTTEVAVKTLK-EDASEEERKDFLKEARVMKKLGHPNVVRLLG 63
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--------LLKVAIDVSKGMNYLHQ 408
CT+ L +V E+M GG + DYL K + VF P LL AI ++KGM YL
Sbjct: 64 VCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS 123
Query: 409 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKP 465
+HRDL A N L+ E+ VVK++DFG++R +TG RWMAPE ++
Sbjct: 124 KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGI 183
Query: 466 YDHKADVFSFGIVLWELLT-GKLPYE 490
+ K+DV+SFG++LWE+ T G PY
Sbjct: 184 FTSKSDVWSFGVLLWEIFTLGATPYP 209
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 198 bits (505), Expect = 1e-60
Identities = 65/186 (34%), Positives = 111/186 (59%), Gaps = 6/186 (3%)
Query: 302 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
G +G +Y + VAIK++K E +S ++ E +E+ I++K+ H N+V+ G
Sbjct: 3 EGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLE-ELLREIEILKKLNHPNIVKLYGVFE 61
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
L +V E+ GGS+ D L + +G +L++ + + +G+ YLH N IIHRDLK
Sbjct: 62 DENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPE 121
Query: 420 NLLMDENE-VVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKP-YDHKADVFSFG 476
N+L+D + VK+ADFG+++ + + ++ GT +MAPEV+ K Y K+D++S G
Sbjct: 122 NILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLG 181
Query: 477 IVLWEL 482
++L+EL
Sbjct: 182 VILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 198 bits (507), Expect = 2e-60
Identities = 80/207 (38%), Positives = 122/207 (58%), Gaps = 4/207 (1%)
Query: 293 HLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN 350
+ K+ G +G++Y+ + ++VAIKV+K E + + +++ E+ I++K +H N
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCKHPN 58
Query: 351 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 410
+V++ G+ K L IV EF SGGS+ D L + V ++ KG+ YLH N
Sbjct: 59 IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 411 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 470
IIHRD+KAAN+L+ + VK+ DFG++ + + GT WMAPEVI KPYD+KA
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKA 178
Query: 471 DVFSFGIVLWELLTGKLPYEYLTPLQA 497
D++S GI EL GK PY L P++A
Sbjct: 179 DIWSLGITAIELAEGKPPYSELPPMKA 205
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 192 bits (489), Expect = 1e-57
Identities = 87/228 (38%), Positives = 134/228 (58%), Gaps = 17/228 (7%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
IDP L F ++ SG +G ++ G + + DVAIK+++ ++ D +F +E +M K+
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLS 57
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H N+VQ G CTK + IVTE+M+ G + +YL + KG LL + DV + M YL
Sbjct: 58 HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVAR--VKAQSGVMTAETGT---YRWMAPEVIE 462
N IHRDL A N L+ E+ VVKV+DFG+AR + Q T+ GT +W PEV +
Sbjct: 118 SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPPEVFD 174
Query: 463 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHSF 509
+ + K+DV+SFG+++WE+ + GK+PYE + + VV+ V +
Sbjct: 175 YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE----VVESVSAGY 218
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 3e-56
Identities = 88/229 (38%), Positives = 133/229 (58%), Gaps = 14/229 (6%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
WEID ++ K+ +G +G+++ G + + VA+K LKP ++ K+F E IM+K
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP---KDFLAEAQIMKK 57
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMN 404
+RH ++Q CT + IVTE M GS+ +YL G KLP L+ +A V+ GM
Sbjct: 58 LRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMA 117
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVI 461
YL N IHRDL A N+L+ EN + KVADFG+ARV + + A G +W APE
Sbjct: 118 YLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED-IYEAREGAKFPIKWTAPEAA 176
Query: 462 EHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHSF 509
+ + K+DV+SFGI+L E++T G++PY +T + V+Q+V +
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE----VLQQVDQGY 221
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 3e-56
Identities = 90/222 (40%), Positives = 134/222 (60%), Gaps = 12/222 (5%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
W I+ K LK G+ + G +GD+ G Y Q VA+K LK +S + F E +M +
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKD---DSTAAQAFLAEASVMTTL 57
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNY 405
RH N+VQ +G + L IVTE+M+ GS+ DYL + + V L L A+DV +GM Y
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117
Query: 406 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIEH 463
L + N +HRDL A N+L+ E+ V KV+DFG+A+ +A G ++G +W APE +
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-EASQGQ---DSGKLPVKWTAPEALRE 173
Query: 464 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQK 504
K + K+DV+SFGI+LWE+ + G++PY + PL+ V V+K
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPHVEK 214
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 186 bits (476), Expect = 9e-56
Identities = 69/210 (32%), Positives = 110/210 (52%), Gaps = 8/210 (3%)
Query: 297 GSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 354
G + GS+G +Y +A+K ++ + + + +E+ I+ ++H N+V++
Sbjct: 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 355 IGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
G+ +L I E++SGGS+ L K G P + K + +G+ YLH N I+
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLKK-FGKLPEPVIRKYTRQILEGLAYLHSNGIV 123
Query: 413 HRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET---GTYRWMAPEVIEHKPYDHK 469
HRD+K AN+L+D + VVK+ADFG A+ GT WMAPEVI + Y
Sbjct: 124 HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRA 183
Query: 470 ADVFSFGIVLWELLTGKLPYEYLTPLQAAV 499
AD++S G + E+ TGK P+ L AA+
Sbjct: 184 ADIWSLGCTVIEMATGKPPWSELGNPMAAL 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 1e-53
Identities = 88/214 (41%), Positives = 130/214 (60%), Gaps = 12/214 (5%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKE-FAQEVFIMR 344
WEI + LK K+ +G +G+++ GT+ + VA+K LKP M E F QE IM+
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKP----GTMSPEAFLQEAQIMK 56
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGM 403
K+RH +VQ C++ + IVTE+MS GS+ D+L +G +LP L+ +A +++GM
Sbjct: 57 KLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGM 116
Query: 404 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEV 460
YL N IHRDL A N+L+ EN V K+ADFG+AR+ TA G +W APE
Sbjct: 117 AYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD-EYTAREGAKFPIKWTAPEA 175
Query: 461 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLT 493
+ + K+DV+SFGI+L E++T G++PY +T
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT 209
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 8e-51
Identities = 80/220 (36%), Positives = 123/220 (55%), Gaps = 10/220 (4%)
Query: 293 HLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN 350
+ + G + G++G +Y+G VAIK + E+I + K QE+ +++ ++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 351 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS---KGMNYLH 407
+V++IG+ SL I+ E+ GS+ + K P L VA+ V +G+ YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG---PFPESL-VAVYVYQVLQGLAYLH 116
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPY 466
+ +IHRD+KAAN+L ++ VVK+ADFGVA ++ S + GT WMAPEVIE
Sbjct: 117 EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGA 176
Query: 467 DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVH 506
+D++S G + ELLTG PY L P+ A +VQ H
Sbjct: 177 STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH 216
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 170 bits (431), Expect = 2e-49
Identities = 81/207 (39%), Positives = 124/207 (59%), Gaps = 9/207 (4%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
I P L ++ SG +G ++ G + + VAIK ++ ++ +++F +E +M K+
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLS 57
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H +VQ G CT+ +C+V EFM G + DYL +G F +LL + +DV +GM YL
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHK 464
+N+IHRDL A N L+ EN+VVKV+DFG+ R T+ TGT +W +PEV
Sbjct: 118 SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWSSPEVFSFS 176
Query: 465 PYDHKADVFSFGIVLWELLT-GKLPYE 490
Y K+DV+SFG+++WE+ + GK PYE
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 5e-49
Identities = 76/208 (36%), Positives = 127/208 (61%), Gaps = 6/208 (2%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
WE + K+ SG +G+++ G + VAIK+LK + + Q++F +EV +++
Sbjct: 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKR 58
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMN 404
+RHK+++ C+ + I+TE M GS+ +L +G V + SL+ +A V++GM
Sbjct: 59 LRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMA 118
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT-YRWMAPEVIEH 463
YL + N IHRDL A N+L+ E+ V KVADFG+AR+ + ++++ Y+W APE H
Sbjct: 119 YLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASH 178
Query: 464 KPYDHKADVFSFGIVLWELLT-GKLPYE 490
+ K+DV+SFGI+L+E+ T G++PY
Sbjct: 179 GTFSTKSDVWSFGILLYEMFTYGQVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 4e-48
Identities = 76/218 (34%), Positives = 120/218 (55%), Gaps = 19/218 (8%)
Query: 290 DP-KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
DP + K K+ G+ G++Y+ T + ++VAIK + R+ ++ E+ IM+
Sbjct: 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM---RLRKQNKELIINEILIMKDC 72
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
+H N+V + + L +V E+M GGS+ D + + P + V +V +G+ YL
Sbjct: 73 KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL 132
Query: 407 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET-------GTYRWMAPE 459
H N+IHRD+K+ N+L+ ++ VK+ADFG A AQ +T E GT WMAPE
Sbjct: 133 HSQNVIHRDIKSDNILLSKDGSVKLADFGFA---AQ---LTKEKSKRNSVVGTPYWMAPE 186
Query: 460 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 497
VI+ K Y K D++S GI+ E+ G+ PY PL+A
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 1e-47
Identities = 79/211 (37%), Positives = 125/211 (59%), Gaps = 13/211 (6%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFAQEVFIMR 344
WE++ + K+ G YG++Y G + VA+K LK + + + EF +E +M+
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMK 57
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKG 402
+++H N+VQ +G CT+ P I+TEFM+ G++ DYL + ++ + LL +A +S
Sbjct: 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSA 116
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 459
M YL + N IHRDL A N L+ EN +VKVADFG++R+ TA G +W APE
Sbjct: 117 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPE 175
Query: 460 VIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
+ + + K+DV++FG++LWE+ T G PY
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 206
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 7e-47
Identities = 84/220 (38%), Positives = 128/220 (58%), Gaps = 9/220 (4%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
IDPK L F ++ +G +G + G + Q DVAIK++K ++ D EF +E +M K+
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLS 57
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H+ +VQ G CTK + IVTE+MS G + +YL + F+ LL++ DV +GM YL
Sbjct: 58 HEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE 117
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHK 464
IHRDL A N L+D+ VKV+DFG++R T+ G+ RW PEV+ +
Sbjct: 118 SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLLYS 176
Query: 465 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503
+ K+DV++FG+++WE+ + GK+PYE + V Q
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ 216
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 9e-47
Identities = 73/205 (35%), Positives = 118/205 (57%), Gaps = 8/205 (3%)
Query: 299 KVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357
K+ G++GD+Y+G +VA+K + +K F QE I+++ H N+V+ IG
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLIGV 60
Query: 358 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 417
C + + IV E + GGS+ +L K K + LL++++D + GM YL N IHRDL
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLA 120
Query: 418 AANLLMDENEVVKVADFGVARVKAQSGVMTAETGT----YRWMAPEVIEHKPYDHKADVF 473
A N L+ EN V+K++DFG++R + + G+ T G +W APE + + Y ++DV+
Sbjct: 121 ARNCLVGENNVLKISDFGMSR-EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVW 179
Query: 474 SFGIVLWELLT-GKLPYEYLTPLQA 497
S+GI+LWE + G PY ++ Q
Sbjct: 180 SYGILLWETFSLGDTPYPGMSNQQT 204
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 1e-45
Identities = 73/208 (35%), Positives = 110/208 (52%), Gaps = 18/208 (8%)
Query: 299 KVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
+ GS+G++Y+ +Q VAIKV+ E +++ + QE+ + + R + ++ G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIE-DIQQEIQFLSQCRSPYITKYYG 66
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ K L I+ E+ GGS D L G + + +V G+ YLH+ IHRD+
Sbjct: 67 SFLKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLLGLEYLHEEGKIHRDI 124
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAET-------GTYRWMAPEVIEHKPYDHK 469
KAAN+L+ E VK+ADFGV SG +T+ GT WMAPEVI+ YD K
Sbjct: 125 KAANILLSEEGDVKLADFGV------SGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEK 178
Query: 470 ADVFSFGIVLWELLTGKLPYEYLTPLQA 497
AD++S GI EL G+ P L P++
Sbjct: 179 ADIWSLGITAIELAKGEPPLSDLHPMRV 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 2e-45
Identities = 67/202 (33%), Positives = 118/202 (58%), Gaps = 14/202 (6%)
Query: 299 KVASGSYGDLYRGTYCSQDVAIKVLKPERIN-SDM---QKEFA-QEVFIMRKVRHKNVVQ 353
++ GS+G +Y D + VLK I+ S+M ++E A EV I++K+ H N+++
Sbjct: 7 QIGKGSFGKVYLVR-RKSDGKLYVLK--EIDLSNMSEKEREDALNEVKILKKLNHPNIIK 63
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS---LLKVAIDVSKGMNYLHQNN 410
+ + + LCIV E+ GG + + K K K +L + + + YLH
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK 123
Query: 411 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDH 468
I+HRD+K N+ + N +VK+ DFG+++V + + + A+T GT +++PE+ ++KPY++
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL-AKTVVGTPYYLSPELCQNKPYNY 182
Query: 469 KADVFSFGIVLWELLTGKLPYE 490
K+D++S G VL+EL T K P+E
Sbjct: 183 KSDIWSLGCVLYELCTLKHPFE 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 5e-45
Identities = 72/203 (35%), Positives = 109/203 (53%), Gaps = 9/203 (4%)
Query: 299 KVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ GSYG +Y+ + Q VAIKV+ E ++ KE + I+++ +V++ G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKE----ISILKQCDSPYIVKYYG 65
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ K L IV E+ GSV D + + + KG+ YLH N IHRD+
Sbjct: 66 SYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDI 125
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFS 474
KA N+L++E K+ADFGV+ + + T GT WMAPEVI+ Y++KAD++S
Sbjct: 126 KAGNILLNEEGQAKLADFGVSG-QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWS 184
Query: 475 FGIVLWELLTGKLPYEYLTPLQA 497
GI E+ GK PY + P++A
Sbjct: 185 LGITAIEMAEGKPPYSDIHPMRA 207
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 1e-44
Identities = 77/215 (35%), Positives = 122/215 (56%), Gaps = 12/215 (5%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQK-EFAQEVFI 342
IDP ++ + G +G++ RG DVAIK LK +SD Q+ +F E I
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG--SSDKQRLDFLTEASI 58
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
M + H N+++ G TK + I+TE+M GS+ +L + G F + L+ + ++ G
Sbjct: 59 MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASG 118
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETG--TYRWMAPE 459
M YL + N +HRDL A N+L++ N V KV+DFG++R S T + G RW APE
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE 178
Query: 460 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLT 493
I ++ + +DV+SFGIV+WE+++ G+ PY ++
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 2e-44
Identities = 77/212 (36%), Positives = 120/212 (56%), Gaps = 7/212 (3%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
I+P L F ++ SG +G ++ G + +Q VAIK + ++ + +F +E +M K+
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLS 57
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H +VQ G CT+ L IVTEFM G + +YL + +G LL + DV +GM YL
Sbjct: 58 HPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE 117
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIEHKP 465
+N+ IHRDL A N L+ VVKV+DFG+ R ++ + +W PEV
Sbjct: 118 RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK 177
Query: 466 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ 496
Y K+DV+SFG+++WE+ T GK+P+E + +
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 3e-44
Identities = 73/207 (35%), Positives = 116/207 (56%), Gaps = 12/207 (5%)
Query: 294 LKFGSKVASGSYGDLYRGTYCSQ------DVAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
L+ + SG++G +Y+G + + VAIKVL+ E + KE E ++M V
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR-EETSPKANKEILDEAYVMASVD 67
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H +VV+ +G C + ++T+ M G + DY+ K LL + ++KGM+YL
Sbjct: 68 HPHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE 126
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHK 464
+ ++HRDL A N+L+ + VK+ DFG+A+ + AE G +WMA E I H+
Sbjct: 127 EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHR 186
Query: 465 PYDHKADVFSFGIVLWELLT-GKLPYE 490
Y HK+DV+S+G+ +WEL+T G PYE
Sbjct: 187 IYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 1e-43
Identities = 77/224 (34%), Positives = 114/224 (50%), Gaps = 13/224 (5%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 348
+ + G+ +Y C ++ VAIK + E+ + + E +EV M + H
Sbjct: 1 DDYELIEVIGVGATAVVYAA-ICLPNNEKVAIKRIDLEKCQTSV-DELRKEVQAMSQCNH 58
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL-HKLK-GVFKLPSLLKVAIDVSKGMNYL 406
NVV++ + L +V ++SGGS+ D + G + V +V KG+ YL
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 407 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET-----GTYRWMAPEVI 461
H N IHRD+KA N+L+ E+ VK+ADFGV+ A G T + GT WMAPEV+
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 462 E-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504
E YD KAD++SFGI EL TG PY P++ + +Q
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN 222
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 2e-43
Identities = 84/221 (38%), Positives = 125/221 (56%), Gaps = 10/221 (4%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
W ++ K LK + G +GD+ G Y VA+K +K N + F E +M ++
Sbjct: 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 56
Query: 347 RHKNVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMN 404
RH N+VQ +G + L IVTE+M+ GS+ DYL + + V LLK ++DV + M
Sbjct: 57 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 116
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 464
YL NN +HRDL A N+L+ E+ V KV+DFG+ K S +W APE + K
Sbjct: 117 YLEANNFVHRDLAARNVLVSEDNVAKVSDFGLT--KEASSTQDTGKLPVKWTAPEALREK 174
Query: 465 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQK 504
+ K+DV+SFGI+LWE+ + G++PY + PL+ V V+K
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEK 214
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 4e-43
Identities = 75/206 (36%), Positives = 113/206 (54%), Gaps = 8/206 (3%)
Query: 298 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 355
++ SG+YGD+Y R + VAIKV+K E D + QE+ ++++ RH N+V +
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIVAYF 66
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
G+ + L IV E+ GGS+ D +G + V + KG+ YLH+ IHRD
Sbjct: 67 GSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRD 126
Query: 416 LKAANLLMDENEVVKVADFGV-ARVKAQSGVMTAETGTYRWMAPEVIEHK---PYDHKAD 471
+K AN+L+ E+ VK+ADFGV A++ A + GT WMAPEV + YD K D
Sbjct: 127 IKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCD 186
Query: 472 VFSFGIVLWELLTGKLPYEYLTPLQA 497
+++ GI EL + P L P++A
Sbjct: 187 IWALGITAIELAELQPPMFDLHPMRA 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 5e-43
Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 13/205 (6%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRK 345
+HLKF ++ G +G + Y VA+K L +F +E+ I+R
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHR-SDFEREIEILRT 62
Query: 346 VRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
+ H+N+V++ G C KP SL ++ E++ GS+ DYL + + L LL + + KGM
Sbjct: 63 LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGM 122
Query: 404 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG----VMTAETGTYRWMAPE 459
+YL IHRDL A N+L++ ++VK++DFG+A+V + V W APE
Sbjct: 123 DYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182
Query: 460 VIEHKPYDHKADVFSFGIVLWELLT 484
+ + +DV+SFG+ L+EL T
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 5e-42
Identities = 73/211 (34%), Positives = 125/211 (59%), Gaps = 13/211 (6%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
W ++ + L G + G +G + +G Y Q VA+K +K + + F +E +M K+
Sbjct: 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKL 56
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNY 405
HKN+V+ +G L IV E MS G++ ++L + + + + LL+ ++DV++GM Y
Sbjct: 57 HHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEY 115
Query: 406 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIEH 463
L ++HRDL A N+L+ E+ V KV+DFG+ARV G M + +W APE ++H
Sbjct: 116 LESKKLVHRDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKH 171
Query: 464 KPYDHKADVFSFGIVLWELLT-GKLPYEYLT 493
K + K+DV+S+G++LWE+ + G+ PY ++
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS 202
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 150 bits (379), Expect = 9e-42
Identities = 73/212 (34%), Positives = 127/212 (59%), Gaps = 9/212 (4%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
WE+ + LK K+ +G +G+++ G Y VAIK LK ++ + F E +M++
Sbjct: 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE---AFLAEANLMKQ 57
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMN 404
++H +V+ T+ P + I+TE+M GS+ D+L +G+ + L+ +A +++GM
Sbjct: 58 LQHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMA 116
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIE 462
++ + N IHRDL+AAN+L+ E K+ADFG+AR+ + E + +W APE I
Sbjct: 117 FIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 176
Query: 463 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLT 493
+ + K+DV+SFGI+L E++T G++PY +T
Sbjct: 177 YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT 208
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 1e-41
Identities = 85/209 (40%), Positives = 131/209 (62%), Gaps = 11/209 (5%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
WEI + L+ K+ G +G+++ GT+ + VAIK LKP ++ + F QE +M+K
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKK 57
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGMN 404
+RH+ +VQ ++ P + IVTE+MS GS+ D+L G + +LP L+ +A ++ GM
Sbjct: 58 LRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 116
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVI 461
Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+ + TA G +W APE
Sbjct: 117 YVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAA 175
Query: 462 EHKPYDHKADVFSFGIVLWELLT-GKLPY 489
+ + K+DV+SFGI+L EL T G++PY
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 5e-41
Identities = 83/209 (39%), Positives = 132/209 (63%), Gaps = 11/209 (5%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
WEI + L+ K+ +G +G+++ GT+ + VA+K LKP ++ + F +E IM+K
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE---SFLEEAQIMKK 57
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMN 404
+RH +VQ ++ P + IVTE+MS GS+ D+L +G KLP+L+ +A V+ GM
Sbjct: 58 LRHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 116
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVI 461
Y+ + N IHRDL++AN+L+ + V K+ADFG+AR+ + TA G +W APE
Sbjct: 117 YIERMNYIHRDLRSANILVGDGLVCKIADFGLARL-IEDNEYTARQGAKFPIKWTAPEAA 175
Query: 462 EHKPYDHKADVFSFGIVLWELLT-GKLPY 489
+ + K+DV+SFGI+L EL+T G++PY
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 8e-41
Identities = 66/201 (32%), Positives = 108/201 (53%), Gaps = 6/201 (2%)
Query: 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN 350
L+ + GS G +Y+ + + A+K + + + +K+ +E+ +R
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH-VDGDEEFRKQLLRELKTLRSCESPY 60
Query: 351 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN- 409
VV+ GA K + IV E+M GGS+ D L K G P L +A + KG++YLH
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQILKGLDYLHTKR 119
Query: 410 NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDH 468
+IIHRD+K +NLL++ VK+ADFG+++V + GT +M+PE I+ + Y +
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSY 179
Query: 469 KADVFSFGIVLWELLTGKLPY 489
AD++S G+ L E GK P+
Sbjct: 180 AADIWSLGLTLLECALGKFPF 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 147 bits (371), Expect = 1e-40
Identities = 86/209 (41%), Positives = 130/209 (62%), Gaps = 11/209 (5%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
WEI + L+ K+ G +G+++ GT+ + VAIK LKP + M + F QE IM+K
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKP---GTMMPEAFLQEAQIMKK 57
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGMN 404
+RH +V ++ P + IVTEFM GS+ D+L + G + KLP L+ +A ++ GM
Sbjct: 58 LRHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMA 116
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVI 461
Y+ + N IHRDL+AAN+L+ +N V K+ADFG+AR+ + TA G +W APE
Sbjct: 117 YIERMNYIHRDLRAANILVGDNLVCKIADFGLARL-IEDNEYTARQGAKFPIKWTAPEAA 175
Query: 462 EHKPYDHKADVFSFGIVLWELLT-GKLPY 489
+ + K+DV+SFGI+L EL+T G++PY
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 1e-40
Identities = 72/207 (34%), Positives = 110/207 (53%), Gaps = 7/207 (3%)
Query: 297 GSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ---KEFAQEVFIMRKVRHKNV 351
G + SGS+G +Y G A+K + Q K+ QE+ ++ K++H N+
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
VQ++G + +L I E + GGS+ L K G F P + + G+ YLH N
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNT 123
Query: 412 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKA 470
+HRD+K AN+L+D N VVK+ADFG+A+ + + G+ WMAPEVI + Y A
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183
Query: 471 DVFSFGIVLWELLTGKLPYEYLTPLQA 497
D++S G + E+ TGK P+ L + A
Sbjct: 184 DIWSLGCTVLEMATGKPPWSQLEGVAA 210
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 3e-40
Identities = 77/208 (37%), Positives = 128/208 (61%), Gaps = 8/208 (3%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
WEI + +K K+ +G +G+++ G Y S VA+K LKP ++ + F +E +M+
Sbjct: 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSV---QAFLEEANLMKT 57
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMN 404
++H +V+ TK + I+TE+M+ GS+ D+L +G LP L+ + +++GM
Sbjct: 58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIE 462
Y+ + N IHRDL+AAN+L+ E+ + K+ADFG+ARV + E + +W APE I
Sbjct: 118 YIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 177
Query: 463 HKPYDHKADVFSFGIVLWELLT-GKLPY 489
+ K+DV+SFGI+L+E++T GK+PY
Sbjct: 178 FGSFTIKSDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 5e-40
Identities = 70/219 (31%), Positives = 115/219 (52%), Gaps = 16/219 (7%)
Query: 291 PKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKE---FAQEVFI 342
P + + G + G++G +Y C +++A+K + + + + +KE E+ +
Sbjct: 1 PTNWRRGKLLGQGAFGRVY---LCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQL 57
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
++ ++H+ +VQ+ G +L I E+M GGSV D L K G K + +G
Sbjct: 58 LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTRQILEG 116
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR----VKAQSGVMTAETGTYRWMAP 458
+ YLH N I+HRD+K AN+L D VK+ DFG ++ + + M + TGT WM+P
Sbjct: 117 VEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 459 EVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 497
EVI + Y KADV+S G + E+LT K P+ + A
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 3e-39
Identities = 74/205 (36%), Positives = 119/205 (58%), Gaps = 11/205 (5%)
Query: 300 VASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358
+ G++G++++GT + VA+K K E + +++ +F E I+++ H N+V+ IG C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCK-EDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 359 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 418
T+ + IV E + GG +L K K K L+K A+D + GM YL N IHRDL A
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAA 121
Query: 419 ANLLMDENEVVKVADFGVAR-----VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 473
N L+ EN V+K++DFG++R + + SG+ +W APE + + Y ++DV+
Sbjct: 122 RNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI---KWTAPEALNYGRYSSESDVW 178
Query: 474 SFGIVLWELLT-GKLPYEYLTPLQA 497
S+GI+LWE + G PY +T QA
Sbjct: 179 SYGILLWETFSLGVCPYPGMTNQQA 203
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 3e-39
Identities = 72/209 (34%), Positives = 114/209 (54%), Gaps = 13/209 (6%)
Query: 299 KVASGSYGDLYRGTYCSQ-----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 353
K+ GS+G + RG + + VA+K LK +++ SD+ +F +E IM + H+N+++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL-SDIMDDFLKEAAIMHSLDHENLIR 60
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
G P L +VTE GS+ D L K G F + +L A+ ++ GM YL I
Sbjct: 61 LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFI 119
Query: 413 HRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGT-YRWMAPEVIEHKPYDH 468
HRDL A N+L+ ++ VK+ DFG+ R Q+ VM + W APE + + + H
Sbjct: 120 HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSH 179
Query: 469 KADVFSFGIVLWELLT-GKLPYEYLTPLQ 496
+DV+ FG+ LWE+ T G+ P+ L+ Q
Sbjct: 180 ASDVWMFGVTLWEMFTYGEEPWAGLSGSQ 208
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 4e-39
Identities = 68/198 (34%), Positives = 106/198 (53%), Gaps = 13/198 (6%)
Query: 302 SGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
G++G + +G Y + VA+K LK E I + +KEF +E +M ++ H +V+ IG
Sbjct: 5 HGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAG-KKEFLREASVMAQLDHPCIVRLIG 63
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
C K L +V E G + YL K + + L ++A V+ GM YL + +HRDL
Sbjct: 64 VC-KGEPLMLVMELAPLGPLLKYLKK-RREIPVSDLKELAHQVAMGMAYLESKHFVHRDL 121
Query: 417 KAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETG---TYRWMAPEVIEHKPYDHKADV 472
A N+L+ K++DFG++R + A S A T +W APE I + + K+DV
Sbjct: 122 AARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDV 181
Query: 473 FSFGIVLWELLT-GKLPY 489
+S+G+ LWE + G PY
Sbjct: 182 WSYGVTLWEAFSYGAKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 8e-39
Identities = 70/215 (32%), Positives = 110/215 (51%), Gaps = 10/215 (4%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVF 341
+EI + + G + G +GD+Y+G Y S + VA+K K S +K F QE +
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAY 59
Query: 342 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 401
IMR+ H ++V+ IG T+ P IV E G + YL K L SL+ + +S
Sbjct: 60 IMRQFDHPHIVKLIGVITENPVW-IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118
Query: 402 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPE 459
+ YL +HRD+ A N+L+ + VK+ DFG++R A G +WMAPE
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178
Query: 460 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLT 493
I + + +DV+ FG+ +WE+L G P++ +
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-38
Identities = 80/232 (34%), Positives = 133/232 (57%), Gaps = 13/232 (5%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRK 345
WEI + LK K+ +G +G+++ TY VA+K +KP ++ + F E +M+
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE---AFLAEANVMKT 57
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMN 404
++H +V+ TK P + I+TEFM+ GS+ D+L +G LP L+ + +++GM
Sbjct: 58 LQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 116
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIE 462
++ Q N IHRDL+AAN+L+ + V K+ADFG+ARV + E + +W APE I
Sbjct: 117 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 176
Query: 463 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHSFLEQR 513
+ K+DV+SFGI+L E++T G++PY P + V++ + + R
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGRIPY----PGMSNPEVIRALERGYRMPR 224
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 68/232 (29%), Positives = 112/232 (48%), Gaps = 31/232 (13%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQD-----VAIKVLKPERINSDMQKEFAQE 339
WE+ + + ++ GS+G +Y G + VAIK + E + + EF E
Sbjct: 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN-ENASMRERIEFLNE 59
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK------GVFKLPSLL 393
+M++ +VV+ +G + +V E M+ G + YL + P+L
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 394 KV---AIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--------KAQ 442
K A +++ GM YL +HRDL A N ++ E+ VK+ DFG+ R K
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGG 179
Query: 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLT 493
G++ RWMAPE ++ + K+DV+SFG+VLWE+ T + PY+ L+
Sbjct: 180 KGLLPV-----RWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 1e-37
Identities = 74/208 (35%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 300 VASGSYGDLYRGTY--CSQDVAIKVLK---PERINSDMQKEFAQEVFIMRKVRH---KNV 351
+ G+YG +YRG + + VA+K++ P+ SD+Q+E A ++ ++R N+
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVA----LLSQLRQSQPPNI 64
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
++ G+ K P L I+ E+ GGSV + G + + +V + Y+H+ +
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGV 122
Query: 412 IHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGTYRWMAPEVI-EHKPYDHK 469
IHRD+KAAN+L+ VK+ DFGVA + Q S + GT WMAPEVI E K YD K
Sbjct: 123 IHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTK 182
Query: 470 ADVFSFGIVLWELLTGKLPYEYLTPLQA 497
AD++S GI ++E+ TG PY + +A
Sbjct: 183 ADIWSLGITIYEMATGNPPYSDVDAFRA 210
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 71/201 (35%), Positives = 115/201 (57%), Gaps = 9/201 (4%)
Query: 294 LKFGSKVASGSYGD----LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 349
L++ ++ +G+ G L+R T + +A+K ++ E IN +QK+ +E+ I+ K
Sbjct: 3 LEYLGELGAGNSGVVSKVLHRPT--GKIMAVKTIRLE-INEAIQKQILRELDILHKCNSP 59
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH-Q 408
+V F GA + I E+M GGS+ L +++G L K+A+ V KG+ YLH +
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 409 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 468
+ IIHRD+K +N+L++ +K+ DFGV+ S T GT +MAPE I+ Y
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-FVGTSSYMAPERIQGNDYSV 178
Query: 469 KADVFSFGIVLWELLTGKLPY 489
K+D++S G+ L EL TG+ PY
Sbjct: 179 KSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 1e-36
Identities = 81/237 (34%), Positives = 120/237 (50%), Gaps = 34/237 (14%)
Query: 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQE 339
D T ++E+ + G+YG +Y+ + Q VAIK++ I D ++E +E
Sbjct: 3 DPTGIFEL-------VEVIGEGTYGKVYKARHKKTGQLVAIKIMD---IIEDEEEEIKEE 52
Query: 340 VFIMRKV-RHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSL 392
I+RK H N+ F GA K +V E GGSV D + KG+ K
Sbjct: 53 YNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV---KGLRKKGKR 109
Query: 393 LKVAI------DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGV 445
LK + +G+ YLH+N +IHRD+K N+L+ +N VK+ DFGV+ + + G
Sbjct: 110 LKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR 169
Query: 446 MTAETGTYRWMAPEVI--EHKP---YDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 497
GT WMAPEVI + +P YD ++DV+S GI EL GK P + P++A
Sbjct: 170 RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA 226
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 1e-36
Identities = 79/231 (34%), Positives = 123/231 (53%), Gaps = 26/231 (11%)
Query: 274 PYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPE 326
PY LK WE +L FG + +G++G + T VA+K+LKP
Sbjct: 25 PYDLK--------WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKP- 75
Query: 327 RINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG 385
+S ++ E+ IM + H+N+V +GACT + ++TE+ G + ++L + +
Sbjct: 76 TAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE 135
Query: 386 VF-KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQS 443
F L LL + V+KGM +L N IHRDL A N+L+ ++VK+ DFG+AR + S
Sbjct: 136 SFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDS 195
Query: 444 GVMTAETGTYR----WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
+ G R WMAPE I + Y ++DV+S+GI+LWE+ + G PY
Sbjct: 196 NYVV--KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY 244
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-36
Identities = 58/198 (29%), Positives = 110/198 (55%), Gaps = 8/198 (4%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ GS+G +++ + + A+K + ++N ++E E ++ K+ ++++
Sbjct: 7 KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKGMNYLHQNNIIHR 414
+ L IV E+ G ++ L +G LP + + I + G+ +LH I+HR
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVWRFFIQILLGLAHLHSKKILHR 125
Query: 415 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADV 472
D+K+ NL +D + VK+ D GVA++ + + A T GT +++PE+ E KPY+ K+DV
Sbjct: 126 DIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-ANTIVGTPYYLSPELCEDKPYNEKSDV 184
Query: 473 FSFGIVLWELLTGKLPYE 490
++ G+VL+E TGK P++
Sbjct: 185 WALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 73/243 (30%), Positives = 122/243 (50%), Gaps = 40/243 (16%)
Query: 279 IPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-------VAIKVLKPERINSD 331
+P D WE+ L G + G++G + + D VA+K+LK + D
Sbjct: 1 LPLD--PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD 58
Query: 332 MQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------- 380
+ + E+ +M+ + +HKN++ +G CT+ L +V E+ + G++ D+L
Sbjct: 59 L-SDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYA 117
Query: 381 -----HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435
+ L+ A V++GM +L IHRDL A N+L+ E+ V+K+ADFG
Sbjct: 118 SPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFG 177
Query: 436 VAR--------VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GK 486
+AR K +G + +WMAPE + + Y H++DV+SFG++LWE+ T G
Sbjct: 178 LARDIHHIDYYRKTTNGRL-----PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG 232
Query: 487 LPY 489
PY
Sbjct: 233 SPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 4e-36
Identities = 71/228 (31%), Positives = 119/228 (52%), Gaps = 27/228 (11%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINSDMQKEFAQEV 340
EI ++F ++ G++G +Y+G + VAIK LK E +Q+EF QE
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQEA 59
Query: 341 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------HKLKG 385
+M ++H N+V +G CTK C++ E+++ G ++++L +K
Sbjct: 60 ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119
Query: 386 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG- 444
L +AI ++ GM YL ++ +HRDL A N L+ E VK++DFG++R +
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY 179
Query: 445 --VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
V + RWM PE I + + ++D++SFG+VLWE+ + G PY
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 9e-36
Identities = 76/212 (35%), Positives = 113/212 (53%), Gaps = 11/212 (5%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERINSDMQKEFAQEVFI 342
EI P H+ + +G +G+++RG VAIK LKP Q +F E I
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQ-DFLSEASI 59
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
M + H N+++ G TK I+TE+M G++ YL G F L+ + ++ G
Sbjct: 60 MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAG 119
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ--SGVMTAETGT--YRWMAP 458
M YL N +HRDL A N+L++ N KV+DFG++RV G T G RW AP
Sbjct: 120 MKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179
Query: 459 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
E I ++ + +DV+SFGIV+WE+++ G+ PY
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGERPY 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 2e-35
Identities = 72/224 (32%), Positives = 120/224 (53%), Gaps = 19/224 (8%)
Query: 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQKE-FAQ 338
+ D+WEI ++ G++G +Y+ + + A K+++ I S+ + E F
Sbjct: 2 NPNDIWEII-------GELGDGAFGKVYKAQHKETGLFAAAKIIQ---IESEEELEDFMV 51
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 398
E+ I+ + +H N+V A L I+ EF GG++ + +L+ P + V
Sbjct: 52 EIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQ 111
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV-ARVKAQSGVMTAETGTYRWMA 457
+ + +N+LH + +IHRDLKA N+L+ + VK+ADFGV A+ K+ GT WMA
Sbjct: 112 MLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMA 171
Query: 458 PEVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 496
PEV+ + PYD+KAD++S GI L EL + P+ L P++
Sbjct: 172 PEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR 215
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 3e-35
Identities = 71/213 (33%), Positives = 117/213 (54%), Gaps = 13/213 (6%)
Query: 297 GSKVASGSYGDLYRG-TYCSQDVAIKVLKPERINSDM-QKEFA---QEVFIMRKVRHKNV 351
G + G+YG +Y G T Q +A+K ++ + N +KE+ +EV +++ ++H N+
Sbjct: 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
VQ++G C ++ I EF+ GGS+ L++ G P K + G+ YLH N +
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 412 IHRDLKAANLLMDENEVVKVADFGVARVKA-------QSGVMTAETGTYRWMAPEVIEHK 464
+HRD+K N+++ N ++K+ DFG AR A S ++ + GT WMAPEVI
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183
Query: 465 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 497
Y K+D++S G ++E+ TGK P + L A
Sbjct: 184 GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA 216
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 70/214 (32%), Positives = 121/214 (56%), Gaps = 9/214 (4%)
Query: 299 KVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
++ G++G+++ G + + VA+K + E + D++ +F QE I+++ H N+V+ IG
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
CT+ + IV E + GG +L K+ L+++ + + GM YL + IHRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT----YRWMAPEVIEHKPYDHKADV 472
A N L+ E V+K++DFG++R + + GV + G +W APE + + Y ++DV
Sbjct: 121 AARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179
Query: 473 FSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKV 505
+SFGI+LWE + G +PY L+ Q + Q V
Sbjct: 180 WSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV 213
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 3e-34
Identities = 60/198 (30%), Positives = 111/198 (56%), Gaps = 6/198 (3%)
Query: 298 SKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 355
K+ GSYG +Y+ S Q A+K + ++ +++ E+ I+ V H N++ +
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK 65
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
A LCIV E+ G + + K + + + ++ I + +G+ LH+ I+
Sbjct: 66 EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKIL 125
Query: 413 HRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADV 472
HRDLK+AN+L+ N++VK+ D G+++V + + + GT +MAPEV + +PY +K+D+
Sbjct: 126 HRDLKSANILLVANDLVKIGDLGISKV-LKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDI 184
Query: 473 FSFGIVLWELLTGKLPYE 490
+S G +L+E+ T P+E
Sbjct: 185 WSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 5e-34
Identities = 74/213 (34%), Positives = 111/213 (52%), Gaps = 24/213 (11%)
Query: 300 VASGSYGDLYRGTYCSQD--------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 351
+ SG++G++Y GT VA+K L+ + + +KEF +E +M H N+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLKEAHLMSNFNHPNI 61
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK------GVFKLPSLLKVAIDVSKGMNY 405
V+ +G C I+ E M GG + YL + + L LL + +DV+KG Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 406 LHQNNIIHRDLKAANLLMDENE-----VVKVADFGVARVKAQSGVMTAETG---TYRWMA 457
L Q + IHRDL A N L+ E VVK+ DFG+AR +S E RWMA
Sbjct: 122 LEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMA 181
Query: 458 PEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
PE + + ++DV+SFG+++WE+LT G+ PY
Sbjct: 182 PESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 6e-34
Identities = 73/226 (32%), Positives = 128/226 (56%), Gaps = 19/226 (8%)
Query: 297 GSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSD-------MQKEFAQEVFIMRKVR 347
G+ + SGS+G +Y G S +A+K ++ +++ M A+E+ ++++++
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H+N+VQ++G+ L I E++ GGSV L+ G F+ + + KG+NYLH
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLH 123
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR--------WMAPE 459
IIHRD+K AN+L+D +K++DFG+++ K ++ ++ +T R WMAPE
Sbjct: 124 NRGIIHRDIKGANILVDNKGGIKISDFGISK-KLEANSLSTKTNGARPSLQGSVFWMAPE 182
Query: 460 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505
V++ Y KAD++S G ++ E+LTGK P+ T LQA + +
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 7e-34
Identities = 70/213 (32%), Positives = 113/213 (53%), Gaps = 13/213 (6%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIM 343
ID +K + +G +G++ RG VAIK LK +++F E IM
Sbjct: 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIM 59
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
+ H N++ G TK + I+TEFM G++ +L + G F + L+ + ++ GM
Sbjct: 60 GQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGM 119
Query: 404 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY------RWMA 457
YL + N +HRDL A N+L++ N V KV+DFG++R T + RW A
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 458 PEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
PE I ++ + +DV+S+GIV+WE+++ G+ PY
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 8e-34
Identities = 61/167 (36%), Positives = 91/167 (54%), Gaps = 6/167 (3%)
Query: 329 NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS--LCIVTEFMSGGS---VYDYLHKL 383
N D+QK+ +E+ I + + +V++ GA S + I E+ GGS +Y + K
Sbjct: 39 NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKR 98
Query: 384 KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443
G L K+A V KG++YLH IIHRD+K +N+L+ VK+ DFGV+ S
Sbjct: 99 GGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158
Query: 444 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490
T TGT +MAPE I+ KPY +DV+S G+ L E+ + P+
Sbjct: 159 LAGTF-TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP 204
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 131 bits (329), Expect = 1e-33
Identities = 70/237 (29%), Positives = 113/237 (47%), Gaps = 16/237 (6%)
Query: 295 KFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRH-KNVV 352
+ K+ GS+G++Y + VA+KVL + + S + F +E+ I+ + H N+V
Sbjct: 3 RILRKLGEGSFGEVYLA-RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKL--KGVFKLPSLLKVAIDVSKGMNYLHQNN 410
+ SL +V E++ GGS+ D L K+ KG L + + + YLH
Sbjct: 62 KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG 121
Query: 411 IIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGV-------MTAETGTYRWMAPEVIE 462
IIHRD+K N+L+D + VVK+ DFG+A++ G + GT +MAPEV+
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 463 HK---PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSFLEQRLRK 516
+D++S GI L+ELLTG P+E A ++ +
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238
|
Length = 384 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 7e-33
Identities = 77/269 (28%), Positives = 128/269 (47%), Gaps = 54/269 (20%)
Query: 288 EIDPKHLKFGSKVASGSYGDLY-RGTYCSQD-----------------VAIKVLKPERIN 329
E + L F K+ G +G+++ QD VA+KVL+P+ +
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD-AS 59
Query: 330 SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHK------- 382
+ +++F +EV I+ ++ N+ + +G CT P LC++ E+M G + +L K
Sbjct: 60 DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSG 119
Query: 383 -LKGVFKLP--SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439
L +LL +A ++ GM YL N +HRDL N L+ +N +K+ADFG++R
Sbjct: 120 LACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSR- 178
Query: 440 KAQSGVMTAETGTY-----------RWMAPEVIEHKPYDHKADVFSFGIVLWELLT--GK 486
+ Y RWMA E + + K+DV++FG+ LWE+LT +
Sbjct: 179 -------NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231
Query: 487 LPYEYLTPLQAAVGVVQKVHHSFLEQRLR 515
PYE+LT Q V++ H F + +
Sbjct: 232 QPYEHLTDQQ----VIENAGHFFRDDGRQ 256
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 8e-33
Identities = 61/208 (29%), Positives = 106/208 (50%), Gaps = 15/208 (7%)
Query: 297 GSKVASGSYGDLYRGTYCSQD----VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
G+K+ G++G +Y + D +A+K ++ + + KE A E+ ++ ++H N+V
Sbjct: 5 GNKIGGGTFGKVYTAV--NLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
++ G + I E+ SGG++ + L + + + + +G+ YLH + I+
Sbjct: 63 KYYGVEVHREKVYIFMEYCSGGTLEELLE-HGRILDEHVIRVYTLQLLEGLAYLHSHGIV 121
Query: 413 HRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-----TGTYRWMAPEVIEHKPYD 467
HRD+K AN+ +D N V+K+ DFG A + E GT +MAPEVI
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGK 181
Query: 468 HK---ADVFSFGIVLWELLTGKLPYEYL 492
AD++S G V+ E+ TGK P+ L
Sbjct: 182 GHGRAADIWSLGCVVLEMATGKRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 68/217 (31%), Positives = 110/217 (50%), Gaps = 18/217 (8%)
Query: 297 GSKVASGSYGDLYRGTYCS--QDVAIK-VLKPERINS-------DMQKEFAQEVFIMRKV 346
G + G+YG +Y + + +A+K V P I DM K E+ ++ +
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
H N+VQ++G T L I E++ GGS+ L G F+ + V +G+ YL
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT-YGRFEEQLVRFFTEQVLEGLAYL 124
Query: 407 HQNNIIHRDLKAANLLMDENEVVKVADFGVAR----VKAQSGVMTAETGTYRWMAPEVIE 462
H I+HRDLKA NLL+D + + K++DFG+++ + M+ + G+ WMAPEVI
Sbjct: 125 HSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAPEVIH 183
Query: 463 --HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 497
+ Y K D++S G V+ E+ G+ P+ + A
Sbjct: 184 SYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA 220
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 71/217 (32%), Positives = 109/217 (50%), Gaps = 22/217 (10%)
Query: 294 LKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVFIMRKVRH 348
LK G + G +G + G D VA+K +K + +EF E M+ H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 349 KNVVQFIGAC------TKPPSLCIVTEFMSGGSVYDYLHKLK---GVFKLP--SLLKVAI 397
NV++ IG C K P ++ FM G ++ +L + KLP +LLK +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 398 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT----Y 453
D++ GM YL N IHRDL A N ++ E+ V VADFG+++ K SG +
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK-KIYSGDYYRQGRIAKMPV 179
Query: 454 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
+W+A E + + Y K+DV++FG+ +WE+ T G+ PY
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 5e-32
Identities = 72/211 (34%), Positives = 111/211 (52%), Gaps = 11/211 (5%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVFIM 343
ID +K + +G +G++ G VAIK LK +++F E IM
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIM 59
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
+ H N++ G TK + IVTE+M GS+ +L K G F + L+ + ++ GM
Sbjct: 60 GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGM 119
Query: 404 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ--SGVMTAETGT--YRWMAPE 459
YL +HRDL A N+L++ N V KV+DFG++RV T G RW APE
Sbjct: 120 KYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 179
Query: 460 VIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
I ++ + +DV+S+GIV+WE+++ G+ PY
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGERPY 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|153200 cd04928, ACT_TyrKc, Uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-32
Identities = 45/68 (66%), Positives = 53/68 (77%)
Query: 179 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLR 238
MHEITF+ DKPKLLSQL++LL D+GLNI EAHAFST DG +LD+FVV GW ET L
Sbjct: 1 MHEITFAAGDKPKLLSQLSSLLGDLGLNIAEAHAFSTDDGLALDIFVVTGWKRGETAALG 60
Query: 239 AALEKEVL 246
AL+KE+
Sbjct: 61 HALQKEID 68
|
This CD includes a novel, yet uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 68 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 7e-32
Identities = 71/215 (33%), Positives = 121/215 (56%), Gaps = 13/215 (6%)
Query: 300 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 353
+ SG++G +Y+G + + VAIK L+ E + KE E ++M V + +V +
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 73
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
+G C ++ ++T+ M G + DY+ + K LL + ++KGMNYL + ++H
Sbjct: 74 LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVH 132
Query: 414 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKA 470
RDL A N+L+ + VK+ DFG+A+ + A AE G +WMA E I H+ Y H++
Sbjct: 133 RDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQS 192
Query: 471 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQK 504
DV+S+G+ +WEL+T G PY+ + P +++K
Sbjct: 193 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEK 226
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 9e-32
Identities = 69/201 (34%), Positives = 112/201 (55%), Gaps = 6/201 (2%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
++ GS+G++Y+G + VAIK++ E +++ + QE+ ++ + + ++ G
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYITRYYG 69
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ K L I+ E++ GGS D L G + + + ++ KG++YLH IHRD+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDI 127
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVM-TAETGTYRWMAPEVIEHKPYDHKADVFSF 475
KAAN+L+ E VK+ADFGVA + + GT WMAPEVI+ YD KAD++S
Sbjct: 128 KAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSL 187
Query: 476 GIVLWELLTGKLPYEYLTPLQ 496
GI EL G+ P L P++
Sbjct: 188 GITAIELAKGEPPNSDLHPMR 208
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 71/221 (32%), Positives = 114/221 (51%), Gaps = 39/221 (17%)
Query: 300 VASGSYGDLYRGTYCS----QD---VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ G++G ++ G D VA+K LK E ++D +K+F +E ++ +H+N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLK-ETASNDARKDFEREAELLTNFQHENIV 71
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHK-------------LKGVFKLPSLLKVAIDV 399
+F G CT+ +V E+M G + +L G L LL++A+ +
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY------ 453
+ GM YL + +HRDL N L+ + VVK+ DFG++R V T T Y
Sbjct: 132 ASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-----DVYT--TDYYRVGGHT 184
Query: 454 ----RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
RWM PE I ++ + ++DV+SFG+VLWE+ T GK P+
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 66/197 (33%), Positives = 106/197 (53%), Gaps = 17/197 (8%)
Query: 309 YRGTYCSQDV------AIKVLKPERINSDMQKEFAQ----EVFIMRKVRHKNVVQFIGAC 358
+ Y ++DV A+K + R S Q+E + E+ +M ++ H ++++ +GA
Sbjct: 13 FSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT 72
Query: 359 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 418
+ + E+M+GGSV L K G FK ++ + +G++YLH+N IIHRD+K
Sbjct: 73 CEDSHFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKG 131
Query: 419 ANLLMDEN-EVVKVADFGVARVKAQSGVMTAE-----TGTYRWMAPEVIEHKPYDHKADV 472
ANLL+D + +++ADFG A A G E GT +MAPEV+ + Y DV
Sbjct: 132 ANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDV 191
Query: 473 FSFGIVLWELLTGKLPY 489
+S G V+ E+ T K P+
Sbjct: 192 WSVGCVIIEMATAKPPW 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 74/229 (32%), Positives = 113/229 (49%), Gaps = 35/229 (15%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRGTYCSQD-------VAIKVLKPERINSDMQKEFAQEV 340
E+ + + G++G++Y G Y +D VA+K L PE + + +F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL-PESCSEQDESDFLMEA 60
Query: 341 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS------LLK 394
IM K H+N+V+ IG + I+ E M+GG + +L + + + PS LL
Sbjct: 61 LIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF 120
Query: 395 VAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVADFGVARVKAQSGVMTAETG 451
A DV+KG YL +N+ IHRD+ A N L+ V K+ADFG+AR ++
Sbjct: 121 CARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY------ 174
Query: 452 TYR----------WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
YR WM PE + K DV+SFG++LWE+ + G +PY
Sbjct: 175 -YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 3e-31
Identities = 59/212 (27%), Positives = 117/212 (55%), Gaps = 6/212 (2%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357
+ G++G+ LYR T V K + R++ +++ E+ I+ ++H N++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 358 CTKPPSLCIVTEFMSGGSVYDYL-HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+L I E+ +GG++YD + + +F+ +L + ++Y+H+ I+HRD+
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDI 127
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFS 474
K N+ + + ++K+ DFG++++ M AET GT +M+PE+ + Y+ K+D+++
Sbjct: 128 KTLNIFLTKAGLIKLGDFGISKILGSEYSM-AETVVGTPYYMSPELCQGVKYNFKSDIWA 186
Query: 475 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKVH 506
G VL+ELLT K ++ PL V +VQ +
Sbjct: 187 LGCVLYELLTLKRTFDATNPLNLVVKIVQGNY 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 71/237 (29%), Positives = 117/237 (49%), Gaps = 40/237 (16%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 337
WE L G + G +G + R D VA+K+LK + D+ +
Sbjct: 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDL-ADLI 65
Query: 338 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK------------ 384
E+ +M+ + +HKN++ +G CT+ L ++ E+ + G++ ++L +
Sbjct: 66 SEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITK 125
Query: 385 ---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--- 438
L+ A V++GM YL IHRDL A N+L+ E+ V+K+ADFG+AR
Sbjct: 126 VPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVH 185
Query: 439 -----VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
K +G + +WMAPE + + Y H++DV+SFGI++WE+ T G PY
Sbjct: 186 DIDYYKKTSNGRLPV-----KWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 5e-31
Identities = 59/174 (33%), Positives = 95/174 (54%), Gaps = 5/174 (2%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A+KVLK ++I + E E I+ ++ H +V+ A L +V E+ GG ++
Sbjct: 22 AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELF 81
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437
+L K +G F A ++ + YLH II+RDLK N+L+D + +K+ DFG+A
Sbjct: 82 SHLSK-EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLA 140
Query: 438 RVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489
+ + S T GT ++APEV+ K Y D +S G++L+E+LTGK P+
Sbjct: 141 KELS-SEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF 193
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 5e-31
Identities = 73/207 (35%), Positives = 118/207 (57%), Gaps = 18/207 (8%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
++ GS+G++++G Q VAIK++ E +++ + QE+ ++ + V ++ G
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYVTKYYG 69
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
+ K L I+ E++ GGS D L F++ ++LK ++ KG++YLH IHRD
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHSEKKIHRD 126
Query: 416 LKAANLLMDENEVVKVADFGVA------RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK 469
+KAAN+L+ E VK+ADFGVA ++K + V GT WMAPEVI+ YD K
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-----GTPFWMAPEVIQQSAYDSK 181
Query: 470 ADVFSFGIVLWELLTGKLPYEYLTPLQ 496
AD++S GI EL G+ P + P++
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDMHPMR 208
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 6e-31
Identities = 56/201 (27%), Positives = 102/201 (50%), Gaps = 23/201 (11%)
Query: 299 KVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ G+YG +Y+ + VA+K ++ + + +E+ ++++++H N+V+ +
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLD 65
Query: 357 ACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
L +V E+ D YL K G + + + +G+ Y H + I+H
Sbjct: 66 VIHTERKLYLVFEYCD----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILH 121
Query: 414 RDLKAANLLMDENEVVKVADFGVAR-----VKAQSGVMTAETGT--YRWMAPEVI-EHKP 465
RDLK N+L++ + V+K+ADFG+AR ++ T E T YR APE++ K
Sbjct: 122 RDLKPQNILINRDGVLKLADFGLARAFGIPLRT----YTHEVVTLWYR--APEILLGSKH 175
Query: 466 YDHKADVFSFGIVLWELLTGK 486
Y D++S G + E++TGK
Sbjct: 176 YSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 7e-31
Identities = 69/201 (34%), Positives = 114/201 (56%), Gaps = 12/201 (5%)
Query: 300 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 353
+ SG++G +Y+G + + VAIK+L E EF E IM + H ++V+
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
+G C P ++ +VT+ M G + DY+H+ K LL + ++KGM YL + ++H
Sbjct: 74 LLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVH 132
Query: 414 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKA 470
RDL A N+L+ VK+ DFG+AR ++ A+ G +WMA E I ++ + H++
Sbjct: 133 RDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQS 192
Query: 471 DVFSFGIVLWELLT-GKLPYE 490
DV+S+G+ +WEL+T G PY+
Sbjct: 193 DVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 8e-31
Identities = 70/201 (34%), Positives = 113/201 (56%), Gaps = 6/201 (2%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ GS+G++++G + VAIK++ E +++ + QE+ ++ + V ++ G
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYVTKYYG 69
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ K L I+ E++ GGS D L G + + ++ KG++YLH IHRD+
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDI 127
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSF 475
KAAN+L+ E+ VK+ADFGVA + + GT WMAPEVI+ YD KAD++S
Sbjct: 128 KAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 187
Query: 476 GIVLWELLTGKLPYEYLTPLQ 496
GI EL G+ P+ L P++
Sbjct: 188 GITAIELAKGEPPHSELHPMK 208
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 73/237 (30%), Positives = 118/237 (49%), Gaps = 40/237 (16%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 337
WE+ L G + G +G + D VA+K+LK + D+ +
Sbjct: 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLS-DLI 71
Query: 338 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------H 381
E+ +M+ + +HKN++ +GACT+ L ++ E+ S G++ +YL
Sbjct: 72 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQ 131
Query: 382 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--- 438
+ L+ A V++GM YL IHRDL A N+L+ E+ V+K+ADFG+AR
Sbjct: 132 VPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 191
Query: 439 -----VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
K +G + +WMAPE + + Y H++DV+SFG++LWE+ T G PY
Sbjct: 192 HIDYYKKTTNGRLPV-----KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 3e-30
Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 14/205 (6%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS-QD-----VAIKVLKPERINSDMQKEFAQEVFIMRK 345
+HLKF ++ G++G + Y QD VA+K L+ ++ ++F +E+ I++
Sbjct: 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKS 61
Query: 346 VRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
++H N+V++ G C +L +V E++ GS+ DYL K + LL A + KGM
Sbjct: 62 LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGM 121
Query: 404 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMTAETGTYR--WMAPE 459
YL +HRDL N+L++ VK+ DFG+ +V Q E G W APE
Sbjct: 122 EYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPE 181
Query: 460 VIEHKPYDHKADVFSFGIVLWELLT 484
+ + +DV+SFG+VL+EL T
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 4e-30
Identities = 70/222 (31%), Positives = 112/222 (50%), Gaps = 25/222 (11%)
Query: 300 VASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQK--EFAQEVFIMRKVRHKNVV 352
+ G +G +Y GT D A+K L RI +D+++ +F +E IM+ H NV+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLN--RI-TDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 353 QFIGACTKPPSL-CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
+G C +V +M G + +++ + L+ + V+KGM YL
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKF 119
Query: 412 IHRDLKAANLLMDENEVVKVADFGVAR---------VKAQSGVMTAETGTYRWMAPEVIE 462
+HRDL A N ++DE+ VKVADFG+AR V +G +WMA E ++
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP----VKWMALESLQ 175
Query: 463 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503
+ + K+DV+SFG++LWEL+T G PY + V ++Q
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ 217
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 4e-30
Identities = 66/197 (33%), Positives = 105/197 (53%), Gaps = 26/197 (13%)
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
VA+K+LK E ++DMQ +F +E +M + H N+V+ +G C +C++ E+M+ G +
Sbjct: 38 VAVKMLK-EEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 96
Query: 378 DYLH-----------------KLKGVFKLP----SLLKVAIDVSKGMNYLHQNNIIHRDL 416
++L + G+ LP L +A V+ GM YL + +HRDL
Sbjct: 97 EFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDL 156
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVF 473
N L+ EN VVK+ADFG++R + A RWM PE I + Y ++DV+
Sbjct: 157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVW 216
Query: 474 SFGIVLWELLT-GKLPY 489
++G+VLWE+ + G PY
Sbjct: 217 AYGVVLWEIFSYGMQPY 233
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 75/246 (30%), Positives = 124/246 (50%), Gaps = 42/246 (17%)
Query: 278 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERI 328
++P D WE L G + G +G + D VA+K+LK +
Sbjct: 3 ELPED--PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT 60
Query: 329 NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--- 384
D+ + E+ +M+ + +HKN++ +GACT+ L ++ E+ S G++ +YL +
Sbjct: 61 EKDLS-DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 119
Query: 385 -----GVFKLPS-------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVA 432
+ ++P L+ V++GM YL IHRDL A N+L+ EN V+K+A
Sbjct: 120 MEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 179
Query: 433 DFGVAR--------VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT 484
DFG+AR K +G + +WMAPE + + Y H++DV+SFG+++WE+ T
Sbjct: 180 DFGLARDVNNIDYYKKTTNGRLPV-----KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
Query: 485 -GKLPY 489
G PY
Sbjct: 235 LGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 76/237 (32%), Positives = 122/237 (51%), Gaps = 40/237 (16%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 337
WE+ L G + G +G + D VA+K+LK + + D+ +
Sbjct: 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLS-DLV 65
Query: 338 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--------GVFK 388
E+ +M+ + +HKN++ +GACT+ L ++ E+ S G++ +YL + K
Sbjct: 66 SEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125
Query: 389 LPS-------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--- 438
LP L+ A V++GM YL IHRDL A N+L+ E+ V+K+ADFG+AR
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVH 185
Query: 439 -----VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
K +G + +WMAPE + + Y H++DV+SFG++LWE+ T G PY
Sbjct: 186 NIDYYKKTTNGRLPV-----KWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 73/214 (34%), Positives = 119/214 (55%), Gaps = 12/214 (5%)
Query: 303 GSYGDLYRGTYCSQDVAIKVLK-PERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361
G+YG +Y S V I + + PER + +Q +E+ + ++H+N+VQ++G+ ++
Sbjct: 19 GTYGIVYAARDLSTQVRIAIKEIPERDSRYVQP-LHEEIALHSYLKHRNIVQYLGSDSEN 77
Query: 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKL--PSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
I E + GGS+ L G K +++ + +G+ YLH N I+HRD+K
Sbjct: 78 GFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGD 137
Query: 420 NLLMDE-NEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKP--YDHKADVFSF 475
N+L++ + VVK++DFG ++ A T TGT ++MAPEVI+ P Y AD++S
Sbjct: 138 NVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSL 197
Query: 476 GIVLWELLTGKLPYEYLTPLQAA---VGVVQKVH 506
G + E+ TGK P+ L QAA VG+ K+H
Sbjct: 198 GCTIVEMATGKPPFIELGEPQAAMFKVGMF-KIH 230
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 1e-29
Identities = 77/214 (35%), Positives = 119/214 (55%), Gaps = 19/214 (8%)
Query: 300 VASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG 356
V +G+YG +Y+G + Q AIKV+ + D ++E QE+ +++K H+N+ + G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNIATYYG 70
Query: 357 ACTK--PP----SLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQN 409
A K PP L +V EF GSV D + KG K + + ++ +G+++LHQ+
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 130
Query: 410 NIIHRDLKAANLLMDENEVVKVADFGV-ARVKAQSGVMTAETGTYRWMAPEVI--EHKP- 465
+IHRD+K N+L+ EN VK+ DFGV A++ G GT WMAPEVI + P
Sbjct: 131 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 190
Query: 466 --YDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 497
YD K+D++S GI E+ G P + P++A
Sbjct: 191 ATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA 224
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 59/231 (25%), Positives = 104/231 (45%), Gaps = 36/231 (15%)
Query: 295 KFGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-----R 347
KFG + GS+ + +++ AIK+L ++ +K + V I ++V
Sbjct: 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK-EKKV--KYVKIEKEVLTRLNG 60
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H +++ +L V E+ G + Y+ K G A ++ + YLH
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLH 119
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVARV-----------------KAQSGVMTAET 450
IIHRDLK N+L+D++ +K+ DFG A+V +Q
Sbjct: 120 SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179
Query: 451 ----GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP----YEYLT 493
GT +++PE++ KP +D+++ G +++++LTGK P EYLT
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT 230
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 74/224 (33%), Positives = 117/224 (52%), Gaps = 26/224 (11%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFI 342
WE +KF + G++G + R + AIK+LK E + + ++FA E+ +
Sbjct: 1 WE----DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK-EFASENDHRDFAGELEV 55
Query: 343 MRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS---------- 391
+ K+ H N++ +GAC L I E+ G++ D+L K + + P+
Sbjct: 56 LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST 115
Query: 392 -----LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 446
LL+ A DV+ GM YL + IHRDL A N+L+ EN K+ADFG++R +
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK 175
Query: 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
T RWMA E + + Y K+DV+SFG++LWE+++ G PY
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 3e-29
Identities = 74/214 (34%), Positives = 117/214 (54%), Gaps = 19/214 (8%)
Query: 300 VASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG 356
V +G+YG +Y+G + Q AIKV+ + D ++E E+ +++K H+N+ + G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMD---VTEDEEEEIKLEINMLKKYSHHRNIATYYG 80
Query: 357 ACTK--PP----SLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQN 409
A K PP L +V EF GSV D + KG K + + ++ +G+ +LH +
Sbjct: 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH 140
Query: 410 NIIHRDLKAANLLMDENEVVKVADFGV-ARVKAQSGVMTAETGTYRWMAPEVI--EHKP- 465
+IHRD+K N+L+ EN VK+ DFGV A++ G GT WMAPEVI + P
Sbjct: 141 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 200
Query: 466 --YDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 497
YD+++D++S GI E+ G P + P++A
Sbjct: 201 ATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA 234
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 60/181 (33%), Positives = 100/181 (55%), Gaps = 7/181 (3%)
Query: 310 RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP--SLCIV 367
G + VA+K LKPE + + + +E+ I+R + H+N+V++ G CT+ + ++
Sbjct: 28 EGDNTGEQVAVKSLKPESGGNHIA-DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI 86
Query: 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427
EF+ GS+ +YL + K L LK A+ + KGM+YL +HRDL A N+L++
Sbjct: 87 MEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH 146
Query: 428 VVKVADFGVAR-VKAQSGVMTAE---TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELL 483
VK+ DFG+ + ++ T + W APE + + +DV+SFG+ L+ELL
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206
Query: 484 T 484
T
Sbjct: 207 T 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 5e-29
Identities = 71/222 (31%), Positives = 117/222 (52%), Gaps = 22/222 (9%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMR 344
++ +KF + G++G + + D AIK +K E + D ++FA E+ ++
Sbjct: 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLC 62
Query: 345 KV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS------------ 391
K+ H N++ +GAC L + E+ G++ D+L K + + P+
Sbjct: 63 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 122
Query: 392 ---LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448
LL A DV++GM+YL Q IHRDL A N+L+ EN V K+ADFG++R + T
Sbjct: 123 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 182
Query: 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
RWMA E + + Y +DV+S+G++LWE+++ G PY
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 224
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 5e-29
Identities = 66/203 (32%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 299 KVASGSYGDLYRGTYCSQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 354
++ SG++G + +G Y + DVAIKVLK E S + E +E IM ++ + +V+
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSV-RDEMMREAEIMHQLDNPYIVRM 60
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
IG C + +L +V E SGG + +L K + +++++ VS GM YL N +HR
Sbjct: 61 IGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119
Query: 415 DLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETG---TYRWMAPEVIEHKPYDHKA 470
DL A N+L+ K++DFG+++ + A A + +W APE I + + ++
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRS 179
Query: 471 DVFSFGIVLWELLT-GKLPYEYL 492
DV+S+GI +WE + G+ PY+ +
Sbjct: 180 DVWSYGITMWEAFSYGQKPYKKM 202
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 5e-29
Identities = 68/201 (33%), Positives = 111/201 (55%), Gaps = 12/201 (5%)
Query: 300 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 353
+ SG++G +Y+G + VAIKVL+ E + KE E ++M V V +
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLR-ENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
+G C ++ +VT+ M G + DY+ + K LL + ++KGM+YL + ++H
Sbjct: 74 LLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVH 132
Query: 414 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKA 470
RDL A N+L+ VK+ DFG+AR + A+ G +WMA E I H+ + H++
Sbjct: 133 RDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQS 192
Query: 471 DVFSFGIVLWELLT-GKLPYE 490
DV+S+G+ +WEL+T G PY+
Sbjct: 193 DVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 58/198 (29%), Positives = 115/198 (58%), Gaps = 6/198 (3%)
Query: 298 SKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 355
K+ GS+G L + + IK + +++ ++E +EV ++ ++H N+VQ+
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
+ + +L IV ++ GG +Y ++ +GV F +L + + + ++H I+HR
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHR 125
Query: 415 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADV 472
D+K+ N+ + ++ +K+ DFG+ARV S V A T GT +++PE+ E++PY++K+D+
Sbjct: 126 DIKSQNIFLTKDGTIKLGDFGIARV-LNSTVELARTCIGTPYYLSPEICENRPYNNKSDI 184
Query: 473 FSFGIVLWELLTGKLPYE 490
++ G VL+E+ T K +E
Sbjct: 185 WALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 67/245 (27%), Positives = 117/245 (47%), Gaps = 41/245 (16%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRGTYCSQD-------------------VAIKVLKPERI 328
E + L+ K+ G +G+++ C + VA+K+L+ + +
Sbjct: 1 EFPRQQLRLKEKLGEGQFGEVH---LCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-V 56
Query: 329 NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH------K 382
+ +F +E+ IM ++++ N+++ +G C LC++TE+M G + +L
Sbjct: 57 TKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIEST 116
Query: 383 LKGVFKLPS-----LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437
+PS LL +A+ ++ GM YL N +HRDL N L+ + +K+ADFG++
Sbjct: 117 FTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
Query: 438 RVKAQSGVMTAETG----TYRWMAPEVIEHKPYDHKADVFSFGIVLWEL--LTGKLPYEY 491
R SG G RWMA E I + +DV++FG+ LWE+ L + PY
Sbjct: 177 R-NLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235
Query: 492 LTPLQ 496
L+ Q
Sbjct: 236 LSDEQ 240
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 2e-28
Identities = 54/195 (27%), Positives = 111/195 (56%), Gaps = 4/195 (2%)
Query: 300 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357
V G++G ++ R + V IK + E++ D + E +++ + H N++++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 358 CTKPPSLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ +L IV E+ GG++ +Y+ K + ++L + + ++++H I+HRDL
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDL 127
Query: 417 KAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 475
K N+L+D+++ VVK+ DFG++++ + GT +++PE+ E KPY+ K+D+++
Sbjct: 128 KTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWAL 187
Query: 476 GIVLWELLTGKLPYE 490
G VL+EL + K +E
Sbjct: 188 GCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 2e-28
Identities = 63/198 (31%), Positives = 115/198 (58%), Gaps = 7/198 (3%)
Query: 299 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ GS+G +Y + S+ IK + ++ ++ +EV ++ K++H N+V F
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
+ + L IV E+ GG + +++ +GV F +L + +S G+ ++H I+HRD
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRD 126
Query: 416 LKAANLLMDEN-EVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADV 472
+K+ N+ + +N V K+ DFG+AR S + A T GT +++PE+ +++PY++K D+
Sbjct: 127 IKSQNIFLSKNGMVAKLGDFGIARQLNDS-MELAYTCVGTPYYLSPEICQNRPYNNKTDI 185
Query: 473 FSFGIVLWELLTGKLPYE 490
+S G VL+EL T K P+E
Sbjct: 186 WSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 6e-28
Identities = 65/195 (33%), Positives = 102/195 (52%), Gaps = 8/195 (4%)
Query: 300 VASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 356
+ G +G + S++ A+K +K I Q+E E I+ + H +V+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
+ ++ E+ GG ++ L +G+F + + +A V YLH II+RD
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRD-RGLFDEYTARFYIACVVL-AFEYLHNRGIIYRD 118
Query: 416 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFS 474
LK NLL+D N VK+ DFG A+ K +SG T GT ++APE+I +K YD D +S
Sbjct: 119 LKPENLLLDSNGYVKLVDFGFAK-KLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWS 177
Query: 475 FGIVLWELLTGKLPY 489
GI+L+ELLTG+ P+
Sbjct: 178 LGILLYELLTGRPPF 192
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 7e-28
Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 13/205 (6%)
Query: 302 SGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358
G+YG ++ + AIKV+ K + I + + E I+ + + VV+ +
Sbjct: 3 KGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF 62
Query: 359 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 418
+L +V E++ GG + L + G ++ + YLH N IIHRDLK
Sbjct: 63 QGKKNLYLVMEYLPGGDLASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKP 121
Query: 419 ANLLMDENEVVKVADFGVARVKAQS-----GVMTAET----GTYRWMAPEVIEHKPYDHK 469
N+L+D N +K+ DFG+++V E GT ++APEVI + +
Sbjct: 122 DNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKT 181
Query: 470 ADVFSFGIVLWELLTGKLPYEYLTP 494
D +S G +L+E L G P+ TP
Sbjct: 182 VDWWSLGCILYEFLVGIPPFHGETP 206
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 8e-28
Identities = 72/220 (32%), Positives = 118/220 (53%), Gaps = 10/220 (4%)
Query: 285 DVWEIDPKH-LKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 341
D+ +P+H + +V SG+YGD+Y R + + A+K++K E D QE+F
Sbjct: 1 DILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIF 58
Query: 342 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 401
++++ +H N+V + G+ L I E+ GGS+ D H + G + V + +
Sbjct: 59 MVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQ 117
Query: 402 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV-ARVKAQSGVMTAETGTYRWMAPEV 460
G+ YLH +HRD+K AN+L+ +N VK+ADFGV A++ A + GT WMAPEV
Sbjct: 118 GLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV 177
Query: 461 I---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 497
++ Y+ D+++ GI EL + P L P++A
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 42/212 (19%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKE-----FAQEVFIMRKVRHKNV 351
++ G+YG +Y+ + VA+K +I + +KE +E+ +++K+RH N+
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALK-----KIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVY---DYL-HKLKGVFKLPSLLKVAIDVSK------ 401
V+ IVT GS+Y +Y+ H L G+ P + K K
Sbjct: 61 VRLK---------EIVTS-KGKGSIYMVFEYMDHDLTGLLDSPEV-KFTESQIKCYMKQL 109
Query: 402 --GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGT--YRW 455
G+ YLH N I+HRD+K +N+L++ + V+K+ADFG+AR K S T T YR
Sbjct: 110 LEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYR- 168
Query: 456 MAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 486
PE++ Y + D++S G +L EL GK
Sbjct: 169 -PPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 55/194 (28%), Positives = 96/194 (49%), Gaps = 7/194 (3%)
Query: 298 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 355
K+ G+YG +Y R + VAIK +K + + K +E+ +++++ H N+++ +
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
L +V EFM +Y + + + + +G+ + H + I+HRD
Sbjct: 65 DVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRD 123
Query: 416 LKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWM-APEVI-EHKPYDHKADV 472
LK NLL++ V+K+ADFG+AR T T RW APE++ K Y D+
Sbjct: 124 LKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVT-RWYRAPELLLGDKGYSTPVDI 182
Query: 473 FSFGIVLWELLTGK 486
+S G + ELL+ +
Sbjct: 183 WSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 74/256 (28%), Positives = 116/256 (45%), Gaps = 64/256 (25%)
Query: 293 HLKFGSKVASGSYGDLYRGTYCSQD---------------------VAIKVLKPERINSD 331
HL F K+ G +G+++ C VA+K+L+P+ N +
Sbjct: 6 HLLFKEKLGEGQFGEVH---LCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD-ANKN 61
Query: 332 MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL--HKLKG---- 385
+ +F +EV I+ +++ N+++ +G C LC++TE+M G + +L H L
Sbjct: 62 ARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEEN 121
Query: 386 ------------VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVAD 433
SLL VA+ ++ GM YL N +HRDL N L+ EN +K+AD
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIAD 181
Query: 434 FGVARVKAQSGVMTAETGTY-----------RWMAPEVIEHKPYDHKADVFSFGIVLWEL 482
FG++R G Y RWMA E I + +DV++FG+ LWE+
Sbjct: 182 FGMSR--------NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233
Query: 483 LT--GKLPYEYLTPLQ 496
L + PY LT Q
Sbjct: 234 LMLCKEQPYGELTDEQ 249
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 3e-27
Identities = 74/208 (35%), Positives = 114/208 (54%), Gaps = 15/208 (7%)
Query: 299 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFA---QEVFIMRKVRHKNVVQ 353
++ SG+YGD+Y R + AIKV+K E ++FA QE+ +M+ +H N+V
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEP-----GEDFAVVQQEIIMMKDCKHSNIVA 70
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
+ G+ + L I EF GGS+ D H + G + V+ + +G+ YLH +H
Sbjct: 71 YFGSYLRRDKLWICMEFCGGGSLQDIYH-VTGPLSESQIAYVSRETLQGLYYLHSKGKMH 129
Query: 414 RDLKAANLLMDENEVVKVADFGV-ARVKAQSGVMTAETGTYRWMAPEV--IEHK-PYDHK 469
RD+K AN+L+ +N VK+ADFGV A++ A + GT WMAPEV +E K Y+
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQL 189
Query: 470 ADVFSFGIVLWELLTGKLPYEYLTPLQA 497
D+++ GI EL + P L P++A
Sbjct: 190 CDIWAVGITAIELAELQPPMFDLHPMRA 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 3e-27
Identities = 69/211 (32%), Positives = 112/211 (53%), Gaps = 22/211 (10%)
Query: 300 VASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQF 354
+ G++G + + D AIK +K E + D ++FA E+ ++ K+ H N++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS---------------LLKVAIDV 399
+GAC L + E+ G++ D+L K + + P+ LL A DV
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 459
++GM+YL Q IHRDL A N+L+ EN V K+ADFG++R + T RWMA E
Sbjct: 122 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIE 181
Query: 460 VIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
+ + Y +DV+S+G++LWE+++ G PY
Sbjct: 182 SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 67/214 (31%), Positives = 116/214 (54%), Gaps = 12/214 (5%)
Query: 290 DP--KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA-QEVFIMR 344
DP K+ +F K+ G+ G +Y + Q+VAIK + + +KE E+ +MR
Sbjct: 16 DPKKKYTRF-EKIGQGASGTVYTAIDVATGQEVAIKQMN---LQQQPKKELIINEILVMR 71
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 404
+ +H N+V ++ + L +V E+++GGS+ D + + + V + + +
Sbjct: 72 ENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALE 129
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEH 463
+LH N +IHRD+K+ N+L+ + VK+ DFG A++ + + GT WMAPEV+
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 464 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 497
K Y K D++S GI+ E++ G+ PY PL+A
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 5e-27
Identities = 63/204 (30%), Positives = 107/204 (52%), Gaps = 20/204 (9%)
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
VA+K LK + +++F +E ++ ++H+++V+F G CT+ L +V E+M G +
Sbjct: 38 VAVKALK--EASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLN 95
Query: 378 DYL-------HKLK-------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
+L L G L +L +A ++ GM YL + +HRDL N L+
Sbjct: 96 RFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV 155
Query: 424 DENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLW 480
+ VVK+ DFG++R + T RWM PE I ++ + ++D++SFG+VLW
Sbjct: 156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLW 215
Query: 481 ELLT-GKLPYEYLTPLQAAVGVVQ 503
E+ T GK P+ L+ +A + Q
Sbjct: 216 EIFTYGKQPWYQLSNTEAIECITQ 239
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 6e-27
Identities = 66/190 (34%), Positives = 105/190 (55%), Gaps = 17/190 (8%)
Query: 316 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG------ACTKPPSLCIVTE 369
Q VA+K+LK + +S +EF +E M++ H NV++ IG A + P ++
Sbjct: 28 QKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILP 87
Query: 370 FMSGGSVYDYLHKLK---GVFKLP--SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD 424
FM G ++ +L + F LP +L++ ID++ GM YL N IHRDL A N +++
Sbjct: 88 FMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN 147
Query: 425 ENEVVKVADFGVARVKAQSGVM----TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLW 480
EN V VADFG+++ K SG A +W+A E + Y +DV++FG+ +W
Sbjct: 148 ENMTVCVADFGLSK-KIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMW 206
Query: 481 ELLT-GKLPY 489
E++T G+ PY
Sbjct: 207 EIMTRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 6e-27
Identities = 60/214 (28%), Positives = 112/214 (52%), Gaps = 12/214 (5%)
Query: 291 PKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMR 344
L+ + SG +G +++G + + VAIK ++ +R +E + M
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ-DRSGRQTFQEITDHMLAMG 64
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 404
+ H +V+ +G C SL +VT+ GS+ D++ + + LL + ++KGM
Sbjct: 65 SLDHAYIVRLLGICPGA-SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMY 123
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVI 461
YL ++ ++HR+L A N+L+ + +V++ADFGVA + + + +WMA E I
Sbjct: 124 YLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 462 EHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTP 494
Y H++DV+S+G+ +WE+++ G PY + P
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP 217
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 29/212 (13%)
Query: 295 KFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQ---KEFAQEVFIMRKVRHK 349
+ G K+ G+Y +Y+ + VAIK +K +E+ ++++++H
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHP 62
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS-------KG 402
N++ + ++ +V EFM L+ V K S++ D+ +G
Sbjct: 63 NIIGLLDVFGHKSNINLVFEFMET--------DLEKVIKDKSIVLTPADIKSYMLMTLRG 114
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWM-APEV 460
+ YLH N I+HRDLK NLL+ + V+K+ADFG+AR MT + T RW APE+
Sbjct: 115 LEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVT-RWYRAPEL 173
Query: 461 I---EHKPYDHKADVFSFGIVLWELLTGKLPY 489
+ H Y D++S G + ELL P+
Sbjct: 174 LFGARH--YGVGVDMWSVGCIFAELLLRV-PF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 71/215 (33%), Positives = 116/215 (53%), Gaps = 17/215 (7%)
Query: 291 PKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQ---EVFIMRK 345
P + + G + G++G++Y +++A+K + + + + KE E+ +++
Sbjct: 1 PVNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKN 60
Query: 346 VRHKNVVQFIGACTKPPS---LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
+RH +VQ+ G C + P L I E+M GGS+ D L K G + + +G
Sbjct: 61 LRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQILQG 118
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-----TGTYRWMA 457
++YLH N I+HRD+K AN+L D VK+ DFG ++ + Q+ M+ TGT WM+
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK-RIQTICMSGTGIKSVTGTPYWMS 177
Query: 458 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPY-EY 491
PEVI + Y KADV+S + E+LT K P+ EY
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
+ GS+G + + S + + K + + +++ EV I+R+++H N+V++
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 357 ACTKPPS--LCIVTEFMSGG---SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH---- 407
+ L IV E+ GG + K + + + ++ + + H
Sbjct: 67 RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126
Query: 408 -QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHK 464
N ++HRDLK AN+ +D N VK+ DFG+A++ A+T GT +M+PE + H
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI-LGHDSSFAKTYVGTPYYMSPEQLNHM 185
Query: 465 PYDHKADVFSFGIVLWELLTGKLPYE 490
YD K+D++S G +++EL P+
Sbjct: 186 SYDEKSDIWSLGCLIYELCALSPPFT 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 65/223 (29%), Positives = 115/223 (51%), Gaps = 29/223 (13%)
Query: 294 LKFGSKVASGSYGDLYRGTYC------SQDVAIKVLKPERINSDMQ-KEFAQEVFIMRKV 346
++F ++ ++G +Y+G +Q VAIK LK IN+ Q EF QE +M ++
Sbjct: 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKD--INNPQQWGEFQQEASLMAEL 64
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL----------------HKLKGVFKLP 390
H N+V +G T+ +C++ E+++ G ++++L +K
Sbjct: 65 HHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 391 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET 450
L +AI ++ GM YL + +H+DL A N+L+ E VK++D G++R + +
Sbjct: 125 DFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184
Query: 451 GTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
+ RWM PE I + + +D++SFG+VLWE+ + G PY
Sbjct: 185 KSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 2e-26
Identities = 70/230 (30%), Positives = 123/230 (53%), Gaps = 23/230 (10%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI----NSDMQKEFAQEV 340
+ WEI ++ G++G +Y+ +Q+ VL ++ + + +++ E+
Sbjct: 5 EFWEII-------GELGDGAFGKVYK----AQNKETGVLAAAKVIDTKSEEELEDYMVEI 53
Query: 341 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 400
I+ H N+V+ + A +L I+ EF +GG+V + +L+ P + V
Sbjct: 54 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTL 113
Query: 401 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAP 458
+ +NYLH+N IIHRDLKA N+L + +K+ADFGV+ K + ++ GT WMAP
Sbjct: 114 EALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVS-AKNTRTIQRRDSFIGTPYWMAP 172
Query: 459 EVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503
EV+ + +PYD+KADV+S GI L E+ + P+ L P++ + + +
Sbjct: 173 EVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK 222
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 56/160 (35%), Positives = 91/160 (56%), Gaps = 3/160 (1%)
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 398
EV IMR +H N+V+ + L +V EF+ GG++ D + + + V +
Sbjct: 66 EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLA 123
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMA 457
V K +++LH +IHRD+K+ ++L+ + VK++DFG A+V + + GT WMA
Sbjct: 124 VLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 183
Query: 458 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 497
PEVI PY + D++S GI++ E++ G+ PY PLQA
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 73/214 (34%), Positives = 117/214 (54%), Gaps = 15/214 (7%)
Query: 291 PKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQ---EVFIMRK 345
P + + G + G++G +Y +++A K ++ + + + KE + E+ +++
Sbjct: 1 PINWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKN 60
Query: 346 VRHKNVVQFIGACTK---PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
++H+ +VQ+ G C + +L I E+M GGSV D L K G K + +G
Sbjct: 61 LQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQILEG 118
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR---VKAQSGV-MTAETGTYRWMAP 458
M+YLH N I+HRD+K AN+L D VK+ DFG ++ SG + + TGT WM+P
Sbjct: 119 MSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178
Query: 459 EVIEHKPYDHKADVFSFGIVLWELLTGKLPY-EY 491
EVI + Y KADV+S G + E+LT K P+ EY
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 62/200 (31%), Positives = 114/200 (57%), Gaps = 11/200 (5%)
Query: 299 KVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 354
++ SG++G + +G Y + VA+K+LK + + ++ E +E +M+++ + +V+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
IG C + S +V E G + +L K K V ++ ++ VS GM YL + N +HR
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHV-TEKNITELVHQVSMGMKYLEETNFVHR 119
Query: 415 DLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAET-GTY--RWMAPEVIEHKPYDHKA 470
DL A N+L+ K++DFG+++ + A A+T G + +W APE + + + K+
Sbjct: 120 DLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKS 179
Query: 471 DVFSFGIVLWELLT-GKLPY 489
DV+SFG+++WE + G+ PY
Sbjct: 180 DVWSFGVLMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 60/193 (31%), Positives = 108/193 (55%), Gaps = 10/193 (5%)
Query: 299 KVASGSYGDLY--RGTYCSQDVAIKVLKP---ERINSDMQKEFAQEVFIMRKVRHKNVVQ 353
++ GS+G +Y + + +KVLK +N + + QE ++ K+ H +V+
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNN 410
F + + + CI+TE+ G + L +LK + + I + G++Y+HQ
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126
Query: 411 IIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGTYRWMAPEVIEHKPYDHK 469
I+HRDLKA N+ + N ++K+ DFGV+R+ S + T TGT +M+PE ++H+ YD K
Sbjct: 127 ILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSK 185
Query: 470 ADVFSFGIVLWEL 482
+D++S G +L+E+
Sbjct: 186 SDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 70/218 (32%), Positives = 114/218 (52%), Gaps = 12/218 (5%)
Query: 291 PKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQ---EVFIMRK 345
P + + G + G++G +Y +++A+K ++ + + + KE E+ +++
Sbjct: 1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKN 60
Query: 346 VRHKNVVQFIGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
+ H+ +VQ+ G P +L I E M GGS+ D L K G K + +G+
Sbjct: 61 LLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYTRQILEGV 119
Query: 404 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR---VKAQSGV-MTAETGTYRWMAPE 459
+YLH N I+HRD+K AN+L D VK+ DFG ++ SG M + TGT WM+PE
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179
Query: 460 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 497
VI + Y KAD++S G + E+LT K P+ + A
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA 217
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 64/208 (30%), Positives = 109/208 (52%), Gaps = 10/208 (4%)
Query: 294 LKFGSKVASGSYGD----LYRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRH 348
+F + +GS+G ++G+ + A+K+L +I Q E E I++ +RH
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSG--KYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
+V G+ +L +V E++ GG ++ +L K G F P A V + YLH
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHS 119
Query: 409 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 468
+I++RDLK NLL+D + +K+ DFG A+ + + T GT ++APE+I K Y
Sbjct: 120 LDIVYRDLKPENLLLDSDGYIKITDFGFAK-RVKGRTYTL-CGTPEYLAPEIILSKGYGK 177
Query: 469 KADVFSFGIVLWELLTGKLPYEYLTPLQ 496
D ++ GI+++E+L G P+ P+Q
Sbjct: 178 AVDWWALGILIYEMLAGYPPFFDDNPIQ 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 61/196 (31%), Positives = 103/196 (52%), Gaps = 21/196 (10%)
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
VA+K LK + + +K+F +E ++ ++H+++V+F G C L +V E+M G +
Sbjct: 38 VAVKALKDPTLAA--RKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN 95
Query: 378 DYLH---------------KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 422
+L + KG L +L +A ++ GM YL + +HRDL N L
Sbjct: 96 KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL 155
Query: 423 MDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVL 479
+ N +VK+ DFG++R + T RWM PE I ++ + ++DV+SFG++L
Sbjct: 156 VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 215
Query: 480 WELLT-GKLPYEYLTP 494
WE+ T GK P+ L+
Sbjct: 216 WEIFTYGKQPWFQLSN 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 6e-26
Identities = 69/229 (30%), Positives = 117/229 (51%), Gaps = 17/229 (7%)
Query: 276 HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ 333
H++ D +VWEI ++ G++G +Y+ A KV+ E + +
Sbjct: 3 HVRRDLDPNEVWEII-------GELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEEL 53
Query: 334 KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL 393
+++ E+ I+ H +V+ +GA L I+ EF GG+V + +L P +
Sbjct: 54 EDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ 113
Query: 394 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGT 452
+ + + + YLH IIHRDLKA N+L+ + +K+ADFGV+ ++ + GT
Sbjct: 114 VICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGT 173
Query: 453 YRWMAPEVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 496
WMAPEV+ + PYD+KAD++S GI L E+ + P+ L P++
Sbjct: 174 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 222
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 65/235 (27%), Positives = 116/235 (49%), Gaps = 35/235 (14%)
Query: 294 LKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
L G + G +G + + T VA+K+LK E +S ++ E ++++V
Sbjct: 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-ENASSSELRDLLSEFNLLKQV 60
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-------------------- 386
H +V++ GAC++ L ++ E+ GS+ +L + + V
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 387 ---FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQ 442
+ L+ A +S+GM YL + ++HRDL A N+L+ E +K++DFG++R V +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 443 SGVMTAETG--TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTP 494
+ G +WMA E + Y ++DV+SFG++LWE++T G PY + P
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 59/217 (27%), Positives = 109/217 (50%), Gaps = 25/217 (11%)
Query: 303 GSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQFI 355
G++G ++ G ++V +K +K S++Q QE ++ + H+N++ +
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPIL 74
Query: 356 GACTK---PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS-------LLKVAIDVSKGMNY 405
C + PP + +M+ G++ +L + + L+ +AI ++ GM+Y
Sbjct: 75 HVCIEDGEPPFVLY--PYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132
Query: 406 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR---WMAPEVIE 462
LH+ +IH+D+ A N ++DE VK+ D ++R R WMA E +
Sbjct: 133 LHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLV 192
Query: 463 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAA 498
+K Y +DV+SFG++LWEL+T G+ PY + P + A
Sbjct: 193 NKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA 229
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 75/245 (30%), Positives = 123/245 (50%), Gaps = 27/245 (11%)
Query: 292 KHLKFGSKVASGSYGD--LYRGTYCSQD----VAIKVLKPERINSDMQKE-FAQEVFIMR 344
++LK + G +G LY + VA+K LK E + +E+ I++
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE--CGQQNTSGWKKEINILK 61
Query: 345 KVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
+ H+N+V++ G C++ L ++ E++ GS+ DYL K K L LL A + +G
Sbjct: 62 TLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEG 119
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGTYR--WMAP 458
M YLH + IHRDL A N+L+D + +VK+ DFG+A+ + E G W A
Sbjct: 120 MAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAV 179
Query: 459 EVIEHKPYDHKADVFSFGIVLWELLTGKLPY--------EYLTPLQAAVGVVQKVHHSFL 510
E ++ + + +DV+SFG+ L+ELLT E + P Q + VV+ + L
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI--ELL 237
Query: 511 EQRLR 515
E+ +R
Sbjct: 238 ERGMR 242
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 47/171 (27%), Positives = 87/171 (50%), Gaps = 4/171 (2%)
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
VA+K + R+ + + +E+ ++ +H VV+ + +V E+M +
Sbjct: 28 VALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLS 86
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437
+ L + + + KG+ Y+H N I+HRDLK ANLL+ + V+K+ADFG+A
Sbjct: 87 EVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLA 146
Query: 438 RV--KAQSGVMTAETGTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELLTG 485
R+ + + + + + T + APE++ YD D+++ G + ELL G
Sbjct: 147 RLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 68/216 (31%), Positives = 109/216 (50%), Gaps = 21/216 (9%)
Query: 294 LKFGSKVASGSYGDLYRGTYCSQD----VAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 349
L G + G +G + G D VA+K +K ++F E M++ H
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 350 NVVQFIGACTKP------PSLCIVTEFMSGGSVYDYL--HKLKGV-FKLPS--LLKVAID 398
NV++ IG C + PS ++ FM G ++ +L +L LP+ L+K D
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE----TGTYR 454
++ GM YL + IHRDL A N +++EN V VADFG+++ K +G + +
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK-KIYNGDYYRQGRIAKMPVK 179
Query: 455 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
W+A E + + Y K+DV+SFG+ +WE+ T G+ PY
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY 215
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 60/195 (30%), Positives = 104/195 (53%), Gaps = 10/195 (5%)
Query: 303 GSYGDL----YRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKV-RHKNVVQFIG 356
GS+G + +GT + A+KVLK + I D E E ++ +H + Q
Sbjct: 6 GSFGKVLLAELKGT--DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHS 63
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
L V E+++GG + ++ + G F P A ++ G+ +LH+ II+RDL
Sbjct: 64 CFQTKDRLFFVMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIYRDL 122
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSF 475
K N+L+D +K+ADFG+ + GV T+ GT ++APE++ ++PY D ++
Sbjct: 123 KLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWAL 182
Query: 476 GIVLWELLTGKLPYE 490
G++L+E+L G+ P+E
Sbjct: 183 GVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 70/243 (28%), Positives = 118/243 (48%), Gaps = 36/243 (14%)
Query: 288 EIDPKHLKFGSKVASGSYGDL----------YRGTYCSQD--------VAIKVLKPERIN 329
E K L F K+ G +G++ + S D VA+K+L+ E N
Sbjct: 1 EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLR-EDAN 59
Query: 330 SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL--HKLKG-- 385
+ + +F +E+ IM +++ N+++ + C LC++TE+M G + +L H+ +
Sbjct: 60 KNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAA 119
Query: 386 ------VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439
+L+ +A ++ GM YL N +HRDL N L+ +N +K+ADFG++R
Sbjct: 120 EKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSR- 178
Query: 440 KAQSGVMTAETG----TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT--GKLPYEYLT 493
SG G RWM+ E I + +DV++FG+ LWE+LT + PY L+
Sbjct: 179 NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238
Query: 494 PLQ 496
Q
Sbjct: 239 DEQ 241
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 62/212 (29%), Positives = 111/212 (52%), Gaps = 13/212 (6%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQEV 340
E+D K +K + +G +G+L RG C + VAI L+ + ++ F E
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRG--CLKLPSKRELPVAIHTLR-AGCSDKQRRGFLAEA 57
Query: 341 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 400
+ + H N+V+ G T+ ++ IVTE+MS G++ +L K +G L+ + ++
Sbjct: 58 LTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLA 117
Query: 401 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG--TYRWMAP 458
GM YL + +H+ L A +L++ + V K++ F + + T +G W AP
Sbjct: 118 SGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAP 177
Query: 459 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
E I++ + +DV+SFGIV+WE+++ G+ PY
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEVMSYGERPY 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 300 VASGSYGDLY------RGTYCSQDVAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK-NV 351
++ G++G +Y G Y AIKVLK + + Q E IM V
Sbjct: 4 ISKGAFGSVYLAKKRSTGDY----FAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYV 59
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
+ + L +V E+++GG + L G + +V G+ LHQ I
Sbjct: 60 AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGI 118
Query: 412 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKA 470
IHRD+K NLL+D+ +K+ DFG++R G+ + GT ++APE I D +
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRN----GLENKKFVGTPDYLAPETILGVGDDKMS 174
Query: 471 DVFSFGIVLWELLTGKLPYEYLTP 494
D +S G V++E L G P+ TP
Sbjct: 175 DWWSLGCVIFEFLFGYPPFHAETP 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 4e-25
Identities = 66/214 (30%), Positives = 116/214 (54%), Gaps = 12/214 (5%)
Query: 290 DPK--HLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMR 344
DPK + +F K+ G+ G +Y Q+VAIK + + +KE E+ +MR
Sbjct: 16 DPKKKYTRF-EKIGQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELIINEILVMR 71
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 404
+ ++ N+V ++ + L +V E+++GGS+ D + + + V + + ++
Sbjct: 72 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALD 129
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEH 463
+LH N +IHRD+K+ N+L+ + VK+ DFG A++ + + GT WMAPEV+
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 464 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 497
K Y K D++S GI+ E++ G+ PY PL+A
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 6e-25
Identities = 61/203 (30%), Positives = 111/203 (54%), Gaps = 9/203 (4%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFI 355
K+ G+ G ++ + Q+VAIK + + +KE E+ +M+++++ N+V F+
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFL 82
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
+ L +V E+++GGS+ D + + + V + + + +LH N +IHRD
Sbjct: 83 DSFLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLHANQVIHRD 140
Query: 416 LKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 474
+K+ N+L+ + VK+ DFG A++ + + GT WMAPEV+ K Y K D++S
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 475 FGIVLWELLTGKLPYEYLTPLQA 497
GI+ E++ G+ PY PL+A
Sbjct: 201 LGIMAIEMVEGEPPYLNENPLRA 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 6e-25
Identities = 70/212 (33%), Positives = 106/212 (50%), Gaps = 12/212 (5%)
Query: 303 GSYGDLYRGTYCSQDVAIKVLK-PERINSDMQKEFAQEVFI-MRKVRHKNVVQFIGACTK 360
G+YG + + + + V + +NS QK ++ I MR V V F GA +
Sbjct: 12 GAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR 71
Query: 361 PPSLCIVTEFMSGGSVYD-YLHKLKGVFKLPS--LLKVAIDVSKGMNYLHQN-NIIHRDL 416
+ I E M S+ Y +P L K+A+ + K + YLH ++IHRD+
Sbjct: 72 EGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDV 130
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI----EHKPYDHKADV 472
K +N+L++ N VK+ DFG++ S T + G +MAPE I K YD K+DV
Sbjct: 131 KPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDV 190
Query: 473 FSFGIVLWELLTGKLPYE-YLTPLQAAVGVVQ 503
+S GI + EL TG+ PY+ + TP Q VV+
Sbjct: 191 WSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 7e-25
Identities = 46/171 (26%), Positives = 83/171 (48%), Gaps = 6/171 (3%)
Query: 321 KVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL 380
K ++ + + + E I++++ H +V + ++ +V + + GG + +L
Sbjct: 37 KCVEKGSVRNVLN-----ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL 91
Query: 381 HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440
+ K F + ++ + YLH IIHRD+K N+L+DE V + DF +A
Sbjct: 92 SQ-KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKV 150
Query: 441 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY 491
+ T+ +GT +MAPEV+ + Y D +S G+ +E L GK PY
Sbjct: 151 TPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 70/209 (33%), Positives = 107/209 (51%), Gaps = 15/209 (7%)
Query: 290 DPKHLKFG-SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQ-KEFAQEVFIMRK 345
DP+ L ++ GS+G +Y R ++ VAIK + S+ + ++ +EV +++
Sbjct: 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQ 71
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 405
+RH N +++ G + + +V E+ G S D L K + + + +G+ Y
Sbjct: 72 LRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAY 130
Query: 406 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK--AQSGVMTAETGTYRWMAPEVI-- 461
LH + IHRD+KA N+L+ E VK+ADFG A + A S V GT WMAPEVI
Sbjct: 131 LHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILA 185
Query: 462 -EHKPYDHKADVFSFGIVLWELLTGKLPY 489
+ YD K DV+S GI EL K P
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 59/163 (36%), Positives = 96/163 (58%), Gaps = 7/163 (4%)
Query: 330 SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL 389
S ++K+ +E+ IM + R +V F GA ++C+ EFM GS+ D ++K G +
Sbjct: 44 SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPV 102
Query: 390 PSLLKVAIDVSKGMNYLH-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448
L K+A+ V +G+ YL+ + I+HRD+K +N+L++ +K+ DFGV+ S A
Sbjct: 103 EILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---IA 159
Query: 449 ET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489
+T GT +M+PE I+ Y K+DV+S GI + EL GK P+
Sbjct: 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPF 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 65/214 (30%), Positives = 115/214 (53%), Gaps = 12/214 (5%)
Query: 290 DPK--HLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMR 344
DPK + +F K+ G+ G +Y Q+VAI+ + + +KE E+ +MR
Sbjct: 17 DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMR 72
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 404
+ ++ N+V ++ + L +V E+++GGS+ D + + + V + + +
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALE 130
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEH 463
+LH N +IHRD+K+ N+L+ + VK+ DFG A++ + + GT WMAPEV+
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 464 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 497
K Y K D++S GI+ E++ G+ PY PL+A
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 68/235 (28%), Positives = 118/235 (50%), Gaps = 31/235 (13%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQE 339
WE+ + + ++ GS+G +Y G VAIK + E + + EF E
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNE 59
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG------VFKLPSL- 392
+M++ +VV+ +G ++ ++ E M+ G + YL L+ V PSL
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119
Query: 393 --LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VKAQ 442
+++A +++ GM YL+ N +HRDL A N ++ E+ VK+ DFG+ R K
Sbjct: 120 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ 496
G++ RWM+PE ++ + +DV+SFG+VLWE+ T + PY+ ++ Q
Sbjct: 180 KGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ 229
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 65/186 (34%), Positives = 95/186 (51%), Gaps = 14/186 (7%)
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
+A+KV+ P I ++QK+ E+ I+ K ++ F GA + I TEFM GGS+
Sbjct: 29 LAVKVI-PLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLD 87
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437
Y L ++A+ V KG+ YL I+HRD+K +N+L++ VK+ DFGV+
Sbjct: 88 VY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVS 142
Query: 438 RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE------- 490
S + GT +MAPE I + Y +DV+S GI EL G+ PY
Sbjct: 143 TQLVNS-IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQG 201
Query: 491 YLTPLQ 496
L PLQ
Sbjct: 202 SLMPLQ 207
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 65/213 (30%), Positives = 109/213 (51%), Gaps = 17/213 (7%)
Query: 306 GDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365
G+ +RG ++ V +K L+ D Q F QEV R++ H NV+Q +G C +
Sbjct: 14 GEAHRGMSKAR-VVVKELR-ASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYL 71
Query: 366 IVTEFMSGGSVYDYLHKLKGVFKLPS----LLKVAIDVSKGMNYLHQNNIIHRDLKAANL 421
+V EF G + +YL +G+ + L ++A +V+ G+ +LHQ + IH DL N
Sbjct: 72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNC 131
Query: 422 LMDENEVVKVADFGVARVK-AQSGVMTAETGTY--RWMAPEVIEH-----KPYDH--KAD 471
+ + VK+ D+G+A + + +T + RW+APE++E P D K++
Sbjct: 132 QLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSN 191
Query: 472 VFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503
++S G+ +WEL T PY L+ Q VV+
Sbjct: 192 IWSLGVTMWELFTAADQPYPDLSDEQVLKQVVR 224
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 66/197 (33%), Positives = 100/197 (50%), Gaps = 11/197 (5%)
Query: 303 GSYGDLYRGTYCSQDVAIKVLKPERINSDM--QKEFAQEV-FIMRKVRHKNVVQFIGACT 359
G++G + + + + V K R D QK ++ +MR +V+F GA
Sbjct: 15 GAFGTVNKMLHKPSGTIMAV-KRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF 73
Query: 360 KPPSLCIVTEFM--SGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRD 415
+ I E M S Y Y++ LK V L K+A+ K +NYL + IIHRD
Sbjct: 74 REGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRD 133
Query: 416 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE---HKPYDHKADV 472
+K +N+L+D N +K+ DFG++ S T + G +MAPE I+ YD ++DV
Sbjct: 134 VKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDV 193
Query: 473 FSFGIVLWELLTGKLPY 489
+S GI L+E+ TGK PY
Sbjct: 194 WSLGITLYEVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 3e-24
Identities = 63/200 (31%), Positives = 103/200 (51%), Gaps = 3/200 (1%)
Query: 299 KVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358
K+ GS G + T + V K + ++ EV IMR H+NVV +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 359 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 418
L +V EF+ GG++ D + + + V + V + ++YLH +IHRD+K+
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 146
Query: 419 ANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGI 477
++L+ + +K++DFG A+V + + GT WMAPEVI PY + D++S GI
Sbjct: 147 DSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGI 206
Query: 478 VLWELLTGKLPYEYLTPLQA 497
++ E++ G+ PY PLQA
Sbjct: 207 MVIEMIDGEPPYFNEPPLQA 226
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 10/212 (4%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRK 345
+ D L+ ++ SG+ G +Y+ + + V + R N + K ++ ++ K
Sbjct: 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLK 69
Query: 346 VRH-KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGM 403
+V+ G + I E MS + D L K ++G L K+ + + K +
Sbjct: 70 SHDCPYIVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKAL 127
Query: 404 NYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE 462
+YL + +IHRD+K +N+L+D + VK+ DFG++ S T G +MAPE I+
Sbjct: 128 HYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERID 187
Query: 463 HKP----YDHKADVFSFGIVLWELLTGKLPYE 490
YD +ADV+S GI L EL TG+ PY+
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVELATGQFPYK 219
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 63/224 (28%), Positives = 110/224 (49%), Gaps = 35/224 (15%)
Query: 303 GSYGDLY----RGTYCSQD---VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 355
G +G+++ +G V +K L+ + + ++Q EF +E+ + RK+ HKNVV+ +
Sbjct: 16 GEFGEVFLAKAKGIEEEGGETLVLVKALQ-KTKDENLQSEFRRELDMFRKLSHKNVVRLL 74
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKG---VFKLPSL-----LKVAIDVSKGMNYLH 407
G C + ++ E+ G + +L K K P L + + ++ GM++L
Sbjct: 75 GLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS 134
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY-------RWMAPEV 460
+HRDL A N L+ VKV+ +++ S E RW+APE
Sbjct: 135 NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS-----EYYKLRNALIPLRWLAPEA 189
Query: 461 IEHKPYDHKADVFSFGIVLWELLT-GKLPY------EYLTPLQA 497
++ + K+DV+SFG+++WE+ T G+LP+ E L LQA
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA 233
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 14/197 (7%)
Query: 298 SKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
V G+YG + + C + VAIK K + D++K +EV ++R++RH+N+V
Sbjct: 7 GVVGEGAYGVVLK---CRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIV 63
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
A + L +V E++ ++ + L G ++ + + + Y H +NII
Sbjct: 64 NLKEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNII 122
Query: 413 HRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMTAETGTYRWM-APEV-IEHKPYDH 468
HRD+K N+L+ E+ V+K+ DFG AR +T T RW APE+ + Y
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVAT-RWYRAPELLVGDTNYGK 181
Query: 469 KADVFSFGIVLWELLTG 485
DV++ G ++ ELL G
Sbjct: 182 PVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 7e-24
Identities = 64/207 (30%), Positives = 111/207 (53%), Gaps = 17/207 (8%)
Query: 299 KVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKE-----FAQEVFIMRKVRHKNV 351
K+ GS G + R + + VA+K++ D++K+ EV IMR +H+NV
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMM-------DLRKQQRRELLFNEVVIMRDYQHQNV 80
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
V+ + L ++ EF+ GG++ D + + + + V V + + YLH +
Sbjct: 81 VEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR--LNEEQIATVCESVLQALCYLHSQGV 138
Query: 412 IHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 470
IHRD+K+ ++L+ + VK++DFG A++ + GT WMAPEVI PY +
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 471 DVFSFGIVLWELLTGKLPYEYLTPLQA 497
D++S GI++ E++ G+ PY +P+QA
Sbjct: 199 DIWSLGIMVIEMVDGEPPYFSDSPVQA 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-24
Identities = 66/210 (31%), Positives = 110/210 (52%), Gaps = 4/210 (1%)
Query: 290 DPK-HLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 348
DP+ +L K+ GS G + T S + V K + ++ EV IMR +H
Sbjct: 17 DPRTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH 76
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
+NVV+ + L +V EF+ GG++ D + + + V + V K ++ LH
Sbjct: 77 ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLHA 134
Query: 409 NNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEHKPYD 467
+IHRD+K+ ++L+ + VK++DFG A+V + + GT WMAPE+I PY
Sbjct: 135 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYG 194
Query: 468 HKADVFSFGIVLWELLTGKLPYEYLTPLQA 497
+ D++S GI++ E++ G+ PY PL+A
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPYFNEPPLKA 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 1e-23
Identities = 59/192 (30%), Positives = 104/192 (54%), Gaps = 5/192 (2%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357
V GSYG+ L R + IK L + +K QE ++ +++H N+V + +
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 358 CTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPS-LLKVAIDVSKGMNYLHQNNIIHRD 415
L IV F GG +Y L + KG + +++ + ++ + YLH+ +I+HRD
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRD 127
Query: 416 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 474
LK N+ + ++KV D G+ARV + Q + + GT +M+PE+ +KPY++K+DV++
Sbjct: 128 LKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWA 187
Query: 475 FGIVLWELLTGK 486
G ++E+ T K
Sbjct: 188 LGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 62/192 (32%), Positives = 102/192 (53%), Gaps = 18/192 (9%)
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
VA+K LK N+ +K+F +E ++ ++H+++V+F G C + L +V E+M G +
Sbjct: 38 VAVKTLKDASDNA--RKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLN 95
Query: 378 DYL--HKLKGVF----------KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE 425
+L H V +L +A ++ GM YL + +HRDL N L+ E
Sbjct: 96 KFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE 155
Query: 426 NEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWEL 482
N +VK+ DFG++R + T RWM PE I ++ + ++DV+S G+VLWE+
Sbjct: 156 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEI 215
Query: 483 LT-GKLPYEYLT 493
T GK P+ L+
Sbjct: 216 FTYGKQPWYQLS 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 68/210 (32%), Positives = 113/210 (53%), Gaps = 26/210 (12%)
Query: 294 LKFGSKVASGSYGDLY----RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 349
L+ +++ SG+ G +Y R T + A+KV+ ++++ +E+ I+R V H
Sbjct: 76 LERVNRIGSGAGGTVYKVIHRPT--GRLYALKVIYGNH-EDTVRRQICREIEILRDVNHP 132
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLH 407
NVV+ + ++ EFM GGS L+G + L VA + G+ YLH
Sbjct: 133 NVVKCHDMFDHNGEIQVLLEFMDGGS-------LEGTHIADEQFLADVARQILSGIAYLH 185
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM---TAETGTYRWMAPEVI--- 461
+ +I+HRD+K +NLL++ + VK+ADFGV+R+ AQ+ M + GT +M+PE I
Sbjct: 186 RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--MDPCNSSVGTIAYMSPERINTD 243
Query: 462 -EHKPYDHKA-DVFSFGIVLWELLTGKLPY 489
H YD A D++S G+ + E G+ P+
Sbjct: 244 LNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-23
Identities = 48/170 (28%), Positives = 94/170 (55%), Gaps = 4/170 (2%)
Query: 341 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAI 397
I ++RH N+V++ + L IV + + G + ++ + LK F + + +
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 398 DVSKGMNYLH-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM 456
+ + YLH + I+HRDL N+++ E++ V + DFG+A+ K +T+ GT +
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYS 180
Query: 457 APEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVH 506
PE+++++PY KADV++FG +L+++ T + P+ L A +V+ V+
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVY 230
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 62/192 (32%), Positives = 101/192 (52%), Gaps = 7/192 (3%)
Query: 299 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFI 355
V GSYG + + Q VAIK E + M K+ A +E+ +++++RH+N+V I
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFL-ESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
+ L +V EF+ +V D L K + K + +G+ + H +NIIHRD
Sbjct: 67 EVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRD 125
Query: 416 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM-APEVIEHKP-YDHKADVF 473
+K N+L+ ++ VVK+ DFG AR A G + + RW APE++ Y D++
Sbjct: 126 IKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIW 185
Query: 474 SFGIVLWELLTG 485
+ G ++ E+LTG
Sbjct: 186 AVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 59/186 (31%), Positives = 93/186 (50%), Gaps = 9/186 (4%)
Query: 309 YRGTYCSQDVAIKVLKPERINSDMQKE---FAQEVF-IMRKVRHKNVVQFIGACTKPPSL 364
Y+ T + AIK LK I + + E + +F RH +V +
Sbjct: 20 YKKT--GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHV 77
Query: 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD 424
C V E+ +GG + ++H VF P + A V G+ YLH+N I++RDLK NLL+D
Sbjct: 78 CFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD 135
Query: 425 ENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELL 483
VK+ADFG+ + G T+ GT ++APEV+ Y D + G++++E+L
Sbjct: 136 TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEML 195
Query: 484 TGKLPY 489
G+ P+
Sbjct: 196 VGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 5e-23
Identities = 79/237 (33%), Positives = 113/237 (47%), Gaps = 35/237 (14%)
Query: 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFAQ 338
D TD WEI + G+YG +Y+ T +D A+K+L P SD+ +E
Sbjct: 19 DPTDTWEII-------ETIGKGTYGKVYKVTN-KKDGSLAAVKILDPI---SDVDEEIEA 67
Query: 339 EVFIMRKV-RHKNVVQFIGACTKPP-----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSL 392
E I++ + H NVV+F G K L +V E +GGSV + + KG+
Sbjct: 68 EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV---KGLLICGQR 124
Query: 393 LKVAI------DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV-ARVKAQSGV 445
L A+ G+ +LH N IIHRD+K N+L+ VK+ DFGV A++ +
Sbjct: 125 LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184
Query: 446 MTAETGTYRWMAPEVIEHK-----PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 497
GT WMAPEVI + YD + DV+S GI EL G P + P++
Sbjct: 185 RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT 241
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 6e-23
Identities = 57/195 (29%), Positives = 109/195 (55%), Gaps = 5/195 (2%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357
V GS+G L + Q A+K ++ + +S ++ +E ++ K++H N+V F +
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDS-RKEAVLLAKMKHPNIVAFKES 66
Query: 358 CTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
L IV E+ GG + + +G +F ++L+ + + G+ ++H+ ++HRD+
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDI 126
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSF 475
K+ N+ + +N VK+ DFG AR+ G GT ++ PE+ E+ PY++K+D++S
Sbjct: 127 KSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSL 186
Query: 476 GIVLWELLTGKLPYE 490
G +L+EL T K P++
Sbjct: 187 GCILYELCTLKHPFQ 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 9e-23
Identities = 52/174 (29%), Positives = 93/174 (53%), Gaps = 4/174 (2%)
Query: 319 AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A K L +R+ ++ A E I+ KV + +V A LC+V M+GG +
Sbjct: 22 ACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLK 81
Query: 378 DYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
+++ + + F + A + G+ +LHQ I++RDLK N+L+D++ V+++D G+
Sbjct: 82 YHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGL 141
Query: 437 A-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489
A +K + GT +MAPEV++ + YD D F+ G L+E++ G+ P+
Sbjct: 142 AVELKGGKKI-KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 3e-22
Identities = 58/228 (25%), Positives = 114/228 (50%), Gaps = 27/228 (11%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEV 340
EI+ ++F ++ +G +Y+G +Q VAIK LK ++ +++EF E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKHEA 59
Query: 341 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------HKLKG 385
+ +++H N+V +G TK L ++ + S ++++L +K
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 386 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQS- 443
+ + + ++ GM +L ++++H+DL N+L+ + VK++D G+ R V A
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY 179
Query: 444 -GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
+M RWM+PE I + + +D++S+G+VLWE+ + G PY
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 3e-22
Identities = 76/236 (32%), Positives = 109/236 (46%), Gaps = 33/236 (13%)
Query: 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYR--GTYCSQDVAIKVLKPERINSDMQKEFAQE 339
D +D WEI + G+YG +++ A+K+L P D+ +E E
Sbjct: 15 DPSDTWEII-------ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAE 64
Query: 340 VFIMRKVR-HKNVVQFIGACTKPP-----SLCIVTEFMSGGSVYDYLHKLKGVFKL---- 389
I++ + H NVV+F G K L +V E +GGSV D + KG K
Sbjct: 65 YNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV---KGFLKRGERM 121
Query: 390 --PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV-ARVKAQSGVM 446
P + + + G+ +LH N IHRD+K N+L+ VK+ DFGV A++ +
Sbjct: 122 EEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 181
Query: 447 TAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 497
GT WMAPEVI YD + DV+S GI EL G P L P++A
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA 237
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 5e-22
Identities = 72/235 (30%), Positives = 119/235 (50%), Gaps = 13/235 (5%)
Query: 277 LKIPNDGTDVWEIDPKHLKFG-SKVASGSYGDLYRGT--YCSQDVAIKVLK--PERINSD 331
+K P ++ DP+ + G ++ GS+G +Y T + ++ VA+K + ++ N
Sbjct: 5 VKDPEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEK 64
Query: 332 MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS 391
Q + +EV +++++H N +++ G K + +V E+ G S D L K +
Sbjct: 65 WQ-DIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQEVE 122
Query: 392 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG 451
+ + +G+ YLH +N+IHRD+KA N+L+ E VK+ADFG A + + G
Sbjct: 123 IAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF---VG 179
Query: 452 TYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503
T WMAPEVI + YD K DV+S GI EL K P + + A + Q
Sbjct: 180 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 234
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 6e-22
Identities = 67/242 (27%), Positives = 117/242 (48%), Gaps = 45/242 (18%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKP-----ERINSDM 332
WE+ + + ++ GS+G +Y G ++D VA+K + ERI
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEGN--ARDIIKGEAETRVAVKTVNESASLRERI---- 54
Query: 333 QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK---- 388
EF E +M+ +VV+ +G +K +V E M+ G + YL L+ +
Sbjct: 55 --EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 112
Query: 389 -----LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR----- 438
L ++++A +++ GM YL+ +HRDL A N ++ + VK+ DFG+ R
Sbjct: 113 RPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET 172
Query: 439 ---VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTP 494
K G++ RWMAPE ++ + +D++SFG+VLWE+ + + PY+ L+
Sbjct: 173 DYYRKGGKGLLPV-----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN 227
Query: 495 LQ 496
Q
Sbjct: 228 EQ 229
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 7e-22
Identities = 71/211 (33%), Positives = 109/211 (51%), Gaps = 10/211 (4%)
Query: 299 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHKNVVQFI 355
++ GS+G +Y R S+ VAIK + S+ + ++ +EV ++K+RH N +Q+
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
G + + +V E+ G S D L K + + V +G+ YLH +N+IHRD
Sbjct: 82 GCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 416 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI---EHKPYDHKADV 472
+KA N+L+ E +VK+ DFG A + A + GT WMAPEVI + YD K DV
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDGKVDV 197
Query: 473 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503
+S GI EL K P + + A + Q
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQ 228
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 58/200 (29%), Positives = 107/200 (53%), Gaps = 19/200 (9%)
Query: 303 GSYGDLY-----RGTYCSQDVAIKVLKP------ERINSDMQKEFAQEVFIMRKVRHKNV 351
GS+G ++ G Q A+KVLK +R+ + M+++ I+ +V H +
Sbjct: 7 GSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERD------ILAEVNHPFI 60
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
V+ A L ++ +F+ GG ++ L K + +F + +++ +++LH I
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 412 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKA 470
I+RDLK N+L+DE +K+ DFG+++ GT +MAPEV+ + + A
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSA 179
Query: 471 DVFSFGIVLWELLTGKLPYE 490
D +SFG++++E+LTG LP++
Sbjct: 180 DWWSFGVLMFEMLTGSLPFQ 199
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 66/232 (28%), Positives = 111/232 (47%), Gaps = 54/232 (23%)
Query: 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFA-----QEVFIMRK 345
+ K+ G++G++Y+ + VA+K +I +K+ +E+ I++K
Sbjct: 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREIKILKK 63
Query: 346 VRHKNVVQFI--------GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 397
++H NVV I + K S+ +VT +M H L G+ + PS V +
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD--------HDLSGLLENPS---VKL 112
Query: 398 DVSK----------GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-------- 439
S+ G+NYLH+N+I+HRD+KAAN+L+D ++K+ADFG+AR
Sbjct: 113 TESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172
Query: 440 KAQSGVMTAE-TG--TYRWM-APEVIEH-KPYDHKADVFSFGIVLWELLTGK 486
K G T + T RW PE++ + Y D++ G V E+ T +
Sbjct: 173 KGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 4e-21
Identities = 53/178 (29%), Positives = 99/178 (55%), Gaps = 10/178 (5%)
Query: 319 AIKVLKPERINSDMQKEFAQEVFIMRKV-----RHKNVVQFIGACTKPPSLCIVTEFMSG 373
AIK+LK + I +Q + + + ++V + + Q L V E+++G
Sbjct: 29 AIKILKKDVI---IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG 85
Query: 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVAD 433
G + ++ ++ G FK P + A +++ G+ +LH II+RDLK N+++D +K+AD
Sbjct: 86 GDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIAD 144
Query: 434 FGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490
FG+ + G T GT ++APE+I ++PY D ++FG++L+E+L G+ P++
Sbjct: 145 FGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 4e-21
Identities = 72/235 (30%), Positives = 120/235 (51%), Gaps = 13/235 (5%)
Query: 277 LKIPNDGTDVWEIDPKHLKFGS--KVASGSYGDLY--RGTYCSQDVAIKVLK-PERINSD 331
LK P ++ DP+ L F ++ GS+G +Y R ++ VAIK + + +++
Sbjct: 9 LKDPEIAELFFKEDPEKL-FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE 67
Query: 332 MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS 391
++ +EV +++++H N +++ G + + +V E+ G S D L K +
Sbjct: 68 KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVE 126
Query: 392 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG 451
+ + +G+ YLH +N+IHRD+KA N+L+ E VK+ADFG A + + + G
Sbjct: 127 IAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF---VG 183
Query: 452 TYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503
T WMAPEVI + YD K DV+S GI EL K P + + A + Q
Sbjct: 184 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 238
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 5e-21
Identities = 57/200 (28%), Positives = 109/200 (54%), Gaps = 6/200 (3%)
Query: 296 FGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNV 351
F + GS+G + D AIK+LK + + + D++ ++ + + + +
Sbjct: 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFL 63
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
Q L V E+++GG + ++ ++ G FK P + A ++S G+ +LH+ I
Sbjct: 64 TQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRGI 122
Query: 412 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKA 470
I+RDLK N+++D +K+ADFG+ + GV T GT ++APE+I ++PY
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSV 182
Query: 471 DVFSFGIVLWELLTGKLPYE 490
D +++G++L+E+L G+ P++
Sbjct: 183 DWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 7e-21
Identities = 46/128 (35%), Positives = 80/128 (62%), Gaps = 2/128 (1%)
Query: 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
L V E+++GG + + ++ G FK P + A +++ G+ +LH II+RDLK N+++
Sbjct: 76 LYFVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 424 DENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWEL 482
D +K+ADFG+ + GV T GT ++APE+I ++PY D ++FG++L+E+
Sbjct: 135 DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 194
Query: 483 LTGKLPYE 490
L G+ P+E
Sbjct: 195 LAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 7e-21
Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 17/202 (8%)
Query: 300 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357
+ G +G++Y R + A+K L +RI + A IM + FI
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 358 CT----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
+ P L + + M+GG ++ +L + GVF + A ++ G+ ++H +++
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 414 RDLKAANLLMDENEVVKVADFGVA----RVKAQSGVMTAETGTYRWMAPEVIEHK-PYDH 468
RDLK AN+L+DE+ V+++D G+A + K + V GT+ +MAPEV++ YD
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-----GTHGYMAPEVLQKGVAYDS 175
Query: 469 KADVFSFGIVLWELLTGKLPYE 490
AD FS G +L++LL G P+
Sbjct: 176 SADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 49/201 (24%), Positives = 105/201 (52%), Gaps = 9/201 (4%)
Query: 298 SKVASGSYGDLYRG--TYCSQDVAIKVLKP-ERINSDMQKEFAQEVFIMRKVRHKNVVQF 354
K+ G + +Y+ + VA+K ++ E +++ +++ +E+ +++++ H NV+++
Sbjct: 8 KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKY 67
Query: 355 IGACTKPPSLCIVTEFMSGGSV---YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
+ + + L IV E G + + K K + ++ K + + + ++H I
Sbjct: 68 LASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRI 127
Query: 412 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHK 469
+HRD+K AN+ + VVK+ D G+ R + S A + GT +M+PE I Y+ K
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERIHENGYNFK 186
Query: 470 ADVFSFGIVLWELLTGKLPYE 490
+D++S G +L+E+ + P+
Sbjct: 187 SDIWSLGCLLYEMAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 1e-20
Identities = 69/219 (31%), Positives = 105/219 (47%), Gaps = 40/219 (18%)
Query: 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQ----EVFIMRKV 346
+ + SG+YG + + VAIK K + D A+ E+ ++R +
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIK--KISNVFDD--LIDAKRILREIKLLRHL 56
Query: 347 RHKNVVQFIGACTKPPS------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI--- 397
RH+N++ + +PPS + IVTE M D LHK V K P L
Sbjct: 57 RHENIIGLLDI-LRPPSPEDFNDVYIVTELMET----D-LHK---VIKSPQPLTDDHIQY 107
Query: 398 ---DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAET 450
+ +G+ YLH N+IHRDLK +N+L++ N +K+ DFG+AR + + G +T
Sbjct: 108 FLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167
Query: 451 GT--YRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 486
T YR APE++ Y D++S G + ELLT K
Sbjct: 168 VTRWYR--APELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 9/197 (4%)
Query: 300 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357
+ G +G++Y R + A+K L +RI + A IM + FI
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 358 CT----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
T P LC + + M+GG ++ +L + GVF + A ++ G+ ++H +++
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 414 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADV 472
RDLK AN+L+DE+ V+++D G+A A GT+ +MAPEV++ YD AD
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADW 179
Query: 473 FSFGIVLWELLTGKLPY 489
FS G +L++LL G P+
Sbjct: 180 FSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 69/236 (29%), Positives = 115/236 (48%), Gaps = 36/236 (15%)
Query: 294 LKFGSKVASGSYGDL----YRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRH 348
+ G + +GS+G + ++GT + AIK LK I Q + AQE I+ ++ H
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGT--GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH 77
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK------- 401
+V + + + + EF+ GG ++ +L K + P+ DV+K
Sbjct: 78 PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG---RFPN------DVAKFYHAELV 128
Query: 402 -GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPE 459
YLH +II+RDLK NLL+D VKV DFG A +V ++ + GT ++APE
Sbjct: 129 LAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL---CGTPEYLAPE 185
Query: 460 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSFLEQRLR 515
VI+ K + D ++ G++L+E + G P+ TP +++ L RL+
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--------RIYEKILAGRLK 233
|
Length = 329 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 2e-20
Identities = 54/194 (27%), Positives = 99/194 (51%), Gaps = 5/194 (2%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
+ G++G L R + A+K+LK E I D E +++ RH +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ LC V E+++GG ++ +L + + VF ++ ++YLH I++RDL
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121
Query: 417 KAANLLMDENEVVKVADFGVARVK-AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 475
K NL++D++ +K+ DFG+ + + M GT ++APEV+E Y D +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181
Query: 476 GIVLWELLTGKLPY 489
G+V++E++ G+LP+
Sbjct: 182 GVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 44/145 (30%), Positives = 72/145 (49%), Gaps = 1/145 (0%)
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 398
E +++ V H +V++ C+V S +Y YL K + L +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAP 458
+ +G+ YLH IIHRD+K N+ +++ + V + D G A+ + GT AP
Sbjct: 166 ILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAP 225
Query: 459 EVIEHKPYDHKADVFSFGIVLWELL 483
EV+ Y+ KAD++S GIVL+E+L
Sbjct: 226 EVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 51/175 (29%), Positives = 93/175 (53%), Gaps = 7/175 (4%)
Query: 319 AIKVLKPERINSDMQKEFAQ---EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 375
A+K+LK E I + + E A E +++ RH + + LC V E+ +GG
Sbjct: 24 AMKILKKEVIIA--KDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81
Query: 376 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435
++ +L + + VF ++ + YLH ++++RDLK NL++D++ +K+ DFG
Sbjct: 82 LFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFG 140
Query: 436 VARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489
+ + G M GT ++APEV+E Y D + G+V++E++ G+LP+
Sbjct: 141 LCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 4e-20
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 25/206 (12%)
Query: 295 KFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFA--------QEVFIMR 344
K ++ G++G +Y + VAIK +K K+F +EV +R
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMK---------KKFYSWEECMNLREVKSLR 52
Query: 345 KV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-DVSKG 402
K+ H N+V+ + L V E+M G ++Y + KG S+++ I + +G
Sbjct: 53 KLNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQG 111
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM-APEVI 461
+ ++H++ HRDLK NLL+ EVVK+ADFG+AR T T RW APE++
Sbjct: 112 LAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVST-RWYRAPEIL 170
Query: 462 EHKP-YDHKADVFSFGIVLWELLTGK 486
Y D+++ G ++ EL T +
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 7e-20
Identities = 59/215 (27%), Positives = 106/215 (49%), Gaps = 41/215 (19%)
Query: 298 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKE-FA----QEVFIMRKVRHKN 350
+K+ G++G+++ R Q VA+K ++ + +KE F +E+ I++ ++H+N
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALK-----KVLMENEKEGFPITALREIKILQLLKHEN 72
Query: 351 VVQFIGACTKPP--------SLCIVTEFMSGGSVYDYLHKLKGV-------FKLPSLLKV 395
VV I C S +V EF H L G+ F L + KV
Sbjct: 73 VVNLIEICRTKATPYNRYKGSFYLVFEFCE--------HDLAGLLSNKNVKFTLSEIKKV 124
Query: 396 AIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-----KAQSGVMTAET 450
+ G+ Y+H+N I+HRD+KAAN+L+ ++ ++K+ADFG+AR ++ T
Sbjct: 125 MKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRV 184
Query: 451 GTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLT 484
T + PE+ + + Y D++ G ++ E+ T
Sbjct: 185 VTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 51/174 (29%), Positives = 94/174 (54%), Gaps = 2/174 (1%)
Query: 319 AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV- 376
A K L+ +RI + A E I+ KV + VV A +LC+V M+GG +
Sbjct: 29 ACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 88
Query: 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
+ H + F+ + A ++ G+ LHQ I++RDLK N+L+D++ ++++D G+
Sbjct: 89 FHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGL 148
Query: 437 ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490
A + + GT +MAPEV++++ Y D ++ G +L+E++ G+ P++
Sbjct: 149 AVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 58/174 (33%), Positives = 96/174 (55%), Gaps = 4/174 (2%)
Query: 319 AIKVLKPERI-NSDMQKE-FAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376
A+KVL+ + + N QK A+ +++ V+H +V + L V +F++GG +
Sbjct: 24 AVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGEL 83
Query: 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
+ +L + + F P A +++ + YLH NI++RDLK N+L+D V + DFG+
Sbjct: 84 FFHLQRER-SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGL 142
Query: 437 ARVK-AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489
+ AQS T GT ++APEVI +PYD+ D + G VL+E+L G P+
Sbjct: 143 CKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 1e-19
Identities = 45/105 (42%), Positives = 63/105 (60%), Gaps = 4/105 (3%)
Query: 389 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--VKAQSGVM 446
L L+ + V++GM +L IHRDL A N+L+ EN VVK+ DFG+AR K V
Sbjct: 172 LEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 231
Query: 447 TAETG-TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
+ +WMAPE I K Y ++DV+SFG++LWE+ + G PY
Sbjct: 232 KGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 56/196 (28%), Positives = 101/196 (51%), Gaps = 11/196 (5%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF-- 354
++ G+YG +YR T + VA+K ++ + + +E+ ++ +RH N+V+
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73
Query: 355 IGACTKPPSLCIVTEFMSG--GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
+ S+ +V E+ S+ D + F + + + + +G+ YLH+N II
Sbjct: 74 VVVGKHLDSIFLVMEYCEQDLASLLD---NMPTPFSESQVKCLMLQLLRGLQYLHENFII 130
Query: 413 HRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGTYRWMAPEVI-EHKPYDHKA 470
HRDLK +NLL+ + +K+ADFG+AR + MT + T + APE++ Y
Sbjct: 131 HRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAI 190
Query: 471 DVFSFGIVLWELLTGK 486
D+++ G +L ELL K
Sbjct: 191 DMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 53/194 (27%), Positives = 98/194 (50%), Gaps = 5/194 (2%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
+ G++G L R + A+K+L+ E I D E +++ RH +
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
A LC V E+ +GG ++ +L + + VF ++ + YLH ++++RD+
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 121
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSF 475
K NL++D++ +K+ DFG+ + G M GT ++APEV+E Y D +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181
Query: 476 GIVLWELLTGKLPY 489
G+V++E++ G+LP+
Sbjct: 182 GVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 62/198 (31%), Positives = 104/198 (52%), Gaps = 15/198 (7%)
Query: 299 KVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ G+YG +Y+G Q VA+K ++ E + +E+ ++++++H N+V
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAI-DVSKGMNYLHQNNIIHR 414
+ L ++ EF+S + YL L KG + L+K + + +G+ + H ++HR
Sbjct: 67 VLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHR 125
Query: 415 DLKAANLLMDENEVVKVADFGVAR-----VKAQSGVMTAETGTYRWMAPEVIEHKP-YDH 468
DLK NLL+D V+K+ADFG+AR V+ V T E T + APEV+ P Y
Sbjct: 126 DLKPQNLLIDNKGVIKLADFGLARAFGIPVR----VYTHEVVTLWYRAPEVLLGSPRYST 181
Query: 469 KADVFSFGIVLWELLTGK 486
D++S G + E+ T K
Sbjct: 182 PVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 4e-19
Identities = 52/176 (29%), Positives = 88/176 (50%), Gaps = 5/176 (2%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A K L +R+ E A E I+ KV + +V A LC+V M+GG +
Sbjct: 22 ACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLR 81
Query: 378 DYLHKLKGV---FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 434
+++ + F P + G+ +LHQ II+RDLK N+L+D + V+++D
Sbjct: 82 YHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDL 141
Query: 435 GVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489
G+A +K GT +MAPE+++ + YD D F+ G+ L+E++ + P+
Sbjct: 142 GLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 5e-19
Identities = 49/173 (28%), Positives = 91/173 (52%), Gaps = 2/173 (1%)
Query: 319 AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A K L+ +RI + A E I+ KV + VV A +LC+V M+GG +
Sbjct: 29 ACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLK 88
Query: 378 DYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
+++ + F+ L A ++ G+ LH+ N ++RDLK N+L+D+ ++++D G+
Sbjct: 89 FHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGL 148
Query: 437 ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489
A + + GT +MAPEV+ ++ Y D + G +++E++ G+ P+
Sbjct: 149 AVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 57/195 (29%), Positives = 101/195 (51%), Gaps = 6/195 (3%)
Query: 300 VASGSYGDLYRGTYCSQDV--AIKVLKPERI-NSDMQKE-FAQEVFIMRKVRHKNVVQFI 355
+ GS+G + + + A+KVL+ + I QK A+ +++ V+H +V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
+ L V ++++GG ++ +L + + F P A +++ + YLH NII+RD
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERS-FPEPRARFYAAEIASALGYLHSLNIIYRD 121
Query: 416 LKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 474
LK N+L+D V + DFG+ + + S + GT ++APEV+ +PYD D +
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWC 181
Query: 475 FGIVLWELLTGKLPY 489
G VL+E+L G P+
Sbjct: 182 LGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 8e-19
Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 14/199 (7%)
Query: 300 VASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQKE--FAQEVFIMRKVRHKNVVQFI 355
+ GS+G + S A+KVL+ + I ++ A+ +++ ++H +V
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
+ L V ++++GG ++ +L + + F P A +V+ + YLH NII+RD
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRER-CFLEPRARFYAAEVASAIGYLHSLNIIYRD 121
Query: 416 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAET-----GTYRWMAPEVIEHKPYDHKA 470
LK N+L+D V + DFG+ + GV ET GT ++APEV+ +PYD
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK----EGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTV 177
Query: 471 DVFSFGIVLWELLTGKLPY 489
D + G VL+E+L G P+
Sbjct: 178 DWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 8e-19
Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 38/208 (18%)
Query: 303 GSYGDLY----RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358
GS+G + +GT ++ AIK LK + + D E + R+V +
Sbjct: 6 GSFGKVMLAELKGT--NEFFAIKALKKDVVLEDDDVECT---MVERRV--------LALA 52
Query: 359 TKPPSLC-------------IVTEFMSGGSVYDYLHKL--KGVFKLPSLLKVAIDVSKGM 403
+ P L V E+++GG D + + G F A ++ G+
Sbjct: 53 WEHPFLTHLFCTFQTKEHLFFVMEYLNGG---DLMFHIQSSGRFDEARARFYAAEIICGL 109
Query: 404 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVI 461
+LH+ II+RDLK N+L+D++ +K+ADFG+ + +G A T GT ++APE++
Sbjct: 110 QFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENM-NGEGKASTFCGTPDYIAPEIL 168
Query: 462 EHKPYDHKADVFSFGIVLWELLTGKLPY 489
+ + Y+ D +SFG++L+E+L G+ P+
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 37/210 (17%)
Query: 298 SKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKE-FA----QEVFIMRKVRHKN 350
+++ G+YG +YR VA+K LK E+ +KE F +E+ I+ K++H N
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEK-----EKEGFPITSLREINILLKLQHPN 65
Query: 351 VVQF--IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK------LPSLLK-VAIDVSK 401
+V + + + +V E++ H LK + + L S +K + + +
Sbjct: 66 IVTVKEVVVGSNLDKIYMVMEYVE--------HDLKSLMETMKQPFLQSEVKCLMLQLLS 117
Query: 402 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRWMA 457
G+ +LH N I+HRDLK +NLL++ ++K+ DFG+AR + S T T YR A
Sbjct: 118 GVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR-EYGSPLKPYTQLVVTLWYR--A 174
Query: 458 PEVIEHKP-YDHKADVFSFGIVLWELLTGK 486
PE++ Y D++S G + ELLT K
Sbjct: 175 PELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 58/235 (24%), Positives = 108/235 (45%), Gaps = 44/235 (18%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFA-------- 337
I ++++ G+ + G+YG + + T + VAIK +K I++D+ K+
Sbjct: 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIH 64
Query: 338 ----QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL 393
+E+ IM +++H+N++ + + + +V + M+ LK V L
Sbjct: 65 FTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS--------DLKKVVDRKIRL 116
Query: 394 KVA------IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-- 445
+ + + G+N LH+ +HRDL AN+ ++ + K+ADFG+AR
Sbjct: 117 TESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176
Query: 446 -------------MTAETGTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 486
MT++ T + APE++ + Y D++S G + ELLTGK
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 50/199 (25%), Positives = 108/199 (54%), Gaps = 9/199 (4%)
Query: 299 KVASGSYGDLYRGTYC---SQDVAIKVLKP-ERINSDMQKEFAQEVFIMRKVRHKNVVQF 354
K+ G + ++YR T C + VA+K ++ E +++ +++ +E+ +++++ H NV+++
Sbjct: 9 KIGRGQFSEVYRAT-CLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKY 67
Query: 355 IGACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
+ + + L IV E G + Y K K + ++ K + + + ++H +
Sbjct: 68 LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRV 127
Query: 412 IHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 470
+HRD+K AN+ + VVK+ D G+ R +++ + GT +M+PE I Y+ K+
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKS 187
Query: 471 DVFSFGIVLWELLTGKLPY 489
D++S G +L+E+ + P+
Sbjct: 188 DIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 52/195 (26%), Positives = 105/195 (53%), Gaps = 6/195 (3%)
Query: 300 VASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQKE--FAQEVFIMRKVRHKNVVQFI 355
+ GS+G + + +++ A+KVL+ + I +++ ++ +++ V+H +V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
+ L V ++++GG ++ +L + + F P A +++ + YLH NI++RD
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIVYRD 121
Query: 416 LKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 474
LK N+L+D + + DFG+ + + +G + GT ++APEV+ +PYD D +
Sbjct: 122 LKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWC 181
Query: 475 FGIVLWELLTGKLPY 489
G VL+E+L G P+
Sbjct: 182 LGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 61/236 (25%), Positives = 113/236 (47%), Gaps = 27/236 (11%)
Query: 299 KVASGSYGDLYRGT----YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 354
++ +G +G + G Y V +K L+ + Q +F +E R ++H N++Q
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQE-QMKFLEEAQPYRSLQHSNLLQC 60
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP----SLLKVAIDVSKGMNYLHQNN 410
+G CT+ +V EF G + YL + + +L ++A +++ G+ +LH+NN
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 411 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEH---- 463
IH DL N L+ + VK+ D+G++ K + + RW+APE+++
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGN 180
Query: 464 ---KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHSFLEQRLR 515
+++V+S G+ +WEL G PY +L+ Q V+ EQ+L+
Sbjct: 181 LLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR-------EQQLK 229
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-18
Identities = 61/196 (31%), Positives = 104/196 (53%), Gaps = 11/196 (5%)
Query: 303 GSYGDLYR-----GTYCSQDVAIKVLKPERINSDMQKEFAQ---EVFIMRKVRHKNVVQF 354
G YG +++ G + A+KVLK I + QK+ A E I+ V+H +V
Sbjct: 7 GGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRN-QKDTAHTKAERNILEAVKHPFIVDL 65
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
I A L ++ E++SGG ++ +L + +G+F + ++S + +LHQ II+R
Sbjct: 66 IYAFQTGGKLYLILEYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYR 124
Query: 415 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVF 473
DLK N+L+D VK+ DFG+ + G +T GT +MAPE++ + D +
Sbjct: 125 DLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWW 184
Query: 474 SFGIVLWELLTGKLPY 489
S G +++++LTG P+
Sbjct: 185 SLGALMYDMLTGAPPF 200
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 47/110 (42%), Positives = 65/110 (59%), Gaps = 4/110 (3%)
Query: 384 KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--VKA 441
K V L L+ + V+KGM +L IHRDL A N+L+ EN VVK+ DFG+AR K
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 232
Query: 442 QSGVMTAETG-TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
V + +WMAPE I + Y ++DV+SFG++LWE+ + G PY
Sbjct: 233 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 49/195 (25%), Positives = 99/195 (50%), Gaps = 13/195 (6%)
Query: 308 LYRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQ----FIGACTKPP 362
+Y+G + +++V I+ K + + E+ +R++ N+++ I P
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 363 SLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAAN 420
L ++ E+ + G + + L K K + FK + L +AID KG+ L++ N +++L + +
Sbjct: 96 RLSLILEYCTRGYLREVLDKEKDLSFK--TKLDMAIDCCKGLYNLYKYTNKPYKNLTSVS 153
Query: 421 LLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIV 478
L+ EN +K+ G+ ++ + Y + +++ Y K D++S G+V
Sbjct: 154 FLVTENYKLKIICHGLEKILSSPPFKNVNFMVYF--SYKMLNDIFSEYTIKDDIYSLGVV 211
Query: 479 LWELLTGKLPYEYLT 493
LWE+ TGK+P+E LT
Sbjct: 212 LWEIFTGKIPFENLT 226
|
Length = 283 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 57/209 (27%), Positives = 109/209 (52%), Gaps = 10/209 (4%)
Query: 300 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIG 356
V +G++G ++ R A+KV+ + Q++ E ++++V H +++
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
L ++ E++ GG ++ YL + G F + L A ++ + YLH I++RDL
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDL 127
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFG 476
K N+L+D+ +K+ DFG A+ K + T GT ++APEVI+ K ++ D ++ G
Sbjct: 128 KPENILLDKEGHIKLTDFGFAK-KLRDRTWTL-CGTPEYLAPEVIQSKGHNKAVDWWALG 185
Query: 477 IVLWELLTGKLPYEYLTPLQAAVGVVQKV 505
I+++E+L G P+ P G+ +K+
Sbjct: 186 ILIYEMLVGYPPFFDDNPF----GIYEKI 210
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 56/193 (29%), Positives = 98/193 (50%), Gaps = 6/193 (3%)
Query: 303 GSYGD--LYRGTYCSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358
GS+G L R + A+KVLK + I + D++ ++ + H + Q
Sbjct: 6 GSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF 65
Query: 359 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 418
P L V EF++GG + ++ K + F A +++ + +LH II+RDLK
Sbjct: 66 QTPDRLFFVMEFVNGGDLMFHIQKSRR-FDEARARFYAAEITSALMFLHDKGIIYRDLKL 124
Query: 419 ANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSFGI 477
N+L+D K+ADFG+ + +G T+ GT ++APE+++ Y D ++ G+
Sbjct: 125 DNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGV 184
Query: 478 VLWELLTGKLPYE 490
+L+E+L G P+E
Sbjct: 185 LLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 3e-18
Identities = 41/102 (40%), Positives = 62/102 (60%), Gaps = 4/102 (3%)
Query: 392 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAET 450
LL + V+KGM++L N IHRDL A N+L+ + K+ DFG+AR ++ S +
Sbjct: 216 LLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN 275
Query: 451 GTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
+WMAPE I + Y ++DV+S+GI+LWE+ + G PY
Sbjct: 276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY 317
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-18
Identities = 46/198 (23%), Positives = 102/198 (51%), Gaps = 7/198 (3%)
Query: 299 KVASGSYGDLYRGTYCSQDVAIKVLKPE---RINSDMQKEFAQEVFIMRKVRHKNVVQFI 355
K+ G + ++YR T V + + K + +++ + + +E+ +++++ H NV+++
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL---PSLLKVAIDVSKGMNYLHQNNII 412
+ + L IV E G + + K +L ++ K + + + ++H ++
Sbjct: 69 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVM 128
Query: 413 HRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKAD 471
HRD+K AN+ + VVK+ D G+ R +++ + GT +M+PE I Y+ K+D
Sbjct: 129 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSD 188
Query: 472 VFSFGIVLWELLTGKLPY 489
++S G +L+E+ + P+
Sbjct: 189 IWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 51/174 (29%), Positives = 93/174 (53%), Gaps = 4/174 (2%)
Query: 319 AIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A+K+LK E I D E +++ RH + + LC V E+ +GG ++
Sbjct: 24 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF 83
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLH-QNNIIHRDLKAANLLMDENEVVKVADFGV 436
+L + + VF ++ ++YLH + N+++RDLK NL++D++ +K+ DFG+
Sbjct: 84 FHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGL 142
Query: 437 ARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489
+ + G M GT ++APEV+E Y D + G+V++E++ G+LP+
Sbjct: 143 CKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 4e-18
Identities = 44/128 (34%), Positives = 71/128 (55%), Gaps = 11/128 (8%)
Query: 392 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG 451
L+ + V+ GM +L N +HRDL A N+L+ E ++VK+ DFG+AR + ++
Sbjct: 241 LVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGS 300
Query: 452 TY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY-------EYLTPLQAAVG 500
T+ +WMAPE I + Y +DV+SFGI+LWE+ T G PY ++ ++
Sbjct: 301 TFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYR 360
Query: 501 VVQKVHHS 508
+ + H S
Sbjct: 361 MAKPAHAS 368
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|153172 cd04900, ACT_UUR-like_1, ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains | Back alignment and domain information |
|---|
Score = 77.9 bits (193), Expect = 5e-18
Identities = 29/72 (40%), Positives = 40/72 (55%), Gaps = 6/72 (8%)
Query: 179 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWPY---E 232
E+ T D+P L +++ L +GLNI +A F+T DGY+LD FVV DG P E
Sbjct: 1 GTEVFIYTPDRPGLFARIAGALDQLGLNILDARIFTTRDGYALDTFVVLDPDGEPIGERE 60
Query: 233 ETEQLRAALEKE 244
++R ALE
Sbjct: 61 RLARIREALEDA 72
|
This ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD is the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 73 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 5e-18
Identities = 53/200 (26%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 319 AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A K L+ +RI + A E I+ KV + VV A +LC+V M+GG +
Sbjct: 29 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 88
Query: 378 DYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
+++ + F + A +++ G+ LH+ I++RDLK N+L+D+ ++++D G+
Sbjct: 89 FHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGL 148
Query: 437 ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 496
A + + GT +MAPEV++++ Y D + G +++E++ GK P+
Sbjct: 149 AVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFR------ 202
Query: 497 AAVGVVQKVHHSFLEQRLRK 516
+KV +E+R+++
Sbjct: 203 ---QRKEKVKREEVERRVKE 219
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 8e-18
Identities = 44/107 (41%), Positives = 63/107 (58%), Gaps = 14/107 (13%)
Query: 392 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VKAQS 443
L+ + V++GM +L IHRDL A N+L+ EN VVK+ DFG+AR V+ S
Sbjct: 176 LICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS 235
Query: 444 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
+ +WMAPE I K Y ++DV+SFG++LWE+ + G PY
Sbjct: 236 ARL-----PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 9e-18
Identities = 57/203 (28%), Positives = 109/203 (53%), Gaps = 22/203 (10%)
Query: 300 VASGSYGDLY----RGTYCSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQ 353
+ GS+G ++ +GT +Q AIK LK + + + D++ ++ + H +
Sbjct: 3 LGKGSFGKVFLAELKGT--NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYL---HKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 410
+L V E+++GG + ++ HK F LP A ++ G+ +LH
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK----FDLPRATFYAAEIICGLQFLHSKG 116
Query: 411 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET----GTYRWMAPEVIEHKPY 466
I++RDLK N+L+D + +K+ADFG+ + ++ + A+T GT ++APE++ + Y
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCK---ENMLGDAKTCTFCGTPDYIAPEILLGQKY 173
Query: 467 DHKADVFSFGIVLWELLTGKLPY 489
+ D +SFG++L+E+L G+ P+
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 52/193 (26%), Positives = 98/193 (50%), Gaps = 6/193 (3%)
Query: 303 GSYGDLYRGTYCSQD--VAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358
GS+G + D AIKVLK + I + D+ ++ + +H +
Sbjct: 6 GSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF 65
Query: 359 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 418
L V E+++GG + + + + F P A +V+ + +LH++ +I+RDLK
Sbjct: 66 QTKDRLFFVMEYVNGGDLMFQIQRSRK-FDEPRSRFYAAEVTLALMFLHRHGVIYRDLKL 124
Query: 419 ANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSFGI 477
N+L+D K+ADFG+ + +GV T GT ++APE+++ Y D ++ G+
Sbjct: 125 DNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGV 184
Query: 478 VLWELLTGKLPYE 490
+++E++ G+ P+E
Sbjct: 185 LMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 295 KFGSKVASGSYGDLYR------GTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR- 347
K K+ G++ ++ + G Y AIK +K + S Q +E+ +R++
Sbjct: 2 KILGKIGEGTFSEVLKAQSRKTGKY----YAIKCMK-KHFKSLEQVNNLREIQALRRLSP 56
Query: 348 HKNVVQFIGAC--TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 405
H N+++ I K L +V E M ++Y+ + K + + K +++
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 406 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM-APE-VIEH 463
+H+N I HRD+K N+L+ ++++K+ADFG R T T RW APE ++
Sbjct: 116 MHRNGIFHRDIKPENILIK-DDILKLADFGSCRGIYSKPPYTEYIST-RWYRAPECLLTD 173
Query: 464 KPYDHKADVFSFGIVLWELLT 484
Y K D+++ G V +E+L+
Sbjct: 174 GYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 45/174 (25%), Positives = 93/174 (53%), Gaps = 2/174 (1%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A K L +R+ ++ A E I+ KV +V A LC+V M+GG +
Sbjct: 22 ACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLK 81
Query: 378 DYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
+++ + ++ ++ + ++ G+ +LH +I++RD+K N+L+D+ +++D G+
Sbjct: 82 YHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGL 141
Query: 437 ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490
A +T GT +MAPE+++ +PY + D F+ G ++E++ G+ P++
Sbjct: 142 AVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 68/216 (31%), Positives = 109/216 (50%), Gaps = 27/216 (12%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDL--YRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 343
VWE+ P + S V SG+YG + T + VAIK L ++ K +E+ ++
Sbjct: 10 VWEV-PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLL 68
Query: 344 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYL--HKLKG---VFKLPSL 392
+ + H+NV+ + T SL +VT M G + + + KL F + +
Sbjct: 69 KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQI 127
Query: 393 LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 452
L+ G+ Y+H IIHRDLK +N+ ++E+ +K+ DFG+AR MT T
Sbjct: 128 LR-------GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--MTGYVAT 178
Query: 453 YRW-MAPEVIEHK-PYDHKADVFSFGIVLWELLTGK 486
RW APE++ + Y+ D++S G ++ ELLTGK
Sbjct: 179 -RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 54/198 (27%), Positives = 107/198 (54%), Gaps = 10/198 (5%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIG 356
+ GSY L R + A+KV+K E +N D ++ Q E + + + + +
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 357 ACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--VAIDVSKGMNYLHQNNIIH 413
+C + S L V E+++GG + ++ + + KLP + ++S +NYLH+ II+
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERGIIY 119
Query: 414 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADV 472
RDLK N+L+D +K+ D+G+ + + G T+ GT ++APE++ + Y D
Sbjct: 120 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179
Query: 473 FSFGIVLWELLTGKLPYE 490
++ G++++E++ G+ P++
Sbjct: 180 WALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 40/213 (18%)
Query: 298 SKVASGSYGDLYRGTYC--SQDVAIKVLKP-ERINSDMQKEFAQ----EVFIMRKVRHKN 350
S + G+YG + T+ VAIK + P E + F Q E+ I+R+ +H+N
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH------QTFCQRTLREIKILRRFKHEN 64
Query: 351 VVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-----DV 399
++ I +PPS IV E M L+K + K L I +
Sbjct: 65 IIG-ILDIIRPPSFESFNDVYIVQELMETD-----LYK---LIKTQHLSNDHIQYFLYQI 115
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ----SGVMTAETGTYRW 455
+G+ Y+H N++HRDLK +NLL++ N +K+ DFG+AR+ +G +T T RW
Sbjct: 116 LRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT-RW 174
Query: 456 M-APEV-IEHKPYDHKADVFSFGIVLWELLTGK 486
APE+ + K Y D++S G +L E+L+ +
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-17
Identities = 54/201 (26%), Positives = 108/201 (53%), Gaps = 10/201 (4%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIG 356
+ GSY L R Q A+KV+K E ++ D ++ Q E + + + +
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 357 ACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--VAIDVSKGMNYLHQNNIIH 413
+C + S L +V E+++GG + ++ + + KLP A ++ +N+LH+ II+
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERGIIY 119
Query: 414 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADV 472
RDLK N+L+D + +K+ D+G+ + G T+ GT ++APE++ + Y D
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDW 179
Query: 473 FSFGIVLWELLTGKLPYEYLT 493
++ G++++E++ G+ P++ +T
Sbjct: 180 WALGVLMFEMMAGRSPFDIIT 200
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 5e-17
Identities = 47/200 (23%), Positives = 96/200 (48%), Gaps = 23/200 (11%)
Query: 299 KVASGSYGDLY----RGTYCSQDVAIKVLKPERINSDMQKEFAQEVF---IMRKVRHKNV 351
K+ G +G + + T + K++K + N+ E +M+ + N
Sbjct: 23 KLIDGKFGKVSVLKHKPT--QKLFVQKIIKAKNFNAI-------EPMVHQLMKD--NPNF 71
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
++ + T ++ +++ G ++D L K +G + K+ + + +N LH++NI
Sbjct: 72 IKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK-EGKLSEAEVKKIIRQLVEALNDLHKHNI 130
Query: 412 IHRDLKAANLLMDENEV-VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 470
IH D+K N+L D + + + D+G+ ++ GT + +PE I+ YD
Sbjct: 131 IHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD---GTLDYFSPEKIKGHNYDVSF 187
Query: 471 DVFSFGIVLWELLTGKLPYE 490
D ++ G++ +ELLTGK P++
Sbjct: 188 DWWAVGVLTYELLTGKHPFK 207
|
Length = 267 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 53/177 (29%), Positives = 96/177 (54%), Gaps = 13/177 (7%)
Query: 315 SQDVAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-PSLCIVTEFMS 372
Q+VAIK ++KP ++ + +E+ +++ +RH+N++ P + VTE +
Sbjct: 35 GQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLRHENIISLSDIFISPLEDIYFVTELLG 93
Query: 373 GGSVYDYLHKLKGVFKL-PSLLK-VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK 430
LH+L L ++ + +G+ Y+H ++HRDLK +N+L++EN +K
Sbjct: 94 TD-----LHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLK 148
Query: 431 VADFGVARVKAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGK 486
+ DFG+AR+ Q MT T + APE+ + + YD + D++S G + E+L GK
Sbjct: 149 ICDFGLARI--QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 6e-17
Identities = 43/111 (38%), Positives = 65/111 (58%), Gaps = 16/111 (14%)
Query: 389 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR---------V 439
L LL+ + V++GM++L N IHRD+ A N+L+ + V K+ DFG+AR V
Sbjct: 211 LDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270
Query: 440 KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
K + + +WMAPE I Y ++DV+S+GI+LWE+ + GK PY
Sbjct: 271 KGNARL------PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY 315
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 292 KHLKFGSKVASGSYGDLY----RGTYCSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKV 346
K + ++V G YG ++ + T + VA+K +K + + + E I+
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDT--GEIVALKRMKKSLLFKLNEVRHVLTERDILTTT 58
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
+ + +V+ + A L + E++ GG L+ L GV ++ + ++ L
Sbjct: 59 KSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDAL 117
Query: 407 HQNNIIHRDLKAANLLMDENEVVKVADFGVAR---VKAQSGVMTAETGTYRWMAPEVIEH 463
H+ IHRDLK N L+D + +K+ DFG+++ A S V G+ +MAPEV+
Sbjct: 118 HELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV-----GSPDYMAPEVLRG 172
Query: 464 KPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494
K YD D +S G +L+E L G P+ TP
Sbjct: 173 KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 8e-17
Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 294 LKFGSKVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFA-QEVFIMRKVRHK 349
F + +GS+G + TY ++D VAIK + +I Q + E I+ + H
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHP 91
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKV--AIDVSKGMNYLH 407
V G+ L +V EF+ GG + +L + K + P+ + A + YL
Sbjct: 92 FCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQ 148
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD 467
NI++RDLK NLL+D++ +K+ DFG A+V + T GT ++APE++ + +
Sbjct: 149 SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-VDTRTYTL-CGTPEYIAPEILLNVGHG 206
Query: 468 HKADVFSFGIVLWELLTGKLPYEYLTPL 495
AD ++ GI ++E+L G P+ PL
Sbjct: 207 KAADWWTLGIFIYEILVGCPPFYANEPL 234
|
Length = 340 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 9e-17
Identities = 56/228 (24%), Positives = 111/228 (48%), Gaps = 31/228 (13%)
Query: 306 GDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365
++Y T ++ V +K LK +S Q EF Q+ R ++H N++Q +G C +
Sbjct: 14 SEIYTDTGVAR-VVVKELKAN-ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYL 71
Query: 366 IVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 422
+V E+ G + YL + + +L L ++A +++ G+ ++H++N +H DL N
Sbjct: 72 LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCF 131
Query: 423 MDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVI-----------EHKPYDH 468
+ + VKV D+G+ + + + E RW+APE++ + KP
Sbjct: 132 LTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKP--- 188
Query: 469 KADVFSFGIVLWELL-TGKLPYEYLTPLQAAVGVVQKVHHSFLEQRLR 515
++V++ G+ LWEL PY +L+ + ++H +Q+++
Sbjct: 189 -SNVWALGVTLWELFENAAQPYSHLSDREV-------LNHVIKDQQVK 228
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 40/102 (39%), Positives = 61/102 (59%), Gaps = 4/102 (3%)
Query: 392 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG 451
LL V++GM +L N +HRDL A N+L+ + ++VK+ DFG+AR ++
Sbjct: 239 LLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGS 298
Query: 452 TY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
T+ +WMAPE I Y +DV+S+GI+LWE+ + G PY
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY 340
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 11/195 (5%)
Query: 298 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 355
SK+ GSYG ++ R Q VAIK + ++K +E+ ++++++H N+V I
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLL--KVAIDVSKGMNYLHQNNII 412
+ L +V E+ + L++L K +P L K+ + +N+ H++N I
Sbjct: 67 EVFRRKRKLHLVFEYCD----HTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCI 122
Query: 413 HRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM-APEVI-EHKPYDHKA 470
HRD+K N+L+ + +K+ DFG AR+ G + RW APE++ Y
Sbjct: 123 HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPV 182
Query: 471 DVFSFGIVLWELLTG 485
DV++ G V ELLTG
Sbjct: 183 DVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 40/97 (41%), Positives = 65/97 (67%), Gaps = 3/97 (3%)
Query: 397 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS---GVMTAETGTY 453
I V ++++H ++IHRD+K+AN+L+ N +VK+ DFG +++ A + V GT
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP 209
Query: 454 RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490
++APE+ KPY KAD+FS G++L+ELLT K P++
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 55/198 (27%), Positives = 104/198 (52%), Gaps = 10/198 (5%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIG 356
+ GSY L + A+KV+K E +N D ++ Q E + + + +
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 357 ACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--VAIDVSKGMNYLHQNNIIH 413
+C + S L V EF+SGG D + ++ KLP + ++S +N+LH+ II+
Sbjct: 63 SCFQTESRLFFVIEFVSGG---DLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIY 119
Query: 414 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADV 472
RDLK N+L+D +K+ D+G+ + + G T+ GT ++APE++ + Y D
Sbjct: 120 RDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179
Query: 473 FSFGIVLWELLTGKLPYE 490
++ G++++E++ G+ P++
Sbjct: 180 WALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 10/177 (5%)
Query: 316 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL------CIVTE 369
Q+VAIK L N K +E+ +M+ V HKN++ + T SL +V E
Sbjct: 42 QNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVME 101
Query: 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVV 429
M ++ + ++ LL + G+ +LH IIHRDLK +N+++ + +
Sbjct: 102 LMDA-NLCQVIQMDLDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 157
Query: 430 KVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK 486
K+ DFG+AR S +MT T + APEVI Y D++S G ++ E++ G
Sbjct: 158 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 17/209 (8%)
Query: 294 LKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQ---EVFIMRKVRHKN 350
++ ++ G+YG +Y+ + V +K R+ D K F Q E+ I+ K
Sbjct: 3 IEVLDELGKGNYGSVYKVLHRPTGV-TMAMKEIRLELDESK-FNQIIMELDILHKAVSPY 60
Query: 351 VVQFIGACTKPPSLCIVTEFMSGGSV---YDYLHKLKGVFKLPSLLKVAIDVSKGMNYL- 406
+V F GA ++ + E+M GS+ Y +G+ + L ++ V KG+ +L
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPE-DVLRRITYAVVKGLKFLK 119
Query: 407 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI----- 461
++NIIHRD+K N+L++ N VK+ DFGV+ S T G +MAPE I
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT-NIGCQSYMAPERIKSGGP 178
Query: 462 -EHKPYDHKADVFSFGIVLWELLTGKLPY 489
++ Y ++DV+S G+ + E+ G+ PY
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYPY 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 45/128 (35%), Positives = 75/128 (58%), Gaps = 4/128 (3%)
Query: 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
L V EF++GG + ++ KG F L A ++ G+ +LH II+RDLK N+++
Sbjct: 71 LFFVMEFLNGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML 129
Query: 424 DENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWE 481
D + +K+ADFG+ + G A T GT ++APE+++ Y D +SFG++L+E
Sbjct: 130 DRDGHIKIADFGMCKENV-FGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYE 188
Query: 482 LLTGKLPY 489
+L G+ P+
Sbjct: 189 MLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 38/99 (38%), Positives = 61/99 (61%), Gaps = 3/99 (3%)
Query: 401 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA--QSGVMTAETGTYRWMAP 458
+G+ YLH I+HRD+K NLL++ N V+K+ DFG+ARV+ +S MT E T + AP
Sbjct: 114 RGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173
Query: 459 EVIEHKP-YDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 496
E++ Y D++S G + ELL ++ ++ +P+Q
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 51/168 (30%), Positives = 90/168 (53%), Gaps = 15/168 (8%)
Query: 328 INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF 387
I ++ + +E+ ++ + +V F GA + I E M GGS+ D + LK
Sbjct: 38 IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQV--LKKAG 94
Query: 388 KLPS--LLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVA----RVK 440
++P L K++I V +G+ YL + I+HRD+K +N+L++ +K+ DFGV+
Sbjct: 95 RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154
Query: 441 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP 488
A S V GT +M+PE ++ Y ++D++S G+ L E+ G+ P
Sbjct: 155 ANSFV-----GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-16
Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 24/214 (11%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQ 338
VWE+ P+ +V SG+YG + CS + VAIK L + K +
Sbjct: 10 VWEL-PERYTSLKQVGSGAYGSV-----CSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR 63
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDY----LHKLKGV-FKLPSLL 393
E+ +++ ++H+NV+ + T S EF V Y L K+ G +
Sbjct: 64 ELTLLKHMQHENVIGLLDVFTSAVSG---DEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQ 120
Query: 394 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY 453
+ + G+ Y+H IIHRDLK NL ++E+ +K+ DFG+AR MT T
Sbjct: 121 YLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVVTR 178
Query: 454 RWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 486
+ APEVI + Y+ D++S G ++ E+LTGK
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 50/209 (23%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 295 KFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 354
G L + + VA+K + + + + K QE+ R+++H N++ +
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAI--DVSKGMNYLHQNN 410
+ + L +V+ M+ GS D LK F LP L I DV ++Y+H
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDL---LKTHFPEGLPELAIAFILKDVLNALDYIHSKG 121
Query: 411 IIHRDLKAANLLMDENEVVKVADFGVA--------RVKAQSGVMTAETGTYRWMAPEVIE 462
IHR +KA+++L+ + V ++ + R + + W++PEV++
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ 181
Query: 463 H--KPYDHKADVFSFGIVLWELLTGKLPY 489
+ Y+ K+D++S GI EL G +P+
Sbjct: 182 QNLQGYNEKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 48/173 (27%), Positives = 89/173 (51%), Gaps = 2/173 (1%)
Query: 319 AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A K L+ +RI + A E I+ KV + VV A +LC+V M+GG +
Sbjct: 29 ACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLK 88
Query: 378 DYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
+++ + F + A ++ G+ L + I++RDLK N+L+D+ ++++D G+
Sbjct: 89 FHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGL 148
Query: 437 ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489
A + + GT +MAPEVI ++ Y D + G +++E++ G+ P+
Sbjct: 149 AVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 58/193 (30%), Positives = 105/193 (54%), Gaps = 9/193 (4%)
Query: 300 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357
V G+YG + R + VAIK K N ++++ +E+ ++R ++ +N+V+ A
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 358 CTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAI-DVSKGMNYLHQNNIIHRD 415
+ L +V E++ ++ + L ++ GV P ++ I + K +++ H+N+I+HRD
Sbjct: 69 FRRRGKLYLVFEYVEK-NMLELLEEMPNGV--PPEKVRSYIYQLIKAIHWCHKNDIVHRD 125
Query: 416 LKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWM-APEVIEHKPYDHKADVF 473
+K NLL+ N+V+K+ DFG AR + S E RW +PE++ PY D++
Sbjct: 126 IKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMW 185
Query: 474 SFGIVLWELLTGK 486
S G +L EL G+
Sbjct: 186 SVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 54/182 (29%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 316 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 375
++VAIK L N K +E+ +M+ V HKN++ + T SL EF
Sbjct: 50 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL---EEFQD--- 103
Query: 376 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 425
VY + + L ++++ +D + G+ +LH IIHRDLK +N+++
Sbjct: 104 VYIVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 426 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 485
+ +K+ DFG+AR S +MT T + APEVI Y D++S G ++ E++ G
Sbjct: 162 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
Query: 486 KL 487
+
Sbjct: 222 GV 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 343
+WE+ P+ + S V SG+YG + T VA+K L + K +E+ ++
Sbjct: 12 IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 394
+ ++H+NV+ + T SL EF VY H L + K L
Sbjct: 71 KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 124
Query: 395 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 454
+ + +G+ Y+H +IIHRDLK +NL ++E+ +K+ DFG+AR MT T
Sbjct: 125 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRW 182
Query: 455 WMAPEV-IEHKPYDHKADVFSFGIVLWELLTGK 486
+ APE+ + Y+ D++S G ++ ELLTG+
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 39/130 (30%), Positives = 73/130 (56%), Gaps = 5/130 (3%)
Query: 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
L ++ ++++GG ++ +L++ + F + ++ +++LHQ II+RD+K N+L+
Sbjct: 80 LHLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL 138
Query: 424 DENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKP--YDHKADVFSFGIVL 479
D V + DFG+++ A + GT +MAPEVI +D D +S G++
Sbjct: 139 DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLT 198
Query: 480 WELLTGKLPY 489
+ELLTG P+
Sbjct: 199 FELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 55/199 (27%), Positives = 97/199 (48%), Gaps = 15/199 (7%)
Query: 299 KVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQ--KEFA-QEVFIMRKVRHKNVVQFI 355
K+ G+YG +++ + I LK R++ D + A +E+ ++++++HKN+V+
Sbjct: 7 KIGEGTYGTVFKAKN-RETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
L +V E+ + Y G + + KG+ + H +N++HRD
Sbjct: 66 DVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRD 124
Query: 416 LKAANLLMDENEVVKVADFGVAR-----VKAQSGVMTAETGTYRWMAPEVI-EHKPYDHK 469
LK NLL+++N +K+ADFG+AR V+ S AE T + P+V+ K Y
Sbjct: 125 LKPQNLLINKNGELKLADFGLARAFGIPVRCYS----AEVVTLWYRPPDVLFGAKLYSTS 180
Query: 470 ADVFSFGIVLWELLTGKLP 488
D++S G + EL P
Sbjct: 181 IDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 57/223 (25%), Positives = 103/223 (46%), Gaps = 47/223 (21%)
Query: 295 KFGSKVASGSYGDLYRG----TYCSQDVAIKVLKPERINSD-MQKEFAQEVFIMRKVRHK 349
+ + G+YG +Y+ ++ AIK K ++ + + +E+ ++R+++H+
Sbjct: 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHE 62
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDY----------LHKLKGVFKLP-----SLLK 394
NVV + + + ++ ++DY H+ +P SLL
Sbjct: 63 NVVSLVEVFLEHADKSV---YL----LFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW 115
Query: 395 VAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAE- 449
++ G++YLH N ++HRDLK AN+L+ E VVK+ D G+AR+ A+
Sbjct: 116 QILN---GVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172
Query: 450 -----TGTYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLT 484
T YR APE++ H Y D+++ G + ELLT
Sbjct: 173 DPVVVTIWYR--APELLLGARH--YTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 66/226 (29%), Positives = 106/226 (46%), Gaps = 44/226 (19%)
Query: 300 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSD--MQKEFAQEVFIMRKV----RHKNV 351
+++G+YG +Y R Q A+K +IN + + Q+VF+ R + + V
Sbjct: 9 ISNGAYGAVYLVRHKETRQRFAMK-----KINKQNLILRNQIQQVFVERDILTFAENPFV 63
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP---SLLKVAIDVSKGMNYLHQ 408
V + LC+V E++ GG D LK + LP + + A V + YLH
Sbjct: 64 VSMFCSFETKRHLCMVMEYVEGG---DCATLLKNIGALPVDMARMYFAETVL-ALEYLHN 119
Query: 409 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET------------------ 450
I+HRDLK NLL+ +K+ DFG++++ G+M+ T
Sbjct: 120 YGIVHRDLKPDNLLITSMGHIKLTDFGLSKI----GLMSLTTNLYEGHIEKDTREFLDKQ 175
Query: 451 --GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494
GT ++APEVI + Y D ++ GI+L+E L G +P+ TP
Sbjct: 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 221
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 53/197 (26%), Positives = 99/197 (50%), Gaps = 14/197 (7%)
Query: 299 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ G+YG +Y R + VA+K ++ E + + +E+ +++++ H N+V+ +
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-DVSKGMNYLHQNNIIHRD 415
L +V EF+ + Y+ P L+K + + +G+ Y H + ++HRD
Sbjct: 66 VVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRD 124
Query: 416 LKAANLLMDENEVVKVADFGVAR-----VKAQSGVMTAETGTYRWMAPEV-IEHKPYDHK 469
LK NLL+D +K+ADFG+AR V+ T E T + APE+ + + Y
Sbjct: 125 LKPQNLLIDREGALKLADFGLARAFGVPVRT----YTHEVVTLWYRAPEILLGSRQYSTP 180
Query: 470 ADVFSFGIVLWELLTGK 486
D++S G + E++ +
Sbjct: 181 VDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 50/162 (30%), Positives = 88/162 (54%), Gaps = 3/162 (1%)
Query: 328 INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF 387
I ++ + +E+ ++ + +V F GA + I E M GGS+ D + K G
Sbjct: 42 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRI 100
Query: 388 KLPSLLKVAIDVSKGMNYLHQNN-IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 446
L KV+I V KG+ YL + + I+HRD+K +N+L++ +K+ DFGV+ S +
Sbjct: 101 PEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA 159
Query: 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP 488
+ GT +M+PE ++ Y ++D++S G+ L E+ G+ P
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 6e-15
Identities = 50/164 (30%), Positives = 90/164 (54%), Gaps = 7/164 (4%)
Query: 328 INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF 387
I ++ + +E+ ++ + +V F GA + I E M GGS+ L + K
Sbjct: 42 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK--- 98
Query: 388 KLPS--LLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444
++P L KV+I V +G+ YL + + I+HRD+K +N+L++ +K+ DFGV+ S
Sbjct: 99 RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157
Query: 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP 488
+ + GT +M+PE ++ Y ++D++S G+ L EL G+ P
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 7e-15
Identities = 61/201 (30%), Positives = 93/201 (46%), Gaps = 33/201 (16%)
Query: 310 RGTY---CS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
RG Y CS + VAIK + N K +E+ ++R + H+NV+ I
Sbjct: 15 RGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIA-IKDIM 73
Query: 360 KPPS------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK------VAIDVSKGMNYLH 407
PP + IV E M LH+ + + L + +G+ Y+H
Sbjct: 74 PPPHREAFNDVYIVYELMDTD-----LHQ---IIRSSQTLSDDHCQYFLYQLLRGLKYIH 125
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVI-EHKP 465
N++HRDLK +NLL++ N +K+ DFG+AR ++ G MT T + APE++
Sbjct: 126 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSE 185
Query: 466 YDHKADVFSFGIVLWELLTGK 486
Y DV+S G + ELL K
Sbjct: 186 YTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 9e-15
Identities = 47/152 (30%), Positives = 75/152 (49%), Gaps = 4/152 (2%)
Query: 337 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 396
A E I+R + H +++Q G T C++ +Y YL + + + +L +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNI-AICDILAIE 188
Query: 397 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA--RVKAQSGVMTAETGTYR 454
V + + YLH+N IIHRD+KA N+ ++ V + DFG A V + GT
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIA 248
Query: 455 WMAPEVIEHKPYDHKADVFSFGIVLWELLTGK 486
APE++ PY D++S GIVL+E+ T
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 58/220 (26%), Positives = 108/220 (49%), Gaps = 23/220 (10%)
Query: 299 KVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKNV 351
K+ G+Y +Y+G D VA+K ++ E +E A +EV +++ ++H N+
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLE------HEEGAPCTAIREVSLLKDLKHANI 66
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
V SL +V E++ + YL + ++ + +G+NY H+ +
Sbjct: 67 VTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKV 125
Query: 412 IHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEV-IEHKPYDHK 469
+HRDLK NLL++E +K+ADFG+AR K+ + + E T + P++ + Y +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQ 185
Query: 470 ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSF 509
D++ G + +E+ TG+ PL V +++H F
Sbjct: 186 IDMWGVGCIFYEMSTGR-------PLFPGSTVEEQLHFIF 218
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 51/196 (26%), Positives = 97/196 (49%), Gaps = 12/196 (6%)
Query: 299 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ G+YG +Y R + VA+K ++ + + +E+ +++++ H N+V+ +
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
L +V EF+ + ++ LP + + +G+ + H + ++HRD
Sbjct: 67 VIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 125
Query: 416 LKAANLLMDENEVVKVADFGVARVKAQSGV----MTAETGTYRWMAPEV-IEHKPYDHKA 470
LK NLL++ +K+ADFG+AR GV T E T + APE+ + K Y
Sbjct: 126 LKPQNLLINTEGAIKLADFGLARA---FGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 182
Query: 471 DVFSFGIVLWELLTGK 486
D++S G + E++T +
Sbjct: 183 DIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 52/201 (25%), Positives = 99/201 (49%), Gaps = 13/201 (6%)
Query: 298 SKVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNV 351
+++ G+YG +++ VA+K ++ + M +EV ++R + H NV
Sbjct: 7 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66
Query: 352 VQFIGACT-----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK-VAIDVSKGMNY 405
V+ CT + L +V E + + YL K+ +K + + +G+++
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 406 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKP 465
LH + ++HRDLK N+L+ + +K+ADFG+AR+ + +T+ T + APEV+
Sbjct: 126 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 185
Query: 466 YDHKADVFSFGIVLWELLTGK 486
Y D++S G + E+ K
Sbjct: 186 YATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 54/184 (29%), Positives = 91/184 (49%), Gaps = 18/184 (9%)
Query: 316 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 375
++VAIK L N K +E+ +M+ V HKN++ + T SL EF
Sbjct: 43 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL---EEFQD--- 96
Query: 376 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 425
VY + + L ++++ +D + G+ +LH IIHRDLK +N+++
Sbjct: 97 VYLVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 154
Query: 426 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 485
+ +K+ DFG+AR S +MT T + APEVI Y D++S G ++ E++
Sbjct: 155 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 214
Query: 486 KLPY 489
K+ +
Sbjct: 215 KILF 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 50/189 (26%), Positives = 91/189 (48%), Gaps = 21/189 (11%)
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
V +KVL + +S F + +M ++ HK++V+ G C + ++ +V E++ G +
Sbjct: 33 VVLKVLGSDHRDSL---AFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLD 88
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENE----VVK 430
+LH+ K L L VA ++ ++YL ++H ++ N+L+ NE +K
Sbjct: 89 VFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIK 148
Query: 431 VADFGVARVKAQSGVMTAETGTYR--WMAPEVIE--HKPYDHKADVFSFGIVLWELLT-G 485
++D G+ V++ E R W+APE I AD +SFG L E+ + G
Sbjct: 149 LSDPGIPI-----TVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNG 203
Query: 486 KLPYEYLTP 494
+ P L+
Sbjct: 204 EEPLSTLSS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 63/234 (26%), Positives = 112/234 (47%), Gaps = 28/234 (11%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 343
VWE+ P+ + + V SG+YG + T Q VA+K L + + +E+ ++
Sbjct: 10 VWEV-PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLL 68
Query: 344 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 397
+ ++H+NV+ + T S+ +VT M L + K L +
Sbjct: 69 KHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGA--------DLNNIVKCQKLSDEHV 120
Query: 398 D-----VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 452
+ +G+ Y+H IIHRDLK +N+ ++E+ +++ DFG+AR MT T
Sbjct: 121 QFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE--MTGYVAT 178
Query: 453 YRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 502
+ APE+ + Y+ D++S G ++ ELL GK + +Y+ L+ + VV
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVV 232
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 51/195 (26%), Positives = 102/195 (52%), Gaps = 10/195 (5%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSD--MQKEFAQEVFIMRKVRHKNVVQF 354
K+ G+Y +Y+G + VA+K + ++++ +E+ +M++++H+N+V+
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEI---HLDAEEGTPSTAIREISLMKELKHENIVRL 63
Query: 355 IGACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
L +V E+M Y H ++G ++ + KG+ + H+N ++H
Sbjct: 64 HDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLH 123
Query: 414 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVI-EHKPYDHKAD 471
RDLK NLL+++ +K+ADFG+AR + E T + AP+V+ + Y D
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSID 183
Query: 472 VFSFGIVLWELLTGK 486
++S G ++ E++TG+
Sbjct: 184 IWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 52/180 (28%), Positives = 90/180 (50%), Gaps = 10/180 (5%)
Query: 317 DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEF 370
+VA+K L N K +E+ +++ V HKN++ + T SL +V E
Sbjct: 48 NVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 107
Query: 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK 430
M ++ +H ++ LL + G+ +LH IIHRDLK +N+++ + +K
Sbjct: 108 MDA-NLCQVIHMELDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 163
Query: 431 VADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490
+ DFG+AR + +MT T + APEVI Y D++S G ++ EL+ G + ++
Sbjct: 164 ILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 39/131 (29%), Positives = 72/131 (54%), Gaps = 3/131 (2%)
Query: 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420
L +VT++MSGG ++ +L K +G F ++ + +LH+ +I++RDLK N
Sbjct: 68 DSDLYLVTDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPEN 126
Query: 421 LLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEV-IEHKPYDHKADVFSFGIV 478
+L+D + + DFG+++ T GT ++APEV ++ K Y D +S G++
Sbjct: 127 ILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVL 186
Query: 479 LWELLTGKLPY 489
++E+ G P+
Sbjct: 187 VFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 70/217 (32%), Positives = 105/217 (48%), Gaps = 29/217 (13%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 338
+WE+ P + +V SG+YG T CS VAIK L + K +
Sbjct: 10 IWEV-PDRYRDLKQVGSGAYG-----TVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR 63
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 391
E+ +++ ++H+NV+ + T SL +V FM L KL KL
Sbjct: 64 ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTD-----LGKLMKHEKLSED 118
Query: 392 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET 450
+ + + KG+ Y+H IIHRDLK NL ++E+ +K+ DFG+AR + S MT
Sbjct: 119 RIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-QTDSE-MTGYV 176
Query: 451 GTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 486
T + APEVI Y D++S G ++ E+LTGK
Sbjct: 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 44/165 (26%), Positives = 74/165 (44%), Gaps = 19/165 (11%)
Query: 334 KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL 393
K +E+ I++ + H+ ++ I A ++C+V D + LP L
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK----CDLFTYVDRSGPLP--L 184
Query: 394 KVAIDVSKGM----NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 449
+ AI + + + YLH IIHRD+K N+ +DE E + DFG A +
Sbjct: 185 EQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAA---CKLDAHPDT 241
Query: 450 TGTYRWM------APEVIEHKPYDHKADVFSFGIVLWELLTGKLP 488
Y W +PE++ PY K D++S G+VL+E+ +
Sbjct: 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 60/216 (27%), Positives = 108/216 (50%), Gaps = 30/216 (13%)
Query: 293 HLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKE-----FAQEVFIMRK 345
++ G+YG +Y R + VA+K ++ D +KE +E+ I+R+
Sbjct: 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALK-----KVRLDNEKEGFPITAIREIKILRQ 62
Query: 346 VRHKNVVQFIGACT-KPPSLCIVTEFMSGGSVYDYL-HKLKGVFK----------LPSLL 393
+ H+N+V T K +L + + V++Y+ H L G+ + + S +
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122
Query: 394 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETG 451
K ++ G+NY H+ N +HRD+K +N+L++ +K+ADFG+AR+ +S T +
Sbjct: 123 KQLLE---GLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 452 TYRWMAPE-VIEHKPYDHKADVFSFGIVLWELLTGK 486
T + PE ++ + Y DV+S G +L EL T K
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 53/200 (26%), Positives = 98/200 (49%), Gaps = 39/200 (19%)
Query: 314 CSQDVAIKVLKPERINSDMQ--KEFAQEVFIMRKVRHKNVVQF--------------IGA 357
C + VA+K + + +D Q K +E+ I+R++ H N+V+ +G+
Sbjct: 29 CDKRVAVKKI----VLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84
Query: 358 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK-----VAIDVSKGMNYLHQNNII 412
T+ S+ IV E+M L V + L + + +G+ Y+H N++
Sbjct: 85 LTELNSVYIVQEYMET--------DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVL 136
Query: 413 HRDLKAANLLMD-ENEVVKVADFGVARV----KAQSGVMTAETGTYRWMAPEVIEH-KPY 466
HRDLK AN+ ++ E+ V+K+ DFG+AR+ + G ++ T + +P ++ Y
Sbjct: 137 HRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNY 196
Query: 467 DHKADVFSFGIVLWELLTGK 486
D+++ G + E+LTGK
Sbjct: 197 TKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-14
Identities = 56/193 (29%), Positives = 100/193 (51%), Gaps = 20/193 (10%)
Query: 310 RGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368
RG+ + V K + +N + Q +A+ E+ + H +V+ L ++
Sbjct: 88 RGSDPKEKVVAKFVM---LNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144
Query: 369 EFMSGGSVYDYLHKLKGVFK--LP------SLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420
E+ SGG D ++K K LP LL I ++ ++ +H ++HRDLK+AN
Sbjct: 145 EYGSGG---DLNKQIKQRLKEHLPFQEYEVGLLFYQIVLA--LDEVHSRKMMHRDLKSAN 199
Query: 421 LLMDENEVVKVADFGVARVKAQS---GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGI 477
+ + ++K+ DFG ++ + S V ++ GT ++APE+ E K Y KAD++S G+
Sbjct: 200 IFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGV 259
Query: 478 VLWELLTGKLPYE 490
+L+ELLT P++
Sbjct: 260 ILYELLTLHRPFK 272
|
Length = 478 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
+ G++G+ L R + A+K+L K E I F +E IM VVQ
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
A L +V E+M GG + + + K +V ++ +H +IHRD+
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTA--EVVLALDAIHSMGLIHRDV 168
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKP----YDHKA 470
K N+L+D++ +K+ADFG ++G++ +T GT +++PEV++ + Y +
Sbjct: 169 KPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 228
Query: 471 DVFSFGIVLWELLTGKLPY 489
D +S G+ L+E+L G P+
Sbjct: 229 DWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 8e-14
Identities = 51/182 (28%), Positives = 91/182 (50%), Gaps = 18/182 (9%)
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
V +KVL P + D+ F + +MR+V HK++V G C + +V EF+ G +
Sbjct: 35 VILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD 92
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM-------DENEVVK 430
++H+ V P KVA ++ ++YL +++H ++ N+L+ + +K
Sbjct: 93 LFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIK 152
Query: 431 VADFGVARVKAQSGVMTAETGTYR--WMAPEVIE-HKPYDHKADVFSFGIVLWEL-LTGK 486
++D G+ V++ + R W+APE +E K AD +SFG LWE+ G+
Sbjct: 153 LSDPGIPIT-----VLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGE 207
Query: 487 LP 488
+P
Sbjct: 208 IP 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 22/200 (11%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKNV 351
K+ G+Y +++G VA+K ++ E +E A +EV +++ ++H N+
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLE------HEEGAPCTAIREVSLLKNLKHANI 65
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI---DVSKGMNYLHQ 408
V L +V E++ D L L S+ V I + +G++Y H+
Sbjct: 66 VTLHDIIHTERCLTLVFEYLDS----DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121
Query: 409 NNIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEV-IEHKPY 466
I+HRDLK NLL++E +K+ADFG+AR K+ + + E T + P+V + Y
Sbjct: 122 RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 467 DHKADVFSFGIVLWELLTGK 486
D++ G +L+E+ TG+
Sbjct: 182 STPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
+ G++G+ L R + A+K+L K E I F +E IM VVQ
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
A L +V E+M GG + + + K +V ++ +H IHRD+
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA--EVVLALDAIHSMGFIHRDV 168
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKP----YDHKA 470
K N+L+D++ +K+ADFG + G++ +T GT +++PEV++ + Y +
Sbjct: 169 KPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 228
Query: 471 DVFSFGIVLWELLTGKLPY 489
D +S G+ L+E+L G P+
Sbjct: 229 DWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 37/94 (39%), Positives = 56/94 (59%), Gaps = 9/94 (9%)
Query: 401 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG------VMTAETGTYR 454
K + Y+H N+IHRDLK +N+L++ + VK+ADFG+AR ++ V+T T R
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT-R 176
Query: 455 WM-APEV-IEHKPYDHKADVFSFGIVLWELLTGK 486
W APE+ + Y D++S G +L E+L GK
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 51/198 (25%), Positives = 102/198 (51%), Gaps = 15/198 (7%)
Query: 299 KVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ G+YG +Y+ ++ +A+K ++ E+ + + +E+ ++++++H N+V+
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-DVSKGMNYLHQNNIIHRD 415
L +V E++ + ++ K P L+K + + +G+ Y H + ++HRD
Sbjct: 69 VVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRD 127
Query: 416 LKAANLLMDE-NEVVKVADFGVAR-----VKAQSGVMTAETGTYRWMAPEV-IEHKPYDH 468
LK NLL+D +K+ADFG+AR V+ T E T + APE+ + + Y
Sbjct: 128 LKPQNLLIDRRTNALKLADFGLARAFGIPVRT----FTHEVVTLWYRAPEILLGSRHYST 183
Query: 469 KADVFSFGIVLWELLTGK 486
D++S G + E++ K
Sbjct: 184 PVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 24/200 (12%)
Query: 300 VASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVVQF 354
+ G+YG +Y+ + VA+K ++ + +E+ +++++ H N+V+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 355 IGACTKPP-----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-DVSK----GMN 404
+ C P L +V E + + YL K P L I D+ + G++
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPK----PGLPPETIKDLMRQLLRGVD 121
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT--YRWMAPEVIE 462
+LH + I+HRDLK N+L+ + VK+ADFG+AR+ + +T+ T YR APEV+
Sbjct: 122 FLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYR--APEVLL 179
Query: 463 HKPYDHKADVFSFGIVLWEL 482
Y D++S G + EL
Sbjct: 180 QSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 18/203 (8%)
Query: 298 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVV 352
+++ G+YG +Y R + VA+K ++ + + +EV +++++ H N+V
Sbjct: 6 AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65
Query: 353 QFIGACT-----KPPSLCIVTEFMSGGSVYDYLHKLKG----VFKLPSLLKVAIDVSKGM 403
+ + C + + +V E + + YL K+ + L++ + +G+
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFL---RGL 121
Query: 404 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH 463
++LH N I+HRDLK N+L+ VK+ADFG+AR+ + +T T + APEV+
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQ 181
Query: 464 KPYDHKADVFSFGIVLWELLTGK 486
Y D++S G + E+ K
Sbjct: 182 STYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 44/135 (32%), Positives = 69/135 (51%), Gaps = 21/135 (15%)
Query: 401 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-----GVMTAETGTYRW 455
+G+ Y+H N+IHRDLK +NLL++E+ +++ DFG+AR + S MT T RW
Sbjct: 118 RGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT-RW 176
Query: 456 M-APEVIEHKP-YDHKADVFSFGIVLWE------LLTGKLPYEYLTPLQAAVGVVQKVHH 507
APE++ P Y D++S G + E L GK Y+ L+ + V+
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK---NYVHQLKLILSVLGSPSE 233
Query: 508 SFLEQ----RLRKSV 518
L + R+RK +
Sbjct: 234 EVLNRIGSDRVRKYI 248
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 37/92 (40%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 402 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-----VKAQSGVMTAETGTYRWM 456
G+ Y+H N++HRDLK NLL++ + +K+ DFG+AR +G MT T RW
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT-RWY 175
Query: 457 -APEV-IEHKPYDHKADVFSFGIVLWELLTGK 486
APE+ + + Y DV+S G +L ELL K
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 23/205 (11%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
+ G++G+ L R Q A+K+L K E I F +E IM + +VQ
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHY 110
Query: 357 ACTKPPSLCIVTEFMSGG------SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 410
A L +V E+M GG S YD K + +L A+D +H
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVL--ALDA------IHSMG 162
Query: 411 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIE----HK 464
IHRD+K N+L+D++ +K+ADFG +G++ +T GT +++PEV++
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 465 PYDHKADVFSFGIVLWELLTGKLPY 489
Y + D +S G+ L+E+L G P+
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 47/192 (24%), Positives = 97/192 (50%), Gaps = 6/192 (3%)
Query: 299 KVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ G+Y +++G + VA+K ++ E +EV +++ ++H N+V
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
SL +V E++ + Y+ + + ++ + +G+ Y H+ ++HRDL
Sbjct: 72 IVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDL 130
Query: 417 KAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEV-IEHKPYDHKADVFS 474
K NLL++E +K+ADFG+AR K+ + + E T + P+V + Y + D++
Sbjct: 131 KPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWG 190
Query: 475 FGIVLWELLTGK 486
G + +E+ +G+
Sbjct: 191 VGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 23/200 (11%)
Query: 308 LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367
L R T V +++ E + K EV + RH N++ T L ++
Sbjct: 18 LARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVI 77
Query: 368 TEFMSGGSVYDYLHKLKGVFK-------LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420
+ FM+ GS LK F + ++L A+ +G+NYLHQN IHR++KA++
Sbjct: 78 SPFMAYGSAN---SLLKTYFPEGMSEALIGNILFGAL---RGLNYLHQNGYIHRNIKASH 131
Query: 421 LLMDENEVVKVADFGV--------ARVKAQSGVMTAETGTYRWMAPEVIEHK--PYDHKA 470
+L+ + +V ++ + K T W++PE++ Y+ K+
Sbjct: 132 ILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKS 191
Query: 471 DVFSFGIVLWELLTGKLPYE 490
D++S GI EL TG++P++
Sbjct: 192 DIYSVGITACELATGRVPFQ 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 7e-13
Identities = 54/204 (26%), Positives = 101/204 (49%), Gaps = 10/204 (4%)
Query: 299 KVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFA--QEVFIMRKVRHKNVVQF 354
K+ GSY +Y+G + VA+KV+ R+ + F +E +++ ++H N+V
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVI---RLQEEEGTPFTAIREASLLKGLKHANIVLL 68
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
+L +V E++ + Y+ K G ++ + +G++Y+HQ I+HR
Sbjct: 69 HDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHR 127
Query: 415 DLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEV-IEHKPYDHKADV 472
DLK NLL+ + +K+ADFG+AR K+ S + E T + P+V + Y D+
Sbjct: 128 DLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDM 187
Query: 473 FSFGIVLWELLTGKLPYEYLTPLQ 496
+ G + E++ G + + +Q
Sbjct: 188 WGVGCIFVEMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 9e-13
Identities = 49/185 (26%), Positives = 89/185 (48%), Gaps = 14/185 (7%)
Query: 315 SQDVAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI-VTEFMS 372
+VAIK+L+ + + Q F +E + ++ H N+V + + PP L V E++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 373 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV---V 429
G ++ + L G ++ + V + H I+HRDLK N+++ + V
Sbjct: 63 GRTLREVLAA-DGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 430 KVADFGVARV-----KAQSGVMTAET---GTYRWMAPEVIEHKPYDHKADVFSFGIVLWE 481
KV DFG+ + A +T T GT + APE + +P +D++++G++ E
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLE 181
Query: 482 LLTGK 486
LTG+
Sbjct: 182 CLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 49/195 (25%), Positives = 96/195 (49%), Gaps = 7/195 (3%)
Query: 300 VASGSYGDLY--RGTYCSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFI 355
+ GS+G + R + A+K ++ I S++ A+ ++ +V +V
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERT-VLAQVNCPFIVPLK 59
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
+ P L +V F++GG ++ +L + +G F L ++ + LH+ N+I+RD
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRD 118
Query: 416 LKAANLLMDENEVVKVADFGVARVK-AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 474
LK N+L+D + + DFG+ ++ GT ++APE++ Y D ++
Sbjct: 119 LKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWT 178
Query: 475 FGIVLWELLTGKLPY 489
G++L+E+LTG P+
Sbjct: 179 LGVLLYEMLTGLPPF 193
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 49/194 (25%), Positives = 85/194 (43%), Gaps = 19/194 (9%)
Query: 300 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
++ G G Y+G + V + +NS E A M K++H N+V+ IG C
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGLCR 753
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN---NIIHRDL 416
++ E++ G ++ + L L + K+AI ++K + +LH ++
Sbjct: 754 SEKGAYLIHEYIEGKNLSEVLRNLSWERRR----KIAIGIAKALRFLHCRCSPAVV---- 805
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR--WMAPEVIEHKPYDHKADVFS 474
L E ++ D R+ + T ++APE E K K+D++
Sbjct: 806 --VGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYG 863
Query: 475 FGIVLWELLTGKLP 488
FG++L ELLTGK P
Sbjct: 864 FGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 53/194 (27%), Positives = 96/194 (49%), Gaps = 10/194 (5%)
Query: 299 KVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFA--QEVFIMRKVRHKNVVQF 354
K+ GSY +Y+G Q VA+KV+ + ++ F +E +++ ++H N+V
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVIS---MKTEEGVPFTAIREASLLKGLKHANIVLL 68
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
+L V E+M + Y+ + G ++ + +G+ Y+H +I+HR
Sbjct: 69 HDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHR 127
Query: 415 DLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEVI-EHKPYDHKADV 472
DLK NLL+ +K+ADFG+AR K+ S ++E T + P+V+ Y D+
Sbjct: 128 DLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDI 187
Query: 473 FSFGIVLWELLTGK 486
+ G + E+L G+
Sbjct: 188 WGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 53/200 (26%), Positives = 99/200 (49%), Gaps = 23/200 (11%)
Query: 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
G + G YG+L++ +V +KVL ++ + + + F + +M ++ HK++V G
Sbjct: 14 GIRREVGDYGELHK-----TEVLLKVL--DKSHRNYSESFFEAASMMSQLSHKHLVLNYG 66
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
C +V E++ GS+ YL K K + + L+VA ++ +++L + H ++
Sbjct: 67 VCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNV 126
Query: 417 KAANLLMDENE--------VVKVADFGVARVKAQSGVMTAETGTYR--WMAPEVIEH-KP 465
A N+L+ E +K++D G++ V+ E R W+ PE IE+ +
Sbjct: 127 CAKNVLLIREEDRKTGNPPFIKLSDPGISIT-----VLPKEILLERIPWVPPECIENPQN 181
Query: 466 YDHKADVFSFGIVLWELLTG 485
AD +SFG LWE+ +G
Sbjct: 182 LSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 39/212 (18%)
Query: 300 VASGSYGDLYRG--TYCSQDVAIKVLKPERIN------SDMQKEFAQEVFIMRKVRHKNV 351
+ GSYG + T+ + VAIK +IN SD + +E+ ++R +RH ++
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIK-----KINDVFEHVSDATR-ILREIKLLRLLRHPDI 61
Query: 352 VQFIGACTKPPS------LCIVTEFMSGG-----SVYDYLHKLKGVFKLPSLLKVAIDVS 400
V+ I PPS + +V E M D L F L LL+
Sbjct: 62 VE-IKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLR------ 114
Query: 401 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWM- 456
+ Y+H N+ HRDLK N+L + + +K+ DFG+ARV + + + RW
Sbjct: 115 -ALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 457 APEVIE--HKPYDHKADVFSFGIVLWELLTGK 486
APE+ Y D++S G + E+LTGK
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|153145 cd04873, ACT_UUR-ACR-like, ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 8e-12
Identities = 24/69 (34%), Positives = 35/69 (50%), Gaps = 2/69 (2%)
Query: 181 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV-DGWPYEETEQLRA 239
+ D+P LL+ +T +LAD+GLNI +A ST +LDVF V D + A
Sbjct: 2 VVEVYAPDRPGLLADITRVLADLGLNIHDAR-ISTTGERALDVFYVTDSDGRPLDPERIA 60
Query: 240 ALEKEVLKL 248
LE+ +
Sbjct: 61 RLEEALEDA 69
|
This ACT domain family, ACT_UUR_ACR-like, includes the two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the four ACT domains of a novel protein composed almost entirely of ACT domain repeats (the ACR protein) and like proteins. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. This CD also includes the first of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein and related domains, as well as, the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 70 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 8e-12
Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 18/194 (9%)
Query: 306 GDLYRGTYCSQDVAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364
GD+Y A+KV+K + + F +E I+ + Q A +L
Sbjct: 26 GDIY---------AMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNL 76
Query: 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD 424
+V E+ GG + L++ + F ++ ++ +HQ +HRD+K N+L+D
Sbjct: 77 YLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLID 136
Query: 425 ENEVVKVADFG-VARVKAQSGVM-TAETGTYRWMAPEVIE------HKPYDHKADVFSFG 476
+K+ADFG AR+ A V GT ++APEV+ Y + D +S G
Sbjct: 137 RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLG 196
Query: 477 IVLWELLTGKLPYE 490
++ +E++ G+ P+
Sbjct: 197 VIAYEMIYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 39/129 (30%), Positives = 76/129 (58%), Gaps = 4/129 (3%)
Query: 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
L ++ +++SGG ++ +L++ + F + + ++ + +LH+ I++RD+K N+L+
Sbjct: 80 LHLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL 138
Query: 424 DENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA-DVFSFGIVLW 480
D V + DFG+++ + + + GT +MAPE+I K KA D +S GI+++
Sbjct: 139 DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIF 198
Query: 481 ELLTGKLPY 489
ELLTG P+
Sbjct: 199 ELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 53/193 (27%), Positives = 95/193 (49%), Gaps = 10/193 (5%)
Query: 299 KVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFA--QEVFIMRKVRHKNVVQF 354
K+ GSY +Y+G Q VA+K + R+ + F +E +++ ++H N+V
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEI---RLEHEEGAPFTAIREASLLKDLKHANIVTL 68
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
+L +V E++ + Y+ G + ++ + +G+ Y HQ ++HR
Sbjct: 69 HDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHR 127
Query: 415 DLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEVI-EHKPYDHKADV 472
DLK NLL+ E +K+ADFG+AR K+ S + E T + P+V+ Y D+
Sbjct: 128 DLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDM 187
Query: 473 FSFGIVLWELLTG 485
+ G + +E+ TG
Sbjct: 188 WGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 45/163 (27%), Positives = 73/163 (44%), Gaps = 45/163 (27%)
Query: 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK-------VAIDVSKGMNYLHQNNIIHRDL 416
L +V E+M GG + + L + K VF + +A+D +H+ IHRD+
Sbjct: 76 LYLVMEYMPGGDLMNLLIR-KDVFP-EETARFYIAELVLALD------SVHKLGFIHRDI 127
Query: 417 KAANLLMDENEVVKVADFGVA-----------------------------RVKAQSGVMT 447
K N+L+D + +K+ADFG+ R Q V
Sbjct: 128 KPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRA 187
Query: 448 -AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489
+ GT ++APEV+ PY + D +S G++L+E+L G P+
Sbjct: 188 NSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 5e-11
Identities = 42/144 (29%), Positives = 77/144 (53%), Gaps = 4/144 (2%)
Query: 300 VASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
++ G++G +Y R S+ A+KV+ K + IN +M + E + + +V
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ ++ +V E++ GG V LH + G F +K +V+ ++YLH++ IIHRDL
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLH-IYGYFDEEMAVKYISEVALALDYLHRHGIIHRDL 130
Query: 417 KAANLLMDENEVVKVADFGVARVK 440
K N+L+ +K+ DFG+++V
Sbjct: 131 KPDNMLISNEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 5e-11
Identities = 53/229 (23%), Positives = 111/229 (48%), Gaps = 43/229 (18%)
Query: 299 KVASGSYGDLY-------RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 351
K+ +G +G+++ + +C + ++ + LK ER S + EV +MR+++HKN+
Sbjct: 20 KIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKS----QLVIEVNVMRELKHKNI 74
Query: 352 VQFIGACTKPPS--LCIVTEFMSGGSVYDYL---HKLKGVFKLPSLLKVAIDVSKGMNYL 406
V++I + L I+ EF G + + +K+ G + +++ + + + Y
Sbjct: 75 VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYC 134
Query: 407 HQ-------NNIIHRDLKAANLLM-----------------DENEVVKVADFGVARVKAQ 442
H ++HRDLK N+ + + + K+ DFG+++
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI 194
Query: 443 SGVMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPY 489
+ + GT + +PE++ H K YD K+D+++ G +++EL +GK P+
Sbjct: 195 ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 5e-11
Identities = 50/226 (22%), Positives = 94/226 (41%), Gaps = 38/226 (16%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFI 355
+ G G++Y CS+ VA+K ++ + N ++K F +E I + H +V
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK-------------LPSLLKVAIDVSKG 402
C+ + ++ G Y LK V++ + + L + +
Sbjct: 69 SICSDGDPVYYTMPYIEG---YTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK------------AQSGVMTAE- 449
+ Y+H ++HRDLK N+L+ V + D+G A K + + +
Sbjct: 126 IEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185
Query: 450 ------TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489
GT +MAPE + P D+++ G++L+++LT PY
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 52/202 (25%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 300 VASGSYGDLY-----RGTYCSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKN-V 351
+ +G+YG ++ G + A+KVLK I + + E ++ +R +
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
V A L ++ ++++GG ++ +L + + FK + + ++ + +LH+ I
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGI 126
Query: 412 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIE--HKPYD 467
I+RD+K N+L+D N V + DFG+++ + V A + GT +MAP+++ +D
Sbjct: 127 IYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHD 186
Query: 468 HKADVFSFGIVLWELLTGKLPY 489
D +S G++++ELLTG P+
Sbjct: 187 KAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-11
Identities = 50/209 (23%), Positives = 95/209 (45%), Gaps = 30/209 (14%)
Query: 299 KVASGSYGDLYRGTYCSQDVA---IKVLKPERINSD-------------MQKEFAQEVFI 342
K+ G+YG +Y+ ++D + LK R+ D + + ++ ++I
Sbjct: 8 KIGEGTYGKVYK----ARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI 63
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLP--SLLKVAIDV 399
+R + ++V + G PSL +V E++ + + LP ++ +
Sbjct: 64 VRLLDVEHVEEKNGK----PSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARV-KAQSGVMTAETGTYRWMA 457
KG+ + H++ ++HRDLK NLL+D + ++K+AD G+ R T E T + A
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRA 179
Query: 458 PEV-IEHKPYDHKADVFSFGIVLWELLTG 485
PEV + Y D++S G + E+
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 45/195 (23%), Positives = 91/195 (46%), Gaps = 13/195 (6%)
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
V ++ + E ++M E+ + + H N+V + L +VT FM+ GS
Sbjct: 28 VTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAK 87
Query: 378 DYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435
D + H + G+ +L ++ + V K ++Y+H +HR +KA+++L+ + V ++
Sbjct: 88 DLICTHFMDGMSEL-AIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLR 146
Query: 436 V--------ARVKAQSGVMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTG 485
R++ W++PEV++ + YD K+D++S GI EL G
Sbjct: 147 SNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 206
Query: 486 KLPYEYLTPLQAAVG 500
+P++ + Q +
Sbjct: 207 HVPFKDMPATQMLLE 221
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 63/212 (29%), Positives = 104/212 (49%), Gaps = 28/212 (13%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 348
K K G+ + +GS+G +Y C S+ VAIK ++ D Q + +E+ IM+ + H
Sbjct: 66 KSYKLGNIIGNGSFGVVYEAI-CIDTSEKVAIK-----KVLQDPQYK-NRELLIMKNLNH 118
Query: 349 KNVV----QFIGACTKPPS----LCIVTEFMSGGSVYDYL-HKLKGVFKLPSLLK--VAI 397
N++ + C K L +V EF+ +V+ Y+ H + LP L +
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSY 177
Query: 398 DVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVAR--VKAQSGVMTAETGTYR 454
+ + + Y+H I HRDLK NLL+D N +K+ DFG A+ + Q V + YR
Sbjct: 178 QLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYR 237
Query: 455 WMAPEV-IEHKPYDHKADVFSFGIVLWELLTG 485
APE+ + Y D++S G ++ E++ G
Sbjct: 238 --APELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 40/122 (32%), Positives = 60/122 (49%), Gaps = 13/122 (10%)
Query: 274 PYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGT-------YCSQDVAIKVLKPE 326
P L P D WE+ +L G + SG++G + T + VA+K+LK
Sbjct: 23 PMQL--PYDSA--WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKST 78
Query: 327 RINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG 385
+S+ Q E+ IM + H N+V +GACTK + I+TE+ G + DYLH+ K
Sbjct: 79 ARSSEKQA-LMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKH 137
Query: 386 VF 387
F
Sbjct: 138 TF 139
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 50/188 (26%), Positives = 88/188 (46%), Gaps = 18/188 (9%)
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
V +KVL P + D+ F + +M +V H ++ G C + +V EF+ G +
Sbjct: 47 VVLKVLDPS--HRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD 104
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM-------DENEVVK 430
L K KG + + VA ++ ++YL N++H ++ A N+L+ + +K
Sbjct: 105 VCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIK 164
Query: 431 VADFGVARVKAQSGVMTAETGTYR--WMAPEVIEHKPYDHKA-DVFSFGIVLWEL-LTGK 486
++D GV+ ++ E R W+APE + A D +SFG L E+ G+
Sbjct: 165 LSDPGVS-----FTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGE 219
Query: 487 LPYEYLTP 494
+P + TP
Sbjct: 220 VPLKERTP 227
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 51/203 (25%), Positives = 83/203 (40%), Gaps = 32/203 (15%)
Query: 319 AIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A+KVL K E I + K E I+ + H + + LC+V ++ GG ++
Sbjct: 30 ALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELF 89
Query: 378 DYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF-- 434
L + G A +V + YLH I++RDLK N+L+ E+ + ++DF
Sbjct: 90 RLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDL 149
Query: 435 -------GVARVKAQSG-------------VMTAET--------GTYRWMAPEVIEHKPY 466
KA + E GT ++APEVI +
Sbjct: 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH 209
Query: 467 DHKADVFSFGIVLWELLTGKLPY 489
D ++ GI+L+E+L G P+
Sbjct: 210 GSAVDWWTLGILLYEMLYGTTPF 232
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 35/109 (32%), Positives = 54/109 (49%), Gaps = 3/109 (2%)
Query: 376 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435
+Y YL L + VA + ++Y+H IIHRD+K N+L++ E + + DFG
Sbjct: 246 LYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFG 305
Query: 436 VA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWE 481
A R + GT APEV+ PY D++S G+V++E
Sbjct: 306 AACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 5e-09
Identities = 36/136 (26%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--VAIDVSKGMNYLHQNNIIHRDLKAAN 420
+L +V ++ GG + L K + +LP + ++ ++ +HQ + +HRD+K N
Sbjct: 75 NLYLVMDYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDN 132
Query: 421 LLMDENEVVKVADFGVARVKAQSGVM--TAETGTYRWMAPEVIEHKP-----YDHKADVF 473
+LMD N +++ADFG + G + + GT +++PE+++ Y + D +
Sbjct: 133 ILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWW 192
Query: 474 SFGIVLWELLTGKLPY 489
S G+ ++E+L G+ P+
Sbjct: 193 SLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 44/183 (24%), Positives = 76/183 (41%), Gaps = 57/183 (31%)
Query: 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-DVSKGMNYLHQNNIIHRDLKAANLL 422
L V +++ GG + L +L G+F+ L + I +++ + +H+ IHRD+K N+L
Sbjct: 76 LYFVMDYIPGGDMMSLLIRL-GIFE-EDLARFYIAELTCAIESVHKMGFIHRDIKPDNIL 133
Query: 423 MDENEVVKVADFGVA--------------------------------------------- 437
+D + +K+ DFG+
Sbjct: 134 IDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRK 193
Query: 438 ----RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 493
R A S V GT ++APEV+ Y D +S G++L+E+L G+ P+ T
Sbjct: 194 RQHQRCLAHSLV-----GTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADT 248
Query: 494 PLQ 496
P +
Sbjct: 249 PAE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 8e-09
Identities = 37/135 (27%), Positives = 74/135 (54%), Gaps = 11/135 (8%)
Query: 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPS-LLKVAI-DVSKGMNYLHQNNIIHRDLKAANL 421
L +V ++ GG + L K + +LP + + I ++ ++ +HQ + +HRD+K N+
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNV 133
Query: 422 LMDENEVVKVADFGVARVKAQSGVM--TAETGTYRWMAPEVIEHK-----PYDHKADVFS 474
L+D N +++ADFG Q G + + GT +++PE+++ Y + D +S
Sbjct: 134 LLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWS 193
Query: 475 FGIVLWELLTGKLPY 489
G+ ++E+L G+ P+
Sbjct: 194 LGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 9e-09
Identities = 32/116 (27%), Positives = 52/116 (44%), Gaps = 12/116 (10%)
Query: 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVAD 433
S+ D L + V + + LH+ K+ N+L+ + ++K+
Sbjct: 1 VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQA------KSGNILLTWDGLLKL-- 52
Query: 434 FGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489
G A + Y +MAPEVI+ + Y KAD++S GI L+E L +LPY
Sbjct: 53 DGSV---AFKTPEQSRPDPY-FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPY 104
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 38/121 (31%), Positives = 60/121 (49%), Gaps = 9/121 (7%)
Query: 277 LKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC----SQ---DVAIKVLKPERIN 329
+++P D WE L G + SG++G + GT SQ VA+K+LKP +
Sbjct: 24 MQLPYDSR--WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS 81
Query: 330 SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL 389
S+ Q ++ + H N+V +GACTK + I+TE+ G + +YLHK + F
Sbjct: 82 SEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLS 141
Query: 390 P 390
Sbjct: 142 R 142
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 56/227 (24%)
Query: 297 GSKVASGSYGDLYRGTYCS----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
G KV G+YG +Y+ +D A+K ++ I+ +E A ++R+++H NV+
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIA----LLRELKHPNVI 61
Query: 353 QFIGACTKPPSLCIVTEFMSGGS-----VYDY----------LHKLKGVFKLP------- 390
+ F+S ++DY H+ K P
Sbjct: 62 S------------LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGM 109
Query: 391 --SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSG 444
SLL +D G++YLH N ++HRDLK AN+L+ E VK+AD G AR+
Sbjct: 110 VKSLLYQILD---GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166
Query: 445 VMTAETG----TYRWMAPE-VIEHKPYDHKADVFSFGIVLWELLTGK 486
A+ T+ + APE ++ + Y D+++ G + ELLT +
Sbjct: 167 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 42/168 (25%), Positives = 76/168 (45%), Gaps = 37/168 (22%)
Query: 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 422
+L ++ EF+ GG + L K + + + +A + ++ +HQ IHRD+K NLL
Sbjct: 75 NLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIHQLGFIHRDIKPDNLL 133
Query: 423 MDENEVVKVADFGV------------------------------ARVKAQS------GVM 446
+D VK++DFG+ ++ KA++ +
Sbjct: 134 LDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLA 193
Query: 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494
+ GT ++APEV Y+ D +S G++++E+L G P+ TP
Sbjct: 194 FSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 43/168 (25%), Positives = 76/168 (45%), Gaps = 37/168 (22%)
Query: 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 422
+L ++ EF+ GG + L K + + + +A V ++ +HQ IHRD+K NLL
Sbjct: 75 NLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVL-AIDAIHQLGFIHRDIKPDNLL 133
Query: 423 MDENEVVKVADFGV------------------------------ARVKAQS------GVM 446
+D VK++DFG+ ++ KA++ +
Sbjct: 134 LDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLA 193
Query: 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494
+ GT ++APEV Y+ D +S G++++E+L G P+ TP
Sbjct: 194 YSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 57/216 (26%), Positives = 105/216 (48%), Gaps = 34/216 (15%)
Query: 297 GSKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
G KV G+YG +Y+ ++ A+K ++ I+ +E A ++R+++H NV+
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIA----LLRELKHPNVI 61
Query: 353 --QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------GVFKLP-SLLKVAI-DV 399
Q + + ++ ++ +D H +K +LP S++K + +
Sbjct: 62 ALQKVFLSHSDRKVWLLFDYAE----HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI 117
Query: 400 SKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETG---- 451
G++YLH N ++HRDLK AN+L+ E VK+AD G AR+ A+
Sbjct: 118 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 452 TYRWMAPE-VIEHKPYDHKADVFSFGIVLWELLTGK 486
T+ + APE ++ + Y D+++ G + ELLT +
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|235342 PRK05092, PRK05092, PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 1e-07
Identities = 24/73 (32%), Positives = 34/73 (46%), Gaps = 7/73 (9%)
Query: 181 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWPYEETEQL 237
E+T D P L S++ A G NI +A F+T DG +LD F + G +E +L
Sbjct: 734 EVTVLAADHPGLFSRIAGACAAAGANIVDARIFTTTDGRALDTFWIQDAFGRDEDEPRRL 793
Query: 238 ---RAALEKEVLK 247
A+E L
Sbjct: 794 ARLAKAIED-ALS 805
|
Length = 931 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 52/235 (22%), Positives = 99/235 (42%), Gaps = 54/235 (22%)
Query: 319 AIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A+K L K + +N + E I+ + ++ VV+ + +L V +++ GG +
Sbjct: 30 AMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMM 89
Query: 378 DYLHKLKGVFKLPSLLK--VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435
L ++ VF P +L +++ + +H+ IHRD+K N+L+D + +K+ DFG
Sbjct: 90 SLLIRM-EVF--PEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFG 146
Query: 436 V------------------------------------------------ARVKAQSGVMT 447
+ A + Q +
Sbjct: 147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAH 206
Query: 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 502
+ GT ++APEV+ K Y D +S G++L+E+L G+ P+ TP + + V+
Sbjct: 207 SLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVI 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 37/135 (27%), Positives = 75/135 (55%), Gaps = 11/135 (8%)
Query: 364 LCIVTEFMSGGSVYDYLHKLKGVFKLP-SLLKVAI-DVSKGMNYLHQNNIIHRDLKAANL 421
L +V ++ GG + L K + +LP + + + ++ ++ +HQ +HRD+K N+
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNV 133
Query: 422 LMDENEVVKVADFGVA-RVKAQSGVMTA-ETGTYRWMAPEVIE-----HKPYDHKADVFS 474
L+D+N +++ADFG R+ A V + GT +++PE+++ Y + D +S
Sbjct: 134 LLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWS 193
Query: 475 FGIVLWELLTGKLPY 489
G+ ++E+L G+ P+
Sbjct: 194 LGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 32/128 (25%), Positives = 51/128 (39%), Gaps = 49/128 (38%)
Query: 406 LHQNNIIHRDLKAANLLMDENEVVKVADFGVA---------------------------- 437
+H+ IHRD+K NLL+D +K++DFG+
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176
Query: 438 ----------------RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWE 481
R A S V GT ++APEV Y+ + D +S G++++E
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTV-----GTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231
Query: 482 LLTGKLPY 489
+L G P+
Sbjct: 232 MLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 30/106 (28%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGT---YCSQD----VAIKVLKPERINSDMQKEFA 337
+ WE +L+FG + +G++G + T +D VA+K+LK ++D ++
Sbjct: 31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKA-SAHTDEREALM 89
Query: 338 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHK 382
E+ I+ + +HKN+V +GACT + ++TE+ G + ++L K
Sbjct: 90 SELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRK 135
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 43/190 (22%), Positives = 81/190 (42%), Gaps = 51/190 (26%)
Query: 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-DVSKGMNYLHQNNIIHRDLKAANL 421
+L V +++ GG + L ++ G+F L + I +++ + +H+ IHRD+K N+
Sbjct: 75 NLYFVMDYIPGGDMMSLLIRM-GIFP-EDLARFYIAELTCAVESVHKMGFIHRDIKPDNI 132
Query: 422 LMDENEVVKVADFGV--------------------------------------------- 436
L+D + +K+ DFG+
Sbjct: 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPL 192
Query: 437 ---ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 493
A + Q + + GT ++APEV+ Y D +S G++L+E+L G+ P+ T
Sbjct: 193 ERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQT 252
Query: 494 PLQAAVGVVQ 503
PL+ + V+
Sbjct: 253 PLETQMKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 32/109 (29%), Positives = 53/109 (48%), Gaps = 8/109 (7%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINSDMQKEFAQE 339
WE LK G + G++G + T + VA+K+LK +S+ + ++
Sbjct: 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSEL 61
Query: 340 VFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF 387
++ H NVV +GACTKP L ++ EF G++ +YL +G F
Sbjct: 62 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEF 110
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|153139 cd02116, ACT, ACT domains are commonly involved in specifically binding an amino acid or other small ligand leading to regulation of the enzyme | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 1e-06
Identities = 24/62 (38%), Positives = 38/62 (61%), Gaps = 3/62 (4%)
Query: 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVF-VVDGWPYEETEQLRAA 240
+T S D+P LL+++ ++LA+ G+NI ++ DG D+F VVDG + E+L A
Sbjct: 1 LTVSGPDRPGLLAKVLSVLAEAGINITSIEQRTSGDGGEADIFIVVDGD--GDLEKLLEA 58
Query: 241 LE 242
LE
Sbjct: 59 LE 60
|
Members of this CD belong to the superfamily of ACT regulatory domains. Pairs of ACT domains are commonly involved in specifically binding an amino acid or other small ligand leading to regulation of the enzyme. The ACT domain has been detected in a number of diverse proteins; some of these proteins are involved in amino acid and purine biosynthesis, phenylalanine hydroxylation, regulation of bacterial metabolism and transcription, and many remain to be characterized. ACT domain-containing enzymes involved in amino acid and purine synthesis are in many cases allosteric enzymes with complex regulation enforced by the binding of ligands. The ACT domain is commonly involved in the binding of a small regulatory molecule, such as the amino acids L-Ser and L-Phe in the case of D-3-phosphoglycerate dehydrogenase and the bifunctional chorismate mutase-prephenate dehydratase enzyme (P-protein), respectively. Aspartokinases typically consist of two C-terminal ACT domains in a tandem repeat, but the second ACT domain is inserted within the first, resulting in, what is normally the terminal beta strand of ACT2, formed from a region N-terminal of ACT1. ACT domain repeats have been shown to have nonequivalent ligand-binding sites with complex regulatory patterns such as those seen in the bifunctional enzyme, aspartokinase-homoserine dehydrogenase (ThrA). In other enzymes, such as phenylalanine hydroxylases, the ACT domain appears to function as a flexible small module providing allosteric regulation via transmission of conformational changes, these conformational changes are not necessarily initiated by regulatory ligand binding at the ACT domain itself. ACT domains are present either singularly, N- or C-terminal, or in pairs present C-terminal or between two catalytic domains. Unique to cyanobacteria are four ACT domains C-terminal to an aspartokinase domain. A few proteins are composed almost entirely of ACT domain repeats as seen in the four ACT domain protein, the ACR protein, found in higher plants; and the two ACT domain protein, the glycine cleavage system transcriptional repressor (GcvR) protein, found in some bacteria. Also seen are single ACT domain proteins similar to the Streptococcus pneumoniae ACT domain protein (uncharacterized pdb structure 1ZPV) found in both bacteria and archaea. Purportedly, the ACT domain is an evolutionarily mobile ligand binding regulatory module that has been fused to different enzymes at various times. Length = 60 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 35/112 (31%), Positives = 54/112 (48%), Gaps = 14/112 (12%)
Query: 287 WEIDPKHLKFGSKVASGSYG--------DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQ 338
WE LK G + G++G + + C + VA+K+LK E + K
Sbjct: 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASC-RTVAVKMLK-EGATASEYKALMT 59
Query: 339 EVFIMRKV-RHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVF 387
E+ I+ + H NVV +GACTKP P + IV E+ G++ +YL + F
Sbjct: 60 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIV-EYCKFGNLSNYLRSKRECF 110
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|225400 COG2844, GlnD, UTP:GlnB (protein PII) uridylyltransferase [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 30/107 (28%), Positives = 48/107 (44%), Gaps = 9/107 (8%)
Query: 169 VHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV-- 226
V +V+ E+ D+P+L + + A L+ GL+I +A F+T DGY+LD F+V
Sbjct: 674 VLISVRPHSGGTEVFVYAPDRPRLFAVVCAALSRRGLSIVDAQIFTTRDGYALDTFIVLE 733
Query: 227 -DGWPYEETEQLR------AALEKEVLKLERQGWPSHRSSSPTSEPE 266
DG+P EE + AL + R+ + P
Sbjct: 734 PDGFPVEEDRRAALRGELIEALLSGKAQPPRRRRIPRKLRHFPIPPR 780
|
Length = 867 |
| >gnl|CDD|190133 pfam01842, ACT, ACT domain | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 5e-06
Identities = 18/64 (28%), Positives = 30/64 (46%), Gaps = 1/64 (1%)
Query: 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRA 239
+ D+P LL+++ LAD G+NI+ ++ D + VV E+ E
Sbjct: 1 TVLEVGVPDRPGLLAEVFGALADRGINIESISQSTSGDKAGIVFIVVVV-DEEDLEAALE 59
Query: 240 ALEK 243
AL+K
Sbjct: 60 ALKK 63
|
This family of domains generally have a regulatory role. ACT domains are linked to a wide range of metabolic enzymes that are regulated by amino acid concentration. Pairs of ACT domains bind specifically to a particular amino acid leading to regulation of the linked enzyme. The ACT domain is found in: D-3-phosphoglycerate dehydrogenase EC:1.1.1.95, which is inhibited by serine. Aspartokinase EC:2.7.2.4, which is regulated by lysine. Acetolactate synthase small regulatory subunit, which is inhibited by valine. Phenylalanine-4-hydroxylase EC:1.14.16.1, which is regulated by phenylalanine. Prephenate dehydrogenase EC:4.2.1.51. formyltetrahydrofolate deformylase EC:3.5.1.10, which is activated by methionine and inhibited by glycine. GTP pyrophosphokinase EC:2.7.6.5. Length = 66 |
| >gnl|CDD|153171 cd04899, ACT_ACR-UUR-like_2, C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains | Back alignment and domain information |
|---|
Score = 43.6 bits (104), Expect = 6e-06
Identities = 27/63 (42%), Positives = 38/63 (60%), Gaps = 6/63 (9%)
Query: 188 DKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWPY--EETEQLRAALE 242
D+P LL+ +T +LA++GLNI A +T+ + DVF V DG P E E LRAAL
Sbjct: 9 DRPGLLADVTRVLAELGLNIHSAKI-ATLGERAEDVFYVTDADGQPLDPERQEALRAALG 67
Query: 243 KEV 245
+ +
Sbjct: 68 EAL 70
|
This ACT domain family, ACT_ACR-UUR-like_2, includes the second of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the second and fourth ACT domains of a novel protein composed almost entirely of ACT domain repeats, the ACR protein. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 70 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 32/111 (28%), Positives = 53/111 (47%), Gaps = 12/111 (10%)
Query: 287 WEIDPKHLKFGSKVASGSYGDL--------YRGTYCSQDVAIKVLKPERINSDMQKEFAQ 338
WE L+ G + G++G + + + C VA+K+LK E + K
Sbjct: 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSC-NTVAVKMLK-EGATASEHKALMS 59
Query: 339 EVFIMRKV-RHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF 387
E+ I+ + H NVV +GACTKP L ++ EF G++ ++L + F
Sbjct: 60 ELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFF 110
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|233534 TIGR01693, UTase_glnD, [Protein-PII] uridylyltransferase | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 19/64 (29%), Positives = 31/64 (48%), Gaps = 3/64 (4%)
Query: 181 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWPYEETEQL 237
E+ D+P L +++ LA + L++ +A +T DG +LD FVV G P
Sbjct: 670 EVFIYAPDQPGLFAKVAGALAMLSLSVHDAQVNTTKDGVALDTFVVQDLFGSPPAAERVF 729
Query: 238 RAAL 241
+ L
Sbjct: 730 QELL 733
|
This model describes GlnD, the uridylyltransferase/uridylyl-removing enzyme for the nitrogen regulatory protein PII. Not all homologs of PII share the property of uridylyltransferase modification on the characteristic Tyr residue (see Prosite pattern PS00496 and document PDOC00439), but the modification site is preserved in the PII homolog of all species with a member of this family [Central intermediary metabolism, Nitrogen metabolism, Regulatory functions, Protein interactions]. Length = 850 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 38/144 (26%), Positives = 66/144 (45%), Gaps = 21/144 (14%)
Query: 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLL 422
+CIV G + D++ K G F L ++ ++Y H +++H DLK N+L
Sbjct: 207 MCIVMP-KYGPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENIL 264
Query: 423 MDENEV----------------VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 466
M+ ++ V++ D G + S T YR +PEV+ +
Sbjct: 265 METSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYR--SPEVVLGLGW 322
Query: 467 DHKADVFSFGIVLWELLTGKLPYE 490
+ D++S G +++EL TGKL Y+
Sbjct: 323 MYSTDMWSMGCIIYELYTGKLLYD 346
|
Length = 467 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 33/124 (26%), Positives = 58/124 (46%), Gaps = 3/124 (2%)
Query: 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 422
S+ +V + GG ++ ++ K + + + A ++ ++ LH+ I+ RDL N+L
Sbjct: 59 SVFLVLQHAEGGKLWSHISKFLNI-PEECVKRWAAEMVVALDALHREGIVCRDLNPNNIL 117
Query: 423 MDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWEL 482
+D+ +++ F S A Y APEV D +S G +L+EL
Sbjct: 118 LDDRGHIQLTYFSRWSEVEDSCDGEAVENMY--CAPEVGGISEETEACDWWSLGAILFEL 175
Query: 483 LTGK 486
LTGK
Sbjct: 176 LTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 32/129 (24%), Positives = 56/129 (43%), Gaps = 8/129 (6%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQE 339
WE L FG + +G++G + T + VA+K+LKP ++ + ++
Sbjct: 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSEL 89
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
+ H N+V +GACT ++TE+ G + ++L + + F P A
Sbjct: 90 KVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAA 149
Query: 400 SKGMNYLHQ 408
N LHQ
Sbjct: 150 LY-KNLLHQ 157
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|235329 PRK05007, PRK05007, PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 2e-04
Identities = 24/75 (32%), Positives = 41/75 (54%), Gaps = 5/75 (6%)
Query: 174 QFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWP 230
Q +R EI + D+P L + + A L L++ +A F++ DG ++D F+V DG P
Sbjct: 696 QATRGGTEIFIWSPDRPYLFAAVCAELDRRNLSVHDAQIFTSRDGMAMDTFIVLEPDGSP 755
Query: 231 YEET--EQLRAALEK 243
+ + +R ALE+
Sbjct: 756 LSQDRHQVIRKALEQ 770
|
Length = 884 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 38/184 (20%), Positives = 82/184 (44%), Gaps = 19/184 (10%)
Query: 314 CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373
C + +A +V R ++ E+ + ++ H+N+++ + ++T+
Sbjct: 192 CERLIAKRVKAGSRAAIQLE----NEILALGRLNHENILKIEEILRSEANTYMITQKYDF 247
Query: 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSK----GMNYLHQNNIIHRDLKAANLLMDENEVV 429
+Y +++ +K LLK + K + Y+H +IHRD+K N+ ++ + +
Sbjct: 248 -DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKI 306
Query: 430 KVADFGVA------RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELL 483
+ DFG A R G + GT +PE++ Y D++S G++L ++L
Sbjct: 307 VLGDFGTAMPFEKEREAFDYGWV----GTVATNSPEILAGDGYCEITDIWSCGLILLDML 362
Query: 484 TGKL 487
+
Sbjct: 363 SHDF 366
|
Length = 501 |
| >gnl|CDD|234709 PRK00275, glnD, PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 8e-04
Identities = 16/72 (22%), Positives = 31/72 (43%), Gaps = 7/72 (9%)
Query: 186 TDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWPY----EETEQLR 238
D+ + A + + LNI +A ++ ++LD ++V DG P EQ+R
Sbjct: 711 APDQHDFFAATVAAMDQLNLNIHDARIITSSSQFTLDTYIVLDDDGEPIGDNPARIEQIR 770
Query: 239 AALEKEVLKLER 250
L + + +
Sbjct: 771 EGLTEALRNPDD 782
|
Length = 895 |
| >gnl|CDD|235123 PRK03381, PRK03381, PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.002
Identities = 19/62 (30%), Positives = 32/62 (51%), Gaps = 3/62 (4%)
Query: 186 TDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVF-VVDGWPYEETEQLRAALEKE 244
D+P LL++L L G++++ A +T+ +DVF V + RAA+E+
Sbjct: 714 AADRPGLLARLARALERAGVDVRWARV-ATLGADVVDVFYVTGAAGGPLADA-RAAVEQA 771
Query: 245 VL 246
VL
Sbjct: 772 VL 773
|
Length = 774 |
| >gnl|CDD|235123 PRK03381, PRK03381, PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 36/135 (26%), Positives = 54/135 (40%), Gaps = 26/135 (19%)
Query: 123 VSSLLDSEVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRP-MHE 181
++L E P P P ALA D VH + + P M E
Sbjct: 560 CRAVLAGEPLP-----EPEPL---DPAQLALA----------ADGGVHVEIAPADPHMVE 601
Query: 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVD---GWPYEET---E 235
+T D+ LLS+ +LA L ++ A + DG ++ FVV G P + +
Sbjct: 602 VTVVAPDRRGLLSKAAGVLALHRLRVRSASV-RSHDGVAVLEFVVSPRFGSPPDAALLRQ 660
Query: 236 QLRAALEKEVLKLER 250
LR AL+ ++ L R
Sbjct: 661 DLRRALDGDLDVLAR 675
|
Length = 774 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 0.003
Identities = 18/73 (24%), Positives = 38/73 (52%), Gaps = 6/73 (8%)
Query: 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE 425
IV E++ G + D ++ L+++ ++ + + LH IIH DL +N+++
Sbjct: 76 IVMEYIEGEPLKDLINSNG-----MEELELSREIGRLVGKLHSAGIIHGDLTTSNMILSG 130
Query: 426 NEVVKVADFGVAR 438
++ + DFG+A
Sbjct: 131 GKIY-LIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|235342 PRK05092, PRK05092, PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.004
Identities = 28/85 (32%), Positives = 44/85 (51%), Gaps = 9/85 (10%)
Query: 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGY---SLDVF-VVDGWPYEETEQL 237
I + D+P LL LT L+D+ LNI AH + Y ++DVF V D + + T +
Sbjct: 846 IEVNGRDRPGLLYDLTRALSDLNLNIASAH----IATYGERAVDVFYVTDLFGLKITNEA 901
Query: 238 R-AALEKEVLKLERQGWPSHRSSSP 261
R AA+ + +L +G R++ P
Sbjct: 902 RQAAIRRALLAALAEGEAEARAARP 926
|
Length = 931 |
| >gnl|CDD|225400 COG2844, GlnD, UTP:GlnB (protein PII) uridylyltransferase [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.004
Identities = 25/114 (21%), Positives = 39/114 (34%), Gaps = 14/114 (12%)
Query: 134 QRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLL 193
PP L I V S + D+P LL
Sbjct: 756 LSGKAQPPRRRRIPRKLRHFPIPP----------RVTILPTASNDKTVLEVRALDRPGLL 805
Query: 194 SQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLK 247
+ L + AD+GL++ A +T DVF+V + + L A L + +L+
Sbjct: 806 AALAGVFADLGLSLHSAKI-TTFGERVEDVFIVTD---ADGQALNAELRQSLLQ 855
|
Length = 867 |
| >gnl|CDD|233534 TIGR01693, UTase_glnD, [Protein-PII] uridylyltransferase | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.004
Identities = 17/51 (33%), Positives = 27/51 (52%), Gaps = 1/51 (1%)
Query: 176 SRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV 226
SR + D+P LL+++ L ++GL+IQ A +T + DVF V
Sbjct: 776 SRKATIMEVRALDRPGLLARVGRTLEELGLSIQSAK-ITTFGEKAEDVFYV 825
|
This model describes GlnD, the uridylyltransferase/uridylyl-removing enzyme for the nitrogen regulatory protein PII. Not all homologs of PII share the property of uridylyltransferase modification on the characteristic Tyr residue (see Prosite pattern PS00496 and document PDOC00439), but the modification site is preserved in the PII homolog of all species with a member of this family [Central intermediary metabolism, Nitrogen metabolism, Regulatory functions, Protein interactions]. Length = 850 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 518 | |||
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.76 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.72 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.65 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.57 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.53 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.47 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.42 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.37 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.35 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.3 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.29 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.28 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.26 | |
| cd04928 | 68 | ACT_TyrKc Uncharacterized, N-terminal ACT domain o | 99.24 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.22 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.21 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.11 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.01 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.01 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.0 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.92 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.82 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.81 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.64 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.61 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.6 | |
| cd04900 | 73 | ACT_UUR-like_1 ACT domain family, ACT_UUR-like_1, | 98.56 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.49 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.49 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.41 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.39 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.33 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.31 | |
| PRK05092 | 931 | PII uridylyl-transferase; Provisional | 98.3 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.18 | |
| PRK04374 | 869 | PII uridylyl-transferase; Provisional | 98.17 | |
| cd04927 | 76 | ACT_ACR-like_2 Second ACT domain, of a novel type | 98.14 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.13 | |
| PRK00275 | 895 | glnD PII uridylyl-transferase; Provisional | 98.12 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.08 | |
| PRK03059 | 856 | PII uridylyl-transferase; Provisional | 98.06 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.05 | |
| cd04925 | 74 | ACT_ACR_2 ACT domain-containing protein which is c | 98.03 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.98 | |
| PRK05007 | 884 | PII uridylyl-transferase; Provisional | 97.98 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.92 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.9 | |
| TIGR01693 | 850 | UTase_glnD [Protein-PII] uridylyltransferase. This | 97.88 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.86 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.76 | |
| PRK01759 | 854 | glnD PII uridylyl-transferase; Provisional | 97.71 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.69 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.61 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.51 | |
| cd04897 | 75 | ACT_ACR_3 ACT domain-containing protein which is c | 97.49 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.49 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.46 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.45 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.37 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.36 | |
| cd04896 | 75 | ACT_ACR-like_3 ACT domain-containing protein which | 97.35 | |
| cd04926 | 72 | ACT_ACR_4 C-terminal ACT domain, of a novel type o | 97.3 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.24 | |
| cd04895 | 72 | ACT_ACR_1 ACT domain-containing protein which is c | 97.23 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.21 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.18 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.16 | |
| PF01842 | 66 | ACT: ACT domain; InterPro: IPR002912 The ACT domai | 97.11 | |
| cd04873 | 70 | ACT_UUR-ACR-like ACT domains of the bacterial sign | 96.85 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.74 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.7 |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-48 Score=399.54 Aligned_cols=230 Identities=47% Similarity=0.844 Sum_probs=214.3
Q ss_pred CCCceeeCCCCeeeeeeeeecCceEEEEEEECCce-EEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC
Q 010078 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (518)
Q Consensus 283 ~~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~~~-vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~ 361 (518)
....|+++..++.+.+.||+|+||+||+|.|.++. ||||++..........+.|.+|+.+|.+++|||||+|+|+|..+
T Consensus 32 ~~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 32 ELPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred cccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 34678999999999999999999999999999999 99999997766555578999999999999999999999999998
Q ss_pred C-CcceeeeecCCCchhHHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCcEEEcCCC-cEEEEeeCcc
Q 010078 362 P-SLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGMNYLHQNN-IIHRDLKAANLLMDENE-VVKVADFGVA 437 (518)
Q Consensus 362 ~-~~~lV~Ey~~ggsL~~~l~~-~~~~l~~~~i~~i~~qIa~aL~yLHs~g-IiHrDLKp~NILid~~~-~vkL~DFGla 437 (518)
. .++||||||++|+|.++++. .+..++...+++++.||++||.|||+++ ||||||||.|||++.++ ++||+|||++
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence 8 79999999999999999988 4788999999999999999999999999 99999999999999997 9999999999
Q ss_pred eecccC-CccccCCCCCcccCchhcc--CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCchhHHH
Q 010078 438 RVKAQS-GVMTAETGTYRWMAPEVIE--HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSFLEQ 512 (518)
Q Consensus 438 ~~~~~~-~~~~~~~gt~~y~APEvl~--~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp~ip~ 512 (518)
+..... ..++...||+.|||||++. ..+|+.|+||||||++||||+||+.||..+.+.+.+..++.++.||.+|.
T Consensus 192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~ 269 (362)
T KOG0192|consen 192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPK 269 (362)
T ss_pred eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCc
Confidence 987765 4566689999999999999 67999999999999999999999999999999999999999999998765
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=376.24 Aligned_cols=223 Identities=30% Similarity=0.569 Sum_probs=199.7
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
.+|.+.++||+|+||+||+|++ .+..||||.+.....++..++.+..|+.||+.++|||||.+++++..++.+|+|||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 5688889999999999999986 46789999999887788888889999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCC------CcEEEEeeCcceecccC
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN------EVVKVADFGVARVKAQS 443 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~------~~vkL~DFGla~~~~~~ 443 (518)
||.||+|.+|++. .+.+++..++.++.||+.||++||+++||||||||.||||+.. -.+||+|||+++.....
T Consensus 90 yC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~ 168 (429)
T KOG0595|consen 90 YCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG 168 (429)
T ss_pred eCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence 9999999999988 6789999999999999999999999999999999999999865 36899999999998877
Q ss_pred CccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh-cCchhHHHHHh
Q 010078 444 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK-VHHSFLEQRLR 515 (518)
Q Consensus 444 ~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~-~~rp~ip~~~~ 515 (518)
......+|++-|||||++..+.|+.|+|+||+|+|+|+|++|+.||+..++.+-...+-+. ...|.+|..++
T Consensus 169 ~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s 241 (429)
T KOG0595|consen 169 SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELS 241 (429)
T ss_pred hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhcc
Confidence 7777889999999999999999999999999999999999999999999998877754322 22245554443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-45 Score=363.76 Aligned_cols=217 Identities=28% Similarity=0.479 Sum_probs=198.4
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhcCCCcceEEeecccCCCCc
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~ 364 (518)
.+..++|++.+.||+|+||+||.++. +++-+|+|++++..... ...+....|..||.+++||+||+++..|++...+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 45678999999999999999999875 56779999998765433 3567788999999999999999999999999999
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS- 443 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~- 443 (518)
|+|+||+.||.|..+|++ .+.|++..++.++..|+.||.|||++|||||||||+|||+|.+|+++|+|||+++.....
T Consensus 101 ylVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EEEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 999999999999999987 789999999999999999999999999999999999999999999999999999955444
Q ss_pred CccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 444 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 444 ~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
......+||+.|||||++.+.+|+.++|+||||+++|||++|..||.+.+..+....|++..
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k 241 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK 241 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc
Confidence 35556799999999999999999999999999999999999999999999999999988755
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=380.07 Aligned_cols=223 Identities=39% Similarity=0.721 Sum_probs=201.1
Q ss_pred CCceeeCCCCeeeeeeeeecCceEEEEEEECCc-eEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~~-~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
.+.|+++++.++++++||+|.||+||.|.|+++ +||+|.++..... .+.|.+|+.+|++|+|+|||+++++|..+.
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~---~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS---PEAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC---hhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 678999999999999999999999999999987 8999999976443 357889999999999999999999999988
Q ss_pred CcceeeeecCCCchhHHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 363 SLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~-~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
.+|||||||+.|+|.+||+. ....+...+++.++.|||.||+||+++++|||||.++|||+++++.+||+|||+++...
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC
Confidence 99999999999999999987 45679999999999999999999999999999999999999999999999999999544
Q ss_pred cCCccccCCC---CCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCchhHH
Q 010078 442 QSGVMTAETG---TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHSFLE 511 (518)
Q Consensus 442 ~~~~~~~~~g---t~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~rp~ip 511 (518)
+. ..+...| ...|+|||.+....|+.|||||||||+||||+| |+.||.+++..+.+.. |++|+|..-|
T Consensus 355 d~-~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~-le~GyRlp~P 426 (468)
T KOG0197|consen 355 DD-EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLEL-LERGYRLPRP 426 (468)
T ss_pred CC-ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHH-HhccCcCCCC
Confidence 43 3333333 458999999999999999999999999999999 9999999999988877 7778885544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=356.55 Aligned_cols=223 Identities=33% Similarity=0.516 Sum_probs=201.6
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCC-
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS- 363 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~- 363 (518)
..+...+++.++.||+|+.|+||++.+. ++-+|+|++.. ..+...++++.+|++++++++|||||.+||+|..+..
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 3466678999999999999999999875 67899999953 3456778899999999999999999999999999985
Q ss_pred cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs-~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
++|+||||.||||.+++.. .+.+++..+.+++.++++||.|||. ++||||||||+||||+..|.|||||||.++....
T Consensus 153 isI~mEYMDgGSLd~~~k~-~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKR-VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred EEeehhhcCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 9999999999999999987 4789999999999999999999995 9999999999999999999999999999987776
Q ss_pred CCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCC-----CCHHHHHHHhhhhcCchhHHHH
Q 010078 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY-----LTPLQAAVGVVQKVHHSFLEQR 513 (518)
Q Consensus 443 ~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~-----~~~~q~~~~iv~~~~rp~ip~~ 513 (518)
+ .-...+||..|||||.+.+..|+.++||||||++++||.+|+.||.. +.+.+.+..|+. +.+|.+|..
T Consensus 232 S-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~-~ppP~lP~~ 305 (364)
T KOG0581|consen 232 S-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD-EPPPRLPEG 305 (364)
T ss_pred h-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc-CCCCCCCcc
Confidence 6 55678999999999999999999999999999999999999999987 478888888887 667777765
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=337.29 Aligned_cols=215 Identities=27% Similarity=0.486 Sum_probs=196.5
Q ss_pred CCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcce
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~l 366 (518)
..++|++.+.||.|+||+|.+.+. .+..+|+|++++...-. ...+...+|..+|+.+.||+++++++.|.+..++||
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 346788899999999999999875 46779999998764432 345667889999999999999999999999999999
Q ss_pred eeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcc
Q 010078 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 446 (518)
Q Consensus 367 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~ 446 (518)
||||++||.|+.++++ .+.|+++.++.++.||+.|++|||+++|++|||||+|||+|.+|.+||+|||+++..... +
T Consensus 122 vmeyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T 198 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--T 198 (355)
T ss_pred EEeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--E
Confidence 9999999999999988 788999999999999999999999999999999999999999999999999999876654 6
Q ss_pred ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCc
Q 010078 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
.+.+|||.|+|||++..++|+.++|+|||||++|||+.|.+||...++.+++.+|++...+
T Consensus 199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~ 259 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK 259 (355)
T ss_pred EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc
Confidence 6789999999999999999999999999999999999999999999999999999886543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=342.87 Aligned_cols=226 Identities=23% Similarity=0.417 Sum_probs=198.5
Q ss_pred CCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEee-cccCCCC-cc
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG-ACTKPPS-LC 365 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g-~~~~~~~-~~ 365 (518)
...+|++.++||.|+||+||+++. ++..+|.|.++....+....+....|+.+|++|+|||||++++ .+.++.. ++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 345799999999999999999964 6788999999988888888999999999999999999999999 5666555 89
Q ss_pred eeeeecCCCchhHHHhh---hcCCCCHHHHHHHHHHHHHHHHHHHH--CC--ceeccCCCCcEEEcCCCcEEEEeeCcce
Q 010078 366 IVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQ--NN--IIHRDLKAANLLMDENEVVKVADFGVAR 438 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~---~~~~l~~~~i~~i~~qIa~aL~yLHs--~g--IiHrDLKp~NILid~~~~vkL~DFGla~ 438 (518)
||||||.+|+|...++. ....+++..+++++.|++.||..+|+ .. |+||||||.||+++.+|.+||+|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 99999999999998853 35679999999999999999999998 44 8999999999999999999999999999
Q ss_pred ecccCC-ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCchhHH-HHHhh
Q 010078 439 VKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSFLE-QRLRK 516 (518)
Q Consensus 439 ~~~~~~-~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp~ip-~~~~~ 516 (518)
...... .....+|||.||+||.+...+|+.+|||||+||++|||+.-+.||.+.+-.+-..+|-+. --|.+| .-+++
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-d~~~~p~~~YS~ 255 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-DYPPLPDEHYST 255 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-CCCCCcHHHhhh
Confidence 876654 345679999999999999999999999999999999999999999999888877776554 444444 55544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=356.44 Aligned_cols=225 Identities=25% Similarity=0.402 Sum_probs=194.3
Q ss_pred CCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCh-----HHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
-.+.|.+.+.||+|+||.|-+|.. +++.||||+++...... .....+.+|++||++|+|||||+++++|..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 346788999999999999999965 67899999998654322 12344679999999999999999999999999
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCC---CcEEEEeeCccee
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN---EVVKVADFGVARV 439 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~---~~vkL~DFGla~~ 439 (518)
..|||||||+||.|.+++-. ++.+.+.....++.|++.|+.|||++||+||||||+|||+..+ -.+||+|||+|++
T Consensus 250 s~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred ceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 99999999999999999977 6778888889999999999999999999999999999999766 5799999999999
Q ss_pred cccCCccccCCCCCcccCchhccCCCC--C-hhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCchhHHHHHh
Q 010078 440 KAQSGVMTAETGTYRWMAPEVIEHKPY--D-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSFLEQRLR 515 (518)
Q Consensus 440 ~~~~~~~~~~~gt~~y~APEvl~~~~~--s-~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp~ip~~~~ 515 (518)
......|.+.+||+.|.|||++..+.+ + .+.|+||+|||||-+|+|.+||........+.+++-+|..++.|..+.
T Consensus 329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~ 407 (475)
T KOG0615|consen 329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWD 407 (475)
T ss_pred cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhh
Confidence 988888999999999999999976543 3 378999999999999999999998877775555566677766655543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=365.08 Aligned_cols=225 Identities=39% Similarity=0.765 Sum_probs=202.2
Q ss_pred CCCCceeeCCCCeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC
Q 010078 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (518)
Q Consensus 282 ~~~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~ 361 (518)
+...+|+|..+++.+++.||+|+||+||+|.|.| +||||+++.........+.|++|+..+++-+|-||+-|.|+|..+
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 3457899999999999999999999999999976 799999999888888899999999999999999999999999998
Q ss_pred CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
+. .||+.+|+|-+|+.+++-.+..|....++.|+.||++||.|||.++|||||||..||++.+++.|||+|||++....
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 76 99999999999999999888889999999999999999999999999999999999999999999999999997544
Q ss_pred c---CCccccCCCCCcccCchhcc---CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCch
Q 010078 442 Q---SGVMTAETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHS 508 (518)
Q Consensus 442 ~---~~~~~~~~gt~~y~APEvl~---~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp 508 (518)
. ........|...|||||++. ..+|+..+|||||||++|||+||.+||....+.|.+..|-+.-++|
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~p 612 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMP 612 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCc
Confidence 3 33445567888999999984 4689999999999999999999999999777777777655543333
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=352.19 Aligned_cols=215 Identities=24% Similarity=0.386 Sum_probs=191.1
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
+..++|++++.||+|+||.||+++. +|.-+|+|++++... .......++.|-.+|...++|+||++|.+|++..++|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 3557899999999999999999975 577899999987644 3455677889999999999999999999999999999
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc---
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ--- 442 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~--- 442 (518)
+||||++||++..+|.+ .+.+++..++.++.+++.|++.||+.|+|||||||+|+|||..|++||+|||++.....
T Consensus 218 LiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 99999999999999987 78999999999999999999999999999999999999999999999999999852111
Q ss_pred -------------------CCcc--------------------------ccCCCCCcccCchhccCCCCChhhHHHHHHH
Q 010078 443 -------------------SGVM--------------------------TAETGTYRWMAPEVIEHKPYDHKADVFSFGI 477 (518)
Q Consensus 443 -------------------~~~~--------------------------~~~~gt~~y~APEvl~~~~~s~ksDVwSlGv 477 (518)
.... ...+|||.|||||++.+++|+..+|+|||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC 376 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence 0000 0126999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 478 VLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 478 iL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
||||||.|.+||.+.+|.++..+|+.-
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nw 403 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNW 403 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 999999999999999999999998753
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=356.92 Aligned_cols=216 Identities=28% Similarity=0.453 Sum_probs=197.3
Q ss_pred CCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCccee
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV 367 (518)
...|+.++.||+|+|+.+|.++. +|+.||+|++.+... .....+.+.+||+|.++|+|||||+|+++|++.++.|||
T Consensus 17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 17 SKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred cceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence 36799999999999999999986 678899999876543 345567899999999999999999999999999999999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-Ccc
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVM 446 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~-~~~ 446 (518)
.|+|+.++|..+++. .++++++.++.++.||+.||.|||+++|||||||..|+|++++-+|||+|||+|...... ...
T Consensus 97 LELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk 175 (592)
T KOG0575|consen 97 LELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERK 175 (592)
T ss_pred EEecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccccc
Confidence 999999999999984 789999999999999999999999999999999999999999999999999999877654 566
Q ss_pred ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCc
Q 010078 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
.+.+|||-|+|||++.+..++..+||||+|||||-||+|++||+..+-.+++..|....+.
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~ 236 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS 236 (592)
T ss_pred ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc
Confidence 7789999999999999999999999999999999999999999998888888887665443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=354.16 Aligned_cols=228 Identities=26% Similarity=0.446 Sum_probs=196.1
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhc-CCCcceEEeecccCCCC
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 363 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~-~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~~ 363 (518)
.-...+|.+++.||.|+|++||+++. .++.|||||+.+....+ ...+.+..|-.+|.+| .||.|++||..|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 34567999999999999999999986 56889999987665433 3345577899999999 69999999999999999
Q ss_pred cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC
Q 010078 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~ 443 (518)
+|+|+||+++|.|.++|++ .+.|++...+.++.+|+.||+|||++|||||||||+|||+|.+++++|+|||.|+.....
T Consensus 149 LYFvLe~A~nGdll~~i~K-~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKK-YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred eEEEEEecCCCcHHHHHHH-hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 9999999999999999998 589999999999999999999999999999999999999999999999999999865432
Q ss_pred Ccc--------------ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc--Cc
Q 010078 444 GVM--------------TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV--HH 507 (518)
Q Consensus 444 ~~~--------------~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~--~r 507 (518)
... ...+||..|.+||++..+..++.+|+|+||||||+|+.|.+||.+.+.--..++|+.-. .+
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp 307 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP 307 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence 211 34689999999999999999999999999999999999999999999877777765432 23
Q ss_pred hhHHHHHhh
Q 010078 508 SFLEQRLRK 516 (518)
Q Consensus 508 p~ip~~~~~ 516 (518)
+..|+..++
T Consensus 308 ~~fp~~a~d 316 (604)
T KOG0592|consen 308 EGFPEDARD 316 (604)
T ss_pred CCCCHHHHH
Confidence 444444433
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=331.58 Aligned_cols=218 Identities=26% Similarity=0.387 Sum_probs=194.7
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
+.|+.+.++|+|+||.||+++. +|+-||||.+.....++...+-.++|+++|++++|+|+|.++++|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 5678888999999999999975 67889999998776677777778999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc-cCCcccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~-~~~~~~~ 448 (518)
||+. ++.+-+......++...+.+++.|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+... .+...+.
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTD 160 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTD 160 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhh
Confidence 9955 6666677777889999999999999999999999999999999999999999999999999999887 4556778
Q ss_pred CCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCchhHH
Q 010078 449 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSFLE 511 (518)
Q Consensus 449 ~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp~ip 511 (518)
.+.|.+|.|||++.+ .+|+...||||+||++.||++|.+.|++.+..+.+-.|+. .+.+.+|
T Consensus 161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~k-tLG~L~p 223 (396)
T KOG0593|consen 161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRK-TLGNLIP 223 (396)
T ss_pred hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHH-HHcccCH
Confidence 899999999999977 7899999999999999999999999999999888877554 4444444
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=349.77 Aligned_cols=215 Identities=31% Similarity=0.579 Sum_probs=197.0
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|.+.+.||+|+||.||+|+. +.+.||||.+.+........+.+.+|++|++.++|||||.++++|+...++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 5688889999999999999975 55789999998877777778889999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc-ccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-MTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~-~~~ 448 (518)
|+.| +|..++.. ++.+++..+..++.+++.||.|||+++|+|||+||.|||++.+|.+|+||||+++....+.. .+.
T Consensus 82 ~a~g-~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlts 159 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTS 159 (808)
T ss_pred hhhh-hHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeee
Confidence 9976 99999987 88999999999999999999999999999999999999999999999999999998776553 345
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCch
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHS 508 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp 508 (518)
..|||.|||||++.+++|+..+|+||+|||+|||++|++||...+..+-...|+....+|
T Consensus 160 ikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~ 219 (808)
T KOG0597|consen 160 IKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKP 219 (808)
T ss_pred ccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCC
Confidence 679999999999999999999999999999999999999999988888888887655544
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=341.53 Aligned_cols=214 Identities=29% Similarity=0.592 Sum_probs=192.1
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC---hHHHHHHHHHHHHHHhcC-CCcceEEeecccCCC
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN---SDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPP 362 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~---~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~ 362 (518)
.....|.+++.||+|+||.|++|.. .+..||+|++...... ......+.+|+.+++.++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4457899999999999999999976 5688999988765222 133456778999999999 999999999999999
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCC-CcEEEEeeCcceec-
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVK- 440 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~-~~vkL~DFGla~~~- 440 (518)
.+|+||||+.||.|++++.. .+++.+..+.+++.||+.|++|||++||+||||||+|||++.+ +.+||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 99999999999999999998 8899999999999999999999999999999999999999999 99999999999987
Q ss_pred ccCCccccCCCCCcccCchhccCCC-CC-hhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 441 AQSGVMTAETGTYRWMAPEVIEHKP-YD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 441 ~~~~~~~~~~gt~~y~APEvl~~~~-~s-~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
.........+||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||+..+.......|..
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~ 237 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK 237 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc
Confidence 4666788899999999999999988 86 679999999999999999999999887777777543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=346.88 Aligned_cols=216 Identities=29% Similarity=0.466 Sum_probs=194.3
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEECC--ceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcC-CCcceEEeecccCCCC
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPS 363 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~~--~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~~ 363 (518)
.+..++|.+.+.||+|+||+|+++..++ +.+|||++|+... ..+..+..+.|.+|+...+ ||.+++++..|+...+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 5677899999999999999999998764 5699999998654 4555677888999988886 9999999999999999
Q ss_pred cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc-c
Q 010078 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA-Q 442 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~-~ 442 (518)
+|+||||+.||++..+.+ .+.|++..+..++..|+.||.|||++||||||||.+|||+|.+|.+||+|||+++... .
T Consensus 444 l~fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred EEEEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 999999999999555543 4789999999999999999999999999999999999999999999999999999766 4
Q ss_pred CCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 443 ~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
...+++.+|||.|||||++.+..|+.+.|+|||||+|||||.|+.||.+.+-.+....|+...
T Consensus 522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~ 584 (694)
T KOG0694|consen 522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE 584 (694)
T ss_pred CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC
Confidence 456778899999999999999999999999999999999999999999998888888877543
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=352.78 Aligned_cols=219 Identities=34% Similarity=0.659 Sum_probs=198.9
Q ss_pred cCCCCCCceeeCCCCeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecc
Q 010078 279 IPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358 (518)
Q Consensus 279 ~p~~~~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~ 358 (518)
+.....+.|+|.-+.+.-++-||+|+.|.||+|+..++.||||.++. .-..+|+-|++|+|+||+.|.|+|
T Consensus 111 ~k~qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~e---------lkETdIKHLRkLkH~NII~FkGVC 181 (904)
T KOG4721|consen 111 HKQQQEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRE---------LKETDIKHLRKLKHPNIITFKGVC 181 (904)
T ss_pred hhhhhhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhh---------hhhhhHHHHHhccCcceeeEeeee
Confidence 34455678999988888889999999999999999999999998762 123488999999999999999999
Q ss_pred cCCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcce
Q 010078 359 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (518)
Q Consensus 359 ~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~ 438 (518)
+..+.+|||||||..|-|++.|+. ...+....+..|..+|+.||.|||.+.|||||||.-||||..+..|||+|||.++
T Consensus 182 tqsPcyCIiMEfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~ 260 (904)
T KOG4721|consen 182 TQSPCYCIIMEFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSK 260 (904)
T ss_pred cCCceeEEeeeccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchH
Confidence 999999999999999999999987 6778899999999999999999999999999999999999999999999999998
Q ss_pred ecccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCc
Q 010078 439 VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
.......+..++||..|||||+|...+.+.|.|||||||||||||||..||...+....+.+|-.+.+.
T Consensus 261 e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~ 329 (904)
T KOG4721|consen 261 ELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLH 329 (904)
T ss_pred hhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCccc
Confidence 877766777889999999999999999999999999999999999999999998887777776555544
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=341.47 Aligned_cols=218 Identities=26% Similarity=0.427 Sum_probs=194.2
Q ss_pred CCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC--CCcc
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLC 365 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~--~~~~ 365 (518)
..+.|+.+++||+|.||.||++++ +++.||+|.++.+........-..+||.||++|+||||+++.+..+.. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 346788899999999999999986 467799999998776666667788999999999999999999988776 6899
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG- 444 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~- 444 (518)
||+|||+ -+|.-++....-.|++.++.-++.||+.||+|||++||+|||||.+|||||.+|.+||+|||+|++.....
T Consensus 195 lVFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 195 LVFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred EEEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 9999995 58888887655679999999999999999999999999999999999999999999999999999765543
Q ss_pred -ccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCch
Q 010078 445 -VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHS 508 (518)
Q Consensus 445 -~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp 508 (518)
.++..+-|.+|.|||++.+ ..|+.+.|+||.||||.||++|++.|.+.+..+.+..|.+-...|
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP 339 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSP 339 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCC
Confidence 6788899999999999876 479999999999999999999999999999999998887654444
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=349.26 Aligned_cols=229 Identities=32% Similarity=0.613 Sum_probs=204.0
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEECC-----ce-EEEEEecCC-CCChHHHHHHHHHHHHHHhcCCCcceEEeec
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QD-VAIKVLKPE-RINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-----~~-vAVKvlk~~-~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~ 357 (518)
..|++..++..+.++||+|+||+||+|++.- .. ||||..+.. ........+|.+|+++|++++|||||+|||+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 5699999999999999999999999998632 23 899998863 3567778999999999999999999999999
Q ss_pred ccCCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcc
Q 010078 358 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437 (518)
Q Consensus 358 ~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla 437 (518)
+.....+++|||+|.||+|.+||++..+.++..+..+++.+.+.||+|||++++|||||..+|+|++.++.+||+|||++
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence 99999999999999999999999997777999999999999999999999999999999999999999999999999998
Q ss_pred eecccCCccc-cCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCchhHHHH
Q 010078 438 RVKAQSGVMT-AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHSFLEQR 513 (518)
Q Consensus 438 ~~~~~~~~~~-~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~rp~ip~~ 513 (518)
+....-.... ...-..+|+|||.+....|+.++|||||||++||+++ |..||.+++..++...|+..++|..+|..
T Consensus 310 ~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~ 387 (474)
T KOG0194|consen 310 RAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSK 387 (474)
T ss_pred cCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCC
Confidence 7665221111 1124569999999999999999999999999999999 89999999999999999888888766653
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=325.95 Aligned_cols=223 Identities=33% Similarity=0.537 Sum_probs=199.1
Q ss_pred CCceeeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~ 361 (518)
...|.++.++|++.+.||.|..+.||+|.. .+..||||++..+..+.+ .+.+.+|+..|+.++||||++++..|...
T Consensus 18 ~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 18 EKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred cccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 356888999999999999999999999976 567899999998876665 68899999999999999999999999999
Q ss_pred CCcceeeeecCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceec
Q 010078 362 PSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~ 440 (518)
..+|+||.||.+||+.+.+... ...+++..+..|++++++||.|||++|.||||||+.||||+.+|.|||+|||.+-..
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 9999999999999999999754 456999999999999999999999999999999999999999999999999987544
Q ss_pred ccCCc-c----ccCCCCCcccCchhc--cCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCc
Q 010078 441 AQSGV-M----TAETGTYRWMAPEVI--EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 441 ~~~~~-~----~~~~gt~~y~APEvl--~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
..++. . ...+||++|||||++ ....|+.|+|||||||+..||.+|..||..+.|.+++...+++..+
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp 250 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPP 250 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCC
Confidence 44331 1 455899999999995 3467999999999999999999999999999999999998886553
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=345.42 Aligned_cols=288 Identities=26% Similarity=0.464 Sum_probs=240.6
Q ss_pred cccceecccccCCCCceeeEEEEcCCChhhHHHHHHHHHHHHHHhhhcCCCCCCCCCCCCCCCCCCCCCCCCccccCCCC
Q 010078 204 GLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDG 283 (518)
Q Consensus 204 ~~~i~~a~~fst~dg~~ldv~vvdgw~~e~~~~l~~~l~~~~~~~~~~~~~s~~sss~~s~~~~~~~~~~~~~~~~p~~~ 283 (518)
.||++.+.+|+.+..-.|+-+ |+...++.+|++++.+-....+..+|.++-.....+.-.... ..+..| +.
T Consensus 31 ~lnvrr~~hf~yVk~eDLl~I---GMgRp~qRRLrea~kkm~~~~k~kswvkKvf~ga~p~h~~~t-----~~~~~p-~~ 101 (1039)
T KOG0199|consen 31 LLNVRRFDHFSYVKDEDLLEI---GMGRPQQRRLREAIKKMSREMKNKSWVKKVFIGADPSHPAQT-----NSVANP-SI 101 (1039)
T ss_pred HhccCchhhhhhcchhhhhhh---ccCcHHHHHHHHHHHHhhhhccccchHHHHhccCCccccccc-----cCCCCc-CC
Confidence 589999999999999888876 999999999999999866555555554433222111111100 011112 34
Q ss_pred CCceeeCCCCeeeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecc
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-----~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~ 358 (518)
...+-|..+++++.++||+|+||.|++|.|+. -.||||+++...... ....|++|+.+|.+|+|+|++++||+.
T Consensus 102 ~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvV 180 (1039)
T KOG0199|consen 102 DLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVV 180 (1039)
T ss_pred CcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeee
Confidence 45678999999999999999999999999964 359999999876654 568899999999999999999999999
Q ss_pred cCCCCcceeeeecCCCchhHHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcc
Q 010078 359 TKPPSLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437 (518)
Q Consensus 359 ~~~~~~~lV~Ey~~ggsL~~~l~~-~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla 437 (518)
.+ ..+.||||.++.|||.+.|++ .+..|-...+..++.||+.||.||.++++|||||...|||+-....|||+|||++
T Consensus 181 l~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLm 259 (1039)
T KOG0199|consen 181 LD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLM 259 (1039)
T ss_pred cc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccce
Confidence 87 668899999999999999988 5667888999999999999999999999999999999999999999999999999
Q ss_pred eecccCCccccC----CCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhh
Q 010078 438 RVKAQSGVMTAE----TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 438 ~~~~~~~~~~~~----~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv 502 (518)
+....+..+... .-...|+|||.+.+..|+.++|||+|||++|||+| |+.||.+....|.+..|-
T Consensus 260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD 329 (1039)
T KOG0199|consen 260 RALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID 329 (1039)
T ss_pred eccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc
Confidence 977766544422 23468999999999999999999999999999999 999999999999998865
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=333.82 Aligned_cols=211 Identities=24% Similarity=0.388 Sum_probs=184.8
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
++|++.+.||+|+||.||++... ++.||||+++.... .......+.+|+.+++.++|+||+++++.+.....+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46889999999999999999864 67899999875322 2233456888999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC----
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---- 444 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~---- 444 (518)
||++||+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 159 (363)
T cd05628 81 EFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159 (363)
T ss_pred cCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence 99999999999976 5679999999999999999999999999999999999999999999999999986432110
Q ss_pred --------------------------------ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCC
Q 010078 445 --------------------------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL 492 (518)
Q Consensus 445 --------------------------------~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (518)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 012347999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHhhh
Q 010078 493 TPLQAAVGVVQ 503 (518)
Q Consensus 493 ~~~q~~~~iv~ 503 (518)
++.+....++.
T Consensus 240 ~~~~~~~~i~~ 250 (363)
T cd05628 240 TPQETYKKVMN 250 (363)
T ss_pred CHHHHHHHHHc
Confidence 98888877765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=339.92 Aligned_cols=222 Identities=30% Similarity=0.517 Sum_probs=196.0
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
..|...++||+|+.|.||.++. .++.||||.+....... .+-+.+|+.+|+..+|+|||.+++.|...+.+|+|||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 4677788999999999999976 45779999987654333 3568899999999999999999999988899999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-cccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~ 448 (518)
||+||+|.+.+.. ..+++.++..|+.++++||+|||.+||+|||||.+|||++.+|.+||+|||+|....... ....
T Consensus 351 ym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T 428 (550)
T KOG0578|consen 351 YMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST 428 (550)
T ss_pred ecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence 9999999999976 459999999999999999999999999999999999999999999999999998666544 5567
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCch-----hHHHHHhhh
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHS-----FLEQRLRKS 517 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp-----~ip~~~~~~ 517 (518)
-+|||+|||||++..+.|+++.||||||++++||+-|++||-..+|++++-.|-.+|.+. .+...|+++
T Consensus 429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdF 502 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDF 502 (550)
T ss_pred ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHH
Confidence 799999999999999999999999999999999999999999999999999987766542 344445544
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=309.48 Aligned_cols=216 Identities=23% Similarity=0.394 Sum_probs=194.0
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
.+|...++||+|.||.||+|++ +|+.||||.++.............+||++|+.++|+||+.++++|...+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4678889999999999999986 57889999999776555555678899999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-cccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~ 448 (518)
|| ..+|...++.....++...+..++.++++|++|||++.|+||||||.|+||+.+|.+||+|||+++...... ..+.
T Consensus 82 fm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~ 160 (318)
T KOG0659|consen 82 FM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH 160 (318)
T ss_pred ec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence 99 569999999888889999999999999999999999999999999999999999999999999999876544 3344
Q ss_pred CCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCch
Q 010078 449 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHS 508 (518)
Q Consensus 449 ~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp 508 (518)
.+-|.+|.|||++.| ..|+...||||.|||+.||+-|.+-|.+.+..+.+..|.+....|
T Consensus 161 ~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP 221 (318)
T KOG0659|consen 161 QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTP 221 (318)
T ss_pred ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCC
Confidence 478999999998865 579999999999999999999999999999999998888765554
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=328.76 Aligned_cols=224 Identities=29% Similarity=0.485 Sum_probs=190.2
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC--Ccce
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP--SLCI 366 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~--~~~l 366 (518)
...+..++.||+|+||.||+++.. +...|||.+.... ....+.+.+|+.+|.+++|||||+++|...... .+++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 455777899999999999999986 5889999887652 222567899999999999999999999744444 5899
Q ss_pred eeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC-CCcEEEEeeCcceeccc---
Q 010078 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVARVKAQ--- 442 (518)
Q Consensus 367 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~-~~~vkL~DFGla~~~~~--- 442 (518)
.|||++||+|.+++....+.+++..+.++++||+.||.|||++|||||||||+|||++. ++.+||+|||.++....
T Consensus 94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 99999999999999986658999999999999999999999999999999999999999 79999999999876553
Q ss_pred -CCccccCCCCCcccCchhccCC-CCChhhHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHhhhhcCchhHHHHHhh
Q 010078 443 -SGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEY-LTPLQAAVGVVQKVHHSFLEQRLRK 516 (518)
Q Consensus 443 -~~~~~~~~gt~~y~APEvl~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~-~~~~q~~~~iv~~~~rp~ip~~~~~ 516 (518)
........||+.|||||++... ....++|||||||++.||+||+.||.. ....++...+.....-|.||..+++
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~ 250 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSD 250 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCH
Confidence 2234456899999999999853 334599999999999999999999998 6778888888776666677766543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=341.00 Aligned_cols=212 Identities=32% Similarity=0.558 Sum_probs=194.0
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCC-CCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPE-RINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~-~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
-|++++.||.|+.|.|-+|++ +|+.+|||++... .........+.+|+-||+.+.|||++++|++|+...++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 467789999999999999987 6899999998765 3344456778999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccccC
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 449 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~~ 449 (518)
|++||.|++++-. +|++++....++++||+.|+.|||..+|+||||||+|+|+|.++.|||+|||+|.+...+....+.
T Consensus 93 yv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTS 171 (786)
T KOG0588|consen 93 YVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETS 171 (786)
T ss_pred ecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcccccc
Confidence 9999999999987 789999999999999999999999999999999999999999999999999999988888888889
Q ss_pred CCCCcccCchhccCCCCC-hhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 450 TGTYRWMAPEVIEHKPYD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 450 ~gt~~y~APEvl~~~~~s-~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
||++.|.|||++.|.+|+ .++||||.|||||.||||++||++-+....+.+|-++.
T Consensus 172 CGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~ 228 (786)
T KOG0588|consen 172 CGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV 228 (786)
T ss_pred CCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc
Confidence 999999999999999995 68999999999999999999999988888887754443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=334.30 Aligned_cols=217 Identities=24% Similarity=0.380 Sum_probs=196.0
Q ss_pred CCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeecccCCC-Ccc
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPP-SLC 365 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~-~~~ 365 (518)
-.++|.+.++||.|+||.||+|+. .+..||||.+|......+ .-.-++|+..|++|+ |||||++.+++.+.. .+|
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 457899999999999999999975 567899999987654432 233468999999999 999999999998888 899
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 445 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~ 445 (518)
+||||| ..+|+++++.++..|++..+..|+.||++||+|+|++|+.|||+||+||||..+..|||+|||+||.......
T Consensus 87 fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP 165 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP 165 (538)
T ss_pred eeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCC
Confidence 999999 6799999998888999999999999999999999999999999999999999999999999999999988888
Q ss_pred cccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCch
Q 010078 446 MTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHS 508 (518)
Q Consensus 446 ~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp 508 (518)
.+..+.|.+|.|||++.. .-|+.+.|||++|||++|+++-++.|.+.+..+.+-+|.+-...|
T Consensus 166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP 229 (538)
T KOG0661|consen 166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTP 229 (538)
T ss_pred cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCC
Confidence 999999999999999854 568999999999999999999999999999999988887755554
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=319.19 Aligned_cols=209 Identities=25% Similarity=0.438 Sum_probs=184.2
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
++|++.+.||+|+||.||++... ++.||+|++..... .......+.+|+.++++++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999875 78899999875432 2233466889999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcccc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~ 448 (518)
||+++++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~ 157 (291)
T cd05612 81 EYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWT 157 (291)
T ss_pred eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--ccc
Confidence 99999999999976 567899999999999999999999999999999999999999999999999998765432 234
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
..||+.|+|||++.+..++.++|||||||++|+|++|+.||...++.+....+..
T Consensus 158 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~ 212 (291)
T cd05612 158 LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA 212 (291)
T ss_pred ccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 5789999999999999999999999999999999999999999888776666554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=326.38 Aligned_cols=220 Identities=32% Similarity=0.610 Sum_probs=181.1
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEeecc
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGAC 358 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~~-------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~ 358 (518)
|++..++|+++++||+|+||.||+|.+. +..||||+++... .......+.+|+.+++++ +||||++++++|
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 7888999999999999999999999742 3569999987543 233456789999999999 899999999988
Q ss_pred cCCC-CcceeeeecCCCchhHHHhhhc-----------------------------------------------------
Q 010078 359 TKPP-SLCIVTEFMSGGSVYDYLHKLK----------------------------------------------------- 384 (518)
Q Consensus 359 ~~~~-~~~lV~Ey~~ggsL~~~l~~~~----------------------------------------------------- 384 (518)
.... .+++||||+++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 7644 5789999999999999987531
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc---cccCCCCC
Q 010078 385 --------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTY 453 (518)
Q Consensus 385 --------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~---~~~~~gt~ 453 (518)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .....++.
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 2367788899999999999999999999999999999999999999999999975432211 11234567
Q ss_pred cccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCc
Q 010078 454 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 454 ~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
.|+|||++.+..++.++|||||||++|||++ |..||.+....+.....+..+.+
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 295 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR 295 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC
Confidence 8999999999999999999999999999997 99999886654444444444433
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=327.46 Aligned_cols=215 Identities=27% Similarity=0.435 Sum_probs=188.4
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEECC---ceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS---QDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~---~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
+.+..++|++.++||+|+||.||+|++.+ ..||+|++..... .......+.+|+.+++.++||||+++++++....
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 35667789999999999999999998643 4699998864322 2334567889999999999999999999999999
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
.+|+||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999999999976 56789999999999999999999999999999999999999999999999999976543
Q ss_pred CCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 443 ~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...++......+.+.
T Consensus 184 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~ 243 (340)
T PTZ00426 184 R--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG 243 (340)
T ss_pred C--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC
Confidence 2 33457999999999999999999999999999999999999999998887776666554
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=323.04 Aligned_cols=215 Identities=25% Similarity=0.520 Sum_probs=197.6
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
-+|++.+.||+|.||.|-++.. .++.||||.++++.. +++..-.+.+||+||..|+||||+++|.+|...+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4788999999999999999974 678999999887655 3445667899999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcccc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~ 448 (518)
||..+|.|++|+.. .+.+++...+.+++||..|+.|+|+++++|||||.+|||+|.|+++||+|||++....+.....+
T Consensus 133 EYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqT 211 (668)
T KOG0611|consen 133 EYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQT 211 (668)
T ss_pred EecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHHH
Confidence 99999999999988 78899999999999999999999999999999999999999999999999999999998888999
Q ss_pred CCCCCcccCchhccCCCC-ChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCc
Q 010078 449 ETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~-s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
.+|++-|.+||++++.+| ++..|.||||++||-|+.|.+||++.+-...+.+|-...+|
T Consensus 212 FCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr 271 (668)
T KOG0611|consen 212 FCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR 271 (668)
T ss_pred hcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc
Confidence 999999999999999999 57899999999999999999999998877777776655554
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=328.91 Aligned_cols=211 Identities=22% Similarity=0.386 Sum_probs=184.3
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
++|++.+.||+|+||.||+++. .++.||||+++.... .......+.+|+.+|+.++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4688999999999999999987 467899999875422 2334466888999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC----
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---- 444 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~---- 444 (518)
||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 81 E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (364)
T cd05599 81 EYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159 (364)
T ss_pred CCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence 99999999999976 5679999999999999999999999999999999999999999999999999986432211
Q ss_pred -----------------------------------ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCC
Q 010078 445 -----------------------------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489 (518)
Q Consensus 445 -----------------------------------~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf 489 (518)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence 011236899999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhh
Q 010078 490 EYLTPLQAAVGVVQ 503 (518)
Q Consensus 490 ~~~~~~q~~~~iv~ 503 (518)
...++.+....+++
T Consensus 240 ~~~~~~~~~~~i~~ 253 (364)
T cd05599 240 CSDNPQETYRKIIN 253 (364)
T ss_pred CCCCHHHHHHHHHc
Confidence 99988887777654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=324.40 Aligned_cols=212 Identities=28% Similarity=0.451 Sum_probs=187.0
Q ss_pred CCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcce
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~l 366 (518)
..++|++.+.||+|+||.||++++. ++.||+|+++.... .......+.+|+.++++++||||+++++++.....+|+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 3468999999999999999999874 57899999875422 22335678899999999999999999999999999999
Q ss_pred eeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcc
Q 010078 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 446 (518)
Q Consensus 367 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~ 446 (518)
||||++|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 96 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~ 172 (329)
T PTZ00263 96 LLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--T 172 (329)
T ss_pred EEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--c
Confidence 9999999999999976 567899999999999999999999999999999999999999999999999999765433 2
Q ss_pred ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.++.+....+.+.
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 230 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG 230 (329)
T ss_pred ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC
Confidence 3457899999999999999999999999999999999999999998887777766543
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=329.96 Aligned_cols=210 Identities=23% Similarity=0.390 Sum_probs=182.2
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
.|+++++||+|+||.||+|+. +++.||||+++.... .......+.+|+.++++++|+||+++++++.....+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578899999999999999987 457799999875432 33445678999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC------
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS------ 443 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~------ 443 (518)
|++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 82 YIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 9999999999976 467889999999999999999999999999999999999999999999999987532100
Q ss_pred ------------------------------------------CccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHH
Q 010078 444 ------------------------------------------GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWE 481 (518)
Q Consensus 444 ------------------------------------------~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~e 481 (518)
......+||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e 240 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence 00123469999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCHHHHHHHhhh
Q 010078 482 LLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 482 LltG~~Pf~~~~~~q~~~~iv~ 503 (518)
|++|+.||...++.+....++.
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~ 262 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVIN 262 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHc
Confidence 9999999998888777666654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=330.24 Aligned_cols=210 Identities=23% Similarity=0.401 Sum_probs=182.4
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
.|+++++||+|+||.||++.. .++.||+|++..... .......+.+|+.++++++|+||+++++.+.....+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999987 457799999875322 23345678899999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC------
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS------ 443 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~------ 443 (518)
|++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 82 YIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 9999999999976 467889999999999999999999999999999999999999999999999997422100
Q ss_pred ------------------------------------------CccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHH
Q 010078 444 ------------------------------------------GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWE 481 (518)
Q Consensus 444 ------------------------------------------~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~e 481 (518)
......+||+.|+|||++.+..|+.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence 00112368999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCHHHHHHHhhh
Q 010078 482 LLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 482 LltG~~Pf~~~~~~q~~~~iv~ 503 (518)
|++|+.||...++.+....++.
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~ 262 (382)
T cd05625 241 MLVGQPPFLAQTPLETQMKVIN 262 (382)
T ss_pred HHhCCCCCCCCCHHHHHHHHHc
Confidence 9999999999998887777664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=329.67 Aligned_cols=211 Identities=20% Similarity=0.337 Sum_probs=181.7
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
++|++.++||+|+||.||++.. +++.||||++.... ........+.+|+.++++++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688899999999999999976 56789999986532 23344567889999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC----
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---- 444 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~---- 444 (518)
||++|++|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 159 (377)
T cd05629 81 EFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159 (377)
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 99999999999976 5678999999999999999999999999999999999999999999999999985321100
Q ss_pred --------------------------------------------ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHH
Q 010078 445 --------------------------------------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLW 480 (518)
Q Consensus 445 --------------------------------------------~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~ 480 (518)
.....+||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (377)
T cd05629 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239 (377)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence 001246899999999999999999999999999999
Q ss_pred HHHcCCCCCCCCCHHHHHHHhhh
Q 010078 481 ELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 481 eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
||++|+.||...++.+....++.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~ 262 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIIN 262 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHc
Confidence 99999999998888776666553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=324.69 Aligned_cols=211 Identities=24% Similarity=0.416 Sum_probs=187.3
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
++|++.++||+|+||.||+++.. ++.||||+++..... ......+.+|+.+++.++|+||+++++++.....+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36889999999999999999986 788999998754322 234567889999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC----
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---- 444 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~---- 444 (518)
||++|++|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (350)
T cd05573 81 EYMPGGDLMNLLIR-KDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159 (350)
T ss_pred cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence 99999999999987 3779999999999999999999999999999999999999999999999999987554332
Q ss_pred --------------------------ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 010078 445 --------------------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA 498 (518)
Q Consensus 445 --------------------------~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~ 498 (518)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 223456899999999999999999999999999999999999999999888777
Q ss_pred HHhhh
Q 010078 499 VGVVQ 503 (518)
Q Consensus 499 ~~iv~ 503 (518)
..+++
T Consensus 240 ~~i~~ 244 (350)
T cd05573 240 NKIIN 244 (350)
T ss_pred HHHhc
Confidence 77665
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=321.15 Aligned_cols=208 Identities=26% Similarity=0.423 Sum_probs=184.1
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
++|++.++||+|+||.||+|++. ++.||||+++.... .......+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36889999999999999999874 67899999875432 2234567889999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcccc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~ 448 (518)
||++|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ....
T Consensus 81 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~ 157 (333)
T cd05600 81 EYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANS 157 (333)
T ss_pred eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCC
Confidence 99999999999976 56789999999999999999999999999999999999999999999999999975443 2345
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv 502 (518)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...++.+....+.
T Consensus 158 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~ 211 (333)
T cd05600 158 VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK 211 (333)
T ss_pred cccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH
Confidence 579999999999999999999999999999999999999999988876665543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=309.67 Aligned_cols=266 Identities=23% Similarity=0.383 Sum_probs=213.8
Q ss_pred CChhhHHHHHHHHHHHHHHhhhcCCCCCCCC-CCC----CCCCCCCCCCCCCccccCCCCCCceeeCCCCeeeeeeeeec
Q 010078 229 WPYEETEQLRAALEKEVLKLERQGWPSHRSS-SPT----SEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASG 303 (518)
Q Consensus 229 w~~e~~~~l~~~l~~~~~~~~~~~~~s~~ss-s~~----s~~~~~~~~~~~~~~~~p~~~~~~~ei~~~~~~i~~~LG~G 303 (518)
-+.++.++|.+|++....+++++..-....+ ... ....+....+...++..+......-.+..++|.+++.||+|
T Consensus 100 es~~eRq~W~~AIq~vsn~l~q~e~~~tn~~p~~~~d~~~~s~s~d~~~e~m~i~~t~~~~~~~kvTm~dFdfLKvLGkG 179 (516)
T KOG0690|consen 100 ESAEERQEWIEAIQAVSNRLKQEELMDTNGNPEGEMDVNMGSPSDDFGSEEMSIAETEEAKRKNKVTMEDFDFLKVLGKG 179 (516)
T ss_pred CCHHHHHHHHHHHHHHhhhhhhhhhcccCCCccccccccCCCCCccccceeeeecccccccccceeccchhhHHHHhcCC
Confidence 4688999999999987766665442110000 000 00000111111222222223333446778899999999999
Q ss_pred CceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecCCCchhHHH
Q 010078 304 SYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL 380 (518)
Q Consensus 304 ~fG~Vy~g~~--~~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL~~~l 380 (518)
.||+|.+++. .++.||||+++++.. .++....-+.|-++|+..+||.+..+-..|+..+.+|+||||..||.|+-+|
T Consensus 180 TFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HL 259 (516)
T KOG0690|consen 180 TFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHL 259 (516)
T ss_pred ccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeeh
Confidence 9999998875 578899999998754 4555667788999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc-CCccccCCCCCcccCch
Q 010078 381 HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGTYRWMAPE 459 (518)
Q Consensus 381 ~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~-~~~~~~~~gt~~y~APE 459 (518)
.. ...|++...+.+...|+.||.|||+++||+||||.+|+|+|.+|++||+|||+++.... ...+...+|||.|+|||
T Consensus 260 sr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPE 338 (516)
T KOG0690|consen 260 SR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPE 338 (516)
T ss_pred hh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccceeccccCChhhcCch
Confidence 76 67899999999999999999999999999999999999999999999999999986544 44677889999999999
Q ss_pred hccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHH
Q 010078 460 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL 495 (518)
Q Consensus 460 vl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~ 495 (518)
++..+.|+.+.|+|.+|++||||++|++||.+.+-.
T Consensus 339 VleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~ 374 (516)
T KOG0690|consen 339 VLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE 374 (516)
T ss_pred hhccccccceeehhhhhHHHHHHHhccCcccccchh
Confidence 999999999999999999999999999999765543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=320.43 Aligned_cols=204 Identities=25% Similarity=0.460 Sum_probs=177.6
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecCCC
Q 010078 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 374 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~gg 374 (518)
+.||+|+||.||+++. .++.||||+++.... .......+.+|+.++++++||||+++++++.....+|+||||++|+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4689999999999986 467899999885432 2334567888999999999999999999999999999999999999
Q ss_pred chhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-CccccCCCCC
Q 010078 375 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGTY 453 (518)
Q Consensus 375 sL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~-~~~~~~~gt~ 453 (518)
+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......||+
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 159 (323)
T cd05571 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159 (323)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCc
Confidence 99999976 567899999999999999999999999999999999999999999999999998753322 2334557999
Q ss_pred cccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 010078 454 RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 454 ~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv 502 (518)
.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.
T Consensus 160 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~ 208 (323)
T cd05571 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208 (323)
T ss_pred cccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH
Confidence 9999999999999999999999999999999999998877665555544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=327.82 Aligned_cols=210 Identities=22% Similarity=0.391 Sum_probs=180.6
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
++|++.++||+|+||.||+++.. ++.||||++..... .......+.+|+.+|+.++|+||+++++.+...+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999864 67899999864322 2223456888999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-----
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS----- 443 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~----- 443 (518)
||++||+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 81 DYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence 99999999999976 567889999999999999999999999999999999999999999999999997422100
Q ss_pred ---------------------------------------CccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc
Q 010078 444 ---------------------------------------GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT 484 (518)
Q Consensus 444 ---------------------------------------~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt 484 (518)
......+||+.|||||++.+..++.++|||||||++|||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence 00113469999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHhh
Q 010078 485 GKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 485 G~~Pf~~~~~~q~~~~iv 502 (518)
|+.||...++.+....+.
T Consensus 240 G~~Pf~~~~~~~~~~~i~ 257 (376)
T cd05598 240 GQPPFLADTPAETQLKVI 257 (376)
T ss_pred CCCCCCCCCHHHHHHHHh
Confidence 999999988877666554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=310.30 Aligned_cols=201 Identities=24% Similarity=0.431 Sum_probs=176.2
Q ss_pred eeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
|++.+.||+|+||.||++.. +++.||+|++...... ......+.+|+.++++++|+||+++++++...+.+|+||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67789999999999999976 5788999998754322 22335678899999999999999999999999999999999
Q ss_pred cCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccccC
Q 010078 371 MSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 449 (518)
Q Consensus 371 ~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~~ 449 (518)
+++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++............
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR 161 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCC
Confidence 9999999887643 346899999999999999999999999999999999999999999999999999875544444556
Q ss_pred CCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 450 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 450 ~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
.||..|+|||++.+..|+.++|||||||++|+|++|+.||...+.
T Consensus 162 ~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 206 (285)
T cd05631 162 VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206 (285)
T ss_pred CCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc
Confidence 799999999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=318.57 Aligned_cols=217 Identities=29% Similarity=0.437 Sum_probs=181.6
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChH------------HHHHHHHHHHHHHhcCCCcceEE
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSD------------MQKEFAQEVFIMRKVRHKNVVQF 354 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~------------~~~~~~~Ei~iL~~L~HpnIv~l 354 (518)
...++|++++.||+|.||.|-+|.. .++.||||++.+.....+ ..+...+||.||++|+|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 4457899999999999999999976 467899999875433221 13578999999999999999999
Q ss_pred eecccCC--CCcceeeeecCCCchhHHHhhhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEE
Q 010078 355 IGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKV 431 (518)
Q Consensus 355 ~g~~~~~--~~~~lV~Ey~~ggsL~~~l~~~~~~-l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL 431 (518)
+.+..++ ..+|||+|||..|.+...=. ... +.+.++++|+.+++.||+|||..|||||||||+|+|++.+|++||
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~--d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP--DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCC--CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence 9998765 46899999998887654321 234 889999999999999999999999999999999999999999999
Q ss_pred EeeCcceecccC------CccccCCCCCcccCchhccCC---CC-ChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 010078 432 ADFGVARVKAQS------GVMTAETGTYRWMAPEVIEHK---PY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV 501 (518)
Q Consensus 432 ~DFGla~~~~~~------~~~~~~~gt~~y~APEvl~~~---~~-s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~i 501 (518)
+|||.+...... .......|||.|||||...+. .| +.+.||||+||+||.|+.|++||.+...++...+|
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI 331 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI 331 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH
Confidence 999999765332 123346899999999998662 23 46789999999999999999999999999999999
Q ss_pred hhhcCc
Q 010078 502 VQKVHH 507 (518)
Q Consensus 502 v~~~~r 507 (518)
+...+-
T Consensus 332 vn~pL~ 337 (576)
T KOG0585|consen 332 VNDPLE 337 (576)
T ss_pred hcCccc
Confidence 876554
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=317.37 Aligned_cols=204 Identities=25% Similarity=0.466 Sum_probs=177.1
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecCCC
Q 010078 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 374 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~gg 374 (518)
+.||+|+||.||++.. .++.||+|+++.... .......+.+|+.+++.++||||+++++++.....+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4689999999999986 467899999875432 2334566788999999999999999999999999999999999999
Q ss_pred chhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc-CCccccCCCCC
Q 010078 375 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGTY 453 (518)
Q Consensus 375 sL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~-~~~~~~~~gt~ 453 (518)
+|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||+
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 159 (323)
T cd05595 81 ELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159 (323)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCc
Confidence 99998876 56789999999999999999999999999999999999999999999999999875322 22334457999
Q ss_pred cccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 010078 454 RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 454 ~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv 502 (518)
.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.
T Consensus 160 ~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~ 208 (323)
T cd05595 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 208 (323)
T ss_pred CcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 9999999999999999999999999999999999998877766555544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=320.84 Aligned_cols=216 Identities=19% Similarity=0.349 Sum_probs=186.2
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
++|++.++||+|+||.||+++.. ++.||+|+++... ........+.+|+.+++.++|+||+++++++...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46899999999999999999874 5679999987532 12233456788999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcc--
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM-- 446 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~-- 446 (518)
||++||+|.+++.+....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 999999999999876678899999999999999999999999999999999999999999999999999765443322
Q ss_pred ccCCCCCcccCchhccC-----CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCc
Q 010078 447 TAETGTYRWMAPEVIEH-----KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~-----~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....++....+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~ 226 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEER 226 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCc
Confidence 23569999999999875 56889999999999999999999999998888877777654433
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=312.09 Aligned_cols=217 Identities=24% Similarity=0.406 Sum_probs=191.0
Q ss_pred CCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCc-ceEEeecccCCC-----
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN-VVQFIGACTKPP----- 362 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Iv~l~g~~~~~~----- 362 (518)
...|...++||+|+||+||+|.. +|+.||+|.++.+...+..-....+|+.+|+.++|+| |+.+++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 55688889999999999999975 5788999999876543334455788999999999999 999999987766
Q ss_pred -CcceeeeecCCCchhHHHhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcce
Q 010078 363 -SLCIVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (518)
Q Consensus 363 -~~~lV~Ey~~ggsL~~~l~~~~---~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~ 438 (518)
.+++|+||+ ..+|..++.... ..++...++.++.||+.||+|||+++|+||||||.||||++.|.+||+|||+|+
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 789999999 679999998765 357778999999999999999999999999999999999999999999999999
Q ss_pred ecccC-CccccCCCCCcccCchhccCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCch
Q 010078 439 VKAQS-GVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHS 508 (518)
Q Consensus 439 ~~~~~-~~~~~~~gt~~y~APEvl~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp 508 (518)
...-+ ...+.+++|.+|.|||++.+. .|+...||||+|||++||++++..|.+.+..+.+..|.+....|
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTP 240 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCC
Confidence 66633 347788999999999999876 79999999999999999999999999999999999888765554
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=324.48 Aligned_cols=211 Identities=24% Similarity=0.393 Sum_probs=184.0
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
++|++.+.||+|+||.||++.. .++.||||+++.... .......+.+|+.++..++|+||+++++.+.....+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3688899999999999999987 467899999875322 2334567888999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC----
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---- 444 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~---- 444 (518)
||++||+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~ 159 (360)
T cd05627 81 EFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 159 (360)
T ss_pred eCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence 99999999999976 5678999999999999999999999999999999999999999999999999986432110
Q ss_pred --------------------------------ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCC
Q 010078 445 --------------------------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL 492 (518)
Q Consensus 445 --------------------------------~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (518)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence 012346999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHhhh
Q 010078 493 TPLQAAVGVVQ 503 (518)
Q Consensus 493 ~~~q~~~~iv~ 503 (518)
++.+....++.
T Consensus 240 ~~~~~~~~i~~ 250 (360)
T cd05627 240 TPQETYRKVMN 250 (360)
T ss_pred CHHHHHHHHHc
Confidence 98887777654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=310.26 Aligned_cols=215 Identities=27% Similarity=0.411 Sum_probs=188.4
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC--CCCccee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPSLCIV 367 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~--~~~~~lV 367 (518)
++|+.+++|++|+||.||+|+++ +.-||+|.++.+......--.-++||.+|.+++|||||.+-.+... -+.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 57899999999999999999875 5669999999765444334456899999999999999999887643 3469999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-Ccc
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVM 446 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~-~~~ 446 (518)
||||+ -+|...+.....+|....+.-++.|+++|+.|||.+.|+||||||+|+|++..|.+||+|||+|+..... ..+
T Consensus 156 Me~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~ 234 (419)
T KOG0663|consen 156 MEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPY 234 (419)
T ss_pred HHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccC
Confidence 99995 5899999888889999999999999999999999999999999999999999999999999999976554 357
Q ss_pred ccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCc
Q 010078 447 TAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
+..+-|.+|.|||++.+ ..|+.+.||||+|||+.||+++++-|.+.+....+..|++-...
T Consensus 235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGt 296 (419)
T KOG0663|consen 235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGT 296 (419)
T ss_pred cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCC
Confidence 77888999999999876 56999999999999999999999999999998888888765443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=311.42 Aligned_cols=223 Identities=22% Similarity=0.391 Sum_probs=189.2
Q ss_pred ceeeCCCCeeee--eeeeecCceEEEEEEECCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCcceEEeecccC--
Q 010078 286 VWEIDPKHLKFG--SKVASGSYGDLYRGTYCSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-- 360 (518)
Q Consensus 286 ~~ei~~~~~~i~--~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~-- 360 (518)
.+.++.+++... ..||+|++|.||+|+++++.||||+++..... ....+.|.+|+.+|++++||||+++++++.+
T Consensus 12 ~~~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~ 91 (283)
T PHA02988 12 IKCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV 91 (283)
T ss_pred ceecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc
Confidence 334555555555 57899999999999999999999999865333 2335678899999999999999999998865
Q ss_pred --CCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEcCCCcEEEEeeCcc
Q 010078 361 --PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVA 437 (518)
Q Consensus 361 --~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~-gIiHrDLKp~NILid~~~~vkL~DFGla 437 (518)
...+++||||++||+|.+++.+ ...+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||++
T Consensus 92 ~~~~~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~ 170 (283)
T PHA02988 92 DDLPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLE 170 (283)
T ss_pred cCCCceEEEEEeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchH
Confidence 3568999999999999999987 46788999999999999999999984 9999999999999999999999999998
Q ss_pred eecccCCccccCCCCCcccCchhccC--CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCchhHH
Q 010078 438 RVKAQSGVMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSFLE 511 (518)
Q Consensus 438 ~~~~~~~~~~~~~gt~~y~APEvl~~--~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp~ip 511 (518)
+..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||...++.+....++.+..++.+|
T Consensus 171 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 244 (283)
T PHA02988 171 KILSSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP 244 (283)
T ss_pred hhhccc--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC
Confidence 754432 234568899999999976 689999999999999999999999999999888888877666654443
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=325.44 Aligned_cols=216 Identities=23% Similarity=0.362 Sum_probs=186.0
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCc
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~ 364 (518)
.+..++|++.++||+|+||.||+++.. ++.||+|+++.... .......+.+|+.+++.++||||+++++++..+..+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 445578999999999999999999874 56799999864322 223345678899999999999999999999999999
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 999999999999999965 458899999999999999999999999999999999999999999999999998654332
Q ss_pred c--cccCCCCCcccCchhccCCC----CChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 445 V--MTAETGTYRWMAPEVIEHKP----YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 445 ~--~~~~~gt~~y~APEvl~~~~----~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
. .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+.......++...
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~ 263 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK 263 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 2 23457999999999997643 7889999999999999999999999988888777776544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=321.89 Aligned_cols=217 Identities=23% Similarity=0.349 Sum_probs=186.8
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCC
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~ 363 (518)
+.+..++|++.+.||+|+||.||++... ++.||+|++..... .......+.+|+.+++.++||||+++++++.....
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 3556688999999999999999999874 57799999864322 22334567889999999999999999999999999
Q ss_pred cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC
Q 010078 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~ 443 (518)
+|+||||++|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 9999999999999999865 45888999999999999999999999999999999999999999999999999865443
Q ss_pred Cc--cccCCCCCcccCchhccCCC----CChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 444 GV--MTAETGTYRWMAPEVIEHKP----YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 444 ~~--~~~~~gt~~y~APEvl~~~~----~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
.. .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+++..
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 263 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 263 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 32 23457999999999997543 7899999999999999999999999988887777776543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=317.19 Aligned_cols=213 Identities=20% Similarity=0.356 Sum_probs=183.8
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
++|++.+.||+|+||.||+++.. ++.||+|+++... ........+.+|+.+++.++|+||+++++++.....+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46889999999999999999874 6789999987422 12233456888999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc--c
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV--M 446 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~--~ 446 (518)
||++|++|.+++.+....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 99999999999987667799999999999999999999999999999999999999999999999999875543322 2
Q ss_pred ccCCCCCcccCchhccC-----CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 447 TAETGTYRWMAPEVIEH-----KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~-----~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....++..
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~ 223 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 223 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC
Confidence 23468999999999863 45788999999999999999999999998887777776543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=316.91 Aligned_cols=205 Identities=28% Similarity=0.475 Sum_probs=177.8
Q ss_pred eeeeecCceEEEEEEE-----CCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 298 SKVASGSYGDLYRGTY-----CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~-----~~~~vAVKvlk~~~~--~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
++||+|+||.||+++. .++.||+|+++.... .......+.+|+.+|+.++||||+++++++.....+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999875 457799999875422 122345678899999999999999999999999999999999
Q ss_pred cCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-ccccC
Q 010078 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAE 449 (518)
Q Consensus 371 ~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~~ 449 (518)
++|++|.+++.. .+.+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .....
T Consensus 82 ~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (323)
T cd05584 82 LSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF 160 (323)
T ss_pred CCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence 999999999976 5678889999999999999999999999999999999999999999999999987543322 23345
Q ss_pred CCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 450 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 450 ~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+..
T Consensus 161 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~ 214 (323)
T cd05584 161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214 (323)
T ss_pred CCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 799999999999999999999999999999999999999999888777666554
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=315.43 Aligned_cols=203 Identities=24% Similarity=0.421 Sum_probs=178.0
Q ss_pred eeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecCCCch
Q 010078 300 VASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (518)
Q Consensus 300 LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL 376 (518)
||+|+||.||++++. ++.||+|+++.... .......+.+|+.++++++||||+++++++.....+|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999874 56799999875322 333456788999999999999999999999999999999999999999
Q ss_pred hHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-CccccCCCCCcc
Q 010078 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGTYRW 455 (518)
Q Consensus 377 ~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~-~~~~~~~gt~~y 455 (518)
.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++..... .......||+.|
T Consensus 81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y 159 (312)
T cd05585 81 FHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159 (312)
T ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCccc
Confidence 999976 567899999999999999999999999999999999999999999999999998754332 233445799999
Q ss_pred cCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 456 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 456 ~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
+|||++.+..++.++|||||||++|+|++|+.||...+..+....+++
T Consensus 160 ~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~ 207 (312)
T cd05585 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ 207 (312)
T ss_pred CCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc
Confidence 999999999999999999999999999999999998887776666554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=323.42 Aligned_cols=199 Identities=34% Similarity=0.638 Sum_probs=175.6
Q ss_pred CCeeeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC-Ccceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-SLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~~-~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~-~~~lV~E 369 (518)
+.|.-...||+|+||.||+|...+ ..||||.+....... ..+|.+|+.++.+++|||+|+|+|+|.+.. ..++|+|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYE 152 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYE 152 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEE
Confidence 455556799999999999999866 889999887654332 456999999999999999999999999988 4999999
Q ss_pred ecCCCchhHHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCcEEEcCCCcEEEEeeCcceeccc-CC
Q 010078 370 FMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNN---IIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SG 444 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~-~l~~~~i~~i~~qIa~aL~yLHs~g---IiHrDLKp~NILid~~~~vkL~DFGla~~~~~-~~ 444 (518)
||++|+|.++|+.... .++|.+..+|+.++|+||+|||... |||||||++|||+|++...||+|||+++.... ..
T Consensus 153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~ 232 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDT 232 (361)
T ss_pred ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcccc
Confidence 9999999999987666 8999999999999999999999854 99999999999999999999999999976654 33
Q ss_pred ccccC-CCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCC
Q 010078 445 VMTAE-TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL 492 (518)
Q Consensus 445 ~~~~~-~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (518)
..... .||.+|+|||++.....+.|+||||||++|.||+||+.|.+..
T Consensus 233 ~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 233 SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 32333 8999999999999999999999999999999999999888754
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=302.88 Aligned_cols=213 Identities=28% Similarity=0.538 Sum_probs=183.7
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCC
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~-----~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~ 363 (518)
++.++|++.+.||+|+||.||+|++. +..||+|+++... .......+.+|+.++++++||||+++++++.....
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 56788999999999999999999753 4579999988653 33445679999999999999999999999999999
Q ss_pred cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC
Q 010078 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~ 443 (518)
.|+||||+++++|.+++....+.+++..++.++.||+.||+|||++|++||||||+|||++.++.++++|||.+......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999999876667899999999999999999999999999999999999999999999999987654322
Q ss_pred Cccc--cCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhh
Q 010078 444 GVMT--AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 444 ~~~~--~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv 502 (518)
.... ...++..|+|||++.+..++.++|||||||++|||++ |+.||...+..+.+..+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~ 222 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE 222 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH
Confidence 2111 2234678999999999999999999999999999876 999999988877666543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=313.14 Aligned_cols=210 Identities=26% Similarity=0.444 Sum_probs=180.9
Q ss_pred CeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCC-cceEEeecccCCCCcceee
Q 010078 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHK-NVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~Hp-nIv~l~g~~~~~~~~~lV~ 368 (518)
+|++.+.||+|+||.||+|+.. ++.||||+++.... .......+..|+.++..++|+ +|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999875 46799999875432 233456788899999999864 6888999998888999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc-CCccc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMT 447 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~-~~~~~ 447 (518)
||++|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .....
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05587 81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR 159 (324)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCcee
Confidence 99999999999976 56789999999999999999999999999999999999999999999999999874322 22334
Q ss_pred cCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
...||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+..+....+.+
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~ 215 (324)
T cd05587 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME 215 (324)
T ss_pred eecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 55799999999999999999999999999999999999999998888776666544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=316.57 Aligned_cols=215 Identities=20% Similarity=0.359 Sum_probs=185.2
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
++|++.++||+|+||.||+++.. ++.+|+|++.... ........+.+|+.++..++|+||+++++++.....+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46889999999999999999875 4679999986422 12233455888999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc--c
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV--M 446 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~--~ 446 (518)
||+++|+|.+++.+....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 99999999999987667899999999999999999999999999999999999999999999999999875433222 2
Q ss_pred ccCCCCCcccCchhcc-----CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcC
Q 010078 447 TAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVH 506 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~-----~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~ 506 (518)
....||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+....++....
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~ 225 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 225 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc
Confidence 3357999999999986 35689999999999999999999999999998888887765443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=306.14 Aligned_cols=211 Identities=24% Similarity=0.430 Sum_probs=181.4
Q ss_pred CCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
.++|++.++||.|+||.||+|.. +++.||+|+++.... ......+.+|+.++++++||||+++++++......|+||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 45799999999999999999986 467899999875432 222356778999999999999999999999888899999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-ccc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT 447 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~ 447 (518)
||+++ +|.+++......++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~ 161 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYS 161 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcccc
Confidence 99965 9999987766668899999999999999999999999999999999999999999999999987543322 233
Q ss_pred cCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 448 AETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
...+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 218 (288)
T cd07871 162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFR 218 (288)
T ss_pred CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 4578999999999865 5689999999999999999999999999888777666554
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=315.95 Aligned_cols=204 Identities=25% Similarity=0.475 Sum_probs=177.5
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecCCC
Q 010078 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 374 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~gg 374 (518)
+.||+|+||.||++.. .++.||+|+++.... .......+.+|+.+++.++||||+++++++.....+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4689999999999986 467899999875432 2344567889999999999999999999999999999999999999
Q ss_pred chhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc-CCccccCCCCC
Q 010078 375 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGTY 453 (518)
Q Consensus 375 sL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~-~~~~~~~~gt~ 453 (518)
+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||+
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 159 (328)
T cd05593 81 ELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP 159 (328)
T ss_pred CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCc
Confidence 99999876 56789999999999999999999999999999999999999999999999999875332 22334457999
Q ss_pred cccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 010078 454 RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 454 ~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv 502 (518)
.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.
T Consensus 160 ~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~ 208 (328)
T cd05593 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208 (328)
T ss_pred CccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc
Confidence 9999999999999999999999999999999999998877766554443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=312.56 Aligned_cols=210 Identities=26% Similarity=0.442 Sum_probs=180.8
Q ss_pred CeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcC-CCcceEEeecccCCCCcceee
Q 010078 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~~~~lV~ 368 (518)
+|.+.+.||+|+||.||++... ++.||||+++.... .......+..|..++..+. |++|+++++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788999999999999999875 46799999876432 2233455777888888775 789999999999989999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-Cccc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMT 447 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~-~~~~ 447 (518)
||+++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~ 159 (323)
T cd05616 81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK 159 (323)
T ss_pred cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccc
Confidence 99999999999876 467899999999999999999999999999999999999999999999999999754322 2334
Q ss_pred cCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.+
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~ 215 (323)
T cd05616 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215 (323)
T ss_pred cCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 55789999999999999999999999999999999999999999888776666554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=305.06 Aligned_cols=211 Identities=24% Similarity=0.459 Sum_probs=179.2
Q ss_pred CCeeeeeeeeecCceEEEEEEEC---CceEEEEEecCCCCChHHHHHHHHHHHHHHhc---CCCcceEEeeccc-----C
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV---RHKNVVQFIGACT-----K 360 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~---~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L---~HpnIv~l~g~~~-----~ 360 (518)
.+|++.+.||+|+||.||+++.. ++.||+|+++...........+.+|+.+++.+ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 46799999876544333345566777777766 6999999999874 3
Q ss_pred CCCcceeeeecCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 361 PPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
...+++||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 456899999995 6899998754 34588999999999999999999999999999999999999999999999999987
Q ss_pred cccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 440 KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 440 ~~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
...........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..++.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~ 223 (290)
T cd07862 160 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 223 (290)
T ss_pred ccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 6555445566789999999999999999999999999999999999999999988887777664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=316.91 Aligned_cols=205 Identities=27% Similarity=0.451 Sum_probs=179.9
Q ss_pred eeeeecCceEEEEEEE-----CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecC
Q 010078 298 SKVASGSYGDLYRGTY-----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 372 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~-----~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ 372 (518)
+.||+|+||.||++.. .++.||+|+++...........+.+|+.+|++++||||+++++++..+..+|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999998864 46789999998644333334567889999999999999999999999999999999999
Q ss_pred CCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-CccccCCC
Q 010078 373 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETG 451 (518)
Q Consensus 373 ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~-~~~~~~~g 451 (518)
+++|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......|
T Consensus 82 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 160 (318)
T cd05582 82 GGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG 160 (318)
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence 9999999976 567899999999999999999999999999999999999999999999999998765443 23345578
Q ss_pred CCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 452 TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 452 t~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
|+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.+
T Consensus 161 ~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~ 212 (318)
T cd05582 161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK 212 (318)
T ss_pred ChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHc
Confidence 9999999999999999999999999999999999999999888777766544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=303.79 Aligned_cols=209 Identities=24% Similarity=0.393 Sum_probs=180.8
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|++.+.||+|+||.||+++.. ++.||+|+++...........+.+|+.+++.++||||+++++++.....+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36889999999999999999875 5679999998655444556678899999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC--ccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMT 447 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~--~~~ 447 (518)
|++++.+..+. .....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT 159 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence 99887665544 335678999999999999999999999999999999999999999999999999997654322 223
Q ss_pred cCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 010078 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV 501 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~i 501 (518)
...||+.|+|||++.+..++.++|+|||||++|||++|+.||...+..+....+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~ 213 (287)
T cd07848 160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTI 213 (287)
T ss_pred ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 456899999999999999999999999999999999999999988776655443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=320.81 Aligned_cols=216 Identities=23% Similarity=0.358 Sum_probs=185.3
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCC
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~ 363 (518)
+.+..++|++.++||+|+||.||+++.. ++.||+|+++.... .......+.+|+.+++.++||||+++++++.....
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3556678999999999999999999874 67899999875322 22234557889999999999999999999999999
Q ss_pred cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC
Q 010078 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~ 443 (518)
+|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999999999865 45888999999999999999999999999999999999999999999999999765433
Q ss_pred Cc--cccCCCCCcccCchhccCC----CCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 444 GV--MTAETGTYRWMAPEVIEHK----PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 444 ~~--~~~~~gt~~y~APEvl~~~----~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
.. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+.......++..
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~ 262 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH 262 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC
Confidence 22 2345799999999998653 4789999999999999999999999998887777776653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=306.40 Aligned_cols=203 Identities=25% Similarity=0.448 Sum_probs=175.2
Q ss_pred CCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
.++|++.++||+|+||.||+|+. +++.||||+++..... .....+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 36799999999999999999987 4678999998754322 22345778999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-Cccc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMT 447 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~-~~~~ 447 (518)
||+ +++|.+++.+..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 161 (303)
T cd07869 83 EYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS 161 (303)
T ss_pred ECC-CcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCC
Confidence 999 56888888776677899999999999999999999999999999999999999999999999998754332 2334
Q ss_pred cCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHH
Q 010078 448 AETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPL 495 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~ 495 (518)
...+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 210 (303)
T cd07869 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI 210 (303)
T ss_pred CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH
Confidence 5578999999999865 46899999999999999999999999886553
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=337.87 Aligned_cols=220 Identities=31% Similarity=0.598 Sum_probs=193.0
Q ss_pred CCCceeeCCCCeeeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEe
Q 010078 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 355 (518)
Q Consensus 283 ~~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 355 (518)
.....++...++++.++||+|+||+||+|+..+ +.||||.+|... ..+.+++|.+|+++|..++|||||+|+
T Consensus 477 ~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLl 555 (774)
T KOG1026|consen 477 DLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLL 555 (774)
T ss_pred ccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEE
Confidence 456778999999999999999999999998643 459999999653 455789999999999999999999999
Q ss_pred ecccCCCCcceeeeecCCCchhHHHhhhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 010078 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLK-------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 422 (518)
Q Consensus 356 g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~-------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NIL 422 (518)
|+|...+.+|||+|||..|+|.+||.... .+++..+.+.|+.||+.||+||-++.+|||||.++|+|
T Consensus 556 GVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCL 635 (774)
T KOG1026|consen 556 GVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCL 635 (774)
T ss_pred EEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhce
Confidence 99999999999999999999999996532 23778899999999999999999999999999999999
Q ss_pred EcCCCcEEEEeeCcceecccCCcccc---CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 010078 423 MDENEVVKVADFGVARVKAQSGVMTA---ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAA 498 (518)
Q Consensus 423 id~~~~vkL~DFGla~~~~~~~~~~~---~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~ 498 (518)
|+++-.|||+|||+++..-....+.. ..-..+|||||.|...+|+.+||||||||+|||+++ |+.||.+++..|++
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI 715 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI 715 (774)
T ss_pred eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence 99999999999999985433322221 223469999999999999999999999999999999 99999999999988
Q ss_pred HHhhh
Q 010078 499 VGVVQ 503 (518)
Q Consensus 499 ~~iv~ 503 (518)
.-|-+
T Consensus 716 e~i~~ 720 (774)
T KOG1026|consen 716 ECIRA 720 (774)
T ss_pred HHHHc
Confidence 87544
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=313.55 Aligned_cols=206 Identities=28% Similarity=0.477 Sum_probs=175.7
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHH-HHHhcCCCcceEEeecccCCCCcceeeeecCC
Q 010078 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVF-IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~-~~~~~~~~~~Ei~-iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (518)
+.||+|+||.||+++. .++.||||++..... .......+..|.. +++.++||||+++++.+.....+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4689999999999987 467899999875422 1222344555554 56889999999999999999999999999999
Q ss_pred CchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc-CCccccCCCC
Q 010078 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT 452 (518)
Q Consensus 374 gsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~-~~~~~~~~gt 452 (518)
++|..++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (323)
T cd05575 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT 159 (323)
T ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence 999999976 56789999999999999999999999999999999999999999999999999875332 2233455799
Q ss_pred CcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 453 ~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....++.+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 211 (323)
T cd05575 160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK 211 (323)
T ss_pred hhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC
Confidence 9999999999999999999999999999999999999998887777766544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=308.84 Aligned_cols=209 Identities=27% Similarity=0.438 Sum_probs=179.4
Q ss_pred CeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC-----Ccc
Q 010078 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-----SLC 365 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~-----~~~ 365 (518)
.|.-.+.+|+|+||.||+|... ++.||||.+-.+.. .-.+|+.+|+.++|||||++..+|.... .+.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 4667789999999999999864 57899998765422 1235999999999999999998874322 356
Q ss_pred eeeeecCCCchhHHHhhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCC-CcEEEEeeCcceecc
Q 010078 366 IVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVKA 441 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~---~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~-~~vkL~DFGla~~~~ 441 (518)
+|||||+ .+|+.+++.. +..++.-.++-+.+||++||.|||+.||+||||||.|+|+|.+ |.+||||||.|+...
T Consensus 99 lVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 99 LVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 8999994 6999998743 5678888999999999999999999999999999999999976 899999999999988
Q ss_pred cCCccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCch
Q 010078 442 QSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHS 508 (518)
Q Consensus 442 ~~~~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp 508 (518)
.+........|..|.|||++.+ ..|+.+.||||.|||+.||+-|++-|.+.+..+.+..|++-...|
T Consensus 178 ~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~P 245 (364)
T KOG0658|consen 178 KGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTP 245 (364)
T ss_pred cCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCC
Confidence 8877788889999999999876 579999999999999999999999999999999998887644433
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=311.83 Aligned_cols=205 Identities=26% Similarity=0.417 Sum_probs=177.7
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCcceEEeecccCCCCcceeeeecCC
Q 010078 298 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG 373 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (518)
+.||+|+||.||+++.. ++.||||+++.... .......+..|..++..+ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999874 57799999875432 223346677888888876 599999999999999999999999999
Q ss_pred CchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc-CCccccCCCC
Q 010078 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT 452 (518)
Q Consensus 374 gsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~-~~~~~~~~gt 452 (518)
++|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus 81 g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (320)
T cd05590 81 GDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT 159 (320)
T ss_pred chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccC
Confidence 999999876 46789999999999999999999999999999999999999999999999999875332 2233456799
Q ss_pred CcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 453 ~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~ 210 (320)
T cd05590 160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210 (320)
T ss_pred ccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc
Confidence 999999999999999999999999999999999999999888777766654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=315.92 Aligned_cols=212 Identities=24% Similarity=0.378 Sum_probs=185.5
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
++|.+.++||+|+||.||++.. .++.||||+++.... .......+.+|+.+++.++|+||+++++++.....+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 3688999999999999999986 467899999886433 2334567888999999999999999999999989999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc--c
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV--M 446 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~--~ 446 (518)
||++|++|.+++.+..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 99999999999988667899999999999999999999999999999999999999999999999999976544332 2
Q ss_pred ccCCCCCcccCchhcc------CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 447 TAETGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~------~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
....||+.|+|||++. ...++.++|||||||++|+|++|+.||...+..+....++.
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~ 223 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMN 223 (330)
T ss_pred ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHc
Confidence 3347899999999986 45688999999999999999999999998888777777654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=311.35 Aligned_cols=208 Identities=29% Similarity=0.483 Sum_probs=177.7
Q ss_pred eeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHH---HhcCCCcceEEeecccCCCCccee
Q 010078 294 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIM---RKVRHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL---~~L~HpnIv~l~g~~~~~~~~~lV 367 (518)
|++.+.||+|+||.||++.+. ++.||||+++.... .....+.+.+|+.++ +.++||||+++++++.....+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 577899999999999999874 67899999875422 223345566676655 566799999999999999999999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-Ccc
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVM 446 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~-~~~ 446 (518)
|||++|++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT 158 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence 999999999988854 57899999999999999999999999999999999999999999999999998753322 233
Q ss_pred ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
....|++.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+....+..
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~ 215 (324)
T cd05589 159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN 215 (324)
T ss_pred cccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 456789999999999999999999999999999999999999999888776666544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.77 Aligned_cols=206 Identities=25% Similarity=0.407 Sum_probs=178.0
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCcceEEeecccCCCCcceeeeecCC
Q 010078 298 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG 373 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (518)
+.||+|+||.||+|+.. ++.||||+++.... .......+..|..+++.+ +||||+++++++.....+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46899999999999875 56799999875432 233345677899998876 699999999999999999999999999
Q ss_pred CchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-CccccCCCC
Q 010078 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGT 452 (518)
Q Consensus 374 gsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~-~~~~~~~gt 452 (518)
++|..++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......||
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (321)
T cd05591 81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT 159 (321)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccC
Confidence 999999876 567899999999999999999999999999999999999999999999999998754322 233455789
Q ss_pred CcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 453 ~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+...
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~ 211 (321)
T cd05591 160 PDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD 211 (321)
T ss_pred ccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 9999999999999999999999999999999999999998887777666543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.39 Aligned_cols=206 Identities=27% Similarity=0.489 Sum_probs=174.5
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEecCCCCC-hHHHHHHHHHH-HHHHhcCCCcceEEeecccCCCCcceeeeecCC
Q 010078 298 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEV-FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~-~~~~~~~~~Ei-~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (518)
+.||+|+||.||++.+. ++.||+|++...... ......+..|. .+++.++|+||+++++++...+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999874 467999998753221 12223444444 457889999999999999999999999999999
Q ss_pred CchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc-CCccccCCCC
Q 010078 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT 452 (518)
Q Consensus 374 gsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~-~~~~~~~~gt 452 (518)
++|.+++.. .+.+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus 81 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt 159 (325)
T cd05602 81 GELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT 159 (325)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCC
Confidence 999999976 56788899999999999999999999999999999999999999999999999875322 2234455799
Q ss_pred CcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 453 ~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+..+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 211 (325)
T cd05602 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 211 (325)
T ss_pred ccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC
Confidence 9999999999999999999999999999999999999998887777776554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=306.47 Aligned_cols=221 Identities=25% Similarity=0.402 Sum_probs=193.1
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC--
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-- 360 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~-- 360 (518)
..|++. ..|...+.||.|+||.|..+.+ +++.||||.+.....+....++..+|+.+|+.++|+||+.+.+++..
T Consensus 16 ~~~~i~-~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~ 94 (359)
T KOG0660|consen 16 ELFEIP-RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPS 94 (359)
T ss_pred eEEecc-ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccc
Confidence 345555 4455578999999999999976 56889999988666666777899999999999999999999998866
Q ss_pred ---CCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcc
Q 010078 361 ---PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437 (518)
Q Consensus 361 ---~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla 437 (518)
-..+|+|+|+| +.+|...++. +..++...+..++.||++|+.|+|+.||+||||||+|+|++.+..+||+|||+|
T Consensus 95 ~~~f~DvYiV~elM-etDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 95 RDKFNDVYLVFELM-ETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred ccccceeEEehhHH-hhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccce
Confidence 23589999999 7799999976 455999999999999999999999999999999999999999999999999999
Q ss_pred eeccc---CCccccCCCCCcccCchhc-cCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCch
Q 010078 438 RVKAQ---SGVMTAETGTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHS 508 (518)
Q Consensus 438 ~~~~~---~~~~~~~~gt~~y~APEvl-~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp 508 (518)
+.... .+.++..+.|.+|.|||++ ....|+.+.||||+||||.||++|++-|.+.+....+..|++-...|
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP 247 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP 247 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC
Confidence 98763 5677888999999999987 45789999999999999999999999999999988888877654444
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=307.68 Aligned_cols=204 Identities=24% Similarity=0.380 Sum_probs=172.7
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC-----CCcc
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-----PSLC 365 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~-----~~~~ 365 (518)
+|++.++||+|+||.||+|.. .++.||||+++...........+.+|+.++++++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 478899999999999999986 467899999875433333446788999999999999999999987543 2479
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG- 444 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~- 444 (518)
+||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~-~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 81 VVFELM-ESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEecC-CCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 999999 5689998876 4568999999999999999999999999999999999999999999999999997543221
Q ss_pred ---ccccCCCCCcccCchhccC--CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 010078 445 ---VMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA 498 (518)
Q Consensus 445 ---~~~~~~gt~~y~APEvl~~--~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~ 498 (518)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.....
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~ 217 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 217 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Confidence 1234578999999999876 67899999999999999999999999887664443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=342.74 Aligned_cols=220 Identities=35% Similarity=0.646 Sum_probs=192.6
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~ 360 (518)
++.++.+++.+.||+|.||.||+|++.+ ..||||.++... +.+...+|++|..+|++++|||||+++|+|..
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 3668899999999999999999999854 238888887643 45567899999999999999999999999999
Q ss_pred CCCcceeeeecCCCchhHHHhhh------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEee
Q 010078 361 PPSLCIVTEFMSGGSVYDYLHKL------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 434 (518)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~l~~~------~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DF 434 (518)
....+|++|||+||+|..||++. ...++...++.++.|||+||.||+++++|||||..+|+|+++...+||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999986 556889999999999999999999999999999999999999999999999
Q ss_pred CcceecccCCccc--cC-CCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCchh
Q 010078 435 GVARVKAQSGVMT--AE-TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHSF 509 (518)
Q Consensus 435 Gla~~~~~~~~~~--~~-~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~rp~ 509 (518)
|+|+..-....+. .+ .-..+|||||.+....|+.|+|||||||+|||++| |..||...+..+...-+++.+ |-.
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~ 924 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLD 924 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccC
Confidence 9999433322111 11 23468999999999999999999999999999999 999999999999999888776 533
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=317.66 Aligned_cols=224 Identities=29% Similarity=0.562 Sum_probs=187.9
Q ss_pred CCceeeCCCCeeeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEe
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI 355 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~-------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~ 355 (518)
...|++..++|+++++||+|+||.||++++. +..||||+++.... ......+.+|+.+|+.+ +||||++++
T Consensus 27 ~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~ 105 (375)
T cd05104 27 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLL 105 (375)
T ss_pred ccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeee
Confidence 3468888899999999999999999999742 34699999975432 33456788999999999 799999999
Q ss_pred ecccCCCCcceeeeecCCCchhHHHhhhc---------------------------------------------------
Q 010078 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLK--------------------------------------------------- 384 (518)
Q Consensus 356 g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~--------------------------------------------------- 384 (518)
++|......++||||++||+|.+++....
T Consensus 106 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 185 (375)
T cd05104 106 GACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADK 185 (375)
T ss_pred eeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccc
Confidence 99999999999999999999999986532
Q ss_pred -----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 385 -----------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 385 -----------------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred ccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 136778889999999999999999999999999999999999999999999997654
Q ss_pred cCCccc---cCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCch
Q 010078 442 QSGVMT---AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHS 508 (518)
Q Consensus 442 ~~~~~~---~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~rp 508 (518)
...... ...++..|+|||++.+..++.++|||||||++|||++ |..||............+..+.++
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 336 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM 336 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC
Confidence 332211 2234567999999999999999999999999999998 999998877666666666655443
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=309.20 Aligned_cols=204 Identities=25% Similarity=0.449 Sum_probs=173.9
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCcceEEeecccCCCCcceeeeecCC
Q 010078 298 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG 373 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (518)
+.||+|+||.||+|+.. ++.||||+++.... .......+..|..++..+ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 46799999986432 222334556677777654 799999999999998999999999999
Q ss_pred CchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc-CCccccCCCC
Q 010078 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT 452 (518)
Q Consensus 374 gsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~-~~~~~~~~gt 452 (518)
++|..++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus 81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt 159 (316)
T cd05592 81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT 159 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCC
Confidence 999999876 56789999999999999999999999999999999999999999999999999975433 2233455799
Q ss_pred CcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 010078 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 453 ~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv 502 (518)
+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~ 209 (316)
T cd05592 160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL 209 (316)
T ss_pred ccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999999999999999999999999999999888776665543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=318.87 Aligned_cols=223 Identities=32% Similarity=0.599 Sum_probs=186.7
Q ss_pred CCceeeCCCCeeeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEe
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI 355 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~ 355 (518)
.+.|.+..++|++++.||+|+||.||++++.+ ..||+|+++.... ......+.+|+.+++.+ +|+||++++
T Consensus 30 ~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 30 NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred cccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEe
Confidence 45788999999999999999999999987522 4699999986532 33456788999999999 899999999
Q ss_pred ecccCCCCcceeeeecCCCchhHHHhhhc---------------------------------------------------
Q 010078 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLK--------------------------------------------------- 384 (518)
Q Consensus 356 g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~--------------------------------------------------- 384 (518)
++|......|+||||+++|+|.+++.+..
T Consensus 109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 99999999999999999999999986421
Q ss_pred ------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcc
Q 010078 385 ------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 446 (518)
Q Consensus 385 ------------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~ 446 (518)
..+++..+++++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 23677889999999999999999999999999999999999999999999998755433211
Q ss_pred ---ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCc
Q 010078 447 ---TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 447 ---~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
....++..|||||++.+..++.++|||||||++|+|++ |+.||......+....++..+.+
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~ 333 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ 333 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccC
Confidence 12234567999999999999999999999999999997 99999887665555555554443
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=302.93 Aligned_cols=210 Identities=33% Similarity=0.616 Sum_probs=177.5
Q ss_pred CCCCeeeeeeeeecCceEEEEEEEC------------------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcc
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTYC------------------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 351 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~~------------------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnI 351 (518)
...+|++.++||+|+||.||++.+. +..||+|+++... .......|.+|+.+|++++||||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCe
Confidence 4567899999999999999999753 2359999988643 34456789999999999999999
Q ss_pred eEEeecccCCCCcceeeeecCCCchhHHHhhhc------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 010078 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413 (518)
Q Consensus 352 v~l~g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~------------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiH 413 (518)
+++++++......|+||||+++++|.+++.... ..+++..+++++.||+.||.|||++||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999999999899999999999999999986421 23677889999999999999999999999
Q ss_pred ccCCCCcEEEcCCCcEEEEeeCcceecccCCc---cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc--CCCC
Q 010078 414 RDLKAANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT--GKLP 488 (518)
Q Consensus 414 rDLKp~NILid~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt--G~~P 488 (518)
|||||+|||++.++.+||+|||+++....... .....++..|+|||++.+..++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999975433221 122345778999999998899999999999999999986 6789
Q ss_pred CCCCCHHHHHHH
Q 010078 489 YEYLTPLQAAVG 500 (518)
Q Consensus 489 f~~~~~~q~~~~ 500 (518)
|...+..+....
T Consensus 242 ~~~~~~~~~~~~ 253 (304)
T cd05096 242 YGELTDEQVIEN 253 (304)
T ss_pred CCcCCHHHHHHH
Confidence 988877665544
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=311.61 Aligned_cols=206 Identities=29% Similarity=0.485 Sum_probs=175.9
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHH-HHHhcCCCcceEEeecccCCCCcceeeeecCC
Q 010078 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVF-IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~-~~~~~~~~~~Ei~-iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (518)
+.||+|+||.||+++. .++.||+|++..... .......+..|.. +++.++||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4689999999999986 467899999875422 2233345556654 57789999999999999999999999999999
Q ss_pred CchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc-CCccccCCCC
Q 010078 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT 452 (518)
Q Consensus 374 gsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~-~~~~~~~~gt 452 (518)
++|..++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (325)
T cd05604 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT 159 (325)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence 999999876 56789999999999999999999999999999999999999999999999999875322 2233455799
Q ss_pred CcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 453 ~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....++..
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~ 211 (325)
T cd05604 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK 211 (325)
T ss_pred hhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC
Confidence 9999999999999999999999999999999999999998887776666543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=311.76 Aligned_cols=203 Identities=26% Similarity=0.468 Sum_probs=175.9
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecCCC
Q 010078 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 374 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~gg 374 (518)
+.||+|+||.||+++. .++.||+|+++.... .......+..|+.+++.++||||+++++++.....+|+||||++|+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4689999999999986 567899999886432 2334567788999999999999999999999999999999999999
Q ss_pred chhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEcCCCcEEEEeeCcceeccc-CCccccCCCC
Q 010078 375 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT 452 (518)
Q Consensus 375 sL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs-~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~-~~~~~~~~gt 452 (518)
+|..++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (325)
T cd05594 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT 159 (325)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCC
Confidence 99998876 5678999999999999999999997 7999999999999999999999999999875332 2233445799
Q ss_pred CcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 010078 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV 501 (518)
Q Consensus 453 ~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~i 501 (518)
+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i 208 (325)
T cd05594 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 208 (325)
T ss_pred cccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH
Confidence 9999999999999999999999999999999999999887765554444
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=305.06 Aligned_cols=222 Identities=23% Similarity=0.341 Sum_probs=194.7
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEECC--ceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~--~~vAVKvlk~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
.-.+..+.|++++.||+|.-|+||++...+ ..+|+|++.+.... .+...+...|-+||+.++||.++.+|..++.+.
T Consensus 71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~ 150 (459)
T KOG0610|consen 71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK 150 (459)
T ss_pred CCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence 346777889999999999999999999876 67999999876553 445567788999999999999999999999999
Q ss_pred CcceeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
..|++||||+||+|...++++. ..|++..++.++..++.||+|||-.|||+|||||+||||.++|+|.|+||.++....
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 9999999999999999998764 459999999999999999999999999999999999999999999999999763110
Q ss_pred c---------------------------------C-C-----------------------ccccCCCCCcccCchhccCC
Q 010078 442 Q---------------------------------S-G-----------------------VMTAETGTYRWMAPEVIEHK 464 (518)
Q Consensus 442 ~---------------------------------~-~-----------------------~~~~~~gt~~y~APEvl~~~ 464 (518)
. . . .....+||-.|+|||+|.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 0 0 00123689999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCc
Q 010078 465 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 465 ~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
..+.+.|+|+|||++||||.|..||.+.+..+++..||.+...
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~ 353 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLK 353 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCc
Confidence 9999999999999999999999999999999999999876654
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=321.37 Aligned_cols=206 Identities=28% Similarity=0.432 Sum_probs=184.1
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-C-----CcceEEeecccCCCCc
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-H-----KNVVQFIGACTKPPSL 364 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-H-----pnIv~l~g~~~~~~~~ 364 (518)
+|.+.+.||+|+||.|.++.+ +++.||||+++.. ....++...|+.||..|+ | -|+|+++++|...+++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 789999999999999999986 4678999999964 445566778999999998 4 4899999999999999
Q ss_pred ceeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC--cEEEEeeCcceecc
Q 010078 365 CIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE--VVKVADFGVARVKA 441 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~--~vkL~DFGla~~~~ 441 (518)
|||+|.+ +.+|+++++.++ ..++...++.|+.||+.||.+||++||||+||||+|||+...+ .|||+|||.++...
T Consensus 264 ciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred eeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence 9999999 789999998753 4589999999999999999999999999999999999997543 79999999998766
Q ss_pred cCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 442 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 442 ~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
+.- ...+.+..|.|||+|.+.+|+.+.||||||||++||++|.+.|.+.+..+.+..|++-
T Consensus 343 q~v--ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~ 403 (586)
T KOG0667|consen 343 QRV--YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEV 403 (586)
T ss_pred Ccc--eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHH
Confidence 542 2667889999999999999999999999999999999999999999998888887764
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=319.91 Aligned_cols=223 Identities=25% Similarity=0.456 Sum_probs=200.7
Q ss_pred CCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCC-ccee
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIV 367 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~-~~lV 367 (518)
.+.|..++++|+|+||.++..+. .+..+++|.+..........+...+|+.++++++|||||.+.+.|..++. +|||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 35788899999999999886654 45679999999888877777889999999999999999999999999888 9999
Q ss_pred eeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-c
Q 010078 368 TEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-V 445 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~ 445 (518)
|+|++||+|.+.+.+.+ ..|++..+++++.||+.|+.|||++.|+|||||+.||+++.++.|+|.|||+++...... .
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~ 162 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL 162 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence 99999999999998776 569999999999999999999999999999999999999999999999999999887765 5
Q ss_pred cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCchhHHHHH
Q 010078 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSFLEQRL 514 (518)
Q Consensus 446 ~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp~ip~~~ 514 (518)
.....||+.||+||++.+.+|+.|+|||||||++|||++-+.+|.+.+...-+.+|++.... .+|..+
T Consensus 163 a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~-Plp~~y 230 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYS-PLPSMY 230 (426)
T ss_pred hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCC-CCCccc
Confidence 56778999999999999999999999999999999999999999999998888888775533 344333
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=306.73 Aligned_cols=210 Identities=26% Similarity=0.458 Sum_probs=180.3
Q ss_pred CeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcC-CCcceEEeecccCCCCcceee
Q 010078 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~~~~lV~ 368 (518)
+|++.+.||+|+||.||++... ++.||||+++.... .......+..|..+++.+. |++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677899999999999999874 67899999875422 2233456778999998887 577888999998888999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-ccc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT 447 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~ 447 (518)
||++|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~ 159 (323)
T cd05615 81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR 159 (323)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcccc
Confidence 99999999999876 5679999999999999999999999999999999999999999999999999987543322 233
Q ss_pred cCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.++.+....+++
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~ 215 (323)
T cd05615 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 215 (323)
T ss_pred CccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 45689999999999999999999999999999999999999999888777666654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=308.98 Aligned_cols=211 Identities=25% Similarity=0.378 Sum_probs=180.7
Q ss_pred CCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC------
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------ 362 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~------ 362 (518)
.++|++.+.||+|+||.||++.. .+..||+|+++...........+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 37899999999999999999976 4678999999765545555677889999999999999999999886543
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
.+|+||||+.+ +|.+.+. ..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 100 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 46999999954 6666664 3478889999999999999999999999999999999999999999999999976555
Q ss_pred CCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 443 ~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+++..
T Consensus 176 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 238 (359)
T cd07876 176 NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQL 238 (359)
T ss_pred CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 444556678999999999999999999999999999999999999999887766655555443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=308.29 Aligned_cols=205 Identities=27% Similarity=0.462 Sum_probs=174.0
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHH-HHHhcCCCcceEEeecccCCCCcceeeeecCC
Q 010078 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVF-IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~-~~~~~~~~~~Ei~-iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (518)
+.||+|+||.||+++. .++.||+|++..... .......+..|.. +++.++||||+++++++......|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999987 467899999875422 2222344555554 67889999999999999999999999999999
Q ss_pred CchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc-CCccccCCCC
Q 010078 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT 452 (518)
Q Consensus 374 gsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~-~~~~~~~~gt 452 (518)
++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (321)
T cd05603 81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT 159 (321)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCC
Confidence 999998876 56788999999999999999999999999999999999999999999999999875322 2233445789
Q ss_pred CcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 453 ~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....++.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 210 (321)
T cd05603 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH 210 (321)
T ss_pred cccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc
Confidence 999999999999999999999999999999999999998887766666554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=299.86 Aligned_cols=202 Identities=25% Similarity=0.442 Sum_probs=176.7
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
.|++.++||+|+||.||++.. +++.||+|++....... .....+.+|+.+++.++|+||+++++.+.....+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 377889999999999999986 46789999987543322 223557789999999999999999999998899999999
Q ss_pred ecCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcccc
Q 010078 370 FMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~ 448 (518)
|+++++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||++...........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG 160 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence 99999999888653 34689999999999999999999999999999999999999999999999999986554444445
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
..|+..|+|||++.+..++.++|+|||||++|+|++|+.||.+.+.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~ 206 (285)
T cd05605 161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206 (285)
T ss_pred ccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch
Confidence 5789999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=294.08 Aligned_cols=212 Identities=36% Similarity=0.670 Sum_probs=184.1
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCccee
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~~-~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV 367 (518)
++.++|++.+.||+|+||.||++++.. ..+|+|.++..... ...+.+|+.++++++||||+++++++......|+|
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred CCHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 355789999999999999999998855 47999987754332 35688999999999999999999999999999999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcc-
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM- 446 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~- 446 (518)
|||+++++|.+++....+.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||.++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999999999999865667899999999999999999999999999999999999999999999999998754332211
Q ss_pred -ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 447 -TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 447 -~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~ 216 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR 216 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC
Confidence 22234568999999998899999999999999999999 9999999888887777654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=318.19 Aligned_cols=216 Identities=34% Similarity=0.529 Sum_probs=188.5
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
..|...+.||+|+||.||+|.+ .++.||||++..+.. .+....+.+|+.+|.+++++||.++|+.+.....++++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 4566678999999999999987 467799999987653 4446789999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-cccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~ 448 (518)
||.||++.+.++. .+.+.+..+..++++++.|+.|||..+.+|||||+.|||+..+|.+||+|||++-...... ....
T Consensus 92 y~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t 170 (467)
T KOG0201|consen 92 YCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT 170 (467)
T ss_pred HhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence 9999999999976 4556888999999999999999999999999999999999999999999999987655433 3367
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCchhH
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSFL 510 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp~i 510 (518)
.+||+.|||||++....|+.|+||||||++.+||.+|.+||..+.|+.++..| -+-.+|.+
T Consensus 171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-pk~~PP~L 231 (467)
T KOG0201|consen 171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-PKSAPPRL 231 (467)
T ss_pred ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-cCCCCCcc
Confidence 79999999999999999999999999999999999999999999996655443 33444443
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=304.45 Aligned_cols=205 Identities=26% Similarity=0.419 Sum_probs=181.4
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcce
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~l 366 (518)
+..++|++.++||+|+||.||+++.. +..+|+|+++... .......+.+|+.+|++++||||+++++++...+.+++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 45678999999999999999999875 5679999987642 34456779999999999999999999999998899999
Q ss_pred eeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc
Q 010078 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 445 (518)
Q Consensus 367 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~-gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~ 445 (518)
||||++|++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.++|+|||+++..... .
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 158 (331)
T cd06649 81 CMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M 158 (331)
T ss_pred EeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-c
Confidence 9999999999999976 45689999999999999999999986 6999999999999999999999999998755432 2
Q ss_pred cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 010078 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 496 (518)
Q Consensus 446 ~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q 496 (518)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+
T Consensus 159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~ 209 (331)
T cd06649 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE 209 (331)
T ss_pred cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 344578999999999999999999999999999999999999998776644
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=330.73 Aligned_cols=219 Identities=33% Similarity=0.612 Sum_probs=197.2
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEEC--C---ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC--S---QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~---~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~ 361 (518)
.||+.+.++|.+.||.|.||+||+|..+ + ..||||.+|... .+..+.+|+.|+.||-+++||||++|.|+.++.
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 4799999999999999999999999864 3 459999999653 556678999999999999999999999999999
Q ss_pred CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
....||+|||++|+|..||+++++.|...++..+++.|+.||.||-+.|+|||||...|||++.+-.+|++|||++++..
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999775
Q ss_pred cCC-c-cccCCC--CCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCc
Q 010078 442 QSG-V-MTAETG--TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 442 ~~~-~-~~~~~g--t~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
+.. . .+..-| ..+|.|||.|...+|+.+||||||||+|||.|+ |..||=.++..+.+.+ +++++|
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIka-Ie~gyR 852 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA-IEQGYR 852 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHH-HHhccC
Confidence 433 1 222212 369999999999999999999999999999998 9999999999888888 566777
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=292.86 Aligned_cols=216 Identities=24% Similarity=0.465 Sum_probs=192.1
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEECC--ceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCC
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~--~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~ 361 (518)
..|.+ ++|++++.||+|.||.||.|..+. .-||+|++.+... .......+.+|++|...|+||||+++|++|.+.
T Consensus 17 ~~~~l--~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~ 94 (281)
T KOG0580|consen 17 KTWTL--DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS 94 (281)
T ss_pred cccch--hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence 34544 479999999999999999998754 5599999865432 334456788999999999999999999999999
Q ss_pred CCcceeeeecCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceec
Q 010078 362 PSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~ 440 (518)
...|+++||.++|+|+..|+.. ...+++.....++.|++.|+.|+|.+++|||||||+|+|++.+|.+||+|||-+-..
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 9999999999999999999843 456999999999999999999999999999999999999999999999999998766
Q ss_pred ccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 441 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 441 ~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
+ .+...+.+||..|.+||...+..++...|+|++|+++||++.|.+||...+..+.+.+|.+
T Consensus 175 p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k 236 (281)
T KOG0580|consen 175 P-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK 236 (281)
T ss_pred C-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH
Confidence 5 5566778999999999999999999999999999999999999999999988888888654
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=309.91 Aligned_cols=198 Identities=25% Similarity=0.416 Sum_probs=171.0
Q ss_pred CeeeeeeeeecCceEEEEEEE-----CCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcC-CCcceEEeecccCCCCc
Q 010078 293 HLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSL 364 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~-----~~~~vAVKvlk~~~~--~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~~~ 364 (518)
+|+++++||+|+||.||++.. .++.||+|+++.... .......+..|+.+++.++ |+||+++++++.....+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999875 457799999875322 1233456788999999995 89999999999999999
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
|+||||++|++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~ 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence 999999999999999976 5678999999999999999999999999999999999999999999999999987543322
Q ss_pred --ccccCCCCCcccCchhccCC-CCChhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 445 --VMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 445 --~~~~~~gt~~y~APEvl~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 22345799999999999765 478999999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=308.56 Aligned_cols=193 Identities=24% Similarity=0.444 Sum_probs=169.5
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEecCCCCC-hHHHHHHHHHHHHHHhc-CCCcceEEeecccCCCCcceeeeecCC
Q 010078 298 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG 373 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~-~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (518)
+.||+|+||.||+++.. ++.||+|+++..... ......+..|..+++.+ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999874 678999999865332 23345688899999998 699999999999999999999999999
Q ss_pred CchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc-cCCccccCCCC
Q 010078 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGT 452 (518)
Q Consensus 374 gsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~-~~~~~~~~~gt 452 (518)
++|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... .........||
T Consensus 81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (329)
T cd05588 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT 159 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCC
Confidence 999999876 5679999999999999999999999999999999999999999999999999987432 22233456799
Q ss_pred CcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 453 ~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
+.|+|||++.+..++.++|+|||||++|+|++|+.||..
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=319.74 Aligned_cols=224 Identities=37% Similarity=0.665 Sum_probs=200.4
Q ss_pred CCceeeCCCCeeeeeeeeecCceEEEEEEECC--ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~--~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~ 361 (518)
.|.|++++.++....+||-|.||+||.|.|+. -.||||.++.+.+ ...+|+.|..+|+.++|||+|+++|+|+.+
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM---eveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch---hHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 38999999999999999999999999999975 4599999986533 368899999999999999999999999999
Q ss_pred CCcceeeeecCCCchhHHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceec
Q 010078 362 PSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~~~~-~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~ 440 (518)
..+|||+|||..|+|.+||+.++. .++.-.++.++.||..||+||..+++|||||...|+|+.++..|||+|||+++++
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 999999999999999999988654 4667778889999999999999999999999999999999999999999999987
Q ss_pred ccCCccccCCC---CCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCchhHHH
Q 010078 441 AQSGVMTAETG---TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHSFLEQ 512 (518)
Q Consensus 441 ~~~~~~~~~~g---t~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~rp~ip~ 512 (518)
... .+++..| ...|+|||-+..+.|+.|+|||+||++|||+.| |-.||.+.+.-|.+.- +++++|.+-|+
T Consensus 416 tgD-TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~L-LEkgyRM~~Pe 489 (1157)
T KOG4278|consen 416 TGD-TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGL-LEKGYRMDGPE 489 (1157)
T ss_pred cCC-ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHH-HhccccccCCC
Confidence 654 3445544 358999999999999999999999999999999 9999999988877654 99999976543
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=307.87 Aligned_cols=212 Identities=26% Similarity=0.375 Sum_probs=184.0
Q ss_pred CCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC------C
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------P 362 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~------~ 362 (518)
.++|++.+.||+|+||.||++.. .++.||||+++...........+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 46899999999999999999986 467899999986554455567788999999999999999999987543 3
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
.+|+||||++ ++|.+++.. .++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 103 DVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred eEEEEEeCCC-CCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 4699999995 577777743 478889999999999999999999999999999999999999999999999987655
Q ss_pred CCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcC
Q 010078 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVH 506 (518)
Q Consensus 443 ~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~ 506 (518)
........+|..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+++...
T Consensus 179 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 242 (364)
T cd07875 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242 (364)
T ss_pred CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 5445566889999999999999999999999999999999999999999998888877766433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=298.13 Aligned_cols=214 Identities=36% Similarity=0.665 Sum_probs=181.4
Q ss_pred eeeeeeeecCceEEEEEEEC------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 295 KFGSKVASGSYGDLYRGTYC------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 295 ~i~~~LG~G~fG~Vy~g~~~------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
++.+.||.|+||.||+|++. +..|+||+++.. ........|.+|+.++++++||||++++|++.....+++||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccccccccccc
Confidence 56789999999999999988 567999999753 34445788999999999999999999999999888899999
Q ss_pred eecCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc--
Q 010078 369 EFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-- 445 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~-- 445 (518)
||+++|+|.+++... ...+++..+..++.||+.||.|||+++++|++|+++||+++.++.+||+|||++........
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999886 56799999999999999999999999999999999999999999999999999987632221
Q ss_pred -cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCchhH
Q 010078 446 -MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHSFL 510 (518)
Q Consensus 446 -~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~rp~i 510 (518)
.........|+|||.+....++.++||||||+++|||++ |+.||...+..+....+ .++.++.+
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~ 226 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPI 226 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccee
Confidence 123346778999999988889999999999999999999 78999999888877776 44555433
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=313.84 Aligned_cols=222 Identities=33% Similarity=0.593 Sum_probs=186.7
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEee
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIG 356 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g 356 (518)
+.|+++.++|.++++||+|+||.||+|++.+ ..||||+++... .....+.+.+|+.+|+++. ||||+++++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 5799999999999999999999999998632 359999997543 3344567999999999996 999999999
Q ss_pred cccCCCCcceeeeecCCCchhHHHhhhc----------------------------------------------------
Q 010078 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------------------------------------------- 384 (518)
Q Consensus 357 ~~~~~~~~~lV~Ey~~ggsL~~~l~~~~---------------------------------------------------- 384 (518)
+|.....+|+||||+++|+|.+++.+..
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 9999999999999999999999986531
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 010078 385 -------------------------------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 421 (518)
Q Consensus 385 -------------------------------------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NI 421 (518)
..+++..+..++.||+.||.|||+++|+||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 1366778889999999999999999999999999999
Q ss_pred EEcCCCcEEEEeeCcceecccCCc---cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHH
Q 010078 422 LMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 497 (518)
Q Consensus 422 Lid~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~ 497 (518)
|++.++.+||+|||+++....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......+.
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 999999999999999976543221 122346678999999999999999999999999999997 9999988766555
Q ss_pred HHHhhhhcCc
Q 010078 498 AVGVVQKVHH 507 (518)
Q Consensus 498 ~~~iv~~~~r 507 (518)
....+..+.+
T Consensus 349 ~~~~~~~~~~ 358 (400)
T cd05105 349 FYNKIKSGYR 358 (400)
T ss_pred HHHHHhcCCC
Confidence 5444444443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=319.12 Aligned_cols=212 Identities=22% Similarity=0.344 Sum_probs=183.1
Q ss_pred CCeeeeeeeeecCceEEEEEEEC---CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~---~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
..|.+.+.||+|+||.||++... ++.|++|.+... .......+.+|+.+|+.++||||+++++++...+.+|+||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 44899999999999999999763 456888876543 2334456788999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-
Q 010078 369 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG- 444 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~---~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~- 444 (518)
||++||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999999988642 3468899999999999999999999999999999999999999999999999998654432
Q ss_pred --ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 445 --VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 445 --~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....++...
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~ 287 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK 287 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 2334569999999999999999999999999999999999999999988877777665543
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.39 Aligned_cols=203 Identities=26% Similarity=0.435 Sum_probs=173.3
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHh-cCCCcceEEeecccCCCCcceeeeecCC
Q 010078 298 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRK-VRHKNVVQFIGACTKPPSLCIVTEFMSG 373 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~-L~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (518)
+.||+|+||.||+|++. ++.||||+++.... .......+..|..+++. ++||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 46799999886432 12233456677788876 4899999999999999999999999999
Q ss_pred CchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc-CCccccCCCC
Q 010078 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT 452 (518)
Q Consensus 374 gsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~-~~~~~~~~gt 452 (518)
++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (316)
T cd05619 81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT 159 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCC
Confidence 999999976 46789999999999999999999999999999999999999999999999999875322 2233445789
Q ss_pred CcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 010078 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV 501 (518)
Q Consensus 453 ~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~i 501 (518)
+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i 208 (316)
T cd05619 160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208 (316)
T ss_pred ccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999999999999999999999999999999999988876655553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=304.96 Aligned_cols=203 Identities=25% Similarity=0.421 Sum_probs=173.3
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCcceEEeecccCCCCcceeeeecCC
Q 010078 298 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG 373 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (518)
+.||+|+||.||++++. ++.||+|+++.... .......+..|..++..+ +||||+++++++...+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999874 57899999875422 122345567788887754 799999999999999999999999999
Q ss_pred CchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc-CCccccCCCC
Q 010078 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT 452 (518)
Q Consensus 374 gsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~-~~~~~~~~gt 452 (518)
++|..++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++.... ........||
T Consensus 81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (316)
T cd05620 81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT 159 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCC
Confidence 999999876 56789999999999999999999999999999999999999999999999999874322 2233456789
Q ss_pred CcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 010078 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV 501 (518)
Q Consensus 453 ~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~i 501 (518)
+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~ 208 (316)
T cd05620 160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI 208 (316)
T ss_pred cCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999999999999999999999999999999999988776555443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=304.64 Aligned_cols=205 Identities=26% Similarity=0.454 Sum_probs=176.6
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCcceEEeecccCCCCcceeeeecCC
Q 010078 298 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG 373 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (518)
+.||+|+||.||++... ++.||||+++.... .......+..|+.+++.+ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999874 56799999885432 223345677899999888 699999999999999999999999999
Q ss_pred CchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-CccccCCCC
Q 010078 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGT 452 (518)
Q Consensus 374 gsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~-~~~~~~~gt 452 (518)
++|..++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++..... .......||
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~ 159 (318)
T cd05570 81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT 159 (318)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecC
Confidence 999999876 467999999999999999999999999999999999999999999999999998753322 223345689
Q ss_pred CcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 453 ~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+....+.+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~ 210 (318)
T cd05570 160 PDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE 210 (318)
T ss_pred ccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc
Confidence 999999999999999999999999999999999999998887766665543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=318.39 Aligned_cols=226 Identities=28% Similarity=0.566 Sum_probs=201.1
Q ss_pred CCCceeeCCCCeeeeeeeeecCceEEEEEEECCc------eEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEee
Q 010078 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ------DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356 (518)
Q Consensus 283 ~~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~~------~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g 356 (518)
+...+++++..+.+.+.||.|.||.||.|.|..- .||||+.|.+... +..+.|++|..+|++++||||++++|
T Consensus 380 ~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~-d~tekflqEa~iMrnfdHphIikLIG 458 (974)
T KOG4257|consen 380 TVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP-DDTEKFLQEASIMRNFDHPHIIKLIG 458 (974)
T ss_pred CCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-hhHHHHHHHHHHHHhCCCcchhheee
Confidence 3457899999999999999999999999998542 3899998876543 34789999999999999999999999
Q ss_pred cccCCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCc
Q 010078 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436 (518)
Q Consensus 357 ~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGl 436 (518)
+|.+. ..|||||.++-|.|..|++.++..++...+..++.||+.||.|||++++|||||..+|||+.....|||+|||+
T Consensus 459 v~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 459 VCVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred eeecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccch
Confidence 99875 48999999999999999999888999999999999999999999999999999999999999999999999999
Q ss_pred ceecccCCccccCCCC--CcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCchhHH
Q 010078 437 ARVKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHSFLE 511 (518)
Q Consensus 437 a~~~~~~~~~~~~~gt--~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~rp~ip 511 (518)
++...+.....+..|. ..|||||.++-..|+.++|||.||+.|||++. |..||.+...-+.+.. +++|-|+.+|
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~-iEnGeRlP~P 614 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH-IENGERLPCP 614 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE-ecCCCCCCCC
Confidence 9988887766665553 57999999999999999999999999999998 9999999887666544 7778776544
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=319.48 Aligned_cols=216 Identities=25% Similarity=0.385 Sum_probs=186.2
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC----
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP---- 362 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~---- 362 (518)
....+|.+.+.||+|+||.||+++. .++.||||++............+.+|+.++..++|+||++++..+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3457899999999999999999976 5788999999876666666778899999999999999999988764332
Q ss_pred ----CcceeeeecCCCchhHHHhhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeC
Q 010078 363 ----SLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435 (518)
Q Consensus 363 ----~~~lV~Ey~~ggsL~~~l~~~---~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFG 435 (518)
.+++||||+++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 267999999999999998653 3468899999999999999999999999999999999999999999999999
Q ss_pred cceecccC---CccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 436 VARVKAQS---GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 436 la~~~~~~---~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
+++..... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....++..
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~ 260 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG 260 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence 99764432 1233457999999999999999999999999999999999999999998887766665543
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=287.93 Aligned_cols=212 Identities=25% Similarity=0.461 Sum_probs=187.4
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
+|.+.+.||+|+||.||+++. +++.|++|.+............+.+|+.++++++||||+++++++...+.+|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 477889999999999999987 467899999876555566678899999999999999999999999999999999999
Q ss_pred cCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-cccc
Q 010078 371 MSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (518)
Q Consensus 371 ~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~ 448 (518)
++|++|.+++... ...++...++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++...... ....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT 160 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence 9999999999875 4568899999999999999999999999999999999999999999999999987654432 2334
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
..+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+..+....+++.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 216 (256)
T cd08529 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG 216 (256)
T ss_pred cccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 56889999999999999999999999999999999999999988877766665553
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=295.79 Aligned_cols=213 Identities=31% Similarity=0.625 Sum_probs=182.1
Q ss_pred CCCCeeeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~~~-------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
+..+|++.+.||+|+||.||+|...+ ..|++|.++... .......|.+|+.++++++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 44578899999999999999998643 459999987543 3445677999999999999999999999999888
Q ss_pred CcceeeeecCCCchhHHHhhhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~ 427 (518)
..|++|||+++++|.+++.... ..++...++.++.||+.||.|||++|++|+||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 9999999999999999997532 4578889999999999999999999999999999999999999
Q ss_pred cEEEEeeCcceecccCC---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 428 VVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 428 ~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
.++|+|||+++...... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.++.+....+.+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS 241 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999987543322 2233456788999999998899999999999999999998 9999999888776655443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=314.47 Aligned_cols=209 Identities=25% Similarity=0.405 Sum_probs=174.0
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC-----
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP----- 361 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~----- 361 (518)
.....|+++++||+|+||.||+|.. .++.||||++.... ....+|+.+|+.++||||+++++++...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 3456899999999999999999987 46789999876432 2234699999999999999998875321
Q ss_pred ---CCcceeeeecCCCchhHHHhh---hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC-cEEEEee
Q 010078 362 ---PSLCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADF 434 (518)
Q Consensus 362 ---~~~~lV~Ey~~ggsL~~~l~~---~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~-~vkL~DF 434 (518)
..+++||||++ ++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 137 ~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 137 EKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred CCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 23678999996 477777653 245689999999999999999999999999999999999999665 7999999
Q ss_pred CcceecccCCccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 435 GVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 435 Gla~~~~~~~~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
|+++............||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..+++.
T Consensus 216 Gla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 286 (440)
T PTZ00036 216 GSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQV 286 (440)
T ss_pred ccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 99986655444455678999999999865 46999999999999999999999999998888777776653
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=304.71 Aligned_cols=210 Identities=26% Similarity=0.368 Sum_probs=181.5
Q ss_pred CCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC------C
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------P 362 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~------~ 362 (518)
.++|++.+.||+|+||.||++.. .++.||||+++...........+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 46899999999999999999976 467899999986655555567788999999999999999999987543 2
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
..|+||||+++ +|.+++.. .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 46999999954 67776643 478889999999999999999999999999999999999999999999999987655
Q ss_pred CCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 443 ~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
........||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+++.
T Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (355)
T cd07874 172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233 (355)
T ss_pred ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 54555668999999999999999999999999999999999999999988877666655543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=307.53 Aligned_cols=209 Identities=26% Similarity=0.409 Sum_probs=179.4
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC-----Ccc
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-----SLC 365 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~-----~~~ 365 (518)
+|++.++||+|+||.||++.. .++.||||++..........+.+.+|+.+++.++|+||+++++++.... .+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 467889999999999999986 5788999998754444445567889999999999999999999987766 689
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC--
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-- 443 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~-- 443 (518)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred EEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 9999995 678888765 567899999999999999999999999999999999999999999999999999765432
Q ss_pred CccccCCCCCcccCchhccCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 444 GVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 444 ~~~~~~~gt~~y~APEvl~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
.......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.++.+....+.+
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 219 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITD 219 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 233445688999999998774 589999999999999999999999999988777666544
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=289.44 Aligned_cols=213 Identities=36% Similarity=0.683 Sum_probs=184.6
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~~-~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
|.++.++|++.++||+|+||.||+|... ++.||+|.++.... ..+.+.+|+.+++.++|+||+++++.+......+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 7888999999999999999999999864 46799998875422 2467899999999999999999999999999999
Q ss_pred eeeeecCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 366 IVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
++|||+++++|.+++... ...++...++.++.|++.|+.|||+++++||||||+||+++.++.++|+|||+++......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 999999999999999764 3458888999999999999999999999999999999999999999999999998654432
Q ss_pred cc--ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhh
Q 010078 445 VM--TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 445 ~~--~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv 502 (518)
.. ....++..|+|||.+.+..++.++|+|||||++|+|++ |+.||...++.+....+.
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~ 218 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ 218 (261)
T ss_pred eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH
Confidence 11 22345678999999998899999999999999999998 999999887766555543
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=298.50 Aligned_cols=216 Identities=31% Similarity=0.609 Sum_probs=181.1
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEEC--Cc----eEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~--~~----~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
+...+|++.+.||+|+||.||+|++. +. .||+|+++.. ......+++.+|+.+++.++||||++++++|...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 45678999999999999999999863 33 3899998753 2344457799999999999999999999998764
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
..++++||+++|+|.+++.+....++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 57899999999999999987666788999999999999999999999999999999999999999999999999986543
Q ss_pred CCcc---ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCc
Q 010078 443 SGVM---TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 443 ~~~~---~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
.... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||.+....+. ..+++++.+
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~ 229 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGER 229 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCCC
Confidence 3221 12234568999999999999999999999999999998 9999998776553 344444443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=288.81 Aligned_cols=220 Identities=30% Similarity=0.502 Sum_probs=186.5
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCh---HHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcce
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS---DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~---~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~l 366 (518)
+.|++++.||+|+||.||++.. .++.|++|+++...... .....+.+|+.++++++||||+++++++.....+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4578889999999999999975 56889999987543322 234578889999999999999999999999999999
Q ss_pred eeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc-
Q 010078 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV- 445 (518)
Q Consensus 367 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~- 445 (518)
||||++|++|.+++.. .+.++...+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||+++.......
T Consensus 82 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 82 FMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred EEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 9999999999999976 45688999999999999999999999999999999999999999999999999875432211
Q ss_pred ---cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCchhHHH
Q 010078 446 ---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSFLEQ 512 (518)
Q Consensus 446 ---~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp~ip~ 512 (518)
.....++..|+|||++.+..++.++||||||+++|+|++|+.||...++......+.....++.+|.
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 230 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPS 230 (263)
T ss_pred cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCc
Confidence 1334678899999999999999999999999999999999999998877776666555544444443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=288.28 Aligned_cols=212 Identities=38% Similarity=0.693 Sum_probs=183.3
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEECCc-eEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCccee
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~~~-~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV 367 (518)
++.++|++.+.||+|+||.||++++.+. .+|+|.++..... ...+.+|+.++++++||||+++++++.....++++
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred CChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 3567899999999999999999988664 5999988754332 35689999999999999999999999988889999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcc-
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM- 446 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~- 446 (518)
|||+.+++|.+++......+++..++.++.||+.|+.|||++|++|+||||+||+++.++.+||+|||.++........
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999999999999875567899999999999999999999999999999999999999999999999998755433211
Q ss_pred -ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 447 -TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 447 -~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~ 216 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ 216 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhc
Confidence 12235578999999998889999999999999999999 9999998887766666544
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=287.84 Aligned_cols=214 Identities=39% Similarity=0.678 Sum_probs=185.0
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~~-~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
|+++.++|++.+.||+|+||.||+|.+. ++.||+|.++..... .+.+.+|+.++++++|+||+++++++......|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 6788899999999999999999999874 467999998764332 456889999999999999999999999999999
Q ss_pred eeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 366 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
++|||+++++|.+++.... ..+++..+..++.|++.|+.|||++|++||||||+||+++.++.++|+|||+++......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 9999999999999997643 458999999999999999999999999999999999999999999999999998665322
Q ss_pred cc--ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 445 VM--TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 445 ~~--~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
.. .....+..|+|||++.+..++.++|+||||+++|+|++ |+.||.+.++.+....+.+
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~ 219 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ 219 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 11 11122457999999999999999999999999999999 9999999888776666543
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=290.59 Aligned_cols=219 Identities=36% Similarity=0.653 Sum_probs=185.5
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCc
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~ 364 (518)
|+++..+|.+.++||.|+||.||+|.+. ++.|++|+++... .....+.+|+.+++.++|+||+++++++.....+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence 6788899999999999999999999874 6779999987532 2346788999999999999999999999999999
Q ss_pred ceeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC
Q 010078 365 CIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~ 443 (518)
+++|||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 99999999999999997543 45888999999999999999999999999999999999999999999999998765433
Q ss_pred Ccc--ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCchh
Q 010078 444 GVM--TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHSF 509 (518)
Q Consensus 444 ~~~--~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~rp~ 509 (518)
... ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+.... +.+..++.
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~ 225 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-LEKGYRME 225 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHCCCCCC
Confidence 211 11234568999999999999999999999999999998 9999998777555444 33344333
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=294.93 Aligned_cols=194 Identities=26% Similarity=0.430 Sum_probs=168.0
Q ss_pred eeecCceEEEEEEE--CCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecCCCch
Q 010078 300 VASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (518)
Q Consensus 300 LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL 376 (518)
||+|+||+||+++. +++.||+|++...... ......+..|+.+++.++|+||+++++++.....+|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999986 4678999998754322 22345678899999999999999999999998999999999999999
Q ss_pred hHHHhh---hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-ccccCCCC
Q 010078 377 YDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGT 452 (518)
Q Consensus 377 ~~~l~~---~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~~~gt 452 (518)
.+++.. ....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... ......||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 988743 23568999999999999999999999999999999999999999999999999987554332 23345789
Q ss_pred CcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCC
Q 010078 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 493 (518)
Q Consensus 453 ~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~ 493 (518)
+.|+|||++.+..++.++|+|||||++|+|++|+.||....
T Consensus 161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=302.36 Aligned_cols=193 Identities=22% Similarity=0.432 Sum_probs=169.0
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEecCCCCC-hHHHHHHHHHHHHHHhc-CCCcceEEeecccCCCCcceeeeecCC
Q 010078 298 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG 373 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~-~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (518)
+.||+|+||.||+++.. ++.||+|+++..... ......+.+|+.++.++ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999864 577999999865332 23456688899999888 599999999999999999999999999
Q ss_pred CchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc-CCccccCCCC
Q 010078 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT 452 (518)
Q Consensus 374 gsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~-~~~~~~~~gt 452 (518)
++|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (327)
T cd05617 81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT 159 (327)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCC
Confidence 999998876 46799999999999999999999999999999999999999999999999999875322 2233456799
Q ss_pred CcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 453 ~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred cccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 999999999999999999999999999999999999953
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=304.73 Aligned_cols=192 Identities=23% Similarity=0.448 Sum_probs=168.0
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCcceEEeecccCCCCcceeeeecCC
Q 010078 298 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG 373 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (518)
+.||+|+||.||++... ++.||+|+++.... .......+..|+.++.++ +||||+++++++.....+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999874 56799999886532 233445677899888877 799999999999999999999999999
Q ss_pred CchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc-CCccccCCCC
Q 010078 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT 452 (518)
Q Consensus 374 gsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~-~~~~~~~~gt 452 (518)
++|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (329)
T cd05618 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT 159 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCC
Confidence 999998876 56789999999999999999999999999999999999999999999999999875322 2233445789
Q ss_pred CcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCC
Q 010078 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490 (518)
Q Consensus 453 ~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~ 490 (518)
+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred ccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 99999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=295.37 Aligned_cols=211 Identities=23% Similarity=0.422 Sum_probs=179.6
Q ss_pred CCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
.++|.+.++||+|+||.||+|+. .++.||+|+++..... .....+.+|+.++++++||||+++++++...+..|+||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 46799999999999999999986 4567999998754322 22345778999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-ccc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT 447 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~ 447 (518)
||++ ++|.+++......++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 84 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 162 (309)
T cd07872 84 EYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS 162 (309)
T ss_pred eCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccccc
Confidence 9996 48888887766678999999999999999999999999999999999999999999999999987543322 223
Q ss_pred cCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 448 AETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
...+|+.|+|||++.+ ..++.++|||||||++|+|+||+.||.+.+..+....+..
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 219 (309)
T cd07872 163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFR 219 (309)
T ss_pred cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 4567899999998865 5689999999999999999999999998887666555443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=287.46 Aligned_cols=223 Identities=30% Similarity=0.520 Sum_probs=185.9
Q ss_pred CCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCcceEEeecccCC--CC
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI---NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PS 363 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~---~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~--~~ 363 (518)
+.+|++++.||+|+||.||+|.. ++..|+||++..... .......+.+|+.++++++|+||+++++++... ..
T Consensus 1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 35788999999999999999986 457899998864322 223456788999999999999999999988654 45
Q ss_pred cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC
Q 010078 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~ 443 (518)
++++|||++|++|.+++.. ...+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++.....
T Consensus 81 ~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKS-YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 7899999999999999876 356888999999999999999999999999999999999999999999999998754321
Q ss_pred ----CccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCchhHHHHH
Q 010078 444 ----GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSFLEQRL 514 (518)
Q Consensus 444 ----~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp~ip~~~ 514 (518)
.......++..|+|||++.+..++.++|+||||+++|+|++|+.||...........+......+.+|..+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHV 234 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhh
Confidence 12334568899999999998889999999999999999999999999887777766655555555555444
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=291.99 Aligned_cols=204 Identities=25% Similarity=0.411 Sum_probs=177.3
Q ss_pred eeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCh-HHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 294 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
|+..+.||+|+||+||++++. ++.||+|++....... .....+.+|+.+|+.++|+||+.+++++...+..|++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999874 6789999987643322 2345578899999999999999999999999999999999
Q ss_pred cCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccccC
Q 010078 371 MSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 449 (518)
Q Consensus 371 ~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~~ 449 (518)
+++++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++............
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR 161 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCC
Confidence 9999999888653 346899999999999999999999999999999999999999999999999998765443333455
Q ss_pred CCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 010078 450 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 497 (518)
Q Consensus 450 ~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~ 497 (518)
.|+..|+|||++.+..++.++|+|||||++|+|++|..||........
T Consensus 162 ~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~ 209 (285)
T cd05632 162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK 209 (285)
T ss_pred CCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 789999999999999999999999999999999999999988766443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=290.15 Aligned_cols=217 Identities=29% Similarity=0.552 Sum_probs=182.9
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeeccc
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~ 359 (518)
|.+..++|++.++||+|+||.||+|.+.+ ..||+|+++... ......++.+|+.+++.++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 67788899999999999999999997643 469999886432 2334567899999999999999999999999
Q ss_pred CCCCcceeeeecCCCchhHHHhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEE
Q 010078 360 KPPSLCIVTEFMSGGSVYDYLHKLK---------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK 430 (518)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~l~~~~---------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vk 430 (518)
.....++||||+++++|.+++.... ..++...+..++.|++.||.|||++|++|+||||+||+++.++.++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence 8899999999999999999997532 2356778899999999999999999999999999999999999999
Q ss_pred EEeeCcceecccCCc---cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhh
Q 010078 431 VADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 431 L~DFGla~~~~~~~~---~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~ 504 (518)
|+|||+++....... .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.++.+....+.+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 237 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG 237 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 999999875432211 112345678999999999999999999999999999999 79999998887666655543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=287.62 Aligned_cols=210 Identities=38% Similarity=0.689 Sum_probs=180.7
Q ss_pred CCCCeeeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~~~-~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
+..+|++.+.||+|+||.||++.+.+ ..+|+|+++..... ...+.+|+.+++.++|+||+++++++......|+||
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 45678899999999999999998754 47999998754332 246888999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcc--
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM-- 446 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~-- 446 (518)
||++|++|.+++......+++..++.++.||+.|+.|||++|++||||||+||+++.++.+||+|||+++........
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 999999999999875667899999999999999999999999999999999999999999999999998765432211
Q ss_pred ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhh
Q 010078 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv 502 (518)
....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...++.+....+.
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~ 215 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS 215 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Confidence 11223457999999999999999999999999999999 899999888777666643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=300.63 Aligned_cols=205 Identities=27% Similarity=0.453 Sum_probs=179.7
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
++..++|++.++||.|+||.||++.+. +..+|+|+++... .......+.+|+.++++++|+||++++++|.....+|
T Consensus 1 ~l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred CcchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 355688999999999999999999875 5679999887643 3344567899999999999999999999999999999
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~-gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
+||||+++++|.+++.. .+.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 80 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred EEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 99999999999999976 56688999999999999999999975 7999999999999999999999999998754332
Q ss_pred ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHH
Q 010078 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL 495 (518)
Q Consensus 445 ~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~ 495 (518)
......|+..|+|||++.+..++.++|+|||||++|+|++|+.||......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 208 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK 208 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 223457899999999999999999999999999999999999999876553
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=288.51 Aligned_cols=208 Identities=37% Similarity=0.691 Sum_probs=180.5
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecc-cCCCCcc
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC-TKPPSLC 365 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~-~~~~~~~ 365 (518)
|.++.++|++.+.||+|+||.||++...+..+++|.++... ..+.+.+|+.++++++|+|++++++++ ......+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence 66788899999999999999999999999999999987432 245788999999999999999999975 4456789
Q ss_pred eeeeecCCCchhHHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 366 IVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~-~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
++|||+++++|.+++.+... .+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||+++......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 99999999999999976433 47889999999999999999999999999999999999999999999999987543322
Q ss_pred ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 010078 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVG 500 (518)
Q Consensus 445 ~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~ 500 (518)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~ 211 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 211 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 23344568999999999999999999999999999998 9999998777665544
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=286.62 Aligned_cols=209 Identities=39% Similarity=0.726 Sum_probs=184.0
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcce
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~l 366 (518)
|.++.++|++.+.||+|+||.||++...++.|++|.++.... ..+++.+|+.+++.++|+||+++++++......|+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 566778899999999999999999999999999999986532 45778999999999999999999999998889999
Q ss_pred eeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc
Q 010078 367 VTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 445 (518)
Q Consensus 367 V~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~ 445 (518)
||||+++++|.+++.... ..+++..++.++.|++.|+.|||++|++|+||||+||+++.++.++|+|||.++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence 999999999999997643 268999999999999999999999999999999999999999999999999997653321
Q ss_pred cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 010078 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVG 500 (518)
Q Consensus 446 ~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~ 500 (518)
.....+..|+|||.+....++.++|+||||+++|+|++ |..||...+..+....
T Consensus 157 -~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~ 211 (256)
T cd05039 157 -DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH 211 (256)
T ss_pred -ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 23345667999999988889999999999999999997 9999988776555444
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=309.27 Aligned_cols=226 Identities=34% Similarity=0.580 Sum_probs=190.6
Q ss_pred CCceeeCCCCeeeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEe
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFI 355 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~ 355 (518)
...|++..++|.++++||+|+||.||+|++.+ ..||+|+++.... ......+.+|+.+|.++. ||||++++
T Consensus 29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~ 107 (401)
T cd05107 29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLL 107 (401)
T ss_pred CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence 34699999999999999999999999998643 4699999986432 333457889999999998 99999999
Q ss_pred ecccCCCCcceeeeecCCCchhHHHhhhc---------------------------------------------------
Q 010078 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLK--------------------------------------------------- 384 (518)
Q Consensus 356 g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~--------------------------------------------------- 384 (518)
++|......++||||+++|+|.++++...
T Consensus 108 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (401)
T cd05107 108 GACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA 187 (401)
T ss_pred EEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence 99999999999999999999999997532
Q ss_pred ----------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 010078 385 ----------------------------------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 418 (518)
Q Consensus 385 ----------------------------------------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp 418 (518)
..+++..++.++.||+.||.|||+++++||||||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp 267 (401)
T cd05107 188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAA 267 (401)
T ss_pred CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCc
Confidence 1256677888999999999999999999999999
Q ss_pred CcEEEcCCCcEEEEeeCcceecccCCc---cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCH
Q 010078 419 ANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTP 494 (518)
Q Consensus 419 ~NILid~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~ 494 (518)
+|||++.++.+||+|||+++....... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999999975432211 122356788999999999999999999999999999998 8999998877
Q ss_pred HHHHHHhhhhcCchhH
Q 010078 495 LQAAVGVVQKVHHSFL 510 (518)
Q Consensus 495 ~q~~~~iv~~~~rp~i 510 (518)
.+.....+.++.++..
T Consensus 348 ~~~~~~~~~~~~~~~~ 363 (401)
T cd05107 348 NEQFYNAIKRGYRMAK 363 (401)
T ss_pred hHHHHHHHHcCCCCCC
Confidence 7766666666655433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=304.80 Aligned_cols=221 Identities=33% Similarity=0.592 Sum_probs=182.2
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEeecc
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGAC 358 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~~-------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~ 358 (518)
|++..++|++.+.||.|+||.||+|... ++.||+|+++.... ......+.+|+.+++++ +|+||++++++|
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-ASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-HHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 8888899999999999999999999643 25699999875432 33446788899999999 799999999987
Q ss_pred cC-CCCcceeeeecCCCchhHHHhhhc-----------------------------------------------------
Q 010078 359 TK-PPSLCIVTEFMSGGSVYDYLHKLK----------------------------------------------------- 384 (518)
Q Consensus 359 ~~-~~~~~lV~Ey~~ggsL~~~l~~~~----------------------------------------------------- 384 (518)
.. ...++++|||+++++|.+++....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 54 456789999999999999986421
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc---cccCCCCCc
Q 010078 385 -------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYR 454 (518)
Q Consensus 385 -------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~ 454 (518)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++....... .....++..
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 2578889999999999999999999999999999999999999999999999976433211 122345678
Q ss_pred ccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCch
Q 010078 455 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHS 508 (518)
Q Consensus 455 y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~rp 508 (518)
|+|||++.+..++.++|||||||++|||++ |..||.+..+.+.....++.+.++
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 295 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM 295 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC
Confidence 999999999999999999999999999998 999998766555554555544443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=305.61 Aligned_cols=214 Identities=27% Similarity=0.519 Sum_probs=193.3
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcC-CCcceEEeecccCCCCcce
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCI 366 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~-~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~~~~l 366 (518)
...|++++.||.|.||.||+++.. ++.+|+|++++.... ......+.+|+.+|+++. |||||.+++++.....+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 467899999999999999999864 678999998765443 223567899999999999 9999999999999999999
Q ss_pred eeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCC----CcEEEEeeCcceeccc
Q 010078 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN----EVVKVADFGVARVKAQ 442 (518)
Q Consensus 367 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~----~~vkL~DFGla~~~~~ 442 (518)
|||++.||.|++.+.+. .+++..+..++.||+.++.|||+.||+||||||+|+|+... +.+|++|||++.....
T Consensus 114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 99999999999999875 39999999999999999999999999999999999999643 4799999999998877
Q ss_pred CCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcC
Q 010078 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVH 506 (518)
Q Consensus 443 ~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~ 506 (518)
.......+||+.|+|||++...+|+..+||||+|+++|.|++|..||.+.+.......|++...
T Consensus 192 ~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~ 255 (382)
T KOG0032|consen 192 GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF 255 (382)
T ss_pred CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC
Confidence 6677888999999999999999999999999999999999999999999999888888776544
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=287.56 Aligned_cols=212 Identities=34% Similarity=0.617 Sum_probs=183.3
Q ss_pred CCCCeeeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCc
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~~-----~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~ 364 (518)
+.++|++.+.||+|+||.||+|.+. ...|+||+++... .......|..|+.++++++||||+++++.+......
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 4577999999999999999999874 2469999987543 344456789999999999999999999999998999
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
+++|||+++++|.+++....+.++...+..++.|++.|+.|||++||+|+||||+||+++.++.++|+|||+++......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 99999999999999998766789999999999999999999999999999999999999999999999999998664211
Q ss_pred -ccc--cCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhh
Q 010078 445 -VMT--AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 445 -~~~--~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv 502 (518)
... ...++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+.
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~ 222 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE 222 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Confidence 111 2234578999999999999999999999999999998 999998887776665543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=291.42 Aligned_cols=210 Identities=24% Similarity=0.430 Sum_probs=174.7
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc---CCCcceEEeecccC-----CC
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV---RHKNVVQFIGACTK-----PP 362 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L---~HpnIv~l~g~~~~-----~~ 362 (518)
+|++.+.||+|+||.||++.. +++.||+|+++...........+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 478889999999999999987 467899999876433332233455677766655 69999999998754 23
Q ss_pred CcceeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
.++++|||+. ++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 4799999996 58988887643 358999999999999999999999999999999999999999999999999998665
Q ss_pred cCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 442 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 442 ~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
.........+|..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~ 221 (288)
T cd07863 160 CQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 221 (288)
T ss_pred CcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHH
Confidence 54444556789999999999999999999999999999999999999988877666655543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=287.09 Aligned_cols=208 Identities=27% Similarity=0.548 Sum_probs=176.0
Q ss_pred eeeecCceEEEEEEE----CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecCCC
Q 010078 299 KVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 374 (518)
Q Consensus 299 ~LG~G~fG~Vy~g~~----~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~gg 374 (518)
+||+|+||.||+|.+ .+..+|+|+++.........+++.+|+.+++.++|+||+++++++.. ...++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 689999999999975 35679999998765556667889999999999999999999998864 5678999999999
Q ss_pred chhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc----cccCC
Q 010078 375 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV----MTAET 450 (518)
Q Consensus 375 sL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~----~~~~~ 450 (518)
+|.+++.. ...+++..+..++.|++.||.|||++||+||||||.||+++.++.++|+|||+++....... .....
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 81 PLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 99999976 45789999999999999999999999999999999999999999999999999876543321 11223
Q ss_pred CCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCchh
Q 010078 451 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHSF 509 (518)
Q Consensus 451 gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~rp~ 509 (518)
+++.|+|||.+....++.++|+|||||++|||++ |+.||...+..+.... ++++.++.
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-i~~~~~~~ 218 (257)
T cd05116 160 WPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM-IESGERME 218 (257)
T ss_pred CCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHCCCCCC
Confidence 4578999999988889999999999999999998 9999998877655554 44444433
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=292.02 Aligned_cols=200 Identities=26% Similarity=0.452 Sum_probs=174.4
Q ss_pred eeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 294 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
|++.+.||+|+||.||++... ++.||+|.+...... ......+.+|+.+++.++|+||+++++.+.....+|+||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999874 678999988754332 22345678899999999999999999999988899999999
Q ss_pred cCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccccC
Q 010078 371 MSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 449 (518)
Q Consensus 371 ~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~~ 449 (518)
++|++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++............
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR 161 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCC
Confidence 9999999998653 235889999999999999999999999999999999999999999999999998765544333445
Q ss_pred CCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCC
Q 010078 450 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 493 (518)
Q Consensus 450 ~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~ 493 (518)
.|+..|+|||++.+..++.++|+||||+++|+|++|+.||....
T Consensus 162 ~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 162 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred CCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 78999999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=290.35 Aligned_cols=217 Identities=29% Similarity=0.536 Sum_probs=182.4
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeeccc
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~~-------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~ 359 (518)
|+++.++|++.++||+|+||.||+|... +..||+|.++.... ......+.+|+.+++.++|+||+++++++.
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 7889999999999999999999999753 24699998875432 233456889999999999999999999999
Q ss_pred CCCCcceeeeecCCCchhHHHhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEE
Q 010078 360 KPPSLCIVTEFMSGGSVYDYLHKLK---------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK 430 (518)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~l~~~~---------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vk 430 (518)
.....|+||||+++|+|.+++.... ..+....+..++.||+.||.|||+++|+||||||+||+++.++.++
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 9899999999999999999997532 2345678889999999999999999999999999999999999999
Q ss_pred EEeeCcceecccCCc---cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhh
Q 010078 431 VADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 431 L~DFGla~~~~~~~~---~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~ 504 (518)
|+|||+++....... .....++..|+|||.+.+..++.++|+|||||++|||++ |..||.+.+..+....++..
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 237 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 237 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 999999875433221 122245678999999999999999999999999999999 89999988877666555443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=302.50 Aligned_cols=196 Identities=30% Similarity=0.511 Sum_probs=167.8
Q ss_pred CCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCccee
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV 367 (518)
..++|+++++||+|+||.||++++. ++.||||++.... .......+.+|+.+++.++|+||+++++++.....+|+|
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 3467888899999999999999874 6889999986543 334457789999999999999999999999999999999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-cc
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VM 446 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~ 446 (518)
|||+++++|.... ...+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 151 ~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 225 (353)
T PLN00034 151 LEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC 225 (353)
T ss_pred EecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence 9999999986532 34677888999999999999999999999999999999999999999999998654332 23
Q ss_pred ccCCCCCcccCchhccC-----CCCChhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 447 TAETGTYRWMAPEVIEH-----KPYDHKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~-----~~~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
....||..|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 45579999999998843 2345689999999999999999999974
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=290.94 Aligned_cols=194 Identities=24% Similarity=0.458 Sum_probs=168.3
Q ss_pred eeecCceEEEEEEE--CCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecCCCch
Q 010078 300 VASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (518)
Q Consensus 300 LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL 376 (518)
||+|+||.||++.. .++.||+|++....... .....+..|+.++++++||||+++++++.....+|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999976 47889999987543322 2234556799999999999999999999999999999999999999
Q ss_pred hHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccccCCCCCcc
Q 010078 377 YDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRW 455 (518)
Q Consensus 377 ~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y 455 (518)
.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.............|+..|
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY 160 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence 9888653 235888999999999999999999999999999999999999999999999998766554444556789999
Q ss_pred cCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCC
Q 010078 456 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 493 (518)
Q Consensus 456 ~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~ 493 (518)
+|||++.+..++.++|+|||||++|||++|+.||....
T Consensus 161 ~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~ 198 (277)
T cd05607 161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198 (277)
T ss_pred cCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence 99999999889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=286.46 Aligned_cols=212 Identities=38% Similarity=0.663 Sum_probs=181.1
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
|++...+|++.++||+|+||.||+|++.+ ..||+|+++..... ...+.+|+.+++.++|+||+++++.+.. ...|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 76 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcE
Confidence 67788899999999999999999998754 46999998864332 2568899999999999999999998754 5689
Q ss_pred eeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 366 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
+||||+++++|.+++.+.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||.++......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 9999999999999997633 457889999999999999999999999999999999999999999999999997654432
Q ss_pred cc--ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhh
Q 010078 445 VM--TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 445 ~~--~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv 502 (518)
.. ....++..|+|||++.+..++.++|+||||+++|+|++ |+.||...++.+....+.
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~ 217 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 217 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh
Confidence 22 12345678999999999999999999999999999999 899999888776665543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=285.07 Aligned_cols=199 Identities=38% Similarity=0.669 Sum_probs=177.8
Q ss_pred eeeeeeeeecCceEEEEEEECC--ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeec
Q 010078 294 LKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~~~--~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 371 (518)
|++++.||+|+||.||++...+ +.||+|++..............+|+.++++++|+||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6889999999999999999865 46999999876544444445567999999999999999999999999999999999
Q ss_pred CCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceec-ccCCccccCC
Q 010078 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK-AQSGVMTAET 450 (518)
Q Consensus 372 ~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~-~~~~~~~~~~ 450 (518)
.+++|.+++.. .+.++...++.++.||+.||.+||++||+|+||||+||+++.++.++|+|||.+... ..........
T Consensus 81 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 159 (260)
T PF00069_consen 81 PGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV 159 (260)
T ss_dssp TTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred ccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999984 677899999999999999999999999999999999999999999999999999753 3334455678
Q ss_pred CCCcccCchhcc-CCCCChhhHHHHHHHHHHHHHcCCCCCCCCC
Q 010078 451 GTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLT 493 (518)
Q Consensus 451 gt~~y~APEvl~-~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~ 493 (518)
++..|+|||++. +..++.++|+||||+++|+|++|..||....
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~ 203 (260)
T PF00069_consen 160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN 203 (260)
T ss_dssp SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccc
Confidence 899999999998 8889999999999999999999999999873
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=293.42 Aligned_cols=211 Identities=34% Similarity=0.585 Sum_probs=177.4
Q ss_pred CCeeeeeeeeecCceEEEEEEECC--c--eEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEeecccCCCCcce
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYCS--Q--DVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCI 366 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~~--~--~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~~~~l 366 (518)
++|++.+.||+|+||.||+|.... . .+++|.++... .....+.+.+|+.+++++ +||||+++++++.....+|+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 578899999999999999998643 2 46888877432 334456789999999999 69999999999998889999
Q ss_pred eeeecCCCchhHHHhhhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEE
Q 010078 367 VTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKV 431 (518)
Q Consensus 367 V~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL 431 (518)
+|||+++++|.+++.+.. ..+++..++.++.||+.|++|||++||+||||||+|||++.++.+||
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEE
Confidence 999999999999997532 24788899999999999999999999999999999999999999999
Q ss_pred EeeCcceecccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 432 ADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 432 ~DFGla~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
+|||++..............+..|+|||++.+..++.++|||||||++|||++ |..||...++.+....+.+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~ 233 (297)
T cd05089 161 ADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 233 (297)
T ss_pred CCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence 99999864332211222233567999999999999999999999999999998 9999999888776666544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=307.24 Aligned_cols=214 Identities=29% Similarity=0.573 Sum_probs=187.1
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCc
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~ 364 (518)
.-++.++.+.++++||+|.||.|.++...+ ..||+|+++... .....++|..|+++|.+|+||||+.++|+|..++.+
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 446778899999999999999999998877 889999999764 445578999999999999999999999999999999
Q ss_pred ceeeeecCCCchhHHHhhhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~-l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~ 443 (518)
|+|||||+.|+|.+|+.++..+ .......+|+.||+.||+||.+.++|||||.+.|+|++.++++||+|||+++..-..
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999999999999886433 355667789999999999999999999999999999999999999999999854332
Q ss_pred Cccc---cCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc--CCCCCCCCCHHHHHHH
Q 010078 444 GVMT---AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT--GKLPYEYLTPLQAAVG 500 (518)
Q Consensus 444 ~~~~---~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt--G~~Pf~~~~~~q~~~~ 500 (518)
.... ..+-..+|||+|.|..++|+.++|+|+||+++||+++ ...||..++..|....
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven 752 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN 752 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh
Confidence 2222 1244579999999999999999999999999999876 7899999998777654
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=289.10 Aligned_cols=213 Identities=30% Similarity=0.566 Sum_probs=179.6
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEE------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~------~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
++.+++++.++||+|+||.||+|++ .+..+++|.++... .......+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 3457789999999999999999985 34679999987543 3344567899999999999999999999999888
Q ss_pred CcceeeeecCCCchhHHHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCC
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLK----------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~----------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~ 426 (518)
..|++|||+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 9999999999999999985321 246788899999999999999999999999999999999999
Q ss_pred CcEEEEeeCcceecccCC---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhh
Q 010078 427 EVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 427 ~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv 502 (518)
+.+||+|||+++...... ......++..|+|||.+.+..++.++|+||||+++|||++ |..||.+.++......+.
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999997543322 1223345678999999998899999999999999999998 999998887755554443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=289.53 Aligned_cols=215 Identities=30% Similarity=0.557 Sum_probs=184.8
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeeccc
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~ 359 (518)
|+++.++|++.+.||+|+||.||+|...+ ..||+|.+.... .......+.+|+.+++.++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 68889999999999999999999998643 569999987543 3334567889999999999999999999999
Q ss_pred CCCCcceeeeecCCCchhHHHhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEE
Q 010078 360 KPPSLCIVTEFMSGGSVYDYLHKLK---------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK 430 (518)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~l~~~~---------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vk 430 (518)
.....|+||||+++++|.+++.... ..+++..+..++.||+.|+.|||+++++||||||+||+++.++.+|
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 9999999999999999999986532 2367788999999999999999999999999999999999999999
Q ss_pred EEeeCcceecccCC---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhh
Q 010078 431 VADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 431 L~DFGla~~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv 502 (518)
|+|||+++...... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...++.+....+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 235 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh
Confidence 99999987544332 1223456788999999988889999999999999999998 999999888877666655
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=298.84 Aligned_cols=216 Identities=27% Similarity=0.447 Sum_probs=189.2
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEECCc--eEEEEEecCCCCCh-HHHHHHHHHHHHHHhcC-CCcceEEeecccCCCC
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYCSQ--DVAIKVLKPERINS-DMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPS 363 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~~~--~vAVKvlk~~~~~~-~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~~ 363 (518)
.|...+|.++..||+|+||.|.++...|. .+|||+++++..-. +..+--+.|-++|.... -|.+++++..|+.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 67778899999999999999999988764 59999999764421 22223345667776654 5789999999999999
Q ss_pred cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC
Q 010078 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~ 443 (518)
+|+||||+.||+|.-.+++ -+.+.++.+..++..|+-||-+||++|||+||||.+|||+|.+|+|||+|||+++.....
T Consensus 425 LyFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred eeeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence 9999999999999999987 688999999999999999999999999999999999999999999999999999865444
Q ss_pred C-ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 444 G-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 444 ~-~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
+ .+.+.+|||.|+|||++..++|+.+.|+||||++|||||.|++||++.+..+...+|++.
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh 565 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH 565 (683)
T ss_pred CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc
Confidence 4 445779999999999999999999999999999999999999999999998888887764
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=282.93 Aligned_cols=212 Identities=34% Similarity=0.531 Sum_probs=185.1
Q ss_pred CCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
.++|++.++||+|+||.||++.. .++.+++|++..... ...+.+.+|+.++++++||||+++++++.....+|++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 36789999999999999999986 457799999875432 24578899999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-ccc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT 447 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~ 447 (518)
||+++++|.+++......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 159 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK 159 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence 9999999999998755789999999999999999999999999999999999999999999999999987544322 233
Q ss_pred cCCCCCcccCchhccCC---CCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 448 AETGTYRWMAPEVIEHK---PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~~---~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
...++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...++.+....+...
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~ 219 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKS 219 (262)
T ss_pred cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 45688899999999777 8999999999999999999999999988877766654443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=294.46 Aligned_cols=223 Identities=32% Similarity=0.605 Sum_probs=185.1
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEECC---------ceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEE
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQF 354 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~---------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l 354 (518)
..|++..++|.++++||+|+||.||++.+.+ ..+|+|+++... .......+.+|+.+++.+ +|+||+++
T Consensus 11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 4688888999999999999999999997532 359999988653 233456788899999999 79999999
Q ss_pred eecccCCCCcceeeeecCCCchhHHHhhhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 010078 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419 (518)
Q Consensus 355 ~g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~ 419 (518)
++++......|+||||+++++|.+++.... ..++...++.++.||+.||+|||++|++||||||+
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 169 (307)
T cd05098 90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169 (307)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence 999999999999999999999999997632 24788899999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEeeCcceecccCC---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 010078 420 NLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPL 495 (518)
Q Consensus 420 NILid~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~ 495 (518)
||+++.++.++|+|||.++...... ......+++.|+|||.+.+..++.++|+|||||++|+|++ |..||...+..
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 9999999999999999987543221 1122234568999999999999999999999999999998 89999886664
Q ss_pred HHHHHhhhhcCchh
Q 010078 496 QAAVGVVQKVHHSF 509 (518)
Q Consensus 496 q~~~~iv~~~~rp~ 509 (518)
+.... +....++.
T Consensus 250 ~~~~~-~~~~~~~~ 262 (307)
T cd05098 250 ELFKL-LKEGHRMD 262 (307)
T ss_pred HHHHH-HHcCCCCC
Confidence 44443 44444433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=290.32 Aligned_cols=208 Identities=29% Similarity=0.503 Sum_probs=183.6
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
++|++.+.||+|+||.||++.+ .++.+|+|+++.... .......+.+|+.++++++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 3688999999999999999987 468899999875432 2334567889999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcccc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~ 448 (518)
||+++++|.+++.. .+.++...+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++...... ...
T Consensus 81 e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~ 157 (290)
T cd05580 81 EYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYT 157 (290)
T ss_pred ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCC
Confidence 99999999999977 467899999999999999999999999999999999999999999999999999765443 344
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv 502 (518)
..+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...++.+....++
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 211 (290)
T cd05580 158 LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL 211 (290)
T ss_pred CCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 568899999999988889999999999999999999999999888766665544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=304.17 Aligned_cols=202 Identities=24% Similarity=0.407 Sum_probs=170.2
Q ss_pred eeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhc---CCCcceEEeecccCCCCcceeeeecCC
Q 010078 300 VASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV---RHKNVVQFIGACTKPPSLCIVTEFMSG 373 (518)
Q Consensus 300 LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L---~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (518)
||+|+||.||+++.. ++.||||++..... .......+..|..++..+ +||||+++++.+.....+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999864 67899999864322 222334455677777665 699999999999999999999999999
Q ss_pred CchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc-CCccccCCCC
Q 010078 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT 452 (518)
Q Consensus 374 gsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~-~~~~~~~~gt 452 (518)
++|..++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.... ........||
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt 159 (330)
T cd05586 81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT 159 (330)
T ss_pred ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCC
Confidence 999999876 56799999999999999999999999999999999999999999999999999875332 2233456799
Q ss_pred CcccCchhccCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 010078 453 YRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 453 ~~y~APEvl~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv 502 (518)
+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+.
T Consensus 160 ~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~ 210 (330)
T cd05586 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIA 210 (330)
T ss_pred ccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHH
Confidence 999999998754 58999999999999999999999999887766655543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=306.83 Aligned_cols=193 Identities=27% Similarity=0.410 Sum_probs=169.4
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcce
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~l 366 (518)
+....|++.++||+|+||.||++.. .++.||+|+... ..+.+|+.+|++++||||+++++++......|+
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 4556799999999999999999986 467899997542 346789999999999999999999998889999
Q ss_pred eeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC--C
Q 010078 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--G 444 (518)
Q Consensus 367 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~--~ 444 (518)
|||++ +++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 161 v~e~~-~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 161 ILPRY-KTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred EEecC-CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 99999 5789988876 456889999999999999999999999999999999999999999999999998653321 2
Q ss_pred ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 445 ~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
......||+.|+|||++.+..|+.++|||||||++|||++|+.||..
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 23345799999999999999999999999999999999999988753
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=287.76 Aligned_cols=216 Identities=31% Similarity=0.606 Sum_probs=180.8
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEEC--Cc----eEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~--~~----~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
+..++|++.++||+|+||.||+|++. +. .||+|+++... .......+.+|+.+++.++|+||+++++++.. .
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~ 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-S 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence 45578999999999999999999863 33 48999987543 34445778999999999999999999999875 4
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
..+++|||+++|+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 57899999999999999987667799999999999999999999999999999999999999999999999999986543
Q ss_pred CCcc---ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCc
Q 010078 443 SGVM---TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 443 ~~~~---~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
.... ....++..|+|||.+.+..++.++|||||||++|||++ |..||.......... .++.+.+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~ 229 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-LLEKGER 229 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCc
Confidence 3221 12234678999999999999999999999999999998 999998876655433 3444443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=310.61 Aligned_cols=227 Identities=27% Similarity=0.423 Sum_probs=208.8
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEECCce--EEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~~~~--vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
+.-.+++++..||-|+||.|-+...+++. +|+|++++... +......+..|-.||..++.|.||++|..|.+....|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 44467888889999999999999988877 89999887554 4455677889999999999999999999999999999
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 445 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~ 445 (518)
|.||-|-||.|+..|++ ++.|+......++..++.|++|||++|||+|||||+|++++.+|.+||.|||+|+....+..
T Consensus 497 mLmEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred hhHHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 99999999999999988 78999999999999999999999999999999999999999999999999999999999989
Q ss_pred cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCchhHHHHHhh
Q 010078 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSFLEQRLRK 516 (518)
Q Consensus 446 ~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp~ip~~~~~ 516 (518)
+.+.+||+.|.|||++.++..+.+.|.||||+++||||+|.+||.+.+|+.++..|++..--..+|.++.+
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k 646 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITK 646 (732)
T ss_pred eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccch
Confidence 99999999999999999999999999999999999999999999999999999999987766677766543
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=326.65 Aligned_cols=219 Identities=22% Similarity=0.455 Sum_probs=184.3
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC--CC
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PP 362 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~--~~ 362 (518)
.++...+|+++++||+|+||.||+++.. +..+|+|++............|..|+.+|++++||||++++++|.. ..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 3455678999999999999999999874 4679999998766666667789999999999999999999998744 35
Q ss_pred CcceeeeecCCCchhHHHhhh---cCCCCHHHHHHHHHHHHHHHHHHHHC-------CceeccCCCCcEEEcC-------
Q 010078 363 SLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQN-------NIIHRDLKAANLLMDE------- 425 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~---~~~l~~~~i~~i~~qIa~aL~yLHs~-------gIiHrDLKp~NILid~------- 425 (518)
.+||||||+++++|.+++... .+.+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 689999999999999999753 35699999999999999999999985 4999999999999964
Q ss_pred ----------CCcEEEEeeCcceecccCCccccCCCCCcccCchhccC--CCCChhhHHHHHHHHHHHHHcCCCCCCCCC
Q 010078 426 ----------NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLT 493 (518)
Q Consensus 426 ----------~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APEvl~~--~~~s~ksDVwSlGviL~eLltG~~Pf~~~~ 493 (518)
.+.+||+|||++.............||+.|+|||++.+ ..++.++||||||||||+|+||+.||....
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 23589999999986654444445679999999999854 458999999999999999999999998877
Q ss_pred HHHHHHHhhhhc
Q 010078 494 PLQAAVGVVQKV 505 (518)
Q Consensus 494 ~~q~~~~iv~~~ 505 (518)
....+...+...
T Consensus 248 ~~~qli~~lk~~ 259 (1021)
T PTZ00266 248 NFSQLISELKRG 259 (1021)
T ss_pred cHHHHHHHHhcC
Confidence 666665555543
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=282.37 Aligned_cols=214 Identities=39% Similarity=0.693 Sum_probs=185.4
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
|+++.++|.+.++||+|+||.||++...+ +.++||.+...... ...+.+|+.++++++|+||+++++++......+
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 78889999999999999999999998654 67999998864332 356889999999999999999999998888899
Q ss_pred eeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 366 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
+||||+++++|.+++.... ..++...+..++.||+.|+.|||++|++|+||||+||+++.++.++|+|||+++......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999999999997643 468999999999999999999999999999999999999999999999999987654321
Q ss_pred c--cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 445 V--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 445 ~--~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
. .....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+.......+..
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~ 219 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER 219 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 1 112234568999999999999999999999999999999 9999999887776666544
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=281.43 Aligned_cols=215 Identities=24% Similarity=0.453 Sum_probs=187.8
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
+|++.+.||.|+||.||.++. .++.+++|.+............+.+|+.++++++|+||+++++++.....++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478899999999998887765 567899999876655556667889999999999999999999999999999999999
Q ss_pred cCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-cccc
Q 010078 371 MSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (518)
Q Consensus 371 ~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~ 448 (518)
+++++|.+++... ...++...+..++.|++.++.|||++|++|+||+|+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence 9999999999764 3568999999999999999999999999999999999999999999999999997654433 2344
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCc
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
..+++.|+|||.+.+..++.++|+||||+++|+|++|..||...++.+....+......
T Consensus 161 ~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 219 (256)
T cd08221 161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT 219 (256)
T ss_pred cCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC
Confidence 57899999999999888999999999999999999999999998887777776654333
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=311.45 Aligned_cols=218 Identities=31% Similarity=0.468 Sum_probs=192.1
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
.|.-++.||.|+||.||.+.+ +.+.||||.+..... .....+.++.|+..|++++|||++.+-|+|......|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 456678899999999999986 456799999886543 34557889999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccccC
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 449 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~~ 449 (518)
|| -||-.+++.-.+.++.+..+..|+.+.+.||.|||+.+.||||||..|||+++.|.|||+|||.+...... ..+
T Consensus 107 YC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---nsF 182 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---NSF 182 (948)
T ss_pred HH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch---hcc
Confidence 99 66888888777889999999999999999999999999999999999999999999999999999766543 567
Q ss_pred CCCCcccCchhcc---CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCchhHHHHH
Q 010078 450 TGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSFLEQRL 514 (518)
Q Consensus 450 ~gt~~y~APEvl~---~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp~ip~~~ 514 (518)
+|||+|||||+|. .+.|+-+.|||||||++.||.-.++|+.+|+.+.++-.|-++..+....+.|
T Consensus 183 vGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eW 250 (948)
T KOG0577|consen 183 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW 250 (948)
T ss_pred cCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchh
Confidence 8999999999984 5679999999999999999999999999999999999988876654333333
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=306.88 Aligned_cols=208 Identities=24% Similarity=0.419 Sum_probs=172.4
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCC------cceEEeeccc
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK------NVVQFIGACT 359 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~Hp------nIv~l~g~~~ 359 (518)
.+...+|++.++||+|+||.||++.. .++.||||+++.. ......+..|+.+++.++|. +++++++++.
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 44567899999999999999999986 4677999998743 22234556677777777654 5888888876
Q ss_pred CC-CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEcCCC----------
Q 010078 360 KP-PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENE---------- 427 (518)
Q Consensus 360 ~~-~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs-~gIiHrDLKp~NILid~~~---------- 427 (518)
.. .++|+|||++ |++|.+++.+ .+.+++..+..++.||+.||+|||+ .|||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 54 4689999998 8899999876 4679999999999999999999998 5999999999999998765
Q ss_pred ------cEEEEeeCcceecccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 010078 428 ------VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV 501 (518)
Q Consensus 428 ------~vkL~DFGla~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~i 501 (518)
.+||+|||.+..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..+
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred cCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 499999998754322 334568999999999999999999999999999999999999999988876665554
Q ss_pred h
Q 010078 502 V 502 (518)
Q Consensus 502 v 502 (518)
.
T Consensus 358 ~ 358 (467)
T PTZ00284 358 E 358 (467)
T ss_pred H
Confidence 3
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=289.95 Aligned_cols=216 Identities=25% Similarity=0.529 Sum_probs=183.1
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~-------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~ 361 (518)
++..+|++.++||+|+||.||+|+.. ++.||||+++... .......+.+|+.++..++||||+++++++...
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 45567888999999999999999864 3569999988543 234456788999999999999999999999999
Q ss_pred CCcceeeeecCCCchhHHHhhh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCC
Q 010078 362 PSLCIVTEFMSGGSVYDYLHKL---------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~~---------------~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~ 426 (518)
...++++||+.+++|.+++... ...++...+.+++.|++.||.|||++||+||||||+||+++.+
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 9999999999999999998531 2347888899999999999999999999999999999999999
Q ss_pred CcEEEEeeCcceecccCCc---cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhh
Q 010078 427 EVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 427 ~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv 502 (518)
+.+||+|||+++....... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+.
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999875433221 223345778999999988889999999999999999998 899999988877777765
Q ss_pred hhc
Q 010078 503 QKV 505 (518)
Q Consensus 503 ~~~ 505 (518)
+..
T Consensus 241 ~~~ 243 (283)
T cd05091 241 NRQ 243 (283)
T ss_pred cCC
Confidence 544
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=298.12 Aligned_cols=213 Identities=25% Similarity=0.442 Sum_probs=180.2
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC-
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP- 361 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~- 361 (518)
..|++. ++|++.+.||+|+||.||++.. .++.||||+++...........+.+|+.+|++++||||+++++++...
T Consensus 9 ~~~~~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07878 9 TVWEVP-ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT 87 (343)
T ss_pred HHhhhh-hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence 345554 6799999999999999999976 457799999876543334456688899999999999999999987543
Q ss_pred -----CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCc
Q 010078 362 -----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436 (518)
Q Consensus 362 -----~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGl 436 (518)
...|++|+++ +++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 88 SIENFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cccccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCcc
Confidence 3468999998 8899888754 5689999999999999999999999999999999999999999999999999
Q ss_pred ceecccCCccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 437 ARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 437 a~~~~~~~~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+
T Consensus 165 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 230 (343)
T cd07878 165 ARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIME 230 (343)
T ss_pred ceecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 9765432 345578999999999876 5789999999999999999999999998877766665543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=282.41 Aligned_cols=203 Identities=32% Similarity=0.645 Sum_probs=173.4
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecCCCc
Q 010078 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 375 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ggs 375 (518)
++||+|+||.||+|+. .++.||+|.++.. ........+.+|+.+++.++||||+++++++......|+||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 4689999999999987 5778999987643 234456779999999999999999999999999999999999999999
Q ss_pred hhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcc---ccCCCC
Q 010078 376 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM---TAETGT 452 (518)
Q Consensus 376 L~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~---~~~~gt 452 (518)
|.+++......+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++........ .....+
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 159 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP 159 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence 99999765556899999999999999999999999999999999999999999999999998754322111 111234
Q ss_pred CcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHh
Q 010078 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 501 (518)
Q Consensus 453 ~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~i 501 (518)
..|+|||.+.+..++.++|+||||+++|+|++ |..||...++.+....+
T Consensus 160 ~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~ 209 (252)
T cd05084 160 VKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI 209 (252)
T ss_pred eeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH
Confidence 57999999999999999999999999999998 99999888776554443
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=284.93 Aligned_cols=208 Identities=31% Similarity=0.593 Sum_probs=174.0
Q ss_pred eeeecCceEEEEEEEC----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecCCC
Q 010078 299 KVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 374 (518)
Q Consensus 299 ~LG~G~fG~Vy~g~~~----~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~gg 374 (518)
.||+|+||.||+|.+. +..||+|+++... .......+.+|+.++++++|+||+++++++.. ...++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence 4899999999999764 3459999987543 34445679999999999999999999998864 5789999999999
Q ss_pred chhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc----cccCC
Q 010078 375 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV----MTAET 450 (518)
Q Consensus 375 sL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~----~~~~~ 450 (518)
+|.+++......+++..+++++.||+.||.|||++|++||||||+|||++.++.+||+|||+++....... .....
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK 159 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCC
Confidence 99999986667899999999999999999999999999999999999999999999999999875433221 11223
Q ss_pred CCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCchh
Q 010078 451 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHSF 509 (518)
Q Consensus 451 gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~rp~ 509 (518)
++..|+|||.+.+..++.++||||||+++|+|++ |..||....+.+.... +.++.++.
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~ 218 (257)
T cd05115 160 WPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSF-IEQGKRLD 218 (257)
T ss_pred CCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH-HHCCCCCC
Confidence 3578999999998889999999999999999997 9999999887665544 44444433
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=283.61 Aligned_cols=201 Identities=23% Similarity=0.473 Sum_probs=175.1
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
++|++.+.||+|+||.||+|+. +++.||||.++... ........+.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4688899999999999999986 57889999886532 34455567899999999999999999999999888999999
Q ss_pred eecCCCchhHHHhhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-
Q 010078 369 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG- 444 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~---~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~- 444 (518)
||+++++|.+++... ...++...+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 999999999988532 3457889999999999999999999999999999999999999999999999987654332
Q ss_pred ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCC
Q 010078 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL 492 (518)
Q Consensus 445 ~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (518)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 223446888999999999989999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=287.01 Aligned_cols=218 Identities=28% Similarity=0.555 Sum_probs=180.1
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEEC--Cc----eEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~--~~----~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
+...+|++.+.||.|+||.||+|.+. ++ .+++|.+... .......++..|+.++++++||||+++++++.. .
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~ 81 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A 81 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence 34567889999999999999999873 43 4777776532 223344678889999999999999999998764 4
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
..++++||+++|+|.+++....+.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 57899999999999999987667899999999999999999999999999999999999999999999999999976533
Q ss_pred CC---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCchh
Q 010078 443 SG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHSF 509 (518)
Q Consensus 443 ~~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~rp~ 509 (518)
.. ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+..+.. ...+++++.++.
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~ 231 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-VPDLLEKGERLA 231 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHCCCcCC
Confidence 22 1223346678999999998899999999999999999998 999999887654 344455555443
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=284.88 Aligned_cols=210 Identities=30% Similarity=0.540 Sum_probs=177.7
Q ss_pred eeeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCC-----
Q 010078 294 LKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS----- 363 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~~~-----~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~----- 363 (518)
|++++.||+|+||.||+|+... ..||+|+++...........+.+|+.+++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4678899999999999998643 569999998765555556789999999999999999999998765544
Q ss_pred -cceeeeecCCCchhHHHhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcc
Q 010078 364 -LCIVTEFMSGGSVYDYLHKL-----KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437 (518)
Q Consensus 364 -~~lV~Ey~~ggsL~~~l~~~-----~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla 437 (518)
.+++|||+++++|..++... ...+++..++.++.|++.||.|||+++++||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 78999999999999998542 235888999999999999999999999999999999999999999999999999
Q ss_pred eecccCCc---cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 438 RVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 438 ~~~~~~~~---~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
+....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.++.+....+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~ 230 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH 230 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 86543321 112235678999999998999999999999999999999 9999998887776655443
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=283.39 Aligned_cols=209 Identities=30% Similarity=0.538 Sum_probs=174.6
Q ss_pred eeeeeeeecCceEEEEEEECCc----eEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC------CCc
Q 010078 295 KFGSKVASGSYGDLYRGTYCSQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------PSL 364 (518)
Q Consensus 295 ~i~~~LG~G~fG~Vy~g~~~~~----~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~------~~~ 364 (518)
.++++||+|+||.||+|.+... .+|+|.++...........+.+|+.+++.++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4678999999999999987542 589999887655556677899999999999999999999976432 246
Q ss_pred ceeeeecCCCchhHHHhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 365 CIVTEFMSGGSVYDYLHKL-----KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~-----~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
+++|||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccc
Confidence 8999999999999987431 23478899999999999999999999999999999999999999999999999986
Q ss_pred cccCCc---cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 440 KAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 440 ~~~~~~---~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
...... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...++.+....+.+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 229 (272)
T cd05075 162 IYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ 229 (272)
T ss_pred cCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 543321 122345678999999999999999999999999999999 8999998887666555443
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=285.63 Aligned_cols=210 Identities=27% Similarity=0.433 Sum_probs=178.9
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
+|++.++||+|+||.||+|+. +++.||||+++...........+.+|+.++++++||||+++++++..+..+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 478889999999999999987 467899999876544444456788899999999999999999999999999999999
Q ss_pred cCCCchhHHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-ccc
Q 010078 371 MSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT 447 (518)
Q Consensus 371 ~~ggsL~~~l~~~~--~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~ 447 (518)
++ ++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... ...
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT 159 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence 96 68888886533 568999999999999999999999999999999999999999999999999987543322 223
Q ss_pred cCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 448 AETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
...+++.|+|||++.+ ..++.++|||||||++|+|+||+.||.+.+....+..+.+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~ 216 (285)
T cd07861 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFR 216 (285)
T ss_pred CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 4467889999998865 4578999999999999999999999998877666555443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=331.67 Aligned_cols=216 Identities=22% Similarity=0.361 Sum_probs=191.5
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCc
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~ 364 (518)
.+..++|.+++.||+|+||.|...+.. ++-||+|++.+-.. ......-|..|-.+|..-+.+.|++++.+|+++.++
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 456688999999999999999998764 56799999875322 122345688899999999999999999999999999
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
|+|||||+||+|..++.+.. .+++..++.++..|.-||+.||+.|+|||||||+|||||..|+|||+|||.|-.....+
T Consensus 151 YlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred EEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence 99999999999999999866 89999999999999999999999999999999999999999999999999986655444
Q ss_pred --ccccCCCCCcccCchhcc----C-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 445 --VMTAETGTYRWMAPEVIE----H-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 445 --~~~~~~gt~~y~APEvl~----~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
.....+|||.|++||++. + +.|+..+|+||+||++|||+.|..||...+..+++-+|+.-
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h 296 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH 296 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch
Confidence 345668999999999984 3 56999999999999999999999999999999999998865
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=283.91 Aligned_cols=223 Identities=29% Similarity=0.511 Sum_probs=186.8
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCC---CChHHHHHHHHHHHHHHhcCCCcceEEeecccCC--CCc
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER---INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSL 364 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~---~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~--~~~ 364 (518)
..|++.+.||+|+||.||+++. ++..|++|++.... ........+.+|+.++++++|+||+++++++... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5688899999999999999986 46789999875432 1234456788999999999999999999988654 457
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS- 443 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~- 443 (518)
+++|||+++++|.+++.. .+.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||+++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 899999999999999876 456889999999999999999999999999999999999999999999999999754321
Q ss_pred ---CccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCchhHHHHHh
Q 010078 444 ---GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSFLEQRLR 515 (518)
Q Consensus 444 ---~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp~ip~~~~ 515 (518)
.......++..|+|||.+.+..++.++|+|||||++|+|++|+.||...........+.....++.+|..++
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~ 235 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVS 235 (264)
T ss_pred ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccC
Confidence 122334688999999999998899999999999999999999999998888777777665555555555443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=281.47 Aligned_cols=213 Identities=38% Similarity=0.680 Sum_probs=180.9
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
|++..+.|.+.++||+|+||.||++++.+ ..+++|++..... ....+.+|+.+++.++|+|++++++++.. ...|
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIY 76 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcE
Confidence 66777889999999999999999998755 4699998775432 23568899999999999999999998764 5689
Q ss_pred eeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 366 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
++|||+++++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 9999999999999997643 347889999999999999999999999999999999999999999999999997654332
Q ss_pred cc--ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 445 VM--TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 445 ~~--~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
.. ....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.++.+....+..
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~ 218 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER 218 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 11 12345678999999998899999999999999999999 9999999887766655443
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=292.98 Aligned_cols=212 Identities=33% Similarity=0.594 Sum_probs=176.8
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEEC--Cc--eEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEeecccCCCC
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQ--DVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 363 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~--~~--~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~~ 363 (518)
+..++|++.+.||+|+||.||+|.+. +. .+++|.++.. ........+.+|+.++.++ +|+||+++++++.....
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 44568899999999999999999864 33 3577766532 2344456788999999999 89999999999999999
Q ss_pred cceeeeecCCCchhHHHhhhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCc
Q 010078 364 LCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~ 428 (518)
+|+||||+++++|.+++.+.. ..+++..++.++.||+.|++|||++|++||||||+|||++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 999999999999999997532 25788999999999999999999999999999999999999999
Q ss_pred EEEEeeCcceecccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHh
Q 010078 429 VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 501 (518)
Q Consensus 429 vkL~DFGla~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~i 501 (518)
+||+|||+++............++..|+|||.+.+..++.++|||||||++|||+| |..||...+..+....+
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 236 (303)
T cd05088 163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236 (303)
T ss_pred EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 99999999864322212222334678999999998889999999999999999998 99999887776655443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=286.82 Aligned_cols=213 Identities=32% Similarity=0.603 Sum_probs=181.5
Q ss_pred CCCCeeeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~~-------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
...+|.+.+.||+|+||.||+|+.. +..||||+++.... ......+.+|+.+|++++|+||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4567888999999999999999753 35699999875432 334578999999999999999999999999999
Q ss_pred CcceeeeecCCCchhHHHhhhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcE
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLK-------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVV 429 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~-------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~v 429 (518)
..|+||||+++++|.+++.... ..+++..+..++.||+.|+.|||++|++||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 9999999999999999997532 347788999999999999999999999999999999999999999
Q ss_pred EEEeeCcceecccCC---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 430 KVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 430 kL~DFGla~~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
+|+|||+++...... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+.+
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 999999987543221 1123345778999999999999999999999999999998 9999988887766666543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=286.39 Aligned_cols=215 Identities=35% Similarity=0.661 Sum_probs=184.7
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~~-~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
|+....+|+++++||.|+||.||+|++. +..+++|+++... ......+..|+.+++.++|+||+++++++.....++
T Consensus 1 ~~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 78 (261)
T cd05148 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY 78 (261)
T ss_pred CcCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeE
Confidence 4455577999999999999999999875 4679999987543 223467889999999999999999999999999999
Q ss_pred eeeeecCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 366 IVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
+||||+++++|.+++... ...++...+..++.||+.|+.|||++|++|+||||+||+++.++.+||+|||.+.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 999999999999999764 3458899999999999999999999999999999999999999999999999987654322
Q ss_pred -ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 445 -VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 445 -~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+..
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~ 219 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA 219 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHh
Confidence 1223345678999999999999999999999999999998 8999999887777666553
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=283.70 Aligned_cols=213 Identities=32% Similarity=0.591 Sum_probs=181.9
Q ss_pred CCCCeeeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCc
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~~-----~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~ 364 (518)
+..+|++.+.||+|+||.||+|... +..+|+|.++.... ......+..|+.+++.++||||+++++++......
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4567889999999999999999763 23589998875433 34456889999999999999999999999998999
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
|+||||+++++|.+++....+.++...+..++.|++.|+.|||++|++||||||+|||++.++.++|+|||+++......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 99999999999999998766678999999999999999999999999999999999999999999999999987654322
Q ss_pred c--c--ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 445 V--M--TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 445 ~--~--~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
. . ....++..|+|||.+.+..++.++|+||||+++|++++ |+.||...++.+....+.+
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~ 224 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE 224 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhC
Confidence 1 1 11223568999999999899999999999999999987 9999998887666665443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=291.11 Aligned_cols=218 Identities=31% Similarity=0.607 Sum_probs=183.8
Q ss_pred CCceeeCCCCeeeeeeeeecCceEEEEEEEC---------CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceE
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQ 353 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~---------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~ 353 (518)
...|.+..++|.++++||+|+||.||+++.. ...+|+|+++.... ......+.+|+.+++++ +||||++
T Consensus 4 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (314)
T cd05099 4 DPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMELMKLIGKHKNIIN 82 (314)
T ss_pred cccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHHHHHHHHHHHHhccCCCCeee
Confidence 3468888899999999999999999999752 24589999875432 34456788999999999 5999999
Q ss_pred EeecccCCCCcceeeeecCCCchhHHHhhhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 010078 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 418 (518)
Q Consensus 354 l~g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp 418 (518)
+++++.....+|++|||+++++|.+++.... ..+++..+..++.||+.||.|||++|++||||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp 162 (314)
T cd05099 83 LLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAA 162 (314)
T ss_pred EEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 9999998889999999999999999997532 3478889999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEEeeCcceecccCC---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCH
Q 010078 419 ANLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTP 494 (518)
Q Consensus 419 ~NILid~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~ 494 (518)
+|||++.++.+||+|||+++...... ......++..|+|||++.+..++.++||||||+++|+|++ |..||...++
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999997554321 1122234567999999999999999999999999999999 9999998877
Q ss_pred HHHHHHhh
Q 010078 495 LQAAVGVV 502 (518)
Q Consensus 495 ~q~~~~iv 502 (518)
.+....+.
T Consensus 243 ~~~~~~~~ 250 (314)
T cd05099 243 EELFKLLR 250 (314)
T ss_pred HHHHHHHH
Confidence 66555543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=280.91 Aligned_cols=218 Identities=33% Similarity=0.548 Sum_probs=185.8
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCccee
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI---NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~---~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV 367 (518)
+|+..+.||+|+||.||+|.. ++..|++|++..... .....+.+.+|+.+++.++|+||+++++++.....+|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 356678999999999999987 478899998865321 234557789999999999999999999999999999999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccc
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT 447 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~ 447 (518)
|||+++++|.+++.. .+.+++..+..++.||+.|+.|||++|++|+||+|+||+++.++.+||+|||++..........
T Consensus 81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 159 (258)
T cd06632 81 LELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK 159 (258)
T ss_pred EEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccccc
Confidence 999999999999976 4568899999999999999999999999999999999999999999999999988665544345
Q ss_pred cCCCCCcccCchhccCCC-CChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCchhHH
Q 010078 448 AETGTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSFLE 511 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~~~-~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp~ip 511 (518)
...++..|++||.+.... ++.++|+||||+++|+|++|+.||....+.+....+......+.+|
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 224 (258)
T cd06632 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIP 224 (258)
T ss_pred ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcC
Confidence 567899999999998776 8999999999999999999999998887766666654433344433
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=280.66 Aligned_cols=205 Identities=39% Similarity=0.711 Sum_probs=180.9
Q ss_pred eeeeecCceEEEEEEEC-----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecC
Q 010078 298 SKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 372 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~-----~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ 372 (518)
++||+|+||.||++... +..|++|+++...... ....+.+|+.+++.++|+||+++++++.....+++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 46899999999999876 6679999998764433 46788999999999999999999999999889999999999
Q ss_pred CCchhHHHhhh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 373 GGSVYDYLHKL--------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 373 ggsL~~~l~~~--------~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
+++|.+++... ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 159 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence 99999999875 3778999999999999999999999999999999999999999999999999998665432
Q ss_pred ---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 445 ---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 445 ---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
......++..|+|||.+....++.++|+||||+++|+|++ |..||...++.+....+..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~ 222 (262)
T cd00192 160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK 222 (262)
T ss_pred ccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 2234457889999999988899999999999999999999 6999999988777666553
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=286.51 Aligned_cols=214 Identities=29% Similarity=0.563 Sum_probs=181.5
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~-------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~ 361 (518)
|...+|.+.+.||.|+||.||++... +..+|+|.++.. .......+.+|+.++++++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 45567899999999999999999742 234888887643 334456799999999999999999999999999
Q ss_pred CCcceeeeecCCCchhHHHhhhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcE
Q 010078 362 PSLCIVTEFMSGGSVYDYLHKLK------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVV 429 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~~~------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~v 429 (518)
..+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 99999999999999999997532 248999999999999999999999999999999999999999999
Q ss_pred EEEeeCcceecccCCc---cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhh
Q 010078 430 KVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 430 kL~DFGla~~~~~~~~---~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~ 504 (518)
+|+|||+++....... .....++..|+|||.+.+..++.++|+|||||++|+|++ |..||...++......+.+.
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~ 238 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 238 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999875433221 122335678999999999999999999999999999998 99999988887766665543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=283.29 Aligned_cols=211 Identities=33% Similarity=0.630 Sum_probs=181.3
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~-~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
|+|..++|++.++||+|+||.||++.. .++.||+|.+...... ...+.+|+.++++++|+||+++++++. ....|
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 678889999999999999999999986 4578999998754433 357889999999999999999999875 45689
Q ss_pred eeeeecCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 366 IVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
++|||+++++|.+++... ...++...+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 999999999999998653 3468889999999999999999999999999999999999999999999999997655322
Q ss_pred cc--ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHh
Q 010078 445 VM--TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 501 (518)
Q Consensus 445 ~~--~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~i 501 (518)
.. ....++..|+|||++.+..++.++|+||||+++|||++ |+.||.+.+..+....+
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 216 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL 216 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH
Confidence 21 12345678999999999999999999999999999999 99999988876655543
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=283.64 Aligned_cols=209 Identities=33% Similarity=0.597 Sum_probs=179.2
Q ss_pred CeeeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCC----hHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCccee
Q 010078 293 HLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERIN----SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~-~~~~vAVKvlk~~~~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV 367 (518)
+|++++.||+|+||.||+|.. .++.+|+|.++..... ......+.+|+.++++++|+||+++++++.....+|++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 467889999999999999986 5677999988754322 23345688999999999999999999999999999999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc-----
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ----- 442 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~----- 442 (518)
|||++|++|.+++.+ .+.++...+..++.|++.||.|||+.+|+|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 81 MEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 999999999999976 45788999999999999999999999999999999999999999999999999875422
Q ss_pred --CCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 010078 443 --SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 443 --~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv 502 (518)
........++..|+|||++.+..++.++|+||||+++|+|++|+.||...+.......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~ 221 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG 221 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh
Confidence 112234468899999999999999999999999999999999999999877765554433
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=281.44 Aligned_cols=213 Identities=37% Similarity=0.666 Sum_probs=182.4
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~~-~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
|++..++|++.++||+|+||.||++... +..+|+|.++..... ...+.+|+.++++++|+|++++++++.. ...|
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIY 76 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcE
Confidence 6788889999999999999999999864 467999998865443 3568899999999999999999998754 5689
Q ss_pred eeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 366 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
++|||+++++|.+++.... ..+++..++.++.|++.|+.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 9999999999999997642 458999999999999999999999999999999999999999999999999997654432
Q ss_pred cc--ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 445 VM--TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 445 ~~--~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
.. ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+..
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~ 218 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER 218 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 11 12234568999999998899999999999999999999 9999999887776666443
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=298.68 Aligned_cols=221 Identities=33% Similarity=0.609 Sum_probs=180.8
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEeecc
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGAC 358 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~-------~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~ 358 (518)
|++..++|+++++||+|+||.||+|.+ .++.||||+++.... ......+.+|+.+|.++ +|+||+++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 788889999999999999999999974 346799999976432 33356788999999999 589999999987
Q ss_pred cCC-CCcceeeeecCCCchhHHHhhhc-----------------------------------------------------
Q 010078 359 TKP-PSLCIVTEFMSGGSVYDYLHKLK----------------------------------------------------- 384 (518)
Q Consensus 359 ~~~-~~~~lV~Ey~~ggsL~~~l~~~~----------------------------------------------------- 384 (518)
... ..++++|||+++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 654 45789999999999999986522
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc---ccc
Q 010078 385 -------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV---MTA 448 (518)
Q Consensus 385 -------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~---~~~ 448 (518)
..+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||++........ ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 2356778889999999999999999999999999999999999999999999875432211 112
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCch
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHS 508 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~rp 508 (518)
..+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+.....+..+.++
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 301 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 301 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC
Confidence 234677999999999999999999999999999997 999998876554455555555443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=291.39 Aligned_cols=221 Identities=32% Similarity=0.612 Sum_probs=186.4
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEeec
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGA 357 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~-------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~ 357 (518)
.|.+..++|.+.+.||+|+||.||+++.. +..||+|+++... .......+.+|+.+++++ +|+||++++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 57888889999999999999999999752 2469999887543 234456789999999999 79999999999
Q ss_pred ccCCCCcceeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCc
Q 010078 358 CTKPPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436 (518)
Q Consensus 358 ~~~~~~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGl 436 (518)
+...+..|++|||+++++|.++++... ..+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||+
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999999997633 3389999999999999999999999999999999999999999999999999
Q ss_pred ceecccCCc---cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCc
Q 010078 437 ARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 437 a~~~~~~~~---~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
++....... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||......+.....+..+.+
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 262 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR 262 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc
Confidence 875433221 112345678999999999999999999999999999998 99999887766555555544433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=312.38 Aligned_cols=216 Identities=31% Similarity=0.511 Sum_probs=184.1
Q ss_pred eeeecCceEEEEEEECCc--eEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecCCCch
Q 010078 299 KVASGSYGDLYRGTYCSQ--DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (518)
Q Consensus 299 ~LG~G~fG~Vy~g~~~~~--~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL 376 (518)
.||+|.||+||.|++... .+|||.+... ++...+-+.+||.+.++|+|+|||+++|.|.+++.+-|.||.++||||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 589999999999987654 4677776532 444567788999999999999999999999999999999999999999
Q ss_pred hHHHhhhcCCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc-CCCcEEEEeeCcceecccCCc-cccCCCC
Q 010078 377 YDYLHKLKGVF--KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSGV-MTAETGT 452 (518)
Q Consensus 377 ~~~l~~~~~~l--~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid-~~~~vkL~DFGla~~~~~~~~-~~~~~gt 452 (518)
.++++..=|++ .+..+..+.+||+.||.|||.+.|||||||-+||||+ ..|.+||+|||.++....-.. +.+.+||
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGT 739 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGT 739 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccc
Confidence 99998866777 7889999999999999999999999999999999997 468999999999987665443 4467999
Q ss_pred CcccCchhccCC--CCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHhhhhcCchhHHHHHhh
Q 010078 453 YRWMAPEVIEHK--PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA-VGVVQKVHHSFLEQRLRK 516 (518)
Q Consensus 453 ~~y~APEvl~~~--~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~-~~iv~~~~rp~ip~~~~~ 516 (518)
..|||||+|..+ .|+.++|||||||++.||.||++||..+...|++ .+|--=...|.||..++.
T Consensus 740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsa 806 (1226)
T KOG4279|consen 740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSA 806 (1226)
T ss_pred hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHH
Confidence 999999999764 5899999999999999999999999888555554 444333456888887764
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=321.80 Aligned_cols=203 Identities=23% Similarity=0.438 Sum_probs=174.5
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
.+|++.++||+|+||.||+|.+ +++.||||+++.... .....+++.+|+.++++++||||+++++++.+.+..|++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5789999999999999999987 467899999875433 3344677999999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhh----------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcce
Q 010078 369 EFMSGGSVYDYLHKL----------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~----------~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~ 438 (518)
||++|++|.+++... ...++...++.++.||+.||+|||++||+||||||+|||++.++.++|+|||+++
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999999998642 1234566788999999999999999999999999999999999999999999997
Q ss_pred ecccCC-------------------ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 439 VKAQSG-------------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 439 ~~~~~~-------------------~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
...... .....+||+.|||||++.+..++.++|||||||++|||+||+.||...+.
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~ 236 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence 652110 11124689999999999999999999999999999999999999976443
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=289.22 Aligned_cols=217 Identities=31% Similarity=0.617 Sum_probs=185.3
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEee
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG 356 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g 356 (518)
..|+++.++|++.+.||+|+||.||++.+.+ ..+|+|+++.... ......+.+|+.+++++ +|+||+++++
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 4688999999999999999999999998643 4689999886533 33456788999999999 7999999999
Q ss_pred cccCCCCcceeeeecCCCchhHHHhhh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 010078 357 ACTKPPSLCIVTEFMSGGSVYDYLHKL---------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 421 (518)
Q Consensus 357 ~~~~~~~~~lV~Ey~~ggsL~~~l~~~---------------~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NI 421 (518)
++.....++++|||+++++|.++++.. ...+++..++.++.||+.|+.|||++||+||||||+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 999999999999999999999999642 24588899999999999999999999999999999999
Q ss_pred EEcCCCcEEEEeeCcceecccCCc---cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHH
Q 010078 422 LMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 497 (518)
Q Consensus 422 Lid~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~ 497 (518)
+++.++.+||+|||+++....... .....++..|+|||++.+..++.++|||||||++|||++ |..||...+..+.
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 243 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence 999999999999999976543221 122234578999999999999999999999999999998 9999998877665
Q ss_pred HHHhh
Q 010078 498 AVGVV 502 (518)
Q Consensus 498 ~~~iv 502 (518)
...+.
T Consensus 244 ~~~~~ 248 (293)
T cd05053 244 FKLLK 248 (293)
T ss_pred HHHHH
Confidence 55543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=278.32 Aligned_cols=211 Identities=26% Similarity=0.457 Sum_probs=181.3
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC-CCCcceeee
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-PPSLCIVTE 369 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~-~~~~~lV~E 369 (518)
.|++.+.||+|+||.||+++. .++.|++|.+..........+.+.+|+.++++++|+|++++++.+.. ...+|++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 478899999999999999986 45779999987655555556778999999999999999999988754 445789999
Q ss_pred ecCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-ccc
Q 010078 370 FMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT 447 (518)
Q Consensus 370 y~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~ 447 (518)
|+++++|.+++... ...+++..++.++.|++.|+.|||++|++||||||+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS 160 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence 99999999999764 3458999999999999999999999999999999999999999999999999997654322 233
Q ss_pred cCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
...+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+.......+..
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~ 216 (257)
T cd08223 161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE 216 (257)
T ss_pred cccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Confidence 45688999999999999999999999999999999999999998777665555443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=282.17 Aligned_cols=211 Identities=33% Similarity=0.591 Sum_probs=180.6
Q ss_pred CCCCeeeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCc
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~~~-----~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~ 364 (518)
+..+|++.+.||+|+||.||+|.... ..|+||+++... .......|..|+.+++.++||||+++++++......
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 34678899999999999999998642 259999987543 344567899999999999999999999999999999
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
++||||+++++|.+++....+.++...++.++.|++.|+.|||++|++|+||||+||+++.++.++|+|||+++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 99999999999999998766778999999999999999999999999999999999999999999999999987543322
Q ss_pred cc---ccCC---CCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHh
Q 010078 445 VM---TAET---GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 501 (518)
Q Consensus 445 ~~---~~~~---gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~i 501 (518)
.. .... .+..|+|||.+.+..++.++|||||||++|||++ |..||...+.......+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i 224 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI 224 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 11 1111 2457999999999999999999999999999997 99999988776665554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=283.13 Aligned_cols=212 Identities=31% Similarity=0.596 Sum_probs=180.4
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-----~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
++...+|.+.++||.|+||.||+|.+.. ..|+||...... .....+.+.+|+.++++++||||+++++++.. .
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 5667789999999999999999998643 358999876543 24456789999999999999999999998875 4
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
..|+||||+++++|.+++......++...++.++.|++.|+.|||++|++|+||||+||+++.++.++|+|||+++....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 57899999999999999987555689999999999999999999999999999999999999999999999999876544
Q ss_pred CCcc--ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHh
Q 010078 443 SGVM--TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 501 (518)
Q Consensus 443 ~~~~--~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~i 501 (518)
.... +...++..|+|||.+....++.++||||||+++|||++ |..||...+..+....+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~ 221 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI 221 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 3221 12234567999999988899999999999999999996 99999988876666553
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=282.33 Aligned_cols=209 Identities=33% Similarity=0.624 Sum_probs=179.5
Q ss_pred eeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCh-------HHHHHHHHHHHHHHhcCCCcceEEeecccCCCCc
Q 010078 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-------DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~-------~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~ 364 (518)
|.+++.||+|+||.||+|.. .++.+|+|.+....... .....+.+|+.++++++||||+++++++......
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 56778999999999999986 45789999887543321 2335688899999999999999999999999999
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
+++|||+++++|.+++.. .+.++...+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.++......
T Consensus 82 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 82 NIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred EEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 999999999999999976 4678899999999999999999999999999999999999999999999999987654221
Q ss_pred -------ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 445 -------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 445 -------~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+.+..+..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 226 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE 226 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc
Confidence 11123578899999999999999999999999999999999999998877776665433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=283.77 Aligned_cols=208 Identities=25% Similarity=0.378 Sum_probs=179.1
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|++.+.||+|+||.||++... ++.||+|++..........+.+.+|+.++++++|+||+++++++.....+++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36888999999999999999874 6789999987544333344568899999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-cccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~ 448 (518)
|+++++|..++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07847 81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD 159 (286)
T ss_pred ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence 9999888877654 4568999999999999999999999999999999999999999999999999998655433 2334
Q ss_pred CCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 010078 449 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 500 (518)
Q Consensus 449 ~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~ 500 (518)
..++..|+|||++.+ ..++.++|+||||+++|+|++|+.||.+.+..+....
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~ 212 (286)
T cd07847 160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYL 212 (286)
T ss_pred cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 567889999999866 5688999999999999999999999998887665544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=279.67 Aligned_cols=210 Identities=27% Similarity=0.473 Sum_probs=182.4
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
+|++.++||.|+||.||+++. .++.+++|.++.... ....+.+.+|+.+++.++|+||+++++.+.....+|++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 478889999999999999986 467899999865432 33456788899999999999999999999999999999999
Q ss_pred cCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc-ccc
Q 010078 371 MSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-MTA 448 (518)
Q Consensus 371 ~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~-~~~ 448 (518)
+++++|.+++... ...++...++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||.++....... ...
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT 159 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence 9999999998653 34588999999999999999999999999999999999999999999999999976544332 234
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
..+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+.......+.+
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~ 214 (255)
T cd08219 160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ 214 (255)
T ss_pred ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc
Confidence 5688999999999999999999999999999999999999998887766666543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=281.98 Aligned_cols=221 Identities=30% Similarity=0.496 Sum_probs=183.8
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCcceEEeecccC--CCCc
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI---NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPSL 364 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~---~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~--~~~~ 364 (518)
..|++.+.||+|+||.||++.. .+..|++|+++.... .......+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4578889999999999999986 467899998875432 22344678899999999999999999998765 3567
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS- 443 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~- 443 (518)
+++|||+++++|.+++.. .+.++...++.++.|++.||.|||+++|+||||||+||+++.++.++|+|||+++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 899999999999999976 456889999999999999999999999999999999999999999999999998754321
Q ss_pred ---CccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCchhHHHH
Q 010078 444 ---GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSFLEQR 513 (518)
Q Consensus 444 ---~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp~ip~~ 513 (518)
.......++..|+|||.+.+..++.++|+|||||++|+|++|+.||....+.+...........+.+|..
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (266)
T cd06651 161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSH 233 (266)
T ss_pred ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchh
Confidence 1122345788999999999999999999999999999999999999988877766665544445554443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=286.08 Aligned_cols=216 Identities=22% Similarity=0.421 Sum_probs=191.8
Q ss_pred CCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
.+.|.+.+.||+|.|+.||+... +|+.+|+|++..........+++.+|+.|.+.|+||||+++.+.+......|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 36788899999999999998864 6788999988766555556688999999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC---CCcEEEEeeCcceecccCCc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVKAQSGV 445 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~---~~~vkL~DFGla~~~~~~~~ 445 (518)
|+|.|+.|..-+-+ +..+++..+-.++.||+.+++|+|.+||||||+||.|+|+-. ..-+||+|||++........
T Consensus 90 e~m~G~dl~~eIV~-R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~ 168 (355)
T KOG0033|consen 90 DLVTGGELFEDIVA-REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA 168 (355)
T ss_pred ecccchHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence 99999999877755 356788888899999999999999999999999999999953 34699999999988775556
Q ss_pred cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCc
Q 010078 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 446 ~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
.....|||.|||||++...+|+..+|||+-|+|||-||.|.+||-+.+....+.+|++..+.
T Consensus 169 ~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd 230 (355)
T KOG0033|consen 169 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYD 230 (355)
T ss_pred cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccC
Confidence 66789999999999999999999999999999999999999999999998888888876554
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=285.78 Aligned_cols=211 Identities=29% Similarity=0.505 Sum_probs=182.2
Q ss_pred CCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCccee
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV 367 (518)
..+.|++.++||+|+||.||+|+.. ++.+++|++... .......+.+|+.+++.++|+||+++++.+.....+|+|
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 3467999999999999999999874 578999998754 344567789999999999999999999999888899999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-Ccc
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVM 446 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~-~~~ 446 (518)
|||++|++|..++.+....+++..+..++.||+.++.|||++|++||||||+||+++.++.++|+|||++...... ...
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 167 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR 167 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccccc
Confidence 9999999999988766677899999999999999999999999999999999999999999999999988653322 222
Q ss_pred ccCCCCCcccCchhcc-----CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 010078 447 TAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~-----~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv 502 (518)
....+++.|+|||++. ...++.++|+|||||++|+|++|+.||...++.+....+.
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~ 228 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA 228 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHh
Confidence 3456889999999984 4557889999999999999999999998888776665544
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=285.72 Aligned_cols=209 Identities=31% Similarity=0.518 Sum_probs=182.1
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
+.|++.++||.|+||.||++++. +..+++|+++.. .......+.+|+.++++++|+||+++++.+.....+|+|||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 56888999999999999999874 678999998754 34445778999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-Ccccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~-~~~~~ 448 (518)
|+++++|.+++.+....+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++...... .....
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 162 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT 162 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccce
Confidence 99999999999876677999999999999999999999999999999999999999999999999987654322 12234
Q ss_pred CCCCCcccCchhcc-----CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 010078 449 ETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 449 ~~gt~~y~APEvl~-----~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv 502 (518)
..+++.|+|||++. ...++.++|+||||+++|+|++|+.||...++.+....+.
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 221 (280)
T cd06611 163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL 221 (280)
T ss_pred eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHh
Confidence 46889999999974 4567889999999999999999999999988877666644
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=269.72 Aligned_cols=224 Identities=30% Similarity=0.468 Sum_probs=193.8
Q ss_pred CceeeCCCCeeeeeeeeecCceEE--EEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEeecccCC
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDL--YRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKP 361 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~V--y~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~ 361 (518)
..+++..+++.-+..||+|+||.| |+-.++|+-.|+|.++.. .+.+.+++.+.|+.+..+. .+|++|.|||+..+.
T Consensus 39 ~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~t-vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re 117 (282)
T KOG0984|consen 39 RNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT-VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE 117 (282)
T ss_pred CccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhh-cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc
Confidence 348899999999999999999985 566678899999998865 3456677888888876554 699999999999999
Q ss_pred CCcceeeeecCCCchhHHHhh---hcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEcCCCcEEEEeeCcc
Q 010078 362 PSLCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVA 437 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~---~~~~l~~~~i~~i~~qIa~aL~yLHs~-gIiHrDLKp~NILid~~~~vkL~DFGla 437 (518)
...+|.||.| ..||..+..+ ..+.+++..+-+|+..+..||.|||++ .+||||+||+|||||.+|.+|+||||.+
T Consensus 118 gdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 118 GDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGIS 196 (282)
T ss_pred ccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccc
Confidence 9999999999 6788887653 367799999999999999999999976 8999999999999999999999999999
Q ss_pred eecccCCccccCCCCCcccCchhcc----CCCCChhhHHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHhhhhcCchhHH
Q 010078 438 RVKAQSGVMTAETGTYRWMAPEVIE----HKPYDHKADVFSFGIVLWELLTGKLPYE-YLTPLQAAVGVVQKVHHSFLE 511 (518)
Q Consensus 438 ~~~~~~~~~~~~~gt~~y~APEvl~----~~~~s~ksDVwSlGviL~eLltG~~Pf~-~~~~~q~~~~iv~~~~rp~ip 511 (518)
....++-..+...|...|||||.+. ...|+.++||||||++++||.+++.||+ ..+|+|.+.+||+.. .|.+|
T Consensus 197 G~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep-~P~Lp 274 (282)
T KOG0984|consen 197 GYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP-SPQLP 274 (282)
T ss_pred eeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC-CCCCc
Confidence 8887777777788999999999984 3479999999999999999999999996 569999999999854 44443
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=280.44 Aligned_cols=214 Identities=33% Similarity=0.610 Sum_probs=182.1
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEEC--Cc---eEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCC
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQ---DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~--~~---~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~ 363 (518)
|..++|+..+.||+|+||.||+|+.. +. .+++|.++... .......+.+|+.++++++|+||+++++++.....
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 45567888999999999999999863 32 58999887543 23345678999999999999999999999999999
Q ss_pred cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC
Q 010078 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~ 443 (518)
.|+||||+++++|.+++....+.+++..+..++.|++.|+.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999999876677899999999999999999999999999999999999999999999999998755432
Q ss_pred Ccc----ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 444 GVM----TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 444 ~~~----~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
... .....+..|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+.+
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~ 225 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND 225 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc
Confidence 111 11123457999999998899999999999999999998 9999988887766666544
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=299.11 Aligned_cols=212 Identities=23% Similarity=0.440 Sum_probs=194.8
Q ss_pred CCeeeeeeeeecCceEEEEEE--ECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~--~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
.-|.+.+.||+|-|++|-+++ ++|..||||++.+...+.-....+.+|++.|+.++|||||++|.+......+|+|+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 457778899999999999886 589999999999888777777889999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc-CCCcEEEEeeCcceecccCCcccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSGVMTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid-~~~~vkL~DFGla~~~~~~~~~~~ 448 (518)
.-.+|+|++|+-++...+.+....+++.||+.|+.|+|+..+|||||||+||.+- .-|.|||.|||++.........+.
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~T 177 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTT 177 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhc
Confidence 9999999999999888999999999999999999999999999999999998875 568999999999988877778889
Q ss_pred CCCCCcccCchhccCCCCC-hhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 449 ETGTYRWMAPEVIEHKPYD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s-~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
.+|+..|.|||++.+..|+ ++.||||||+|||-|++|++||...+.-+.+-.|+.
T Consensus 178 sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImD 233 (864)
T KOG4717|consen 178 SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMD 233 (864)
T ss_pred ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhc
Confidence 9999999999999999997 578999999999999999999998887777766654
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=281.51 Aligned_cols=214 Identities=34% Similarity=0.680 Sum_probs=181.1
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcce
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~l 366 (518)
|-+..++|++.+.||+|+||.||++...++.||+|+++... ....+.+|+.+++.++||||+++++++... ..++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred CcccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 34455789999999999999999999999999999987532 235788999999999999999999998764 5799
Q ss_pred eeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc
Q 010078 367 VTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 445 (518)
Q Consensus 367 V~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~ 445 (518)
+|||+++++|.+++.... ..++...++.++.|++.|+.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999999999997643 35788999999999999999999999999999999999999999999999998754322
Q ss_pred cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCch
Q 010078 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHS 508 (518)
Q Consensus 446 ~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~rp 508 (518)
......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+.... +.++.++
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~ 216 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC-VEKGYRM 216 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH-HhCCCCC
Confidence 122334568999999998899999999999999999998 9999998887665544 3334443
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=288.82 Aligned_cols=215 Identities=32% Similarity=0.628 Sum_probs=182.8
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEEC---------CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEe
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI 355 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~---------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~ 355 (518)
.|++...+|.+++.||+|+||.||++++. +..||+|+++... .......+.+|+.+++.+ +||||++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchhee
Confidence 57888999999999999999999999752 2358999887543 233456789999999999 799999999
Q ss_pred ecccCCCCcceeeeecCCCchhHHHhhhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 010078 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420 (518)
Q Consensus 356 g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~N 420 (518)
+++......|+||||+++++|.+++.... ..++...+..++.||+.||.|||++|++||||||+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 99999999999999999999999997632 246778899999999999999999999999999999
Q ss_pred EEEcCCCcEEEEeeCcceecccCC---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 010078 421 LLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ 496 (518)
Q Consensus 421 ILid~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q 496 (518)
|+++.++.+||+|||+++...... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 999999999999999997654322 1223345678999999998899999999999999999998 899999887766
Q ss_pred HHHHh
Q 010078 497 AAVGV 501 (518)
Q Consensus 497 ~~~~i 501 (518)
....+
T Consensus 248 ~~~~~ 252 (304)
T cd05101 248 LFKLL 252 (304)
T ss_pred HHHHH
Confidence 65554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=286.45 Aligned_cols=209 Identities=24% Similarity=0.425 Sum_probs=178.0
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
.++|++.++||.|+||.||+|... ++.||+|.++..... .....+.+|+.+++.++|+||+++++++.....+|+||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 367999999999999999999874 678999998754322 22345778999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-ccc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT 447 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~ 447 (518)
||++ ++|.+++......+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... ...
T Consensus 84 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (301)
T cd07873 84 EYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYS 162 (301)
T ss_pred eccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccc
Confidence 9996 59999988766778999999999999999999999999999999999999999999999999987543322 223
Q ss_pred cCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 010078 448 AETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV 501 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~i 501 (518)
...+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~ 217 (301)
T cd07873 163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217 (301)
T ss_pred ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 4567889999999865 45889999999999999999999999988876554443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=282.79 Aligned_cols=207 Identities=32% Similarity=0.520 Sum_probs=177.4
Q ss_pred CCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
.++|++.++||+|+||.||+|+. .++.||+|+++.... .....+.+|+.++++++||||+++++++.....+|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 35789999999999999999986 467799999875422 22356788999999999999999999999889999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-ccc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT 447 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~ 447 (518)
||+++++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....... ...
T Consensus 86 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06646 86 EYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164 (267)
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence 99999999999876 5678999999999999999999999999999999999999999999999999997654322 233
Q ss_pred cCCCCCcccCchhcc---CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 010078 448 AETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 500 (518)
Q Consensus 448 ~~~gt~~y~APEvl~---~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~ 500 (518)
...++..|+|||.+. ...++.++|+|||||++|||++|+.||....+.+....
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~ 220 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL 220 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee
Confidence 456889999999984 45578899999999999999999999987766554433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=278.91 Aligned_cols=210 Identities=36% Similarity=0.656 Sum_probs=180.4
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~~-~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
|++..+.|++.++||+|+||.||++.+. +..+++|.++.. ......+.+|+.++++++|+||+++++.+.. ...+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 7888999999999999999999999864 456999988753 2234678899999999999999999999887 7789
Q ss_pred eeeeecCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 366 IVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
++|||+++++|.+++.+. ...++...+..++.||+.|+.|||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999999999763 3457888899999999999999999999999999999999999999999999987654322
Q ss_pred c--cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 010078 445 V--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVG 500 (518)
Q Consensus 445 ~--~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~ 500 (518)
. .....++..|+|||++....++.++|+||||+++|+|++ |+.||...+..+....
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~ 215 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA 215 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 1 122345677999999998889999999999999999999 9999998877655544
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=277.47 Aligned_cols=212 Identities=25% Similarity=0.450 Sum_probs=185.3
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
+|++.+.||.|+||.||++.. .++.+++|++............+.+|+.+++.++||||+++++.+......++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 478889999999999999876 567899999876655555677899999999999999999999999888899999999
Q ss_pred cCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCC-CcEEEEeeCcceecccCCcccc
Q 010078 371 MSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVKAQSGVMTA 448 (518)
Q Consensus 371 ~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~-~~vkL~DFGla~~~~~~~~~~~ 448 (518)
++|++|.+++.... ..+++..+..++.|++.++.|||++|++|+||+|+||+++.+ +.++|+|||.+...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT 160 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccc
Confidence 99999999997643 358899999999999999999999999999999999999855 4689999999987655444445
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
..++..|+|||.+.+..++.++||||||+++|+|++|+.||...+....+..+...
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 216 (256)
T cd08220 161 VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG 216 (256)
T ss_pred cccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc
Confidence 67889999999999988999999999999999999999999988877666665543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=310.47 Aligned_cols=212 Identities=30% Similarity=0.522 Sum_probs=185.7
Q ss_pred eeeeeeeeecCceEEEEEEECCce--EEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeec
Q 010078 294 LKFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~~~~~--vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 371 (518)
+.|+..||.|+||.||++...... .|-|++... .......|+-||.||..++||+||+++++|...+.++|+.|||
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 455678999999999999865433 567776543 4556788999999999999999999999999999999999999
Q ss_pred CCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCccee-cccCCccccCC
Q 010078 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-KAQSGVMTAET 450 (518)
Q Consensus 372 ~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~-~~~~~~~~~~~ 450 (518)
.||-+...+-.....+++.++..++.|++.||.|||+++|||||||..|||++-+|.|+|+|||++-. ...-.......
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFI 191 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFI 191 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhcccc
Confidence 99999999988888999999999999999999999999999999999999999999999999998642 22233456789
Q ss_pred CCCcccCchhc-----cCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCch
Q 010078 451 GTYRWMAPEVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHS 508 (518)
Q Consensus 451 gt~~y~APEvl-----~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp 508 (518)
|||+|||||++ ...+|++++|||||||+|.||..+.+|...++|+..+.+|-. --+|
T Consensus 192 GTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK-SePP 253 (1187)
T KOG0579|consen 192 GTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-SEPP 253 (1187)
T ss_pred CCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh-cCCC
Confidence 99999999986 467899999999999999999999999999999999999544 4444
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=280.47 Aligned_cols=204 Identities=33% Similarity=0.637 Sum_probs=176.8
Q ss_pred eeeeecCceEEEEEEECC-----ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecC
Q 010078 298 SKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 372 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~~-----~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ 372 (518)
++||+|+||.||+|.+.. ..||||.++..... ...+.+.+|+.++++++|+||+++++.+.. ..+++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999998643 25899998876543 556789999999999999999999999888 88999999999
Q ss_pred CCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC----ccc
Q 010078 373 GGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG----VMT 447 (518)
Q Consensus 373 ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~----~~~ 447 (518)
+++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||+++...... ...
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 158 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE 158 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence 999999997754 568999999999999999999999999999999999999999999999999987654422 112
Q ss_pred cCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
...++..|+|||.+.+..++.++|||||||++|+|++ |+.||...+..+....+..
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~ 215 (257)
T cd05040 159 HLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK 215 (257)
T ss_pred CCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 3456788999999999999999999999999999999 9999998888776666543
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=281.33 Aligned_cols=207 Identities=30% Similarity=0.532 Sum_probs=169.7
Q ss_pred eeeeecCceEEEEEEEC----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecCC
Q 010078 298 SKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~----~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (518)
++||+|+||.||+|+.. ...+++|.++... .......+.+|+.+++.++|+||+++++.+.....+|+||||+++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 36899999999999753 2457888766432 344456788999999999999999999999999999999999999
Q ss_pred CchhHHHhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc---c
Q 010078 374 GSVYDYLHKLKG----VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV---M 446 (518)
Q Consensus 374 gsL~~~l~~~~~----~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~---~ 446 (518)
++|.+++..... ..++..+..++.||+.|+.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence 999999976432 245678889999999999999999999999999999999999999999999865433211 1
Q ss_pred ccCCCCCcccCchhcc-------CCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhc
Q 010078 447 TAETGTYRWMAPEVIE-------HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~-------~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~ 505 (518)
....++..|+|||++. ...++.++|||||||++|||++ |..||...++.+....++...
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 226 (269)
T cd05042 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQ 226 (269)
T ss_pred CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhcc
Confidence 2234567899999974 3457889999999999999999 899999988877766655443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=282.92 Aligned_cols=201 Identities=25% Similarity=0.426 Sum_probs=180.2
Q ss_pred CeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
.|++.+.||.|+||.||++... ++.|++|++..... .....+.+.+|+.++++++||||+++++.+......|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788999999999999999875 78899999875433 22456789999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccccC
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 449 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~~ 449 (518)
|+.|++|.+++.. ...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+............
T Consensus 81 ~~~~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 159 (258)
T cd05578 81 LLLGGDLRYHLSQ-KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST 159 (258)
T ss_pred CCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcccccc
Confidence 9999999999977 367899999999999999999999999999999999999999999999999998766554444556
Q ss_pred CCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 450 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 450 ~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
.++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 160 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 160 SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred CCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 788999999999988899999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=278.31 Aligned_cols=208 Identities=37% Similarity=0.714 Sum_probs=180.0
Q ss_pred CCCCeeeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~~-~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
+..+|++.+.||+|+||.||++.+. +..+++|+++..... ...+.+|+.++++++|||++++++++......|+||
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 4568899999999999999999875 678999998754433 246889999999999999999999999989999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc--c
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV--M 446 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~--~ 446 (518)
||+++++|.+++....+.+++..++.++.|++.++.|||+++++|+||||+||+++.++.++|+|||.++....... .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 99999999999987666789999999999999999999999999999999999999999999999999875433221 1
Q ss_pred ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 010078 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVG 500 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~ 500 (518)
....++..|+|||.+.+..++.++|+||||+++|||++ |+.||...........
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 213 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVET 213 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 12234578999999998899999999999999999998 9999988776555544
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=281.38 Aligned_cols=210 Identities=24% Similarity=0.427 Sum_probs=183.9
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
+|++.+.||+|+||.||+|++ .++.|++|++............+.+|+.++++++||||+++++++.....+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 478899999999999999987 467899999887654455567899999999999999999999999999999999999
Q ss_pred cCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC--cccc
Q 010078 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMTA 448 (518)
Q Consensus 371 ~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~--~~~~ 448 (518)
+ +++|.+++......+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence 9 999999997766779999999999999999999999999999999999999999999999999987655433 2334
Q ss_pred CCCCCcccCchhccCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 449 ETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
..++..|+|||.+.+. .++.++||||||+++|+|++|..||.+.+.......++.
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~ 215 (286)
T cd07832 160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFR 215 (286)
T ss_pred ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHH
Confidence 5788999999998654 568999999999999999999999988877666655554
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=277.78 Aligned_cols=207 Identities=34% Similarity=0.555 Sum_probs=183.4
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
.++|++.++||+|+||.||+|... ++.+++|.++... ....+.+|+.++++++|+||+++++.+.....+|+++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 367888999999999999999875 5789999987532 1578999999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-ccc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT 447 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~ 447 (518)
||+++++|.+++......+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN 157 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccc
Confidence 9999999999998766788999999999999999999999999999999999999999999999999987654432 233
Q ss_pred cCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 010078 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV 501 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~i 501 (518)
...++..|+|||++.+..++.++||||||+++|+|++|+.||...++.+....+
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~ 211 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI 211 (256)
T ss_pred cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh
Confidence 445788999999999999999999999999999999999999988776655443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=294.11 Aligned_cols=207 Identities=34% Similarity=0.550 Sum_probs=186.4
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
+-|.++++||.|+||.||++.+ .|+-+|||.+..+ ...+++..|+.||++++.|++|++||.+.+...+|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 3467789999999999999965 5788999987743 236789999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-Ccccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~-~~~~~ 448 (518)
||..||+.+.++.++.++.+..+..++...++||+|||...-||||||..|||++.+|..||+|||++....+. .....
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT 188 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT 188 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence 99999999999998999999999999999999999999999999999999999999999999999999655432 23345
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv 502 (518)
..||+.|||||++..-.|+.++||||||++..||..|++||....|..++.-|-
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP 242 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP 242 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc
Confidence 689999999999999999999999999999999999999999999987766543
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=282.01 Aligned_cols=212 Identities=33% Similarity=0.616 Sum_probs=180.7
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEEC--C----ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYC--S----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~--~----~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
+...+|++.+.||+|+||.||+|.+. + ..+|+|+++.... ......+.+|+.++++++|+||+++++++.. .
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 45578899999999999999999863 2 2589998875533 3445778999999999999999999999877 7
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
..++||||+++++|.+++......+++..+..++.||+.|+.|||++|++||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 89999999999999999987667799999999999999999999999999999999999999999999999999976543
Q ss_pred CCccc---cCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhh
Q 010078 443 SGVMT---AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 443 ~~~~~---~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv 502 (518)
..... ...++..|+|||.+....++.++|+||||+++|||++ |+.||...++.+....+.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 225 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Confidence 22111 1223568999999988899999999999999999999 999999988766555443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=282.94 Aligned_cols=213 Identities=30% Similarity=0.571 Sum_probs=180.7
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~-------~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~ 361 (518)
+...++.+.++||+|+||.||++.. .+..+++|.++.. .......+.+|+.+++.++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 4567888999999999999999964 2346888887643 344567899999999999999999999999988
Q ss_pred CCcceeeeecCCCchhHHHhhhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC
Q 010078 362 PSLCIVTEFMSGGSVYDYLHKLK--------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~~~--------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~ 427 (518)
...|++|||+++++|.+++.... ..+++..++.++.||+.|+.|||++|++||||||+|||++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 89999999999999999997642 2478899999999999999999999999999999999999999
Q ss_pred cEEEEeeCcceecccCCc---cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 428 VVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 428 ~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
.++|+|||+++....... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+.+
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 999999999875433221 112234678999999999999999999999999999998 9999988888776666544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.19 Aligned_cols=196 Identities=24% Similarity=0.422 Sum_probs=170.8
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEEC----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCc
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~----~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~ 364 (518)
+-..+|+++++||.|+||.||++... +..|++|.+... ..+.+|+.+|++++||||+++++++......
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 44568999999999999999999764 356899987643 2346799999999999999999999988899
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
|++||++ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 162 ~lv~e~~-~~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 162 CMVMPKY-KCDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EEEehhc-CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9999999 5689998844 5779999999999999999999999999999999999999999999999999987544322
Q ss_pred ---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCC
Q 010078 445 ---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 493 (518)
Q Consensus 445 ---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~ 493 (518)
......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+..
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 1234579999999999999999999999999999999999999997643
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=285.62 Aligned_cols=212 Identities=28% Similarity=0.569 Sum_probs=178.1
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEECC----------------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcce
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYCS----------------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~~----------------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 352 (518)
+...+|++.++||+|+||.||++...+ ..||+|+++... .......|.+|+.++++++|+|++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcC
Confidence 445689999999999999999987532 248999987643 344566799999999999999999
Q ss_pred EEeecccCCCCcceeeeecCCCchhHHHhhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 010078 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK-----------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 421 (518)
Q Consensus 353 ~l~g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~-----------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NI 421 (518)
++++++......|+||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999986532 1367888999999999999999999999999999999
Q ss_pred EEcCCCcEEEEeeCcceecccCCc---cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc--CCCCCCCCCHHH
Q 010078 422 LMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT--GKLPYEYLTPLQ 496 (518)
Q Consensus 422 Lid~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt--G~~Pf~~~~~~q 496 (518)
+++.++.+||+|||++........ .....++..|+|||++.+..++.++|+|||||++|+|++ |..||...+..+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999875433221 122345678999999998899999999999999999988 778999887766
Q ss_pred HHHHh
Q 010078 497 AAVGV 501 (518)
Q Consensus 497 ~~~~i 501 (518)
....+
T Consensus 241 ~~~~~ 245 (295)
T cd05097 241 VIENT 245 (295)
T ss_pred HHHHH
Confidence 55543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=282.02 Aligned_cols=212 Identities=32% Similarity=0.569 Sum_probs=176.4
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~~-------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~ 361 (518)
+..+.|.+.+.||+|+||.||+|.+.+ ..|++|.+.... .......|.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 344678899999999999999998744 568888876432 233456789999999999999999999999888
Q ss_pred CCcceeeeecCCCchhHHHhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC---cEEEE
Q 010078 362 PSLCIVTEFMSGGSVYDYLHKLK------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VVKVA 432 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~~~------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~---~vkL~ 432 (518)
...++||||++|++|.+++.... ..+++..+++++.||+.|+.|||+++++||||||+||+++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 89999999999999999997643 2588899999999999999999999999999999999998654 59999
Q ss_pred eeCcceecccCCc---cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHh
Q 010078 433 DFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 501 (518)
Q Consensus 433 DFGla~~~~~~~~---~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~i 501 (518)
|||+++....... ......+..|+|||++.+..++.++|||||||++|||++ |..||...+.......+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~ 234 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV 234 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999976532211 112233567999999998899999999999999999997 99999988766554443
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=284.11 Aligned_cols=206 Identities=24% Similarity=0.407 Sum_probs=173.8
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
+|++.++||+|+||.||++++ +++.|++|+++...........+.+|+.++++++|+||+++++++.....+|+|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 478889999999999999987 467899999876543333345678899999999999999999999999999999999
Q ss_pred cCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-CccccC
Q 010078 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAE 449 (518)
Q Consensus 371 ~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~-~~~~~~ 449 (518)
++ ++|.+++....+.+++..++.++.||++||.|||++||+||||||+||+++.++.++|+|||+++..... ......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE 159 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCC
Confidence 95 5888888765677999999999999999999999999999999999999999999999999998754332 223345
Q ss_pred CCCCcccCchhccCC-CCChhhHHHHHHHHHHHHHcCCCCC-CCCCHHHHHH
Q 010078 450 TGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPY-EYLTPLQAAV 499 (518)
Q Consensus 450 ~gt~~y~APEvl~~~-~~s~ksDVwSlGviL~eLltG~~Pf-~~~~~~q~~~ 499 (518)
.++..|+|||++.+. .++.++|||||||++|+|++|..|| .+.+....+.
T Consensus 160 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~ 211 (284)
T cd07839 160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 211 (284)
T ss_pred ccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHH
Confidence 678899999998664 4799999999999999999998885 4444433333
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=277.34 Aligned_cols=218 Identities=24% Similarity=0.446 Sum_probs=184.7
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC--CCCcceee
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPSLCIVT 368 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~--~~~~~lV~ 368 (518)
+|++.+.||+|+||.||++.. .++.+++|+++...........+.+|+.++++++|+||+++++.+.. ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477889999999999999976 45789999988765566666789999999999999999999997753 34578999
Q ss_pred eecCCCchhHHHhhh---cCCCCHHHHHHHHHHHHHHHHHHH-----HCCceeccCCCCcEEEcCCCcEEEEeeCcceec
Q 010078 369 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLH-----QNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~---~~~l~~~~i~~i~~qIa~aL~yLH-----s~gIiHrDLKp~NILid~~~~vkL~DFGla~~~ 440 (518)
||+++++|.+++... ...+++..++.++.||+.|+.||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999764 457899999999999999999999 899999999999999999999999999999876
Q ss_pred ccCCc-cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCchhHH
Q 010078 441 AQSGV-MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSFLE 511 (518)
Q Consensus 441 ~~~~~-~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp~ip 511 (518)
..... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+.... +.++..+.+|
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~ 231 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASK-IKEGKFRRIP 231 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHH-HhcCCCCCCc
Confidence 55433 3445789999999999998899999999999999999999999998875554444 4444444444
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=305.56 Aligned_cols=215 Identities=28% Similarity=0.503 Sum_probs=196.3
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
..|.+.++||+|.|++|.+++. ++..||||++.+...+....+.+.+|+++|+.|+|||||+++.+...+..+|+|||
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e 135 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME 135 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence 5688889999999999999976 67889999999888888777889999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccccC
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 449 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~~ 449 (518)
|+.+|.+++|+.+ .+.+.+.....++.|+.+|++|||+++|+|||||++|||++.+-++||+|||++.+..........
T Consensus 136 ya~~ge~~~yl~~-~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~ 214 (596)
T KOG0586|consen 136 YASGGELFDYLVK-HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQTF 214 (596)
T ss_pred eccCchhHHHHHh-cccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccccccccc
Confidence 9999999999988 677777999999999999999999999999999999999999999999999999998877777889
Q ss_pred CCCCcccCchhccCCCC-ChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCc
Q 010078 450 TGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 450 ~gt~~y~APEvl~~~~~-s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
+|++.|.|||++.+..| ++.+|+||+|+++|-|++|.+||++-+..+--..++...+|
T Consensus 215 cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~r 273 (596)
T KOG0586|consen 215 CGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYR 273 (596)
T ss_pred CCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeec
Confidence 99999999999999888 47899999999999999999999987766665555555544
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=274.88 Aligned_cols=204 Identities=35% Similarity=0.643 Sum_probs=175.0
Q ss_pred eeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecCCCch
Q 010078 298 SKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~-~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL 376 (518)
+.||+|+||.||+|... ++.+|+|+++... .......+.+|+.++++++||||+++++++......++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 36899999999999864 5679999987543 334455788999999999999999999999999999999999999999
Q ss_pred hHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcc--ccCCCCCc
Q 010078 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM--TAETGTYR 454 (518)
Q Consensus 377 ~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~--~~~~gt~~ 454 (518)
.+++......+++..+..++.|++.+|.|||++|++||||||+||+++.++.++|+|||++......... ....++..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK 159 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccc
Confidence 9999765667899999999999999999999999999999999999999999999999998754332211 12234567
Q ss_pred ccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhh
Q 010078 455 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 455 y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv 502 (518)
|+|||++.+..++.++|+||||+++|+|++ |..||......+....+.
T Consensus 160 y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~ 208 (250)
T cd05085 160 WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE 208 (250)
T ss_pred ccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 999999998899999999999999999999 999999888776665543
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=283.49 Aligned_cols=212 Identities=30% Similarity=0.583 Sum_probs=179.3
Q ss_pred CCCCeeeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~~-------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
...+|.+.+.||.|+||.||+++.. +..+++|.++.. .......+.+|+.++++++|+||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 3456888899999999999999753 245888887643 2333467889999999999999999999999999
Q ss_pred CcceeeeecCCCchhHHHhhhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~ 427 (518)
..++||||+++++|.+++.... +.+++..++.++.||+.|+.|||++||+||||||+||+++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 9999999999999999996532 3478899999999999999999999999999999999999999
Q ss_pred cEEEEeeCcceecccCC---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 428 VVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 428 ~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|||+| |+.||...++.+....+.+
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 240 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 240 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC
Confidence 99999999987543321 1223456788999999999999999999999999999999 9999988888776655433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=289.92 Aligned_cols=218 Identities=32% Similarity=0.620 Sum_probs=184.0
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEECC---------ceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEE
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQF 354 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~---------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l 354 (518)
..|++...+|+++++||+|+||.||++.+.+ ..||+|+++... .......+.+|+.+++++ +||||+++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 4789999999999999999999999997532 258999887542 333457889999999999 79999999
Q ss_pred eecccCCCCcceeeeecCCCchhHHHhhhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 010078 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419 (518)
Q Consensus 355 ~g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~ 419 (518)
+++|.....++++|||+++++|.+++.... ..++...+..++.||+.||.|||++|++||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 163 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 999999999999999999999999997532 23677888999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEeeCcceecccCC---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 010078 420 NLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPL 495 (518)
Q Consensus 420 NILid~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~ 495 (518)
|||++.++.+||+|||+++...... ......++..|+|||++.+..++.++||||||+++|||++ |..||.+.+..
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 9999999999999999997654322 1222334567999999999999999999999999999998 89999988776
Q ss_pred HHHHHhhh
Q 010078 496 QAAVGVVQ 503 (518)
Q Consensus 496 q~~~~iv~ 503 (518)
+....+.+
T Consensus 244 ~~~~~~~~ 251 (334)
T cd05100 244 ELFKLLKE 251 (334)
T ss_pred HHHHHHHc
Confidence 66555433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=281.61 Aligned_cols=207 Identities=32% Similarity=0.544 Sum_probs=178.2
Q ss_pred CCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
.++|++.++||+|+||.||+++. +++.||+|+++... ......+.+|+.+++.++||||+++++.+.....+|++|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 35788899999999999999987 46789999987543 223456788999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-Cccc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMT 447 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~-~~~~ 447 (518)
||+++++|.+++.. .+.+++..++.++.|++.|+.|||++|++|+||||+||+++.++.++|+|||++...... ....
T Consensus 86 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06645 86 EFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK 164 (267)
T ss_pred eccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence 99999999999876 567999999999999999999999999999999999999999999999999998754432 2233
Q ss_pred cCCCCCcccCchhcc---CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 010078 448 AETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 500 (518)
Q Consensus 448 ~~~gt~~y~APEvl~---~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~ 500 (518)
...|+..|+|||++. ...++.++|+|||||++|+|++|+.||....+......
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~ 220 (267)
T cd06645 165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL 220 (267)
T ss_pred cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh
Confidence 457899999999984 45688999999999999999999999977666544443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=285.22 Aligned_cols=206 Identities=29% Similarity=0.524 Sum_probs=179.3
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
.+|++.+.||+|+||.||+|.. .++.|++|.+...... ....+.+|+.+++.++|+||+++++.+......|+|||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 5788899999999999999986 4678999988764432 24668899999999999999999999998889999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-cccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~ 448 (518)
|++|++|.+++.. ..++...+..++.|++.|+.|||++||+||||||+||+++.++.++|+|||++....... ....
T Consensus 98 ~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 175 (296)
T cd06654 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (296)
T ss_pred ccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCc
Confidence 9999999999864 468899999999999999999999999999999999999999999999999987543322 2234
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV 501 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~i 501 (518)
..+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...++......+
T Consensus 176 ~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~ 228 (296)
T cd06654 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228 (296)
T ss_pred ccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHH
Confidence 57889999999999988999999999999999999999999888775544443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=284.73 Aligned_cols=214 Identities=29% Similarity=0.551 Sum_probs=177.1
Q ss_pred CeeeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 293 HLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~~~-------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
+|++.+.||+|+||.||+|+... ..+++|+++.... ......+.+|+.+++.++||||+++++.+......+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 36788999999999999998643 3588888875433 333567899999999999999999999999999999
Q ss_pred eeeeecCCCchhHHHhhhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 010078 366 IVTEFMSGGSVYDYLHKLK-----------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 422 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~-----------------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NIL 422 (518)
++|||+.+++|.+++.... ..++...++.++.|++.|+.|||++|++||||||+|||
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 9999999999999986421 24778899999999999999999999999999999999
Q ss_pred EcCCCcEEEEeeCcceecccCCc---cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 010078 423 MDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAA 498 (518)
Q Consensus 423 id~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~ 498 (518)
++.++.++|+|||+++....... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..+.+..
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 239 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999999999875433221 122345678999999998899999999999999999999 99999988765544
Q ss_pred HHhhhhcCch
Q 010078 499 VGVVQKVHHS 508 (518)
Q Consensus 499 ~~iv~~~~rp 508 (518)
.. +.+..++
T Consensus 240 ~~-~~~~~~~ 248 (290)
T cd05045 240 NL-LKTGYRM 248 (290)
T ss_pred HH-HhCCCCC
Confidence 33 4333333
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=282.30 Aligned_cols=213 Identities=31% Similarity=0.583 Sum_probs=180.4
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~-------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~ 361 (518)
++.++|++.++||.|+||.||++... +..||+|+++... .......+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 45678999999999999999999863 4679999987543 344557799999999999999999999999999
Q ss_pred CCcceeeeecCCCchhHHHhhhc---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 010078 362 PSLCIVTEFMSGGSVYDYLHKLK---------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~~~---------------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~N 420 (518)
...|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999997432 236778889999999999999999999999999999
Q ss_pred EEEcCCCcEEEEeeCcceecccCC---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 010078 421 LLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ 496 (518)
Q Consensus 421 ILid~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q 496 (518)
|+++.++.++|+|||+++...... .......+..|+|||.+.+..++.++|||||||++|||++ |..||.+.++.+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999987543221 1122334667999999999999999999999999999998 889999888776
Q ss_pred HHHHhh
Q 010078 497 AAVGVV 502 (518)
Q Consensus 497 ~~~~iv 502 (518)
....+.
T Consensus 241 ~~~~~~ 246 (288)
T cd05050 241 VIYYVR 246 (288)
T ss_pred HHHHHh
Confidence 665543
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=283.19 Aligned_cols=212 Identities=33% Similarity=0.602 Sum_probs=180.5
Q ss_pred CCCCeeeeeeeeecCceEEEEEEECC------------------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcc
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTYCS------------------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 351 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~~~------------------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnI 351 (518)
...+|+++++||+|+||.||+++... ..||+|++..... ......+.+|+.++++++|+||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCE
Confidence 45678999999999999999987643 3489999886532 3456789999999999999999
Q ss_pred eEEeecccCCCCcceeeeecCCCchhHHHhhhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 010078 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK----------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 421 (518)
Q Consensus 352 v~l~g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~----------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NI 421 (518)
+++++++......+++|||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999899999999999999999997643 2688999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEeeCcceecccCC---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc--CCCCCCCCCHHH
Q 010078 422 LMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT--GKLPYEYLTPLQ 496 (518)
Q Consensus 422 Lid~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt--G~~Pf~~~~~~q 496 (518)
+++.++.++|+|||+++...... ......++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 99999999999999987543322 1223345778999999988889999999999999999998 789998887766
Q ss_pred HHHHhh
Q 010078 497 AAVGVV 502 (518)
Q Consensus 497 ~~~~iv 502 (518)
....+.
T Consensus 242 ~~~~~~ 247 (296)
T cd05051 242 VIENAG 247 (296)
T ss_pred HHHHHH
Confidence 555443
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=282.09 Aligned_cols=206 Identities=34% Similarity=0.561 Sum_probs=181.3
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|++.+.||.|+||.||+|.. +++.|++|++.... .......+.+|+.+++.++|+||+++++++.....+|+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 3578889999999999999987 46789999987543 23345678899999999999999999999998899999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-Ccccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~-~~~~~ 448 (518)
|+++++|.+++.. ..+++..++.++.|++.|+.|||+.+++|+||+|+||+++.++.++|+|||+++..... .....
T Consensus 80 ~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 80 YCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred eeCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence 9999999999976 37899999999999999999999999999999999999999999999999999766543 23345
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 500 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~ 500 (518)
..++..|+|||.+.+..++.++||||||+++|+|+||+.||...++.+....
T Consensus 158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~ 209 (274)
T cd06609 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL 209 (274)
T ss_pred ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH
Confidence 5788899999999988899999999999999999999999988777665544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=277.29 Aligned_cols=212 Identities=35% Similarity=0.557 Sum_probs=183.8
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|++++.||.|+||.||+|.. .+..+++|++....... ....+.+|+.+++.++|+||+++++.+......+++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 4688999999999999999986 45779999987654443 46789999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcc-
Q 010078 370 FMSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM- 446 (518)
Q Consensus 370 y~~ggsL~~~l~~~~--~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~- 446 (518)
|++|++|.+++.... ..+++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||++.........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 999999999997642 46899999999999999999999999999999999999999999999999998755443221
Q ss_pred ----ccCCCCCcccCchhccCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 447 ----TAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 447 ----~~~~gt~~y~APEvl~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
....++..|+|||.+... .++.++|+||||+++|+|++|+.||...++.+...++++.
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~ 222 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN 222 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC
Confidence 334688999999998776 7899999999999999999999999988877666665554
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=289.49 Aligned_cols=207 Identities=21% Similarity=0.385 Sum_probs=174.0
Q ss_pred eeeeeeec--CceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeec
Q 010078 296 FGSKVASG--SYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (518)
Q Consensus 296 i~~~LG~G--~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 371 (518)
++++||+| +||+||+++. +++.||+|+++...........+.+|+.+++.++||||+++++++..++..|+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 6889999976 4678999999876555555667788999999999999999999999999999999999
Q ss_pred CCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC------
Q 010078 372 SGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG------ 444 (518)
Q Consensus 372 ~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~------ 444 (518)
++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++++||+........+
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 161 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV 161 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence 999999999654 3458999999999999999999999999999999999999999999999998654322111
Q ss_pred --ccccCCCCCcccCchhccC--CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 010078 445 --VMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 445 --~~~~~~gt~~y~APEvl~~--~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv 502 (518)
......++..|+|||++.+ ..|+.++|||||||++|||++|+.||......+......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 223 (327)
T cd08227 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 223 (327)
T ss_pred ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHh
Confidence 1122356778999999976 468999999999999999999999999877766555544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=281.43 Aligned_cols=208 Identities=32% Similarity=0.540 Sum_probs=179.0
Q ss_pred eeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeec
Q 010078 294 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 371 (518)
|++.++||+|+||.||+|... +..+++|.+... .......+.+|+.+++.++|+||+++++++......|+||||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 577889999999999999875 456788887643 3344567889999999999999999999999989999999999
Q ss_pred CCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-CccccCC
Q 010078 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAET 450 (518)
Q Consensus 372 ~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~-~~~~~~~ 450 (518)
++++|..++......+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++...... .......
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 164 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 164 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccccccc
Confidence 999999988765677999999999999999999999999999999999999999999999999998654322 1223456
Q ss_pred CCCcccCchhcc-----CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 451 GTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 451 gt~~y~APEvl~-----~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
++..|+|||++. +..++.++|+|||||++|+|++|+.||...++.+....+.+
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~ 222 (282)
T cd06643 165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK 222 (282)
T ss_pred ccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhh
Confidence 889999999983 45678899999999999999999999999888777666543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=278.81 Aligned_cols=202 Identities=29% Similarity=0.473 Sum_probs=178.0
Q ss_pred eeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecCCCch
Q 010078 300 VASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (518)
Q Consensus 300 LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL 376 (518)
||.|+||.||+++.. ++.+++|++..... .....+.+.+|+.+++.++||||+++++.+.....+|++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999986 78899999875433 234457799999999999999999999999999999999999999999
Q ss_pred hHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccccCCCCCccc
Q 010078 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM 456 (518)
Q Consensus 377 ~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~ 456 (518)
.+++.+ ...++...+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.............++..|+
T Consensus 81 ~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
T cd05572 81 WTILRD-RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYV 159 (262)
T ss_pred HHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCcc
Confidence 999976 4568899999999999999999999999999999999999999999999999998665543334457889999
Q ss_pred CchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHhh
Q 010078 457 APEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT--PLQAAVGVV 502 (518)
Q Consensus 457 APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~--~~q~~~~iv 502 (518)
+||.+.+..++.++|+||||+++|+|++|..||.... +.+....++
T Consensus 160 ~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 207 (262)
T cd05572 160 APEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDIL 207 (262)
T ss_pred ChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHh
Confidence 9999988889999999999999999999999998877 655555554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=276.69 Aligned_cols=201 Identities=29% Similarity=0.536 Sum_probs=177.2
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
+|++.++||+|+||.||+|.. +++.|++|+++.........+.+.+|+.+++.++|+||+++++.+.....+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 478889999999999999986 567899999987655555678899999999999999999999999888899999999
Q ss_pred cCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcc----
Q 010078 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM---- 446 (518)
Q Consensus 371 ~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~---- 446 (518)
+++++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 81 CSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred CCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 999999999976 456888999999999999999999999999999999999999999999999998765443221
Q ss_pred -ccCCCCCcccCchhccCCC---CChhhHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 447 -TAETGTYRWMAPEVIEHKP---YDHKADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 447 -~~~~gt~~y~APEvl~~~~---~s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
....++..|+|||++.+.. ++.++||||||+++|+|++|+.||.....
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~ 211 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN 211 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc
Confidence 1346788999999998766 88999999999999999999999987643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=285.66 Aligned_cols=213 Identities=23% Similarity=0.379 Sum_probs=183.1
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCh-HHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
++|++.+.||+|+||.||++... ++.||+|.+....... .....+..|+.+++.++|+||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999874 5889999987654432 34567889999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc--
Q 010078 369 EFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-- 445 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~-- 445 (518)
||+.|++|.+++... ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998764 35689999999999999999999999999999999999999999999999998864322110
Q ss_pred ----------------------------cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 010078 446 ----------------------------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 497 (518)
Q Consensus 446 ----------------------------~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~ 497 (518)
.....||..|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 1123578899999999999999999999999999999999999998887766
Q ss_pred HHHhhhh
Q 010078 498 AVGVVQK 504 (518)
Q Consensus 498 ~~~iv~~ 504 (518)
...+.++
T Consensus 241 ~~~~~~~ 247 (316)
T cd05574 241 FSNILKK 247 (316)
T ss_pred HHHHhcC
Confidence 6665543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=278.99 Aligned_cols=212 Identities=26% Similarity=0.527 Sum_probs=180.3
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEECC------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC-
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK- 360 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~~------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~- 360 (518)
.++.++|++.+.||+|+||.||+|.+.. ..|++|+++.. ........+.+|+.++++++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 3567889999999999999999998754 67999988743 344456778999999999999999999998765
Q ss_pred CCCcceeeeecCCCchhHHHhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEe
Q 010078 361 PPSLCIVTEFMSGGSVYDYLHKLK-------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVAD 433 (518)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~l~~~~-------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~D 433 (518)
....+++++|+++++|.+++.... ..+++..++.++.||+.||.|||+++++||||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 467899999999999999987532 4588999999999999999999999999999999999999999999999
Q ss_pred eCcceecccCC---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 010078 434 FGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVG 500 (518)
Q Consensus 434 FGla~~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~ 500 (518)
||+++...... ......++..|+|||++.+..++.++||||||+++||+++ |+.||...++.+....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~ 231 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAY 231 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHH
Confidence 99997543221 1122345678999999999999999999999999999999 9999998887765554
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=275.63 Aligned_cols=201 Identities=32% Similarity=0.606 Sum_probs=171.0
Q ss_pred eeeeecCceEEEEEEECC-----ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecC
Q 010078 298 SKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 372 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~~-----~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ 372 (518)
++||+|+||.||+|.+.. ..+|+|.++..... .....+.+|+.+++.++|+||+++++++.. ...++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCC
Confidence 479999999999998633 56999998865443 445779999999999999999999998764 46899999999
Q ss_pred CCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcc-c---c
Q 010078 373 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM-T---A 448 (518)
Q Consensus 373 ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~-~---~ 448 (518)
+++|.+++.. ...+++..+..++.|++.|+.|||.++++|+||||+|||++.++.+||+|||+++........ . .
T Consensus 79 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 79 LGPLLKYLKK-RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 9999999977 347899999999999999999999999999999999999999999999999998755433211 1 1
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHh
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 501 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~i 501 (518)
..++..|+|||.+.+..++.++||||||+++|+|++ |..||...++.+....+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~ 211 (257)
T cd05060 158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML 211 (257)
T ss_pred ccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 123467999999999999999999999999999998 99999988876655554
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=275.81 Aligned_cols=201 Identities=23% Similarity=0.463 Sum_probs=176.1
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
+.|++.+.||.|+||.||+|... ++.|++|.++.... .......+.+|+.++++++|+|++++++++......++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 46889999999999999999874 78899998875332 3344678899999999999999999999999989999999
Q ss_pred eecCCCchhHHHhhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-
Q 010078 369 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG- 444 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~---~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~- 444 (518)
||+++++|.+++... ...++...++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 999999999998642 3458899999999999999999999999999999999999999999999999987654332
Q ss_pred ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCC
Q 010078 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL 492 (518)
Q Consensus 445 ~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (518)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 223456888999999999999999999999999999999999999543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=284.41 Aligned_cols=200 Identities=26% Similarity=0.436 Sum_probs=176.1
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|++.++||+|+||.||++... +..+++|.++... .......+.+|+.++++++||||+++++++...+.+|+|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 36889999999999999999874 5678999887542 34455678899999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs-~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~ 448 (518)
|++|++|.+++.+ .+.+++..+..++.||+.||.|||+ .+++|+||||+|||++.++.++|+|||++...... ....
T Consensus 80 y~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~ 157 (308)
T cd06615 80 HMDGGSLDQVLKK-AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANS 157 (308)
T ss_pred ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-cccc
Confidence 9999999999976 4678999999999999999999997 59999999999999999999999999998754332 2234
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
..++..|+|||++.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~ 203 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA 203 (308)
T ss_pred CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch
Confidence 5788999999999988899999999999999999999999976654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=307.87 Aligned_cols=194 Identities=30% Similarity=0.557 Sum_probs=171.2
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC------Ccceeee
Q 010078 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------SLCIVTE 369 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~------~~~lV~E 369 (518)
+.||+|+||.||+|+. .|+.||||.++... .....+...+|+++|++++|+|||++.++-.... ...+|||
T Consensus 19 e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 19 ERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 6899999999999974 67889999998754 3334577889999999999999999998754433 4579999
Q ss_pred ecCCCchhHHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc--CCC--cEEEEeeCcceecccC
Q 010078 370 FMSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD--ENE--VVKVADFGVARVKAQS 443 (518)
Q Consensus 370 y~~ggsL~~~l~~~~--~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid--~~~--~vkL~DFGla~~~~~~ 443 (518)
||.||||...|.+.. ..+++..++.++.+++.||.|||++||+||||||.||++- ++| ..||+|||.|+...++
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~ 177 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDN 177 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCC
Confidence 999999999997643 4699999999999999999999999999999999999984 333 5799999999999998
Q ss_pred CccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCC
Q 010078 444 GVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYL 492 (518)
Q Consensus 444 ~~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (518)
.......||..|.+||++.. +.|+...|.|||||++|++.||..||...
T Consensus 178 s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 178 SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 88999999999999999995 78899999999999999999999999643
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=275.76 Aligned_cols=213 Identities=24% Similarity=0.465 Sum_probs=185.0
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
+|++.++||+|+||.+|+++. .++.|++|.+............+.+|+.++++++||||+++++++......|+||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 478899999999999999876 567899999876544455567899999999999999999999999999999999999
Q ss_pred cCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc-ccc
Q 010078 371 MSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-MTA 448 (518)
Q Consensus 371 ~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~-~~~ 448 (518)
+.+++|.+++.... ..+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART 160 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence 99999999997643 3578899999999999999999999999999999999999999999999999976544321 223
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
..|++.|+|||++.+..++.++|+|||||++|+|++|+.||......+....++.+.
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~ 217 (256)
T cd08218 161 CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS 217 (256)
T ss_pred ccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC
Confidence 457889999999999999999999999999999999999999888777776665433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=286.28 Aligned_cols=191 Identities=25% Similarity=0.451 Sum_probs=158.7
Q ss_pred eeeeeecCceEEEEEEEC----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC--CCCcceeeee
Q 010078 297 GSKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPSLCIVTEF 370 (518)
Q Consensus 297 ~~~LG~G~fG~Vy~g~~~----~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~--~~~~~lV~Ey 370 (518)
+++||+|+||.||+|+.. ++.||+|.++..... ..+.+|+.+|++++||||+++++++.. ...+|++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999853 467999998754322 346789999999999999999998754 3457899999
Q ss_pred cCCCchhHHHhhh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE----cCCCcEEEEeeCcce
Q 010078 371 MSGGSVYDYLHKL--------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVAR 438 (518)
Q Consensus 371 ~~ggsL~~~l~~~--------~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILi----d~~~~vkL~DFGla~ 438 (518)
+ +++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 82 A-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred c-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 9 56888887532 1258889999999999999999999999999999999999 456789999999997
Q ss_pred ecccCC----ccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCC
Q 010078 439 VKAQSG----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYL 492 (518)
Q Consensus 439 ~~~~~~----~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (518)
...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 654321 2334578999999999876 45899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=280.16 Aligned_cols=200 Identities=27% Similarity=0.470 Sum_probs=171.9
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
+.|++.++||+|+||.||+|+. .++.||||.+...... .....+.+|+.+++.++|+||+++++++......|+|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 5788999999999999999986 4678999998754322 122456789999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-cccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~ 448 (518)
|+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||+++...... ....
T Consensus 84 ~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (291)
T cd07844 84 YLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN 162 (291)
T ss_pred cCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccc
Confidence 996 49999998766678999999999999999999999999999999999999999999999999987543221 1223
Q ss_pred CCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCC
Q 010078 449 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLT 493 (518)
Q Consensus 449 ~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~ 493 (518)
..++..|+|||++.+ ..++.++||||||+++|+|++|+.||....
T Consensus 163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 356889999999865 568999999999999999999999998765
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=281.07 Aligned_cols=194 Identities=32% Similarity=0.544 Sum_probs=170.7
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|++.+.||+|+||.||+|.. +++.||+|++.... .......+.+|+.++++++||||+++++.+......++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 3578889999999999999986 56789999987542 34445679999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccccC
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 449 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~~ 449 (518)
|+++++|..+ ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++...... .....
T Consensus 80 ~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~ 153 (279)
T cd06619 80 FMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTY 153 (279)
T ss_pred cCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCC
Confidence 9999998654 24678889999999999999999999999999999999999999999999999755432 23445
Q ss_pred CCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCC
Q 010078 450 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL 492 (518)
Q Consensus 450 ~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (518)
.+|..|+|||++.+..++.++|+||||+++|+|++|+.||...
T Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 196 (279)
T cd06619 154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI 196 (279)
T ss_pred CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence 7899999999999999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=279.71 Aligned_cols=202 Identities=23% Similarity=0.463 Sum_probs=175.5
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
++|++.+.||+|+||.||++.. .+..++||.+.... ........+.+|+.+++.++|+||+++++++......+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4677889999999999999985 57889999876432 23344568899999999999999999999999889999999
Q ss_pred eecCCCchhHHHhhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-
Q 010078 369 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG- 444 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~---~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~- 444 (518)
||++|++|.+++... ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 999999999998642 3458899999999999999999999999999999999999999999999999987654332
Q ss_pred ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCC
Q 010078 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 493 (518)
Q Consensus 445 ~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~ 493 (518)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+..
T Consensus 162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08229 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence 2234568899999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=279.63 Aligned_cols=210 Identities=33% Similarity=0.511 Sum_probs=172.8
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHH-HHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFI-MRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~i-L~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
++|++.+.||+|+||.||++... ++.||||+++....... ...+..|+.+ ++.++||||+++++++......|++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 36888999999999999999874 68899999876543333 3455556664 67778999999999999989999999
Q ss_pred eecCCCchhHHHhhh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 369 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~---~~~l~~~~i~~i~~qIa~aL~yLHs~-gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
||++ ++|.+++... ...+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|||+++......
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9995 6888887542 34689999999999999999999997 99999999999999999999999999987654443
Q ss_pred ccccCCCCCcccCchhccC----CCCChhhHHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHhhh
Q 010078 445 VMTAETGTYRWMAPEVIEH----KPYDHKADVFSFGIVLWELLTGKLPYEYL-TPLQAAVGVVQ 503 (518)
Q Consensus 445 ~~~~~~gt~~y~APEvl~~----~~~s~ksDVwSlGviL~eLltG~~Pf~~~-~~~q~~~~iv~ 503 (518)
..+...++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||... .+.+....+++
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 222 (283)
T cd06617 159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222 (283)
T ss_pred ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh
Confidence 3344578899999998864 55789999999999999999999999753 34455555443
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=277.09 Aligned_cols=204 Identities=33% Similarity=0.592 Sum_probs=169.7
Q ss_pred eeeeecCceEEEEEEECC--c--eEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEeecccCCCCcceeeeecC
Q 010078 298 SKVASGSYGDLYRGTYCS--Q--DVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMS 372 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~~--~--~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~~~~lV~Ey~~ 372 (518)
+.||+|+||.||+|+..+ . .+++|.++... .......+.+|+.+++++ +||||+++++++.....+|++|||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 368999999999998743 2 46888877432 334456788999999999 79999999999999999999999999
Q ss_pred CCchhHHHhhhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcc
Q 010078 373 GGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437 (518)
Q Consensus 373 ggsL~~~l~~~~---------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla 437 (518)
+++|.+++.... ..+++..++.++.|++.|++|||++|++||||||+||+++.++.+||+|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 999999997532 24788999999999999999999999999999999999999999999999998
Q ss_pred eecccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhh
Q 010078 438 RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 438 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv 502 (518)
..............+..|+|||++.+..++.++|+||||+++|||++ |..||...+..+....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~ 225 (270)
T cd05047 160 RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 225 (270)
T ss_pred cccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh
Confidence 63322111122234567999999999999999999999999999997 999998887766555543
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=279.31 Aligned_cols=206 Identities=34% Similarity=0.582 Sum_probs=179.6
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
..|+..++||.|+||.||+|++ .+..||+|+++.... ......+.+|+.++++++|+||+++++++......|+|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 3467778999999999999986 467899999875432 3445788999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-cccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~ 448 (518)
|++|++|.+++.. +.++...+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 83 ~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06640 83 YLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred cCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence 9999999999865 568899999999999999999999999999999999999999999999999997654332 2233
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 500 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~ 500 (518)
..++..|+|||++.+..++.++|+||||+++|||++|+.||...++......
T Consensus 161 ~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~ 212 (277)
T cd06640 161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL 212 (277)
T ss_pred ccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh
Confidence 4678899999999998999999999999999999999999998887665544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=283.92 Aligned_cols=203 Identities=30% Similarity=0.537 Sum_probs=177.7
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
.+|++.++||+|+||.||++.. .++.||+|.+...... ....+.+|+.+++.++|+||+++++++......|+|||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 6788899999999999999986 5788999998754332 24668899999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-cccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~ 448 (518)
|+++++|.+++.+ ..++...+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++....... ....
T Consensus 97 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 174 (297)
T cd06656 97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (297)
T ss_pred ccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCc
Confidence 9999999999865 567889999999999999999999999999999999999999999999999987544322 2234
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA 498 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~ 498 (518)
..+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...++.+..
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~ 224 (297)
T cd06656 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224 (297)
T ss_pred ccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe
Confidence 56888999999999999999999999999999999999999876664443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=281.96 Aligned_cols=211 Identities=26% Similarity=0.419 Sum_probs=179.9
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
++|++.+.||+|+||.||++... ++.|++|.+..... .......+.+|+.+++.++||||+++++.+.....+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999874 56799998875432 2234567889999999999999999999999988999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC----
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---- 444 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~---- 444 (518)
||++|++|.+++.. .+.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++......
T Consensus 81 e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (305)
T cd05609 81 EYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159 (305)
T ss_pred ecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence 99999999999976 4678999999999999999999999999999999999999999999999999886421110
Q ss_pred ------------ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 445 ------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 445 ------------~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
......++..|+|||.+.+..++.++|+|||||++|||++|..||.+.++.+....++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~ 230 (305)
T cd05609 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 230 (305)
T ss_pred cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 11123577889999999988999999999999999999999999998887766665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=282.12 Aligned_cols=211 Identities=26% Similarity=0.399 Sum_probs=181.2
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC--CCccee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIV 367 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~--~~~~lV 367 (518)
++|++.+.||.|+||.||+|++. ++.+++|.++...........+.+|+.++++++||||+++++++... ...|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999985 67799999886544444445677899999999999999999988766 789999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-Ccc
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVM 446 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~-~~~ 446 (518)
|||+. ++|.+++......+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...... ...
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 163 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY 163 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcccc
Confidence 99996 5999998775667999999999999999999999999999999999999999999999999998865543 233
Q ss_pred ccCCCCCcccCchhccCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 447 TAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....++.
T Consensus 164 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~ 221 (293)
T cd07843 164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFK 221 (293)
T ss_pred ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 445678899999998654 468999999999999999999999998888777666543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=279.76 Aligned_cols=209 Identities=34% Similarity=0.572 Sum_probs=175.1
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEeecccCC------C
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKP------P 362 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~------~ 362 (518)
..|++.++||+|+||.||+|.. .++.||+|++.... .....+.+|+.+++++ +|+||+++++++... .
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4577788999999999999987 45779999987542 2235688899999998 699999999988643 3
Q ss_pred CcceeeeecCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
.+|++|||+++++|.+++... ...+++..+..++.|++.|+.|||+++|+|+||||+||+++.++.++|+|||++....
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence 578999999999999999764 3468899999999999999999999999999999999999999999999999987654
Q ss_pred cC-CccccCCCCCcccCchhcc-----CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 442 QS-GVMTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 442 ~~-~~~~~~~gt~~y~APEvl~-----~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
.. .......|++.|+|||++. +..++.++|||||||++|||++|+.||....+......+..
T Consensus 163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~ 230 (272)
T cd06637 163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 230 (272)
T ss_pred cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc
Confidence 32 2334557899999999985 34688899999999999999999999988777665554443
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=277.49 Aligned_cols=203 Identities=28% Similarity=0.497 Sum_probs=167.8
Q ss_pred eeeeecCceEEEEEEECC----ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecCC
Q 010078 298 SKVASGSYGDLYRGTYCS----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~~----~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (518)
+.||+|+||.||+|++.+ ..+++|.++.... ......+.+|+.+++.++||||+++++++......++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 368999999999998643 4589998876543 23345788999999999999999999999988899999999999
Q ss_pred CchhHHHhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc---c
Q 010078 374 GSVYDYLHKLK----GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV---M 446 (518)
Q Consensus 374 gsL~~~l~~~~----~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~---~ 446 (518)
++|.+++.... ...+...+..++.|++.|+.|||++|++||||||+||+++.++.++|+|||+++....... .
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence 99999997532 2356677888999999999999999999999999999999999999999999875433221 1
Q ss_pred ccCCCCCcccCchhccCC-------CCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHh
Q 010078 447 TAETGTYRWMAPEVIEHK-------PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 501 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~-------~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~i 501 (518)
....++..|+|||++.+. .++.++|+||||+++|||++ |+.||...++.+.....
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~ 222 (269)
T cd05087 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT 222 (269)
T ss_pred CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH
Confidence 234567889999998642 35789999999999999996 99999988776655443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=279.45 Aligned_cols=209 Identities=27% Similarity=0.416 Sum_probs=178.4
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|++.++||+|+||.||++.+. ++.||+|++..........+.+.+|+.+++.++||||+++++++......|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36888999999999999999974 6789999887544444445678899999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-cccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~ 448 (518)
|+++++|..+... ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07846 81 FVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD 159 (286)
T ss_pred cCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence 9999988887755 4568999999999999999999999999999999999999999999999999987654322 2334
Q ss_pred CCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 010078 449 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV 501 (518)
Q Consensus 449 ~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~i 501 (518)
..++..|+|||++.+ ..++.++||||||+++|+|++|+.||...+..+....+
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~ 213 (286)
T cd07846 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHI 213 (286)
T ss_pred ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Confidence 567889999999865 45788999999999999999999999877665544443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=294.61 Aligned_cols=191 Identities=26% Similarity=0.436 Sum_probs=167.2
Q ss_pred CCCCeeeeeeeeecCceEEEEEEECC--ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCccee
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~~~--~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV 367 (518)
....|++.+.||+|+||.||+|+..+ +.||+|+.... ....|+.++++++|+||+++++++......|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 34569999999999999999999854 57999985432 234689999999999999999999999999999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccc
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT 447 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~ 447 (518)
|||+ .++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 136 ~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 214 (357)
T PHA03209 136 LPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL 214 (357)
T ss_pred EEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccc
Confidence 9999 568999987767789999999999999999999999999999999999999999999999999997654443444
Q ss_pred cCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCC
Q 010078 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf 489 (518)
...||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 567999999999999999999999999999999999854444
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=281.04 Aligned_cols=210 Identities=30% Similarity=0.572 Sum_probs=175.7
Q ss_pred CCCCeeeeeeeeecCceEEEEEEECC------------------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcc
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTYCS------------------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 351 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~~~------------------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnI 351 (518)
..++|++.++||+|+||.||++.+.+ ..+|+|+++... .......+.+|+.+++.++|+||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCc
Confidence 34678999999999999999985432 358999987542 34445789999999999999999
Q ss_pred eEEeecccCCCCcceeeeecCCCchhHHHhhhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 010078 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK----------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 421 (518)
Q Consensus 352 v~l~g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~----------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NI 421 (518)
+++++++......|+||||+++++|.+++.... ..+++..+..++.||+.|+.|||++|++|+||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999997632 2366778999999999999999999999999999999
Q ss_pred EEcCCCcEEEEeeCcceecccCCc---cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc--CCCCCCCCCHHH
Q 010078 422 LMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT--GKLPYEYLTPLQ 496 (518)
Q Consensus 422 Lid~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt--G~~Pf~~~~~~q 496 (518)
|++.++.++|+|||+++....... .....++..|++||...+..++.++|+|||||++|||++ |..||...++.+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999875433221 112234578999999888889999999999999999998 789998887766
Q ss_pred HHHH
Q 010078 497 AAVG 500 (518)
Q Consensus 497 ~~~~ 500 (518)
....
T Consensus 242 ~~~~ 245 (296)
T cd05095 242 VIEN 245 (296)
T ss_pred HHHH
Confidence 5543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=281.32 Aligned_cols=202 Identities=28% Similarity=0.453 Sum_probs=173.8
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|++.+.||+|+||.||++.+. +..||+|.++... .......+.+|+.++++++|+||+++++.+.....+|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 36888999999999999999875 7889999887542 33445778999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcc
Q 010078 370 FMSGGSVYDYLHKL--KGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 446 (518)
Q Consensus 370 y~~ggsL~~~l~~~--~~~l~~~~i~~i~~qIa~aL~yLHs-~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~ 446 (518)
|++|++|..++... ...+++..+..++.||+.||.|||+ .||+|+||||+||+++.++.++|+|||.+...... ..
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~ 158 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-LA 158 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-cc
Confidence 99999999998763 2368999999999999999999996 59999999999999999999999999998754332 23
Q ss_pred ccCCCCCcccCchhccCC------CCChhhHHHHHHHHHHHHHcCCCCCCCCCHH
Q 010078 447 TAETGTYRWMAPEVIEHK------PYDHKADVFSFGIVLWELLTGKLPYEYLTPL 495 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~------~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~ 495 (518)
....+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||...+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 213 (286)
T cd06622 159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA 213 (286)
T ss_pred ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh
Confidence 345688899999998543 3588999999999999999999999765543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=273.50 Aligned_cols=209 Identities=39% Similarity=0.720 Sum_probs=180.5
Q ss_pred eeeeeeeeecCceEEEEEEECC------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCccee
Q 010078 294 LKFGSKVASGSYGDLYRGTYCS------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~~~------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV 367 (518)
+++.+.||.|+||.||++.+.. ..||+|+++.... ......+.+|+.+++.++|+||+++++.+...+..|++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3567899999999999998865 6799999976533 22467899999999999999999999999998999999
Q ss_pred eeecCCCchhHHHhhhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcc
Q 010078 368 TEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 446 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~-l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~ 446 (518)
|||+++++|.+++...... +++..+..++.||+.|+.|||++|++|+||||+||+++.++.++|+|||+++........
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 9999999999999764444 899999999999999999999999999999999999999999999999999765543222
Q ss_pred c--cCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 447 T--AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 447 ~--~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
. ...+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+.+
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~ 219 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK 219 (258)
T ss_pred ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Confidence 2 1236789999999988889999999999999999998 8999998877776666443
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=287.61 Aligned_cols=209 Identities=26% Similarity=0.378 Sum_probs=180.4
Q ss_pred CCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC------C
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------P 362 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~------~ 362 (518)
.++|++.+.||+|+||.||++.. .++.||||++............+.+|+.++++++|+||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 36799999999999999999986 567899999876544444556788899999999999999999987544 2
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
..|+||||+. ++|.+++.. .++...+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred cEEEEEeccC-CCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 4699999995 588888754 288899999999999999999999999999999999999999999999999987655
Q ss_pred CCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 443 ~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
........++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......++.
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 231 (353)
T cd07850 171 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIE 231 (353)
T ss_pred CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 4444556788999999999999999999999999999999999999998877666666554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=282.47 Aligned_cols=213 Identities=26% Similarity=0.426 Sum_probs=181.0
Q ss_pred CCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC--CCcc
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLC 365 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~--~~~~ 365 (518)
..++|++.+.||.|+||.||+|+. +++.||+|+++...........+.+|+.++++++|+||+++++++... ..++
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 346799999999999999999987 467899999875543333334567899999999999999999988654 4589
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-C
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-G 444 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~-~ 444 (518)
+||||+. ++|.+++......+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++...... .
T Consensus 85 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 85 LVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred EEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence 9999995 5898888776677999999999999999999999999999999999999999999999999999765443 2
Q ss_pred ccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 445 VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 445 ~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...++.+....+.+
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~ 223 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQ 223 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 2333456788999999865 5689999999999999999999999999999888777655
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=273.61 Aligned_cols=205 Identities=32% Similarity=0.576 Sum_probs=169.4
Q ss_pred eeeeecCceEEEEEEEC-----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeeccc-CCCCcceeeeec
Q 010078 298 SKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT-KPPSLCIVTEFM 371 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~-----~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~-~~~~~~lV~Ey~ 371 (518)
+.||+|+||.||+|.+. ...+|||.+... ........+.+|+.+++.++||||+++++++. .+...+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 36899999999999863 245899987532 23344578889999999999999999999765 455689999999
Q ss_pred CCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-----cc
Q 010078 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-----VM 446 (518)
Q Consensus 372 ~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-----~~ 446 (518)
.+++|.+++.......+...+..++.||+.|+.|||+++++||||||+|||++.++.+||+|||+++...... ..
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 159 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence 9999999998755567788889999999999999999999999999999999999999999999987543221 11
Q ss_pred ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
....++..|+|||.+.+..++.++|||||||++|||++ |.+||...++.+....+.+
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~ 217 (262)
T cd05058 160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ 217 (262)
T ss_pred ccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence 12345678999999998999999999999999999999 5778888777666655443
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=276.46 Aligned_cols=226 Identities=28% Similarity=0.462 Sum_probs=195.7
Q ss_pred CCceeeCCCCeeeeeeeeecCceEEEEEEECC--ceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeecccC
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTK 360 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~--~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~ 360 (518)
......+.++++++..||+|+.|.|+++++.. .-.|||.+.... ++...++++..+.++.+.+ +|+||+.+|+|..
T Consensus 84 g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~ 162 (391)
T KOG0983|consen 84 GQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT 162 (391)
T ss_pred CcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence 44556677889999999999999999999865 778999988653 4555677888888776665 8999999999999
Q ss_pred CCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs-~gIiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
+...+|.||.| +..+..++....+++++..+-++...+++||.||-. .||||||+||+|||+|+.|++||||||.+..
T Consensus 163 n~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGr 241 (391)
T KOG0983|consen 163 NTDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGR 241 (391)
T ss_pred CchHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccce
Confidence 99999999999 778888888878899999999999999999999985 5999999999999999999999999999988
Q ss_pred cccCCccccCCCCCcccCchhcc---CCCCChhhHHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHhhhhcCchhHHH
Q 010078 440 KAQSGVMTAETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYL-TPLQAAVGVVQKVHHSFLEQ 512 (518)
Q Consensus 440 ~~~~~~~~~~~gt~~y~APEvl~---~~~~s~ksDVwSlGviL~eLltG~~Pf~~~-~~~q~~~~iv~~~~rp~ip~ 512 (518)
...+...+...|.+.|||||.+. ...|+.++||||||++++||.||+.||.+. +.++++-.|++ ..+|-+|.
T Consensus 242 lvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~ 317 (391)
T KOG0983|consen 242 LVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPG 317 (391)
T ss_pred eecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCc
Confidence 88887788889999999999985 457999999999999999999999999985 55788888777 44465553
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=279.67 Aligned_cols=210 Identities=25% Similarity=0.388 Sum_probs=179.5
Q ss_pred CeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC---hHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCccee
Q 010078 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN---SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~---~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV 367 (518)
+|++.+.||.|+||.||+|... ++.|+||.++..... ......+..|+.+++.++|+||+++++++.....+++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3778899999999999999874 678999998865433 33445677899999999999999999999998899999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-cc
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VM 446 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~ 446 (518)
|||+ +++|.+++......+++..++.++.||++||.|||++||+|+||||+||+++.++.++|+|||+++...... ..
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 9999 899999997644479999999999999999999999999999999999999999999999999997654432 23
Q ss_pred ccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 447 TAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......+.+
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~ 217 (298)
T cd07841 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFE 217 (298)
T ss_pred cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHH
Confidence 34467888999998854 5678999999999999999999999988777665555443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=277.47 Aligned_cols=208 Identities=26% Similarity=0.388 Sum_probs=179.6
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|++.++||+|+||.||+|... ++.|++|+++...........+.+|+.++++++|+||+++++++...+..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999874 6789999987655445556788999999999999999999999998889999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC--ccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMT 447 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~--~~~ 447 (518)
|++++.+..+..+ ...++...+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (288)
T cd07833 81 YVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159 (288)
T ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence 9988666655544 5668999999999999999999999999999999999999999999999999987655443 334
Q ss_pred cCCCCCcccCchhccCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 010078 448 AETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 500 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~ 500 (518)
...++..|+|||++.+. .++.++|+||||+++|+|++|+.||...+....+..
T Consensus 160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~ 213 (288)
T cd07833 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL 213 (288)
T ss_pred CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 45678899999999887 889999999999999999999999987766554443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=275.70 Aligned_cols=200 Identities=31% Similarity=0.556 Sum_probs=172.8
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC----hHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcce
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN----SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~l 366 (518)
.|+.++.||+|+||.||+++. +++.||+|+++..... ......+.+|+.++++++|+||+++++++...+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 367778999999999999975 5688999998754321 2245678999999999999999999999999999999
Q ss_pred eeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC-cEEEEeeCcceecccCC-
Q 010078 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSG- 444 (518)
Q Consensus 367 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~-~vkL~DFGla~~~~~~~- 444 (518)
||||++|++|.+++.. .+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||.+.......
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 81 FVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred EEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 9999999999999976 46789999999999999999999999999999999999998776 69999999987554321
Q ss_pred ----ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCC
Q 010078 445 ----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 493 (518)
Q Consensus 445 ----~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~ 493 (518)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 1123467889999999988899999999999999999999999997543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=297.71 Aligned_cols=214 Identities=23% Similarity=0.403 Sum_probs=184.2
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCC-CCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCc
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPE-RINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~-~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~ 364 (518)
..+...|..++.||-|+||+|.++... ...||+|.+++. ..........+.|-.||..-+.+.||+||..|.+.+.+
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence 466778888999999999999999754 456999988753 33445556788899999999999999999999999999
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc---
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA--- 441 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~--- 441 (518)
|+||+|++||++..+|-+ .+.|.+..++.++..+.+|+++.|+.|+|||||||+|||||.+|+|||.|||+|.-..
T Consensus 705 YFVMdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred EEEEeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999999999999876 6889999999999999999999999999999999999999999999999999985210
Q ss_pred c-----CC-----------------------------------ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHH
Q 010078 442 Q-----SG-----------------------------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWE 481 (518)
Q Consensus 442 ~-----~~-----------------------------------~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~e 481 (518)
+ .+ .-...+||+-|+|||++....|+..+|+||.|+||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 0 00 0011269999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCHHHHHHHhh
Q 010078 482 LLTGKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 482 LltG~~Pf~~~~~~q~~~~iv 502 (518)
|+.|+.||...+|.++-.+|+
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~ 884 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVI 884 (1034)
T ss_pred HhhCCCCccCCCCCcceeeee
Confidence 999999999988877655543
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=272.27 Aligned_cols=202 Identities=35% Similarity=0.674 Sum_probs=174.0
Q ss_pred eeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecCCCch
Q 010078 298 SKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~-~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL 376 (518)
++||.|+||.||++... ++.|++|+++..... .....+.+|+.++++++|+||+++++++......++||||++|++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 47899999999999875 788999998765433 4557899999999999999999999999999999999999999999
Q ss_pred hHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcc---ccCCCCC
Q 010078 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM---TAETGTY 453 (518)
Q Consensus 377 ~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~---~~~~gt~ 453 (518)
.+++.+....++...+..++.+++.++.|||+++++||||||+||+++.++.++|+|||+++........ ....++.
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI 159 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCccee
Confidence 9999775667889999999999999999999999999999999999999999999999998755422111 1123356
Q ss_pred cccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 010078 454 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVG 500 (518)
Q Consensus 454 ~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~ 500 (518)
.|+|||.+.+..++.++|+||||+++|+|+| |..||....+......
T Consensus 160 ~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~ 207 (251)
T cd05041 160 KWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER 207 (251)
T ss_pred ccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH
Confidence 7999999998899999999999999999999 8999988776554444
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=292.61 Aligned_cols=206 Identities=26% Similarity=0.418 Sum_probs=184.2
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEE--ECCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhcCCCcceEEeecccCCCC
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~--~~~~~vAVKvlk~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~ 363 (518)
+.+..+.|..-+.||+|+||.||-++ .+|+-||+|.+.+.+... ......++|-.||.+++.+.||.+-.+|...+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 35666778888999999999999775 467889999876554432 223457789999999999999999999999999
Q ss_pred cceeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 364 LCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
+|+||..|.||+|.-+|.+.. ..|++..++.++.+|+.||++||+.+||+|||||+|||+|+.|+++|+|+|+|.....
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999998886643 4699999999999999999999999999999999999999999999999999998888
Q ss_pred CCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCC
Q 010078 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL 492 (518)
Q Consensus 443 ~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (518)
.......+||.+|||||++.+..|+...|+|||||+||||+.|+.||..-
T Consensus 340 g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 340 GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 87777889999999999999999999999999999999999999999753
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=305.49 Aligned_cols=210 Identities=25% Similarity=0.435 Sum_probs=178.9
Q ss_pred CCceeeCCCCeeeeeeeeecCceEEEEEEECC--ceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeecc-c
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGAC-T 359 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~--~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~-~ 359 (518)
+..++|..-++++.+.|.+|+|+.||+++..+ ..||+|.+-.. ++...+.+.+||.+|++|. |+|||.+++.. .
T Consensus 29 G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~ 106 (738)
T KOG1989|consen 29 GQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI 106 (738)
T ss_pred ceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence 35789999999999999999999999998753 68999987654 6677888999999999998 99999999942 2
Q ss_pred CC------CCcceeeeecCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEcCCCcEE
Q 010078 360 KP------PSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVK 430 (518)
Q Consensus 360 ~~------~~~~lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~g--IiHrDLKp~NILid~~~~vk 430 (518)
.. ..+.|.||||.||+|.+++.++ ...|++..+++|+.|+++|+.+||... |||||||-+||||+.+|.+|
T Consensus 107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~K 186 (738)
T KOG1989|consen 107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYK 186 (738)
T ss_pred cccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEE
Confidence 11 2367899999999999999754 455999999999999999999999998 99999999999999999999
Q ss_pred EEeeCcceecccCCccc----------cCCCCCcccCchhc---cCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHH
Q 010078 431 VADFGVARVKAQSGVMT----------AETGTYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL 495 (518)
Q Consensus 431 L~DFGla~~~~~~~~~~----------~~~gt~~y~APEvl---~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~ 495 (518)
|||||.+......-... ...-|+.|+|||.| .+.+.+.|+|||+|||+||-|+....||+....+
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l 264 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL 264 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce
Confidence 99999987543322111 12468999999987 5788999999999999999999999999976443
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=277.50 Aligned_cols=198 Identities=33% Similarity=0.526 Sum_probs=176.4
Q ss_pred CeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
+|++.+.||+|+||.||++... ++.+++|++..... ......+.+|+.+++.++||||+++++.+.....++++|||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 5778899999999999999875 67899999876533 34567789999999999999999999999998999999999
Q ss_pred cCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccccC
Q 010078 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 449 (518)
Q Consensus 371 ~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs-~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~~ 449 (518)
+++++|.+++......+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||.+......... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~~ 159 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-TF 159 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-cc
Confidence 99999999998755788999999999999999999999 99999999999999999999999999998655332222 26
Q ss_pred CCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCC
Q 010078 450 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL 492 (518)
Q Consensus 450 ~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (518)
.++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 160 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 160 VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred cCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 7889999999999999999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=278.74 Aligned_cols=207 Identities=29% Similarity=0.528 Sum_probs=180.7
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
..|++.++||.|+||.||+|.. .++.|++|.+..... .....+.+|+.+++.++|+||+++++.+.....+|+|||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 5689999999999999999975 578899998875432 234678899999999999999999999999899999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-cccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~ 448 (518)
|+++++|..++.. ..+++..+..++.|++.|+.|||++|++|+||||+||+++.++.++|+|||++....... ....
T Consensus 97 ~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 174 (296)
T cd06655 97 YLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST 174 (296)
T ss_pred ecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCC
Confidence 9999999999865 468999999999999999999999999999999999999999999999999987543322 2234
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv 502 (518)
..++..|+|||.+.+..++.++|+|||||++|+|++|+.||...++......+.
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~ 228 (296)
T cd06655 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228 (296)
T ss_pred cCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 468889999999999999999999999999999999999999888766655443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=281.93 Aligned_cols=191 Identities=25% Similarity=0.450 Sum_probs=158.0
Q ss_pred eeeeeecCceEEEEEEEC----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeeccc--CCCCcceeeee
Q 010078 297 GSKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT--KPPSLCIVTEF 370 (518)
Q Consensus 297 ~~~LG~G~fG~Vy~g~~~----~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~--~~~~~~lV~Ey 370 (518)
+.+||+|+||.||+|+.. +..||+|.++.... ...+.+|+.++++++||||+++++++. ....+|+||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 468999999999999864 35799999875432 245778999999999999999999874 34567999999
Q ss_pred cCCCchhHHHhhh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE----cCCCcEEEEeeCcce
Q 010078 371 MSGGSVYDYLHKL--------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVAR 438 (518)
Q Consensus 371 ~~ggsL~~~l~~~--------~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILi----d~~~~vkL~DFGla~ 438 (518)
+. ++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 95 5888877532 2247888999999999999999999999999999999999 466789999999998
Q ss_pred ecccCC----ccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCC
Q 010078 439 VKAQSG----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYL 492 (518)
Q Consensus 439 ~~~~~~----~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (518)
...... ......+|+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 654322 2234568899999999876 45899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=270.65 Aligned_cols=200 Identities=33% Similarity=0.516 Sum_probs=178.3
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|++.+.||+|+||.||+++.. ++.|++|++...... .....+..|+.++++++|+||+++++++.....+++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 35788899999999999999874 678999998765432 456789999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcc-c
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM-T 447 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs-~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~-~ 447 (518)
|+++++|.+++.. ...+++..++.++.|++.|+.|||+ +|++|+||+|+||+++.++.++|+|||.+......... .
T Consensus 80 ~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 158 (264)
T cd06623 80 YMDGGSLADLLKK-VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN 158 (264)
T ss_pred ecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence 9999999999976 4778999999999999999999999 99999999999999999999999999998865543322 2
Q ss_pred cCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCC
Q 010078 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 493 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~ 493 (518)
...++..|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 4467889999999999999999999999999999999999998874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=274.98 Aligned_cols=214 Identities=30% Similarity=0.516 Sum_probs=179.2
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC--------hHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN--------SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~--------~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
+|.+.+.||.|+||.||+|.. +++.+|+|.++..... ....+.+.+|+.+++.++|+|++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467788999999999999975 5678999987643211 112356888999999999999999999999999
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
..++||||+++++|.+++... +.++...+..++.||+.|+.|||++|++||||+|+||+++.++.++|+|||+++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 999999999999999999774 6789999999999999999999999999999999999999999999999999875432
Q ss_pred CC---ccccCCCCCcccCchhccCCC--CChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCc
Q 010078 443 SG---VMTAETGTYRWMAPEVIEHKP--YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 443 ~~---~~~~~~gt~~y~APEvl~~~~--~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
.. ......++..|+|||.+.... ++.++|+||||+++|+|++|..||......+....+.....+
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 230 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA 230 (272)
T ss_pred cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccC
Confidence 21 123346788999999987654 889999999999999999999999887776666554433333
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=275.83 Aligned_cols=199 Identities=32% Similarity=0.578 Sum_probs=168.9
Q ss_pred CCCeeeeeeeeecCceEEEEEEE------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC--CC
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PP 362 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~------~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~--~~ 362 (518)
..+|++.+.||+|+||.||++.+ .+..|++|.++.. .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 45788999999999999999875 3567999998754 34445778999999999999999999997643 34
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
.+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||+++....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 68899999999999999977566789999999999999999999999999999999999999999999999999986543
Q ss_pred CCcc----ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 443 SGVM----TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 443 ~~~~----~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
.... ....++..|+|||++.+..++.++|+||||+++|||++|..|+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 213 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence 3211 112234569999999998999999999999999999998777643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=279.54 Aligned_cols=203 Identities=31% Similarity=0.514 Sum_probs=178.2
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcce
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~l 366 (518)
+..++|++.++||+|+||.||++... ++.||+|++.... .......+.+|+.+++.++||||+++++++.....+|+
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 34568899999999999999999875 7789999887543 23446788999999999999999999999999999999
Q ss_pred eeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc
Q 010078 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 445 (518)
Q Consensus 367 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs-~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~ 445 (518)
||||+++++|.+++.+ .+.++...+..++.+++.+|.|||+ .+++||||||+||+++.++.++|+|||++...... .
T Consensus 81 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-~ 158 (284)
T cd06620 81 CMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-I 158 (284)
T ss_pred EEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-c
Confidence 9999999999999876 5678999999999999999999997 59999999999999999999999999998654322 2
Q ss_pred cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 446 ~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
.....|+..|+|||++.+..++.++|+|||||++|+|++|+.||.....
T Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 2345789999999999888999999999999999999999999986554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=279.84 Aligned_cols=206 Identities=34% Similarity=0.583 Sum_probs=177.7
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
+.|...+.||+|+||.||+|.. .+..||+|+++.... ......+.+|+.++++++||||+++++.+......|+|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 3466778899999999999986 456799999875432 3345678999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-cccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~ 448 (518)
|+++++|.+++.. +.+++..+..++.||+.|+.|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 83 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06642 83 YLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred ccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhc
Confidence 9999999999864 568899999999999999999999999999999999999999999999999987654332 2223
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 500 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~ 500 (518)
..++..|+|||.+.+..++.++|+|||||++|||++|+.||....+......
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~ 212 (277)
T cd06642 161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL 212 (277)
T ss_pred ccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh
Confidence 4678899999999999999999999999999999999999987766554433
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=276.84 Aligned_cols=196 Identities=32% Similarity=0.553 Sum_probs=166.6
Q ss_pred eeeeeeeeecCceEEEEEEE------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC--CCcc
Q 010078 294 LKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLC 365 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~------~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~--~~~~ 365 (518)
|++.+.||+|+||.||++.+ .+..||+|+++... .......+.+|+.+|++++||||+++++++... ..++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 48889999999999988764 34579999987643 233456788999999999999999999987543 3578
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 445 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~ 445 (518)
++|||+++++|.+++.. ..+++..++.++.|++.|+.|||++||+||||||+|||++.++.++|+|||+++.......
T Consensus 85 lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 85 LIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred EEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 99999999999999975 4589999999999999999999999999999999999999999999999999876543221
Q ss_pred ----cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCC
Q 010078 446 ----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL 492 (518)
Q Consensus 446 ----~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (518)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 11224566799999999889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=276.10 Aligned_cols=201 Identities=25% Similarity=0.425 Sum_probs=171.1
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
+.|++.+.||+|+||.||+|.. +++.|++|+++.... ......+.+|+.+++.++|+||+++++++......|+|||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 5788999999999999999976 478899999875432 2223457789999999999999999999998889999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-cccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~ 448 (518)
|+. ++|.+++......+.+..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++...... ....
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 162 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS 162 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCC
Confidence 995 67877776555667888999999999999999999999999999999999999999999999987543322 2234
Q ss_pred CCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 449 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 449 ~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
..+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~ 209 (291)
T cd07870 163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD 209 (291)
T ss_pred ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence 467899999999875 4588999999999999999999999987654
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=274.54 Aligned_cols=192 Identities=28% Similarity=0.533 Sum_probs=163.8
Q ss_pred eeeeecCceEEEEEEECC--------------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCC
Q 010078 298 SKVASGSYGDLYRGTYCS--------------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~~--------------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~ 363 (518)
+.||+|+||.||+|++.. ..|++|++... .......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 468999999999998532 24888887654 23445678899999999999999999999999889
Q ss_pred cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCc-------EEEEeeCc
Q 010078 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV-------VKVADFGV 436 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~-------vkL~DFGl 436 (518)
.++||||+++++|..++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++. ++++|||+
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 99999999999999998776677999999999999999999999999999999999999987654 89999998
Q ss_pred ceecccCCccccCCCCCcccCchhcc-CCCCChhhHHHHHHHHHHHHH-cCCCCCCCCCH
Q 010078 437 ARVKAQSGVMTAETGTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELL-TGKLPYEYLTP 494 (518)
Q Consensus 437 a~~~~~~~~~~~~~gt~~y~APEvl~-~~~~s~ksDVwSlGviL~eLl-tG~~Pf~~~~~ 494 (518)
+..... .....++..|+|||++. +..++.++|||||||++|||+ +|..||.....
T Consensus 159 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 215 (262)
T cd05077 159 PITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL 215 (262)
T ss_pred CccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch
Confidence 864432 22345788999999986 567899999999999999998 58999987654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=268.21 Aligned_cols=208 Identities=33% Similarity=0.572 Sum_probs=183.3
Q ss_pred CeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC--CCcceee
Q 010078 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVT 368 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~--~~~~lV~ 368 (518)
+|.+.+.||+|++|.||+|... ++.|++|+++...........+.+|+.++++++|+||+++++.+... ..++++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3677899999999999999885 78899999887655455678899999999999999999999999887 7899999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc---
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV--- 445 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~--- 445 (518)
||+++++|.+++... ..+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 81 EYVSGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 999999999999874 4889999999999999999999999999999999999999999999999999987666543
Q ss_pred cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHh
Q 010078 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT-PLQAAVGV 501 (518)
Q Consensus 446 ~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~-~~q~~~~i 501 (518)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ..+....+
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 216 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKI 216 (260)
T ss_pred ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhc
Confidence 445678899999999998889999999999999999999999998775 34444443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=272.06 Aligned_cols=190 Identities=25% Similarity=0.491 Sum_probs=163.8
Q ss_pred eeeeecCceEEEEEEECCce------------EEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 298 SKVASGSYGDLYRGTYCSQD------------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~~~~------------vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
+.||+|+||.||+|.+.... +++|+++..... ...+.+|+.++++++|+||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 46899999999999885433 778876644221 5788999999999999999999999887 7789
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC-------cEEEEeeCcce
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-------VVKVADFGVAR 438 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~-------~vkL~DFGla~ 438 (518)
+||||+++++|.+++......++...+..++.||+.||.|||++||+||||||+|||++.++ .++|+|||++.
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 99999999999999987555789999999999999999999999999999999999999887 79999999987
Q ss_pred ecccCCccccCCCCCcccCchhccCC--CCChhhHHHHHHHHHHHHHc-CCCCCCCCCH
Q 010078 439 VKAQSGVMTAETGTYRWMAPEVIEHK--PYDHKADVFSFGIVLWELLT-GKLPYEYLTP 494 (518)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~APEvl~~~--~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~ 494 (518)
.... .....++..|+|||++.+. .++.++|+||||+++|+|++ |..||...++
T Consensus 157 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~ 212 (259)
T cd05037 157 TVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS 212 (259)
T ss_pred cccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc
Confidence 5443 2234567789999999876 78999999999999999999 6889977754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=279.25 Aligned_cols=215 Identities=32% Similarity=0.639 Sum_probs=177.6
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEEC--Cc----eEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~--~~----~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
+..++|+..+.||+|+||.||+|++. +. .||+|++.... ......++.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 34567888999999999999999863 33 47888887543 233345788999999999999999999988654
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
..++++||+++|+|.+++......++...+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 57799999999999999987666789999999999999999999999999999999999999999999999999986543
Q ss_pred CCc---cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcC
Q 010078 443 SGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVH 506 (518)
Q Consensus 443 ~~~---~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~ 506 (518)
... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.+....+ ...+++.+.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~ 228 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPDLLEKGE 228 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHCCC
Confidence 222 122335678999999999999999999999999999997 999998876544 334444443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=265.64 Aligned_cols=208 Identities=38% Similarity=0.658 Sum_probs=183.5
Q ss_pred CeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
+|.+.+.||+|++|.||+++.. ++.+++|++..... .....+.+|+.++++++|+|++++++.+......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 4677899999999999999985 67899999876543 3457899999999999999999999999888899999999
Q ss_pred cCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccccCC
Q 010078 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET 450 (518)
Q Consensus 371 ~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~~~ 450 (518)
++|++|.+++......+++..+..++.|++.++.|||++|++|+||+|+||+++.++.++|+|||.+.............
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 158 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV 158 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccccccee
Confidence 99999999998755679999999999999999999999999999999999999999999999999987665443234557
Q ss_pred CCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 010078 451 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 451 gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv 502 (518)
++..|+|||.+.+..++.++|+||||+++|+|++|+.||...++.+....+.
T Consensus 159 ~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 210 (253)
T cd05122 159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA 210 (253)
T ss_pred cCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH
Confidence 8899999999998889999999999999999999999999886665555443
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=301.29 Aligned_cols=212 Identities=26% Similarity=0.505 Sum_probs=181.2
Q ss_pred CeeeeeeeeecCceEEEEEEEC--CceEEEEEecCC--CCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCC--cce
Q 010078 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPE--RINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS--LCI 366 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~--~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~--~~l 366 (518)
.+++.+.||+|+|-+||+|.+. |..||.-.++.. ...+...++|..|+.+|+.|+||||++||.+|.+..+ +.+
T Consensus 41 y~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~ 120 (632)
T KOG0584|consen 41 YLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINF 120 (632)
T ss_pred eeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeee
Confidence 3567789999999999999764 555654433322 2244556899999999999999999999999977665 778
Q ss_pred eeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEcC-CCcEEEEeeCcceecccC
Q 010078 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDE-NEVVKVADFGVARVKAQS 443 (518)
Q Consensus 367 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~g--IiHrDLKp~NILid~-~~~vkL~DFGla~~~~~~ 443 (518)
|+|.|.+|+|..|+.+ -+.++...+..|++||++||.|||++. |||||||.+||+|+. .|.|||+|+|+|.....+
T Consensus 121 iTEL~TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 121 ITELFTSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred eeecccCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999999988 567888999999999999999999985 999999999999985 489999999999887766
Q ss_pred CccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHhhhhcCc
Q 010078 444 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE-YLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 444 ~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~-~~~~~q~~~~iv~~~~r 507 (518)
.... -+|||.|||||++. ..|+...||||||+.|.||+|+..||. ..++.|.+.+|+.+..+
T Consensus 200 ~aks-vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP 262 (632)
T KOG0584|consen 200 HAKS-VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKP 262 (632)
T ss_pred ccce-eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCH
Confidence 4443 68999999999998 669999999999999999999999995 56889999998875544
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=298.28 Aligned_cols=191 Identities=25% Similarity=0.356 Sum_probs=166.8
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
...|.+.++||+|+||.||++.+. ++.||||.... ..+.+|+.+|++++|+||+++++++......|+||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 346899999999999999999875 46799996432 23568999999999999999999998888999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc---
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV--- 445 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~--- 445 (518)
|++ .++|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.++|+|||+++.......
T Consensus 240 e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 240 PKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred Ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 999 5789999877566799999999999999999999999999999999999999999999999999976543221
Q ss_pred cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCC
Q 010078 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490 (518)
Q Consensus 446 ~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~ 490 (518)
.....||..|+|||++.+..++.++|||||||+||||++|..|+.
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 223468999999999999999999999999999999999876553
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=274.90 Aligned_cols=212 Identities=26% Similarity=0.505 Sum_probs=179.1
Q ss_pred CCCCeeeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~~-------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
..+.|++.+.||.|+||.||+|+.. .+.+++|.+.... .......+.+|+.++++++|+||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 4467889999999999999999863 3468999876532 2334577999999999999999999999999988
Q ss_pred CcceeeeecCCCchhHHHhhhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEee
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLK--------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 434 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~--------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DF 434 (518)
..|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999999997643 15899999999999999999999999999999999999999999999999
Q ss_pred CcceecccCC--ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhh
Q 010078 435 GVARVKAQSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 435 Gla~~~~~~~--~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv 502 (518)
|++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~ 232 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ 232 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH
Confidence 9986433221 2223355678999999988889999999999999999999 899998877766555544
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=267.17 Aligned_cols=212 Identities=28% Similarity=0.533 Sum_probs=187.9
Q ss_pred CeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
+|.+.+.||+|+||.||++... ++.+++|++............+.+|+++++.++|+|++++++.+......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999876 78899999987666556677899999999999999999999999888999999999
Q ss_pred cCCCchhHHHhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-cc
Q 010078 371 MSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VM 446 (518)
Q Consensus 371 ~~ggsL~~~l~~~~---~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~ 446 (518)
+++++|.+++.... ..++...+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence 99999999997753 679999999999999999999999999999999999999999999999999997655443 23
Q ss_pred ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...++.+....+++.
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~ 218 (258)
T cd08215 161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKG 218 (258)
T ss_pred cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcC
Confidence 3456888999999999999999999999999999999999999988877766665543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=273.82 Aligned_cols=203 Identities=37% Similarity=0.654 Sum_probs=171.3
Q ss_pred eeeecCceEEEEEEECC--------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 299 KVASGSYGDLYRGTYCS--------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 299 ~LG~G~fG~Vy~g~~~~--------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
.||+|+||.||+|+... +.++||.+..... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 68999999999998643 4689998765422 23356788999999999999999999999998999999999
Q ss_pred cCCCchhHHHhhh------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC-----cEEEEeeCccee
Q 010078 371 MSGGSVYDYLHKL------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-----VVKVADFGVARV 439 (518)
Q Consensus 371 ~~ggsL~~~l~~~------~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~-----~vkL~DFGla~~ 439 (518)
+++++|.+++... ...+++..+..++.||+.|+.|||+++++|+||||+||+++.++ .++|+|||+++.
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999999999652 23478889999999999999999999999999999999999887 899999999875
Q ss_pred cccCC---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhh
Q 010078 440 KAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 440 ~~~~~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv 502 (518)
..... ......++..|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 227 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT 227 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh
Confidence 43321 1122345678999999999999999999999999999998 999999888777665543
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=278.26 Aligned_cols=207 Identities=31% Similarity=0.478 Sum_probs=177.6
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
+.|.+.++||+|+||.||+|+. .++.|++|++.... ........+.+|+.+++.++||||++++++|......|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 5588889999999999999986 46889999886432 23344567889999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcccc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~ 448 (518)
||+. ++|.+++......+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++...... ..
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---~~ 170 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---NS 170 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---CC
Confidence 9996 5787877655667999999999999999999999999999999999999999999999999998754332 34
Q ss_pred CCCCCcccCchhcc---CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 010078 449 ETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 449 ~~gt~~y~APEvl~---~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv 502 (518)
..+++.|+|||++. ...++.++||||||+++|||++|+.||...++......+.
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~ 227 (307)
T cd06607 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 227 (307)
T ss_pred ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHh
Confidence 56788999999874 4668999999999999999999999999887766555443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=272.53 Aligned_cols=213 Identities=24% Similarity=0.430 Sum_probs=187.2
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC------ChHHHHHHHHHHHHHHhcC-CCcceEEeecccCCCC
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI------NSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPS 363 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~------~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~~ 363 (518)
.|.-.+.||.|..+.|.++.. .++.+|+|++..... .....+.-.+|+.||+++. ||+|+++.+++..+..
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 455667899999999998854 578899998753221 2344566778999999996 9999999999999999
Q ss_pred cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC
Q 010078 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~ 443 (518)
+++|+|.|+.|.|+++|.. .-.+++....+|++|++.|++|||.++|+||||||+|||++++.+++|+|||+++....+
T Consensus 98 ~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCc
Confidence 9999999999999999977 567899999999999999999999999999999999999999999999999999988888
Q ss_pred CccccCCCCCcccCchhcc------CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcC
Q 010078 444 GVMTAETGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVH 506 (518)
Q Consensus 444 ~~~~~~~gt~~y~APEvl~------~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~ 506 (518)
......+|||+|+|||.+. +..|+...|+|+.|+|||.||.|.+||-.-..+-++.-|++..+
T Consensus 177 ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGky 245 (411)
T KOG0599|consen 177 EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKY 245 (411)
T ss_pred hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccc
Confidence 8888999999999999984 45789999999999999999999999988777777777776544
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=274.45 Aligned_cols=210 Identities=22% Similarity=0.433 Sum_probs=178.0
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
.|++.+.||.|+||.||+|+. +++.|+||+++...........+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 377889999999999999987 467899999876544444446788999999999999999999999999999999999
Q ss_pred cCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-cccc
Q 010078 371 MSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (518)
Q Consensus 371 ~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~ 448 (518)
+. ++|.+++... ...+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||+++...... ....
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 159 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence 95 6898888653 3568899999999999999999999999999999999999999999999999987543322 2233
Q ss_pred CCCCCcccCchhccCCC-CChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 449 ETGTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~-~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
..++..|+|||++.+.. ++.++||||||+++|+|+||+.||...+.......+++
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~ 215 (284)
T cd07860 160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 215 (284)
T ss_pred ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 45688999999886644 68899999999999999999999988777666655554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=275.10 Aligned_cols=211 Identities=21% Similarity=0.353 Sum_probs=176.2
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeecccCCCC-----
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPS----- 363 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~~----- 363 (518)
++|++.+.||+|+||.||+|.+ +++.||+|+++...........+.+|+.+++.+. |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3688899999999999999987 4678999998765433334467888999999996 6999999998876655
Q ss_pred cceeeeecCCCchhHHHhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC-CCcEEEEeeCcce
Q 010078 364 LCIVTEFMSGGSVYDYLHKLK----GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVAR 438 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~----~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~-~~~vkL~DFGla~ 438 (518)
.|+||||+++ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.++|+|||+++
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 7999999975 8888886532 35799999999999999999999999999999999999998 8899999999987
Q ss_pred ecccC-CccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 439 VKAQS-GVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 439 ~~~~~-~~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
..... .......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||.+.++.+....+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 226 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFK 226 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 54332 22234467889999998865 5679999999999999999999999999888777766554
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=278.50 Aligned_cols=198 Identities=32% Similarity=0.567 Sum_probs=169.5
Q ss_pred CCCeeeeeeeeecCceEEEEEEE------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC--C
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--P 362 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~------~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~--~ 362 (518)
...|++.++||+|+||.||++++ .+..||+|.++... .......+.+|+.+++.++||||+++++++... .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 34578899999999999999975 35679999987543 234456799999999999999999999988765 5
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
..++||||++|++|.+++.+....+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||+++....
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 67899999999999999977555689999999999999999999999999999999999999999999999999876543
Q ss_pred CCc----cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCC
Q 010078 443 SGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489 (518)
Q Consensus 443 ~~~----~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf 489 (518)
... .....++..|+|||++.+..++.++||||||+++|+|++++.|+
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 321 12334667899999999889999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=268.42 Aligned_cols=210 Identities=29% Similarity=0.513 Sum_probs=184.0
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
+|++.++||.|+||.||+++. +++.+++|.+............+.+|+.+++.++|+||+++++++......|+||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 477889999999999999976 467899999886555555567788999999999999999999999988999999999
Q ss_pred cCCCchhHHHhhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccc
Q 010078 371 MSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT 447 (518)
Q Consensus 371 ~~ggsL~~~l~~~---~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~ 447 (518)
+++++|.+++... ...+++..++.++.|++.||.|||++|++|+||+|.||+++.++.++|+|||++...... ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~ 159 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAK 159 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Ccc
Confidence 9999999998653 346888999999999999999999999999999999999999999999999999766544 334
Q ss_pred cCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
...+++.|++||.+.+..++.++|+||||+++|+|++|+.||...+.......+..
T Consensus 160 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~ 215 (256)
T cd08530 160 TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR 215 (256)
T ss_pred cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 45688999999999999999999999999999999999999998887665555443
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=272.84 Aligned_cols=209 Identities=27% Similarity=0.444 Sum_probs=179.4
Q ss_pred eeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC--CCcceeee
Q 010078 294 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVTE 369 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~--~~~~lV~E 369 (518)
|++.++||+|+||.||+|+.. ++.+++|+++...........+.+|+.+++.++|+|++++++++... ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567899999999999999875 57899999987643344456788999999999999999999999887 78999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC--ccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMT 447 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~--~~~ 447 (518)
|++ ++|.+++......+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ..+
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (287)
T cd07840 81 YMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159 (287)
T ss_pred ccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence 996 58999987655679999999999999999999999999999999999999999999999999997655443 233
Q ss_pred cCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 448 AETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+..
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~ 216 (287)
T cd07840 160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFE 216 (287)
T ss_pred ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 4467889999998764 4689999999999999999999999998887666665544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=274.51 Aligned_cols=210 Identities=22% Similarity=0.408 Sum_probs=176.0
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|++.++||.|+||.||+|+.. ++.|++|+++...........+.+|+.++++++|+||+++++++......|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46889999999999999999864 6789999987654444445678899999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC-CCcEEEEeeCcceecccC-Ccc
Q 010078 370 FMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVARVKAQS-GVM 446 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~-~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~-~~~vkL~DFGla~~~~~~-~~~ 446 (518)
|++ ++|.+++..... .+++..+..++.||+.||.|||++|++|+||+|+||+++. ++.+||+|||++...... ...
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence 995 588888755332 3678888999999999999999999999999999999985 557999999999754322 122
Q ss_pred ccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 010078 447 TAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv 502 (518)
+...+++.|+|||++.+ ..++.++||||||+++|+|+||+.||...+..+....++
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~ 217 (294)
T PLN00009 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIF 217 (294)
T ss_pred ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 34467889999999866 467899999999999999999999999888877666654
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=276.25 Aligned_cols=207 Identities=27% Similarity=0.419 Sum_probs=172.9
Q ss_pred CCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCC-----
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS----- 363 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~----- 363 (518)
.++|++.++||+|+||.||++.. +++.||||++............+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 46799999999999999999987 46789999887543333333456789999999999999999998765543
Q ss_pred ---cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceec
Q 010078 364 ---LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 364 ---~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~ 440 (518)
.++||||+. ++|.+++......+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++...
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 499999995 5888888765557899999999999999999999999999999999999999999999999998755
Q ss_pred ccCC-----ccccCCCCCcccCchhccCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 010078 441 AQSG-----VMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA 498 (518)
Q Consensus 441 ~~~~-----~~~~~~gt~~y~APEvl~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~ 498 (518)
.... ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.++....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~ 233 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQL 233 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 4322 12234578899999988664 4788999999999999999999999887765443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=271.46 Aligned_cols=205 Identities=23% Similarity=0.379 Sum_probs=173.3
Q ss_pred eeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeecccCC--CCcceee
Q 010078 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKP--PSLCIVT 368 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~--~~~~lV~ 368 (518)
|++.++||+|+||.||+++. +++.||+|+++....... .....+|+.+++++. |+|++++++++... +.+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 56789999999999999986 567899999876433322 234457888898886 99999999999877 7899999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcccc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~ 448 (518)
||++ ++|.+++......+++..++.++.||+.||.|||++|++||||+|+||+++. +.+||+|||+++..........
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~ 157 (282)
T cd07831 80 ELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTE 157 (282)
T ss_pred ecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcCC
Confidence 9996 5888888765567899999999999999999999999999999999999999 9999999999986655444445
Q ss_pred CCCCCcccCchhcc-CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 010078 449 ETGTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV 501 (518)
Q Consensus 449 ~~gt~~y~APEvl~-~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~i 501 (518)
..++..|+|||.+. +..++.++|+|||||++|||++|..||.+.++.+....+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~ 211 (282)
T cd07831 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKI 211 (282)
T ss_pred CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHH
Confidence 56889999999764 455788999999999999999999999988876655544
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=272.71 Aligned_cols=214 Identities=26% Similarity=0.493 Sum_probs=182.0
Q ss_pred eeeeeeeeecCceEEEEEEECC---ceEEEEEecCCC--------CChHHHHHHHHHHHHHHh-cCCCcceEEeecccCC
Q 010078 294 LKFGSKVASGSYGDLYRGTYCS---QDVAIKVLKPER--------INSDMQKEFAQEVFIMRK-VRHKNVVQFIGACTKP 361 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~~~---~~vAVKvlk~~~--------~~~~~~~~~~~Ei~iL~~-L~HpnIv~l~g~~~~~ 361 (518)
|++.+.||+|+||.||++...+ +.+|+|.+.... .......++.+|+.++.+ ++||||+++++++...
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 6778899999999999998754 679999876432 123344567889988875 7899999999999999
Q ss_pred CCcceeeeecCCCchhHHHhh---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEcCCCcEEEEeeCcc
Q 010078 362 PSLCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVA 437 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~---~~~~l~~~~i~~i~~qIa~aL~yLHs-~gIiHrDLKp~NILid~~~~vkL~DFGla 437 (518)
...|++|||++|++|.+++.. ....++...++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 161 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccce
Confidence 999999999999999998753 24568899999999999999999996 78999999999999999999999999999
Q ss_pred eecccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCc
Q 010078 438 RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 438 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
.............++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+.+...+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (269)
T cd08528 162 KQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE 231 (269)
T ss_pred eecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC
Confidence 8765554445667899999999999988999999999999999999999999888777766666554443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=273.50 Aligned_cols=206 Identities=34% Similarity=0.588 Sum_probs=178.7
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
-|++.++||+|+||.||+|.. .+..||+|++..... ......+.+|+.++++++||||+++++++......|+||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 467788999999999999976 467899998764432 33456788999999999999999999999999999999999
Q ss_pred cCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-ccccC
Q 010078 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAE 449 (518)
Q Consensus 371 ~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~~ 449 (518)
+++++|.+++.. ..++...+..++.|++.++.|||++|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 84 ~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06641 84 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccc
Confidence 999999999864 568899999999999999999999999999999999999999999999999987554322 22344
Q ss_pred CCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 010078 450 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV 501 (518)
Q Consensus 450 ~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~i 501 (518)
.++..|+|||.+.+..++.++|+|||||++|+|++|..||....+......+
T Consensus 162 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 213 (277)
T cd06641 162 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI 213 (277)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH
Confidence 6788999999999888999999999999999999999999988776655553
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=272.91 Aligned_cols=205 Identities=25% Similarity=0.488 Sum_probs=167.0
Q ss_pred eeeecCceEEEEEEEC-Cc---eEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecCCC
Q 010078 299 KVASGSYGDLYRGTYC-SQ---DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 374 (518)
Q Consensus 299 ~LG~G~fG~Vy~g~~~-~~---~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~gg 374 (518)
+||+|+||.||+|... +. .+++|.++... .......+.+|+.+++.++||||+++++.|......|+||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 6899999999999753 32 35566655432 2334578999999999999999999999999999999999999999
Q ss_pred chhHHHhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC---cccc
Q 010078 375 SVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMTA 448 (518)
Q Consensus 375 sL~~~l~~~~---~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~---~~~~ 448 (518)
+|.+++.+.. ..++...+..++.||+.||.|||+++++||||||+|||++.++.++|+|||++....... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 160 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD 160 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence 9999997632 345667788999999999999999999999999999999999999999999975422211 1234
Q ss_pred CCCCCcccCchhccC-------CCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhh
Q 010078 449 ETGTYRWMAPEVIEH-------KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 449 ~~gt~~y~APEvl~~-------~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~ 504 (518)
..++..|+|||++.. ..++.++||||||+++|||++ |..||...+..+....++.+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 224 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKD 224 (268)
T ss_pred CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhh
Confidence 467889999999853 346789999999999999997 68899988887777665544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=272.75 Aligned_cols=211 Identities=31% Similarity=0.518 Sum_probs=175.6
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEeeccc----
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACT---- 359 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~---- 359 (518)
+....++|++.+.||+|+||.||+++. .++.+++|+++... .....+..|+.+++.+ +|+||+++++++.
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 344557899999999999999999976 46789999886532 1235677899999999 6999999999873
Q ss_pred -CCCCcceeeeecCCCchhHHHhhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeC
Q 010078 360 -KPPSLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435 (518)
Q Consensus 360 -~~~~~~lV~Ey~~ggsL~~~l~~~---~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFG 435 (518)
....+++||||++|++|.+++... ...+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence 345689999999999999987532 3568889999999999999999999999999999999999999999999999
Q ss_pred cceecccCC-ccccCCCCCcccCchhcc-----CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 010078 436 VARVKAQSG-VMTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 500 (518)
Q Consensus 436 la~~~~~~~-~~~~~~gt~~y~APEvl~-----~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~ 500 (518)
+++...... ......|++.|+|||++. +..++.++|||||||++|+|++|+.||....+......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~ 240 (286)
T cd06638 170 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK 240 (286)
T ss_pred ceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh
Confidence 987654322 223446899999999985 34588999999999999999999999998877665544
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=274.55 Aligned_cols=210 Identities=33% Similarity=0.562 Sum_probs=175.0
Q ss_pred CCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEeecccC------C
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTK------P 361 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~------~ 361 (518)
...|++.++||+|+||.||+|.. .++.+|+|++... ......+..|+.+++++ +|+||+++++++.. .
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 35788889999999999999987 4578999998643 23345688899999998 69999999998853 3
Q ss_pred CCcceeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceec
Q 010078 362 PSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~ 440 (518)
..+|++|||+++++|.+++.... ..+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++...
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence 46799999999999999987643 45788889999999999999999999999999999999999999999999998754
Q ss_pred ccC-CccccCCCCCcccCchhcc-----CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 441 AQS-GVMTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 441 ~~~-~~~~~~~gt~~y~APEvl~-----~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
... .......|+..|+|||.+. +..++.++|+|||||++|+|++|+.||....+......+..
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 240 (282)
T cd06636 172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 240 (282)
T ss_pred hccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh
Confidence 322 1233456889999999985 45688899999999999999999999988877666555443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=274.95 Aligned_cols=194 Identities=26% Similarity=0.470 Sum_probs=163.5
Q ss_pred eeeecCceEEEEEEECC--------------------------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcce
Q 010078 299 KVASGSYGDLYRGTYCS--------------------------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352 (518)
Q Consensus 299 ~LG~G~fG~Vy~g~~~~--------------------------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 352 (518)
+||+|+||.||+|.... ..|++|++... .......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 68999999999997421 24888888643 233456788999999999999999
Q ss_pred EEeecccCCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC-----
Q 010078 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE----- 427 (518)
Q Consensus 353 ~l~g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~----- 427 (518)
++++++......++||||+++++|..++....+.+++..+..++.||+.||.|||++||+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence 999999999999999999999999999977667889999999999999999999999999999999999997644
Q ss_pred --cEEEEeeCcceecccCCccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHH-cCCCCCCCCCHHHH
Q 010078 428 --VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELL-TGKLPYEYLTPLQA 497 (518)
Q Consensus 428 --~vkL~DFGla~~~~~~~~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLl-tG~~Pf~~~~~~q~ 497 (518)
.++++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||...++.+.
T Consensus 160 ~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 160 SPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 4899999987543221 23357788999998865 56899999999999999995 69999988766543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=274.99 Aligned_cols=212 Identities=33% Similarity=0.549 Sum_probs=184.0
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
+.|++.+.||+|+||.||++.+. ++.+++|+++.... ....+.+|+.+++.++|+|++++++.+......|+++|
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 45777889999999999999885 78899999875433 45678899999999999999999999998899999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-cccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~ 448 (518)
|++|++|.+++......++...+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 175 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS 175 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhcc
Confidence 999999999998754479999999999999999999999999999999999999999999999999876443322 2233
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcC
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVH 506 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~ 506 (518)
..++..|++||.+.+..++.++|+||||+++|+|++|+.||....+......+..+..
T Consensus 176 ~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~ 233 (286)
T cd06614 176 VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI 233 (286)
T ss_pred ccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Confidence 4578899999999998999999999999999999999999998888766665544433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=274.50 Aligned_cols=195 Identities=27% Similarity=0.450 Sum_probs=169.3
Q ss_pred eeecCceEEEEEEE--CCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecCCCch
Q 010078 300 VASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (518)
Q Consensus 300 LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL 376 (518)
||+|+||.||++.. +++.|++|++...... ......+..|+.+++.++||||+++++++...+.+|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999976 4678999998754322 22345667899999999999999999999998999999999999999
Q ss_pred hHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccccCCCCCcc
Q 010078 377 YDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRW 455 (518)
Q Consensus 377 ~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y 455 (518)
.+++.+.. ..+++..+..++.|++.|+.|||++|++||||+|+||+++.++.++|+|||.+.............++..|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY 160 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence 99997643 36899999999999999999999999999999999999999999999999998765544344455678899
Q ss_pred cCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 456 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 456 ~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
+|||.+.+..++.++|+||||+++|+|++|+.||.....
T Consensus 161 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred CCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 999999888899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=268.98 Aligned_cols=211 Identities=29% Similarity=0.550 Sum_probs=180.9
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
+|.+.+.||+|+||.||++.. .+..+|+|.+............+.+|+.+++.++|+||+++++.+.....+|+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 477889999999999999987 457899999876544444456788999999999999999999999999999999999
Q ss_pred cCCCchhHHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC-cEEEEeeCcceecccCC-ccc
Q 010078 371 MSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSG-VMT 447 (518)
Q Consensus 371 ~~ggsL~~~l~~~~~-~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~-~vkL~DFGla~~~~~~~-~~~ 447 (518)
+++++|.+++....+ .+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++|+|||.+....... ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence 999999999976433 578999999999999999999999999999999999999886 46999999987654332 122
Q ss_pred cCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
...|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+..+....+.+
T Consensus 161 ~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 216 (257)
T cd08225 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ 216 (257)
T ss_pred ccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc
Confidence 34688899999999988899999999999999999999999998777666665444
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=273.10 Aligned_cols=209 Identities=23% Similarity=0.428 Sum_probs=178.0
Q ss_pred eeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeec
Q 010078 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 371 (518)
|++.++||.|++|.||+|.. ++..|++|++............+.+|+.+++.++|+|++++++++......|++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 46678999999999999986 5788999998765444444467888999999999999999999999999999999999
Q ss_pred CCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-ccccC
Q 010078 372 SGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAE 449 (518)
Q Consensus 372 ~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~~ 449 (518)
+++|.+++.... ..+++..++.++.|++.||.|||+++++||||+|+||+++.++.++|+|||+++...... .....
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~ 159 (283)
T cd07835 81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE 159 (283)
T ss_pred -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCcc
Confidence 568999987643 368999999999999999999999999999999999999999999999999987543221 22334
Q ss_pred CCCCcccCchhccCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 450 TGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 450 ~gt~~y~APEvl~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
.++..|+|||++.+. .++.++|+||||+++|+|++|+.||...+.......+++
T Consensus 160 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 214 (283)
T cd07835 160 VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFR 214 (283)
T ss_pred ccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 568899999988654 578999999999999999999999998888766666554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=275.06 Aligned_cols=201 Identities=33% Similarity=0.620 Sum_probs=173.9
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC--CC
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PP 362 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~--~~ 362 (518)
..+|++.+.||+|+||.||++++. +..+|||+++..... .....|.+|+.+++.++|+||+++++++.. ..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 356888899999999999999864 467999999865433 346789999999999999999999998876 55
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
..+++|||+++++|.+++......+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 78999999999999999987666799999999999999999999999999999999999999999999999999986653
Q ss_pred CCcc----ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCC
Q 010078 443 SGVM----TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL 492 (518)
Q Consensus 443 ~~~~----~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (518)
.... ....++..|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 2211 1224456799999998889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=271.75 Aligned_cols=209 Identities=24% Similarity=0.460 Sum_probs=177.3
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
+|++.++||.|++|.||+|+. ++..||||+++..... .....+.+|+.++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 478889999999999999997 4678999998765322 2235677899999999999999999999999999999999
Q ss_pred cCCCchhHHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-ccc
Q 010078 371 MSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT 447 (518)
Q Consensus 371 ~~ggsL~~~l~~~~--~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~ 447 (518)
+++ +|.+++.... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++....... ...
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS 158 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence 975 8888886543 468999999999999999999999999999999999999999999999999987543322 223
Q ss_pred cCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 448 AETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
...++..|++||++.+ ..++.++|+||||+++|+|++|+.||.+.+..+....+.+
T Consensus 159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 215 (284)
T cd07836 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFR 215 (284)
T ss_pred cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 4567889999998865 4578999999999999999999999998887766666554
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=279.13 Aligned_cols=203 Identities=31% Similarity=0.520 Sum_probs=175.6
Q ss_pred eeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeec
Q 010078 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 371 (518)
|....+||.|+||.||++.. .+..||||.+... .......+.+|+.+++.++|+||+++++.+...+..|+||||+
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 44457899999999999986 4678999988643 2334567889999999999999999999999999999999999
Q ss_pred CCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-ccccCC
Q 010078 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAET 450 (518)
Q Consensus 372 ~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~~~ 450 (518)
++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... ......
T Consensus 102 ~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 179 (292)
T cd06658 102 EGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV 179 (292)
T ss_pred CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceee
Confidence 99999998854 468899999999999999999999999999999999999999999999999986543222 223456
Q ss_pred CCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 010078 451 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 500 (518)
Q Consensus 451 gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~ 500 (518)
++..|+|||.+.+..++.++|+||||+++|||++|+.||...++.+....
T Consensus 180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~ 229 (292)
T cd06658 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR 229 (292)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 88999999999998999999999999999999999999998887665544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=268.92 Aligned_cols=201 Identities=28% Similarity=0.408 Sum_probs=169.8
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCCC-hHHHHHHHHHHHHH-HhcCCCcceEEeecccCCCCcceeeeecCC
Q 010078 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIM-RKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~-~~~~~~~~~Ei~iL-~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (518)
+.||+|+||.||+|+. .++.||+|+++..... ......+..|..++ ...+|+|++++++++.....+|+||||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5789999999999987 5678999998754322 22233445555444 445799999999999998999999999999
Q ss_pred CchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccccCCCCC
Q 010078 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY 453 (518)
Q Consensus 374 gsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~~~gt~ 453 (518)
++|.+++.. .+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||+++.... .....++.
T Consensus 82 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~ 157 (260)
T cd05611 82 GDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTP 157 (260)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCc
Confidence 999999976 46789999999999999999999999999999999999999999999999999875433 23346888
Q ss_pred cccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 010078 454 RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 454 ~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv 502 (518)
.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.
T Consensus 158 ~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 206 (260)
T cd05611 158 DYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL 206 (260)
T ss_pred CccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 9999999988889999999999999999999999999888776655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=272.20 Aligned_cols=210 Identities=31% Similarity=0.502 Sum_probs=176.3
Q ss_pred CCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEeecccCC-----C
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKP-----P 362 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~-----~ 362 (518)
.++|.+.+.||+|+||.||+++. .++.+|+|++.... .....+.+|+.+++++ +|||++++++++... .
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 46799999999999999999987 46789999987532 2235677899999999 799999999988643 3
Q ss_pred CcceeeeecCCCchhHHHhh---hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 363 SLCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~---~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
.+|+||||++|++|.++++. ....+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++..
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 57999999999999998863 245689999999999999999999999999999999999999999999999999875
Q ss_pred cccCC-ccccCCCCCcccCchhccCC-----CCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 440 KAQSG-VMTAETGTYRWMAPEVIEHK-----PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 440 ~~~~~-~~~~~~gt~~y~APEvl~~~-----~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
..... ......++..|+|||++... .++.++|+|||||++|+|++|+.||....+.+.+..+.+
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~ 247 (291)
T cd06639 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR 247 (291)
T ss_pred cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc
Confidence 44322 22345688999999998543 368899999999999999999999999888777766543
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=270.53 Aligned_cols=210 Identities=35% Similarity=0.549 Sum_probs=177.1
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEeecccCCC-----
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPP----- 362 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~----- 362 (518)
.++|++.+.||+|+||.||+|+.. ++.+++|++.... .....+.+|+.+++++ +|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 367899999999999999999874 5679999987543 2346788999999999 6999999999986544
Q ss_pred -CcceeeeecCCCchhHHHhhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcce
Q 010078 363 -SLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (518)
Q Consensus 363 -~~~lV~Ey~~ggsL~~~l~~~---~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~ 438 (518)
.+|+||||+++++|.+++... +..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 489999999999999998653 3678999999999999999999999999999999999999999999999999987
Q ss_pred ecccCC-ccccCCCCCcccCchhccC-----CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 439 VKAQSG-VMTAETGTYRWMAPEVIEH-----KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 439 ~~~~~~-~~~~~~gt~~y~APEvl~~-----~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
...... ......++..|+|||++.. ..++.++||||||++||+|++|+.||....+......+..
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 232 (275)
T cd06608 162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR 232 (275)
T ss_pred ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc
Confidence 544322 2334568899999998753 3578899999999999999999999988776666555443
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=270.21 Aligned_cols=209 Identities=24% Similarity=0.440 Sum_probs=179.2
Q ss_pred eeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhc---CCCcceEEeecccCCCC-----
Q 010078 294 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV---RHKNVVQFIGACTKPPS----- 363 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L---~HpnIv~l~g~~~~~~~----- 363 (518)
|++.+.||+|+||.||+|++. ++.||+|+++...........+.+|+.+++++ +|+||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567899999999999999974 68899999986544444445677788877766 59999999999987776
Q ss_pred cceeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 364 LCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
++++|||+. ++|.+++.... ..+++..++.++.||+.||.|||+++++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 899999996 58999887643 3589999999999999999999999999999999999999999999999999987655
Q ss_pred CCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 443 ~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
........++..|+|||++.+..++.++|+|||||++|+|++|+.||...+..+....+.+
T Consensus 160 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~ 220 (287)
T cd07838 160 EMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFD 220 (287)
T ss_pred CcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHH
Confidence 4444445678899999999999999999999999999999999999999888777766654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=276.94 Aligned_cols=204 Identities=30% Similarity=0.539 Sum_probs=177.2
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
.+|++.+.||+|+||.||++.. .++.|++|.+..... .....+.+|+.++++++||||+++++.+......|+|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 6788899999999999999975 567899999864322 234678899999999999999999999998889999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-cccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~ 448 (518)
|+++++|.+++.+ ..++...+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 97 ~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~ 174 (293)
T cd06647 97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (293)
T ss_pred cCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccccc
Confidence 9999999999865 457889999999999999999999999999999999999999999999999886543322 2233
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV 499 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~ 499 (518)
..+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...++.....
T Consensus 175 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~ 225 (293)
T cd06647 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 225 (293)
T ss_pred ccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee
Confidence 468889999999998889999999999999999999999998877655433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=256.32 Aligned_cols=213 Identities=23% Similarity=0.413 Sum_probs=190.2
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
.|.-.++||+|.||+||+|+. .++.||+|.++.+..++.......+|+.+|+.++|+|||+++++...++.+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 455568999999999999975 456799999987766666667788999999999999999999999888999999999
Q ss_pred cCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-ccccC
Q 010078 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAE 449 (518)
Q Consensus 371 ~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~~ 449 (518)
| ...|..|....++.++...+..++.|+++|+.++|+.++.||||||.|+||+.+|.+|++|||+++...... -.+++
T Consensus 83 c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysae 161 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE 161 (292)
T ss_pred h-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeece
Confidence 9 679999999999999999999999999999999999999999999999999999999999999998766543 45678
Q ss_pred CCCCcccCchhccCC-CCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcC
Q 010078 450 TGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVH 506 (518)
Q Consensus 450 ~gt~~y~APEvl~~~-~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~ 506 (518)
+-|.+|.+|.++.+. -|+...|+||.|||+.|+.. |++.|++.+..+.+..|.....
T Consensus 162 vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg 220 (292)
T KOG0662|consen 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220 (292)
T ss_pred eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhC
Confidence 899999999998765 58899999999999999998 8899999999888888776443
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=265.34 Aligned_cols=209 Identities=36% Similarity=0.607 Sum_probs=184.0
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
+|++.++||+|++|.||+++. .++.|++|.+............+.+|+.++++++|+|++++++++......+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 477889999999999999986 457899999987655545667899999999999999999999999888899999999
Q ss_pred cCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc-cccC
Q 010078 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-MTAE 449 (518)
Q Consensus 371 ~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~-~~~~ 449 (518)
+++++|.+++.. .+.+++..+..++.|++.|+.|||++||+||||+|+||+++.++.++|+|||.+........ ....
T Consensus 81 ~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 159 (254)
T cd06627 81 AENGSLRQIIKK-FGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV 159 (254)
T ss_pred CCCCcHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence 999999999976 46789999999999999999999999999999999999999999999999999986654332 2345
Q ss_pred CCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 010078 450 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 450 ~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv 502 (518)
.++..|+|||.+.+..++.++|+||||+++|+|++|+.||...++......+.
T Consensus 160 ~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~ 212 (254)
T cd06627 160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV 212 (254)
T ss_pred ccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence 67889999999988889999999999999999999999998877766555544
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=272.99 Aligned_cols=192 Identities=30% Similarity=0.489 Sum_probs=160.2
Q ss_pred eeeecCceEEEEEEE--CCceEEEEEecCCCCChH-HHHHHHHHHHHHHh---cCCCcceEEeecccCCCCcceeeeecC
Q 010078 299 KVASGSYGDLYRGTY--CSQDVAIKVLKPERINSD-MQKEFAQEVFIMRK---VRHKNVVQFIGACTKPPSLCIVTEFMS 372 (518)
Q Consensus 299 ~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~-~~~~~~~Ei~iL~~---L~HpnIv~l~g~~~~~~~~~lV~Ey~~ 372 (518)
.||+|+||.||++.. +++.+|+|++........ ....+.+|..+++. .+||||+.+++++...+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999986 467899999876543222 12334445444443 469999999999998889999999999
Q ss_pred CCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccccCCCC
Q 010078 373 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 452 (518)
Q Consensus 373 ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~~~gt 452 (518)
|++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++...... ......|+
T Consensus 81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~ 158 (279)
T cd05633 81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGT 158 (279)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc-CccCcCCC
Confidence 9999999876 567999999999999999999999999999999999999999999999999998654332 22345789
Q ss_pred CcccCchhcc-CCCCChhhHHHHHHHHHHHHHcCCCCCCCC
Q 010078 453 YRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYL 492 (518)
Q Consensus 453 ~~y~APEvl~-~~~~s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (518)
..|+|||.+. +..++.++|+|||||++|+|++|+.||...
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 199 (279)
T cd05633 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (279)
T ss_pred cCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence 9999999986 466899999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=274.77 Aligned_cols=213 Identities=24% Similarity=0.402 Sum_probs=178.5
Q ss_pred CCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC-----
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP----- 362 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~----- 362 (518)
..++|++.++||+|+||.||+|+.. ++.|++|+++...........+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 3467889999999999999999974 678999998765433333456788999999999999999999887654
Q ss_pred -----CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcc
Q 010078 363 -----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437 (518)
Q Consensus 363 -----~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla 437 (518)
.+|+||||+++ ++..++......+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence 78999999965 777877765567899999999999999999999999999999999999999999999999998
Q ss_pred eecccCC--ccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 438 RVKAQSG--VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 438 ~~~~~~~--~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
....... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..+.+..+.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 7654432 2223356788999998865 4578999999999999999999999998887776666544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=269.31 Aligned_cols=202 Identities=30% Similarity=0.516 Sum_probs=169.9
Q ss_pred CCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCccee
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV 367 (518)
+.+.+.....||+|+||.||+|++. +..|++|.+... .....+.+.+|+.+++.++|+||+++++++......++|
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 3344444468999999999999864 467999987754 233456789999999999999999999999999999999
Q ss_pred eeecCCCchhHHHhhhcCCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC-CCcEEEEeeCcceecccCC
Q 010078 368 TEFMSGGSVYDYLHKLKGVF--KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l--~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~-~~~vkL~DFGla~~~~~~~ 444 (518)
|||+++++|.+++......+ +...+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||.+.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 99999999999998654555 78889999999999999999999999999999999986 6799999999987543322
Q ss_pred -ccccCCCCCcccCchhccCCC--CChhhHHHHHHHHHHHHHcCCCCCCCCC
Q 010078 445 -VMTAETGTYRWMAPEVIEHKP--YDHKADVFSFGIVLWELLTGKLPYEYLT 493 (518)
Q Consensus 445 -~~~~~~gt~~y~APEvl~~~~--~s~ksDVwSlGviL~eLltG~~Pf~~~~ 493 (518)
......+++.|+|||++.+.. ++.++|+||||+++|+|++|+.||....
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 233446889999999986643 7899999999999999999999997654
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=305.72 Aligned_cols=226 Identities=31% Similarity=0.638 Sum_probs=197.4
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEEC---------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEe
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFI 355 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~---------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~ 355 (518)
.|+++.+.+++.+.||+|.||.|++|... ...||||.++..... ...+.+..|+.+|+.+. |+||+.++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 89999999999999999999999999743 346999999977655 56788999999999996 99999999
Q ss_pred ecccCCCCcceeeeecCCCchhHHHhhhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 010078 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420 (518)
Q Consensus 356 g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~N 420 (518)
|+|+....+++|+||+..|+|.+|++..+ ..+....++.++.||+.||+||++..+|||||..+|
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN 448 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence 99999999999999999999999998765 348889999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEeeCcceecccCCcccc--CCC--CCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 010078 421 LLMDENEVVKVADFGVARVKAQSGVMTA--ETG--TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPL 495 (518)
Q Consensus 421 ILid~~~~vkL~DFGla~~~~~~~~~~~--~~g--t~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~ 495 (518)
||+..+..+||+|||+++.......... ..+ ...|||||.+....|+.++|||||||+||||+| |..||.+..+.
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 9999999999999999986555443322 222 346999999999999999999999999999999 99999998755
Q ss_pred HHHHHhhhhcCchhHHH
Q 010078 496 QAAVGVVQKVHHSFLEQ 512 (518)
Q Consensus 496 q~~~~iv~~~~rp~ip~ 512 (518)
+.+..-++.|.|..-|.
T Consensus 529 ~~l~~~l~~G~r~~~P~ 545 (609)
T KOG0200|consen 529 EELLEFLKEGNRMEQPE 545 (609)
T ss_pred HHHHHHHhcCCCCCCCC
Confidence 55566788888865553
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=269.05 Aligned_cols=209 Identities=30% Similarity=0.536 Sum_probs=173.5
Q ss_pred eeeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC------
Q 010078 294 LKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------ 362 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~~-----~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~------ 362 (518)
|++.+.||+|+||.||+|.+. ++.||||+++.........+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 466789999999999999753 467999999876666666778999999999999999999999875432
Q ss_pred CcceeeeecCCCchhHHHhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKL-----KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~-----~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla 437 (518)
..+++++|+.+++|.+++... ...++...++.++.||+.|+.|||++||+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 236889999999999887432 124788899999999999999999999999999999999999999999999998
Q ss_pred eecccCC---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhh
Q 010078 438 RVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 438 ~~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv 502 (518)
+...... ......+++.|++||.+....++.++|||||||++|+|++ |+.||...+..+....+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 229 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI 229 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH
Confidence 7553322 1223345678999999999999999999999999999999 999998887755544443
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=276.88 Aligned_cols=211 Identities=31% Similarity=0.483 Sum_probs=180.0
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
..|...+.||+|+||.||+++. .+..+|+|++..... .......+.+|+.++++++|+|++++++++......++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 4477888999999999999986 467899999875422 3344567889999999999999999999999988999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcccc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~ 448 (518)
||+. |+|.+++......+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++..... ...
T Consensus 105 e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~~~ 180 (317)
T cd06635 105 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---ANS 180 (317)
T ss_pred eCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---ccc
Confidence 9996 578888766567789999999999999999999999999999999999999999999999999865432 234
Q ss_pred CCCCCcccCchhcc---CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcC
Q 010078 449 ETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVH 506 (518)
Q Consensus 449 ~~gt~~y~APEvl~---~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~ 506 (518)
..+++.|+|||.+. ...++.++|||||||++|+|++|+.||...........+.....
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~ 241 (317)
T cd06635 181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES 241 (317)
T ss_pred ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccC
Confidence 56889999999973 45689999999999999999999999988877776666555443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=273.75 Aligned_cols=198 Identities=24% Similarity=0.436 Sum_probs=169.9
Q ss_pred CeeeeeeeeecCceEEEEEEE-----CCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhc-CCCcceEEeecccCCCCc
Q 010078 293 HLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSL 364 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~-----~~~~vAVKvlk~~~~--~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~~~ 364 (518)
.|++.+.||.|+||.||+++. ++..||+|+++.... .....+.+.+|+.+++++ +|+||+++++.+.....+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 367889999999999999976 567899999875432 122346688899999999 489999999999988889
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
|+||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++||||+|+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159 (290)
T ss_pred EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence 999999999999999976 4678899999999999999999999999999999999999999999999999987654322
Q ss_pred --ccccCCCCCcccCchhccC--CCCChhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 445 --VMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 445 --~~~~~~gt~~y~APEvl~~--~~~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||..
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 2234568899999999875 3478899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=274.21 Aligned_cols=201 Identities=31% Similarity=0.483 Sum_probs=169.4
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeecccCCCCccee
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~~~~lV 367 (518)
.++|+..++||+|+||.||++... ++.||+|.+...... .....+.+|+.++.++. |+||+++++++..+...+++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 346777889999999999999874 578999998754333 44567889999999997 99999999999888899999
Q ss_pred eeecCCCchhHHH---hh-hcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 368 TEFMSGGSVYDYL---HK-LKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 368 ~Ey~~ggsL~~~l---~~-~~~~l~~~~i~~i~~qIa~aL~yLHs~-gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
|||+. +++.++. .. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++....
T Consensus 82 ~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred Eeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 99985 4555543 22 236789999999999999999999975 999999999999999999999999999876544
Q ss_pred CCccccCCCCCcccCchhccCC---CCChhhHHHHHHHHHHHHHcCCCCCCCCC
Q 010078 443 SGVMTAETGTYRWMAPEVIEHK---PYDHKADVFSFGIVLWELLTGKLPYEYLT 493 (518)
Q Consensus 443 ~~~~~~~~gt~~y~APEvl~~~---~~s~ksDVwSlGviL~eLltG~~Pf~~~~ 493 (518)
........|+..|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 4444455788999999999776 68999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=269.20 Aligned_cols=210 Identities=24% Similarity=0.410 Sum_probs=182.6
Q ss_pred eeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeec
Q 010078 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 371 (518)
|++.+.||+|++|.||++.. .++.+++|.++...........+.+|+.++++++|+||+++++++..+...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 45678999999999999986 4678999998866555445677889999999999999999999999999999999999
Q ss_pred CCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-ccccCC
Q 010078 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAET 450 (518)
Q Consensus 372 ~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~~~ 450 (518)
++ +|.+++......+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~ 159 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV 159 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCcc
Confidence 65 8888887756789999999999999999999999999999999999999999999999999987665443 233456
Q ss_pred CCCcccCchhccCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 451 GTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 451 gt~~y~APEvl~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+.+.
T Consensus 160 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~ 214 (283)
T cd05118 160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRT 214 (283)
T ss_pred CcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 78899999998776 7899999999999999999999999988887776665544
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=291.86 Aligned_cols=195 Identities=28% Similarity=0.514 Sum_probs=178.3
Q ss_pred eeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecCCC
Q 010078 297 GSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 374 (518)
Q Consensus 297 ~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~gg 374 (518)
.+.||+|.||+||-|+. +|++||||++.+.+........+.+|+.||++++||.||.+--.|+.++..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 36899999999999875 6899999999988777666788999999999999999999999999999999999999666
Q ss_pred chhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC---cEEEEeeCcceecccCCccccCCC
Q 010078 375 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VVKVADFGVARVKAQSGVMTAETG 451 (518)
Q Consensus 375 sL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~---~vkL~DFGla~~~~~~~~~~~~~g 451 (518)
-|.-.|....+.+++.....++.||+.||.|||-+||+|+||||+|||+.... .+||||||+++...........+|
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVG 728 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVG 728 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcC
Confidence 66666666688999999999999999999999999999999999999997553 799999999999988877788899
Q ss_pred CCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 452 TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 452 t~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
|+.|+|||++..+.|...-||||+|+|+|--|+|..||..
T Consensus 729 TPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 729 TPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred CccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 9999999999999999999999999999999999999964
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=274.49 Aligned_cols=212 Identities=25% Similarity=0.433 Sum_probs=175.2
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC------
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------ 362 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~------ 362 (518)
.++|++.++||+|+||.||++++. ++.++||++............+.+|+.+++.++|+||+++++.+....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999874 678999988654333333345778999999999999999999874433
Q ss_pred --CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceec
Q 010078 363 --SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 363 --~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~ 440 (518)
.+++||||+. ++|...+......+++..+..++.||++||.|||++||+|+||||+||+++.++.++|+|||+++..
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 3699999995 5777777665667999999999999999999999999999999999999999999999999998754
Q ss_pred ccCCc------------cccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 441 AQSGV------------MTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 441 ~~~~~------------~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
..... .+...+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 33221 122356788999998765 4589999999999999999999999998888776666544
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=277.52 Aligned_cols=204 Identities=30% Similarity=0.504 Sum_probs=176.0
Q ss_pred eeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeec
Q 010078 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 371 (518)
|....+||.|+||.||++.. .++.||+|++..... .....+.+|+.+++.++||||+++++.+......|++|||+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 34455899999999999976 578899999865322 23456889999999999999999999999999999999999
Q ss_pred CCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-ccccCC
Q 010078 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAET 450 (518)
Q Consensus 372 ~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~~~ 450 (518)
++++|..++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++....... ......
T Consensus 101 ~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 178 (297)
T cd06659 101 QGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV 178 (297)
T ss_pred CCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccccee
Confidence 99999998754 568899999999999999999999999999999999999999999999999986443321 223456
Q ss_pred CCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 010078 451 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV 501 (518)
Q Consensus 451 gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~i 501 (518)
++..|+|||++.+..++.++|||||||++|||++|+.||...++.+....+
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~ 229 (297)
T cd06659 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL 229 (297)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 889999999999989999999999999999999999999988877665543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=297.21 Aligned_cols=211 Identities=18% Similarity=0.331 Sum_probs=164.3
Q ss_pred CCCeeeeeeeeecCceEEEEEEECC---ceEEEEE---------------ecCCCCChHHHHHHHHHHHHHHhcCCCcce
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYCS---QDVAIKV---------------LKPERINSDMQKEFAQEVFIMRKVRHKNVV 352 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~~---~~vAVKv---------------lk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 352 (518)
..+|+++++||+|+||.||++.... ..+++|. .+...........+.+|+.+|++++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 3689999999999999999986532 1122221 111111223445688999999999999999
Q ss_pred EEeecccCCCCcceeeeecCCCchhHHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCc
Q 010078 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKL----KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428 (518)
Q Consensus 353 ~l~g~~~~~~~~~lV~Ey~~ggsL~~~l~~~----~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~ 428 (518)
++++++...+..|+||+++ +++|.+++... ........++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 9999999999999999999 56788877532 122345677889999999999999999999999999999999999
Q ss_pred EEEEeeCcceecccCC--ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCC-CCCCC--CHHHHHHHhh
Q 010078 429 VKVADFGVARVKAQSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKL-PYEYL--TPLQAAVGVV 502 (518)
Q Consensus 429 vkL~DFGla~~~~~~~--~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~-Pf~~~--~~~q~~~~iv 502 (518)
+||+|||+++...... ......||..|+|||++.+..|+.++|||||||+||||++|.. ||... .+...+..++
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~ 384 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII 384 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence 9999999998654432 2234579999999999999999999999999999999999875 55432 3444444433
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=272.17 Aligned_cols=194 Identities=25% Similarity=0.475 Sum_probs=164.0
Q ss_pred eeeeecCceEEEEEEECC---------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 298 SKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~~---------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
+.||+|+||.||+|.... ..+++|++... .....+.+.+|+.+++.++||||+++++++......++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 468999999999997632 34788887543 2334567889999999999999999999999888999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCc--------EEEEeeCcceec
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV--------VKVADFGVARVK 440 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~--------vkL~DFGla~~~ 440 (518)
||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++. ++++|||++...
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 999999999999876667899999999999999999999999999999999999987664 699999988644
Q ss_pred ccCCccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcC-CCCCCCCCHHH
Q 010078 441 AQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTG-KLPYEYLTPLQ 496 (518)
Q Consensus 441 ~~~~~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG-~~Pf~~~~~~q 496 (518)
.. .....++..|+|||++.+ ..++.++||||||+++|+|++| ..||...++..
T Consensus 159 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~ 213 (258)
T cd05078 159 LP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK 213 (258)
T ss_pred CC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH
Confidence 32 233467889999999976 4589999999999999999998 57877766644
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=273.57 Aligned_cols=217 Identities=27% Similarity=0.470 Sum_probs=180.4
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeecccCC
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKP 361 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~ 361 (518)
..|.++.++|++.++||+|+||.||++++. ++.||||+++.... ......+..|+.++.++. |+||+++++++...
T Consensus 8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 86 (296)
T cd06618 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITD 86 (296)
T ss_pred eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence 456778889999999999999999999986 78899999875432 233456667777666665 99999999999999
Q ss_pred CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEcCCCcEEEEeeCcceec
Q 010078 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs-~gIiHrDLKp~NILid~~~~vkL~DFGla~~~ 440 (518)
...|++|||+ +++|.+++......+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.++|+|||++...
T Consensus 87 ~~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 87 SDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred CeEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 9999999998 557888776656788999999999999999999997 59999999999999999999999999998765
Q ss_pred ccCCccccCCCCCcccCchhccCCC----CChhhHHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHhhh
Q 010078 441 AQSGVMTAETGTYRWMAPEVIEHKP----YDHKADVFSFGIVLWELLTGKLPYEYLTP-LQAAVGVVQ 503 (518)
Q Consensus 441 ~~~~~~~~~~gt~~y~APEvl~~~~----~s~ksDVwSlGviL~eLltG~~Pf~~~~~-~q~~~~iv~ 503 (518)
..........++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||..... .+.+..++.
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 233 (296)
T cd06618 166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ 233 (296)
T ss_pred cCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc
Confidence 5444444556788999999987554 88999999999999999999999976433 444444443
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=272.83 Aligned_cols=204 Identities=18% Similarity=0.257 Sum_probs=158.2
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEECCc-----eEEEEEecCCCCChHH---------HHHHHHHHHHHHhcCCCcceE
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYCSQ-----DVAIKVLKPERINSDM---------QKEFAQEVFIMRKVRHKNVVQ 353 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~~~-----~vAVKvlk~~~~~~~~---------~~~~~~Ei~iL~~L~HpnIv~ 353 (518)
++..++|++.++||+|+||.||+|...+. .+++|+.......... ......+...+..+.|+|+++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 56668999999999999999999987543 5677764432211100 011223444556678999999
Q ss_pred EeecccCCC----CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcE
Q 010078 354 FIGACTKPP----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVV 429 (518)
Q Consensus 354 l~g~~~~~~----~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~v 429 (518)
+++.+.... ..+++++++ ..++.+.+.. ....++..++.++.|++.||.|||+++|+||||||+|||++.++.+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EEEeeeEecCCceEEEEEEehh-ccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 998764433 236777877 4467666654 3446788899999999999999999999999999999999999999
Q ss_pred EEEeeCcceecccCC--------ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCC
Q 010078 430 KVADFGVARVKAQSG--------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 493 (518)
Q Consensus 430 kL~DFGla~~~~~~~--------~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~ 493 (518)
+|+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 999999997653221 1223469999999999999999999999999999999999999998774
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-32 Score=271.29 Aligned_cols=206 Identities=31% Similarity=0.509 Sum_probs=177.5
Q ss_pred eeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeec
Q 010078 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 371 (518)
|.-.++||+|++|.||++.. .++.+++|+++.. .....+.+.+|+.+++.++|+||+++++++......|+++||+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 44457999999999999976 4577999988643 2233466889999999999999999999999889999999999
Q ss_pred CCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-ccccCC
Q 010078 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAET 450 (518)
Q Consensus 372 ~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~~~ 450 (518)
+|++|.+++.. +.++...+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||.+....... ......
T Consensus 99 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 176 (285)
T cd06648 99 EGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV 176 (285)
T ss_pred CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccccc
Confidence 99999999876 568899999999999999999999999999999999999999999999999876543322 223356
Q ss_pred CCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 451 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 451 gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...++.+....+..
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~ 229 (285)
T cd06648 177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRD 229 (285)
T ss_pred CCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHh
Confidence 88999999999988999999999999999999999999998887776665443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=268.86 Aligned_cols=210 Identities=25% Similarity=0.493 Sum_probs=182.0
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcC-CCcceEEeecccCCCCccee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~~~~lV 367 (518)
++|.+.+.||+|+||.||+++. .++.|++|++..... .......+..|+.++++++ |+||+++++.+......++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4688999999999999999987 578899999876433 2333567888999999999 99999999999999999999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC---
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--- 444 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~--- 444 (518)
|||+++++|.+++.+ .+.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 81 LEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred EcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 999999999999987 4579999999999999999999999999999999999999999999999999987543322
Q ss_pred ------------------ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 010078 445 ------------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 445 ------------------~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv 502 (518)
......++..|+|||++.+..++.++|+||||+++|+|++|+.||...+..+....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 235 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL 235 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 1123357889999999988889999999999999999999999999887766555544
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=270.86 Aligned_cols=205 Identities=34% Similarity=0.582 Sum_probs=176.4
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC---CCcceEEeecccCCCCccee
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~---HpnIv~l~g~~~~~~~~~lV 367 (518)
.|++.++||+|+||.||+|.+ .++.|++|+++.... ......+.+|+.+++.++ |||++++++++......|+|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 467788999999999999986 467899999875432 333467888999999997 99999999999988899999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-cc
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VM 446 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~ 446 (518)
|||++|++|.+++.. +.+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++....... ..
T Consensus 81 ~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 81 MEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred EecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence 999999999999865 478999999999999999999999999999999999999999999999999987654432 23
Q ss_pred ccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 010078 447 TAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 500 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~ 500 (518)
....|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...++......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~ 213 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML 213 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc
Confidence 34568899999998864 4578999999999999999999999998877655443
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=275.43 Aligned_cols=207 Identities=22% Similarity=0.384 Sum_probs=177.0
Q ss_pred eeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecCC
Q 010078 294 LKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (518)
+.+++.+|.|+++.||+++.+++.||||+++...........+.+|+.+++.++|+||+++++++......+++|||+++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 45667777888888888888899999999987644555667899999999999999999999999999999999999999
Q ss_pred CchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC--------
Q 010078 374 GSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-------- 444 (518)
Q Consensus 374 gsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-------- 444 (518)
++|.+++... ...+++..+..++.||+.||.|||+++|+||||||+||+++.++.++|+|||.+.......
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 9999999764 3458899999999999999999999999999999999999999999999999886443221
Q ss_pred ccccCCCCCcccCchhccC--CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 010078 445 VMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 500 (518)
Q Consensus 445 ~~~~~~gt~~y~APEvl~~--~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~ 500 (518)
......++..|+|||++.+ ..++.++|+|||||++|||++|+.||...........
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~ 221 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE 221 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 1233457788999999876 4588999999999999999999999998776655544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=273.49 Aligned_cols=216 Identities=24% Similarity=0.435 Sum_probs=178.7
Q ss_pred eeeeeecCceEEEEEE--ECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeecccCCCCcceeeeecCC
Q 010078 297 GSKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSG 373 (518)
Q Consensus 297 ~~~LG~G~fG~Vy~g~--~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (518)
.+.||+|+|+.|-.+. +++..||||++.+.. ...+.++.+|++++.+++ |+||++++++|.++..+|+|||-|.|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 3679999999998775 578999999998763 334678999999999997 99999999999999999999999999
Q ss_pred CchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC---cEEEEeeCcceecccCC------
Q 010078 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VVKVADFGVARVKAQSG------ 444 (518)
Q Consensus 374 gsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~---~vkL~DFGla~~~~~~~------ 444 (518)
|+|..++++ ...|++..+.++..+|+.||+|||.+||.||||||+|||....+ -||||||.+..-.....
T Consensus 161 GplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 161 GPLLSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred chHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 999999988 66799999999999999999999999999999999999997654 48999999876432221
Q ss_pred --ccccCCCCCcccCchhcc-----CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCH--------------HHHHHHhhh
Q 010078 445 --VMTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTP--------------LQAAVGVVQ 503 (518)
Q Consensus 445 --~~~~~~gt~~y~APEvl~-----~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~--------------~q~~~~iv~ 503 (518)
.....+|+..|||||+.. ...|+.++|.||||+|||-||+|.+||.+.-. .+.+..-+|
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ 319 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ 319 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence 223557888999999863 34689999999999999999999999976422 344445566
Q ss_pred hcCchhHHHHHh
Q 010078 504 KVHHSFLEQRLR 515 (518)
Q Consensus 504 ~~~rp~ip~~~~ 515 (518)
.|...+..+.|.
T Consensus 320 EGkYeFPdkdWa 331 (463)
T KOG0607|consen 320 EGKYEFPDKDWA 331 (463)
T ss_pred ccCCcCChhhhH
Confidence 666655555443
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=265.68 Aligned_cols=203 Identities=28% Similarity=0.446 Sum_probs=176.3
Q ss_pred eeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecCCCch
Q 010078 300 VASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (518)
Q Consensus 300 LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL 376 (518)
||.|+||.||++++. ++.+++|++..... .......+.+|+.++++++|+||+++++.+......|++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999985 78899999876533 234456788999999999999999999999988999999999999999
Q ss_pred hHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC---------ccc
Q 010078 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---------VMT 447 (518)
Q Consensus 377 ~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~---------~~~ 447 (518)
.+++.+ .+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 159 (265)
T cd05579 81 ASLLEN-VGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK 159 (265)
T ss_pred HHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccccc
Confidence 999977 3478999999999999999999999999999999999999999999999999987543321 122
Q ss_pred cCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
...++..|+|||.+.+..++.++|+||||+++|+|++|+.||...++.+....+..
T Consensus 160 ~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~ 215 (265)
T cd05579 160 RIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN 215 (265)
T ss_pred CcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 34578899999999888899999999999999999999999998887776666543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-31 Score=268.17 Aligned_cols=199 Identities=32% Similarity=0.483 Sum_probs=171.3
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC--CCccee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIV 367 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~--~~~~lV 367 (518)
+.|+..++||.|++|.||++.. .++.+|+|++..... ......+.+|+.++++++||||+++++++... ..+|+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 3578889999999999999987 467899999875432 34457789999999999999999999987543 468999
Q ss_pred eeecCCCchhHHHhh---hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 368 TEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~---~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
|||++|++|.+++.. ....++...+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 999999999988753 23558889999999999999999999999999999999999999999999999986543322
Q ss_pred ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCC
Q 010078 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL 492 (518)
Q Consensus 445 ~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (518)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 160 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 160 -AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred -cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 22345788999999999999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=274.09 Aligned_cols=201 Identities=23% Similarity=0.423 Sum_probs=167.6
Q ss_pred CeeeeeeeeecCceEEEEEEE----CCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCcceEEeecccCC--CCcc
Q 010078 293 HLKFGSKVASGSYGDLYRGTY----CSQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLC 365 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~----~~~~vAVKvlk~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~--~~~~ 365 (518)
.|.+.++||+|+||.||+|.. .++.||+|+++... ........+.+|+.++++++||||+++++++... ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 477889999999999999987 45789999988643 1122335678899999999999999999999887 7799
Q ss_pred eeeeecCCCchhHHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC----CCcEEEEeeCcc
Q 010078 366 IVTEFMSGGSVYDYLHKL----KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE----NEVVKVADFGVA 437 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~----~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~----~~~vkL~DFGla 437 (518)
+||||++ ++|.+++... ...+++..++.++.||+.||.|||+++|+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999996 4677766432 236889999999999999999999999999999999999999 899999999998
Q ss_pred eecccCCc----cccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 438 RVKAQSGV----MTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 438 ~~~~~~~~----~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
+....... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 76543221 223467889999998866 4689999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=276.27 Aligned_cols=210 Identities=26% Similarity=0.396 Sum_probs=182.9
Q ss_pred CeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC-----Ccc
Q 010078 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-----SLC 365 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~-----~~~ 365 (518)
+|++.+.||+|+||.||+++.. ++.|+||++..........+.+.+|+.+++.++|+||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788899999999999999874 578999998865433455678999999999999999999999987765 789
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG- 444 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~- 444 (518)
++|||++ ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||.|||++.++.++|+|||.+.......
T Consensus 81 lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 81 IVTELME-TDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEecchh-hhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 9999996 589998876 4589999999999999999999999999999999999999999999999999998665542
Q ss_pred ---ccccCCCCCcccCchhccCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 445 ---VMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 445 ---~~~~~~gt~~y~APEvl~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....++..
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 222 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEV 222 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHh
Confidence 23455688899999999887 8999999999999999999999999998887776666553
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-34 Score=274.87 Aligned_cols=221 Identities=28% Similarity=0.425 Sum_probs=186.5
Q ss_pred CCCceeeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHH-HHhcCCCcceEEeeccc
Q 010078 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI-MRKVRHKNVVQFIGACT 359 (518)
Q Consensus 283 ~~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~i-L~~L~HpnIv~l~g~~~ 359 (518)
....|++..++++-...||.|+||+|++-.+ .++..|||.++.... ...+++++.|... ++.-++||||+|||++.
T Consensus 55 ~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F 133 (361)
T KOG1006|consen 55 DAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALF 133 (361)
T ss_pred cccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence 3456888889999999999999999999876 468899999987654 3446778888875 44556899999999999
Q ss_pred CCCCcceeeeecCCCchhHHHh----hhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEcCCCcEEEEee
Q 010078 360 KPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADF 434 (518)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~l~----~~~~~l~~~~i~~i~~qIa~aL~yLHs-~gIiHrDLKp~NILid~~~~vkL~DF 434 (518)
.++..||.||.| ..||..+.. ..+..+++..+..|..-...||+||-. .+|||||+||+|||++..|.||||||
T Consensus 134 ~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDF 212 (361)
T KOG1006|consen 134 SEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDF 212 (361)
T ss_pred cCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecc
Confidence 999999999999 667766543 224678999999999999999999985 58999999999999999999999999
Q ss_pred CcceecccCCccccCCCCCcccCchhcc--CCCCChhhHHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHhhhhc
Q 010078 435 GVARVKAQSGVMTAETGTYRWMAPEVIE--HKPYDHKADVFSFGIVLWELLTGKLPYEYL-TPLQAAVGVVQKV 505 (518)
Q Consensus 435 Gla~~~~~~~~~~~~~gt~~y~APEvl~--~~~~s~ksDVwSlGviL~eLltG~~Pf~~~-~~~q~~~~iv~~~ 505 (518)
|.+.....+-..+...|...|||||.+. +..|+.+|||||||++|||+.||+.||..- +.++.+..|+.+.
T Consensus 213 GIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gd 286 (361)
T KOG1006|consen 213 GICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGD 286 (361)
T ss_pred cchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCC
Confidence 9998777776777888999999999984 456999999999999999999999999865 4577777766643
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=276.45 Aligned_cols=212 Identities=26% Similarity=0.448 Sum_probs=177.7
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC--
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-- 361 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~-- 361 (518)
.|.+. ++|.+.+.||+|+||.||++.. +++.||+|+++...........+.+|+.++++++|+||+++++++...
T Consensus 12 ~~~~~-~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 12 IWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred Hhhcc-CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 34444 6799999999999999999975 567899999876543344456788899999999999999999987533
Q ss_pred ----CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcc
Q 010078 362 ----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437 (518)
Q Consensus 362 ----~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla 437 (518)
...|++++++ |++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~ 167 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 167 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccc
Confidence 3468888887 8899888864 46899999999999999999999999999999999999999999999999998
Q ss_pred eecccCCccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 438 RVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 438 ~~~~~~~~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
+.... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+++
T Consensus 168 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (345)
T cd07877 168 RHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 232 (345)
T ss_pred ccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 75433 2334568899999999866 5789999999999999999999999988877666555444
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=277.20 Aligned_cols=204 Identities=26% Similarity=0.384 Sum_probs=173.4
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC-----CCc
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-----PSL 364 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~-----~~~ 364 (518)
.+|++.+.||+|+||.||+++. ++..||||.++...........+.+|+.+++.++|+||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 4689999999999999999986 467899999876443344456678899999999999999999987644 247
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS- 443 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~- 443 (518)
|+||||+ +++|.+++.. .+.+++..+..++.||+.||.|||+++++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 85 YIVYELM-DTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEEEeCC-CCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 9999999 4789988876 567999999999999999999999999999999999999999999999999999765443
Q ss_pred CccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 010078 444 GVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 497 (518)
Q Consensus 444 ~~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~ 497 (518)
.......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+....
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 217 (337)
T cd07858 163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ 217 (337)
T ss_pred ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH
Confidence 23345568899999998865 5689999999999999999999999987765433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=278.43 Aligned_cols=208 Identities=24% Similarity=0.376 Sum_probs=175.1
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC----CCCcc
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK----PPSLC 365 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~----~~~~~ 365 (518)
.+|++.+.||.|+||.||+++. +++.|++|++............+.+|+.+|++++||||+++++++.. ...+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 6788889999999999999986 47889999987654433445677889999999999999999998753 34579
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG- 444 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~- 444 (518)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 85 lv~e~~~-~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 85 VVMDLME-SDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEehhh-hhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 9999995 689998865 4568999999999999999999999999999999999999999999999999987544322
Q ss_pred ----ccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 010078 445 ----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV 501 (518)
Q Consensus 445 ----~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~i 501 (518)
......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLI 224 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHH
Confidence 1234478899999999865 56899999999999999999999999888765554443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=268.69 Aligned_cols=192 Identities=29% Similarity=0.472 Sum_probs=160.6
Q ss_pred eeeecCceEEEEEEE--CCceEEEEEecCCCCCh-HHHHHHHHHHH---HHHhcCCCcceEEeecccCCCCcceeeeecC
Q 010078 299 KVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVF---IMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 372 (518)
Q Consensus 299 ~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~-~~~~~~~~Ei~---iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ 372 (518)
.||+|+||.||++.. .++.||+|++....... .....+..|.. +++...||||+.+++++...+.+|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 379999999999876 46789999987543321 11222334433 4445579999999999999999999999999
Q ss_pred CCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccccCCCC
Q 010078 373 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 452 (518)
Q Consensus 373 ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~~~gt 452 (518)
|++|..++.. .+.+++..++.++.|++.||.|||+++|+||||||+||+++.++.++|+|||++...... ......|+
T Consensus 81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~ 158 (278)
T cd05606 81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGT 158 (278)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcCcCCC
Confidence 9999998875 567999999999999999999999999999999999999999999999999998754332 22345789
Q ss_pred CcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCC
Q 010078 453 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYL 492 (518)
Q Consensus 453 ~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (518)
..|+|||++.+ ..++.++|+||||+++|+|++|+.||...
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred cCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 99999999974 46899999999999999999999999876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=275.08 Aligned_cols=204 Identities=26% Similarity=0.464 Sum_probs=169.9
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC-----CCc
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-----PSL 364 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~-----~~~ 364 (518)
++|++.++||+|+||.||+|.. +++.||||+++... .......+.+|+.++++++|+||+++++++... ...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 5799999999999999999976 56789999987432 223456688899999999999999999876543 347
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
|++|||+. ++|..++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 84 ~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 84 YIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 99999995 588887754 568999999999999999999999999999999999999999999999999987543322
Q ss_pred ----ccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 010078 445 ----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV 499 (518)
Q Consensus 445 ----~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~ 499 (518)
......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+......
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~ 220 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLN 220 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 1223468899999998754 568999999999999999999999998766544333
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=275.29 Aligned_cols=206 Identities=23% Similarity=0.415 Sum_probs=171.8
Q ss_pred eeeeec--CceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecCC
Q 010078 298 SKVASG--SYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373 (518)
Q Consensus 298 ~~LG~G--~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (518)
..||.| +||.||++++ .++.||+|+++.........+.+.+|+.+++.++||||++++++|.....+|+||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 9999999987 678999999987655555567889999999999999999999999999999999999999
Q ss_pred CchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc-------
Q 010078 374 GSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV------- 445 (518)
Q Consensus 374 gsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~------- 445 (518)
++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++++||+.+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence 99999987642 3588999999999999999999999999999999999999999999999986532221110
Q ss_pred -cccCCCCCcccCchhccC--CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 446 -MTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 446 -~~~~~gt~~y~APEvl~~--~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
.....++..|+|||++.+ ..++.++|||||||++|+|++|+.||......+.....+.
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 224 (328)
T cd08226 164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLK 224 (328)
T ss_pred ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhc
Confidence 011234567999999976 4578999999999999999999999998877666655443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=283.21 Aligned_cols=208 Identities=22% Similarity=0.357 Sum_probs=180.6
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeecccCCC
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPP 362 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~ 362 (518)
..+.|....|++.++||+|+.+.||++...+ +.||+|.+.....+.....-|.+|+.+|.+|+ |.+||++|++-..++
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 4677888999999999999999999998754 56888887777778888899999999999997 899999999998899
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
.+||||||= ..+|..+|++....++...++.+..|++.++.++|+.||||.||||.|+|+- .|.+||+|||.|.....
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred eEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 999999985 6799999988666666568889999999999999999999999999999996 67999999999986654
Q ss_pred CC---ccccCCCCCcccCchhccCCC-----------CChhhHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 443 SG---VMTAETGTYRWMAPEVIEHKP-----------YDHKADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 443 ~~---~~~~~~gt~~y~APEvl~~~~-----------~s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
.. .....+||.-||+||.+.... .+.++||||||||||+|+.|+.||.....
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n 577 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN 577 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH
Confidence 32 334668999999999985332 46789999999999999999999986553
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-31 Score=273.92 Aligned_cols=212 Identities=28% Similarity=0.461 Sum_probs=179.1
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC-
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP- 362 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~- 362 (518)
.|.+. ++|++.+.||+|+||.||++.. .+..||||+++...........+.+|+.+|+.++|+||+++++++....
T Consensus 10 ~~~~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 10 IWEVP-DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhccc-cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 55553 6799999999999999999976 4678999998755444445567889999999999999999999886554
Q ss_pred -----CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcc
Q 010078 363 -----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437 (518)
Q Consensus 363 -----~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla 437 (518)
.+|+||||+ |++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 348999999 7899888864 56899999999999999999999999999999999999999999999999998
Q ss_pred eecccCCccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 438 RVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 438 ~~~~~~~~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.......++.
T Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~ 230 (343)
T cd07880 166 RQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMK 230 (343)
T ss_pred cccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 754332 234467889999999876 4588999999999999999999999998877666555443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=266.66 Aligned_cols=207 Identities=27% Similarity=0.415 Sum_probs=176.7
Q ss_pred eeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeecccCCCCcceeeee
Q 010078 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
|.+.+.||+|+||.||+|+. .++.|+||.+....... ......+|+..+++++ |+||+++++++......|+||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 56788999999999999997 45779999987543322 2234567899999999 99999999999999999999999
Q ss_pred cCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccccC
Q 010078 371 MSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 449 (518)
Q Consensus 371 ~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~~ 449 (518)
+ +++|.+++.... ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||.+............
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 158 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDY 158 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCC
Confidence 9 889999987644 46899999999999999999999999999999999999999999999999999866554444556
Q ss_pred CCCCcccCchhcc-CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 010078 450 TGTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 450 ~gt~~y~APEvl~-~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv 502 (518)
.++..|+|||++. ...++.++|+||||+++|+|++|+.||...+....+..+.
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~ 212 (283)
T cd07830 159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKIC 212 (283)
T ss_pred CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHH
Confidence 7889999999874 4568899999999999999999999998887766555433
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=266.27 Aligned_cols=209 Identities=25% Similarity=0.448 Sum_probs=180.8
Q ss_pred eeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeec
Q 010078 294 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 371 (518)
|++.+.||+|.||.||+|+.. ++.+++|+++...........+.+|+.++++++|+||+++++++......++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456788999999999999874 688999998865433444567888999999999999999999999999999999999
Q ss_pred CCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-ccccCC
Q 010078 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAET 450 (518)
Q Consensus 372 ~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~~~ 450 (518)
+ ++|.+++......+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||.++...... ......
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV 159 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccc
Confidence 6 59999998755679999999999999999999999999999999999999999999999999987654432 333455
Q ss_pred CCCcccCchhccCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 451 GTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 451 gt~~y~APEvl~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
++..|+|||.+.+. .++.++|+||||+++|||++|+.||...+.......+.+
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~ 213 (282)
T cd07829 160 VTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ 213 (282)
T ss_pred cCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHH
Confidence 67889999998766 889999999999999999999999998887766666544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-31 Score=270.51 Aligned_cols=206 Identities=32% Similarity=0.484 Sum_probs=175.8
Q ss_pred eeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
|...++||+|+||.||+|+. .++.|++|++..... .......+.+|+.+++.++|||++++++++......|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567899999999999986 567899999875433 334456788999999999999999999999998999999999
Q ss_pred cCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccccCC
Q 010078 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET 450 (518)
Q Consensus 371 ~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~~~ 450 (518)
+. ++|.+++......+++..+..++.||+.++.|||++|++|+||+|+||+++.++.++|+|||++.... ......
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---~~~~~~ 178 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PANSFV 178 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---CCCCcc
Confidence 95 58888887656778999999999999999999999999999999999999999999999999986432 233457
Q ss_pred CCCcccCchhcc---CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 451 GTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 451 gt~~y~APEvl~---~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
|+..|+|||++. ...++.++||||||+++|+|++|..||...++......+..
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~ 234 (313)
T cd06633 179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 234 (313)
T ss_pred ccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Confidence 889999999984 46689999999999999999999999988877666655443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=275.84 Aligned_cols=210 Identities=24% Similarity=0.423 Sum_probs=175.3
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEeecccCC--CCcce
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKP--PSLCI 366 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~--~~~~l 366 (518)
++|++.+.||+|+||.||+|.+ .++.+++|.+............+.+|+.+++++ +||||+++++++... ..+|+
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 5688889999999999999987 467899998865433334456677899999999 999999999987543 35799
Q ss_pred eeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC--
Q 010078 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-- 444 (518)
Q Consensus 367 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-- 444 (518)
||||+. ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 87 v~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 87 VFEYME-TDLHAVIRA--NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163 (337)
T ss_pred Eecccc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence 999996 599998865 378888999999999999999999999999999999999999999999999987544322
Q ss_pred ----ccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 445 ----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 445 ----~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+..+......+...
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~ 228 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEV 228 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 2223468889999998755 56788999999999999999999999988877666555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-33 Score=314.49 Aligned_cols=222 Identities=28% Similarity=0.438 Sum_probs=189.9
Q ss_pred eeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeec
Q 010078 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 371 (518)
+.-+.+||.|.||.||.+.. +|...|+|-++...........+.+|..++..++|||+|++||+-.+.+..+|.||||
T Consensus 1237 Wqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC 1316 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYC 1316 (1509)
T ss_pred eccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHh
Confidence 34467899999999999975 5677899988765444445567889999999999999999999999999999999999
Q ss_pred CCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-----cc
Q 010078 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-----VM 446 (518)
Q Consensus 372 ~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-----~~ 446 (518)
+||+|.+.+.. .+..++.....+..|++.|+.|||+.|||||||||+||+++.+|.+|++|||.|.....+. ..
T Consensus 1317 ~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1317 EGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred ccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHH
Confidence 99999999875 4556777788899999999999999999999999999999999999999999998665542 22
Q ss_pred ccCCCCCcccCchhccCC---CCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCchhHHHHHhh
Q 010078 447 TAETGTYRWMAPEVIEHK---PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSFLEQRLRK 516 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~---~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp~ip~~~~~ 516 (518)
....||+-|||||+|.+. ...-+.||||+|||..||+||+.||..++..=++.=-|--|..|.+|++++.
T Consensus 1396 ~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~ 1468 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSS 1468 (1509)
T ss_pred HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhH
Confidence 345799999999999653 4567899999999999999999999988775555555778999999999864
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=269.87 Aligned_cols=203 Identities=31% Similarity=0.490 Sum_probs=174.6
Q ss_pred eeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeec
Q 010078 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 371 (518)
|....+||+|+||.||++.. +++.||||++... .......+.+|+.+++.++|+||+++++.+...+..|++|||+
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 33346899999999999987 4678999987543 2334567889999999999999999999999999999999999
Q ss_pred CCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-ccccCC
Q 010078 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAET 450 (518)
Q Consensus 372 ~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~~~ 450 (518)
++++|.+++.. +.+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 100 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 177 (292)
T cd06657 100 EGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV 177 (292)
T ss_pred CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccc
Confidence 99999998754 468899999999999999999999999999999999999999999999999886543321 223456
Q ss_pred CCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 010078 451 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 500 (518)
Q Consensus 451 gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~ 500 (518)
+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+....+....
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~ 227 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM 227 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 88999999999888899999999999999999999999988777655444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-31 Score=273.54 Aligned_cols=212 Identities=27% Similarity=0.442 Sum_probs=176.9
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
..|++. .+|.+.+.||+|+||.||+|+. +++.||||+++...........+.+|+.+++.++|+||+++++++....
T Consensus 9 ~~~~~~-~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 87 (342)
T cd07879 9 TVWELP-ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV 87 (342)
T ss_pred hhhccc-cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccc
Confidence 456774 5799999999999999999986 4788999998765433444566889999999999999999999886543
Q ss_pred ------CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCc
Q 010078 363 ------SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436 (518)
Q Consensus 363 ------~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGl 436 (518)
.+|+||||+. .+|..++ ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 88 SGDEFQDFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred cCCCCceEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 3589999995 4676655 34688999999999999999999999999999999999999999999999999
Q ss_pred ceecccCCccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 437 ARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 437 a~~~~~~~~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
++.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+....+..++.
T Consensus 164 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~ 229 (342)
T cd07879 164 ARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 229 (342)
T ss_pred CcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 875432 2334567889999999866 5689999999999999999999999998877666655444
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=260.74 Aligned_cols=203 Identities=29% Similarity=0.452 Sum_probs=176.9
Q ss_pred eeecCceEEEEEEEC--CceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecCCCch
Q 010078 300 VASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (518)
Q Consensus 300 LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL 376 (518)
||.|+||.||+++.. ++.+++|+++..... ......+..|+.++++++|+||+++++.+......|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999875 678999998765332 23456789999999999999999999999999999999999999999
Q ss_pred hHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-CccccCCCCCcc
Q 010078 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGTYRW 455 (518)
Q Consensus 377 ~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~-~~~~~~~gt~~y 455 (518)
.+++.. ...+++..+..++.|++.|+.|||+++++|+||+|+||+++.++.++|+|||++...... .......++..|
T Consensus 81 ~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05123 81 FSHLSK-EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY 159 (250)
T ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccc
Confidence 999976 456899999999999999999999999999999999999999999999999998765443 233455688899
Q ss_pred cCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 456 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 456 ~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
++||.+.+..++.++|+||||+++|+|++|+.||...+..+....+.+
T Consensus 160 ~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~ 207 (250)
T cd05123 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK 207 (250)
T ss_pred cChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 999999988899999999999999999999999988876555555443
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-31 Score=271.78 Aligned_cols=209 Identities=25% Similarity=0.375 Sum_probs=173.1
Q ss_pred CeeeeeeeeecCceEEEEEEEC----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeecccC----CCC
Q 010078 293 HLKFGSKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTK----PPS 363 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~~----~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~----~~~ 363 (518)
.|++.+.||+|+||.||++... +..||+|++..........+.+.+|+.++++++ ||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999975 457999998754434444567888999999995 9999999986432 245
Q ss_pred cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC
Q 010078 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~ 443 (518)
.|++|+|+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||+++.....
T Consensus 81 ~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 81 LYLYEELM-EADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred EEEEEecc-cCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 68899998 4689998865 567899999999999999999999999999999999999999999999999999754432
Q ss_pred C-----ccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 444 G-----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 444 ~-----~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
. ......||..|+|||++.+ ..++.++|+||||+++|+|++|+.||...+.......+++
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~ 224 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQ 224 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHH
Confidence 1 1233468899999998765 5789999999999999999999999998776665555444
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=272.23 Aligned_cols=212 Identities=25% Similarity=0.417 Sum_probs=175.2
Q ss_pred CCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChH------------HHHHHHHHHHHHHhcCCCcceEEe
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSD------------MQKEFAQEVFIMRKVRHKNVVQFI 355 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~------------~~~~~~~Ei~iL~~L~HpnIv~l~ 355 (518)
......+.+.||.|+||.||++.. .++.||||+++....... ....+.+|+.++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 333344567899999999999985 467899999875432210 012477899999999999999999
Q ss_pred ecccCCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeC
Q 010078 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435 (518)
Q Consensus 356 g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFG 435 (518)
+++......|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 99999999999999996 689999865 5678999999999999999999999999999999999999999999999999
Q ss_pred cceecccC---------------CccccCCCCCcccCchhccCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 010078 436 VARVKAQS---------------GVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV 499 (518)
Q Consensus 436 la~~~~~~---------------~~~~~~~gt~~y~APEvl~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~ 499 (518)
.++..... .......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...+..+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 98755411 112234567889999998764 47899999999999999999999999988877666
Q ss_pred Hhhh
Q 010078 500 GVVQ 503 (518)
Q Consensus 500 ~iv~ 503 (518)
.+..
T Consensus 245 ~i~~ 248 (335)
T PTZ00024 245 RIFE 248 (335)
T ss_pred HHHH
Confidence 5544
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=270.06 Aligned_cols=207 Identities=26% Similarity=0.430 Sum_probs=173.9
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC-CC
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-PP 362 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~-~~ 362 (518)
.|.+. ++|++.+.||.|+||.||++.. +++.||||++............+.+|+.+++.++||||+++++++.. ..
T Consensus 5 ~~~~~-~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 5 VFEIT-NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred eeccc-cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34444 5699999999999999999975 46779999887544444445678899999999999999999998865 45
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
..|++|||+ +++|.+++.. ..++...+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||.+.....
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred cEEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 789999999 6789888864 4678888999999999999999999999999999999999999999999999875432
Q ss_pred CCccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 010078 443 SGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA 498 (518)
Q Consensus 443 ~~~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~ 498 (518)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||....+....
T Consensus 161 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~ 215 (328)
T cd07856 161 --QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQF 215 (328)
T ss_pred --CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 2234467889999998865 67899999999999999999999999887764443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=275.13 Aligned_cols=219 Identities=32% Similarity=0.527 Sum_probs=181.0
Q ss_pred CCCeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHh--cCCCcceEEeecccCCC----Cc
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK--VRHKNVVQFIGACTKPP----SL 364 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~--L~HpnIv~l~g~~~~~~----~~ 364 (518)
...+++.+.||+|.||.||+|++.++.||||++.. ...+.|..|-.|... ++|+||++|+++-.... .+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 45677888999999999999999999999999874 335667777777665 56999999999865554 78
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHH---------CCceeccCCCCcEEEcCCCcEEEEeeC
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ---------NNIIHRDLKAANLLMDENEVVKVADFG 435 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs---------~gIiHrDLKp~NILid~~~~vkL~DFG 435 (518)
++|++|.+.|||.+||.. ..+++..+.+++..+++||+|||. -.|+|||||..|||+..++...|+|||
T Consensus 284 wLVt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred eEEeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 999999999999999976 679999999999999999999996 259999999999999999999999999
Q ss_pred cceecccC---CccccCCCCCcccCchhccCCC-CC-----hhhHHHHHHHHHHHHHcCC------------CCCC----
Q 010078 436 VARVKAQS---GVMTAETGTYRWMAPEVIEHKP-YD-----HKADVFSFGIVLWELLTGK------------LPYE---- 490 (518)
Q Consensus 436 la~~~~~~---~~~~~~~gt~~y~APEvl~~~~-~s-----~ksDVwSlGviL~eLltG~------------~Pf~---- 490 (518)
++...... +.....+||.+|||||++.+.- +. .+.||||+|.|||||++.- +||.
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 99765432 2334579999999999997642 22 3589999999999999732 3453
Q ss_pred -CCCHHHHHHHhhhhcCchhHHHHHhh
Q 010078 491 -YLTPLQAAVGVVQKVHHSFLEQRLRK 516 (518)
Q Consensus 491 -~~~~~q~~~~iv~~~~rp~ip~~~~~ 516 (518)
..+-.++-.-||++..||.+|..|.+
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~ 468 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRK 468 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhc
Confidence 22335566677899999999988765
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=263.79 Aligned_cols=190 Identities=24% Similarity=0.461 Sum_probs=160.4
Q ss_pred Ceeeeeee--eecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEeecccCCCCccee
Q 010078 293 HLKFGSKV--ASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 293 ~~~i~~~L--G~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~~~~lV 367 (518)
.|++.+++ |+|+||.||++.. ++..+++|+++....... |+.....+ +|+||+++++.+...+.+|+|
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 44555555 9999999999985 467799999875432211 22222222 699999999999999999999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC-cEEEEeeCcceecccCCcc
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVM 446 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~-~vkL~DFGla~~~~~~~~~ 446 (518)
|||+++++|.+++.. ...+++..++.++.||++|+.|||+.|++||||||+||+++.++ .++|+|||+++.....
T Consensus 88 ~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--- 163 (267)
T PHA03390 88 MDYIKDGDLFDLLKK-EGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--- 163 (267)
T ss_pred EEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---
Confidence 999999999999976 34889999999999999999999999999999999999999988 9999999998765433
Q ss_pred ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCC
Q 010078 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 493 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~ 493 (518)
....++..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 210 (267)
T PHA03390 164 SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210 (267)
T ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 23468899999999999999999999999999999999999998654
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=269.74 Aligned_cols=208 Identities=34% Similarity=0.496 Sum_probs=176.3
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
..|...+.||+|+||.||+|+. ++..+++|.+..... .......+.+|+.+++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 4477778999999999999987 467799998864322 3344567889999999999999999999999888999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcccc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~ 448 (518)
||+. ++|.+++......++...+..++.|++.|+.|||+++++||||+|+||+++.++.++|+|||++..... ...
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---~~~ 170 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANX 170 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC---ccc
Confidence 9995 688888765566789999999999999999999999999999999999999999999999999875543 234
Q ss_pred CCCCCcccCchhcc---CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 449 ETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 449 ~~gt~~y~APEvl~---~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
..++..|+|||.+. ...++.++|||||||++|+|++|..||...+..+....+.+
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 228 (308)
T cd06634 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228 (308)
T ss_pred ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh
Confidence 56889999999974 35688899999999999999999999988777665555444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=272.45 Aligned_cols=212 Identities=28% Similarity=0.466 Sum_probs=180.6
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCC
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~ 363 (518)
.|++. ++|++.+.||+|+||.||+|... ++.||||++............+.+|+.++++++|+||+++++++.....
T Consensus 10 ~~~~~-~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07851 10 VWEVP-DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS 88 (343)
T ss_pred eeccc-CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence 45554 57999999999999999999874 6789999987654444445677889999999999999999988765554
Q ss_pred ------cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcc
Q 010078 364 ------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437 (518)
Q Consensus 364 ------~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla 437 (518)
.|+|+||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++
T Consensus 89 ~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 89 LEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999999 7799999865 56899999999999999999999999999999999999999999999999999
Q ss_pred eecccCCccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 438 RVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 438 ~~~~~~~~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+....+.+..+.+
T Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~ 230 (343)
T cd07851 166 RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMN 230 (343)
T ss_pred cccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 755432 344567889999999865 4678999999999999999999999998888776666554
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=293.46 Aligned_cols=147 Identities=28% Similarity=0.481 Sum_probs=133.1
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCccee
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV 367 (518)
.++|.+.++||+|+||.||+|.+. ++.||||+++... ........+..|+.+++.++|+||+++++++.....+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367899999999999999999986 7889999987543 3445557788999999999999999999999888899999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcce
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~ 438 (518)
|||+.|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999976 4568899999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=259.98 Aligned_cols=210 Identities=29% Similarity=0.496 Sum_probs=175.8
Q ss_pred CeeeeeeeeecCceEEEEEEECC--ceEEEEEecCCC---CChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCccee
Q 010078 293 HLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPER---INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~~~--~~vAVKvlk~~~---~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV 367 (518)
+|.+.++||+|+||.||++.+.. ..+++|+++... ........+..|+.++++++||||+++++++......|+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47888999999999999998754 456777766422 1223345677899999999999999999999999999999
Q ss_pred eeecCCCchhHHHhh---hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 368 TEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~---~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
|||+++++|.+++.. ....+++..++.++.|++.|+.|||++|++|+||+|+||+++. +.++|+|||+++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999998864 2456899999999999999999999999999999999999975 579999999987654332
Q ss_pred -ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 445 -VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 445 -~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+.+
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~ 219 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE 219 (260)
T ss_pred ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc
Confidence 23345688899999999888899999999999999999999999988777666666443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=291.65 Aligned_cols=215 Identities=33% Similarity=0.603 Sum_probs=186.7
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCc
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~ 364 (518)
..+++..++||+|+||+||+|.|- +.+||||++.... ..+...+++.|+.+|.+|+|||+++++++|.... +
T Consensus 695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence 356677789999999999999873 2469999987543 3344578999999999999999999999998765 8
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
-||++||++|+|.+|++..+..+-...++.|+.||++||.|||.+.++||||.++|||+.+-..+||.|||+++......
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 89999999999999999989999999999999999999999999999999999999999999999999999998766544
Q ss_pred -ccccCCC--CCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCch
Q 010078 445 -VMTAETG--TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHS 508 (518)
Q Consensus 445 -~~~~~~g--t~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~rp 508 (518)
..++..| .+.|||-|.+....|++++|||||||++||+|| |..||+++... .+...++++.|-
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-eI~dlle~geRL 919 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-EIPDLLEKGERL 919 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-HhhHHHhccccC
Confidence 2333333 458999999999999999999999999999999 99999998654 456668888774
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=255.91 Aligned_cols=204 Identities=21% Similarity=0.351 Sum_probs=175.6
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
+..-|+.++|++.+.||.|+|+-||+++. ++..||+|.+.... .+..+..++|++..++++|||+++++++...+.
T Consensus 14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~ 91 (302)
T KOG2345|consen 14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREE 91 (302)
T ss_pred CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence 44578999999999999999999999884 56779999988764 445678899999999999999999999875544
Q ss_pred C-----cceeeeecCCCchhHHHhhh--c-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEcCCCcEEEE
Q 010078 363 S-----LCIVTEFMSGGSVYDYLHKL--K-GVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVKVA 432 (518)
Q Consensus 363 ~-----~~lV~Ey~~ggsL~~~l~~~--~-~~l~~~~i~~i~~qIa~aL~yLHs~g--IiHrDLKp~NILid~~~~vkL~ 432 (518)
. .|++++|...|||.+.+... + ..+++.++++|+.+|++||.+||... +.||||||.|||+.+.+.++|.
T Consensus 92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~ 171 (302)
T KOG2345|consen 92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLM 171 (302)
T ss_pred ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEE
Confidence 3 89999999999999998754 2 36999999999999999999999998 9999999999999999999999
Q ss_pred eeCcceecccCC----------ccccCCCCCcccCchhcc---CCCCChhhHHHHHHHHHHHHHcCCCCCC
Q 010078 433 DFGVARVKAQSG----------VMTAETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYE 490 (518)
Q Consensus 433 DFGla~~~~~~~----------~~~~~~gt~~y~APEvl~---~~~~s~ksDVwSlGviL~eLltG~~Pf~ 490 (518)
|||.++.....- ....+..|..|.|||++. +...+.++|||||||+||.||.|.-||+
T Consensus 172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe 242 (302)
T KOG2345|consen 172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFE 242 (302)
T ss_pred eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcch
Confidence 999987543211 122446789999999985 4567889999999999999999999996
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=274.06 Aligned_cols=219 Identities=32% Similarity=0.640 Sum_probs=178.7
Q ss_pred CCCeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHh--cCCCcceEEeecccCCC----Cc
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK--VRHKNVVQFIGACTKPP----SL 364 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~--L~HpnIv~l~g~~~~~~----~~ 364 (518)
..++.+.+.||+|.||+||+|.|.|..||||++.... ...+.+|.+|.+. |+|+||+.|+++-..+. ++
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hheeEEEEEecCccccceeeccccCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 3678899999999999999999999999999987431 3456666666665 58999999999865543 58
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCcEEEcCCCcEEEEeeCc
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN--------NIIHRDLKAANLLMDENEVVKVADFGV 436 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~--------gIiHrDLKp~NILid~~~~vkL~DFGl 436 (518)
|+|++|.+.|||+|||.. ..++....++++..++.||++||.. .|.|||||..|||+..+|..-|+|+|+
T Consensus 285 wLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 999999999999999976 6789999999999999999999952 499999999999999999999999999
Q ss_pred ceecccC-----CccccCCCCCcccCchhccCC----CCC--hhhHHHHHHHHHHHHHc----C------CCCCCCCCH-
Q 010078 437 ARVKAQS-----GVMTAETGTYRWMAPEVIEHK----PYD--HKADVFSFGIVLWELLT----G------KLPYEYLTP- 494 (518)
Q Consensus 437 a~~~~~~-----~~~~~~~gt~~y~APEvl~~~----~~s--~ksDVwSlGviL~eLlt----G------~~Pf~~~~~- 494 (518)
|-..... ...+..+||.+|||||++... -|. ..+||||||.|+||+.. | ++||..+.|
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 9654332 234567899999999998543 221 35899999999999874 2 479976654
Q ss_pred ---HHHHHHhh-hhcCchhHHHHHhh
Q 010078 495 ---LQAAVGVV-QKVHHSFLEQRLRK 516 (518)
Q Consensus 495 ---~q~~~~iv-~~~~rp~ip~~~~~ 516 (518)
.+...+|| -+.+||.+|++++.
T Consensus 443 DPs~eeMrkVVCv~~~RP~ipnrW~s 468 (513)
T KOG2052|consen 443 DPSFEEMRKVVCVQKLRPNIPNRWKS 468 (513)
T ss_pred CCCHHHHhcceeecccCCCCCccccc
Confidence 45555554 56789999998864
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=264.17 Aligned_cols=198 Identities=26% Similarity=0.421 Sum_probs=169.0
Q ss_pred CeeeeeeeeecCceEEEEEEE-----CCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhc-CCCcceEEeecccCCCCc
Q 010078 293 HLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERIN--SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSL 364 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~-----~~~~vAVKvlk~~~~~--~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~~~ 364 (518)
+|++.+.||+|+||.||+++. .+..||||+++..... ......+.+|+.+++++ +|+||+++++.+.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 377889999999999999875 3467999998754221 22345688999999999 599999999999988899
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
|+||||+++++|.+++.. ...+++..+..++.|++.+|.|||+.|++||||+|.||+++.++.++|+|||+++......
T Consensus 81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159 (288)
T ss_pred EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence 999999999999999876 4568899999999999999999999999999999999999999999999999987544332
Q ss_pred c--cccCCCCCcccCchhccCCC--CChhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 445 V--MTAETGTYRWMAPEVIEHKP--YDHKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 445 ~--~~~~~gt~~y~APEvl~~~~--~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
. .....|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||..
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 1 12345789999999987665 78899999999999999999999963
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=269.47 Aligned_cols=207 Identities=24% Similarity=0.407 Sum_probs=172.3
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC--------
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-------- 361 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~-------- 361 (518)
.+|.+.+.||.|+||.||+|.. +++.|++|++..... ...+.+.+|+.++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 6799999999999999999987 467899998865432 3346788899999999999999999876543
Q ss_pred ------CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC-CCcEEEEee
Q 010078 362 ------PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADF 434 (518)
Q Consensus 362 ------~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~-~~~vkL~DF 434 (518)
...|+||||++ ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++. ++.++|+||
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 34789999996 589888854 56899999999999999999999999999999999999974 567899999
Q ss_pred CcceecccCC----ccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 435 GVARVKAQSG----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 435 Gla~~~~~~~----~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
|.++...... ......++..|+|||.+.. ..++.++|+|||||++|+|++|+.||...++.+....++.
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~ 233 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9987543221 1233467889999998754 5688999999999999999999999999888777666554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=265.73 Aligned_cols=199 Identities=24% Similarity=0.400 Sum_probs=167.6
Q ss_pred CCeeeeeeeeecCceEEEEEEEC------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC-CCCc
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-PPSL 364 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~-~~~~ 364 (518)
..|+...+||+|.||.||++... .+.+|||.++.+......-....+|+.+++.++|||++.+..++.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 56888999999999999999532 2368999998764333334567789999999999999999999877 7789
Q ss_pred ceeeeecCCCchhHHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCC----CcEEEEeeCc
Q 010078 365 CIVTEFMSGGSVYDYLHKL----KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN----EVVKVADFGV 436 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~----~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~----~~vkL~DFGl 436 (518)
++++||.+ -+|++.++.. ...++...+..|++||+.|+.|||++-|+||||||.|||+..+ |.|||+|||+
T Consensus 104 ~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 104 WLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred EEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence 99999995 5899888643 2458889999999999999999999999999999999999876 8999999999
Q ss_pred ceecccCCcc----ccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 437 ARVKAQSGVM----TAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 437 a~~~~~~~~~----~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
++.....-.. ...+-|.+|.|||++.+ ..|+.+.|||+.|||+.||+|-++.|.+
T Consensus 183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9976654322 23356889999999876 5699999999999999999999988865
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=264.46 Aligned_cols=206 Identities=22% Similarity=0.417 Sum_probs=180.7
Q ss_pred CCceeeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHH-HHHHHHHHHHHhc-CCCcceEEeeccc
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQ-KEFAQEVFIMRKV-RHKNVVQFIGACT 359 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~-~~~~~Ei~iL~~L-~HpnIv~l~g~~~ 359 (518)
...|.+.-.+|.++..||+|+|++|..+.. +.+.||+|++|++..+.+.- .=...|-.+..+- +||.+|-++..|+
T Consensus 242 ~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq 321 (593)
T KOG0695|consen 242 KISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ 321 (593)
T ss_pred ccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc
Confidence 457888889999999999999999998875 45679999999876654322 2233455555444 6999999999999
Q ss_pred CCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
.+..+++|.||++||+|.-+++. ...+++..++.+...|+.||.|||++|||+||||.+|||+|..|++||.|+|+++.
T Consensus 322 tesrlffvieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 322 TESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred ccceEEEEEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc
Confidence 99999999999999999988876 56799999999999999999999999999999999999999999999999999986
Q ss_pred cccCC-ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCC
Q 010078 440 KAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490 (518)
Q Consensus 440 ~~~~~-~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~ 490 (518)
....+ .+++.+|||-|+|||++.+..|+...|+|+||++|+||+.|+.||+
T Consensus 401 ~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 401 GLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred CCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 55544 5667899999999999999999999999999999999999999996
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=261.95 Aligned_cols=190 Identities=28% Similarity=0.453 Sum_probs=165.7
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeecccC----CCCcceeeee
Q 010078 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTK----PPSLCIVTEF 370 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~----~~~~~lV~Ey 370 (518)
++||-|-.|.|..+.. +++.+|+|++... ....+|+++.-... |||||.+++++.. ...+.+|||.
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~ 140 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMEC 140 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeec
Confidence 5799999999998865 5788999998742 34567888766554 9999999998754 3457799999
Q ss_pred cCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC---CCcEEEEeeCcceecccCCcc
Q 010078 371 MSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVKAQSGVM 446 (518)
Q Consensus 371 ~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~---~~~vkL~DFGla~~~~~~~~~ 446 (518)
|+||.|+..++.+ ...|++..+..|+.||+.|+.|||+.+|.||||||+|+|... |..+||+|||+|+....++.+
T Consensus 141 meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L 220 (400)
T KOG0604|consen 141 MEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDL 220 (400)
T ss_pred ccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCccc
Confidence 9999999999874 345999999999999999999999999999999999999964 457999999999987777788
Q ss_pred ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
...+-|+.|.|||++...+|+..+|+||+|++||-||+|.+||-...-
T Consensus 221 ~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg 268 (400)
T KOG0604|consen 221 MTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_pred cCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC
Confidence 889999999999999999999999999999999999999999965443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=244.63 Aligned_cols=217 Identities=32% Similarity=0.548 Sum_probs=185.2
Q ss_pred eeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeec
Q 010078 294 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 371 (518)
|.+.+.||+|++|.||++... ++.+++|.+...... .....+.+|+..+++++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 456789999999999999885 488999998865433 24578889999999999999999999998888999999999
Q ss_pred CCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC--ccccC
Q 010078 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMTAE 449 (518)
Q Consensus 372 ~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~--~~~~~ 449 (518)
++++|.+++......+++..+..++.+++.++.+||+++++|+||+|.||+++.++.++|+|||.+....... .....
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV 159 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence 9999999998744338899999999999999999999999999999999999999999999999998765543 33445
Q ss_pred CCCCcccCchhc-cCCCCChhhHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHhhhhcCchhHH
Q 010078 450 TGTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGKLPYEY-LTPLQAAVGVVQKVHHSFLE 511 (518)
Q Consensus 450 ~gt~~y~APEvl-~~~~~s~ksDVwSlGviL~eLltG~~Pf~~-~~~~q~~~~iv~~~~rp~ip 511 (518)
.++..|++||.+ ....++.++|+|+||+++++|++|+.||.. ..+...+.+.+.++.++..|
T Consensus 160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 223 (225)
T smart00221 160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLWE 223 (225)
T ss_pred eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCccccc
Confidence 678899999998 777888999999999999999999999988 56665555556656654443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=282.74 Aligned_cols=223 Identities=32% Similarity=0.531 Sum_probs=187.1
Q ss_pred CCCeeeeeeeeecCceEEEEEE--ECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeeccc-----CCC
Q 010078 291 PKHLKFGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACT-----KPP 362 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~--~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~-----~~~ 362 (518)
.+.++|.+.||.|.+|.||+++ ..++.+|+||+.+.. +...++..|..||+... |||++.+||++. .++
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 3456777999999999999886 567889999988653 33467788999999886 899999999874 346
Q ss_pred CcceeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
.+|+|||||.|||..|+++... ..+.+..+..|+..++.|+.+||.+.++|||||-.|||++.++.|||+|||++...+
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 7999999999999999997654 468999999999999999999999999999999999999999999999999986554
Q ss_pred c-CCccccCCCCCcccCchhccC-----CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCchhH-HHHH
Q 010078 442 Q-SGVMTAETGTYRWMAPEVIEH-----KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSFL-EQRL 514 (518)
Q Consensus 442 ~-~~~~~~~~gt~~y~APEvl~~-----~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp~i-p~~~ 514 (518)
. -+...+.+||+.|||||++.. ..|+..+|+||||++..||--|.+|+..+-|.-++..|-++..+... |..|
T Consensus 175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kW 254 (953)
T KOG0587|consen 175 STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKW 254 (953)
T ss_pred cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhH
Confidence 4 335567789999999999953 35788999999999999999999999999999999886664443322 4444
Q ss_pred hh
Q 010078 515 RK 516 (518)
Q Consensus 515 ~~ 516 (518)
++
T Consensus 255 s~ 256 (953)
T KOG0587|consen 255 SK 256 (953)
T ss_pred HH
Confidence 43
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=248.89 Aligned_cols=179 Identities=23% Similarity=0.291 Sum_probs=153.9
Q ss_pred cCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecCCCchhHHH
Q 010078 303 GSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL 380 (518)
Q Consensus 303 G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL~~~l 380 (518)
|.||.||++.+ +++.||+|+++... .+.+|...+....||||+++++++......|+||||++|++|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 88999999986 56789999987542 2334555555667999999999999999999999999999999999
Q ss_pred hhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccccCCCCCcccCchh
Q 010078 381 HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEV 460 (518)
Q Consensus 381 ~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APEv 460 (518)
.+ ...+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||.+...... .....++..|+|||.
T Consensus 77 ~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~ 153 (237)
T cd05576 77 SK-FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEV 153 (237)
T ss_pred HH-hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCcc
Confidence 76 456899999999999999999999999999999999999999999999999987654332 233456778999999
Q ss_pred ccCCCCChhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 461 IEHKPYDHKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 461 l~~~~~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
+.+..++.++|+||+|+++|||++|+.||..
T Consensus 154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 154 GGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred cCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 9888899999999999999999999988754
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=261.97 Aligned_cols=215 Identities=23% Similarity=0.391 Sum_probs=181.2
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC--C----cceEEeecccCCC
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--K----NVVQFIGACTKPP 362 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~H--p----nIv~l~g~~~~~~ 362 (518)
..+|++.+.+|.|.||.|-.+.+. +..||||+++.- ....+..+-|+.+|+++.+ | -+|++.++|...+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 468999999999999999998764 467999999843 3445566779999999953 3 3788889999999
Q ss_pred CcceeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC----------------
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---------------- 425 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~---------------- 425 (518)
+.|||+|.+ |.|+++++..++ .+++...++.++.||+.+|.|||+++++|.||||+|||+..
T Consensus 165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcccee
Confidence 999999999 889999998743 46899999999999999999999999999999999999831
Q ss_pred ----CCcEEEEeeCcceecccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 010078 426 ----NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV 501 (518)
Q Consensus 426 ----~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~i 501 (518)
+-.|+|+|||.++...... +..+.|..|.|||++.+-+|+.++||||+||||+|++||...|..-+..+-+ +.
T Consensus 244 r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL-aM 320 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL-AM 320 (415)
T ss_pred ccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH-HH
Confidence 2259999999998765543 5667899999999999999999999999999999999999999887766655 55
Q ss_pred hhhcCchhHHH
Q 010078 502 VQKVHHSFLEQ 512 (518)
Q Consensus 502 v~~~~rp~ip~ 512 (518)
+++.+.|....
T Consensus 321 MerIlGp~P~~ 331 (415)
T KOG0671|consen 321 MERILGPIPSR 331 (415)
T ss_pred HHHhhCCCcHH
Confidence 66666654433
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=290.66 Aligned_cols=192 Identities=27% Similarity=0.474 Sum_probs=160.4
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC--------
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-------- 361 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~-------- 361 (518)
.+|+..+.||+|+||.||+++. +|+.||||.+.... .......+.+|+.+|.+|+|||||++|.+|...
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 4677788999999999999975 78999999988765 556667899999999999999999999765320
Q ss_pred --------------------------------------------------------------------------------
Q 010078 362 -------------------------------------------------------------------------------- 361 (518)
Q Consensus 362 -------------------------------------------------------------------------------- 361 (518)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred -------------------------------CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 010078 362 -------------------------------PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 410 (518)
Q Consensus 362 -------------------------------~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~g 410 (518)
..+||-||||+..+|.++++.+...-.....++++++|+.|+.|+|+.|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0157889999888888888763222246788999999999999999999
Q ss_pred ceeccCCCCcEEEcCCCcEEEEeeCcceecc-------------------cCCccccCCCCCcccCchhccCC---CCCh
Q 010078 411 IIHRDLKAANLLMDENEVVKVADFGVARVKA-------------------QSGVMTAETGTYRWMAPEVIEHK---PYDH 468 (518)
Q Consensus 411 IiHrDLKp~NILid~~~~vkL~DFGla~~~~-------------------~~~~~~~~~gt~~y~APEvl~~~---~~s~ 468 (518)
||||||||.||++++++.|||+|||++.... ..+..+..+||.-|+|||++.+. .|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999997511 11234566899999999999764 4999
Q ss_pred hhHHHHHHHHHHHHHc
Q 010078 469 KADVFSFGIVLWELLT 484 (518)
Q Consensus 469 ksDVwSlGviL~eLlt 484 (518)
|+|||||||||+||+.
T Consensus 798 KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY 813 (1351)
T ss_pred hhhhHHHHHHHHHHhc
Confidence 9999999999999974
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=257.41 Aligned_cols=213 Identities=25% Similarity=0.402 Sum_probs=182.4
Q ss_pred eeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC-----Ccceee
Q 010078 296 FGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-----SLCIVT 368 (518)
Q Consensus 296 i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~-----~~~lV~ 368 (518)
-.+.||.|+||.||..++ .++.|++|.+..-..+-...+.+.+|+.+|...+|.|++..++....+. .+|+++
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 346899999999999986 5788999988754444444578899999999999999999888765442 368899
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC--Ccc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVM 446 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~--~~~ 446 (518)
|.| ..+|.+.+-. ...++...++-++.||++||.|||+.||+||||||.|+|++.|..+||||||+++..... ..|
T Consensus 137 ELm-QSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hM 214 (449)
T KOG0664|consen 137 ELM-QSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNM 214 (449)
T ss_pred HHH-Hhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhh
Confidence 999 4578887765 667899999999999999999999999999999999999999999999999999976543 467
Q ss_pred ccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCchhH
Q 010078 447 TAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSFL 510 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp~i 510 (518)
+.++-|..|.|||++.+ ..|+.+.||||+|||+.||+..+..|...+|.|.+.-|.+-...|.+
T Consensus 215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~ 279 (449)
T KOG0664|consen 215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQ 279 (449)
T ss_pred HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcH
Confidence 78888999999999876 46999999999999999999999999999999999887765555544
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-31 Score=255.18 Aligned_cols=212 Identities=26% Similarity=0.424 Sum_probs=177.2
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC-----
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP----- 361 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~----- 361 (518)
...+.|+-..+||+|.||+||+++. .++.||+|++-.+......-....+|+.+|+.|+|+|++.+++.|...
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 3446677788999999999998864 567789887654333333345578899999999999999999987432
Q ss_pred ---CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcce
Q 010078 362 ---PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (518)
Q Consensus 362 ---~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~ 438 (518)
..+|+||.+|+ .+|.-.+......++...+.+++.++..||.|+|++.|+|||+|++|+||+.+|.+||+|||+++
T Consensus 94 r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 94 RDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred cccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 24899999995 58888888767789999999999999999999999999999999999999999999999999997
Q ss_pred ecccCC-----ccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 010078 439 VKAQSG-----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV 501 (518)
Q Consensus 439 ~~~~~~-----~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~i 501 (518)
...... ..+..+-|.+|.+||.+.+ ..|+++.|||..||||.||+||.+-+.+.+..+.+..|
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~I 241 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLI 241 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHH
Confidence 654432 3456677999999998865 67999999999999999999999999998887766554
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=238.75 Aligned_cols=202 Identities=37% Similarity=0.601 Sum_probs=173.9
Q ss_pred CceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecCCCchhHHHh
Q 010078 304 SYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH 381 (518)
Q Consensus 304 ~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL~~~l~ 381 (518)
+||.||+|++. ++.+++|++........ ...+.+|+..+++++|+||+++++.+......+++|||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999985 48899999886543322 5789999999999999999999999998889999999999999999997
Q ss_pred hhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccccCCCCCcccCchhc
Q 010078 382 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI 461 (518)
Q Consensus 382 ~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APEvl 461 (518)
.. ..++...+..++.+++.++.|||+.+++|+||+|.||+++.++.++|+|||.+.............++..|++||.+
T Consensus 80 ~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 80 KR-GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL 158 (244)
T ss_pred hc-cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence 63 33889999999999999999999999999999999999999999999999999877665455566788999999999
Q ss_pred cCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCc
Q 010078 462 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 462 ~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
.+..++.++|+||||+++|+|++|..||......+.....+.+...
T Consensus 159 ~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~ 204 (244)
T smart00220 159 LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKP 204 (244)
T ss_pred ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCC
Confidence 9888999999999999999999999999884444444444444444
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=239.91 Aligned_cols=205 Identities=20% Similarity=0.412 Sum_probs=175.5
Q ss_pred CCCCeeeeeeeeecCceEEEEEE--ECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeecccCCC--Cc
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPP--SL 364 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~--~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~--~~ 364 (518)
..++|++.+++|+|.|++||.|. .++++++||++++- ..+.+.+|+.||+.|+ ||||+.++++..++. ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 44789999999999999999998 46788999999864 3577999999999998 999999999987654 46
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCC-CcEEEEeeCcceecccC
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVKAQS 443 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~-~~vkL~DFGla~~~~~~ 443 (518)
.+|+||+.+.+..... ..++...+..++.++++||+|+|+.||+|||+||.|++||.. ..++|+|||+|.+....
T Consensus 111 aLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 8999999887666554 347788899999999999999999999999999999999954 57999999999998888
Q ss_pred CccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHhhh
Q 010078 444 GVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYE-YLTPLQAAVGVVQ 503 (518)
Q Consensus 444 ~~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~-~~~~~q~~~~iv~ 503 (518)
......+.+..|.-||++.. +.|+..-|+|||||+|..|+..+.||. +-+.-+.+.+|.+
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIak 248 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAK 248 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHH
Confidence 77888888999999999855 568999999999999999999998874 4555555555443
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-30 Score=260.78 Aligned_cols=209 Identities=22% Similarity=0.424 Sum_probs=173.3
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChH-----HHHHHHHHHHHHHhcCCCcceEEeeccc-C
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSD-----MQKEFAQEVFIMRKVRHKNVVQFIGACT-K 360 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~g~~~-~ 360 (518)
.-.++|.++..||+|+|+.||++-+ ..+.||||+......+.+ +.+...+|..|.+.|+||.||++|++|. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 3446788889999999999999965 457799999765433332 2345678999999999999999999985 5
Q ss_pred CCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCCCcEEEcC---CCcEEEEeeC
Q 010078 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN--NIIHRDLKAANLLMDE---NEVVKVADFG 435 (518)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~--gIiHrDLKp~NILid~---~~~vkL~DFG 435 (518)
...+|-|+|||+|.+|.-||+. ...+++..++.|+.||+.||.||... -|||-||||.|||+-. -|.+||.|||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred cccceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 5679999999999999999876 66799999999999999999999976 4999999999999953 4789999999
Q ss_pred cceecccCC--------ccccCCCCCcccCchhccC----CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 010078 436 VARVKAQSG--------VMTAETGTYRWMAPEVIEH----KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA 498 (518)
Q Consensus 436 la~~~~~~~--------~~~~~~gt~~y~APEvl~~----~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~ 498 (518)
+++.+.... .++...||++|++||.+.- .+.+.+.||||+|||+|.++.|+.||...-..|.+
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI 693 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI 693 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH
Confidence 999776532 2345579999999998732 35788999999999999999999999875444433
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=291.47 Aligned_cols=185 Identities=24% Similarity=0.443 Sum_probs=157.9
Q ss_pred CeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
.+...+.||+|+||.||+|+. .+..||||.++..... ...|+.++++++|||||+++++|......|+||||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 355567899999999999986 5678999988643211 12468899999999999999999999999999999
Q ss_pred cCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccc
Q 010078 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH---QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT 447 (518)
Q Consensus 371 ~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLH---s~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~ 447 (518)
+++|+|.++++. +++..+.+++.||++||+||| +.+|+||||||+||+++.++..++. ||....... ..
T Consensus 765 ~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---~~ 836 (968)
T PLN00113 765 IEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---DT 836 (968)
T ss_pred CCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---CC
Confidence 999999999964 788999999999999999999 6799999999999999998887775 665543222 12
Q ss_pred cCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
...+|+.|||||++.+..|+.++|||||||++|||+||+.||+.
T Consensus 837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 34688999999999999999999999999999999999999853
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=265.99 Aligned_cols=194 Identities=24% Similarity=0.427 Sum_probs=164.7
Q ss_pred CCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEeecccCCCCccee
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~~~~lV 367 (518)
...|++...+|.|+|+.|-++.. +++..++|++..... ...+|+.++... +||||+++++.+.+..+.|+|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 46788888899999999998875 567899999886522 233466555544 599999999999999999999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE-cCCCcEEEEeeCcceecccCCcc
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM-DENEVVKVADFGVARVKAQSGVM 446 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILi-d~~~~vkL~DFGla~~~~~~~~~ 446 (518)
||.+.|+-|.+.+.. ...+. ..+..|+.+|+.|+.|||.+|+|||||||+|||+ +..|.++|+|||.++..... .
T Consensus 395 ~e~l~g~ell~ri~~-~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~ 470 (612)
T KOG0603|consen 395 MELLDGGELLRRIRS-KPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--C 470 (612)
T ss_pred ehhccccHHHHHHHh-cchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--h
Confidence 999999998888866 23333 6777899999999999999999999999999999 68899999999999866555 4
Q ss_pred ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
...+-|..|.|||++....|+.++||||||++||+||+|+.||..-..
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~ 518 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA 518 (612)
T ss_pred cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc
Confidence 455678899999999999999999999999999999999999976433
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-28 Score=261.45 Aligned_cols=206 Identities=22% Similarity=0.346 Sum_probs=155.2
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEE------------------CCceEEEEEecCCCCCh------------HHHHHHH
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTY------------------CSQDVAIKVLKPERINS------------DMQKEFA 337 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~------------------~~~~vAVKvlk~~~~~~------------~~~~~~~ 337 (518)
....++|.+.++||+|+||.||+|.+ .++.||||.++...... ...+.+.
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 34678899999999999999999964 23569999987542110 0112234
Q ss_pred HHHHHHHhcCCCcc-----eEEeecccC--------CCCcceeeeecCCCchhHHHhhhcC-------------------
Q 010078 338 QEVFIMRKVRHKNV-----VQFIGACTK--------PPSLCIVTEFMSGGSVYDYLHKLKG------------------- 385 (518)
Q Consensus 338 ~Ei~iL~~L~HpnI-----v~l~g~~~~--------~~~~~lV~Ey~~ggsL~~~l~~~~~------------------- 385 (518)
.|+.++.+++|.++ ++++++|.. ....++||||+++++|.++++...+
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 57778888876654 667777653 3457999999999999999864221
Q ss_pred ----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccc--cCCCCCcccCch
Q 010078 386 ----VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT--AETGTYRWMAPE 459 (518)
Q Consensus 386 ----~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~--~~~gt~~y~APE 459 (518)
.+++..++.++.|++.+|.|||+++|+||||||+|||++.++.+||+|||++.......... ...+|+.|+|||
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 23456788899999999999999999999999999999999999999999997543322222 224478999999
Q ss_pred hccCCC--------------------CC--hhhHHHHHHHHHHHHHcCCC-CCCCCC
Q 010078 460 VIEHKP--------------------YD--HKADVFSFGIVLWELLTGKL-PYEYLT 493 (518)
Q Consensus 460 vl~~~~--------------------~s--~ksDVwSlGviL~eLltG~~-Pf~~~~ 493 (518)
.+.... |+ .+.|+||+|||+++|++|.. ||....
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~ 437 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIR 437 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchh
Confidence 985432 11 24699999999999999886 886543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=260.25 Aligned_cols=219 Identities=25% Similarity=0.383 Sum_probs=185.6
Q ss_pred CCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC------CcceEEeecccCCC
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH------KNVVQFIGACTKPP 362 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~H------pnIv~l~g~~~~~~ 362 (518)
..+|.+....|+|-|+.|.+|.+ .++.|||||++. ++.+.+.=+.|++||++|+. -++++|+..|...+
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn---NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN---NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeec---chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 36777777889999999999986 467899999985 35556667889999999973 47899999999999
Q ss_pred CcceeeeecCCCchhHHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCC-CcEEEEeeCccee
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARV 439 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~--~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~-~~vkL~DFGla~~ 439 (518)
++|||+|.+ ..+|.+.|.+... .+....+..++.|++-||..|-++||+|.||||+|||+++. ..+||||||.|..
T Consensus 508 HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~ 586 (752)
T KOG0670|consen 508 HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASF 586 (752)
T ss_pred eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccc
Confidence 999999998 7899999988633 47788999999999999999999999999999999999976 4689999999976
Q ss_pred cccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCchhHHHHHh
Q 010078 440 KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSFLEQRLR 515 (518)
Q Consensus 440 ~~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp~ip~~~~ 515 (518)
...+. .+...-+..|.|||+|.|.+|++..|+||+||+||||+||++.|++.+..+++.-.++ ...++..+.++
T Consensus 587 ~~ene-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me-~KGk~p~KmlR 660 (752)
T KOG0670|consen 587 ASENE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME-LKGKFPNKMLR 660 (752)
T ss_pred ccccc-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH-hcCCCcHHHhh
Confidence 65543 3444556789999999999999999999999999999999999999999999877654 44444444444
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-29 Score=260.36 Aligned_cols=198 Identities=27% Similarity=0.450 Sum_probs=173.5
Q ss_pred CCeeeeeeeeecCceEEEEEEECC--ceEEEEEecCCCCChHHH------HHHHHHHHHHHhcC---CCcceEEeecccC
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ------KEFAQEVFIMRKVR---HKNVVQFIGACTK 360 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~~--~~vAVKvlk~~~~~~~~~------~~~~~Ei~iL~~L~---HpnIv~l~g~~~~ 360 (518)
.+|...+++|.|+||.|++++++. ..|+||.+++++.-.+.. -.+-.||.||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 458999999999999999999864 569999988775533221 12556999999998 9999999999999
Q ss_pred CCCcceeeeec-CCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 361 PPSLCIVTEFM-SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 361 ~~~~~lV~Ey~-~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
++.+|++||-- +|.+|++++.. +..+++.....|++|++.|+++||+.||||||||-+||.++.+|.+||+|||.+..
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence 99999999976 45599999976 67899999999999999999999999999999999999999999999999999864
Q ss_pred cccCCccccCCCCCcccCchhccCCCCC-hhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 440 KAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 440 ~~~~~~~~~~~gt~~y~APEvl~~~~~s-~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
. .++.....+||..|.|||++.+.+|- ..-|||++|++||.++...-||-+
T Consensus 720 ~-ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 720 T-KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred h-cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 3 45677889999999999999999984 557999999999999999999865
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-28 Score=238.86 Aligned_cols=216 Identities=25% Similarity=0.347 Sum_probs=185.9
Q ss_pred eCCCCeeeeeeeeecCceEEEEEE--ECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC----
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP---- 362 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~--~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~---- 362 (518)
..+.+|.-.+.+|.|.- .|-.+- ..++.||+|.+..+..+....++..+|..++..++|+||+.++.+|+-..
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 33467777788899887 454443 35789999988766666666678889999999999999999999997654
Q ss_pred --CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceec
Q 010078 363 --SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 363 --~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~ 440 (518)
..|+|||+| ..+|...++- .++-..+..+..|++.|+.|||+.||+||||||+||++..++.+||.|||+++..
T Consensus 93 ~~e~y~v~e~m-~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 93 FQEVYLVMELM-DANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHhHHHHHHhh-hhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence 369999999 6789888863 4677889999999999999999999999999999999999999999999999877
Q ss_pred ccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCchh
Q 010078 441 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSF 509 (518)
Q Consensus 441 ~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp~ 509 (518)
...-.++..+.|..|.|||++.+..|....||||+||++.||++|+.-|.+.+.....-++++....|.
T Consensus 169 ~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd 237 (369)
T KOG0665|consen 169 DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPD 237 (369)
T ss_pred CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCC
Confidence 666567788899999999999888899999999999999999999999999999888888887665553
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=259.48 Aligned_cols=197 Identities=17% Similarity=0.274 Sum_probs=142.2
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEEC------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeec----
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYC------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA---- 357 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~---- 357 (518)
....++|.+.++||+|+||.||+|++. +..||+|.++..... ..+..+ .++...+.++..++..
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 345578999999999999999999874 467999987643211 111111 1122222333322222
Q ss_pred --ccCCCCcceeeeecCCCchhHHHhhhcCC-------------------CCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 010078 358 --CTKPPSLCIVTEFMSGGSVYDYLHKLKGV-------------------FKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416 (518)
Q Consensus 358 --~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~-------------------l~~~~i~~i~~qIa~aL~yLHs~gIiHrDL 416 (518)
+.....+++||||+.+++|.+++...... .....+..++.||+.||.|||++||+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 24556789999999999999998753211 112346679999999999999999999999
Q ss_pred CCCcEEEcC-CCcEEEEeeCcceecccC--CccccCCCCCcccCchhccCC----------------------CCChhhH
Q 010078 417 KAANLLMDE-NEVVKVADFGVARVKAQS--GVMTAETGTYRWMAPEVIEHK----------------------PYDHKAD 471 (518)
Q Consensus 417 Kp~NILid~-~~~vkL~DFGla~~~~~~--~~~~~~~gt~~y~APEvl~~~----------------------~~s~ksD 471 (518)
||+|||++. ++.+||+|||+++..... .......+|+.|||||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999986 579999999999754322 233456789999999976322 2345679
Q ss_pred HHHHHHHHHHHHcCCCCCC
Q 010078 472 VFSFGIVLWELLTGKLPYE 490 (518)
Q Consensus 472 VwSlGviL~eLltG~~Pf~ 490 (518)
||||||+||||+++..|++
T Consensus 362 VwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred cHHHHHHHHHHHhCcCCCc
Confidence 9999999999999877755
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=240.93 Aligned_cols=220 Identities=24% Similarity=0.456 Sum_probs=184.6
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeeccc
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~ 359 (518)
..+...++++...+-+|.||.||+|.|.. +.|.+|.++... +.-....+++|..++..+.|||+.++.+++.
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 34555677777889999999999996543 457888887543 3445678999999999999999999999875
Q ss_pred C-CCCcceeeeecCCCchhHHHhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEE
Q 010078 360 K-PPSLCIVTEFMSGGSVYDYLHKLK-------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKV 431 (518)
Q Consensus 360 ~-~~~~~lV~Ey~~ggsL~~~l~~~~-------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL 431 (518)
. ....++++.++.-|+|..|+..++ ..++-.++..++.|++.||+|||+.|+||.||..+|.+||+.-.+||
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEe
Confidence 4 455678899999999999998443 23566788889999999999999999999999999999999999999
Q ss_pred EeeCcceec---ccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCc
Q 010078 432 ADFGVARVK---AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 432 ~DFGla~~~---~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
+|=.+++-. +.++....+.....||+||.+.+..|+.++|+||||++||||+| |+.||...+|+++.-= +.+|+|
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y-lkdGyR 516 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY-LKDGYR 516 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH-Hhccce
Confidence 999998843 23445566677889999999999999999999999999999999 9999999999998766 556777
Q ss_pred h
Q 010078 508 S 508 (518)
Q Consensus 508 p 508 (518)
-
T Consensus 517 l 517 (563)
T KOG1024|consen 517 L 517 (563)
T ss_pred e
Confidence 4
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-26 Score=211.92 Aligned_cols=182 Identities=36% Similarity=0.677 Sum_probs=160.9
Q ss_pred eeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecCCCchh
Q 010078 300 VASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377 (518)
Q Consensus 300 LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL~ 377 (518)
||+|++|.||+++.. ++.+++|++....... ....+.+|+..++.+.|++|+++++++......+++|||+.|++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999987 7889999988654322 3467899999999999999999999999888999999999999999
Q ss_pred HHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC-CCcEEEEeeCcceecccCC-ccccCCCCCcc
Q 010078 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVARVKAQSG-VMTAETGTYRW 455 (518)
Q Consensus 378 ~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~-~~~vkL~DFGla~~~~~~~-~~~~~~gt~~y 455 (518)
+++......++...+..++.++++++.+||+.|++|+||+|.||+++. ++.++|+|||.+....... ......+...|
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 159 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAY 159 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCc
Confidence 999774457899999999999999999999999999999999999999 8999999999997665442 23345678899
Q ss_pred cCchhccCC-CCChhhHHHHHHHHHHHH
Q 010078 456 MAPEVIEHK-PYDHKADVFSFGIVLWEL 482 (518)
Q Consensus 456 ~APEvl~~~-~~s~ksDVwSlGviL~eL 482 (518)
++||.+... .++.+.|+|++|+++++|
T Consensus 160 ~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 160 MAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 999999877 888999999999999999
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-28 Score=256.21 Aligned_cols=213 Identities=31% Similarity=0.497 Sum_probs=186.4
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|++..++|+|+||+||++++ .++..|+|+++.+..+ ...-+.+|+-+++.++|+|||.++|.+.....++|.||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d--d~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD--DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCc--cccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 6788999999999999999976 5678999999976433 24567789999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc-CCcccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~-~~~~~~ 448 (518)
||.||+|.+..+- .+++++.++..+++..++|+.|||+.|-+|||||-.|||+++.|.+|++|||.+-.... -.....
T Consensus 93 ycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krks 171 (829)
T KOG0576|consen 93 YCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKS 171 (829)
T ss_pred ecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhc
Confidence 9999999998765 78899999999999999999999999999999999999999999999999998754332 234456
Q ss_pred CCCCCcccCchhc---cCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCc
Q 010078 449 ETGTYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 449 ~~gt~~y~APEvl---~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
..||+.|||||+- ....|...+|+|++|++..|+---+.|-..+-|.+++.-..+-+..
T Consensus 172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~q 233 (829)
T KOG0576|consen 172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQ 233 (829)
T ss_pred ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCC
Confidence 7899999999985 4567999999999999999999999999999999988775544443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-27 Score=256.19 Aligned_cols=192 Identities=27% Similarity=0.446 Sum_probs=159.1
Q ss_pred eeeeeecCceE-EEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeecccCCCCcceeeeecCCC
Q 010078 297 GSKVASGSYGD-LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSGG 374 (518)
Q Consensus 297 ~~~LG~G~fG~-Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~~~~lV~Ey~~gg 374 (518)
.+.+|.|+.|+ ||+|.+.++.||||.+-.+. .....+|+..|+.-+ |||||++|+.-.+....||..|.| .-
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~-----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~ 587 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYEGREVAVKRLLEEF-----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-AC 587 (903)
T ss_pred HHHcccCCCCcEEEEEeeCCceehHHHHhhHh-----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hh
Confidence 45689999988 89999999999999876432 345668999999886 999999999999999999999999 66
Q ss_pred chhHHHhhh--cCCCCH-HHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC---C--CcEEEEeeCcceecccCC--
Q 010078 375 SVYDYLHKL--KGVFKL-PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---N--EVVKVADFGVARVKAQSG-- 444 (518)
Q Consensus 375 sL~~~l~~~--~~~l~~-~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~---~--~~vkL~DFGla~~~~~~~-- 444 (518)
+|.+++... ...+.. ...+.++.|+++|+++||+.+||||||||.||||+. + ..++|+|||+++......
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS 667 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS 667 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence 999999762 111111 345778899999999999999999999999999976 3 368999999998665433
Q ss_pred --ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCH
Q 010078 445 --VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTP 494 (518)
Q Consensus 445 --~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~ 494 (518)
......||.+|+|||++....-+.+.||||||||+|+.++ |..||.....
T Consensus 668 ~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~ 720 (903)
T KOG1027|consen 668 FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE 720 (903)
T ss_pred hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH
Confidence 2334579999999999988888889999999999999999 5999975433
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.8e-26 Score=232.74 Aligned_cols=130 Identities=25% Similarity=0.437 Sum_probs=111.8
Q ss_pred CCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-----C---CcceEEeeccc
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-----H---KNVVQFIGACT 359 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-----H---pnIv~l~g~~~ 359 (518)
...+|.+.+|||.|-|++||++.+. .+.||+||.|. ...+.+..+.||.+|++++ | .+||+|++.|.
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS---AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS---AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh---hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 3478999999999999999999764 56799999984 3455667888999999985 2 46999999885
Q ss_pred C----CCCcceeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEE
Q 010078 360 K----PPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLM 423 (518)
Q Consensus 360 ~----~~~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs-~gIiHrDLKp~NILi 423 (518)
. ..++|||+|++ |.+|..++.+.+ ..++...++.|++||+.||+|||. +||||.||||+|||+
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 4 45789999999 889999997754 459999999999999999999996 599999999999998
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-25 Score=210.91 Aligned_cols=218 Identities=25% Similarity=0.327 Sum_probs=183.6
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC-CcceEEeecccCCCCc
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFIGACTKPPSL 364 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~H-pnIv~l~g~~~~~~~~ 364 (518)
.|-...|+++++||+|+||++|.|.. .|..||||+-+.....+ .+..|..+.+.|++ ..|..+..+..+...-
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 45567899999999999999999975 67899999977554433 35668888888885 7788888888888888
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCC---CcEEEEeeCcceecc
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN---EVVKVADFGVARVKA 441 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~---~~vkL~DFGla~~~~ 441 (518)
.+||+.+ |.||.+.+.-+...|+..+++-++-|++.-++|+|.+++|||||||+|+|++-+ ..+.|+|||+++...
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999999 999999999888899999999999999999999999999999999999999744 579999999997543
Q ss_pred cCC--------ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHhhhhcCchhH
Q 010078 442 QSG--------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP---LQAAVGVVQKVHHSFL 510 (518)
Q Consensus 442 ~~~--------~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~---~q~~~~iv~~~~rp~i 510 (518)
+.. .....+||.+|.+-....+...+.+.|+-|+|.+|.++.-|.+||.++.+ .|.+..|.++.....+
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i 245 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI 245 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence 321 22345799999998888788888999999999999999999999998755 6777777776655433
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-24 Score=220.69 Aligned_cols=199 Identities=27% Similarity=0.397 Sum_probs=166.5
Q ss_pred CeeeeeeeeecCceEEEEEEECCc---eEEEEEecCCCCChHHHHHHHHHHHHHHhcCC----CcceEEeecc-cCCCCc
Q 010078 293 HLKFGSKVASGSYGDLYRGTYCSQ---DVAIKVLKPERINSDMQKEFAQEVFIMRKVRH----KNVVQFIGAC-TKPPSL 364 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~~~~---~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~H----pnIv~l~g~~-~~~~~~ 364 (518)
.|++.++||+|+||.||.+..... .+|+|+......... ..+..|..++..+.. +++..+++.. ......
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 799999999999999999997654 589998765422211 156678888888873 6889999988 477788
Q ss_pred ceeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCC-----CcEEEEeeCcce
Q 010078 365 CIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-----EVVKVADFGVAR 438 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~-----~~vkL~DFGla~ 438 (518)
||||+.+ |.+|.++..... +.++..++.+++.|++.+|.+||+.|++||||||.|++++.. ..+.|.|||+++
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 9999988 999999886554 789999999999999999999999999999999999999865 469999999998
Q ss_pred --ecc-cCC-------c-cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 439 --VKA-QSG-------V-MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 439 --~~~-~~~-------~-~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
... ..+ . .....||.+|+++.+..+...+.+.|+||++.++.+|+.|.+||.....
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 321 111 1 1234599999999999999999999999999999999999999988764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-25 Score=217.99 Aligned_cols=193 Identities=22% Similarity=0.393 Sum_probs=155.2
Q ss_pred CCeeeeeeeeecCceEEEEEEECC--ceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEee-cccCCCCccee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIG-ACTKPPSLCIV 367 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~~--~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g-~~~~~~~~~lV 367 (518)
+.|.+.+.||.|.||.+.++.+.+ +.+++|.+..+. ...++|.+|...--.|. |.||+.-|+ +|+..+.+.++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 578888999999999999998754 679999877543 23567888876655554 899999887 47777888899
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC--CCcEEEEeeCcceecccCCc
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE--NEVVKVADFGVARVKAQSGV 445 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~--~~~vkL~DFGla~~~~~~~~ 445 (518)
|||++-|+|..-+.. ..+-+....+++.|+++|+.|+|++++||||||.+||||-. .-.|||||||+.+.......
T Consensus 101 qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~ 178 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK 178 (378)
T ss_pred eccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence 999999999988754 55778889999999999999999999999999999999942 23799999999865433211
Q ss_pred cccCCCCCcccCchhccCC-----CCChhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 446 MTAETGTYRWMAPEVIEHK-----PYDHKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 446 ~~~~~gt~~y~APEvl~~~-----~~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
...-+..|.+||+.... ...+.+|+|.||||+|.+|||..||..
T Consensus 179 --~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk 227 (378)
T KOG1345|consen 179 --YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK 227 (378)
T ss_pred --hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence 11234568899986432 356789999999999999999999974
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.4e-24 Score=210.47 Aligned_cols=212 Identities=22% Similarity=0.358 Sum_probs=179.4
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEE--ECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeecccCCCCc
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSL 364 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~--~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~~~ 364 (518)
.+-.-.|+++++||+|+||++|.|+ ++++.||||.-......+ ++..|....+.|. .++|.+.|.+.....+.
T Consensus 24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~AP----QLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAP----QLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred eEecccceeccccccCcceeeecccccccCceEEEEeccccCCcc----hHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 3445679999999999999999997 478999999855433333 3455777777776 69999999998888889
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCC-----CcEEEEeeCccee
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-----EVVKVADFGVARV 439 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~-----~~vkL~DFGla~~ 439 (518)
.+|+|.+ |.||.|++.-+...|+..+++.++.|++.-|+|+|++.+|+|||||+|+||+.. ..|.|+|||+|+.
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9999999 999999999888999999999999999999999999999999999999999743 4699999999986
Q ss_pred cccCC--------ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHhhhh
Q 010078 440 KAQSG--------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL---TPLQAAVGVVQK 504 (518)
Q Consensus 440 ~~~~~--------~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~---~~~q~~~~iv~~ 504 (518)
..+.. ......||.+||+-....+...+.+.|+-|||-++++.|-|.+||.++ +..+.+.+|-++
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET 254 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc
Confidence 54432 223457999999999999999999999999999999999999999876 446667766543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-23 Score=201.82 Aligned_cols=200 Identities=34% Similarity=0.562 Sum_probs=174.7
Q ss_pred eeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChH-HHHHHHHHHHHHHhcCCC-cceEEeecccCCCCcceeeeec
Q 010078 294 LKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSD-MQKEFAQEVFIMRKVRHK-NVVQFIGACTKPPSLCIVTEFM 371 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~-~~~~~~~Ei~iL~~L~Hp-nIv~l~g~~~~~~~~~lV~Ey~ 371 (518)
|.+.+.||.|+||.||++... ..+++|.+........ ....+.+|+.+++.+.|+ +++.+++.+......+++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 677889999999999999988 8899999887655443 567899999999999988 7999999997776689999999
Q ss_pred CCCchhHHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC-cEEEEeeCcceecccCC----
Q 010078 372 SGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSG---- 444 (518)
Q Consensus 372 ~ggsL~~~l~~~~--~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~-~vkL~DFGla~~~~~~~---- 444 (518)
.++++.+++.... ..+.......++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.++......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSS 160 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccc
Confidence 9999997776533 2688999999999999999999999999999999999999988 79999999997554433
Q ss_pred ---ccccCCCCCcccCchhccC---CCCChhhHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 445 ---VMTAETGTYRWMAPEVIEH---KPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 445 ---~~~~~~gt~~y~APEvl~~---~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
......||..|++||.+.+ ..++...|+||+|++++++++|..||.....
T Consensus 161 ~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 161 IPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred ccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 2456789999999999987 5788999999999999999999999887763
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=217.60 Aligned_cols=164 Identities=19% Similarity=0.195 Sum_probs=128.4
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEE---CCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCcceE-EeecccC
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTY---CSQDVAIKVLKPERI---NSDMQKEFAQEVFIMRKVRHKNVVQ-FIGACTK 360 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~---~~~~vAVKvlk~~~~---~~~~~~~~~~Ei~iL~~L~HpnIv~-l~g~~~~ 360 (518)
..-...|.+.+.||+|+||.||+|.+ .++.||||++..... .......|.+|+.+|++++|+|+++ +++.
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 34457799999999999999999976 356689998753311 2334567999999999999999985 5542
Q ss_pred CCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCcEEEcCCCcEEEEeeCccee
Q 010078 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL-KAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDL-Kp~NILid~~~~vkL~DFGla~~ 439 (518)
...|+||||++|++|.. +.. .. ...++.|++++|.|||++||+|||| ||+|||++.++.+||+|||+++.
T Consensus 91 -~~~~LVmE~~~G~~L~~-~~~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHL-ARP----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred -CCcEEEEEccCCCCHHH-hCc----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 35799999999999963 211 11 1467889999999999999999999 99999999999999999999986
Q ss_pred cccCCcc---------ccCCCCCcccCchhccC
Q 010078 440 KAQSGVM---------TAETGTYRWMAPEVIEH 463 (518)
Q Consensus 440 ~~~~~~~---------~~~~gt~~y~APEvl~~ 463 (518)
....+.. +...+++.|+|||.+..
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 5543311 23467888999999853
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-24 Score=219.97 Aligned_cols=203 Identities=23% Similarity=0.376 Sum_probs=165.6
Q ss_pred CCeeeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeecccCCCCcc
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~-----~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~~~~ 365 (518)
+.|..+++||.|+|+.||+++.. ...||+|.+..... ..++..|+++|..+. +.||+++.+++..+++.+
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 56788899999999999999753 45699998765322 245889999999997 899999999999999999
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC-CCcEEEEeeCcceeccc--
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVARVKAQ-- 442 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~-~~~vkL~DFGla~~~~~-- 442 (518)
+||||++.....+++.. ++...+.++++.+++||.++|++|||||||||+|+|.+. .+.-.|+|||++.....
T Consensus 112 ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred EEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence 99999999988888765 678999999999999999999999999999999999985 46788999999861000
Q ss_pred ------C------Cc-------------------------------cccCCCCCcccCchhccC-CCCChhhHHHHHHHH
Q 010078 443 ------S------GV-------------------------------MTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIV 478 (518)
Q Consensus 443 ------~------~~-------------------------------~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGvi 478 (518)
. .. .-...||++|.|||++.. ...++++||||.|+|
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence 0 00 001259999999999865 456889999999999
Q ss_pred HHHHHcCCCCCCCC-CHHHHHHHhh
Q 010078 479 LWELLTGKLPYEYL-TPLQAAVGVV 502 (518)
Q Consensus 479 L~eLltG~~Pf~~~-~~~q~~~~iv 502 (518)
+..+++++.||... +...++.+++
T Consensus 268 ~Lslls~~~PFf~a~dd~~al~ei~ 292 (418)
T KOG1167|consen 268 LLSLLSRRYPFFKAKDDADALAEIA 292 (418)
T ss_pred eehhhccccccccCccccchHHHHH
Confidence 99999999998653 3344444443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.3e-24 Score=242.29 Aligned_cols=145 Identities=17% Similarity=0.217 Sum_probs=115.5
Q ss_pred cCC-CcceEEeecc-------cCCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 010078 346 VRH-KNVVQFIGAC-------TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 417 (518)
Q Consensus 346 L~H-pnIv~l~g~~-------~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLK 417 (518)
++| +||+.++++| .....++++|||+ +++|.+++......++...++.++.||+.||+|||++||+|||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 455 5788888877 2334578889988 779999998756679999999999999999999999999999999
Q ss_pred CCcEEEcCCC-------------------cEEEEeeCcceecccC-----------------CccccCCCCCcccCchhc
Q 010078 418 AANLLMDENE-------------------VVKVADFGVARVKAQS-----------------GVMTAETGTYRWMAPEVI 461 (518)
Q Consensus 418 p~NILid~~~-------------------~vkL~DFGla~~~~~~-----------------~~~~~~~gt~~y~APEvl 461 (518)
|+||||+..| .+|++|||+++..... .......||+.|||||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 9999996544 4556666665432110 001123578899999999
Q ss_pred cCCCCChhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 462 EHKPYDHKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 462 ~~~~~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
.+..|+.++|||||||+||||++|..||..
T Consensus 188 ~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 188 NGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred ccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 999999999999999999999999998764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.1e-24 Score=206.13 Aligned_cols=222 Identities=28% Similarity=0.591 Sum_probs=187.6
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCccee
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV 367 (518)
.|+...+.+..+|...-.|++|+|+|.+.+++.|+++.........+.|..|.-.|+-+.||||..++++|..++++.+|
T Consensus 186 gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~i 265 (448)
T KOG0195|consen 186 GIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII 265 (448)
T ss_pred CcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence 46677888889999999999999999999999999987666666678899999999999999999999999999999999
Q ss_pred eeecCCCchhHHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEcCCCcEEEE--eeCcceeccc
Q 010078 368 TEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVKVA--DFGVARVKAQ 442 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~-~l~~~~i~~i~~qIa~aL~yLHs~g--IiHrDLKp~NILid~~~~vkL~--DFGla~~~~~ 442 (518)
..||+.|||+..++...+ ..+..++.+++.++++||.|||+.. |----|....|+||++-+.+|+ |--++ -+
T Consensus 266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs---fq 342 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS---FQ 342 (448)
T ss_pred eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee---ee
Confidence 999999999999987543 3677899999999999999999975 4444688899999998776654 32222 11
Q ss_pred CCccccCCCCCcccCchhccCCCCC---hhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCchhHHHHHh
Q 010078 443 SGVMTAETGTYRWMAPEVIEHKPYD---HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSFLEQRLR 515 (518)
Q Consensus 443 ~~~~~~~~gt~~y~APEvl~~~~~s---~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp~ip~~~~ 515 (518)
.....-.+.||+||.++.++-+ .++|+|||++++|||.|...||...+|.+.-.+|--.|+|+.||..++
T Consensus 343 ---e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis 415 (448)
T KOG0195|consen 343 ---EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGIS 415 (448)
T ss_pred ---ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCcc
Confidence 1122346889999999887755 468999999999999999999999999999999888899999987664
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=182.10 Aligned_cols=110 Identities=29% Similarity=0.437 Sum_probs=99.0
Q ss_pred CchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccccCCCCC
Q 010078 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY 453 (518)
Q Consensus 374 gsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~~~gt~ 453 (518)
|+|.+++......+++..++.++.||+.||.|||+++ ||+|||++.++.+++ ||+++..... ...||+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~~ 68 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVDP 68 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCcc
Confidence 6899999876677999999999999999999999998 999999999999999 9999765443 236899
Q ss_pred cccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHH
Q 010078 454 RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL 495 (518)
Q Consensus 454 ~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~ 495 (518)
.|||||++.+..|+.++|||||||++|||+||+.||......
T Consensus 69 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 110 (176)
T smart00750 69 YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL 110 (176)
T ss_pred cccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh
Confidence 999999999999999999999999999999999999876554
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=187.03 Aligned_cols=140 Identities=16% Similarity=0.176 Sum_probs=108.1
Q ss_pred eeeeeecCceEEEEEEE-CCceEEEEEecCCCCChHH------------------------HHHHHHHHHHHHhcCCCcc
Q 010078 297 GSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDM------------------------QKEFAQEVFIMRKVRHKNV 351 (518)
Q Consensus 297 ~~~LG~G~fG~Vy~g~~-~~~~vAVKvlk~~~~~~~~------------------------~~~~~~Ei~iL~~L~HpnI 351 (518)
...||+|+||.||+|.. +|+.||||+++........ .....+|+.+++++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999986 5789999999865321111 1122459999999987776
Q ss_pred eEEeecccCCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCcEEEcCCCcEE
Q 010078 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL-HQNNIIHRDLKAANLLMDENEVVK 430 (518)
Q Consensus 352 v~l~g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yL-Hs~gIiHrDLKp~NILid~~~~vk 430 (518)
........ ...+|||||++|+++...+.. .+.++...+..++.|++.+|.|+ |+.||+||||||+|||++ ++.++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 33222211 224899999988777655333 46789999999999999999999 799999999999999998 47899
Q ss_pred EEeeCcceec
Q 010078 431 VADFGVARVK 440 (518)
Q Consensus 431 L~DFGla~~~ 440 (518)
|+|||++...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=190.51 Aligned_cols=173 Identities=14% Similarity=0.198 Sum_probs=135.3
Q ss_pred CCCCeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChH-HHHH------HHHHHHHHHhcCCCcceEEeecccCC-
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSD-MQKE------FAQEVFIMRKVRHKNVVQFIGACTKP- 361 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~-~~~~------~~~Ei~iL~~L~HpnIv~l~g~~~~~- 361 (518)
-..+|++.+.||.|+||.||+....+..+|||++++...... .... +.+|+..+.++.|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 357899999999999999999887788999999986644332 2222 57899999999999999988875432
Q ss_pred -------CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEee
Q 010078 362 -------PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 434 (518)
Q Consensus 362 -------~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DF 434 (518)
...+++|||++|.+|.++.. ++. ....+++.++..||+.|++|||++|+||+++.+| ++|+||
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 35789999999999988742 222 2456999999999999999999999999999988 999999
Q ss_pred CcceecccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHH
Q 010078 435 GVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELL 483 (518)
Q Consensus 435 Gla~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLl 483 (518)
|..+......... .++....|+.++|+||||+++.-+.
T Consensus 179 g~~~~~~e~~a~d-----------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAKD-----------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhHH-----------HHHHHhHhcccccccceeEeehHHH
Confidence 9886443221111 1344556778999999999887543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=178.36 Aligned_cols=142 Identities=16% Similarity=0.158 Sum_probs=110.1
Q ss_pred eeeeeecCceEEEEEEE-CCceEEEEEecCCCCCh-----------------------H-HHHHHHHHHHHHHhcCCCcc
Q 010078 297 GSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINS-----------------------D-MQKEFAQEVFIMRKVRHKNV 351 (518)
Q Consensus 297 ~~~LG~G~fG~Vy~g~~-~~~~vAVKvlk~~~~~~-----------------------~-~~~~~~~Ei~iL~~L~HpnI 351 (518)
...||+|+||.||+|+. +|+.||||+++...... . ....+..|...+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999987 48899999988653210 0 01224578999999999987
Q ss_pred eEEeecccCCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEcCCCcEE
Q 010078 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVK 430 (518)
Q Consensus 352 v~l~g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs-~gIiHrDLKp~NILid~~~~vk 430 (518)
.....+... ..|+||||++|+++...... ...++......++.|++.++.++|+ +||+||||||+|||++ ++.++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 433332222 24899999988855443222 3567888999999999999999999 9999999999999999 88999
Q ss_pred EEeeCcceeccc
Q 010078 431 VADFGVARVKAQ 442 (518)
Q Consensus 431 L~DFGla~~~~~ 442 (518)
|+|||+++....
T Consensus 158 liDFG~a~~~~~ 169 (190)
T cd05145 158 IIDVSQAVELDH 169 (190)
T ss_pred EEEcccceecCC
Confidence 999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.3e-20 Score=178.04 Aligned_cols=184 Identities=15% Similarity=0.133 Sum_probs=140.6
Q ss_pred eeeeeeecCceEEEEEEECCceEEEEEecCCCCChH--HHHHHHHHHHHHHhcC-CCcceEEeecccCCCCcceeeeecC
Q 010078 296 FGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSD--MQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMS 372 (518)
Q Consensus 296 i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~--~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~~~~lV~Ey~~ 372 (518)
....|++|+||+||.+...+.+++.+.+........ ....+.+|+.+|++|. |+++++++++ ...|++|||+.
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 346799999999998888888888887775433211 2235789999999996 5889999886 34699999999
Q ss_pred CCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCcEEEcCCCcEEEEeeCcceecccCCcc-----
Q 010078 373 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL-KAANLLMDENEVVKVADFGVARVKAQSGVM----- 446 (518)
Q Consensus 373 ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDL-Kp~NILid~~~~vkL~DFGla~~~~~~~~~----- 446 (518)
|.+|...+.. ....++.|++.++.++|++||+|||| ||.|||++.+|.++|+|||++.........
T Consensus 82 G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~ 153 (218)
T PRK12274 82 GAAMYQRPPR--------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLA 153 (218)
T ss_pred CccHHhhhhh--------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHH
Confidence 9998754421 11357789999999999999999999 799999999999999999999855443310
Q ss_pred ---------ccCCCCCcccCchhccC-CCCC-hhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 447 ---------TAETGTYRWMAPEVIEH-KPYD-HKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 447 ---------~~~~gt~~y~APEvl~~-~~~s-~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
.-...++.|++|+...- ...+ .+.++++-|+-+|.++|+.+|+-+
T Consensus 154 ~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 154 REDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 01135677788865322 1233 678999999999999999988643
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.3e-22 Score=209.52 Aligned_cols=186 Identities=28% Similarity=0.454 Sum_probs=162.2
Q ss_pred eeecCceEEEEEE-----ECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeecccCCCCcceeeeecCC
Q 010078 300 VASGSYGDLYRGT-----YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSG 373 (518)
Q Consensus 300 LG~G~fG~Vy~g~-----~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (518)
+|.|+||.|++.. +.+.-+|+|++++.............|..++..++ ||.++++..++..+..++++++|..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 6899999999653 44567999998876554333346677888999988 99999999999999999999999999
Q ss_pred CchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccccCCCCC
Q 010078 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY 453 (518)
Q Consensus 374 gsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~~~gt~ 453 (518)
|.|...+.+ ...+.+.....+...++-+++.+|+.+|+|||+|++||+++.+|++++.|||+.+........ +||.
T Consensus 82 g~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt~ 157 (612)
T KOG0603|consen 82 GDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGTY 157 (612)
T ss_pred chhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccch
Confidence 999998876 556778888889999999999999999999999999999999999999999999866554322 8999
Q ss_pred cccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 454 RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 454 ~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
.|||||+++ ....+.|+||||++++||+||..||..
T Consensus 158 eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 158 EYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 999999998 567889999999999999999999998
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-19 Score=205.20 Aligned_cols=197 Identities=22% Similarity=0.331 Sum_probs=165.1
Q ss_pred CCceeeCCCCeeeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC---CCcceEEeeccc
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVVQFIGACT 359 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~-~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~---HpnIv~l~g~~~ 359 (518)
...+++....|.|-+.||.|+||.||+|+. +++.||+|+-++...++ |.--.+++.+|+ -+.|..+..++.
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~ 764 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHV 764 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHc
Confidence 346789999999999999999999999985 57789999988775543 222233444444 345666777777
Q ss_pred CCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC-------CCcEEEE
Q 010078 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-------NEVVKVA 432 (518)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~-------~~~vkL~ 432 (518)
-.+..++|+||.+-|+|.+++.. .+.+++..+..++.|++..++.||..+|||+||||+|+||.. .-.++|+
T Consensus 765 ~~~~S~lv~ey~~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 765 FQNASVLVSEYSPYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred cCCcceeeeeccccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence 77778999999999999999984 778999999999999999999999999999999999999942 3469999
Q ss_pred eeCcce---ecccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCC
Q 010078 433 DFGVAR---VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK 486 (518)
Q Consensus 433 DFGla~---~~~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~ 486 (518)
|||.+- +..........++|-.+-.+|...|.+|++.+|.|.|+.+++.||.|+
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 999874 444555667788999999999999999999999999999999999997
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6e-20 Score=202.69 Aligned_cols=199 Identities=25% Similarity=0.407 Sum_probs=158.3
Q ss_pred eeeeeeeeecCceEEEEEEEC--CceEEEEEec----CCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCccee
Q 010078 294 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLK----PERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk----~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV 367 (518)
......+|.|++|.|+..... ....+.|..+ +.....+....+..|+.+-..+.|+|++..+..+.+....+-.
T Consensus 320 ~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~ 399 (601)
T KOG0590|consen 320 GKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQS 399 (601)
T ss_pred CCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhh
Confidence 356678999999977766542 1223333222 2212222233377788888999999998888877766666666
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC---
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--- 444 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~--- 444 (518)
|||+++ +|+.++.. .+.+....+..++.|++.|+.|+|+.||.|||+|++|+++..+|.+||+|||.+.......
T Consensus 400 mE~~~~-Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hhcccH-HHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 999999 99999876 4578888999999999999999999999999999999999999999999999987655433
Q ss_pred --ccccCCCCCcccCchhccCCCCChh-hHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 445 --VMTAETGTYRWMAPEVIEHKPYDHK-ADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 445 --~~~~~~gt~~y~APEvl~~~~~s~k-sDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
.....+|+..|+|||++.+..|++. .||||.|++++.|.+|+.||.....
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~ 530 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKK 530 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccc
Confidence 2345689999999999999999876 7999999999999999999975444
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.5e-19 Score=170.08 Aligned_cols=134 Identities=16% Similarity=0.220 Sum_probs=103.9
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-----CCCcceEEeecccCCC---Ccc-ee
Q 010078 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-----RHKNVVQFIGACTKPP---SLC-IV 367 (518)
Q Consensus 297 ~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-----~HpnIv~l~g~~~~~~---~~~-lV 367 (518)
.+.||+|+||.||....... .+||++..... ...+.+.+|+.+++.+ .||||++++|++..+. ..+ +|
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEECCCCcC-eEEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 46899999999997333333 47898875422 2346789999999999 5799999999997763 323 78
Q ss_pred eee--cCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHH-HHHHHCCceeccCCCCcEEEcCC----CcEEEEeeCcc
Q 010078 368 TEF--MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM-NYLHQNNIIHRDLKAANLLMDEN----EVVKVADFGVA 437 (518)
Q Consensus 368 ~Ey--~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL-~yLHs~gIiHrDLKp~NILid~~----~~vkL~DFGla 437 (518)
||| +.+++|.+++.+ +.+++. ..++.|++.++ +|||+++|+||||||+|||++.+ +.++|+||+.+
T Consensus 84 ~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred ecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 999 557999999965 345555 35678888777 99999999999999999999743 37999995443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=166.81 Aligned_cols=136 Identities=23% Similarity=0.399 Sum_probs=114.9
Q ss_pred eeeeecCceEEEEEEECCceEEEEEecCCCCChH------HHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeec
Q 010078 298 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSD------MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 371 (518)
+.||+|++|.||+|.+.+..+++|+......... ....+.+|+.++..+.|++++....++......+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 5789999999999999999999998765433211 1245788999999999998876666666667789999999
Q ss_pred CCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 372 ~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
+|++|.+++.... . ....++.+++.+|.++|+.|++|+|++|.|||++ ++.++|+|||.++.
T Consensus 82 ~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999986521 2 7888999999999999999999999999999999 78899999999865
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.1e-18 Score=164.41 Aligned_cols=133 Identities=20% Similarity=0.361 Sum_probs=107.7
Q ss_pred eeeecCceEEEEEEECCceEEEEEecCCCCC-h-----HHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecC
Q 010078 299 KVASGSYGDLYRGTYCSQDVAIKVLKPERIN-S-----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 372 (518)
Q Consensus 299 ~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~-~-----~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ 372 (518)
.||+|+||.||+|.+.+..+++|+....... . ....++.+|+.+++.+.|+++.....++......++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 3799999999999999999999986543221 1 123567789999999998765443333445566799999999
Q ss_pred CCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceec
Q 010078 373 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 373 ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~ 440 (518)
|++|.+++..... .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||+++..
T Consensus 81 g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998755211 7899999999999999999999999999999 889999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=2e-18 Score=173.44 Aligned_cols=219 Identities=16% Similarity=0.269 Sum_probs=137.0
Q ss_pred CeeeeeeeeecCceEEEEEEECC--ceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCC----------CcceEEeecc-
Q 010078 293 HLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRH----------KNVVQFIGAC- 358 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~~~--~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~H----------pnIv~l~g~~- 358 (518)
.+..++.||.|+++.||.+++.. +++|+|+...... .....+.+.+|.-....+.+ -.++-.++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 57788999999999999999854 8899998764432 22345667776655554322 1121111111
Q ss_pred -----------cCCC-----CcceeeeecCCCchhHHHhh---hcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 010078 359 -----------TKPP-----SLCIVTEFMSGGSVYDYLHK---LKGV---FKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416 (518)
Q Consensus 359 -----------~~~~-----~~~lV~Ey~~ggsL~~~l~~---~~~~---l~~~~i~~i~~qIa~aL~yLHs~gIiHrDL 416 (518)
.+.. +.+++|+-+ -++|.+++.. .... ........+..|+++.+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1111 346788877 5688887642 1111 122233456689999999999999999999
Q ss_pred CCCcEEEcCCCcEEEEeeCcceecccCCccccCCCCCcccCchhccC--------CCCChhhHHHHHHHHHHHHHcCCCC
Q 010078 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH--------KPYDHKADVFSFGIVLWELLTGKLP 488 (518)
Q Consensus 417 Kp~NILid~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APEvl~~--------~~~s~ksDVwSlGviL~eLltG~~P 488 (518)
+|+|++++.+|.++|+||+.......... ....+..|.+||.... -.++.+.|.|+||+++|.|+||+.|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~--~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP 249 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYR--CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP 249 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEE--GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceee--ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence 99999999999999999998765443222 1345578999998743 3578999999999999999999999
Q ss_pred CCCCCHHHHHHHhhhhcCchhHHHHHhh
Q 010078 489 YEYLTPLQAAVGVVQKVHHSFLEQRLRK 516 (518)
Q Consensus 489 f~~~~~~q~~~~iv~~~~rp~ip~~~~~ 516 (518)
|...++........+... .+|+.++.
T Consensus 250 f~~~~~~~~~~~~f~~C~--~~Pe~v~~ 275 (288)
T PF14531_consen 250 FGLSSPEADPEWDFSRCR--DMPEPVQF 275 (288)
T ss_dssp TCCCGGGSTSGGGGTTSS-----HHHHH
T ss_pred CCCCCccccccccchhcC--CcCHHHHH
Confidence 987655333322233333 55555543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.7e-19 Score=197.28 Aligned_cols=195 Identities=19% Similarity=0.277 Sum_probs=153.9
Q ss_pred CeeeeeeeeecCceEEEEEEECCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 293 HLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~--~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
++...+.||++.|=+|.++++....|+||++-+... .-....+-+.|++ ....++||++++.-+.......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 678889999999999999998887899998764432 1111223333444 5566899999999988888888999999
Q ss_pred cCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceec----ccCCcc
Q 010078 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 446 (518)
Q Consensus 371 ~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~----~~~~~~ 446 (518)
. .-+|+|.+.. +..+..-+.++|+.||++|+.-+|..||+|||||.+||||+.-+.+.|+||..-+.. +++...
T Consensus 103 v-khnLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf 180 (1431)
T KOG1240|consen 103 V-KHNLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADF 180 (1431)
T ss_pred H-hhhhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccc
Confidence 9 5699999976 556777888999999999999999999999999999999999999999999876521 111111
Q ss_pred c----cCCCCCcccCchhccC----------CC-CChhhHHHHHHHHHHHHHc-CCCCCC
Q 010078 447 T----AETGTYRWMAPEVIEH----------KP-YDHKADVFSFGIVLWELLT-GKLPYE 490 (518)
Q Consensus 447 ~----~~~gt~~y~APEvl~~----------~~-~s~ksDVwSlGviL~eLlt-G~~Pf~ 490 (518)
+ +...-..|+|||.+.. .+ .+++.||||+||+++||++ |++||.
T Consensus 181 ~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 181 TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred eEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 1 2223347999998743 12 5788999999999999999 899985
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.5e-18 Score=167.22 Aligned_cols=143 Identities=16% Similarity=0.187 Sum_probs=111.8
Q ss_pred CeeeeeeeeecCceEEEEEE---ECCceEEEEEecCCCCCh----------------------HHHHHHHHHHHHHHhcC
Q 010078 293 HLKFGSKVASGSYGDLYRGT---YCSQDVAIKVLKPERINS----------------------DMQKEFAQEVFIMRKVR 347 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~---~~~~~vAVKvlk~~~~~~----------------------~~~~~~~~Ei~iL~~L~ 347 (518)
.|.+.+.||+|+||.||+|. ..++.||||+++...... .....+..|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46777899999999999998 367899999987543110 01234568999999998
Q ss_pred CC--cceEEeecccCCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCcEEEc
Q 010078 348 HK--NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN-IIHRDLKAANLLMD 424 (518)
Q Consensus 348 Hp--nIv~l~g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~g-IiHrDLKp~NILid 424 (518)
+. .+.++++. ...++||||++|.+|..+... ...+....+..++.||+.++.+||+.| |+||||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 63 34455543 235899999999888776533 345666677899999999999999999 99999999999999
Q ss_pred CCCcEEEEeeCcceecc
Q 010078 425 ENEVVKVADFGVARVKA 441 (518)
Q Consensus 425 ~~~~vkL~DFGla~~~~ 441 (518)
++.++|+|||.+....
T Consensus 184 -~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 -DGKVVIIDVSQSVELD 199 (237)
T ss_pred -CCCEEEEEChhhhccC
Confidence 8899999999986443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.4e-18 Score=184.67 Aligned_cols=145 Identities=21% Similarity=0.342 Sum_probs=117.6
Q ss_pred ceeeCCCC---eeeeeeeeecCceEEEEEEECCceEEEEEecCCCC-Ch-----HHHHHHHHHHHHHHhcCCCcceEEee
Q 010078 286 VWEIDPKH---LKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI-NS-----DMQKEFAQEVFIMRKVRHKNVVQFIG 356 (518)
Q Consensus 286 ~~ei~~~~---~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~-~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~g 356 (518)
.|...... +...++||+|+||.||+|.+.+..+++|+...... .. .....+.+|+.+++.++|++++..+.
T Consensus 324 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~ 403 (535)
T PRK09605 324 TWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI 403 (535)
T ss_pred eeccccccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence 35544433 34478999999999999999888877775432211 11 12356889999999999999988777
Q ss_pred cccCCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCc
Q 010078 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436 (518)
Q Consensus 357 ~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGl 436 (518)
++......++||||++|++|.+++. ....++.+++.+|.|||+.|++||||||+|||+ .++.++|+|||+
T Consensus 404 ~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 404 YDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred EEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcc
Confidence 7766677899999999999999885 346789999999999999999999999999999 578899999999
Q ss_pred ceec
Q 010078 437 ARVK 440 (518)
Q Consensus 437 a~~~ 440 (518)
++..
T Consensus 474 a~~~ 477 (535)
T PRK09605 474 GKYS 477 (535)
T ss_pred cccC
Confidence 9754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.9e-17 Score=158.34 Aligned_cols=137 Identities=19% Similarity=0.237 Sum_probs=107.9
Q ss_pred eeeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCh--------------------HHHHHHHHHHHHHHhcCCC--c
Q 010078 294 LKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINS--------------------DMQKEFAQEVFIMRKVRHK--N 350 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~-~~~~vAVKvlk~~~~~~--------------------~~~~~~~~Ei~iL~~L~Hp--n 350 (518)
|.+.+.||+|+||.||++.. .++.||||+++...... .....+..|+.++..+.++ .
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 56678999999999999987 57899999977543110 0112367789999999887 4
Q ss_pred ceEEeecccCCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEE
Q 010078 351 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK 430 (518)
Q Consensus 351 Iv~l~g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vk 430 (518)
++..++. ...++||||++|++|...... .....++.+++.++.++|+.||+||||||+||+++.++.++
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 5555542 345899999999998765421 34567889999999999999999999999999999999999
Q ss_pred EEeeCcceecc
Q 010078 431 VADFGVARVKA 441 (518)
Q Consensus 431 L~DFGla~~~~ 441 (518)
|+|||.+....
T Consensus 166 liDfg~~~~~~ 176 (198)
T cd05144 166 IIDWPQMVSTD 176 (198)
T ss_pred EEECCccccCC
Confidence 99999985443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.5e-18 Score=188.75 Aligned_cols=172 Identities=29% Similarity=0.434 Sum_probs=127.2
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
.+|..++.|..|+||.||..+++ .+.+|+|+-+.. -+.+- |+.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~--------lilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN--------LILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccc--------hhhhc--cccccCCccee-----------------
Confidence 56788899999999999999765 678888663321 11111 22222333333
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-----
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG----- 444 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~----- 444 (518)
|+-...++. -+.++... +.+++|||+.||+|||+||+|++|+.-|++|+.|||+.+......
T Consensus 136 ----gDc~tllk~-~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 136 ----GDCATLLKN-IGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred ----chhhhhccc-CCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 233333322 34454433 678999999999999999999999999999999999986432111
Q ss_pred -----------ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 445 -----------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 445 -----------~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
.-...+||+.|+|||++..+.|+...|+|++|+|+||.+-|..||.+.+|.+..-.++.
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis 272 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 272 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh
Confidence 00123799999999999999999999999999999999999999999999776666554
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.2e-17 Score=165.41 Aligned_cols=142 Identities=25% Similarity=0.425 Sum_probs=110.2
Q ss_pred CCCcceEEeecccCC---------------------------CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHH
Q 010078 347 RHKNVVQFIGACTKP---------------------------PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399 (518)
Q Consensus 347 ~HpnIv~l~g~~~~~---------------------------~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qI 399 (518)
+|||||++.++|.+. ..+|+||... .-+|..|+.. ...+.....-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~--~~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT--RHRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc--CCCchHHHHHHHHHH
Confidence 599999999987552 2468888877 4588888854 456777888899999
Q ss_pred HHHHHHHHHCCceeccCCCCcEEEc--CCC--cEEEEeeCcceecccCCc-------cccCCCCCcccCchhccCCC---
Q 010078 400 SKGMNYLHQNNIIHRDLKAANLLMD--ENE--VVKVADFGVARVKAQSGV-------MTAETGTYRWMAPEVIEHKP--- 465 (518)
Q Consensus 400 a~aL~yLHs~gIiHrDLKp~NILid--~~~--~vkL~DFGla~~~~~~~~-------~~~~~gt~~y~APEvl~~~~--- 465 (518)
+.|+.|||+.||.|||+|.+|||+. +++ .+.|+|||.+--....+. ....-|.-..||||+....+
T Consensus 351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~ 430 (598)
T KOG4158|consen 351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN 430 (598)
T ss_pred HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence 9999999999999999999999994 333 578999998743322221 11224666789999986532
Q ss_pred ---CChhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 466 ---YDHKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 466 ---~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
--.|+|.|+.|.+.||+++..-||..
T Consensus 431 avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 431 AVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred eeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 12479999999999999999999975
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.2e-16 Score=148.80 Aligned_cols=138 Identities=21% Similarity=0.298 Sum_probs=99.9
Q ss_pred eeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHH----------------------HHHHHHHHHhcCCC--cc
Q 010078 297 GSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKE----------------------FAQEVFIMRKVRHK--NV 351 (518)
Q Consensus 297 ~~~LG~G~fG~Vy~g~~~-~~~vAVKvlk~~~~~~~~~~~----------------------~~~Ei~iL~~L~Hp--nI 351 (518)
++.||+|+||.||++... ++.||||+++........... ...|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 568999999999999876 788999998764322111111 13566666666543 34
Q ss_pred eEEeecccCCCCcceeeeecCCCchhH-HHhhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEcCCCcE
Q 010078 352 VQFIGACTKPPSLCIVTEFMSGGSVYD-YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVV 429 (518)
Q Consensus 352 v~l~g~~~~~~~~~lV~Ey~~ggsL~~-~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs-~gIiHrDLKp~NILid~~~~v 429 (518)
.+.++.. ..++||||++|+.+.. .+.... . ...+..++.+++.++.++|. .||+|+||||+||+++ ++.+
T Consensus 82 ~~~~~~~----~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 82 PKPIDLN----RHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CceEecC----CCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 5555432 3689999999854332 121111 1 15678899999999999999 9999999999999999 8899
Q ss_pred EEEeeCcceeccc
Q 010078 430 KVADFGVARVKAQ 442 (518)
Q Consensus 430 kL~DFGla~~~~~ 442 (518)
+|+|||.+.....
T Consensus 154 ~liDfg~a~~~~~ 166 (187)
T cd05119 154 YIIDVPQAVEIDH 166 (187)
T ss_pred EEEECcccccccC
Confidence 9999999965443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.8e-16 Score=138.73 Aligned_cols=132 Identities=17% Similarity=0.219 Sum_probs=113.7
Q ss_pred eeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC--CcceEEeecccCCCCcceeeeecCC
Q 010078 296 FGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGACTKPPSLCIVTEFMSG 373 (518)
Q Consensus 296 i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~H--pnIv~l~g~~~~~~~~~lV~Ey~~g 373 (518)
+.+.||.|.++.||+++..+..+++|+.+.... ...+.+|+.+++.+++ .++++++.+....+..+++|||++|
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 357899999999999999888999999876432 4578899999999987 5899999988888889999999988
Q ss_pred CchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN---NIIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 374 gsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~---gIiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
+.+..+ +......++.+++.++.+||.. +++|+|++|+||+++..+.++++|||.+..
T Consensus 78 ~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 877654 4456677889999999999985 799999999999999989999999998853
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.5e-15 Score=150.02 Aligned_cols=137 Identities=14% Similarity=0.167 Sum_probs=106.5
Q ss_pred eeee-ecCceEEEEEEECCceEEEEEecCCCC-----------ChHHHHHHHHHHHHHHhcCCCcc--eEEeecccCCCC
Q 010078 298 SKVA-SGSYGDLYRGTYCSQDVAIKVLKPERI-----------NSDMQKEFAQEVFIMRKVRHKNV--VQFIGACTKPPS 363 (518)
Q Consensus 298 ~~LG-~G~fG~Vy~g~~~~~~vAVKvlk~~~~-----------~~~~~~~~~~Ei~iL~~L~HpnI--v~l~g~~~~~~~ 363 (518)
..|| .|+.|+||.....+..++||.+..... .......+.+|+.++.+++|++| +..+++......
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4577 788899999988899999998753221 11223567889999999998775 667766433222
Q ss_pred ----cceeeeecCC-CchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcce
Q 010078 364 ----LCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (518)
Q Consensus 364 ----~~lV~Ey~~g-gsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~ 438 (518)
.++||||++| .+|.+++.. ..++.. .+.+|+.++.+||++||+||||||.|||++.++.++|+|||.++
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~ 190 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGE 190 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence 2599999997 689888854 345543 35789999999999999999999999999999999999999986
Q ss_pred ec
Q 010078 439 VK 440 (518)
Q Consensus 439 ~~ 440 (518)
..
T Consensus 191 ~~ 192 (239)
T PRK01723 191 LR 192 (239)
T ss_pred cC
Confidence 53
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.4e-15 Score=159.87 Aligned_cols=119 Identities=28% Similarity=0.555 Sum_probs=106.4
Q ss_pred CcceeeeecCCCchhHHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceec
Q 010078 363 SLCIVTEFMSGGSVYDYLHKL--KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~--~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~ 440 (518)
.+||.|++|...+|.+|+... ....+....+.++.|++.|++| +|.+|+|+||.||+...+..+||.|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 589999999999999999642 2346677889999999999999 99999999999999999999999999998765
Q ss_pred ccCC-------ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc
Q 010078 441 AQSG-------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT 484 (518)
Q Consensus 441 ~~~~-------~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt 484 (518)
.... ..+..+||.+||+||.|.++.|+.++||||||+||+|++.
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 5444 5677789999999999999999999999999999999997
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=7.2e-15 Score=156.65 Aligned_cols=149 Identities=32% Similarity=0.580 Sum_probs=127.0
Q ss_pred HHhcCCCcceEEeecccCCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCc-eeccCCCCcE
Q 010078 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI-IHRDLKAANL 421 (518)
Q Consensus 343 L~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gI-iHrDLKp~NI 421 (518)
|+.+.|.|+.+|+|.+.+++..++|.+||..|+|.+.+......++.-....++++|+.||.|||..-| .|+.++..|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 467889999999999999999999999999999999998866778888888899999999999998766 9999999999
Q ss_pred EEcCCCcEEEEeeCcceecccC---CccccCCCCCcccCchhccCCC-------CChhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 422 LMDENEVVKVADFGVARVKAQS---GVMTAETGTYRWMAPEVIEHKP-------YDHKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 422 Lid~~~~vkL~DFGla~~~~~~---~~~~~~~gt~~y~APEvl~~~~-------~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
++|....+||+|||+....... ..........-|.|||.+.... .+.+.|+||||++++|+++.+-||+.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 9999999999999998766421 1111222446799999986631 46679999999999999999999976
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.1e-15 Score=168.92 Aligned_cols=204 Identities=28% Similarity=0.491 Sum_probs=166.2
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC---CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeecccCCCCcce
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCI 366 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~---~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~~~~l 366 (518)
...|.+.+.||+|+|+.|-..... ...+|+|.+...............|..+-+.+. |+|++.+++........++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 345666777999999998876543 234666666544333444456667888888888 9999999999999999999
Q ss_pred eeeecCCCchhHHH-hhhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCcEEEcCCC-cEEEEeeCcceeccc-
Q 010078 367 VTEFMSGGSVYDYL-HKLKGVFKLPSLLKVAIDVSKGMNYLH-QNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQ- 442 (518)
Q Consensus 367 V~Ey~~ggsL~~~l-~~~~~~l~~~~i~~i~~qIa~aL~yLH-s~gIiHrDLKp~NILid~~~-~vkL~DFGla~~~~~- 442 (518)
+++|..|+++.+-+ .......+......++.|+..++.|+| .+++.|+||||+|.+++..+ .++++|||++.....
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 99999999999988 442226777788899999999999999 99999999999999999999 999999999986655
Q ss_pred CC---ccccCCC-CCcccCchhccCCCC-ChhhHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 443 SG---VMTAETG-TYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 443 ~~---~~~~~~g-t~~y~APEvl~~~~~-s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
.+ .....+| ++.|+|||...+..| .+..|+||.|+++.-|++|..||.....
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~ 235 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR 235 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence 33 2335578 999999999988544 5678999999999999999999976543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.1e-13 Score=144.85 Aligned_cols=139 Identities=17% Similarity=0.274 Sum_probs=98.4
Q ss_pred eeeeecCceEEEEEEE-CCceEEEEEecCCCCCh---H-------------------------H----------HHHHHH
Q 010078 298 SKVASGSYGDLYRGTY-CSQDVAIKVLKPERINS---D-------------------------M----------QKEFAQ 338 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~-~~~~vAVKvlk~~~~~~---~-------------------------~----------~~~~~~ 338 (518)
+.||+|++|.||+|+. +|+.||||+.++..... + . .-.|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 4699999999999987 68999999998652110 0 0 012455
Q ss_pred HHHHHHhcC-----CCcc--eEEeecccCCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHH-HHHHHHHCC
Q 010078 339 EVFIMRKVR-----HKNV--VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK-GMNYLHQNN 410 (518)
Q Consensus 339 Ei~iL~~L~-----HpnI--v~l~g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~-aL~yLHs~g 410 (518)
|...+.+++ ++++ .+++. ......++||||++|++|.++......... ...++.+++. .+..+|..|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 666665553 2332 23332 223346899999999999988754222222 3445666655 478899999
Q ss_pred ceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 411 IIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 411 IiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
++|+|++|.||+++.++.++++|||++....
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.42 E-value=6.6e-13 Score=122.72 Aligned_cols=128 Identities=17% Similarity=0.195 Sum_probs=98.0
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcc-eEEeecccCCCCcceeeeecCCCc
Q 010078 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCIVTEFMSGGS 375 (518)
Q Consensus 297 ~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~g~~~~~~~~~lV~Ey~~ggs 375 (518)
.+.|+.|.++.||+++..+..|++|+...... ....+..|+.+++.+.+.++ .+++.... ...++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 35789999999999999999999999765421 12345778999998876554 44555433 34589999999988
Q ss_pred hhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 376 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI-----IHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 376 L~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gI-----iHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
+.... . ....++.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 78 l~~~~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTED------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 76530 1 113456789999999999985 9999999999999 67899999998853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.37 E-value=5e-12 Score=120.94 Aligned_cols=137 Identities=17% Similarity=0.200 Sum_probs=99.6
Q ss_pred eeeeecCceEEEEEEEC--------CceEEEEEecCCCC--------------------ChHHHHHHH----HHHHHHHh
Q 010078 298 SKVASGSYGDLYRGTYC--------SQDVAIKVLKPERI--------------------NSDMQKEFA----QEVFIMRK 345 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~--------~~~vAVKvlk~~~~--------------------~~~~~~~~~----~Ei~iL~~ 345 (518)
..||.|.-+.||.|... +..+|||+.+.... .....+.+. +|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999754 36899999763211 011122233 79999999
Q ss_pred cCC--CcceEEeecccCCCCcceeeeecCCCchhH-HHhhhcCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCcE
Q 010078 346 VRH--KNVVQFIGACTKPPSLCIVTEFMSGGSVYD-YLHKLKGVFKLPSLLKVAIDVSKGMNYL-HQNNIIHRDLKAANL 421 (518)
Q Consensus 346 L~H--pnIv~l~g~~~~~~~~~lV~Ey~~ggsL~~-~l~~~~~~l~~~~i~~i~~qIa~aL~yL-Hs~gIiHrDLKp~NI 421 (518)
+.. -+++..+++ ...+|||||+.+..+.. .+. +..++...+..+..+++.+|..| |+.||+|+||++.||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 874 466777764 35689999997654422 222 22345566778889999999999 899999999999999
Q ss_pred EEcCCCcEEEEeeCcceecc
Q 010078 422 LMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 422 Lid~~~~vkL~DFGla~~~~ 441 (518)
|++ ++.++|+|||.+-...
T Consensus 157 L~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 157 LWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEE-CCcEEEEECCCceeCC
Confidence 997 4679999999885443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.35 E-value=2e-12 Score=140.82 Aligned_cols=139 Identities=17% Similarity=0.224 Sum_probs=89.0
Q ss_pred eeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC----------------------------h----HHHHH----
Q 010078 294 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN----------------------------S----DMQKE---- 335 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~----------------------------~----~~~~~---- 335 (518)
|.. +.||+|++|.||+|+.. |+.||||++++.... . +..+.
T Consensus 122 fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~E 200 (537)
T PRK04750 122 FDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDE 200 (537)
T ss_pred cCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHh
Confidence 444 68999999999999874 789999999865210 0 11112
Q ss_pred --HHHHHHHHHhcC----CCcc---eEEeecccCCCCcceeeeecCCCchhHHHhhhcCCCC-----HHHHHHHHHHHHH
Q 010078 336 --FAQEVFIMRKVR----HKNV---VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK-----LPSLLKVAIDVSK 401 (518)
Q Consensus 336 --~~~Ei~iL~~L~----HpnI---v~l~g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~-----~~~i~~i~~qIa~ 401 (518)
+.+|+..+.+++ +.+. .++|.- .....++||||+.|+.+.++-.-.....+ ...+..++.|
T Consensus 201 lD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d--~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 201 LDLMREAANASQLRRNFEDSDMLYVPEVYWD--YCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred hCHHHHHHHHHHHHHHccCCCCeecceeecc--cCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 334444444442 2222 223321 12346899999999999875321112222 2223333333
Q ss_pred HHHHHHHCCceeccCCCCcEEEcCCC----cEEEEeeCcceeccc
Q 010078 402 GMNYLHQNNIIHRDLKAANLLMDENE----VVKVADFGVARVKAQ 442 (518)
Q Consensus 402 aL~yLHs~gIiHrDLKp~NILid~~~----~vkL~DFGla~~~~~ 442 (518)
+...|++|+|++|+||+++.+| .++++|||++.....
T Consensus 276 ----if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 ----VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3468999999999999999888 999999999875543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.7e-11 Score=113.29 Aligned_cols=135 Identities=21% Similarity=0.356 Sum_probs=102.3
Q ss_pred eeeeecCceEEEEEEECCceEEEEEecCCCC-ChHH-----HHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeec
Q 010078 298 SKVASGSYGDLYRGTYCSQDVAIKVLKPERI-NSDM-----QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~-~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 371 (518)
..+++|+-+.+|.+.+.+.++++|.-.+... .+.. ..+..+|+.++.+++--.|.-.+=+..++....|+|||+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 3578999999999999888888886543332 2221 245677999999998655443333345566778999999
Q ss_pred CCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 372 ~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
+|..|.+++... . ..++..+-..+.-||.+||+|+||.++||++...+ +.++|||++....
T Consensus 82 ~G~~lkd~l~~~----~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 82 EGELLKDALEEA----R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred CChhHHHHHHhc----c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 999999998763 1 34566666677889999999999999999998665 9999999997443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.5e-11 Score=112.13 Aligned_cols=144 Identities=23% Similarity=0.289 Sum_probs=107.7
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCC-h-----HHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERIN-S-----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 297 ~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~-~-----~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
...|-+|+-+.|+++.+.|+.+.||.-...... + -...+..+|+++|.++.--.|.-.--++.+...-+|+|||
T Consensus 12 l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred ceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 457889999999999999999999975433221 1 2245678899999999754443222234455567899999
Q ss_pred cCC-CchhHHHhhhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC---cEEEEeeCcceec
Q 010078 371 MSG-GSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VVKVADFGVARVK 440 (518)
Q Consensus 371 ~~g-gsL~~~l~~~~~~-l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~---~vkL~DFGla~~~ 440 (518)
++| .++.+++...... ........++.+|-..+.-||.++|||+||.++||++..++ .+.++|||++...
T Consensus 92 ~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred ccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 977 4788888765333 33334478889999999999999999999999999997655 3589999998654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=4e-11 Score=129.81 Aligned_cols=162 Identities=16% Similarity=0.255 Sum_probs=125.9
Q ss_pred CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecCCCchhHHHhhhcCCCCHHHHH
Q 010078 314 CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL 393 (518)
Q Consensus 314 ~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~ 393 (518)
.+.+|.|.+.+.... .......+-++-|+.++||||++++..+...+.+|+|+|.+. .|..++.+. ....+.
T Consensus 36 ~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l----~~~~v~ 107 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL----GKEEVC 107 (690)
T ss_pred cCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh----HHHHHH
Confidence 467788887775432 334556778889999999999999999999999999999983 677777662 356677
Q ss_pred HHHHHHHHHHHHHH-HCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcc-ccCCCCCcccCchhccCCCCChhhH
Q 010078 394 KVAIDVSKGMNYLH-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM-TAETGTYRWMAPEVIEHKPYDHKAD 471 (518)
Q Consensus 394 ~i~~qIa~aL~yLH-s~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~-~~~~gt~~y~APEvl~~~~~s~ksD 471 (518)
.-+.||+.||.||| .++++|++|.-+.|+++..|..||.+|.++....+...+ ....---.|..|+.+.... -..|
T Consensus 108 ~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D 185 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSID 185 (690)
T ss_pred HHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchh
Confidence 78899999999997 678999999999999999999999999998755443321 1111122456677654443 3479
Q ss_pred HHHHHHHHHHHHcC
Q 010078 472 VFSFGIVLWELLTG 485 (518)
Q Consensus 472 VwSlGviL~eLltG 485 (518)
.|-|||++||++.|
T Consensus 186 ~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 186 SWGLGCLIEELFNG 199 (690)
T ss_pred hhhHHHHHHHHhCc
Confidence 99999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.26 E-value=4e-12 Score=136.05 Aligned_cols=195 Identities=26% Similarity=0.327 Sum_probs=156.6
Q ss_pred Ceeeeeeeee--cCceEEEEEEE----CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeecccCCCCcc
Q 010078 293 HLKFGSKVAS--GSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 293 ~~~i~~~LG~--G~fG~Vy~g~~----~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~~~~ 365 (518)
.+.+.+.+|. |.+|.||.+.. .+..+|+|.-+...........-.+|+...++++ |+|.++.+..+...+.++
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3445567899 99999998865 4567888874433322222233455777777776 899999999999999999
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHH----HHHHHHHCCceeccCCCCcEEEcCC-CcEEEEeeCcceec
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK----GMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVK 440 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~----aL~yLHs~gIiHrDLKp~NILid~~-~~vkL~DFGla~~~ 440 (518)
+-+|++ +.+|..+.+.....++...++.+..+... |+..+|+.+++|-|+||.||++..+ ...+++|||+....
T Consensus 195 iqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i 273 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKI 273 (524)
T ss_pred eeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEc
Confidence 999999 78999999886677888999999999999 9999999999999999999999999 88999999998876
Q ss_pred ccCCccc------cCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCC
Q 010078 441 AQSGVMT------AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489 (518)
Q Consensus 441 ~~~~~~~------~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf 489 (518)
....... ...|...|++||+.++. ++.+.|+|++|.++.+-.+|..+.
T Consensus 274 ~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 274 SDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred cCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccc
Confidence 6544211 12567789999998765 788999999999999988875443
|
|
| >cd04928 ACT_TyrKc Uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.6e-11 Score=96.73 Aligned_cols=67 Identities=67% Similarity=1.026 Sum_probs=64.7
Q ss_pred ccceeeecCChhhHHHHHHHHHHhhcccceecccccCCCCceeeEEEEcCCChhhHHHHHHHHHHHH
Q 010078 179 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEV 245 (518)
Q Consensus 179 ~~ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~dg~~ldv~vvdgw~~e~~~~l~~~l~~~~ 245 (518)
+|||++.+.|+|+|+++++.+|+..|+||+.|.+|+|.||+.+|.|+|.+|..++++.|.+++++.+
T Consensus 1 ~~eI~V~~~Dr~gLFa~iag~L~~~~LnI~~A~i~tt~dG~~LDtF~V~d~~~~~~~~~~~~~~~~~ 67 (68)
T cd04928 1 MHEITFAAGDKPKLLSQLSSLLGDLGLNIAEAHAFSTDDGLALDIFVVTGWKRGETAALGHALQKEI 67 (68)
T ss_pred CEEEEEEECCCcchHHHHHHHHHHCCCceEEEEEEEcCCCeEEEEEEEecCCccchHHHHHHHHHhh
Confidence 5899999999999999999999999999999999999999999999999999999999999998764
|
This CD includes a novel, yet uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.22 E-value=9.8e-11 Score=112.47 Aligned_cols=139 Identities=19% Similarity=0.297 Sum_probs=104.6
Q ss_pred eeeeecCceEEEEEEECC-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCC--cceEEeecccCCC---Ccceeeeec
Q 010078 298 SKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK--NVVQFIGACTKPP---SLCIVTEFM 371 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~~-~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIv~l~g~~~~~~---~~~lV~Ey~ 371 (518)
+.|+.|.++.||+++..+ ..+++|+....... .....+.+|+.+++.+.+. ++.+++.+..... ..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998776 88999997654321 1235678899999999863 4577777766542 568999999
Q ss_pred CCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 010078 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ------------------------------------------- 408 (518)
Q Consensus 372 ~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs------------------------------------------- 408 (518)
+|.++.+.+.. ..++......++.+++++|..||+
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99888775531 345566666666777777776663
Q ss_pred -------------CCceeccCCCCcEEEcC--CCcEEEEeeCccee
Q 010078 409 -------------NNIIHRDLKAANLLMDE--NEVVKVADFGVARV 439 (518)
Q Consensus 409 -------------~gIiHrDLKp~NILid~--~~~vkL~DFGla~~ 439 (518)
..++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 24699999999999998 67789999998853
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.2e-11 Score=138.89 Aligned_cols=217 Identities=22% Similarity=0.311 Sum_probs=162.2
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEECC--ceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCC
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~--~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~ 363 (518)
+....+.+.+.+.+-+|+++.++.++-.+ ...++|+.+.... .....+....+-.++-..++|-++.....+.-...
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 45666778888899999999999876533 3344444332110 11112333444445545566777777666666677
Q ss_pred cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc--
Q 010078 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA-- 441 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~-- 441 (518)
.+++++|+.|++|...++. .+..+......+...+..+.+|||...+.|+|++|.|+|+..++..++.|||......
T Consensus 879 ~~L~~~~~~~~~~~Skl~~-~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHN-SGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred cchhhHHhccCCchhhhhc-CCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccc
Confidence 8999999999999999987 4456666677788888999999999999999999999999999999999998432100
Q ss_pred ----cC--------------------------CccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 442 ----QS--------------------------GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 442 ----~~--------------------------~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
.. .......+|+.|.+||...+......+|+|++|++++|.++|..||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 00 011233689999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHhhhh
Q 010078 492 LTPLQAAVGVVQK 504 (518)
Q Consensus 492 ~~~~q~~~~iv~~ 504 (518)
.++.+....+...
T Consensus 1038 ~tpq~~f~ni~~~ 1050 (1205)
T KOG0606|consen 1038 ETPQQIFENILNR 1050 (1205)
T ss_pred cchhhhhhccccC
Confidence 9998887665543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.2e-09 Score=109.85 Aligned_cols=136 Identities=15% Similarity=0.088 Sum_probs=98.5
Q ss_pred CceEEEEEEECCceEEEEEecCCCCChHH---------HHHHHHHHHHHHhcCCCcc--eEEeecccC-----CCCccee
Q 010078 304 SYGDLYRGTYCSQDVAIKVLKPERINSDM---------QKEFAQEVFIMRKVRHKNV--VQFIGACTK-----PPSLCIV 367 (518)
Q Consensus 304 ~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~---------~~~~~~Ei~iL~~L~HpnI--v~l~g~~~~-----~~~~~lV 367 (518)
....|++..+.|+.|.||.........-. ...+.+|...+.+|...+| +..+++... ....++|
T Consensus 34 ~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 34 EGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred CCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 33457788888999999976543321101 1147788888888854333 333333321 2346899
Q ss_pred eeecCCC-chhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC-------CCcEEEEeeCcce
Q 010078 368 TEFMSGG-SVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-------NEVVKVADFGVAR 438 (518)
Q Consensus 368 ~Ey~~gg-sL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~-------~~~vkL~DFGla~ 438 (518)
||++++. +|.+++... ....+......++.+++..+.-||.+||+|+|+++.|||++. +..+.|+||+.++
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999886 899988542 234556677789999999999999999999999999999975 4689999999885
Q ss_pred e
Q 010078 439 V 439 (518)
Q Consensus 439 ~ 439 (518)
.
T Consensus 194 ~ 194 (268)
T PRK15123 194 I 194 (268)
T ss_pred c
Confidence 3
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.8e-10 Score=123.44 Aligned_cols=193 Identities=22% Similarity=0.223 Sum_probs=149.4
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC---CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeecccCCCCcce
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCI 366 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~---~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~~~~l 366 (518)
..++..+.+||.|.|+.||..... +..|++|.++...........-..|+.+...+. |.+++..+..|....+.|+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 356788899999999999987653 456888877655443332333456777777776 8999999998888888999
Q ss_pred eeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCC-CcEEEEeeCcceecccCCc
Q 010078 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVKAQSGV 445 (518)
Q Consensus 367 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~-~~vkL~DFGla~~~~~~~~ 445 (518)
-.||+.++++...+. ....+.+...+++..|++.++.++|+..++|+|+||+||++..+ +..++.|||......-. .
T Consensus 344 p~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~-~ 421 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS-S 421 (524)
T ss_pred chhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee-c
Confidence 999999998887763 34567888899999999999999999999999999999999876 77899999987532211 1
Q ss_pred cccCCCCCccc--CchhccCCCCChhhHHHHHHHHHHHHHcCC
Q 010078 446 MTAETGTYRWM--APEVIEHKPYDHKADVFSFGIVLWELLTGK 486 (518)
Q Consensus 446 ~~~~~gt~~y~--APEvl~~~~~s~ksDVwSlGviL~eLltG~ 486 (518)
. .....-+++ ++.......+..+.|+||||..+.+..+|.
T Consensus 422 ~-~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~ 463 (524)
T KOG0601|consen 422 G-VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGS 463 (524)
T ss_pred c-cccccccccccchhhccccccccccccccccccccccccCc
Confidence 1 112233444 566667788899999999999999988875
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=4.6e-10 Score=112.50 Aligned_cols=147 Identities=20% Similarity=0.365 Sum_probs=114.4
Q ss_pred HHHhcCCCcceEEeecccCCC-----CcceeeeecCCCchhHHHhhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--c
Q 010078 342 IMRKVRHKNVVQFIGACTKPP-----SLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNN--I 411 (518)
Q Consensus 342 iL~~L~HpnIv~l~g~~~~~~-----~~~lV~Ey~~ggsL~~~l~~~---~~~l~~~~i~~i~~qIa~aL~yLHs~g--I 411 (518)
-|-++-|.|||+++.+|.+.+ ...+++|||+.|+|..+|++. ...+....+.+|+.||+.||.|||+.. |
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 344566999999999987654 367899999999999999754 345778889999999999999999985 9
Q ss_pred eeccCCCCcEEEcCCCcEEEEeeCccee--cc---cCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCC
Q 010078 412 IHRDLKAANLLMDENEVVKVADFGVARV--KA---QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK 486 (518)
Q Consensus 412 iHrDLKp~NILid~~~~vkL~DFGla~~--~~---~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~ 486 (518)
+|+++..+.|++..+|-||+.--.-... .. ........++-++|.+||.=.....+.++|||+||....+|..|.
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence 9999999999999999888753221110 00 011122345678999999876667778899999999999998876
Q ss_pred CC
Q 010078 487 LP 488 (518)
Q Consensus 487 ~P 488 (518)
.-
T Consensus 280 iq 281 (458)
T KOG1266|consen 280 IQ 281 (458)
T ss_pred ec
Confidence 53
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.9e-09 Score=99.27 Aligned_cols=127 Identities=20% Similarity=0.283 Sum_probs=83.0
Q ss_pred EEEEEEE-CCceEEEEEecCCCCC------------------------hHHHHHHHHHHHHHHhcCCC--cceEEeeccc
Q 010078 307 DLYRGTY-CSQDVAIKVLKPERIN------------------------SDMQKEFAQEVFIMRKVRHK--NVVQFIGACT 359 (518)
Q Consensus 307 ~Vy~g~~-~~~~vAVKvlk~~~~~------------------------~~~~~~~~~Ei~iL~~L~Hp--nIv~l~g~~~ 359 (518)
.||.|.. .+..+|+|+.+..... ........+|...|.++... ++++++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4898886 5778999998643110 01123467799999999865 567777553
Q ss_pred CCCCcceeeeecC--CCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHH-HHHCCceeccCCCCcEEEcCCCcEEEEeeCc
Q 010078 360 KPPSLCIVTEFMS--GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY-LHQNNIIHRDLKAANLLMDENEVVKVADFGV 436 (518)
Q Consensus 360 ~~~~~~lV~Ey~~--ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~y-LHs~gIiHrDLKp~NILid~~~~vkL~DFGl 436 (518)
..+|||||++ |..+..+... . ++......++.+++..+.. +|..||+|+||.+.|||++++ .+.|+|||.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-D--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-G--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ---CCEEEEEecCCCccchhhHHhc-c--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 3589999998 6555554332 1 1134456677788875555 579999999999999999977 899999998
Q ss_pred ceecc
Q 010078 437 ARVKA 441 (518)
Q Consensus 437 a~~~~ 441 (518)
+....
T Consensus 153 av~~~ 157 (188)
T PF01163_consen 153 AVDSS 157 (188)
T ss_dssp EEETT
T ss_pred ceecC
Confidence 86443
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.2e-08 Score=105.50 Aligned_cols=192 Identities=17% Similarity=0.254 Sum_probs=134.8
Q ss_pred eeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceE--------EeecccCCCCc
Q 010078 294 LKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQ--------FIGACTKPPSL 364 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~--------l~g~~~~~~~~ 364 (518)
+..+..||+|+-+.+|..-.-+. .+-|+......... .+.+..|... .||-+-. ++|. .....+
T Consensus 13 i~~gr~LgqGgea~ly~l~e~~d-~VAKIYh~Pppa~~-----aqk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~i 85 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEVRD-QVAKIYHAPPPAAQ-----AQKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVI 85 (637)
T ss_pred cCCCccccCCccceeeecchhhc-hhheeecCCCchHH-----HHHHHHhccCCCCcchhhhhcccHHHhhCC-Ccccee
Confidence 34567899999999996433333 34466554332211 1122333333 3443222 2221 112236
Q ss_pred ceeeeecCCCc-hhHHHh-----hhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcce
Q 010078 365 CIVTEFMSGGS-VYDYLH-----KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (518)
Q Consensus 365 ~lV~Ey~~ggs-L~~~l~-----~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~ 438 (518)
.++|..++|.. +..++. +....+.++.++++++.|+.+...||..|.+-+|++++|+|+.+++.|.|+|-..-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 78888887752 222221 112457889999999999999999999999999999999999999999999977766
Q ss_pred ecccCCccccCCCCCcccCchhcc-----CCCCChhhHHHHHHHHHHHHHcC-CCCCCCC
Q 010078 439 VKAQSGVMTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTG-KLPYEYL 492 (518)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~APEvl~-----~~~~s~ksDVwSlGviL~eLltG-~~Pf~~~ 492 (518)
...........+|...|++||.-. +..-+..+|.|.||++++++|.| +.||.+.
T Consensus 166 i~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 166 INANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred eccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 666666677889999999999754 44556789999999999999995 9999875
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.82 E-value=2e-08 Score=97.06 Aligned_cols=106 Identities=17% Similarity=0.278 Sum_probs=82.2
Q ss_pred HHHHHHHHHHHhcCCCc--ceEEeecccCC----CCcceeeeecCCC-chhHHHhhhcCCCCHHHHHHHHHHHHHHHHHH
Q 010078 334 KEFAQEVFIMRKVRHKN--VVQFIGACTKP----PSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406 (518)
Q Consensus 334 ~~~~~Ei~iL~~L~Hpn--Iv~l~g~~~~~----~~~~lV~Ey~~gg-sL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yL 406 (518)
....+|...+..|...+ ++..+++.... ...++|||+++|. +|.+++..... .+......++.+++..+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 45777888777775433 34444444332 2348999999884 89999876322 66677788999999999999
Q ss_pred HHCCceeccCCCCcEEEcCCC---cEEEEeeCcceec
Q 010078 407 HQNNIIHRDLKAANLLMDENE---VVKVADFGVARVK 440 (518)
Q Consensus 407 Hs~gIiHrDLKp~NILid~~~---~vkL~DFGla~~~ 440 (518)
|.+||+|+|+++.|||++.++ .+.++||+.++..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999999999999999887 8999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.8e-08 Score=98.27 Aligned_cols=136 Identities=19% Similarity=0.257 Sum_probs=101.3
Q ss_pred eeeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCC-------h-------------HHHHHHHHHHHHHHhcCCC--c
Q 010078 294 LKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERIN-------S-------------DMQKEFAQEVFIMRKVRHK--N 350 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~-~~~~vAVKvlk~~~~~-------~-------------~~~~~~~~Ei~iL~~L~Hp--n 350 (518)
..++.+||-|.-+.||.|.. .+.++|||..+..+.+ . -......+|..+|+.|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 34567899999999999987 4899999986533211 0 1123466799999999755 6
Q ss_pred ceEEeecccCCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEE
Q 010078 351 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK 430 (518)
Q Consensus 351 Iv~l~g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vk 430 (518)
++..++ .+..++||||++|..|+..- ++......++..|+.-+.-+-..||||+|+.+-||+++++|.+.
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCccc----cccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 666664 34568999999997776543 12334445566666666666689999999999999999999999
Q ss_pred EEeeCccee
Q 010078 431 VADFGVARV 439 (518)
Q Consensus 431 L~DFGla~~ 439 (518)
++||-.+..
T Consensus 243 vIDwPQ~v~ 251 (304)
T COG0478 243 VIDWPQAVP 251 (304)
T ss_pred EEeCccccc
Confidence 999988743
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.64 E-value=4.1e-07 Score=87.82 Aligned_cols=139 Identities=12% Similarity=0.081 Sum_probs=102.0
Q ss_pred eecCceEEEEEEECCceEEEEEecCCCC----ChHHHHHHHHHHHHHHhcCCCc--ceEEeecc-c-CC--CCcceeeee
Q 010078 301 ASGSYGDLYRGTYCSQDVAIKVLKPERI----NSDMQKEFAQEVFIMRKVRHKN--VVQFIGAC-T-KP--PSLCIVTEF 370 (518)
Q Consensus 301 G~G~fG~Vy~g~~~~~~vAVKvlk~~~~----~~~~~~~~~~Ei~iL~~L~Hpn--Iv~l~g~~-~-~~--~~~~lV~Ey 370 (518)
|.|+.+.|++..+.|+.+-+|.-..... .+--...|.+|...|++|..-+ +++..... . .+ -.-+||+|-
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~ 106 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED 106 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence 6688888999998888888887542110 0223467899999999987432 44444221 1 11 125799998
Q ss_pred cCC-CchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCc--EEEEeeCccee
Q 010078 371 MSG-GSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV--VKVADFGVARV 439 (518)
Q Consensus 371 ~~g-gsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~--vkL~DFGla~~ 439 (518)
+.| .+|.+++... -.+.+......++.+++..+.-||+.|+.|+|+.+.|||++.+|. ++++||.-++.
T Consensus 107 L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 107 MAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred CCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 854 4888888552 224566677789999999999999999999999999999987777 99999998763
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.1e-07 Score=101.19 Aligned_cols=140 Identities=18% Similarity=0.278 Sum_probs=94.8
Q ss_pred eeeeecCceEEEEEEEC-CceEEEEEecCCCCCh---H-------------------------HH----------HHHHH
Q 010078 298 SKVASGSYGDLYRGTYC-SQDVAIKVLKPERINS---D-------------------------MQ----------KEFAQ 338 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~-~~~vAVKvlk~~~~~~---~-------------------------~~----------~~~~~ 338 (518)
+.|++++-|.||+|+.. |+.||||+.++..... + .. -.+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 57899999999999986 8999999988642110 0 00 12344
Q ss_pred HHHHHHhcC-----CCc--ceEEeecccCCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 010078 339 EVFIMRKVR-----HKN--VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411 (518)
Q Consensus 339 Ei~iL~~L~-----Hpn--Iv~l~g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gI 411 (518)
|..-+.+++ .++ |.++| +.....-.++|||++|..+.+........++...+.....++. +.-+-..|+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~--we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgf 286 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVY--WEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceee--hhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence 555555553 233 23333 2223446899999999999998544345566444444333332 333445899
Q ss_pred eeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 412 IHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 412 iHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
+|.|..|.||+++.+|.+.+.|||.+....
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecCC
Confidence 999999999999999999999999986544
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.2e-06 Score=93.18 Aligned_cols=174 Identities=18% Similarity=0.242 Sum_probs=127.0
Q ss_pred eEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC----CCCcceeeeecCC-CchhH
Q 010078 306 GDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK----PPSLCIVTEFMSG-GSVYD 378 (518)
Q Consensus 306 G~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~----~~~~~lV~Ey~~g-gsL~~ 378 (518)
.+.|+++. +|..|++|.++..+... ......-+++++++.|.|+|+|..++.. ...+++|++|.++ ++|++
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 55888864 67889999985433221 1223345788999999999999998762 3458999999986 47877
Q ss_pred HHhhh--------------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 379 YLHKL--------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 379 ~l~~~--------------~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
+.-.. +...++..+|.++.||..||.++|+.|+..+-|.+.+||++.+..++|+..|...+.....
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~ 447 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP 447 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence 64211 1236678999999999999999999999999999999999988899999888876544331
Q ss_pred ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCC-CCCCCHHHH
Q 010078 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP-YEYLTPLQA 497 (518)
Q Consensus 445 ~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~P-f~~~~~~q~ 497 (518)
+ +-++. -.+-|.-.||.++..|.||..- |....+.+.
T Consensus 448 ------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s 485 (655)
T KOG3741|consen 448 ------T-------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSS 485 (655)
T ss_pred ------C-------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHH
Confidence 0 11211 2356999999999999999543 333334333
|
|
| >cd04900 ACT_UUR-like_1 ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.6e-07 Score=75.45 Aligned_cols=66 Identities=35% Similarity=0.536 Sum_probs=53.5
Q ss_pred cceeeecCChhhHHHHHHHHHHhhcccceecccccCCCCceeeEEEEcCCChh--hHHHHHHHHHHHH
Q 010078 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYE--ETEQLRAALEKEV 245 (518)
Q Consensus 180 ~ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~dg~~ldv~vvdgw~~e--~~~~l~~~l~~~~ 245 (518)
.||.+.+.|+|+|+++++.+|+++|+||..|.+|++.+|+.+|+|.|.++... ..++..+.+++.+
T Consensus 2 ~~i~v~~~Dr~gLl~~i~~~l~~~~l~I~~A~i~T~~~~~v~D~F~v~~~~~~~~~~~~~~~~l~~~L 69 (73)
T cd04900 2 TEVFIYTPDRPGLFARIAGALDQLGLNILDARIFTTRDGYALDTFVVLDPDGEPIGERERLARIREAL 69 (73)
T ss_pred EEEEEEecCCCCHHHHHHHHHHHCCCCeEEeEEEEeCCCeEEEEEEEECCCCCCCChHHHHHHHHHHH
Confidence 58999999999999999999999999999999999999999999999654322 1233334455444
|
This ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD is the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.6e-06 Score=84.05 Aligned_cols=138 Identities=17% Similarity=0.204 Sum_probs=92.7
Q ss_pred CCCeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChH-HHH------HHHHHHHHHHhcC---CCcceEEeecccC
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSD-MQK------EFAQEVFIMRKVR---HKNVVQFIGACTK 360 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~-~~~------~~~~Ei~iL~~L~---HpnIv~l~g~~~~ 360 (518)
..+|++.+.+-......|.+-...++.+++|..+......+ ... ...+.+..+.+++ ...+..++.+...
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek 109 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK 109 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence 35677777777777777888888999999999876432211 111 1223444444443 2333333333322
Q ss_pred -----CCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeC
Q 010078 361 -----PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435 (518)
Q Consensus 361 -----~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFG 435 (518)
....+++|||++|..|.++.. +++ .+...|..++.-||+.|+.|+|+.|+|++++.++ ++++||+
T Consensus 110 k~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~ 179 (229)
T PF06176_consen 110 KIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQ 179 (229)
T ss_pred eeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECc
Confidence 233568999999988877642 222 2445677789999999999999999999998554 9999998
Q ss_pred cce
Q 010078 436 VAR 438 (518)
Q Consensus 436 la~ 438 (518)
..+
T Consensus 180 ~k~ 182 (229)
T PF06176_consen 180 GKR 182 (229)
T ss_pred ccc
Confidence 765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.3e-06 Score=85.79 Aligned_cols=135 Identities=17% Similarity=0.216 Sum_probs=85.3
Q ss_pred eeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCc--ceEEeecccCCCCcceeeeecCCCc
Q 010078 298 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--VVQFIGACTKPPSLCIVTEFMSGGS 375 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Iv~l~g~~~~~~~~~lV~Ey~~ggs 375 (518)
..||.|..+.||+. .+..+++|+...... .....+|.++++.+..-+ +.+.+++.......++|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~~----~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGFD----KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCCC----HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 57899999999984 366788898765321 234678999999987443 4677777777777889999998863
Q ss_pred -hhHH---------------------Hhhhc-CCCCHHHH-HHHHHH----------HHH-HHHHHHH----CCceeccC
Q 010078 376 -VYDY---------------------LHKLK-GVFKLPSL-LKVAID----------VSK-GMNYLHQ----NNIIHRDL 416 (518)
Q Consensus 376 -L~~~---------------------l~~~~-~~l~~~~i-~~i~~q----------Ia~-aL~yLHs----~gIiHrDL 416 (518)
+... ++... ........ ..+..+ +.. ...+|.. ..++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 1111 11110 01111111 111111 111 1222321 24789999
Q ss_pred CCCcEEEcCCCcEEEEeeCccee
Q 010078 417 KAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 417 Kp~NILid~~~~vkL~DFGla~~ 439 (518)
.|.||++++++ +.|+||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.8e-06 Score=80.72 Aligned_cols=139 Identities=19% Similarity=0.240 Sum_probs=99.5
Q ss_pred CCCCeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcc-eEEeecccCCCCcceee
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCIVT 368 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~g~~~~~~~~~lV~ 368 (518)
..-.....+.||+|.+|.||+|.|.+..+|+|+-+.+.. ...+..|+++|..+.--++ .++|.+..+ ++.|
T Consensus 20 ~~~~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~----r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~m 91 (201)
T COG2112 20 GKYELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP----RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRM 91 (201)
T ss_pred cchhhhhhhhhhcccccEEEEeeccCceEEEEEecCCcc----hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhh
Confidence 334556667899999999999999999999999876533 4568889999999987665 445554432 4569
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC-CCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK-AANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLK-p~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
||+.|..|.+.-.. .+..++.. ++..---|-..||-|+.|. |...+|..++.+.|+||..|+....+.
T Consensus 92 e~i~G~~L~~~~~~----~~rk~l~~----vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~p~ 160 (201)
T COG2112 92 EYIDGRPLGKLEIG----GDRKHLLR----VLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKKKPR 160 (201)
T ss_pred hhhcCcchhhhhhc----ccHHHHHH----HHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhccCCc
Confidence 99999888877543 13334433 3344445667799999884 555555556689999999998655544
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.39 E-value=3.4e-06 Score=81.12 Aligned_cols=139 Identities=21% Similarity=0.279 Sum_probs=84.6
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCC--cceEEeeccc---CCCCcceeeeec
Q 010078 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK--NVVQFIGACT---KPPSLCIVTEFM 371 (518)
Q Consensus 297 ~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIv~l~g~~~---~~~~~~lV~Ey~ 371 (518)
++.|+.|..+.||+.+..+..+++|+.... .....+.+|..+++.+... .+.+++.... .....+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 467999999999999998889999997643 3456778899998888643 3556666332 222368899999
Q ss_pred CCCchhH----------------HH---hhhcCC---CCHHH---------HHHH------------HHHHHH-HHHHHH
Q 010078 372 SGGSVYD----------------YL---HKLKGV---FKLPS---------LLKV------------AIDVSK-GMNYLH 407 (518)
Q Consensus 372 ~ggsL~~----------------~l---~~~~~~---l~~~~---------i~~i------------~~qIa~-aL~yLH 407 (518)
+|..+.. .+ +..... +.... .... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9988877 11 111111 11000 0000 111222 233333
Q ss_pred H-------CCceeccCCCCcEEEc-CCCcEEEEeeCccee
Q 010078 408 Q-------NNIIHRDLKAANLLMD-ENEVVKVADFGVARV 439 (518)
Q Consensus 408 s-------~gIiHrDLKp~NILid-~~~~vkL~DFGla~~ 439 (518)
+ ..++|+|+.|.|||++ .++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2 3599999999999999 666678999998753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.33 E-value=4.5e-06 Score=82.19 Aligned_cols=136 Identities=18% Similarity=0.176 Sum_probs=85.5
Q ss_pred eeeecCc-eEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeecccCCCCcceeeeecCCCch
Q 010078 299 KVASGSY-GDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (518)
Q Consensus 299 ~LG~G~f-G~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL 376 (518)
.|..|.+ +.||+....+..+.+|+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.+|
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 4555655 7799998777788888876432 234667888888885 34466778777666678999999999877
Q ss_pred hHHH-------------------hhhcC---CCCHH--HHHHHHH--------------------HHHHHHHHHH-----
Q 010078 377 YDYL-------------------HKLKG---VFKLP--SLLKVAI--------------------DVSKGMNYLH----- 407 (518)
Q Consensus 377 ~~~l-------------------~~~~~---~l~~~--~i~~i~~--------------------qIa~aL~yLH----- 407 (518)
.... +.... .+... ....... .+......|-
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 6431 11100 11100 0000000 0111122221
Q ss_pred --HCCceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 408 --QNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 408 --s~gIiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
...++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 13489999999999999988889999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.5e-06 Score=85.30 Aligned_cols=136 Identities=18% Similarity=0.184 Sum_probs=89.9
Q ss_pred eeeecCceEEEEEEE-CCceEEEEEecCCCCChHHHH---------------------H-HHHHHHHHHhcCC--CcceE
Q 010078 299 KVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQK---------------------E-FAQEVFIMRKVRH--KNVVQ 353 (518)
Q Consensus 299 ~LG~G~fG~Vy~g~~-~~~~vAVKvlk~~~~~~~~~~---------------------~-~~~Ei~iL~~L~H--pnIv~ 353 (518)
.|.+|.-+.||+|.. .+..+|+|+.+.....-.... . ...|..-|+++.. =.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 566777777999875 578899999875432211100 0 2235555665542 23344
Q ss_pred EeecccCCCCcceeeeecCCC-chhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEcCCCcEEE
Q 010078 354 FIGACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKV 431 (518)
Q Consensus 354 l~g~~~~~~~~~lV~Ey~~gg-sL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs-~gIiHrDLKp~NILid~~~~vkL 431 (518)
-+++. ...+||||+... .-.-.|.. -.+.......+..++++.|.-|-. .++||+||..-|||+. ++.+.|
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~i 207 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYI 207 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEE
Confidence 44433 347999999543 11111211 223333677788899999999887 8999999999999999 889999
Q ss_pred EeeCcceecc
Q 010078 432 ADFGVARVKA 441 (518)
Q Consensus 432 ~DFGla~~~~ 441 (518)
+|||.+....
T Consensus 208 ID~~QaV~~~ 217 (268)
T COG1718 208 IDVSQAVTID 217 (268)
T ss_pred EECccccccC
Confidence 9999986544
|
|
| >PRK05092 PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=98.30 E-value=5.5e-06 Score=97.03 Aligned_cols=119 Identities=29% Similarity=0.369 Sum_probs=92.3
Q ss_pred HHHHHHHhccCCcccccccCCCchhhhHhHHHHHHHhcCCCCCCeEEEEEEEeecCCCCCCcccccCCCCCccccCCCCC
Q 010078 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRNSAVSSLLDSEVPAQRQSIHP 140 (518)
Q Consensus 61 ~~~l~~hf~rlp~~y~~d~~~~~~edvl~h~~ll~~a~~~~~~p~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (518)
.+++.++|.+||.+|-+-.. ++++.-|-+++....+....|++.+|.-. .
T Consensus 680 ~~~~~~~~~~~~~~yf~~~~---~~~i~~h~~~~~~~~~~~~~~~v~~~~~~---~------------------------ 729 (931)
T PRK05092 680 KADRDAYLARHYPAYWLAVD---LDTQARHARFIRDADDAGRPLATEVRPDP---A------------------------ 729 (931)
T ss_pred HHHHHHHHHhCCcHHhcCCC---HHHHHHHHHHHHhccccCCCcEEEEEecC---C------------------------
Confidence 35678899999999999865 45999999999887654455665553211 0
Q ss_pred CCCCCCChhhHHHhhhhcCCCCCCCCCcccccccccCcccceeeecCChhhHHHHHHHHHHhhcccceecccccCCCCce
Q 010078 141 PPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYS 220 (518)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~dg~~ 220 (518)
+-.-+|+|.+.|+|+|+++++.+|+..|+||..|++|+|.||+.
T Consensus 730 ------------------------------------~~~t~v~I~~~Dr~GLfa~i~~~L~~~glnI~~A~I~t~~dg~a 773 (931)
T PRK05092 730 ------------------------------------RGVTEVTVLAADHPGLFSRIAGACAAAGANIVDARIFTTTDGRA 773 (931)
T ss_pred ------------------------------------CCeEEEEEEeCCCCcHHHHHHHHHHHCCCcEEEEEEEEecCCeE
Confidence 01339999999999999999999999999999999999999999
Q ss_pred eeEEEE---cCCC---hhhHHHHHHHHHHHH
Q 010078 221 LDVFVV---DGWP---YEETEQLRAALEKEV 245 (518)
Q Consensus 221 ldv~vv---dgw~---~e~~~~l~~~l~~~~ 245 (518)
+|+|.| +|.+ .+..+.+++.|...+
T Consensus 774 lD~F~V~~~~g~~~~~~~~~~~l~~~L~~~l 804 (931)
T PRK05092 774 LDTFWIQDAFGRDEDEPRRLARLAKAIEDAL 804 (931)
T ss_pred EEEEEEECCCCCCCCCHHHHHHHHHHHHHHH
Confidence 999999 5543 234555666665544
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.18 E-value=9.4e-06 Score=88.42 Aligned_cols=141 Identities=19% Similarity=0.273 Sum_probs=92.0
Q ss_pred eeeeecCceEEEEEEE-CCceEEEEEecCCCCCh---H--------------------------HHH------HHHHHHH
Q 010078 298 SKVASGSYGDLYRGTY-CSQDVAIKVLKPERINS---D--------------------------MQK------EFAQEVF 341 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~-~~~~vAVKvlk~~~~~~---~--------------------------~~~------~~~~Ei~ 341 (518)
+.||.-+.|.||+|+. .|+.||||+-++.-... + ..+ .|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5689999999999986 56789999987642111 0 011 2444444
Q ss_pred HHHhc----CCCc------ceEEeecccCCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 010078 342 IMRKV----RHKN------VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411 (518)
Q Consensus 342 iL~~L----~Hpn------Iv~l~g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gI 411 (518)
-..++ .|-+ |+++|-.++ ..-.++||||+|..+.+.-.-....++...+..-+.++.. +-+=..|+
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~Gf 322 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTGF 322 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcCC
Confidence 33333 3444 555554443 3468999999998777664333355666655444444322 22334689
Q ss_pred eeccCCCCcEEEcC----CCcEEEEeeCcceeccc
Q 010078 412 IHRDLKAANLLMDE----NEVVKVADFGVARVKAQ 442 (518)
Q Consensus 412 iHrDLKp~NILid~----~~~vkL~DFGla~~~~~ 442 (518)
+|+|-.|.||++.. ++.+.+.|||+......
T Consensus 323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 99999999999984 56899999999875543
|
|
| >PRK04374 PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.7e-05 Score=91.79 Aligned_cols=105 Identities=19% Similarity=0.220 Sum_probs=81.1
Q ss_pred hHHHHHHHhccCCcccccccCCCchhhhHhHHHHHHHhcCCCCCCeEEEEEEEeecCCCCCCcccccCCCCCccccCCCC
Q 010078 60 FDDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRNSAVSSLLDSEVPAQRQSIH 139 (518)
Q Consensus 60 ~~~~l~~hf~rlp~~y~~d~~~~~~edvl~h~~ll~~a~~~~~~p~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (518)
=.+++.++|++||.||-+--. ++++.-|-+++.... ...|.+-++-..
T Consensus 638 ~~~~~~~~~~~l~~~Y~~~~~---~~~I~~h~~~~~~~~--~~~~~v~~~~~~--------------------------- 685 (869)
T PRK04374 638 DDATIDRQFAGMPDENFLRFR---PEQLAWQAASLIEVE--IGQTLVKARRAV--------------------------- 685 (869)
T ss_pred CHHHHHHHHHhCCchhhcCCC---HHHHHHHHHHHHhcC--CCCCeEEEeeec---------------------------
Confidence 356688899999999998755 569999999997653 222222221100
Q ss_pred CCCCCCCChhhHHHhhhhcCCCCCCCCCcccccccccCcccceeeecCChhhHHHHHHHHHHhhcccceecccccCCCCc
Q 010078 140 PPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGY 219 (518)
Q Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~dg~ 219 (518)
| .+-.-||++.+.|+|+|+++++.+|+..|+||..|.+|+|.||+
T Consensus 686 --~---------------------------------~~~~~~v~v~~~d~~gLFa~i~g~l~~~~lnI~~A~i~t~~~g~ 730 (869)
T PRK04374 686 --P---------------------------------DNDALEVFVYSPDRDGLFAAIVATLDRKGYGIHRARVLDAPHDA 730 (869)
T ss_pred --c---------------------------------CCCeEEEEEEeCCCccHHHHHHHHHHHCCCeEEEEEEEEcCCCE
Confidence 0 01133999999999999999999999999999999999999999
Q ss_pred eeeEEEEcCCCh
Q 010078 220 SLDVFVVDGWPY 231 (518)
Q Consensus 220 ~ldv~vvdgw~~ 231 (518)
.+|+|.|.....
T Consensus 731 ~ld~f~V~~~~~ 742 (869)
T PRK04374 731 IFDVFEVLPQDT 742 (869)
T ss_pred EEEEEEEeCCCC
Confidence 999999986443
|
|
| >cd04927 ACT_ACR-like_2 Second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=98.14 E-value=6.3e-06 Score=66.81 Aligned_cols=49 Identities=27% Similarity=0.441 Sum_probs=44.7
Q ss_pred eeeecCChhhHHHHHHHHHHhhcccceecccccCCCCceeeEEEEcCCC
Q 010078 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWP 230 (518)
Q Consensus 182 i~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~dg~~ldv~vvdgw~ 230 (518)
+-+.+.|+|+|+.+++.+|++.|+||..|.+++|.+|+.+|+|.|....
T Consensus 3 ~ei~~~Dr~gLfa~i~~~l~~~~l~I~~A~I~Tt~~~~v~D~F~V~d~~ 51 (76)
T cd04927 3 LKLFCSDRKGLLHDVTEVLYELELTIERVKVSTTPDGRVLDLFFITDAR 51 (76)
T ss_pred EEEEECCCCCHHHHHHHHHHHCCCeEEEEEEEECCCCEEEEEEEEeCCC
Confidence 4567789999999999999999999999999999999999999996543
|
This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) have been described, however, the ACR-like sequences in this CD are distinct from those characterized. This CD includes the Oryza sativa ACR-like protein (Os05g0113000) encoded on chromosome 5 and the Arabidopsis thaliana predicted gene product, At2g39570. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.13 E-value=5.2e-07 Score=97.81 Aligned_cols=186 Identities=20% Similarity=0.202 Sum_probs=135.7
Q ss_pred CeeeeeeeeecCceEEEEEEECCce-EEEEEecCCCCChHHHHHHHHHHHHHHhcCCCc-ceEEeecccCCCCcceeeee
Q 010078 293 HLKFGSKVASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN-VVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~~~~~-vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Iv~l~g~~~~~~~~~lV~Ey 370 (518)
.+...+-+++|+++++|+.+...+. ...+++... ....-++++|.+++||| .+..++-++.+...++.|++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 3455667899999999987654322 224443322 34455889999999999 77777778888889999999
Q ss_pred cCCC-chhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccccC
Q 010078 371 MSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 449 (518)
Q Consensus 371 ~~gg-sL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~~ 449 (518)
+.++ +-..-+....-.+...+...+++.-+++++++|+.--+|+| ||+..+ +..+..||+........-.....
T Consensus 316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~ 390 (829)
T KOG0576|consen 316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTA 390 (829)
T ss_pred hcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcccccccC
Confidence 9877 22222211122233445556667778899999998778998 776654 67899999988766555455667
Q ss_pred CCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCC
Q 010078 450 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490 (518)
Q Consensus 450 ~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~ 490 (518)
.+|+.|+|||++..+.+....|.|++|.-..+|--|-+|-.
T Consensus 391 ~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 89999999999999999999999999987777776766644
|
|
| >PRK00275 glnD PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=98.12 E-value=2.3e-05 Score=91.25 Aligned_cols=105 Identities=19% Similarity=0.309 Sum_probs=80.7
Q ss_pred HHHHHHHhccCCcccccccCCCchhhhHhHHHHHHHhcCCCCCCeEEEEEEEeecCCCCCCcccccCCCCCccccCCCCC
Q 010078 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRNSAVSSLLDSEVPAQRQSIHP 140 (518)
Q Consensus 61 ~~~l~~hf~rlp~~y~~d~~~~~~edvl~h~~ll~~a~~~~~~p~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (518)
.+++.++|++||.||-+--. ++++.-|-+++....++.. |.+-+|.-. . .+
T Consensus 650 ~~~~~~~~~~~~~~Y~l~~~---~~~I~~h~~~~~~~~~~~~-~~v~~~~~~---~---~~------------------- 700 (895)
T PRK00275 650 PDDAEQLWSQLGDDYFLRHT---AGDIAWHTEAILQHPDDGG-PLVLIKETT---Q---RE------------------- 700 (895)
T ss_pred HHHHHHHHHhCCcHHhcCCC---HHHHHHHHHHHHhcccCCC-CeEEEEecC---c---cC-------------------
Confidence 46678889999999999865 4599999999977644333 333222110 0 00
Q ss_pred CCCCCCChhhHHHhhhhcCCCCCCCCCcccccccccCcccceeeecCChhhHHHHHHHHHHhhcccceecccccCCCCce
Q 010078 141 PPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYS 220 (518)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~dg~~ 220 (518)
. +-.-||++.+.|+|+|++.++.+|+..|+||..|.+|+|.||+.
T Consensus 701 ---~--------------------------------~~~t~V~V~~~DrpgLFa~i~g~L~~~~lnI~~A~I~Tt~dg~a 745 (895)
T PRK00275 701 ---F--------------------------------EGGTQIFIYAPDQHDFFAATVAAMDQLNLNIHDARIITSSSQFT 745 (895)
T ss_pred ---C--------------------------------CCeEEEEEEeCCCCcHHHHHHHHHHHCCCeEEEEEEEEcCCCeE
Confidence 0 01229999999999999999999999999999999999999999
Q ss_pred eeEEEEcCC
Q 010078 221 LDVFVVDGW 229 (518)
Q Consensus 221 ldv~vvdgw 229 (518)
+|+|+|...
T Consensus 746 lD~F~V~d~ 754 (895)
T PRK00275 746 LDTYIVLDD 754 (895)
T ss_pred EEEEEEeCC
Confidence 999999643
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.08 E-value=3.9e-05 Score=88.96 Aligned_cols=143 Identities=16% Similarity=0.293 Sum_probs=90.8
Q ss_pred eeeeeecCceEEEEEEECC----ceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcc--eEEeecccCC---CCcce
Q 010078 297 GSKVASGSYGDLYRGTYCS----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNV--VQFIGACTKP---PSLCI 366 (518)
Q Consensus 297 ~~~LG~G~fG~Vy~g~~~~----~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnI--v~l~g~~~~~---~~~~l 366 (518)
.+.|+.|.++.+|+.+..+ ..+++|+........ ....+.+|+.+|+.+. |.++ .+++.+|.+. +..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~-~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ-SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc-cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 4678999999999987654 367777754332211 1346789999999996 6654 7888887764 45789
Q ss_pred eeeecCCCchhH--------------------H---HhhhcCC---C---------CHHHHHHHHH--------------
Q 010078 367 VTEFMSGGSVYD--------------------Y---LHKLKGV---F---------KLPSLLKVAI-------------- 397 (518)
Q Consensus 367 V~Ey~~ggsL~~--------------------~---l~~~~~~---l---------~~~~i~~i~~-------------- 397 (518)
||||++|..+.+ . ||..... + ...++..+..
T Consensus 122 VME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 201 (822)
T PLN02876 122 IMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRN 201 (822)
T ss_pred EEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCC
Confidence 999998865321 1 1111100 0 0112222211
Q ss_pred -HHHHHHHHHHH-----------CCceeccCCCCcEEEcCC--CcEEEEeeCcceec
Q 010078 398 -DVSKGMNYLHQ-----------NNIIHRDLKAANLLMDEN--EVVKVADFGVARVK 440 (518)
Q Consensus 398 -qIa~aL~yLHs-----------~gIiHrDLKp~NILid~~--~~vkL~DFGla~~~ 440 (518)
.+...+++|.. ..+||+|+++.||+++.+ ..+-|+||+++...
T Consensus 202 ~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 202 PKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 12234566643 249999999999999853 34689999987643
|
|
| >PRK03059 PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=98.06 E-value=3.6e-05 Score=89.26 Aligned_cols=102 Identities=26% Similarity=0.415 Sum_probs=80.0
Q ss_pred hHHHHHHHhccCCcccccccCCCchhhhHhHHHHHHHhcCCCCCCeEEEEEEEeecCCCCCCcccccCCCCCccccCCCC
Q 010078 60 FDDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRNSAVSSLLDSEVPAQRQSIH 139 (518)
Q Consensus 60 ~~~~l~~hf~rlp~~y~~d~~~~~~edvl~h~~ll~~a~~~~~~p~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (518)
=.+.+.++|.+||.+|-+-- .++++.-|-+++....+.. .|.+-+ ...+.
T Consensus 626 ~~~~~~~~~~~~~~~Yf~~~---~~~~I~~h~~~~~~~~~~~-~~~v~~---~~~~~----------------------- 675 (856)
T PRK03059 626 PDDAHEALWDQLDVGYFLRH---DAADIAWHTRHLYRHVDTD-TPIVRA---RLSPA----------------------- 675 (856)
T ss_pred CHHHHHHHHHhCChHHhccC---CHHHHHHHHHHHHhcccCC-CCeEEE---EecCC-----------------------
Confidence 34567889999999999875 4569999999997754322 233222 21100
Q ss_pred CCCCCCCChhhHHHhhhhcCCCCCCCCCcccccccccCcccceeeecCChhhHHHHHHHHHHhhcccceecccccCCCCc
Q 010078 140 PPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGY 219 (518)
Q Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~dg~ 219 (518)
+-.-||++.+.|+|+|+++++.+|+..|+||..|.+|+|.||+
T Consensus 676 -------------------------------------~~~~~v~i~~~d~~gLFa~i~g~l~~~~l~I~~A~i~t~~~g~ 718 (856)
T PRK03059 676 -------------------------------------GEGLQVMVYTPDQPDLFARICGYFDRAGFSILDARVHTTRHGY 718 (856)
T ss_pred -------------------------------------CCeEEEEEEecCCCcHHHHHHHHHHHCCCceeeeEEEEcCCCe
Confidence 0123999999999999999999999999999999999999999
Q ss_pred eeeEEEEcC
Q 010078 220 SLDVFVVDG 228 (518)
Q Consensus 220 ~ldv~vvdg 228 (518)
.+|+|.|..
T Consensus 719 ~ld~f~V~~ 727 (856)
T PRK03059 719 ALDTFQVLD 727 (856)
T ss_pred EEEEEEEeC
Confidence 999999953
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.05 E-value=0.00011 Score=70.60 Aligned_cols=127 Identities=19% Similarity=0.321 Sum_probs=90.6
Q ss_pred CCeeeeeeeeecCc-eEEEEEEECCceEEEEEecC---CC-------CCh---------HHHHHHHHHHHHHHhcC---C
Q 010078 292 KHLKFGSKVASGSY-GDLYRGTYCSQDVAIKVLKP---ER-------INS---------DMQKEFAQEVFIMRKVR---H 348 (518)
Q Consensus 292 ~~~~i~~~LG~G~f-G~Vy~g~~~~~~vAVKvlk~---~~-------~~~---------~~~~~~~~Ei~iL~~L~---H 348 (518)
.++++++.||.|.- |.||+.+..|+.+|+|+.+. .. ... ....-|..|.+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 78899999999999 99999999999999999331 10 000 12345777887766665 4
Q ss_pred Ccc--eEEeecccCC------------------CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHH
Q 010078 349 KNV--VQFIGACTKP------------------PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408 (518)
Q Consensus 349 pnI--v~l~g~~~~~------------------~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs 408 (518)
.++ |+.+|+..-. ....||.||++... .+.. +-+.+|.+-|..+|+
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~----~~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQI----RDIPQMLRDLKILHK 182 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccch----hHHHHHHHHHHHHHH
Confidence 566 8999876211 12357888776533 1222 234566777889999
Q ss_pred CCceeccCCCCcEEEcCCCcEEEEeeCcc
Q 010078 409 NNIIHRDLKAANLLMDENEVVKVADFGVA 437 (518)
Q Consensus 409 ~gIiHrDLKp~NILid~~~~vkL~DFGla 437 (518)
.||+-+|+++.|.. + -+|+|||.+
T Consensus 183 ~gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred CCeeeccCcccccc---C--CEEEecccC
Confidence 99999999999987 3 388999965
|
|
| >cd04925 ACT_ACR_2 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=98.03 E-value=1.5e-05 Score=64.14 Aligned_cols=46 Identities=39% Similarity=0.525 Sum_probs=41.8
Q ss_pred eeeecCChhhHHHHHHHHHHhhcccceecccccCCCCceeeEEEEcC
Q 010078 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDG 228 (518)
Q Consensus 182 i~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~dg~~ldv~vvdg 228 (518)
|.+.+.|+|+|+..++.+|++.|+||..|+++ |.+|+.+|+|.|..
T Consensus 3 ~~v~~~Dr~gLl~~i~~~l~~~~lnI~~A~i~-t~~~~~~d~f~V~d 48 (74)
T cd04925 3 IELTGTDRPGLLSEVFAVLADLHCNVVEARAW-THNGRLACVIYVRD 48 (74)
T ss_pred EEEEECCCCCHHHHHHHHHHHCCCcEEEEEEE-EECCEEEEEEEEEc
Confidence 46678899999999999999999999999999 55999999999853
|
This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.98 E-value=5.1e-05 Score=74.48 Aligned_cols=73 Identities=15% Similarity=0.218 Sum_probs=46.6
Q ss_pred eeeeecCce-EEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCC---cceEEeecccCC---CCcceeeee
Q 010078 298 SKVASGSYG-DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK---NVVQFIGACTKP---PSLCIVTEF 370 (518)
Q Consensus 298 ~~LG~G~fG-~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~Hp---nIv~l~g~~~~~---~~~~lV~Ey 370 (518)
+.|+.|+.. .||+. +..+++|+.+... ....+.+|..+|+.+... .+..+++..... ...+++|++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 456766665 58874 3567788755321 234688899999888632 345555544332 234889999
Q ss_pred cCCCchh
Q 010078 371 MSGGSVY 377 (518)
Q Consensus 371 ~~ggsL~ 377 (518)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9987664
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK05007 PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=97.98 E-value=6.6e-05 Score=87.45 Aligned_cols=117 Identities=24% Similarity=0.381 Sum_probs=87.3
Q ss_pred HHHHHHHhccCCcccccccCCCchhhhHhHHHHHHHhcCCCCCCeEEEEEEEeecCCCCCCcccccCCCCCccccCCCCC
Q 010078 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRNSAVSSLLDSEVPAQRQSIHP 140 (518)
Q Consensus 61 ~~~l~~hf~rlp~~y~~d~~~~~~edvl~h~~ll~~a~~~~~~p~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (518)
.+++.++|.++|.+|-+-- .++++.-|-+++..+.. ..|.+.++. .+ .
T Consensus 651 ~~~~~~~~~~~~~~yf~~~---~~~~I~~h~~~~~~~~~--~~p~V~i~~---~~-----~------------------- 698 (884)
T PRK05007 651 EEALHQIWSRCRADYFLRH---TPNQLAWHARHLLQHDL--DKPLVLLSK---QA-----T------------------- 698 (884)
T ss_pred HHHHHHHHHhCChHHhcCC---CHHHHHHHHHHHHhccC--CCCeEEEEe---cC-----C-------------------
Confidence 4567789999999999875 45699999999977642 334433211 10 0
Q ss_pred CCCCCCChhhHHHhhhhcCCCCCCCCCcccccccccCcccceeeecCChhhHHHHHHHHHHhhcccceecccccCCCCce
Q 010078 141 PPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYS 220 (518)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~dg~~ 220 (518)
...-+|++.+.|+|+|+++++.+|+..|+||..|.+|++.||+.
T Consensus 699 ------------------------------------~~~t~V~V~a~DrpGLfa~Ia~~La~~~L~I~~A~I~T~~dg~a 742 (884)
T PRK05007 699 ------------------------------------RGGTEIFIWSPDRPYLFAAVCAELDRRNLSVHDAQIFTSRDGMA 742 (884)
T ss_pred ------------------------------------CCeEEEEEEecCCcCHHHHHHHHHHHCCCEEEEEEEEEcCCCeE
Confidence 01239999999999999999999999999999999999999999
Q ss_pred eeEEEEcCCC-----hhhHHHHHHHHHHHH
Q 010078 221 LDVFVVDGWP-----YEETEQLRAALEKEV 245 (518)
Q Consensus 221 ldv~vvdgw~-----~e~~~~l~~~l~~~~ 245 (518)
+|+|.|.... .+..+.+++.|.+.+
T Consensus 743 lD~F~V~d~~g~~~~~~~~~~I~~~L~~aL 772 (884)
T PRK05007 743 MDTFIVLEPDGSPLSQDRHQVIRKALEQAL 772 (884)
T ss_pred EEEEEEECCCCCCCCHHHHHHHHHHHHHHH
Confidence 9999995432 123344555555555
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.92 E-value=1.6e-06 Score=94.97 Aligned_cols=95 Identities=20% Similarity=0.389 Sum_probs=74.8
Q ss_pred HHHHHHHHHHHHC-CceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc----------cccCCCCCcccCchhccCCC
Q 010078 397 IDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV----------MTAETGTYRWMAPEVIEHKP 465 (518)
Q Consensus 397 ~qIa~aL~yLHs~-gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~----------~~~~~gt~~y~APEvl~~~~ 465 (518)
.+++.||.|+|.. ++||++|.|++|.++.++..||+.|+++........ ........-|.|||++.+..
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 3444899999965 999999999999999999999999998754333111 11113456799999999988
Q ss_pred CChhhHHHHHHHHHHHHHc-CCCCCCC
Q 010078 466 YDHKADVFSFGIVLWELLT-GKLPYEY 491 (518)
Q Consensus 466 ~s~ksDVwSlGviL~eLlt-G~~Pf~~ 491 (518)
-+.++|+||+|+++|.+.. |+.-+..
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a 212 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAA 212 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhc
Confidence 8999999999999999994 6655543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00017 Score=69.40 Aligned_cols=133 Identities=22% Similarity=0.393 Sum_probs=94.1
Q ss_pred eeeeecCceEEEEEEECCceEEEEEecCCC--------------CChHHHHHHHHHHHHHHhcC------CCcceEEeec
Q 010078 298 SKVASGSYGDLYRGTYCSQDVAIKVLKPER--------------INSDMQKEFAQEVFIMRKVR------HKNVVQFIGA 357 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~--------------~~~~~~~~~~~Ei~iL~~L~------HpnIv~l~g~ 357 (518)
..||+|+.-.||.-- .+...+||+.++.. ......+++.+|+.....+. +..|.+++|.
T Consensus 7 ~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 468999999999633 34457899988765 00112355666766666665 7889999999
Q ss_pred ccCCCCcceeeeecCC------CchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC----
Q 010078 358 CTKPPSLCIVTEFMSG------GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---- 427 (518)
Q Consensus 358 ~~~~~~~~lV~Ey~~g------gsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~---- 427 (518)
...+.-..+|+|.+.. .+|.+++.. +.++. .+ ...+-.-.+||-+++|+.+|++|.||++..++
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~ 159 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEF 159 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCce
Confidence 9888888999998743 378888854 44554 33 33344456788999999999999999996432
Q ss_pred cEEEEe-eCcc
Q 010078 428 VVKVAD-FGVA 437 (518)
Q Consensus 428 ~vkL~D-FGla 437 (518)
.+.|+| ||..
T Consensus 160 ~lvlIDG~G~~ 170 (199)
T PF10707_consen 160 RLVLIDGLGEK 170 (199)
T ss_pred EEEEEeCCCCc
Confidence 577777 4543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR01693 UTase_glnD [Protein-PII] uridylyltransferase | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00011 Score=85.61 Aligned_cols=119 Identities=22% Similarity=0.270 Sum_probs=88.1
Q ss_pred HHHHHHHhccCCcccccccCCCchhhhHhHHHHHHHhcCCCCCCeEEEEEEEeecCCCCCCcccccCCCCCccccCCCCC
Q 010078 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRNSAVSSLLDSEVPAQRQSIHP 140 (518)
Q Consensus 61 ~~~l~~hf~rlp~~y~~d~~~~~~edvl~h~~ll~~a~~~~~~p~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (518)
.+++..++.++|.||-+-..+ +++.-|-+++..+.+..+ |.+.+. . . .
T Consensus 617 ~~~~~~~~~~~~~~y~~~~~~---~~I~~h~~~~~~~~~~~~-~~v~~~--~---~----~------------------- 664 (850)
T TIGR01693 617 SNEAEVLWLRAYDDYFLRFTH---KEIAWHAESLRRALSSGG-PLALID--G---T----R------------------- 664 (850)
T ss_pred HHHHHHHHHhCCchhhcCCCH---HHHHHHHHHHHhcccCCC-CEEEEe--c---c----C-------------------
Confidence 455778899999999998765 599999999987644222 222111 0 0 0
Q ss_pred CCCCCCChhhHHHhhhhcCCCCCCCCCcccccccccCcccceeeecCChhhHHHHHHHHHHhhcccceecccccCCCCce
Q 010078 141 PPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYS 220 (518)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~dg~~ 220 (518)
....-+|++.+.|+|+|+++++.+|+..|+||..|++|+|.+|+.
T Consensus 665 -----------------------------------~~~~t~i~V~~~DrpgLla~i~~~L~~~~l~I~~A~I~tt~~g~~ 709 (850)
T TIGR01693 665 -----------------------------------PSGGTEVFIYAPDQPGLFAKVAGALAMLSLSVHDAQVNTTKDGVA 709 (850)
T ss_pred -----------------------------------CCCeEEEEEEeCCCCcHHHHHHHHHHHCCCeEEEEEEEEecCCEE
Confidence 011339999999999999999999999999999999999999999
Q ss_pred eeEEEEcCCCh------hhHHHHHHHHHHHHH
Q 010078 221 LDVFVVDGWPY------EETEQLRAALEKEVL 246 (518)
Q Consensus 221 ldv~vvdgw~~------e~~~~l~~~l~~~~~ 246 (518)
+|+|.|..... +..+.++++|...+.
T Consensus 710 lD~F~V~~~~g~~~~~~~~~~~i~~~L~~~L~ 741 (850)
T TIGR01693 710 LDTFVVQDLFGSPPAAERVFQELLQGLVDVLA 741 (850)
T ss_pred EEEEEEECCCCCCCCcHHHHHHHHHHHHHHHc
Confidence 99999964331 124456666666553
|
This model describes GlnD, the uridylyltransferase/uridylyl-removing enzyme for the nitrogen regulatory protein PII. Not all homologs of PII share the property of uridylyltransferase modification on the characteristic Tyr residue (see Prosite pattern PS00496 and document PDOC00439), but the modification site is preserved in the PII homolog of all species with a member of this family. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.86 E-value=5.3e-05 Score=72.28 Aligned_cols=99 Identities=17% Similarity=0.306 Sum_probs=80.3
Q ss_pred HHHHHHHHhcCC-CcceEEeecccCCCCcceeeeecCCCchhHH---HhhhcCCCCHHHHHHHHHHHHHHHHHHHH---C
Q 010078 337 AQEVFIMRKVRH-KNVVQFIGACTKPPSLCIVTEFMSGGSVYDY---LHKLKGVFKLPSLLKVAIDVSKGMNYLHQ---N 409 (518)
Q Consensus 337 ~~Ei~iL~~L~H-pnIv~l~g~~~~~~~~~lV~Ey~~ggsL~~~---l~~~~~~l~~~~i~~i~~qIa~aL~yLHs---~ 409 (518)
..|.-+|+.+.+ +++++++|+|.. ++++||...++++.. +.. -...++....+|+.+++..+++|+. .
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 358889999986 699999999964 678999987766421 111 1235889999999999999999997 3
Q ss_pred CceeccCCCCcEEEcCCCcEEEEeeCcceec
Q 010078 410 NIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 410 gIiHrDLKp~NILid~~~~vkL~DFGla~~~ 440 (518)
.+.-.|++++|+-++.+|.+|++|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 5888999999999999999999999877544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00043 Score=70.78 Aligned_cols=76 Identities=14% Similarity=0.125 Sum_probs=57.1
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC---CcceEEeecccC---CCCcceeeee
Q 010078 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH---KNVVQFIGACTK---PPSLCIVTEF 370 (518)
Q Consensus 297 ~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~H---pnIv~l~g~~~~---~~~~~lV~Ey 370 (518)
.+.||.|..+.||+....+..+.+|+.+... . ...+..|...|+.|.. -.++++++.|.. .+..++|||+
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~-~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGNPMPLMARSFS-T---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeecCCccceeEEEEEcCCCCEEEEEecccc-c---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 4579999999999988766678888865311 1 2468889999998863 357888887754 3557999999
Q ss_pred cCCCch
Q 010078 371 MSGGSV 376 (518)
Q Consensus 371 ~~ggsL 376 (518)
++|.++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >PRK01759 glnD PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.0002 Score=83.19 Aligned_cols=117 Identities=23% Similarity=0.353 Sum_probs=85.7
Q ss_pred hHHHHHHHhccCCcccccccCCCchhhhHhHHHHHHHhcCCCCCCeEEEEEEEeecCCCCCCcccccCCCCCccccCCCC
Q 010078 60 FDDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRNSAVSSLLDSEVPAQRQSIH 139 (518)
Q Consensus 60 ~~~~l~~hf~rlp~~y~~d~~~~~~edvl~h~~ll~~a~~~~~~p~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (518)
=.+.+.++|+++|.+|-+- ..+|+++-|-+++..... .|.+.+ ... .
T Consensus 627 ~~~~~~~~~~~~~~~yf~~---~~~~~I~~h~~~~~~~~~---~~~V~i-----~~~----~------------------ 673 (854)
T PRK01759 627 SETQIEQLWQRCPEDYFLR---NTPKQIAWHALLLLDFRG---DLLVKI-----SNR----F------------------ 673 (854)
T ss_pred CHHHHHHHHHhCCcHHhcC---CCHHHHHHHHHHHHhcCC---CCEEEE-----Eec----C------------------
Confidence 3456788999999999995 466799999999865432 233221 100 0
Q ss_pred CCCCCCCChhhHHHhhhhcCCCCCCCCCcccccccccCcccceeeecCChhhHHHHHHHHHHhhcccceecccccCCCCc
Q 010078 140 PPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGY 219 (518)
Q Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~dg~ 219 (518)
+ ...-+|++.+.|+|+|+++++.+|+..|+||..|.+|+|.+|+
T Consensus 674 ------------------~------------------~~~t~V~V~~~DrpGLfa~Ia~~L~~~~L~I~~A~I~T~~~g~ 717 (854)
T PRK01759 674 ------------------S------------------RGGTEIFIYCQDQANLFLKVVSTIGAKKLSIHDAQIITSQDGY 717 (854)
T ss_pred ------------------C------------------CCeEEEEEEecCCccHHHHHHHHHHHCCCeEEEEEEEEccCCE
Confidence 0 0123999999999999999999999999999999999999999
Q ss_pred eeeEEEEcCCC---h--hhHHHHHHHHHHHH
Q 010078 220 SLDVFVVDGWP---Y--EETEQLRAALEKEV 245 (518)
Q Consensus 220 ~ldv~vvdgw~---~--e~~~~l~~~l~~~~ 245 (518)
.+|+|.|.... . +..+.++++|.+.+
T Consensus 718 alD~F~V~d~~g~~~~~~~~~~l~~~L~~aL 748 (854)
T PRK01759 718 VLDSFIVTELNGKLLEFDRRRQLEQALTKAL 748 (854)
T ss_pred EEEEEEEeCCCCCCCCHHHHHHHHHHHHHHH
Confidence 99999995332 2 23334555555554
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.69 E-value=3.2e-05 Score=78.68 Aligned_cols=134 Identities=19% Similarity=0.289 Sum_probs=95.5
Q ss_pred eeeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCC-------hH-----------H--HHHHHHHHHHHHhcCC--Cc
Q 010078 294 LKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERIN-------SD-----------M--QKEFAQEVFIMRKVRH--KN 350 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~~-~~~vAVKvlk~~~~~-------~~-----------~--~~~~~~Ei~iL~~L~H--pn 350 (518)
+.++++||-|.-+.||.+-+. |++.++|+.+..+.. .+ . +-...+|...|+.|.. --
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 345788999999999998875 888998875432211 10 0 1234568888888863 23
Q ss_pred ceEEeecccCCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEE
Q 010078 351 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK 430 (518)
Q Consensus 351 Iv~l~g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vk 430 (518)
+++.++. ...|+|||++.|..|....+- .+.+. +...+..-+--|..+|+||+|..-=||+|++++.++
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v----~d~~~---ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVRHV----EDPPT---LYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeeeec----CChHH---HHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 4555543 346999999999887765432 22233 444555566778899999999999999999999999
Q ss_pred EEeeCcce
Q 010078 431 VADFGVAR 438 (518)
Q Consensus 431 L~DFGla~ 438 (518)
++||-.+-
T Consensus 243 vIDFPQmv 250 (465)
T KOG2268|consen 243 VIDFPQMV 250 (465)
T ss_pred EeechHhh
Confidence 99998764
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00051 Score=67.04 Aligned_cols=72 Identities=13% Similarity=0.193 Sum_probs=48.2
Q ss_pred eeeeecCceEEEEEEEC---CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCc-ceEEeecccCCCCcceeeeecCC
Q 010078 298 SKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN-VVQFIGACTKPPSLCIVTEFMSG 373 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~---~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Iv~l~g~~~~~~~~~lV~Ey~~g 373 (518)
+.|..|-...+|+.+.. ++.|++|+....... .....+|+.+++.+...+ .+++++.+. -.++|||++|
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G 76 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPG 76 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCC
Confidence 56788889999998865 467999986643211 122346888888886433 445554433 2479999998
Q ss_pred Cch
Q 010078 374 GSV 376 (518)
Q Consensus 374 gsL 376 (518)
.++
T Consensus 77 ~~l 79 (235)
T cd05157 77 RTL 79 (235)
T ss_pred CcC
Confidence 765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00052 Score=68.20 Aligned_cols=135 Identities=14% Similarity=0.137 Sum_probs=80.4
Q ss_pred eeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcc-eEEeecccCCCCcceeeeecCCCchh
Q 010078 299 KVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCIVTEFMSGGSVY 377 (518)
Q Consensus 299 ~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~g~~~~~~~~~lV~Ey~~ggsL~ 377 (518)
.+..|-.+.+|+.+..+..+++|+...... .......+|..+++.+....+ .++++.+. -++||||++|..+.
T Consensus 3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~~--~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHPGISFVWRPQSPVCK--ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred cCCCcCcCCeEEEEeCCccEEEeeCCcccc--cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 345688889999988888899998553211 110134678888888874333 44554432 37899999987653
Q ss_pred HH-----------------Hhhhc---CCCCHH-HHHHHHHHH---------HHHHHHHHH--------CCceeccCCCC
Q 010078 378 DY-----------------LHKLK---GVFKLP-SLLKVAIDV---------SKGMNYLHQ--------NNIIHRDLKAA 419 (518)
Q Consensus 378 ~~-----------------l~~~~---~~l~~~-~i~~i~~qI---------a~aL~yLHs--------~gIiHrDLKp~ 419 (518)
.. +|... .+++.. .+..+..++ ...+..+-. ..++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 21 11111 111111 111221111 111222222 24899999999
Q ss_pred cEEEcCCCcEEEEeeCcceec
Q 010078 420 NLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 420 NILid~~~~vkL~DFGla~~~ 440 (518)
||+++.++ +.|+||+.+...
T Consensus 157 Nil~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred cEEEeCCC-CEEEeccccCcC
Confidence 99999877 789999988643
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd04897 ACT_ACR_3 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00041 Score=56.00 Aligned_cols=64 Identities=22% Similarity=0.309 Sum_probs=50.5
Q ss_pred eeeecCChhhHHHHHHHHHHhhcccceecccccCCCCceeeEEEE---cCCC---hhhHHHHHHHHHHHHH
Q 010078 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWP---YEETEQLRAALEKEVL 246 (518)
Q Consensus 182 i~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~dg~~ldv~vv---dgw~---~e~~~~l~~~l~~~~~ 246 (518)
|.+.+.|+|+||..+...|.++|++|.-|++-. ..+...|+|-| +|.+ .+..+.++++|...+.
T Consensus 4 veV~~~DRpGLL~~i~~~l~~~~l~I~~A~I~T-~gera~D~FyV~d~~g~kl~~~~~~~~l~~~L~~al~ 73 (75)
T cd04897 4 VTVQCRDRPKLLFDVVCTLTDMDYVVFHATIDT-DGDDAHQEYYIRHKDGRTLSTEGERQRVIKCLEAAIE 73 (75)
T ss_pred EEEEeCCcCcHHHHHHHHHHhCCeEEEEEEEee-cCceEEEEEEEEcCCCCccCCHHHHHHHHHHHHHHHh
Confidence 567899999999999999999999999998755 45689999998 4433 3445667777776654
|
This CD includes the third ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0012 Score=66.92 Aligned_cols=138 Identities=18% Similarity=0.198 Sum_probs=85.6
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCc--ceEEeecc------cCCCCcceee
Q 010078 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--VVQFIGAC------TKPPSLCIVT 368 (518)
Q Consensus 297 ~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Iv~l~g~~------~~~~~~~lV~ 368 (518)
.+.|..|....+|+....+..+++|+... .. ...+..|+.+++.+.+.+ +++++... ...+..++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~--~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK--VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC--CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 45677888889999887778899998764 11 244667888888885432 45554421 2234568899
Q ss_pred eecCCCchhH----H----------HhhhcCCCCH--------HHHH------------HHHHHHHHHHHHHHH------
Q 010078 369 EFMSGGSVYD----Y----------LHKLKGVFKL--------PSLL------------KVAIDVSKGMNYLHQ------ 408 (518)
Q Consensus 369 Ey~~ggsL~~----~----------l~~~~~~l~~--------~~i~------------~i~~qIa~aL~yLHs------ 408 (518)
+|++|..+.. . ++.....+.. .... .....+..++.++.+
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999876532 0 1111111100 0000 011112334444443
Q ss_pred -CCceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 409 -NNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 409 -~gIiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
.+++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999887789999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0014 Score=66.92 Aligned_cols=138 Identities=21% Similarity=0.259 Sum_probs=83.6
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCC--cceEEeeccc------CCCCcceee
Q 010078 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK--NVVQFIGACT------KPPSLCIVT 368 (518)
Q Consensus 297 ~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIv~l~g~~~------~~~~~~lV~ 368 (518)
.+.++.|....+|+.+..+..+++|+.+.... ......|+.+++.|... .+++++.... ..+..++++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~----~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRVK----AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred ccccCCccccceEEEEeCCCcEEEEEecCCCC----HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 45678888888999876667788998764321 13345567777777532 2445544321 234568999
Q ss_pred eecCCCchh-----------HH---HhhhcCCC--------CHHHHH---------------HHHHHHHHHHHHHHH---
Q 010078 369 EFMSGGSVY-----------DY---LHKLKGVF--------KLPSLL---------------KVAIDVSKGMNYLHQ--- 408 (518)
Q Consensus 369 Ey~~ggsL~-----------~~---l~~~~~~l--------~~~~i~---------------~i~~qIa~aL~yLHs--- 408 (518)
+|++|..+. .. ++.....+ ...... .....+.+.++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 999885432 11 12111111 011100 001123345555543
Q ss_pred ----CCceeccCCCCcEEEcCCCcEEEEeeCcce
Q 010078 409 ----NNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (518)
Q Consensus 409 ----~gIiHrDLKp~NILid~~~~vkL~DFGla~ 438 (518)
.+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 589999999999999988877899999885
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.002 Score=66.11 Aligned_cols=138 Identities=16% Similarity=0.220 Sum_probs=77.6
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCc--ceEEeec------ccCCCCcceee
Q 010078 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--VVQFIGA------CTKPPSLCIVT 368 (518)
Q Consensus 297 ~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Iv~l~g~------~~~~~~~~lV~ 368 (518)
.+.|+.|....+|+.+..+..+++|+.. . ... .....|+.+++.|...+ +.+.+.. ....+..++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g~~vLK~~~-~-~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~ 101 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQGEYVLTLFE-R-LTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV 101 (319)
T ss_pred cchhccccccceEEEEeCCCcEEEEEec-c-CCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence 3467778888999988777789999876 2 222 23334556666554222 3343321 12234568999
Q ss_pred eecCCCchh-----------HHH---hhhcCCC--------CH---HHH-HH-----------HHHH-HHHHHHHHH---
Q 010078 369 EFMSGGSVY-----------DYL---HKLKGVF--------KL---PSL-LK-----------VAID-VSKGMNYLH--- 407 (518)
Q Consensus 369 Ey~~ggsL~-----------~~l---~~~~~~l--------~~---~~i-~~-----------i~~q-Ia~aL~yLH--- 407 (518)
+|++|..+. ..+ +.....+ .. ... .+ .+.+ +...++.+.
T Consensus 102 ~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 181 (319)
T PRK05231 102 TFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA 181 (319)
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence 999887431 111 1111111 10 010 00 1111 111223332
Q ss_pred ----HCCceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 408 ----QNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 408 ----s~gIiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
..++||+|+.+.||+++.+...-|+||+.+..
T Consensus 182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 23899999999999999776668999998853
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0039 Score=66.31 Aligned_cols=76 Identities=13% Similarity=0.003 Sum_probs=53.2
Q ss_pred eeeeecCceEEEEEEECCc--eEEEEEecCCCC-----ChHHHHHHHHHHHHHHhcC---CCcceEEeecccCCCCccee
Q 010078 298 SKVASGSYGDLYRGTYCSQ--DVAIKVLKPERI-----NSDMQKEFAQEVFIMRKVR---HKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~~~--~vAVKvlk~~~~-----~~~~~~~~~~Ei~iL~~L~---HpnIv~l~g~~~~~~~~~lV 367 (518)
+.||.|.++.||+.+..+. .++||.-.+... ..-...++..|...|+.+. ..++++++.+.. ...++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence 5789999999999988653 799998542211 1123456777888888764 246777887643 557899
Q ss_pred eeecCCCc
Q 010078 368 TEFMSGGS 375 (518)
Q Consensus 368 ~Ey~~ggs 375 (518)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99997643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00082 Score=77.99 Aligned_cols=153 Identities=20% Similarity=0.241 Sum_probs=120.1
Q ss_pred HHHHHHHHHHhcCCCcceEEeecccCCCC----cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 010078 335 EFAQEVFIMRKVRHKNVVQFIGACTKPPS----LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 410 (518)
Q Consensus 335 ~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~----~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~g 410 (518)
...-|+..+.++.|+|++.++.+...... ..+..+++.+.++...++. .+.++...++.+..++.+|+.|+|+..
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 34457778888999999999987654432 3345688888888888876 677889999999999999999999997
Q ss_pred ceeccCCCC---cEEEcCCCcEEEE--eeCcceecccCCccccCCCCCcccCchhccCCCCChh--hHHHHHHHHHHHHH
Q 010078 411 IIHRDLKAA---NLLMDENEVVKVA--DFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK--ADVFSFGIVLWELL 483 (518)
Q Consensus 411 IiHrDLKp~---NILid~~~~vkL~--DFGla~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~k--sDVwSlGviL~eLl 483 (518)
..|.-|..+ +..++..+.+.+. ||+..+.............+..|.+||....+.+..+ .|+|.+|..+..+.
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~ 386 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLS 386 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhh
Confidence 777666555 5555666777777 9998887777766666667778889999887776655 79999999999999
Q ss_pred cCCCC
Q 010078 484 TGKLP 488 (518)
Q Consensus 484 tG~~P 488 (518)
.|..+
T Consensus 387 ~~~~i 391 (1351)
T KOG1035|consen 387 QGEDI 391 (1351)
T ss_pred hcCcc
Confidence 87643
|
|
| >cd04896 ACT_ACR-like_3 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.00079 Score=54.33 Aligned_cols=64 Identities=20% Similarity=0.203 Sum_probs=50.1
Q ss_pred eeeecCChhhHHHHHHHHHHhhcccceeccccc-CCCCceeeEEEEcCCC-----hhhHHHHHHHHHHHH
Q 010078 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFS-TVDGYSLDVFVVDGWP-----YEETEQLRAALEKEV 245 (518)
Q Consensus 182 i~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fs-t~dg~~ldv~vvdgw~-----~e~~~~l~~~l~~~~ 245 (518)
|-+.+.|+|+||..+..++.++|++|+-|++-+ |..+...|+|.||..+ ++..+.|+++|.+.+
T Consensus 3 lev~a~DRpGLL~~i~~~l~~~~l~i~~AkI~~~T~Gerv~D~Fyv~~~g~kl~d~~~~~~L~~~L~~~l 72 (75)
T cd04896 3 LQIRCVDQKGLLYDILRTSKDCNIQISYGRFSSKVKGYREVDLFIVQSDGKKIMDPKKQAALCARLREEM 72 (75)
T ss_pred EEEEeCCcccHHHHHHHHHHHCCeEEEEEEEecCcccCEEEEEEEEeCCCCccCCHHHHHHHHHHHHHHh
Confidence 456788999999999999999999999999875 5555667999998655 334556666666554
|
This CD includes the third ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) have been described, however, the ACR-like sequences in this CD are distinct from those characterized. This CD includes the Oryza sativa ACR-like protein (Os05g0113000) encoded on chromosome 5 and the Arabidopsis thaliana predicted gene product, At2g39570. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >cd04926 ACT_ACR_4 C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.00065 Score=54.27 Aligned_cols=47 Identities=26% Similarity=0.467 Sum_probs=43.2
Q ss_pred ceeeecCChhhHHHHHHHHHHhhcccceecccccCCCCceeeEEEEcC
Q 010078 181 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDG 228 (518)
Q Consensus 181 ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~dg~~ldv~vvdg 228 (518)
+|++.+.|+|.+|.+++.+|++.|+||..|.+|.+ +|+.+|+|.|..
T Consensus 3 ri~V~~~D~~Gll~~i~~~l~~~~lnI~sa~i~t~-~~~~~d~f~v~~ 49 (72)
T cd04926 3 RLELRTEDRVGLLSDVTRVFRENGLTVTRAEISTQ-GDMAVNVFYVTD 49 (72)
T ss_pred EEEEEECCccCHHHHHHHHHHHCCcEEEEEEEecC-CCeEEEEEEEEC
Confidence 78899999999999999999999999999999855 889999999854
|
This CD includes the C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.00012 Score=86.28 Aligned_cols=186 Identities=11% Similarity=0.099 Sum_probs=127.7
Q ss_pred eEEEEEEECCce---EEEEEecCC---CCChHHHHHHHHHHHHHHhcCCCcceEEeecccC--CCCcceeeeecCCCchh
Q 010078 306 GDLYRGTYCSQD---VAIKVLKPE---RINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPSLCIVTEFMSGGSVY 377 (518)
Q Consensus 306 G~Vy~g~~~~~~---vAVKvlk~~---~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~--~~~~~lV~Ey~~ggsL~ 377 (518)
+..+++++.+.. ..+|+.+.. ...+...+....|...++...|+++...+.-... ....|..++|+.+|.+.
T Consensus 1240 ~~~~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f 1319 (2724)
T KOG1826|consen 1240 HFHFRNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLF 1319 (2724)
T ss_pred ceeeccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHH
Confidence 334566554332 455565532 1122333445566667777889988776654433 23468999999999999
Q ss_pred HHHhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC-C----ceeccCCCCcEEEcCCCcEEEEeeCcceec-ccCCcccc
Q 010078 378 DYLHKLKG---VFKLPSLLKVAIDVSKGMNYLHQN-N----IIHRDLKAANLLMDENEVVKVADFGVARVK-AQSGVMTA 448 (518)
Q Consensus 378 ~~l~~~~~---~l~~~~i~~i~~qIa~aL~yLHs~-g----IiHrDLKp~NILid~~~~vkL~DFGla~~~-~~~~~~~~ 448 (518)
+.+-+... .+....+.....+......-+|+. | -+|++||+-|.+|..+-.+++.++|+.+.. ........
T Consensus 1320 ~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl 1399 (2724)
T KOG1826|consen 1320 SIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGL 1399 (2724)
T ss_pred HHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhh
Confidence 99865322 233333333334434555555543 2 689999999999999999999999999833 33333445
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
..+++.|+.|++.++-.++.++|+|..|+.+|+...|..+|..
T Consensus 1400 ~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~ 1442 (2724)
T KOG1826|consen 1400 ELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIF 1442 (2724)
T ss_pred hhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHH
Confidence 6778899999999999999999999999999999888877654
|
|
| >cd04895 ACT_ACR_1 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.00083 Score=53.78 Aligned_cols=47 Identities=30% Similarity=0.467 Sum_probs=40.9
Q ss_pred eeeecCChhhHHHHHHHHHHhhcccceecccccCCCCceeeEEEEcCC
Q 010078 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGW 229 (518)
Q Consensus 182 i~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~dg~~ldv~vvdgw 229 (518)
|.+.+.|+|+||..++.+|.++|++|+-|++ +|-.+...|+|-|..-
T Consensus 4 iev~a~DRpGLL~~i~~~l~~~gl~I~~AkI-sT~Gerv~DvFyV~d~ 50 (72)
T cd04895 4 VKVDSARKPGILLEAVQVLTDLDLCITKAYI-SSDGGWFMDVFHVTDQ 50 (72)
T ss_pred EEEEECCcCCHHHHHHHHHHHCCcEEEEEEE-eecCCeEEEEEEEECC
Confidence 4578899999999999999999999999987 5666799999999543
|
This CD includes the N-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0042 Score=63.99 Aligned_cols=144 Identities=19% Similarity=0.343 Sum_probs=88.3
Q ss_pred eeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC--CcceEEeecccCCC--CcceeeeecCC
Q 010078 298 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGACTKPP--SLCIVTEFMSG 373 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~H--pnIv~l~g~~~~~~--~~~lV~Ey~~g 373 (518)
+.+-.|....+|+....++.++++ ...............+|..+++.+.- --+...++.|.... ..+.||+|++|
T Consensus 31 ~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veG 109 (321)
T COG3173 31 EEISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEG 109 (321)
T ss_pred eeccCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecc
Confidence 344445555677766668888888 33222233445667788888888763 23456677777665 67999999988
Q ss_pred Cchh------------------HHHhhh---c-------C---CCCHHHHHHHHHH--------------HHHHHHHHHH
Q 010078 374 GSVY------------------DYLHKL---K-------G---VFKLPSLLKVAID--------------VSKGMNYLHQ 408 (518)
Q Consensus 374 gsL~------------------~~l~~~---~-------~---~l~~~~i~~i~~q--------------Ia~aL~yLHs 408 (518)
..+. ++|... . + .....++..+..+ ......+|+.
T Consensus 110 e~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~ 189 (321)
T COG3173 110 EVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEA 189 (321)
T ss_pred eeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHh
Confidence 3222 222110 0 0 0111122222211 2233456654
Q ss_pred C--------CceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 409 N--------NIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 409 ~--------gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
+ .++|+|+.+.||+++.++-+-|+||+++.+.+.
T Consensus 190 ~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 190 NRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred cCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 3 489999999999999998899999999876554
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0019 Score=65.67 Aligned_cols=73 Identities=15% Similarity=0.322 Sum_probs=48.1
Q ss_pred eeeeecCceEEEEEEEC--------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcc-eEEeecccCCCCcceee
Q 010078 298 SKVASGSYGDLYRGTYC--------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCIVT 368 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~--------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~g~~~~~~~~~lV~ 368 (518)
+.|..|-...+|+.+.. ++.+++|+...... ......+|..+++.+...++ .++++++.. .+|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~ 76 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE---LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIE 76 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc---ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchh
Confidence 45666778889988765 36799999664321 12345678888888864333 456655542 4689
Q ss_pred eecCCCchh
Q 010078 369 EFMSGGSVY 377 (518)
Q Consensus 369 Ey~~ggsL~ 377 (518)
||++|.++.
T Consensus 77 e~i~G~~l~ 85 (302)
T cd05156 77 EFIPSRTLT 85 (302)
T ss_pred heeCCCcCC
Confidence 999887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0028 Score=65.88 Aligned_cols=137 Identities=17% Similarity=0.210 Sum_probs=89.4
Q ss_pred eeeecCceEEEEEEE-CCceEEEEEecCCCC----------------------C-hHHHHH-HHHHHHHHHhcCCCcceE
Q 010078 299 KVASGSYGDLYRGTY-CSQDVAIKVLKPERI----------------------N-SDMQKE-FAQEVFIMRKVRHKNVVQ 353 (518)
Q Consensus 299 ~LG~G~fG~Vy~g~~-~~~~vAVKvlk~~~~----------------------~-~~~~~~-~~~Ei~iL~~L~HpnIv~ 353 (518)
-|..|.-+-||.++. .|..+|||+.+.... + ..+.+- ...|++-|++++...|.-
T Consensus 151 CiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~ 230 (520)
T KOG2270|consen 151 CISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPC 230 (520)
T ss_pred ccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 456677777999985 577799999873311 1 112222 234777777776554432
Q ss_pred EeecccCCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCcEEEcCCCcEEEE
Q 010078 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH-QNNIIHRDLKAANLLMDENEVVKVA 432 (518)
Q Consensus 354 l~g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLH-s~gIiHrDLKp~NILid~~~~vkL~ 432 (518)
.--... ....+||+|+. .+=+-.=.-....++...+..+-.+++.-|.-|. .+++||.||.--|+|+. +|.+.|+
T Consensus 231 PePIlL--k~hVLVM~FlG-rdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~lyiI 306 (520)
T KOG2270|consen 231 PEPILL--KNHVLVMEFLG-RDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGKLYII 306 (520)
T ss_pred CCceee--ecceEeeeecc-CCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCEEEEE
Confidence 111111 23578999994 3222111111345777788888888888888885 57999999999999996 6789999
Q ss_pred eeCccee
Q 010078 433 DFGVARV 439 (518)
Q Consensus 433 DFGla~~ 439 (518)
|.+.+..
T Consensus 307 DVSQSVE 313 (520)
T KOG2270|consen 307 DVSQSVE 313 (520)
T ss_pred Ecccccc
Confidence 9997753
|
|
| >PF01842 ACT: ACT domain; InterPro: IPR002912 The ACT domain is found in a variety of contexts and is proposed to be a conserved regulatory binding fold | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.00078 Score=51.93 Aligned_cols=63 Identities=33% Similarity=0.410 Sum_probs=51.8
Q ss_pred cceeeecCChhhHHHHHHHHHHhhcccceecccccCCCCceeeEEEEcCCChhhHHHHHHHHHH
Q 010078 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEK 243 (518)
Q Consensus 180 ~ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~dg~~ldv~vvdgw~~e~~~~l~~~l~~ 243 (518)
|.|++...|+|++|.+++.+|++.|+||..++.+++.++ ....+++......+.+.+.++|++
T Consensus 1 ~~v~v~~~drpG~l~~v~~~la~~~inI~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~ 63 (66)
T PF01842_consen 1 YRVRVIVPDRPGILADVTEILADHGINIDSISQSSDKDG-VGIVFIVIVVDEEDLEKLLEELEA 63 (66)
T ss_dssp EEEEEEEETSTTHHHHHHHHHHHTTEEEEEEEEEEESST-TEEEEEEEEEEGHGHHHHHHHHHH
T ss_pred CEEEEEcCCCCCHHHHHHHHHHHcCCCHHHeEEEecCCC-ceEEEEEEECCCCCHHHHHHHHHc
Confidence 567888999999999999999999999999999999985 444444445566777778777765
|
ACT domains are linked to a wide range of metabolic enzymes that are regulated by amino acid concentration. The archetypical ACT domain is the C-terminal regulatory domain of 3-phosphoglycerate dehydrogenase (3PGDH), which folds with a ferredoxin-like topology. A pair of ACT domains form an eight-stranded antiparallel sheet with two molecules of allosteric inhibitor serine bound in the interface. Biochemical exploration of a few other proteins containing ACT domains supports the suggestions that these domains contain the archetypical ACT structure [].; GO: 0016597 amino acid binding, 0008152 metabolic process; PDB: 3L76_B 2F06_B 3NRB_C 1Y7P_C 2QMX_A 2DT9_A 2ZHO_D 3K5P_A 3TVI_K 3C1M_C .... |
| >cd04873 ACT_UUR-ACR-like ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.0037 Score=48.69 Aligned_cols=48 Identities=40% Similarity=0.598 Sum_probs=43.6
Q ss_pred ceeeecCChhhHHHHHHHHHHhhcccceecccccCCCCceeeEEEEcCC
Q 010078 181 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGW 229 (518)
Q Consensus 181 ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~dg~~ldv~vvdgw 229 (518)
+|++...|+|++++.++.+|++.|+||..+.++++-+ +..++|.|++.
T Consensus 2 ~l~i~~~d~~g~l~~i~~~l~~~~~~I~~~~~~~~~~-~~~~~~~v~~~ 49 (70)
T cd04873 2 VVEVYAPDRPGLLADITRVLADLGLNIHDARISTTGE-RALDVFYVTDS 49 (70)
T ss_pred EEEEEeCCCCCHHHHHHHHHHHCCCeEEEEEEeecCC-EEEEEEEEECC
Confidence 6889999999999999999999999999999988865 89999988753
|
This ACT domain family, ACT_UUR_ACR-like, includes the two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the four ACT domains of a novel protein composed almost entirely of ACT domain repeats (the ACR protein) and like proteins. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. This CD also includes the first of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein and related domains, as well as, the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted t |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.015 Score=59.07 Aligned_cols=29 Identities=28% Similarity=0.460 Sum_probs=25.7
Q ss_pred CCceeccCCCCcEEEcCCCcEEEEeeCcce
Q 010078 409 NNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (518)
Q Consensus 409 ~gIiHrDLKp~NILid~~~~vkL~DFGla~ 438 (518)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999999765
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.022 Score=60.68 Aligned_cols=75 Identities=15% Similarity=0.029 Sum_probs=51.5
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCC-----ChHHHHHHHHHHHHHHhcC---CCcceEEeecccCCCCcceee
Q 010078 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERI-----NSDMQKEFAQEVFIMRKVR---HKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 297 ~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~-----~~~~~~~~~~Ei~iL~~L~---HpnIv~l~g~~~~~~~~~lV~ 368 (518)
.+.||-|....||+.+..+..++||.-.+... ......+-..|...|+.+. ..+++++|.++.+ ..+++|
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlvM 114 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIGM 114 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEEE
Confidence 46789999999999988777899997542111 0112233444566666654 2478889988874 468899
Q ss_pred eecCC
Q 010078 369 EFMSG 373 (518)
Q Consensus 369 Ey~~g 373 (518)
||+++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99976
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 518 | ||||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-49 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-49 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-45 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-44 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-44 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-44 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-44 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-44 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-44 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-44 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-44 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-43 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-43 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-43 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-43 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-43 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-41 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-41 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-40 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-40 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-40 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-40 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-39 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-39 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-38 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-38 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-38 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-38 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-38 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-38 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-38 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-38 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-37 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-37 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-37 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-37 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-37 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-37 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-37 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-37 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-37 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-37 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-37 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-37 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-37 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-37 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-37 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-37 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-37 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-37 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-37 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-37 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-37 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-37 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-37 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-37 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-37 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-37 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-37 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-37 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-37 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-37 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-37 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-36 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-36 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-36 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-36 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-36 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-36 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-36 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-36 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-36 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-36 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-36 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-36 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-35 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-35 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-35 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-35 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-34 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-34 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-34 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-34 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-34 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-33 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-33 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-32 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-32 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-32 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-32 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-32 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-32 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-32 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-32 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-32 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-32 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-32 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-32 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-32 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-32 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-31 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-31 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-31 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-31 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-30 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-30 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-30 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-30 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-30 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-30 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-30 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-30 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-30 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-29 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-29 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-29 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-29 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-29 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-29 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-29 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-29 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-28 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-28 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-28 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-28 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-28 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-28 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-28 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-28 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-28 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-28 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-28 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-28 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-28 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-28 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-28 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-28 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-28 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-28 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-28 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-28 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-28 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-28 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-28 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-28 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-28 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-28 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-28 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-28 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-27 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-27 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-27 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-27 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-27 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-27 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-27 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-27 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-27 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-27 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-27 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-27 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-27 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-27 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-27 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-27 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-27 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-27 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-27 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-27 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-27 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-27 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-27 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-27 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-27 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-27 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-27 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-27 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-27 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-27 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-27 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-27 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-27 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-27 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-27 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-27 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-27 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-27 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-27 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-27 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-27 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-27 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-27 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-27 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-27 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-27 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-27 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-27 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-27 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-27 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-27 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-27 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-27 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-27 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-27 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-27 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-27 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-27 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-26 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-26 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-26 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-26 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-26 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-26 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-26 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-26 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-26 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-26 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-26 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-26 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-26 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-26 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-26 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-26 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-26 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-26 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-26 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-26 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-26 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-26 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-26 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-25 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-25 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-25 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-25 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-25 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-25 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-25 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-24 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-24 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-24 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-24 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-24 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-24 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-24 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-24 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-24 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-24 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-24 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-24 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-24 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-24 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-24 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-24 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-24 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-24 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-24 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-24 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-24 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-24 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-24 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-24 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-24 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-24 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-24 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-24 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-24 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-24 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-24 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-24 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-24 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-24 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-24 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-24 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-24 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-24 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-23 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-23 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-23 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-23 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-23 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-23 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-23 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-23 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-23 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-23 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-23 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-23 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-23 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-23 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-23 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-23 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-23 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-23 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-23 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-23 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-23 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-23 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-23 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-23 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-23 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-23 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-23 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-23 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-23 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-23 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-23 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-23 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-23 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-23 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-23 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-23 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-23 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-23 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-23 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-23 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-23 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-23 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-23 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-23 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-23 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-23 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-23 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-23 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-23 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-23 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-23 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-23 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-23 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-23 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-23 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-23 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-23 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-23 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-23 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-23 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-23 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-23 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-23 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-23 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-23 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-23 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-23 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-23 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-23 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-23 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-23 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-23 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-23 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-23 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-23 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-23 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-23 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-23 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-23 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-23 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-23 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-23 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-23 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-23 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-22 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-22 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-22 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-22 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-22 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-22 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-22 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-22 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-22 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-22 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-22 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-22 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-22 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-22 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-22 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-22 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-22 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-22 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-22 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-22 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-22 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-22 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-22 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-22 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-22 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-22 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-22 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-22 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-22 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-22 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-22 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-22 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-22 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-22 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-22 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-22 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-22 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-22 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-22 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-22 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-22 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-22 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-22 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-22 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-22 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-22 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-22 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-22 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-22 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-22 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-22 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-22 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-22 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-22 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-22 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-22 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 9e-22 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-21 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-21 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-21 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-21 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-21 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-21 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-21 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-21 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-21 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-21 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-21 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-21 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-21 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-21 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-21 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-21 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-21 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-21 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-21 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-21 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-21 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-21 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-21 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-21 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-21 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-21 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-21 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-21 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-21 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-21 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-21 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-21 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-21 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 9e-21 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-21 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-21 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-21 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-20 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-20 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-20 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-20 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-20 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-20 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-20 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-20 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-20 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-20 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-20 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-20 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-20 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-20 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-20 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-20 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-20 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-20 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-20 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-20 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-20 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-20 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-20 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-20 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-20 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-20 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-20 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-20 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-20 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-20 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-20 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-19 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-19 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-19 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-19 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-19 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-19 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-19 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-19 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-19 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-19 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-19 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-19 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-19 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-19 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-19 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-19 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-19 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-19 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-19 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-19 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-19 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-19 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-19 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-19 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-19 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-19 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-19 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-19 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-19 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-19 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-19 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-19 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-19 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-19 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-19 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-19 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-19 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-19 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-19 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-19 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-19 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-19 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-19 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-19 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-18 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-18 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-18 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-18 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-18 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-18 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-18 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-18 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-18 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-18 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-18 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-18 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-18 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-18 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-18 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-18 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-18 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-18 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-18 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-18 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-18 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-18 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-18 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-18 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-18 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-18 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-18 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-18 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-18 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-18 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-18 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-17 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-17 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-17 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-17 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-17 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-17 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-17 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-17 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-17 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-17 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-17 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-17 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-17 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-17 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-17 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-17 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-17 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-17 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-17 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-17 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-17 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-17 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-17 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-17 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-17 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-17 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-17 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-17 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-17 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-17 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-17 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-17 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-17 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-17 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-17 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-17 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-17 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-17 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-17 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-17 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-17 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-17 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-17 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-17 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-17 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-17 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-17 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-17 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-17 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-17 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-17 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-17 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-17 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-17 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-17 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-17 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-17 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-17 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-17 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-17 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-17 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-17 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-17 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-17 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-16 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-16 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-16 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-16 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-16 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-16 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-16 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-16 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-16 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-16 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-16 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-16 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-16 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-16 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-16 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-16 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-16 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-16 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-16 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-16 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-16 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-16 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-16 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-16 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-16 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-16 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-16 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-16 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-16 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-16 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-16 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-16 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-16 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-16 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-16 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-16 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-16 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-16 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-16 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-16 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-16 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-16 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-16 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-16 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-16 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-16 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-16 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-16 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-16 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-16 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-16 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-16 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-16 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-16 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-16 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-16 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-16 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-16 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-16 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-16 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-16 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-16 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-16 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-16 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-16 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-16 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-16 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-16 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-16 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-16 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-16 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-16 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-15 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-15 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-15 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-15 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-15 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-15 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-15 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-15 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-15 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-15 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-15 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-15 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-15 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-15 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-15 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-15 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-15 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-15 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-15 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-15 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-15 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-15 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-15 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-15 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-15 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-15 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-15 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-15 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-15 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-15 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-15 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-15 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-15 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-15 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-15 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-15 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-15 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-15 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-15 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-15 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-15 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-15 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-15 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-15 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-15 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-15 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-15 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-15 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 8e-15 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-15 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-15 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-15 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 9e-15 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 9e-15 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-15 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-15 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-15 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-15 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-15 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-15 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-14 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-14 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-14 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-14 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-14 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-14 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-14 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-14 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-14 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-14 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-14 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-14 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-14 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-14 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-14 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-14 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-14 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-14 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-14 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-14 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-14 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-14 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-14 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-14 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-14 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-14 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-14 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-14 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-14 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-14 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-14 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-14 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-14 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-14 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-14 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-14 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-14 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-13 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-13 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-13 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-13 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-13 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-13 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-13 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-13 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-13 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-13 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-13 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-13 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-13 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-13 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-13 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-13 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 8e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-13 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-12 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-12 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-12 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-12 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-12 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-12 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-12 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-12 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-12 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-12 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-12 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-12 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-12 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-12 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-12 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-12 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-12 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-12 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-12 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-12 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-12 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-12 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-12 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-12 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-12 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-12 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-12 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-12 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-11 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-11 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 5e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-11 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-11 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 9e-11 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-10 |
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 384 bits (989), Expect = e-132
Identities = 101/254 (39%), Positives = 154/254 (60%), Gaps = 8/254 (3%)
Query: 256 HRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS 315
H P S+ + ++ + + D +I L K+ +GS+G ++R +
Sbjct: 4 HHHHHPMSDYDIPTTENLYFQGAMDGD---DMDIPWCDLNIKEKIGAGSFGTVHRAEWHG 60
Query: 316 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 375
DVA+K+L + +++ EF +EV IM+++RH N+V F+GA T+PP+L IVTE++S GS
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 376 VYDYLHKLKGVFKLP--SLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVKV 431
+Y LHK +L L +A DV+KGMNYLH N I+HR+LK+ NLL+D+ VKV
Sbjct: 121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKV 180
Query: 432 ADFGVARVKAQSGV-MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490
DFG++R+KA + + + GT WMAPEV+ +P + K+DV+SFG++LWEL T + P+
Sbjct: 181 CDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240
Query: 491 YLTPLQAAVGVVQK 504
L P Q V K
Sbjct: 241 NLNPAQVVAAVGFK 254
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 377 bits (969), Expect = e-129
Identities = 91/240 (37%), Positives = 142/240 (59%), Gaps = 8/240 (3%)
Query: 271 KSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINS 330
K H +H D D WEI + G ++ SGS+G +Y+G + DVA+K+L
Sbjct: 3 KGHHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH-GDVAVKMLNVTAPTP 61
Query: 331 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP 390
+ F EV ++RK RH N++ F+G T P L IVT++ G S+Y +LH + F++
Sbjct: 62 QQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMK 120
Query: 391 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ---SGVMT 447
L+ +A ++GM+YLH +IIHRDLK+ N+ + E+ VK+ DFG+A K++ S
Sbjct: 121 KLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE 180
Query: 448 AETGTYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504
+G+ WMAPEVI + PY ++DV++FGIVL+EL+TG+LPY + + +V +
Sbjct: 181 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR 240
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 361 bits (929), Expect = e-123
Identities = 79/232 (34%), Positives = 126/232 (54%), Gaps = 16/232 (6%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERIN--SDMQKEFAQEVFIM 343
+ EID L + G +G +YR + +VA+K + + S + QE +
Sbjct: 1 LLEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
++H N++ G C K P+LC+V EF GG + L + L+ A+ +++GM
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGM 118
Query: 404 NYLHQNN---IIHRDLKAANLLMDE--------NEVVKVADFGVARVKAQSGVMTAETGT 452
NYLH IIHRDLK++N+L+ + N+++K+ DFG+AR ++ M+A G
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGA 177
Query: 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504
Y WMAPEVI + +DV+S+G++LWELLTG++P+ + L A GV
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN 229
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 359 bits (923), Expect = e-122
Identities = 73/233 (31%), Positives = 110/233 (47%), Gaps = 15/233 (6%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
P L G + G +G + T+ + + + R + + Q+ F +EV +MR +
Sbjct: 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL 64
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
H NV++FIG K L +TE++ GG++ + + + + A D++ GM YL
Sbjct: 65 EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 407 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA---------------QSGVMTAETG 451
H NIIHRDL + N L+ EN+ V VADFG+AR+ G
Sbjct: 125 HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 452 TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504
WMAPE+I + YD K DVFSFGIVL E++ P G+ +
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR 237
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 358 bits (921), Expect = e-121
Identities = 72/258 (27%), Positives = 120/258 (46%), Gaps = 17/258 (6%)
Query: 261 PTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAI 320
P +S P + W+I + L+ G + G +G +Y G + +VAI
Sbjct: 2 PEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH-GEVAI 60
Query: 321 KVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL 380
+++ ER N D K F +EV R+ RH+NVV F+GAC PP L I+T G ++Y +
Sbjct: 61 RLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV 120
Query: 381 HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440
K V + ++A ++ KGM YLH I+H+DLK+ N+ D V + DFG+ +
Sbjct: 121 RDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNG-KVVITDFGLFSIS 179
Query: 441 A------QSGVMTAETGTYRWMAPEVI---------EHKPYDHKADVFSFGIVLWELLTG 485
+ + + G +APE+I + P+ +DVF+ G + +EL
Sbjct: 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR 239
Query: 486 KLPYEYLTPLQAAVGVVQ 503
+ P++ +
Sbjct: 240 EWPFKTQPAEAIIWQMGT 257
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 352 bits (905), Expect = e-120
Identities = 64/226 (28%), Positives = 119/226 (52%), Gaps = 12/226 (5%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
ID K L F +K+ G+L++G + D+ +KVLK ++ ++F +E +R
Sbjct: 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64
Query: 347 RHKNVVQFIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGM 403
H NV+ +GAC PP+ ++T +M GS+Y+ LH+ V +K A+D+++GM
Sbjct: 65 SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124
Query: 404 NYLH--QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI 461
+LH + I L + ++++DE+ +++ V W+APE +
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF----QSPGRMYAPAWVAPEAL 180
Query: 462 EHKPYD---HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504
+ KP D AD++SF ++LWEL+T ++P+ L+ ++ + V +
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE 226
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 343 bits (881), Expect = e-116
Identities = 65/243 (26%), Positives = 121/243 (49%), Gaps = 22/243 (9%)
Query: 280 PNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ---- 333
+ + + +++ ++ G +G +++G VAIK L + +
Sbjct: 7 EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66
Query: 334 -KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL 392
+EF +EVFIM + H N+V+ G PP +V EF+ G +Y L K
Sbjct: 67 FQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVK 124
Query: 393 LKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENE-----VVKVADFGVARVKAQSGV 445
L++ +D++ G+ Y+ N I+HRDL++ N+ + + KVADFG+++ S
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-- 182
Query: 446 MTAETGTYRWMAPEVI--EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV--GV 501
++ G ++WMAPE I E + Y KAD +SF ++L+ +LTG+ P++ + + +
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242
Query: 502 VQK 504
++
Sbjct: 243 REE 245
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 335 bits (861), Expect = e-112
Identities = 77/226 (34%), Positives = 120/226 (53%), Gaps = 15/226 (6%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
+ ID K ++ V G++G + + + ++DVAIK ++ E +K F E+ + +
Sbjct: 2 LHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSR 57
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGM 403
V H N+V+ GAC P +C+V E+ GGS+Y+ LH + + + + S+G+
Sbjct: 58 VNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 404 NYLHQ---NNIIHRDLKAANLLMDEN-EVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 459
YLH +IHRDLK NLL+ V+K+ DFG A MT G+ WMAPE
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPE 173
Query: 460 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL-TPLQAAVGVVQK 504
V E Y K DVFS+GI+LWE++T + P++ + P + V
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN 219
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 303 bits (779), Expect = e-100
Identities = 70/263 (26%), Positives = 120/263 (45%), Gaps = 41/263 (15%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
V K ++ ++ G YG+++ G + + VA+KV S ++ E++
Sbjct: 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRE---TEIYQTVL 87
Query: 346 VRHKNVVQFIGACTKP----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 401
+RH+N++ FI A K L ++T++ GS+YDYL S+LK+A
Sbjct: 88 MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVS 145
Query: 402 GMNYLH--------QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-----VMTA 448
G+ +LH + I HRDLK+ N+L+ +N +AD G+A
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205
Query: 449 ETGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTG----------KLPYEYL 492
GT R+M PEV++ H AD++SFG++LWE+ +LPY L
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265
Query: 493 TPLQAAVGVVQKVHHSFLEQRLR 515
P + ++++ ++LR
Sbjct: 266 VPSDPSYEDMREIV---CIKKLR 285
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 293 bits (753), Expect = 1e-96
Identities = 64/247 (25%), Positives = 118/247 (47%), Gaps = 38/247 (15%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 351
+ + V G YG+++RG++ ++VA+K+ S ++ E++ +RH+N+
Sbjct: 8 RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRE---TELYNTVMLRHENI 64
Query: 352 VQFIGACTK----PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
+ FI + L ++T + GS+YDYL S L++ + ++ G+ +LH
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLH 122
Query: 408 --------QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM-----TAETGTYR 454
+ I HRDLK+ N+L+ +N +AD G+A + +QS GT R
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 455 WMAPEVIEHKP------YDHKADVFSFGIVLWELLTG----------KLPYEYLTPLQAA 498
+MAPEV++ + D+++FG+VLWE+ K P+ + P +
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242
Query: 499 VGVVQKV 505
++KV
Sbjct: 243 FEDMRKV 249
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 287 bits (737), Expect = 1e-93
Identities = 69/263 (26%), Positives = 126/263 (47%), Gaps = 41/263 (15%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
V + + + G +G+++RG + ++VA+K+ S ++ E++
Sbjct: 36 VQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE---AEIYQTVM 92
Query: 346 VRHKNVVQFIGACTK----PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 401
+RH+N++ FI A K L +V+++ GS++DYL++ + ++K+A+ +
Sbjct: 93 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTAS 150
Query: 402 GMNYLHQN--------NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-----VMTA 448
G+ +LH I HRDLK+ N+L+ +N +AD G+A +
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210
Query: 449 ETGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTG----------KLPYEYL 492
GT R+MAPEV++ H +AD+++ G+V WE+ +LPY L
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270
Query: 493 TPLQAAVGVVQKVHHSFLEQRLR 515
P +V ++KV EQ+LR
Sbjct: 271 VPSDPSVEEMRKVV---CEQKLR 290
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 284 bits (729), Expect = 1e-92
Identities = 67/245 (27%), Positives = 118/245 (48%), Gaps = 32/245 (13%)
Query: 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFI 342
GT+ L+ A G +G +++ ++ VA+K+ + + EV+
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ---DKQSWQNEYEVYS 71
Query: 343 MRKVRHKNVVQFIGACTKPPS----LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 398
+ ++H+N++QFIGA + S L ++T F GS+ D+L V L +A
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAET 129
Query: 399 VSKGMNYLHQN----------NIIHRDLKAANLLMDENEVVKVADFGVARVK---AQSGV 445
+++G+ YLH++ I HRD+K+ N+L+ N +ADFG+A +G
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 446 MTAETGTYRWMAPEVIEH-----KPYDHKADVFSFGIVLWELLTGKLPY-----EYLTPL 495
+ GT R+MAPEV+E + + D+++ G+VLWEL + EY+ P
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249
Query: 496 QAAVG 500
+ +G
Sbjct: 250 EEEIG 254
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 2e-82
Identities = 62/262 (23%), Positives = 112/262 (42%), Gaps = 42/262 (16%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQE--VFIMR 344
+D +LK + G YG +Y+G+ + VA+KV + Q F E ++ +
Sbjct: 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFA----NRQ-NFINEKNIYRVP 62
Query: 345 KVRHKNVVQFIGACTKPPS-----LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
+ H N+ +FI + + +V E+ GS+ YL S ++A V
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS--LHTSDWVSSCRLAHSV 120
Query: 400 SKGMNYLH---------QNNIIHRDLKAANLLMDENEVVKVADFGVARVKA--------- 441
++G+ YLH + I HRDL + N+L+ + ++DFG++
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180
Query: 442 QSGVMTAETGTYRWMAPEVIE-------HKPYDHKADVFSFGIVLWELLTGK---LPYEY 491
+ +E GT R+MAPEV+E + + D+++ G++ WE+ P E
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240
Query: 492 LTPLQAAVGVVQKVHHSFLEQR 513
+ Q A H +F + +
Sbjct: 241 VPEYQMAFQTEVGNHPTFEDMQ 262
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 1e-77
Identities = 79/229 (34%), Positives = 120/229 (52%), Gaps = 19/229 (8%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMR 344
W ++ K LK + G +GD+ G Y VA+K +K + F E +M
Sbjct: 14 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN----DATAQAFLAEASVMT 69
Query: 345 KVRHKNVVQFIGACTK-PPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 402
++RH N+VQ +G + L IVTE+M+ GS+ DYL V LLK ++DV +
Sbjct: 70 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 129
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 459
M YL NN +HRDL A N+L+ E+ V KV+DFG+ + + + +W APE
Sbjct: 130 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE-----ASSTQDTGKLPVKWTAPE 184
Query: 460 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHH 507
+ K + K+DV+SFGI+LWE+ + G++PY + VV +V
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRVEK 229
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 1e-77
Identities = 82/212 (38%), Positives = 129/212 (60%), Gaps = 9/212 (4%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRK 345
W IDP L F ++ SG +G ++ G + ++ VAIK ++ + +++F +E +M K
Sbjct: 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE---GAMSEEDFIEEAEVMMK 59
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 405
+ H +VQ G C + +C+VTEFM G + DYL +G+F +LL + +DV +GM Y
Sbjct: 60 LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119
Query: 406 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIE 462
L + +IHRDL A N L+ EN+V+KV+DFG+ R T+ TGT +W +PEV
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS 178
Query: 463 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLT 493
Y K+DV+SFG+++WE+ + GK+PYE +
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 2e-77
Identities = 75/230 (32%), Positives = 123/230 (53%), Gaps = 13/230 (5%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 342
D W ++ + L G ++ G++G+++ G + VA+K + E + D++ +F QE I
Sbjct: 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARI 165
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
+++ H N+V+ IG CT+ + IV E + GG +L ++ +LL++ D + G
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT----YRWMAP 458
M YL IHRDL A N L+ E V+K++DFG++R GV A G +W AP
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSRE-EADGVYAASGGLRQVPVKWTAP 284
Query: 459 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHH 507
E + + Y ++DV+SFGI+LWE + G PY L+ Q + V
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ----TREFVEK 330
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 4e-77
Identities = 79/214 (36%), Positives = 128/214 (59%), Gaps = 9/214 (4%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 343
WEIDPK L F ++ +G +G + G + Q DVAIK++K S + EF +E +M
Sbjct: 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMSEDEFIEEAKVM 73
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
+ H+ +VQ G CTK + I+TE+M+ G + +YL +++ F+ LL++ DV + M
Sbjct: 74 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 133
Query: 404 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEV 460
YL +HRDL A N L+++ VVKV+DFG++R T+ G+ RW PEV
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEV 192
Query: 461 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLT 493
+ + + K+D+++FG+++WE+ + GK+PYE T
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 226
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 5e-77
Identities = 74/233 (31%), Positives = 122/233 (52%), Gaps = 16/233 (6%)
Query: 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFA 337
+ I K L+ K+ GS+G + RG + + VA+K LKP+ ++ +F
Sbjct: 10 SLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI 69
Query: 338 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 397
+EV M + H+N+++ G PP + +VTE GS+ D L K +G F L +L + A+
Sbjct: 70 REVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 128
Query: 398 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT---Y 453
V++GM YL IHRDL A NLL+ ++VK+ DFG+ R + + +
Sbjct: 129 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 188
Query: 454 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKV 505
W APE ++ + + H +D + FG+ LWE+ T G+ P+ L Q ++ K+
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ----ILHKI 237
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 1e-75
Identities = 80/224 (35%), Positives = 124/224 (55%), Gaps = 13/224 (5%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRK 345
E+ + + ++ SG +G + G + Q DVA+K++K S + EF QE M K
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKE---GSMSEDEFFQEAQTMMK 59
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 405
+ H +V+F G C+K + IVTE++S G + +YL + LL++ DV +GM +
Sbjct: 60 LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF 119
Query: 406 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIE 462
L + IHRDL A N L+D + VKV+DFG+ R + GT +W APEV
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVKWSAPEVFH 178
Query: 463 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKV 505
+ Y K+DV++FGI++WE+ + GK+PY+ T + VV KV
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE----VVLKV 218
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 2e-75
Identities = 79/227 (34%), Positives = 121/227 (53%), Gaps = 19/227 (8%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMR 344
W ++ K LK + G +GD+ G Y VA+K +K + + F E +M
Sbjct: 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND----ATAQAFLAEASVMT 241
Query: 345 KVRHKNVVQFIGACTK-PPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 402
++RH N+VQ +G + L IVTE+M+ GS+ DYL V LLK ++DV +
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 301
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 459
M YL NN +HRDL A N+L+ E+ V KV+DFG+ + + + +W APE
Sbjct: 302 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE-----ASSTQDTGKLPVKWTAPE 356
Query: 460 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKV 505
+ K + K+DV+SFGI+LWE+ + G++PY + VV +V
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRV 399
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 2e-75
Identities = 63/231 (27%), Positives = 112/231 (48%), Gaps = 14/231 (6%)
Query: 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFA 337
G + I + + + G +G++Y G Y + VA+K K + D +++F
Sbjct: 3 GGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFM 61
Query: 338 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 397
E IM+ + H ++V+ IG + P I+ E G + YL + K K+ +L+ ++
Sbjct: 62 SEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120
Query: 398 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RW 455
+ K M YL N +HRD+ N+L+ E VK+ DFG++R A +W
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW 180
Query: 456 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKV 505
M+PE I + + +DV+ F + +WE+L+ GK P+ +L V+ +
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD----VIGVL 227
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 2e-75
Identities = 85/233 (36%), Positives = 131/233 (56%), Gaps = 17/233 (7%)
Query: 280 PNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFA 337
PN D WE++ + K+ G YG++Y G + S VA+K LK ++ +EF
Sbjct: 3 PNY--DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFL 57
Query: 338 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVA 396
+E +M++++H N+VQ +G CT+ P I+TEFM+ G++ DYL + LL +A
Sbjct: 58 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117
Query: 397 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---Y 453
+S M YL + N IHRDL A N L+ EN +VKVADFG++R+ TA G
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPI 176
Query: 454 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKV 505
+W APE + + + K+DV++FG++LWE+ T G PY + Q V + +
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYELL 225
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 2e-75
Identities = 77/227 (33%), Positives = 131/227 (57%), Gaps = 15/227 (6%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 343
D WE+ + LK ++ +G +G+++ G Y VA+K LK S F E +M
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMSPDAFLAEANLM 62
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 402
++++H+ +V+ T+ P + I+TE+M GS+ D+L G + LL +A +++G
Sbjct: 63 KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 459
M ++ + N IHRDL+AAN+L+ + K+ADFG+AR+ + TA G +W APE
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPE 180
Query: 460 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKV 505
I + + K+DV+SFGI+L E++T G++PY +T + V+Q +
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----VIQNL 223
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 235 bits (603), Expect = 2e-74
Identities = 69/219 (31%), Positives = 116/219 (52%), Gaps = 10/219 (4%)
Query: 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFA 337
T +EI + ++ G + G +GD+++G Y S + VAIK K + ++++F
Sbjct: 6 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFL 64
Query: 338 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 397
QE MR+ H ++V+ IG T+ P + I+ E + G + +L K L SL+ A
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 123
Query: 398 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RW 455
+S + YL +HRD+ A N+L+ N+ VK+ DFG++R S A G +W
Sbjct: 124 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 183
Query: 456 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLT 493
MAPE I + + +DV+ FG+ +WE+L G P++ +
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 1e-73
Identities = 66/247 (26%), Positives = 113/247 (45%), Gaps = 15/247 (6%)
Query: 270 MKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVL 323
M H +H D + +HLK+ S++ G++G + Y VA+K L
Sbjct: 1 MGHHHHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL 60
Query: 324 KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLH 381
+ D Q++F +E+ I++ + +V++ G P SL +V E++ G + D+L
Sbjct: 61 QHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ 118
Query: 382 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VK 440
+ + LL + + KGM YL +HRDL A N+L++ VK+ADFG+A+ +
Sbjct: 119 RHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178
Query: 441 AQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ 496
W APE + + ++DV+SFG+VL+EL T
Sbjct: 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL 238
Query: 497 AAVGVVQ 503
+G +
Sbjct: 239 RMMGCER 245
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 1e-73
Identities = 65/219 (29%), Positives = 115/219 (52%), Gaps = 12/219 (5%)
Query: 285 DVWEIDPKHLKFGSKV-ASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQE 339
+D K L K SG++G + +G Y + VA+K+LK E + ++ E E
Sbjct: 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE 68
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
+M+++ + +V+ IG C +V E G + YL + K +++++ V
Sbjct: 69 ANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQV 126
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT---YRW 455
S GM YL ++N +HRDL A N+L+ K++DFG+++ ++A A+T +W
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 186
Query: 456 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLT 493
APE I + + K+DV+SFG+++WE + G+ PY +
Sbjct: 187 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 1e-73
Identities = 71/237 (29%), Positives = 121/237 (51%), Gaps = 19/237 (8%)
Query: 280 PNDGTDVWE-IDPKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDM 332
PN + + K + SG++G +Y+G + + VAIK L+
Sbjct: 4 PNQA--LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN 61
Query: 333 QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL 392
KE E ++M V + +V + +G C + ++T+ M G + DY+ + K L
Sbjct: 62 -KEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 393 LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETG 451
L + ++KGMNYL ++HRDL A N+L+ + VK+ DFG+A+ + A+ AE G
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 452 TY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKV 505
+WMA E I H+ Y H++DV+S+G+ +WEL+T G PY+ + + + +
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSIL 232
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 3e-73
Identities = 61/230 (26%), Positives = 113/230 (49%), Gaps = 18/230 (7%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQ-KEFAQE 339
L+ + SG +G +++G + + V IKV++ + + +
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK--SGRQSFQAVTDH 65
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
+ + + H ++V+ +G C L +VT+++ GS+ D++ + +G LL + +
Sbjct: 66 MLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI 124
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWM 456
+KGM YL ++ ++HR+L A N+L+ V+VADFGVA + + +WM
Sbjct: 125 AKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184
Query: 457 APEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKV 505
A E I Y H++DV+S+G+ +WEL+T G PY L + V +
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE----VPDLL 230
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 5e-73
Identities = 64/231 (27%), Positives = 112/231 (48%), Gaps = 15/231 (6%)
Query: 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEF 336
G+D + + +HLKF ++ G++G + Y + VA+K L+ + ++F
Sbjct: 1 GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDF 58
Query: 337 AQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK 394
+E+ I++ ++H N+V++ G C +L ++ E++ GS+ DYL K K LL+
Sbjct: 59 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118
Query: 395 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT- 452
+ KGM YL IHRDL N+L++ VK+ DFG+ + + +
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178
Query: 453 --YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVG 500
W APE + + +DV+SFG+VL+EL T + +G
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 229
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 6e-73
Identities = 73/219 (33%), Positives = 109/219 (49%), Gaps = 11/219 (5%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQE 339
EI+ + + SG G++ G VAIK LK +++F E
Sbjct: 42 FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ-RRDFLSE 100
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
IM + H N+++ G T+ IVTE+M GS+ +L G F + L+ + V
Sbjct: 101 ASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGV 160
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT---YRW 455
GM YL +HRDL A N+L+D N V KV+DFG++R ++ TG RW
Sbjct: 161 GAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRW 220
Query: 456 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLT 493
APE I + + +DV+SFG+V+WE+L G+ PY +T
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 2e-72
Identities = 71/220 (32%), Positives = 117/220 (53%), Gaps = 12/220 (5%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQ 338
EI P + + +G +G++Y+G VAIK LK + +F
Sbjct: 37 FTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ-RVDFLG 95
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 398
E IM + H N+++ G +K + I+TE+M G++ +L + G F + L+ +
Sbjct: 96 EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT---YR 454
++ GM YL N +HRDL A N+L++ N V KV+DFG++R ++ +G R
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 215
Query: 455 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLT 493
W APE I ++ + +DV+SFGIV+WE++T G+ PY L+
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS 255
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 5e-72
Identities = 83/242 (34%), Positives = 133/242 (54%), Gaps = 15/242 (6%)
Query: 271 KSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI 328
K + + + D WE++ + K+ G YG++Y G + S VA+K LK
Sbjct: 199 KRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--- 255
Query: 329 NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VF 387
++ +EF +E +M++++H N+VQ +G CT+ P I+TEFM+ G++ DYL +
Sbjct: 256 DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV 315
Query: 388 KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT 447
LL +A +S M YL + N IHR+L A N L+ EN +VKVADFG++R+ T
Sbjct: 316 SAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYT 374
Query: 448 AETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503
A G +W APE + + + K+DV++FG++LWE+ T G PY + Q V +
Sbjct: 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYE 430
Query: 504 KV 505
+
Sbjct: 431 LL 432
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 5e-72
Identities = 64/241 (26%), Positives = 112/241 (46%), Gaps = 14/241 (5%)
Query: 256 HRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-- 313
H + T + + D + + +HLKF ++ G++G + Y
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDP 64
Query: 314 ----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIV 367
+ VA+K L+ + ++F +E+ I++ ++H N+V++ G C +L ++
Sbjct: 65 LQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 122
Query: 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427
E++ GS+ DYL K K LL+ + KGM YL IHRDL N+L++
Sbjct: 123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN 182
Query: 428 VVKVADFGVAR-VKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELL 483
VK+ DFG+ + + + W APE + + +DV+SFG+VL+EL
Sbjct: 183 RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 242
Query: 484 T 484
T
Sbjct: 243 T 243
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 6e-72
Identities = 82/227 (36%), Positives = 133/227 (58%), Gaps = 15/227 (6%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIM 343
D WEI + LK K+ +G +G+++ TY VA+K +KP S + F E +M
Sbjct: 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP---GSMSVEAFLAEANVM 237
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 402
+ ++H +V+ TK P + I+TEFM+ GS+ D+L +G LP L+ + +++G
Sbjct: 238 KTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 296
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 459
M ++ Q N IHRDL+AAN+L+ + V K+ADFG+ARV + TA G +W APE
Sbjct: 297 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPE 355
Query: 460 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKV 505
I + K+DV+SFGI+L E++T G++PY ++ + V++ +
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE----VIRAL 398
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 9e-72
Identities = 63/220 (28%), Positives = 112/220 (50%), Gaps = 14/220 (6%)
Query: 285 DVWEIDPKHLKFG-SKVASGSYGDLYRGTYCSQ----DVAIKVLKPERINSDMQK-EFAQ 338
+ +L ++ G++G + +G Y + DVAIKVLK E +
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMR 59
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 398
E IM ++ + +V+ IG C L +V E GG ++ +L + + ++ ++
Sbjct: 60 EAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT---YR 454
VS GM YL + N +HRDL A N+L+ K++DFG+++ + A TA + +
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 178
Query: 455 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLT 493
W APE I + + ++DV+S+G+ +WE L+ G+ PY+ +
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 5e-71
Identities = 67/230 (29%), Positives = 111/230 (48%), Gaps = 16/230 (6%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQ-KEFA 337
D + + LK + G +G + Y + VA+K LKPE + +
Sbjct: 14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLK 71
Query: 338 QEVFIMRKVRHKNVVQFIGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKV 395
+E+ I+R + H+N+V++ G CT+ + ++ EF+ GS+ +YL K K L LK
Sbjct: 72 KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY 131
Query: 396 AIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT-- 452
A+ + KGM+YL +HRDL A N+L++ VK+ DFG+ + ++ T +
Sbjct: 132 AVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS 191
Query: 453 -YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVG 500
W APE + + +DV+SFG+ L ELLT + +G
Sbjct: 192 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG 241
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 1e-70
Identities = 69/219 (31%), Positives = 113/219 (51%), Gaps = 11/219 (5%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERINSDMQKEFAQE 339
E+D ++ V +G +G++ G VAIK LK +++F E
Sbjct: 38 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGE 96
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
IM + H N+++ G TK + IVTE+M GS+ +L K F + L+ + +
Sbjct: 97 ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT---YRW 455
+ GM YL +HRDL A N+L++ N V KV+DFG+ R ++ G RW
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW 216
Query: 456 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLT 493
+PE I ++ + +DV+S+GIVLWE+++ G+ PY ++
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 5e-70
Identities = 82/313 (26%), Positives = 148/313 (47%), Gaps = 23/313 (7%)
Query: 206 NIQEAHAFST-VDGY----SLDVFVVDGWPYEETEQLRAALEKEVLKLERQGWPSHRSSS 260
++ A + +DGY + P +E E+ ++ K ++ S S
Sbjct: 303 SLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVS 362
Query: 261 PTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD--- 317
T + + + Y +P+ +EI + ++ G + G +GD+++G Y S +
Sbjct: 363 ETDDYAEIIDEEDTY--TMPST--RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPA 418
Query: 318 --VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 375
VAIK K + ++++F QE MR+ H ++V+ IG T+ P + I+ E + G
Sbjct: 419 MAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGE 476
Query: 376 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435
+ +L K L SL+ A +S + YL +HRD+ A N+L+ N+ VK+ DFG
Sbjct: 477 LRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 536
Query: 436 VARVKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 492
++R S A G +WMAPE I + + +DV+ FG+ +WE+L G P++ +
Sbjct: 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596
Query: 493 TPLQAAVGVVQKV 505
V+ ++
Sbjct: 597 KNND----VIGRI 605
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 7e-70
Identities = 88/239 (36%), Positives = 136/239 (56%), Gaps = 15/239 (6%)
Query: 273 HPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSD 331
+ D WEI + L+ K+ G +G+++ GT+ VAIK LKP +
Sbjct: 165 PTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTM 221
Query: 332 MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLP 390
+ F QE +M+K+RH+ +VQ ++ P + IVTE+MS GS+ D+L G +LP
Sbjct: 222 SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLP 280
Query: 391 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET 450
L+ +A ++ GM Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+ + TA
Sbjct: 281 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQ 339
Query: 451 GT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKV 505
G +W APE + + K+DV+SFGI+L EL T G++PY + + V+ +V
Sbjct: 340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 394
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 5e-69
Identities = 57/242 (23%), Positives = 103/242 (42%), Gaps = 36/242 (14%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY---------CSQDVAIKVLKPERINSDMQKEFA 337
+I + L F + G++ +++G +V +KVL + + + F
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFF 60
Query: 338 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 397
+ +M K+ HK++V G C +V EF+ GS+ YL K K + L+VA
Sbjct: 61 EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120
Query: 398 DVSKGMNYLHQNNIIHRDLKAANLLMD--------ENEVVKVADFGVARVKAQSGVMTAE 449
++ M++L +N +IH ++ A N+L+ +K++D G++
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-------VLP 173
Query: 450 TGTY----RWMAPEVIEH-KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503
W+ PE IE+ K + D +SFG LWE+ + G P L + +Q
Sbjct: 174 KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR----KLQ 229
Query: 504 KV 505
Sbjct: 230 FY 231
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 7e-69
Identities = 71/228 (31%), Positives = 119/228 (52%), Gaps = 15/228 (6%)
Query: 280 PNDGTDVWE-IDPKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDM 332
PN + + K + SG++G +Y+G + + VAIK L+
Sbjct: 4 PNQA--LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN 61
Query: 333 QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL 392
KE E ++M V + +V + +G C + ++T+ M G + DY+ + K L
Sbjct: 62 -KEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 393 LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETG 451
L + ++KGMNYL ++HRDL A N+L+ + VK+ DFG+A+ + A+ AE G
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 452 TY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ 496
+WMA E I H+ Y H++DV+S+G+ +WEL+T G PY+ + +
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 1e-68
Identities = 71/251 (28%), Positives = 117/251 (46%), Gaps = 25/251 (9%)
Query: 273 HPYHLKIPNDG---------TDVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQD 317
H +H + G D ++LK + G +G + Y +
Sbjct: 3 HHHHHHHHHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEM 62
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGS 375
VA+K LK + + + QE+ I+R + H++++++ G C SL +V E++ GS
Sbjct: 63 VAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGS 121
Query: 376 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435
+ DYL + L LL A + +GM YLH + IHRDL A N+L+D + +VK+ DFG
Sbjct: 122 LRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFG 179
Query: 436 VAR-VKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE 490
+A+ V W APE ++ + + +DV+SFG+ L+ELLT
Sbjct: 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239
Query: 491 YLTPLQAAVGV 501
T +G+
Sbjct: 240 PPTKFLELIGI 250
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 228 bits (582), Expect = 2e-68
Identities = 88/227 (38%), Positives = 135/227 (59%), Gaps = 15/227 (6%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 343
D WEI + L+ K+ G +G+++ GT+ VAIK LKP + + F QE +M
Sbjct: 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQVM 316
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 402
+K+RH+ +VQ ++ P + IVTE+MS GS+ D+L G +LP L+ +A ++ G
Sbjct: 317 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 375
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 459
M Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+ + TA G +W APE
Sbjct: 376 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 434
Query: 460 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKV 505
+ + K+DV+SFGI+L EL T G++PY + + V+ +V
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 477
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 5e-67
Identities = 76/241 (31%), Positives = 120/241 (49%), Gaps = 28/241 (11%)
Query: 273 HPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC----SQDVAIKVLKPERI 328
H +H K D T +D +KF + G++G + + D AIK +K E
Sbjct: 6 HHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYA 64
Query: 329 NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL------- 380
+ D ++FA E+ ++ K+ H N++ +GAC L + E+ G++ D+L
Sbjct: 65 SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLE 124
Query: 381 --------HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVA 432
+ LL A DV++GM+YL Q IHRDL A N+L+ EN V K+A
Sbjct: 125 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 184
Query: 433 DFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLP 488
DFG++R V +T RWMA E + + Y +DV+S+G++LWE+++ G P
Sbjct: 185 DFGLSR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
Query: 489 Y 489
Y
Sbjct: 242 Y 242
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 3e-66
Identities = 65/235 (27%), Positives = 113/235 (48%), Gaps = 28/235 (11%)
Query: 281 NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQ 333
+ G V I + + ++ G++G ++ VA+K LK +
Sbjct: 4 HSGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAAR 61
Query: 334 KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL------------- 380
K+F +E ++ ++H+++V+F G C L +V E+M G + +L
Sbjct: 62 KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 121
Query: 381 --HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 438
+ KG L +L +A ++ GM YL + +HRDL N L+ N +VK+ DFG++R
Sbjct: 122 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
Query: 439 VKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
+ T RWM PE I ++ + ++DV+SFG++LWE+ T GK P+
Sbjct: 182 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 236
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 9e-66
Identities = 60/230 (26%), Positives = 113/230 (49%), Gaps = 27/230 (11%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQ 338
+ EI ++F ++ +G +Y+G +Q VAIK LK + +++EF
Sbjct: 3 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK-AEGPLREEFRH 61
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------HKL 383
E + +++H NVV +G TK L ++ + S G ++++L +
Sbjct: 62 EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 384 KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443
K + P + + ++ GM YL ++++H+DL N+L+ + VK++D G+ R +
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181
Query: 444 GVMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
+ RWMAPE I + + +D++S+G+VLWE+ + G PY
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 231
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 9e-66
Identities = 64/224 (28%), Positives = 106/224 (47%), Gaps = 19/224 (8%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQE 339
+ ID L G + G +G + G +D VA+K +K + + +EF E
Sbjct: 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86
Query: 340 VFIMRKVRHKNVVQFIGACTK-----PPSLCIVTEFMSGGSVYDYLHKLK-----GVFKL 389
M+ H NV++ +G C + P ++ FM G ++ YL + L
Sbjct: 87 AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146
Query: 390 PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 449
+LLK +D++ GM YL N +HRDL A N ++ ++ V VADFG+++
Sbjct: 147 QTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQG 206
Query: 450 TGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
+W+A E + + Y K+DV++FG+ +WE+ T G PY
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY 250
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 2e-65
Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 15/217 (6%)
Query: 287 WEI--DPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQE 339
I + + G +G +Y G Y Q AIK L ++ F +E
Sbjct: 14 VLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVE-AFLRE 72
Query: 340 VFIMRKVRHKNVVQFIGACTKP-PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 398
+MR + H NV+ IG P ++ +M G + ++ + + L+ +
Sbjct: 73 GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY----- 453
V++GM YL + +HRDL A N ++DE+ VKVADFG+AR + + +
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV 192
Query: 454 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
+W A E ++ + K+DV+SFG++LWELLT G PY
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 2e-65
Identities = 69/241 (28%), Positives = 111/241 (46%), Gaps = 32/241 (13%)
Query: 278 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINS 330
++P D WE L FG + +G++G + T + VA+K+LK +
Sbjct: 11 QLPYD--HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSAHL 67
Query: 331 DMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL--------- 380
++ E+ ++ + H N+V +GACT ++TE+ G + ++L
Sbjct: 68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127
Query: 381 --------HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVA 432
+ L LL + V+KGM +L N IHRDL A N+L+ + K+
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKIC 187
Query: 433 DFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLP 488
DFG+AR + +WMAPE I + Y ++DV+S+GI LWEL + G P
Sbjct: 188 DFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
Query: 489 Y 489
Y
Sbjct: 248 Y 248
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 4e-65
Identities = 74/265 (27%), Positives = 123/265 (46%), Gaps = 36/265 (13%)
Query: 254 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 313
SH + +P G+ ++P D WE L G + G++G +
Sbjct: 3 SSHHHHHHSQDPMLAGVS----EYELPED--PKWEFPRDKLTLGKPLGEGAFGQVVMAEA 56
Query: 314 C---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 363
+ VA+K+LK + + E+ +M+ + +HKN++ +GACT+
Sbjct: 57 VGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 115
Query: 364 LCIVTEFMSGGSVYDYL---------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
L ++ E+ S G++ +YL + L+ +++GM YL
Sbjct: 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175
Query: 409 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKP 465
IHRDL A N+L+ EN V+K+ADFG+AR T +WMAPE + +
Sbjct: 176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 235
Query: 466 YDHKADVFSFGIVLWELLT-GKLPY 489
Y H++DV+SFG+++WE+ T G PY
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGSPY 260
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 4e-65
Identities = 61/225 (27%), Positives = 107/225 (47%), Gaps = 20/225 (8%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQE 339
+ I + G + G +G + +D VA+K+LK + I S +EF +E
Sbjct: 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 340 VFIMRKVRHKNVVQFIGACTK------PPSLCIVTEFMSGGSVYDYLHKLK-----GVFK 388
M++ H +V + +G + P ++ FM G ++ +L +
Sbjct: 76 AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 389 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448
L +L++ +D++ GM YL N IHRDL A N ++ E+ V VADFG++R
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQ 195
Query: 449 ETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
+ +W+A E + Y +DV++FG+ +WE++T G+ PY
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY 240
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 5e-65
Identities = 67/223 (30%), Positives = 104/223 (46%), Gaps = 13/223 (5%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEV 340
V + F + G +G +Y GT D A+K L + +F E
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEG 77
Query: 341 FIMRKVRHKNVVQFIGACTKP-PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
IM+ H NV+ +G C + S +V +M G + +++ + L+ + V
Sbjct: 78 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY-----R 454
+KGM YL +HRDL A N ++DE VKVADFG+AR + T +
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 197
Query: 455 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ 496
WMA E ++ + + K+DV+SFG++LWEL+T G PY +
Sbjct: 198 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 5e-65
Identities = 74/275 (26%), Positives = 126/275 (45%), Gaps = 33/275 (12%)
Query: 258 SSSPTSEPEDTGMKSHPYHLKIPN--DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-- 313
S S S E G + ++ P V I + + ++ G++G ++
Sbjct: 5 SGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHN 64
Query: 314 -----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368
VA+K LK + +++F +E ++ ++H+++V+F G CT+ L +V
Sbjct: 65 LLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVF 122
Query: 369 EFMSGGSVYDYL--------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
E+M G + +L G L LL VA V+ GM YL + +HR
Sbjct: 123 EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHR 182
Query: 415 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKAD 471
DL N L+ + VVK+ DFG++R + T RWM PE I ++ + ++D
Sbjct: 183 DLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESD 242
Query: 472 VFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKV 505
V+SFG+VLWE+ T GK P+ L+ + + +
Sbjct: 243 VWSFGVVLWEIFTYGKQPWYQLSNTE----AIDCI 273
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 220 bits (561), Expect = 9e-65
Identities = 68/251 (27%), Positives = 120/251 (47%), Gaps = 13/251 (5%)
Query: 253 WPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKV-ASGSYGDLYRG 311
P P DT + P+ + +L G++G + +G
Sbjct: 297 ARITSPDKPRPMPMDTSVFESPFSDPEELKDKK-LFLKRDNLLIADIELGCGNFGSVRQG 355
Query: 312 TYCSQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367
Y + DVAIKVLK +D +E +E IM ++ + +V+ IG C L +V
Sbjct: 356 VYRMRKKQIDVAIKVLKQGTEKAD-TEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLV 413
Query: 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427
E GG ++ +L + + ++ ++ VS GM YL + N +HR+L A N+L+
Sbjct: 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH 473
Query: 428 VVKVADFGVAR-VKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELL 483
K++DFG+++ + A TA + +W APE I + + ++DV+S+G+ +WE L
Sbjct: 474 YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 533
Query: 484 T-GKLPYEYLT 493
+ G+ PY+ +
Sbjct: 534 SYGQKPYKKMK 544
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 2e-64
Identities = 69/246 (28%), Positives = 115/246 (46%), Gaps = 29/246 (11%)
Query: 272 SHPYHLKIPN--------DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQ 316
+H +H PN +D+ E+ K++ + G++G++Y G
Sbjct: 2 AHHHHHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPL 61
Query: 317 DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376
VA+K L E + + +F E I+ K H+N+V+ IG + I+ E M+GG +
Sbjct: 62 QVAVKTLP-EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDL 120
Query: 377 YDYLHKLK------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENE 427
+L + + + LL VA D++ G YL +N+ IHRD+ A N L+
Sbjct: 121 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 180
Query: 428 VVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT 484
V K+ DFG+AR ++ +WM PE + K D +SFG++LWE+ +
Sbjct: 181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
Query: 485 -GKLPY 489
G +PY
Sbjct: 241 LGYMPY 246
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 2e-64
Identities = 76/265 (28%), Positives = 124/265 (46%), Gaps = 32/265 (12%)
Query: 254 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 313
P R ++ S DT M + ++P D WE L G + G +G +
Sbjct: 45 PLVRITTRLSSTADTPMLAGVSEYELPED--PKWEFPRDKLTLGKPLGEGCFGQVVMAEA 102
Query: 314 C---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 363
+ VA+K+LK + + E+ +M+ + +HKN++ +GACT+
Sbjct: 103 VGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 161
Query: 364 LCIVTEFMSGGSVYDYL---------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
L ++ E+ S G++ +YL + L+ +++GM YL
Sbjct: 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 221
Query: 409 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKP 465
IHRDL A N+L+ EN V+K+ADFG+AR T +WMAPE + +
Sbjct: 222 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 281
Query: 466 YDHKADVFSFGIVLWELLT-GKLPY 489
Y H++DV+SFG+++WE+ T G PY
Sbjct: 282 YTHQSDVWSFGVLMWEIFTLGGSPY 306
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 4e-64
Identities = 67/246 (27%), Positives = 117/246 (47%), Gaps = 37/246 (15%)
Query: 278 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINS 330
KI D WE K+L G + G +G + + T VA+K+LK E +
Sbjct: 11 KILED--PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK-ENASP 67
Query: 331 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------- 380
++ E ++++V H +V++ GAC++ L ++ E+ GS+ +L
Sbjct: 68 SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 381 -------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427
H + + L+ A +S+GM YL + ++HRDL A N+L+ E
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR 187
Query: 428 VVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT 484
+K++DFG++R + + +WMA E + Y ++DV+SFG++LWE++T
Sbjct: 188 KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
Query: 485 -GKLPY 489
G PY
Sbjct: 248 LGGNPY 253
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 8e-64
Identities = 66/223 (29%), Positives = 105/223 (47%), Gaps = 13/223 (5%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEV 340
V + F + G +G +Y GT D A+K L ++ +F E
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEG 141
Query: 341 FIMRKVRHKNVVQFIGACTKP-PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
IM+ H NV+ +G C + S +V +M G + +++ + L+ + V
Sbjct: 142 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 201
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY-----R 454
+KGM +L +HRDL A N ++DE VKVADFG+AR + T +
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 261
Query: 455 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ 496
WMA E ++ + + K+DV+SFG++LWEL+T G PY +
Sbjct: 262 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 1e-63
Identities = 65/232 (28%), Positives = 115/232 (49%), Gaps = 21/232 (9%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFA 337
D WE+ + + ++ GS+G +Y G VAIK + E + + EF
Sbjct: 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 76
Query: 338 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------GVFK 388
E +M++ +VV+ +G ++ ++ E M+ G + YL L+
Sbjct: 77 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 389 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448
L ++++A +++ GM YL+ N +HRDL A N ++ E+ VK+ DFG+ R ++
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 449 ETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ 496
RWM+PE ++ + +DV+SFG+VLWE+ T + PY+ L+ Q
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 248
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 1e-63
Identities = 79/258 (30%), Positives = 115/258 (44%), Gaps = 36/258 (13%)
Query: 260 SPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY------ 313
P P D + PY WE LK G + G++G +
Sbjct: 2 DPDELPLDEHCERLPYD-------ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKT 54
Query: 314 -CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKP-PSLCIVTEF 370
+ VA+K+LK E + E+ I+ + H NVV +GACTKP L ++ EF
Sbjct: 55 ATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEF 113
Query: 371 MSGGSVYDYL---------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
G++ YL K L L+ + V+KGM +L IHRD
Sbjct: 114 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 173
Query: 416 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADV 472
L A N+L+ E VVK+ DFG+AR + + +WMAPE I + Y ++DV
Sbjct: 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 233
Query: 473 FSFGIVLWELLT-GKLPY 489
+SFG++LWE+ + G PY
Sbjct: 234 WSFGVLLWEIFSLGASPY 251
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 2e-63
Identities = 69/237 (29%), Positives = 119/237 (50%), Gaps = 28/237 (11%)
Query: 278 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINS 330
++P + + WE +L+FG + +G++G + T VA+K+LK ++
Sbjct: 34 QLPYN--EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHA 90
Query: 331 DMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK- 388
D ++ E+ IM + +H+N+V +GACT + ++TE+ G + ++L + V +
Sbjct: 91 DEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLET 150
Query: 389 ------------LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
LL + V++GM +L N IHRD+ A N+L+ V K+ DFG+
Sbjct: 151 DPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL 210
Query: 437 ARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
AR + +WMAPE I Y ++DV+S+GI+LWE+ + G PY
Sbjct: 211 ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 4e-63
Identities = 79/265 (29%), Positives = 125/265 (47%), Gaps = 33/265 (12%)
Query: 255 SHRSSSPTSE-PEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 313
H PT+E GM + ++P D WE+ L G + G++G +
Sbjct: 33 HHDYDIPTTENLYFQGMLAGVSEYELPED--PRWELPRDRLVLGKPLGEGAFGQVVLAEA 90
Query: 314 ---------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 363
VA+K+LK + E+ +M+ + +HKN++ +GACT+
Sbjct: 91 IGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 149
Query: 364 LCIVTEFMSGGSVYDYL---------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
L ++ E+ S G++ +YL H + L+ A V++GM YL
Sbjct: 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 209
Query: 409 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKP 465
IHRDL A N+L+ E+ V+K+ADFG+AR T +WMAPE + +
Sbjct: 210 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI 269
Query: 466 YDHKADVFSFGIVLWELLT-GKLPY 489
Y H++DV+SFG++LWE+ T G PY
Sbjct: 270 YTHQSDVWSFGVLLWEIFTLGGSPY 294
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 5e-63
Identities = 69/256 (26%), Positives = 118/256 (46%), Gaps = 21/256 (8%)
Query: 254 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 313
P ++ S + T + + +D+ E+ K++ + G++G++Y G
Sbjct: 33 PEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQV 92
Query: 314 -------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366
VA+K L E + + +F E I+ K H+N+V+ IG + I
Sbjct: 93 SGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI 151
Query: 367 VTEFMSGGSVYDYLHKLK------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420
+ E M+GG + +L + + + LL VA D++ G YL +N+ IHRD+ A N
Sbjct: 152 LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARN 211
Query: 421 LLMD---ENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVFS 474
L+ V K+ DFG+AR ++G +WM PE + K D +S
Sbjct: 212 CLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWS 271
Query: 475 FGIVLWELLT-GKLPY 489
FG++LWE+ + G +PY
Sbjct: 272 FGVLLWEIFSLGYMPY 287
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 9e-63
Identities = 73/246 (29%), Positives = 118/246 (47%), Gaps = 37/246 (15%)
Query: 278 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINS 330
+ D WE ++L+FG + SG++G + T S VA+K+LK E+ +S
Sbjct: 33 EYEYD--LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADS 89
Query: 331 DMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL 389
++ E+ +M ++ H+N+V +GACT + ++ E+ G + +YL + F
Sbjct: 90 SEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSE 149
Query: 390 PS----------------------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427
LL A V+KGM +L + +HRDL A N+L+ +
Sbjct: 150 DEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK 209
Query: 428 VVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT 484
VVK+ DFG+AR +WMAPE + Y K+DV+S+GI+LWE+ +
Sbjct: 210 VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
Query: 485 -GKLPY 489
G PY
Sbjct: 270 LGVNPY 275
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 2e-61
Identities = 70/277 (25%), Positives = 128/277 (46%), Gaps = 38/277 (13%)
Query: 250 RQGWPSHRSSSPTSEPEDTGMKSHPYHLKIP---NDGTDVWEIDPKHLKFGSKVASGSYG 306
+ ++ SE + +P + ++P N E ++++ + G++G
Sbjct: 2 AMESAAVTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFG 61
Query: 307 DLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
+++ VA+K+LK E ++DMQ +F +E +M + + N+V+ +G C
Sbjct: 62 RVFQARAPGLLPYEPFTMVAVKMLK-EEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKG-----------------------VFKLPSLLKVA 396
+C++ E+M+ G + ++L + L +A
Sbjct: 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIA 180
Query: 397 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--- 453
V+ GM YL + +HRDL N L+ EN VVK+ADFG++R + A+
Sbjct: 181 RQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPI 240
Query: 454 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
RWM PE I + Y ++DV+++G+VLWE+ + G PY
Sbjct: 241 RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 1e-59
Identities = 66/230 (28%), Positives = 112/230 (48%), Gaps = 14/230 (6%)
Query: 279 IPNDGTDVWEIDP--KHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQK 334
I T + + LKF ++ GS+ +Y+G T + +VA L+ ++ ++
Sbjct: 11 IEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ 70
Query: 335 EFAQEVFIMRKVRHKNVVQFIGA----CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP 390
F +E +++ ++H N+V+F + + +VTE M+ G++ YL + V K+
Sbjct: 71 RFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIK 129
Query: 391 SLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMT 447
L + KG+ +LH IIHRDLK N+ + VK+ D G+A +K S
Sbjct: 130 VLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA 189
Query: 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 497
GT +MAPE+ E K YD DV++FG+ + E+ T + PY
Sbjct: 190 -VIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQ 237
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 4e-57
Identities = 76/227 (33%), Positives = 115/227 (50%), Gaps = 17/227 (7%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMR 344
W I+ + + SG+ + + VAIK + E+ + M E +E+ M
Sbjct: 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAMS 68
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYD-YLHKLKGVFKLPSLLK---VAI--- 397
+ H N+V + + L +V + +SGGSV D H + +L +A
Sbjct: 69 QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 398 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET------G 451
+V +G+ YLH+N IHRD+KA N+L+ E+ V++ADFGV+ A G +T G
Sbjct: 129 EVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 452 TYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 497
T WMAPEV+E + YD KAD++SFGI EL TG PY P++
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV 235
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-56
Identities = 79/237 (33%), Positives = 126/237 (53%), Gaps = 19/237 (8%)
Query: 270 MKSHPYHLKIPNDGTDVWEIDPKHL-KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPE 326
M P +P G + DP+ L K+ GS+G++++G + VAIK++ E
Sbjct: 1 MAHSPVQSGLP--GMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE 58
Query: 327 RINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV 386
+++ + QE+ ++ + V ++ G+ K L I+ E++ GGS D L G
Sbjct: 59 EAEDEIE-DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GP 115
Query: 387 FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA------RVK 440
+ + ++ KG++YLH IHRD+KAAN+L+ E+ VK+ADFGVA ++K
Sbjct: 116 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175
Query: 441 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 497
+ V GT WMAPEVI+ YD KAD++S GI EL G+ P+ L P++
Sbjct: 176 RNTFV-----GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV 227
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-55
Identities = 59/261 (22%), Positives = 101/261 (38%), Gaps = 18/261 (6%)
Query: 246 LKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSY 305
L + W S + PE + K+ + E + + +V GS+
Sbjct: 13 LASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYRE-EVHWMTHQPRVGRGSF 71
Query: 306 GDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363
G+++R A+K + ++ +E+ + +V GA + P
Sbjct: 72 GEVHRMKDKQTGFQCAVKKV-------RLEVFRVEELVACAGLSSPRIVPLYGAVREGPW 124
Query: 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
+ I E + GGS+ + K G L +G+ YLH I+H D+KA N+L+
Sbjct: 125 VNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL 183
Query: 424 DEN-EVVKVADFGVARVKAQSGVMTAET------GTYRWMAPEVIEHKPYDHKADVFSFG 476
+ + DFG A G+ + GT MAPEV+ KP D K D++S
Sbjct: 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSC 243
Query: 477 IVLWELLTGKLPYEYLTPLQA 497
++ +L G P+
Sbjct: 244 CMMLHMLNGCHPWTQYFRGPL 264
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 2e-54
Identities = 65/239 (27%), Positives = 128/239 (53%), Gaps = 9/239 (3%)
Query: 273 HPYHLKIPNDGTDVWEIDPKHLK---FGSKVASGSYGD--LYRGTYCSQDVAIKVLKPER 327
H +H + + ++ K+ GS+G L + T + IK + R
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR 61
Query: 328 INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV- 386
++S ++E +EV ++ ++H N+VQ+ + + SL IV ++ GG ++ ++ KGV
Sbjct: 62 MSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL 121
Query: 387 FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 446
F+ +L + + + ++H I+HRD+K+ N+ + ++ V++ DFG+ARV S V
Sbjct: 122 FQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV-LNSTVE 180
Query: 447 TAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503
A GT +++PE+ E+KPY++K+D+++ G VL+EL T K +E + + ++
Sbjct: 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS 239
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 5e-54
Identities = 73/222 (32%), Positives = 109/222 (49%), Gaps = 18/222 (8%)
Query: 285 DVWEIDPKHL-KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVF 341
D P+ + K+ GSYG +Y+ + Q VAIK + E +E +E+
Sbjct: 21 DSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEIS 76
Query: 342 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 401
IM++ +VV++ G+ K L IV E+ GSV D + + + K
Sbjct: 77 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLK 136
Query: 402 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA------RVKAQSGVMTAETGTYRW 455
G+ YLH IHRD+KA N+L++ K+ADFGVA K + + GT W
Sbjct: 137 GLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-----GTPFW 191
Query: 456 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 497
MAPEVI+ Y+ AD++S GI E+ GK PY + P++A
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA 233
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 1e-53
Identities = 48/241 (19%), Positives = 105/241 (43%), Gaps = 14/241 (5%)
Query: 257 RSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG--TYC 314
+S P + + + I K+ G + ++YR
Sbjct: 4 QSQGMQGPPVPQFQPQKALRPDMGYNTLANFRI-------EKKIGRGQFSEVYRAACLLD 56
Query: 315 SQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373
VA+K ++ + + +E+ +++++ H NV+++ + + L IV E
Sbjct: 57 GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA 116
Query: 374 GSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK 430
G + + K + ++ K + + + ++H ++HRD+K AN+ + VVK
Sbjct: 117 GDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVK 176
Query: 431 VADFGVARV-KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489
+ D G+ R +++ + GT +M+PE I Y+ K+D++S G +L+E+ + P+
Sbjct: 177 LGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236
Query: 490 E 490
Sbjct: 237 Y 237
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 1e-53
Identities = 71/235 (30%), Positives = 117/235 (49%), Gaps = 27/235 (11%)
Query: 276 HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ 333
H++ D +VWEI ++ G++G +Y+ A KV++ + + +
Sbjct: 10 HVRRDLDPNEVWEIV-------GELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEEL 60
Query: 334 KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL 393
+++ E+ I+ H +V+ +GA L I+ EF GG+V + +L P +
Sbjct: 61 EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ 120
Query: 394 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA------RVKAQSGVMT 447
V + + +N+LH IIHRDLKA N+LM +++ADFGV+ K S +
Sbjct: 121 VVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-- 178
Query: 448 AETGTYRWMAPEVIEH-----KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 497
GT WMAPEV+ PYD+KAD++S GI L E+ + P+ L P++
Sbjct: 179 ---GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV 230
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 4e-53
Identities = 47/206 (22%), Positives = 82/206 (39%), Gaps = 5/206 (2%)
Query: 295 KFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNV 351
+ S++ GSYG++++ + A+K + EV KV +H
Sbjct: 60 QRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCC 119
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
V+ A + L + TE G S+ + + D + +LH +
Sbjct: 120 VRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGL 178
Query: 412 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKAD 471
+H D+K AN+ + K+ DFG+ +G + G R+MAPE+++ Y AD
Sbjct: 179 VHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ-GSYGTAAD 237
Query: 472 VFSFGIVLWELLTGKLPYEYLTPLQA 497
VFS G+ + E+ Q
Sbjct: 238 VFSLGLTILEVACNMELPHGGEGWQQ 263
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 1e-52
Identities = 48/258 (18%), Positives = 97/258 (37%), Gaps = 29/258 (11%)
Query: 255 SHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASG--SYGDLYRGT 312
+H GM S + + + + G +
Sbjct: 2 AHHHHHHMENLYFQGMSSFL--------------PEGGCYELLTVIGKGFEDLMTVNLAR 47
Query: 313 YCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370
Y + V ++ + E +++M E+ + + H N+V + L +VT F
Sbjct: 48 YKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 107
Query: 371 MSGGSVYDYL-HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVV 429
M+ GS D + ++ + V K ++Y+H +HR +KA+++L+ + V
Sbjct: 108 MAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKV 167
Query: 430 KVADFGVA--------RVKAQSGVMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVL 479
++ R + W++PEV++ + YD K+D++S GI
Sbjct: 168 YLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITA 227
Query: 480 WELLTGKLPYEYLTPLQA 497
EL G +P++ + Q
Sbjct: 228 CELANGHVPFKDMPATQM 245
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 1e-52
Identities = 60/207 (28%), Positives = 108/207 (52%), Gaps = 17/207 (8%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ G+ G +Y + Q+VAI+ + + ++ E+ +MR+ ++ N+V ++
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ L +V E+++GGS+ D + + + V + + + +LH N +IHRD+
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDI 142
Query: 417 KAANLLMDENEVVKVADFGVA------RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 470
K+ N+L+ + VK+ DFG + K + V GT WMAPEV+ K Y K
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----GTPYWMAPEVVTRKAYGPKV 197
Query: 471 DVFSFGIVLWELLTGKLPYEYLTPLQA 497
D++S GI+ E++ G+ PY PL+A
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRA 224
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 1e-52
Identities = 54/222 (24%), Positives = 102/222 (45%), Gaps = 28/222 (12%)
Query: 289 IDPKHLK---FGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIM 343
+D + + SG +G +++ + + IK +K ++ +EV +
Sbjct: 5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKAL 58
Query: 344 RKVRHKNVVQFIGA----------------CTKPPSLCIVTEFMSGGSVYDYLHKLKGV- 386
K+ H N+V + G +K L I EF G++ ++ K +G
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 387 FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 446
L++ ++KG++Y+H +I+RDLK +N+ + + + VK+ DFG+ G
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178
Query: 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP 488
T GT R+M+PE I + Y + D+++ G++L ELL
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 7e-52
Identities = 65/210 (30%), Positives = 111/210 (52%), Gaps = 11/210 (5%)
Query: 297 GSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 354
+ G+YG +Y G S +AIK + +S + +E+ + + ++HKN+VQ+
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQY 84
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP-SLLKV-AIDVSKGMNYLHQNNII 412
+G+ ++ + I E + GGS+ L G K + + +G+ YLH N I+
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144
Query: 413 HRDLKAANLLMDENE-VVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKP--YDH 468
HRD+K N+L++ V+K++DFG + R+ + TGT ++MAPE+I+ P Y
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGK 204
Query: 469 KADVFSFGIVLWELLTGKLPY-EYLTPLQA 497
AD++S G + E+ TGK P+ E P A
Sbjct: 205 AADIWSLGCTIIEMATGKPPFYELGEPQAA 234
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-51
Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 17/207 (8%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ GS G + + VA+K++ ++ EV IMR +H NVV+
Sbjct: 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ L ++ EF+ GG++ D + + + V V + + YLH +IHRD+
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDI 167
Query: 417 KAANLLMDENEVVKVADFGVA------RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 470
K+ ++L+ + VK++DFG K +S V GT WMAPEVI Y +
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-----GTPYWMAPEVISRSLYATEV 222
Query: 471 DVFSFGIVLWELLTGKLPYEYLTPLQA 497
D++S GI++ E++ G+ PY +P+QA
Sbjct: 223 DIWSLGIMVIEMVDGEPPYFSDSPVQA 249
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 4e-51
Identities = 66/224 (29%), Positives = 109/224 (48%), Gaps = 12/224 (5%)
Query: 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQE 339
W+ + LK ++ G+YG + + + Q +A+K ++ ++ QK+ +
Sbjct: 12 SPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST-VDEKEQKQLLMD 70
Query: 340 V-FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDY---LHKLKGVFKLPSLLKV 395
+ +MR +VQF GA + I E MS Y L V L K+
Sbjct: 71 LDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKI 130
Query: 396 AIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 454
+ K +N+L +N IIHRD+K +N+L+D + +K+ DFG++ S T + G
Sbjct: 131 TLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRP 190
Query: 455 WMAPEVIE----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494
+MAPE I+ + YD ++DV+S GI L+EL TG+ PY
Sbjct: 191 YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS 234
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 5e-51
Identities = 74/251 (29%), Positives = 117/251 (46%), Gaps = 11/251 (4%)
Query: 254 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHL-KFGSKVASGSYGDLYRGT 312
P+ + + LK P+ ++ DP+ L ++ GS+G +Y
Sbjct: 15 PTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFAR 74
Query: 313 YCS--QDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369
+ VAIK + S + ++ +EV ++K+RH N +Q+ G + + +V E
Sbjct: 75 DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134
Query: 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVV 429
+ GS D L K + + V +G+ YLH +N+IHRD+KA N+L+ E +V
Sbjct: 135 YC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLV 193
Query: 430 KVADFGVARVKAQSGVMTAETGTYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGK 486
K+ DFG A + + GT WMAPEVI + YD K DV+S GI EL K
Sbjct: 194 KLGDFGSA---SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
Query: 487 LPYEYLTPLQA 497
P + + A
Sbjct: 251 PPLFNMNAMSA 261
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 8e-51
Identities = 58/212 (27%), Positives = 107/212 (50%), Gaps = 6/212 (2%)
Query: 281 NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQ 338
V E+ + S++ +G+ G +++ ++ +A K++ E I ++ + +
Sbjct: 22 TQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIR 80
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 398
E+ ++ + +V F GA + I E M GGS+ L K G L KV+I
Sbjct: 81 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSIA 139
Query: 399 VSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMA 457
V KG+ YL + I+HRD+K +N+L++ +K+ DFGV+ S + GT +M+
Sbjct: 140 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-VGTRSYMS 198
Query: 458 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489
PE ++ Y ++D++S G+ L E+ G+ P
Sbjct: 199 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 9e-51
Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 12/221 (5%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEV-FIMR 344
E+ L+ ++ G+YG + + + Q +A+K ++ +NS QK ++ MR
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRLLMDLDISMR 61
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGG--SVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
V V F GA + + I E M Y + L K+A+ + K
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 403 MNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI 461
+ +LH ++IHRD+K +N+L++ VK+ DFG++ + G +MAPE I
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERI 181
Query: 462 E----HKPYDHKADVFSFGIVLWELLTGKLPY-EYLTPLQA 497
K Y K+D++S GI + EL + PY + TP Q
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ 222
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 2e-50
Identities = 69/196 (35%), Positives = 115/196 (58%), Gaps = 8/196 (4%)
Query: 303 GSYGDLYRGTYCSQDVAIKVLKPERINSDMQ--KEFAQEVFIMRKVRHKNVVQFIGACTK 360
G +G +Y+G + VA+K L + + ++F QE+ +M K +H+N+V+ +G +
Sbjct: 42 GGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD 101
Query: 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKL--PSLLKVAIDVSKGMNYLHQNNIIHRDLKA 418
LC+V +M GS+ D L L G L K+A + G+N+LH+N+ IHRD+K+
Sbjct: 102 GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKS 161
Query: 419 ANLLMDENEVVKVADFGVAR---VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 475
AN+L+DE K++DFG+AR AQ+ + + GT +MAPE + + K+D++SF
Sbjct: 162 ANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITP-KSDIYSF 220
Query: 476 GIVLWELLTGKLPYEY 491
G+VL E++TG +
Sbjct: 221 GVVLLEIITGLPAVDE 236
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 4e-50
Identities = 46/227 (20%), Positives = 94/227 (41%), Gaps = 29/227 (12%)
Query: 297 GSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQ 353
K+ SG +G +++ AIK K S ++ +EV+ + +H +VV+
Sbjct: 16 LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 75
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYL---HKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 410
+ A + + I E+ +GGS+ D + +++ FK L + + V +G+ Y+H +
Sbjct: 76 YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 135
Query: 411 IIHRDLKAANLLMDEN-------------------EVVKVADFGVARVKAQSGVMTAETG 451
++H D+K +N+ + + K+ D G + E G
Sbjct: 136 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV---TRISSPQVEEG 192
Query: 452 TYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 497
R++A EV+ E+ + KAD+F+ + + +
Sbjct: 193 DSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE 239
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 9e-50
Identities = 74/225 (32%), Positives = 116/225 (51%), Gaps = 20/225 (8%)
Query: 290 DPKHL-KFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
DP + + V +G+YG +Y+G + Q AIKV+ D ++E QE+ +++K
Sbjct: 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---GDEEEEIKQEINMLKKY 77
Query: 347 -RHKNVVQFIGA------CTKPPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAID 398
H+N+ + GA L +V EF GSV D + K K + + +
Sbjct: 78 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 137
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV-ARVKAQSGVMTAETGTYRWMA 457
+ +G+++LHQ+ +IHRD+K N+L+ EN VK+ DFGV A++ G GT WMA
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 197
Query: 458 PEVIEHK-----PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 497
PEVI YD K+D++S GI E+ G P + P++A
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA 242
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-49
Identities = 59/229 (25%), Positives = 100/229 (43%), Gaps = 19/229 (8%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ G+ +++RG + AIKV + + +E +++K+ HKN+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIV 70
Query: 353 QFIGA--CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGMNYLHQ 408
+ T ++ EF GS+Y L + + LP L V DV GMN+L +
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 409 NNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-- 462
N I+HR++K N++ D V K+ DFG AR + GT ++ P++ E
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERA 190
Query: 463 ------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505
K Y D++S G+ + TG LP+ + V+ K+
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 5e-49
Identities = 54/217 (24%), Positives = 102/217 (47%), Gaps = 11/217 (5%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEV-FIM 343
++ + L+ ++ SG+ G +++ + +A+K ++ N + K ++ ++
Sbjct: 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS-GNKEENKRILMDLDVVL 78
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
+ +VQ G + I E M + +++G L K+ + + K +
Sbjct: 79 KSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKK-RMQGPIPERILGKMTVAIVKAL 137
Query: 404 NYLH-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE 462
YL ++ +IHRD+K +N+L+DE +K+ DFG++ G +MAPE I+
Sbjct: 138 YYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERID 197
Query: 463 -----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494
YD +ADV+S GI L EL TG+ PY+
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT 234
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-48
Identities = 51/222 (22%), Positives = 100/222 (45%), Gaps = 34/222 (15%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ + + G++G + + + AIK ++ + EV ++ + H+ VV
Sbjct: 9 EEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASLNHQYVV 65
Query: 353 QFIGA-------------CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
++ A K +L I E+ G++YD +H + ++ +
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV---------------KAQSG 444
+ ++Y+H IIHRDLK N+ +DE+ VK+ DFG+A+ S
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 445 VMTAETGTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELLTG 485
+T+ GT ++A EV++ Y+ K D++S GI+ +E++
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-47
Identities = 59/229 (25%), Positives = 100/229 (43%), Gaps = 19/229 (8%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ G+ +++RG + AIKV + + +E +++K+ HKN+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIV 70
Query: 353 QFIGA--CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGMNYLHQ 408
+ T ++ EF GS+Y L + + LP L V DV GMN+L +
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 409 NNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-- 462
N I+HR++K N++ D V K+ DFG AR + GT ++ P++ E
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERA 190
Query: 463 ------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505
K Y D++S G+ + TG LP+ + V+ K+
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 5e-47
Identities = 51/250 (20%), Positives = 100/250 (40%), Gaps = 30/250 (12%)
Query: 269 GMKSHPYHLKIPNDGTD----VWEIDPKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKV 322
G H +H + + ID KH F K+ G + + G + A+K
Sbjct: 2 GSSHHHHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKR 61
Query: 323 LKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPS----LCIVTEFMSGGSVY 377
+ + +E A +E + R H N+++ + C + ++ F G+++
Sbjct: 62 I---LCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLW 118
Query: 378 DYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 434
+ + +LK +L + + + +G+ +H HRDLK N+L+ + + D
Sbjct: 119 NEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDL 178
Query: 435 GVARVK----------AQSGVMTAETGTYRWMAPEVIEHKPY---DHKADVFSFGIVLWE 481
G A+ T + APE+ + + D + DV+S G VL+
Sbjct: 179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYA 238
Query: 482 LLTGKLPYEY 491
++ G+ PY+
Sbjct: 239 MMFGEGPYDM 248
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-46
Identities = 48/212 (22%), Positives = 92/212 (43%), Gaps = 30/212 (14%)
Query: 302 SGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC- 358
G +G + + AIK ++ +++ +EV + K+ H +V++ A
Sbjct: 15 RGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWL 73
Query: 359 -----------TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKGMNY 405
+ L I + ++ D+++ + + L + + +++ + +
Sbjct: 74 EKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEF 133
Query: 406 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-------------KAQSGVMTAETGT 452
LH ++HRDLK +N+ ++VVKV DFG+ T + GT
Sbjct: 134 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGT 193
Query: 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT 484
+M+PE I Y HK D+FS G++L+ELL
Sbjct: 194 KLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-46
Identities = 54/203 (26%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 302 SGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA-- 357
+GSYG R + + K L + ++ EV ++R+++H N+V++
Sbjct: 16 TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75
Query: 358 CTKPPSLCIVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQ-----N 409
+L IV E+ GG + + K +L+V ++ + H+ +
Sbjct: 76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGH 135
Query: 410 NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYD 467
++HRDLK AN+ +D + VK+ DFG+AR+ A+T GT +M+PE + Y+
Sbjct: 136 TVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKTFVGTPYYMSPEQMNRMSYN 194
Query: 468 HKADVFSFGIVLWELLTGKLPYE 490
K+D++S G +L+EL P+
Sbjct: 195 EKSDIWSLGCLLYELCALMPPFT 217
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-46
Identities = 45/232 (19%), Positives = 100/232 (43%), Gaps = 20/232 (8%)
Query: 295 KFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--V 351
++ SG +++ Q AIK + E ++ + E+ + K++ + +
Sbjct: 12 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 71
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
++ + +V E + +L K K ++ + ++ +HQ+ I
Sbjct: 72 IRLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGI 129
Query: 412 IHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAET--GTYRWMAPEVIEHKP--- 465
+H DLK AN L+ + ++K+ DFG+A ++ + + ++ GT +M PE I+
Sbjct: 130 VHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188
Query: 466 --------YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSF 509
K+DV+S G +L+ + GK P++ + + + + +H
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 240
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-46
Identities = 46/259 (17%), Positives = 105/259 (40%), Gaps = 20/259 (7%)
Query: 252 GWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG 311
G ++ + D+ K + + + + ++ SG +++
Sbjct: 16 GMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQV 75
Query: 312 TYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--VVQFIGACTKPPSLCIVT 368
Q AIK + E ++ + E+ + K++ + +++ + +V
Sbjct: 76 LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135
Query: 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
E + +L K K ++ + ++ +HQ+ I+H DLK AN L+ + +
Sbjct: 136 EC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-M 192
Query: 429 VKVADFGVAR-VKAQSGVMTAET--GTYRWMAPEVIEHKP-----------YDHKADVFS 474
+K+ DFG+A ++ + + ++ G +M PE I+ K+DV+S
Sbjct: 193 LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS 252
Query: 475 FGIVLWELLTGKLPYEYLT 493
G +L+ + GK P++ +
Sbjct: 253 LGCILYYMTYGKTPFQQII 271
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 5e-46
Identities = 46/219 (21%), Positives = 94/219 (42%), Gaps = 20/219 (9%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
+ + ++ SG +++ Q AIK + E ++ + E+ + K++
Sbjct: 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 84
Query: 348 HKN--VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 405
+ +++ + +V E + +L K K ++ + ++
Sbjct: 85 QHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHT 142
Query: 406 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIE 462
+HQ+ I+H DLK AN L+ + ++K+ DFG+A S V ++ GT +M PE I+
Sbjct: 143 IHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201
Query: 463 HKP-----------YDHKADVFSFGIVLWELLTGKLPYE 490
K+DV+S G +L+ + GK P++
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 7e-46
Identities = 61/203 (30%), Positives = 108/203 (53%), Gaps = 15/203 (7%)
Query: 302 SGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQ--KEFAQEVFIMRKVRHKNVVQFIGAC 358
G +G +Y+G VA+K PE Q +EF E+ + RH ++V IG C
Sbjct: 49 HGVFGKVYKGVLRDGAKVALKRRTPE----SSQGIEEFETEIETLSFCRHPHLVSLIGFC 104
Query: 359 TKPPSLCIVTEFMSGGSVYDYLH-KLKGVFKL--PSLLKVAIDVSKGMNYLHQNNIIHRD 415
+ + ++ ++M G++ +L+ + L++ I ++G++YLH IIHRD
Sbjct: 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRD 164
Query: 416 LKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPE-VIEHKPYDHKAD 471
+K+ N+L+DEN V K+ DFG+++ + + T GT ++ PE I+ + + K+D
Sbjct: 165 VKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTE-KSD 223
Query: 472 VFSFGIVLWELLTGKLPYEYLTP 494
V+SFG+VL+E+L + P
Sbjct: 224 VYSFGVVLFEVLCARSAIVQSLP 246
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-45
Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 295 KFGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ ++ +G +G + R + VAIK + E + ++ + E+ IM+K+ H NVV
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER-WCLEIQIMKKLNHPNVV 75
Query: 353 QFI------GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGMN 404
+ E+ GG + YL++ + L + + D+S +
Sbjct: 76 SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 405 YLHQNNIIHRDLKAANLLMDENE---VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI 461
YLH+N IIHRDLK N+++ + K+ D G A+ Q + T GT +++APE++
Sbjct: 136 YLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL 195
Query: 462 EHKPYDHKADVFSFGIVLWELLTGKLPYE 490
E K Y D +SFG + +E +TG P+
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRPFL 224
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-44
Identities = 53/193 (27%), Positives = 93/193 (48%), Gaps = 6/193 (3%)
Query: 303 GSYGDLYRGTYCS--QDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
GS+ +YR +VAIK++ K + M + EV I +++H ++++
Sbjct: 22 GSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE 81
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
+ +V E G + YL F + GM YLH + I+HRDL +
Sbjct: 82 DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLS 141
Query: 420 NLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGI 477
NLL+ N +K+ADFG+A + + T GT +++PE+ + ++DV+S G
Sbjct: 142 NLLLTRNMNIKIADFGLA-TQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGC 200
Query: 478 VLWELLTGKLPYE 490
+ + LL G+ P++
Sbjct: 201 MFYTLLIGRPPFD 213
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-44
Identities = 67/206 (32%), Positives = 108/206 (52%), Gaps = 10/206 (4%)
Query: 299 KVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357
+ G +G +Y+G VA+K LK ER + +F EV ++ H+N+++ G
Sbjct: 37 ILGRGGFGKVYKGRLADGTLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGF 95
Query: 358 CTKPPSLCIVTEFMSGGSVYDYLH-KLKGVFKL--PSLLKVAIDVSKGMNYLHQN---NI 411
C P +V +M+ GSV L + + L P ++A+ ++G+ YLH + I
Sbjct: 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKI 155
Query: 412 IHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGTYRWMAPEVIEHKPYDHK 469
IHRD+KAAN+L+DE V DFG+A++ + V TA GT +APE + K
Sbjct: 156 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 215
Query: 470 ADVFSFGIVLWELLTGKLPYEYLTPL 495
DVF +G++L EL+TG+ ++
Sbjct: 216 TDVFGYGVMLLELITGQRAFDLARLA 241
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 3e-44
Identities = 57/209 (27%), Positives = 101/209 (48%), Gaps = 8/209 (3%)
Query: 289 IDPKHLK---FGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERI-NSDMQKEFAQEVFI 342
+DP+ + G + G + + + + A K++ + +++ + E+ I
Sbjct: 9 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISI 68
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
R + H++VV F G + +V E S+ + K + P + G
Sbjct: 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLG 127
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVI 461
YLH+N +IHRDLK NL ++E+ VK+ DFG+A +V+ GT ++APEV+
Sbjct: 128 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL 187
Query: 462 EHKPYDHKADVFSFGIVLWELLTGKLPYE 490
K + + DV+S G +++ LL GK P+E
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-44
Identities = 61/244 (25%), Positives = 106/244 (43%), Gaps = 10/244 (4%)
Query: 254 PSHRSSSPTSEPEDTGMKSH---PYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYR 310
P+ P + P +IP D + G + G + +
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSR--RRYVRGRFLGKGGFAKCFE 59
Query: 311 GT--YCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367
+ + A K++ + +++ + E+ I R + H++VV F G + +V
Sbjct: 60 ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119
Query: 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427
E S+ + K + P + G YLH+N +IHRDLK NL ++E+
Sbjct: 120 LELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL 178
Query: 428 VVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK 486
VK+ DFG+A +V+ GT ++APEV+ K + + DV+S G +++ LL GK
Sbjct: 179 EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
Query: 487 LPYE 490
P+E
Sbjct: 239 PPFE 242
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 7e-44
Identities = 53/191 (27%), Positives = 95/191 (49%), Gaps = 5/191 (2%)
Query: 303 GSYGDLY--RGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
G +G++Y R +A+KVL ++ ++ + +E+ I +RH N+++
Sbjct: 25 GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
+ ++ EF G +Y L K G F +++ ++Y H+ +IHRD+K
Sbjct: 85 DRKRIYLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPE 143
Query: 420 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 479
NLLM +K+ADFG + T GT ++ PE+IE K +D K D++ G++
Sbjct: 144 NLLMGYKGELKIADFGWSVHAPSLRRRTM-CGTLDYLPPEMIEGKTHDEKVDLWCAGVLC 202
Query: 480 WELLTGKLPYE 490
+E L G P++
Sbjct: 203 YEFLVGMPPFD 213
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-43
Identities = 55/191 (28%), Positives = 98/191 (51%), Gaps = 5/191 (2%)
Query: 303 GSYGDLY--RGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
G +G++Y R +A+KVL ++ + ++ + +EV I +RH N+++ G
Sbjct: 20 GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
+ ++ E+ G+VY L K F +++ ++Y H +IHRD+K
Sbjct: 80 DATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 138
Query: 420 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 479
NLL+ +K+ADFG + S GT ++ PE+IE + +D K D++S G++
Sbjct: 139 NLLLGSAGELKIADFGWSVHAPSSRRTDL-CGTLDYLPPEMIEGRMHDEKVDLWSLGVLC 197
Query: 480 WELLTGKLPYE 490
+E L GK P+E
Sbjct: 198 YEFLVGKPPFE 208
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-41
Identities = 44/221 (19%), Positives = 89/221 (40%), Gaps = 26/221 (11%)
Query: 295 KFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI---------------NSDMQKEFAQE 339
+ + G + + ++ A+K + + +F E
Sbjct: 34 RIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNE 93
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-------KGVFKLPSL 392
+ I+ ++++ + G T + I+ E+M S+ + + +
Sbjct: 94 LQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI 153
Query: 393 LKVAIDVSKGMNYLH-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG 451
+ V +Y+H + NI HRD+K +N+LMD+N VK++DFG + + G
Sbjct: 154 KCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES-EYMVDKKIKGSRG 212
Query: 452 TYRWMAPEVIEHKP--YDHKADVFSFGIVLWELLTGKLPYE 490
TY +M PE ++ K D++S GI L+ + +P+
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 152 bits (384), Expect = 1e-41
Identities = 47/280 (16%), Positives = 104/280 (37%), Gaps = 43/280 (15%)
Query: 235 EQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHL 294
++L L L P SS P + + + +K + +++ K +
Sbjct: 24 DKLIFKL------LSGLSKPV--SSYPNTFEWQCKLPA----IKPKTE----FQLGSKLV 67
Query: 295 KFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
+ G++ +Y T Q +KV KP + Q + ++
Sbjct: 68 YVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW-EFYIGT-QLMERLKPSM 125
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK----GVFKLPSLLKVAIDVSKGM 403
++F A +V E S G++ + ++ K V ++ A+ + +
Sbjct: 126 QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMI 185
Query: 404 NYLHQNNIIHRDLKAANLLM-----------DENEVVKVADFGVA---RVKAQSGVMTAE 449
+H IIH D+K N ++ D + + + D G + ++ + + TA+
Sbjct: 186 EQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245
Query: 450 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489
T + E++ +KP++++ D F ++ +L G
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK 285
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 5e-40
Identities = 61/191 (31%), Positives = 104/191 (54%), Gaps = 4/191 (2%)
Query: 303 GSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360
G++ + + ++VAIK++ ++N ++ +EV IM+ + H N+V+
Sbjct: 26 GNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET 85
Query: 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420
+L ++ E+ SGG V+DYL G K + + Y HQ I+HRDLKA N
Sbjct: 86 EKTLYLIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAEN 144
Query: 421 LLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSFGIVL 479
LL+D + +K+ADFG + G + A G + APE+ + K YD + DV+S G++L
Sbjct: 145 LLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVIL 204
Query: 480 WELLTGKLPYE 490
+ L++G LP++
Sbjct: 205 YTLVSGSLPFD 215
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 6e-40
Identities = 55/246 (22%), Positives = 105/246 (42%), Gaps = 33/246 (13%)
Query: 259 SSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGD-LYRGTYCSQD 317
SSP+ E +D ++ T V + + G+ G +YRG + ++D
Sbjct: 3 SSPSLEQDD------------GDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRD 50
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376
VA+K RI + +EV ++R+ H NV+++ I E ++
Sbjct: 51 VAVK-----RILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATL 104
Query: 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-----VVKV 431
+Y+ + + + + G+ +LH NI+HRDLK N+L+ +
Sbjct: 105 QEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMI 164
Query: 432 ADFGVARV----KAQSGVMTAETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLT 484
+DFG+ + + + GT W+APE++ + + D+FS G V + +++
Sbjct: 165 SDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224
Query: 485 -GKLPY 489
G P+
Sbjct: 225 EGSHPF 230
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-39
Identities = 59/264 (22%), Positives = 109/264 (41%), Gaps = 43/264 (16%)
Query: 259 SSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLY--RGTYCSQ 316
+ P S +G + G V E+ L+ +A G + +Y + +
Sbjct: 2 AGPGSLGGASGRDQSDF------VGQTV-ELGELRLRVRRVLAEGGFAFVYEAQDVGSGR 54
Query: 317 DVAIK-VLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPS--------LCI 366
+ A+K +L + + QEV M+K+ H N+VQF A + +
Sbjct: 55 EYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLL 111
Query: 367 VTEFMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLL 422
+TE G + ++L + +G ++LK+ + + ++H+ IIHRDLK NLL
Sbjct: 112 LTEL-CKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLL 170
Query: 423 MDENEVVKVADFGVARVKAQSGVMTAET-------------GTYRWMAPEVIE---HKPY 466
+ +K+ DFG A + + T + PE+I+ + P
Sbjct: 171 LSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI 230
Query: 467 DHKADVFSFGIVLWELLTGKLPYE 490
K D+++ G +L+ L + P+E
Sbjct: 231 GEKQDIWALGCILYLLCFRQHPFE 254
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 7e-39
Identities = 54/192 (28%), Positives = 109/192 (56%), Gaps = 5/192 (2%)
Query: 303 GSYGDLYRGTYCS--QDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
G++G + G + VA+K+L ++I S D+ + +E+ ++ RH ++++ +
Sbjct: 22 GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS 81
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
P +V E++SGG ++DY+ K G + ++ + ++Y H++ ++HRDLK
Sbjct: 82 TPTDFFMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPE 140
Query: 420 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSFGIV 478
N+L+D + K+ADFG++ + + + G+ + APEVI + Y + D++S G++
Sbjct: 141 NVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVI 200
Query: 479 LWELLTGKLPYE 490
L+ LL G LP++
Sbjct: 201 LYALLCGTLPFD 212
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 58/202 (28%), Positives = 106/202 (52%), Gaps = 7/202 (3%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 349
+ + GS+G++ + Q+ A+KV+ + +EV +++K+ H
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
N+++ S IV E +GG ++D + K + F ++ V G+ Y+H++
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 410 NIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 466
NI+HRDLK N+L+ +++ +K+ DFG++ Q+ M GT ++APEV+ Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTY 199
Query: 467 DHKADVFSFGIVLWELLTGKLP 488
D K DV+S G++L+ LL+G P
Sbjct: 200 DEKCDVWSAGVILYILLSGTPP 221
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-38
Identities = 58/195 (29%), Positives = 103/195 (52%), Gaps = 8/195 (4%)
Query: 302 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
G+YG++ + VA+K++ +R D + +E+ I + + H+NVV+F G
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
+ + E+ SGG ++D + P + + G+ YLH I HRD+K
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE 134
Query: 420 NLLMDENEVVKVADFG---VARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSF 475
NLL+DE + +K++DFG V R + ++ GT ++APE+++ + + DV+S
Sbjct: 135 NLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 194
Query: 476 GIVLWELLTGKLPYE 490
GIVL +L G+LP++
Sbjct: 195 GIVLTAMLAGELPWD 209
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-38
Identities = 47/199 (23%), Positives = 101/199 (50%), Gaps = 6/199 (3%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
++ G++ + R + + + A K++ +++++ ++ +E I RK++H N+V
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
+ + + +V + ++GG +++ + + + + + + Y H N I+
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIV 127
Query: 413 HRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK 469
HR+LK NLL+ + VK+ADFG+A S GT +++PEV++ PY
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKP 187
Query: 470 ADVFSFGIVLWELLTGKLP 488
D+++ G++L+ LL G P
Sbjct: 188 VDIWACGVILYILLVGYPP 206
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-38
Identities = 61/239 (25%), Positives = 115/239 (48%), Gaps = 21/239 (8%)
Query: 270 MKSHPYHLKIPNDGTDVWEIDP--------------KHLKFGSKVASGSYGDLYRGTYCS 315
M H +H + ++ + + K+ SG+YG++
Sbjct: 1 MHHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV 60
Query: 316 --QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373
+ AIK+++ +++ + +EV +++ + H N+++ + +V E G
Sbjct: 61 THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120
Query: 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVK 430
G ++D + + F + V G+ YLH++NI+HRDLK NLL+ +++ ++K
Sbjct: 121 GELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIK 179
Query: 431 VADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489
+ DFG++ V M GT ++APEV+ K YD K DV+S G++L+ LL G P+
Sbjct: 180 IVDFGLSAVFENQKKMKERLGTAYYIAPEVL-RKKYDEKCDVWSIGVILFILLAGYPPF 237
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-38
Identities = 58/202 (28%), Positives = 106/202 (52%), Gaps = 7/202 (3%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 349
+ + GS+G++ + Q+ A+KV+ + +EV +++K+ H
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
N+++ S IV E +GG ++D + K + F ++ V G+ Y+H++
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 410 NIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 466
NI+HRDLK N+L+ +++ +K+ DFG++ Q+ M GT ++APEV+ Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTY 199
Query: 467 DHKADVFSFGIVLWELLTGKLP 488
D K DV+S G++L+ LL+G P
Sbjct: 200 DEKCDVWSAGVILYILLSGTPP 221
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-38
Identities = 59/229 (25%), Positives = 100/229 (43%), Gaps = 36/229 (15%)
Query: 295 KFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERI------------------------ 328
++ GSYG L + A+KVL +++
Sbjct: 16 TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75
Query: 329 NSDMQKEFAQEVFIMRKVRHKNVVQF---IGACTKPPSLCIVTEFMSGGSVYDYLHKLKG 385
++ QE+ I++K+ H NVV+ + + L +V E ++ G V +
Sbjct: 76 PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNED-HLYMVFELVNQGPVMEVPTL--K 132
Query: 386 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 445
D+ KG+ YLH IIHRD+K +NLL+ E+ +K+ADFGV+ S
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 446 MTAET-GTYRWMAPEVI--EHKPYD-HKADVFSFGIVLWELLTGKLPYE 490
+ + T GT +MAPE + K + DV++ G+ L+ + G+ P+
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-37
Identities = 55/207 (26%), Positives = 104/207 (50%), Gaps = 6/207 (2%)
Query: 297 GSKVASGSYGDLYRG--TYCSQDVAIKVLKPE-RINSDMQKEFAQEVFIMRKVRHKNVVQ 353
K+ G +Y T + VAIK + R + K F +EV ++ H+N+V
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
I + +V E++ G ++ +Y+ G + + + + G+ + H I+H
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRIVH 134
Query: 414 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKAD 471
RD+K N+L+D N+ +K+ DFG+A+ +++ + GT ++ +PE + + D D
Sbjct: 135 RDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTD 194
Query: 472 VFSFGIVLWELLTGKLPYEYLTPLQAA 498
++S GIVL+E+L G+ P+ T + A
Sbjct: 195 IYSIGIVLYEMLVGEPPFNGETAVSIA 221
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-37
Identities = 51/205 (24%), Positives = 96/205 (46%), Gaps = 10/205 (4%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 349
F K+ SG++GD++ S + IK + +R M++ E+ +++ + H
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQ-IEAEIEVLKSLDHP 80
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---HKLKGVFKLPSLLKVAIDVSKGMNYL 406
N+++ ++ IV E GG + + + + ++ + + Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 407 HQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH 463
H +++H+DLK N+L + +K+ DFG+A + T GT +MAPEV
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF-K 199
Query: 464 KPYDHKADVFSFGIVLWELLTGKLP 488
+ K D++S G+V++ LLTG LP
Sbjct: 200 RDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-37
Identities = 58/195 (29%), Positives = 103/195 (52%), Gaps = 8/195 (4%)
Query: 302 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
G+YG++ + VA+K++ +R D + +E+ I + + H+NVV+F G
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
+ + E+ SGG ++D + P + + G+ YLH I HRD+K
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE 134
Query: 420 NLLMDENEVVKVADFG---VARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSF 475
NLL+DE + +K++DFG V R + ++ GT ++APE+++ + + DV+S
Sbjct: 135 NLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 194
Query: 476 GIVLWELLTGKLPYE 490
GIVL +L G+LP++
Sbjct: 195 GIVLTAMLAGELPWD 209
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-37
Identities = 57/204 (27%), Positives = 106/204 (51%), Gaps = 8/204 (3%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRH 348
K + GS+G++ Q+ A+KV+ K + ++ +EV +++++ H
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
N+++ +V E +GG ++D + + F ++ V G+ Y+H+
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHK 144
Query: 409 NNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKP 465
N I+HRDLK NLL+ ++ +++ DFG++ S M + GT ++APEV+ H
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGT 203
Query: 466 YDHKADVFSFGIVLWELLTGKLPY 489
YD K DV+S G++L+ LL+G P+
Sbjct: 204 YDEKCDVWSTGVILYILLSGCPPF 227
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 9e-37
Identities = 52/208 (25%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERI------NSDMQKEFAQEVFIMRKV 346
+ SG+ G++ + VAI+++ + +D E+ I++K+
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
H +++ IV E M GG ++D + K + + + YL
Sbjct: 198 NHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYL 255
Query: 407 HQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE- 462
H+N IIHRDLK N+L+ +E+ ++K+ DFG +++ ++ +M GT ++APEV+
Sbjct: 256 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVS 315
Query: 463 --HKPYDHKADVFSFGIVLWELLTGKLP 488
Y+ D +S G++L+ L+G P
Sbjct: 316 VGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-36
Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 9/202 (4%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 349
++ + + GS+G++ A K + + F QE+ IM+ + H
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHP 66
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
N+++ + +V E +GG +++ + K VF+ ++ DV + Y H+
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 410 NIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 466
N+ HRDLK N L + +K+ DFG+A +M + GT +++P+V+ Y
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL-EGLY 184
Query: 467 DHKADVFSFGIVLWELLTGKLP 488
+ D +S G++++ LL G P
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPP 206
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 65/213 (30%), Positives = 107/213 (50%), Gaps = 12/213 (5%)
Query: 297 GSKVASGSYGDLYRG--TYCSQDVAIKVLKPE-RINSDMQKEFAQEVFIMRKVRHKNVVQ 353
G + G +++ +DVA+KVL+ + + F +E + H +V
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 354 F--IGACTKPPSLC--IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
G P IV E++ G ++ D +H +G ++V D + +N+ HQN
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQN 135
Query: 410 NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET----GTYRWMAPEVIEHKP 465
IIHRD+K AN+++ VKV DFG+AR A SG +T GT ++++PE
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 195
Query: 466 YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA 498
D ++DV+S G VL+E+LTG+ P+ +P+ A
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA 228
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 61/192 (31%), Positives = 107/192 (55%), Gaps = 6/192 (3%)
Query: 303 GSYGDLYRGTYCS--QDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
GS+G + T+ Q VA+K + + + SDM +E+ ++ +RH ++++ T
Sbjct: 20 GSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT 79
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
P + +V E+ +GG ++DY+ + K + + + Y H++ I+HRDLK
Sbjct: 80 TPTDIVMVIEY-AGGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPE 137
Query: 420 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSFGIV 478
NLL+D+N VK+ADFG++ + + G+ + APEVI K Y + DV+S GIV
Sbjct: 138 NLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIV 197
Query: 479 LWELLTGKLPYE 490
L+ +L G+LP++
Sbjct: 198 LYVMLVGRLPFD 209
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 47/199 (23%), Positives = 101/199 (50%), Gaps = 6/199 (3%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
++ G++ + R + + + A K++ +++++ ++ +E I RK++H N+V
Sbjct: 32 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 91
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
+ + + +V + ++GG +++ + + + + + + Y H N I+
Sbjct: 92 RLHDSIQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIV 150
Query: 413 HRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK 469
HR+LK NLL+ + VK+ADFG+A S GT +++PEV++ PY
Sbjct: 151 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKP 210
Query: 470 ADVFSFGIVLWELLTGKLP 488
D+++ G++L+ LL G P
Sbjct: 211 VDIWACGVILYILLVGYPP 229
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-36
Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS--DMQKEFAQEVFIMRKVRHKN 350
G + GSYG + A+K+LK +++ + + +E+ ++R++RHKN
Sbjct: 8 LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKN 67
Query: 351 VVQF---IGACTKPPSLCIVTEFMSGGS--VYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 405
V+Q + K + +V E+ G + D + + F + + G+ Y
Sbjct: 68 VIQLVDVLYNEEKQ-KMYMVMEYCVCGMQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEY 124
Query: 406 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIE 462
LH I+H+D+K NLL+ +K++ GVA A G+ + PE+
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184
Query: 463 -HKPYD-HKADVFSFGIVLWELLTGKLPYE 490
+ K D++S G+ L+ + TG P+E
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 9e-36
Identities = 42/192 (21%), Positives = 80/192 (41%), Gaps = 15/192 (7%)
Query: 309 YRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368
++ + + + + ++ M KN V + + L I
Sbjct: 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQM 140
Query: 369 EFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+ ++ D++++ + L + I +++ + +LH ++HRDLK +N+ +
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD 200
Query: 427 EVVKVADFGVARV-------------KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 473
+VVKV DFG+ T + GT +M+PE I Y HK D+F
Sbjct: 201 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIF 260
Query: 474 SFGIVLWELLTG 485
S G++L+ELL
Sbjct: 261 SLGLILFELLYS 272
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 9e-36
Identities = 55/192 (28%), Positives = 110/192 (57%), Gaps = 5/192 (2%)
Query: 303 GSYGDLYRGTYCS--QDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
G++G + G + VA+K+L ++I S D+ + +E+ ++ RH ++++ +
Sbjct: 27 GTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS 86
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
P + +V E++SGG ++DY+ K G ++ + G++Y H++ ++HRDLK
Sbjct: 87 TPSDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPE 145
Query: 420 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSFGIV 478
N+L+D + K+ADFG++ + + + G+ + APEVI + Y + D++S G++
Sbjct: 146 NVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVI 205
Query: 479 LWELLTGKLPYE 490
L+ LL G LP++
Sbjct: 206 LYALLCGTLPFD 217
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-35
Identities = 57/200 (28%), Positives = 104/200 (52%), Gaps = 11/200 (5%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNV 351
F + SG++ +++ + A+K + K E+ +++K++H+N+
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS---LENEIAVLKKIKHENI 68
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
V +V + +SGG ++D + + +GV+ V V + YLH+N I
Sbjct: 69 VTLEDIYESTTHYYLVMQLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGI 127
Query: 412 IHRDLKAANLL---MDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 468
+HRDLK NLL +EN + + DFG+++++ Q+G+M+ GT ++APEV+ KPY
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKME-QNGIMSTACGTPGYVAPEVLAQKPYSK 186
Query: 469 KADVFSFGIVLWELLTGKLP 488
D +S G++ + LL G P
Sbjct: 187 AVDCWSIGVITYILLCGYPP 206
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 57/194 (29%), Positives = 94/194 (48%), Gaps = 9/194 (4%)
Query: 302 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
SG++G + VA+K ++ + + +E+ R +RH N+V+F
Sbjct: 30 SGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
P L I+ E+ SGG +Y+ + G F + G++Y H I HRDLK
Sbjct: 87 TPTHLAIIMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLE 145
Query: 420 NLLMDENEV--VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSFG 476
N L+D + +K+ DFG ++ + GT ++APEV+ + YD ADV+S G
Sbjct: 146 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCG 205
Query: 477 IVLWELLTGKLPYE 490
+ L+ +L G P+E
Sbjct: 206 VTLYVMLVGAYPFE 219
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 55/247 (22%), Positives = 95/247 (38%), Gaps = 53/247 (21%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVL---KPERINSDMQKEFAQEVFIMRKVRHK 349
+ GSYG + AIK++ K +IN + EV +M+K+ H
Sbjct: 29 HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL---------------- 393
N+ + +C+V E GG + D L+ +
Sbjct: 89 NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 394 -----------------------KVAIDVSKGMNYLHQNNIIHRDLKAANLLM--DENEV 428
+ + ++YLH I HRD+K N L +++
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFE 208
Query: 429 VKVADFGVARV-----KAQSGVMTAETGTYRWMAPEVIE--HKPYDHKADVFSFGIVLWE 481
+K+ DFG+++ + MT + GT ++APEV+ ++ Y K D +S G++L
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268
Query: 482 LLTGKLP 488
LL G +P
Sbjct: 269 LLMGAVP 275
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 43/200 (21%), Positives = 101/200 (50%), Gaps = 7/200 (3%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ ++ G++ + R Q+ A ++ +++++ ++ +E I R ++H N+V
Sbjct: 14 QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
+ + ++ ++ + ++GG +++ + + + + + + + HQ ++
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVV 132
Query: 413 HRDLKAANLLM---DENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPYDH 468
HR+LK NLL+ + VK+ADFG+A V+ + GT +++PEV+ PY
Sbjct: 133 HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGK 192
Query: 469 KADVFSFGIVLWELLTGKLP 488
D+++ G++L+ LL G P
Sbjct: 193 PVDLWACGVILYILLVGYPP 212
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 48/206 (23%), Positives = 96/206 (46%), Gaps = 11/206 (5%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA------QEVFIMRKV 346
S + SG++G ++ ++V +K +K E++ D E E+ I+ +V
Sbjct: 27 STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86
Query: 347 RHKNVVQFIGACTKPPSLCIVTEF-MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 405
H N+++ + +V E SG ++ ++ + P + + + Y
Sbjct: 87 EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGY 145
Query: 406 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKP 465
L +IIHRD+K N+++ E+ +K+ DFG A + + GT + APEV+ P
Sbjct: 146 LRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNP 205
Query: 466 YD-HKADVFSFGIVLWELLTGKLPYE 490
Y + +++S G+ L+ L+ + P+
Sbjct: 206 YRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 4e-35
Identities = 32/298 (10%), Positives = 87/298 (29%), Gaps = 42/298 (14%)
Query: 237 LRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKF 296
+R L++E + + + + E + + + + + LK
Sbjct: 11 MRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQ----GERKLKL 66
Query: 297 GSKVASGSYGDLYRGTYCS--QDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQ 353
+ G ++ +D A+KV + + + F ++ ++ +
Sbjct: 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEE 126
Query: 354 FIGAC--------------------------TKPPSLCIVTEFMSG-----GSVYDYLHK 382
+ ++ S S D+++
Sbjct: 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYV 186
Query: 383 LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442
+G + +L + + + L ++H NL + + + + D
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246
Query: 443 SGVMTAETGTYRWMAPEVIEHK--PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA 498
G ++ TY E + + H + + G+ ++ + LP+ +TP
Sbjct: 247 RGPASSVPVTY--APREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-35
Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERI------NSDMQKEFAQEVFIMRKV 346
+ SG+ G++ + VAIK++ + +D E+ I++K+
Sbjct: 13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
H +++ IV E M GG ++D + K + + + YL
Sbjct: 73 NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYL 130
Query: 407 HQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE- 462
H+N IIHRDLK N+L+ +E+ ++K+ DFG +++ ++ +M GT ++APEV+
Sbjct: 131 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVS 190
Query: 463 --HKPYDHKADVFSFGIVLWELLTGKLP 488
Y+ D +S G++L+ L+G P
Sbjct: 191 VGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-35
Identities = 58/247 (23%), Positives = 111/247 (44%), Gaps = 14/247 (5%)
Query: 247 KLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYG 306
L + SS T+ P + ++ + + S++ G+
Sbjct: 12 DLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDAL----SDFFEVESELGRGATS 67
Query: 307 DLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364
+YR + A+KVLK ++ E+ ++ ++ H N+++ P +
Sbjct: 68 IVYRCKQKGTQKPYALKVLKKTVDKKIVR----TEIGVLLRLSHPNIIKLKEIFETPTEI 123
Query: 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM- 423
+V E ++GG ++D + + KG + + + + YLH+N I+HRDLK NLL
Sbjct: 124 SLVLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYA 182
Query: 424 --DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWE 481
+ +K+ADFG++++ +M GT + APE++ Y + D++S GI+ +
Sbjct: 183 TPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYI 242
Query: 482 LLTGKLP 488
LL G P
Sbjct: 243 LLCGFEP 249
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 9e-35
Identities = 52/201 (25%), Positives = 102/201 (50%), Gaps = 11/201 (5%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ----KEFAQEVFIMRKVRH 348
+ G ++ SG + + + ++ A K +K R++S + +E +EV I+R++RH
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
N++ + ++ E +SGG ++D+L + K + + G++YLH
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHS 126
Query: 409 NNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 464
I H DLK N+++ N +K+ DFG+A GT ++APE++ ++
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 186
Query: 465 PYDHKADVFSFGIVLWELLTG 485
P +AD++S G++ + LL+G
Sbjct: 187 PLGLEADMWSIGVITYILLSG 207
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 14/207 (6%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSD---MQKEFAQEVFIMRKVRHK 349
+ + G + + R Q A+K++ + S ++ +E I ++H
Sbjct: 27 ELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHP 86
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK----GMNY 405
++V+ + + L +V EFM G + + K + VA + + Y
Sbjct: 87 HIVELLETYSSDGMLYMVFEFMDGADLCFEIVK-RADAGFVYSEAVASHYMRQILEALRY 145
Query: 406 LHQNNIIHRDLKAANLLM---DENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVI 461
H NNIIHRD+K +L+ + + VK+ FGVA + V GT +MAPEV+
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 462 EHKPYDHKADVFSFGIVLWELLTGKLP 488
+ +PY DV+ G++L+ LL+G LP
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-34
Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 17/210 (8%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS-------DMQKEFAQEVFIMRK 345
+ + G + R + ++ A+K++ S ++++ +EV I+RK
Sbjct: 20 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79
Query: 346 V-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 404
V H N++Q +V + M G ++DYL + K K+ + + +
Sbjct: 80 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVIC 138
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-- 462
LH+ NI+HRDLK N+L+D++ +K+ DFG + + GT ++APE+IE
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECS 198
Query: 463 ----HKPYDHKADVFSFGIVLWELLTGKLP 488
H Y + D++S G++++ LL G P
Sbjct: 199 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 48/194 (24%), Positives = 93/194 (47%), Gaps = 7/194 (3%)
Query: 302 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFIGAC 358
G + + + S Q+ A K LK R D + E E+ ++ + V+
Sbjct: 39 RGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98
Query: 359 TKPPSLCIVTEFMSGGSVYDYL-HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 417
+ ++ E+ +GG ++ +L + ++++ + +G+ YLHQNNI+H DLK
Sbjct: 99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLK 158
Query: 418 AANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 474
N+L+ +K+ DFG++R + + GT ++APE++ + P D+++
Sbjct: 159 PQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWN 218
Query: 475 FGIVLWELLTGKLP 488
GI+ + LLT P
Sbjct: 219 IGIIAYMLLTHTSP 232
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 53/204 (25%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ----KEFAQEVFIMRKVRH 348
G ++ SG + + + S + A K +K + + + +E +EV I+R+V H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
NV+ + ++ E +SGG ++D+L + K + G+NYLH
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHT 133
Query: 409 NNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 464
I H DLK N+++ +K+ DFG+A GT ++APE++ ++
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 465 PYDHKADVFSFGIVLWELLTGKLP 488
P +AD++S G++ + LL+G P
Sbjct: 194 PLGLEADMWSIGVITYILLSGASP 217
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-34
Identities = 44/199 (22%), Positives = 83/199 (41%), Gaps = 6/199 (3%)
Query: 297 GSKVASGSYGDLYRG--TYCSQDVAIKVLKPE-RINSDMQKEFAQEVFIMRKVRHKNVVQ 353
V G GD+Y T + VA+K++ + + +E +++ +VV
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
L + ++G + L + +G P + + + ++ H H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATH 157
Query: 414 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKAD 471
RD+K N+L+ ++ + DFG+A + GT +MAPE ++AD
Sbjct: 158 RDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRAD 217
Query: 472 VFSFGIVLWELLTGKLPYE 490
+++ VL+E LTG PY+
Sbjct: 218 IYALTCVLYECLTGSPPYQ 236
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 52/250 (20%), Positives = 114/250 (45%), Gaps = 18/250 (7%)
Query: 254 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 313
+ + E+ +S ++P+ E + + G + R +
Sbjct: 58 AKKLNDAQPKGTENLYFQSMGPEDELPDWAAAK-EFY-QKYDPKDVIGRGVSSVVRRCVH 115
Query: 314 CS--QDVAIKVLK------PERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSL 364
+ + A+K+++ ++++ +E I+R+V H +++ I + +
Sbjct: 116 RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175
Query: 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD 424
+V + M G ++DYL + K + + + +++LH NNI+HRDLK N+L+D
Sbjct: 176 FLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD 234
Query: 425 ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE------HKPYDHKADVFSFGIV 478
+N ++++DFG + + GT ++APE+++ H Y + D+++ G++
Sbjct: 235 DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294
Query: 479 LWELLTGKLP 488
L+ LL G P
Sbjct: 295 LFTLLAGSPP 304
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-34
Identities = 54/213 (25%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLK-----------PERINSDMQKEFAQ 338
+ K+ SG+YG++ + + AIKV+K + +E
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 398
E+ +++ + H N+++ +VTEF GG +++ + + F +
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQ 154
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRW 455
+ G+ YLH++NI+HRD+K N+L+ + +K+ DFG++ ++ + GT +
Sbjct: 155 ILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYY 214
Query: 456 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP 488
+APEV+ K Y+ K DV+S G++++ LL G P
Sbjct: 215 IAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-34
Identities = 42/198 (21%), Positives = 88/198 (44%), Gaps = 7/198 (3%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ G +G ++R S + K +K + + + K +E+ I+ RH+N++
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHRNIL 64
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
+ L ++ EF+SG +++ ++ ++ V + + +LH +NI
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 413 HRDLKAANLLM--DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 470
H D++ N++ + +K+ +FG AR + APEV +H
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 471 DVFSFGIVLWELLTGKLP 488
D++S G +++ LL+G P
Sbjct: 185 DMWSLGTLVYVLLSGINP 202
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 52/204 (25%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLK----PERINSDMQKEFAQEVFIMRKVRH 348
G ++ SG + + + S + A K +K ++E +EV I+R+V H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
N++ + ++ E +SGG ++D+L + K + G+NYLH
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHT 133
Query: 409 NNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 464
I H DLK N+++ +K+ DFG+A GT ++APE++ ++
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 465 PYDHKADVFSFGIVLWELLTGKLP 488
P +AD++S G++ + LL+G P
Sbjct: 194 PLGLEADMWSIGVITYILLSGASP 217
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-34
Identities = 60/268 (22%), Positives = 113/268 (42%), Gaps = 14/268 (5%)
Query: 230 PYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTD-VWE 288
P E T + ++ + R+G+ Y I E
Sbjct: 93 PCEPTAPVLIPGDE---RKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVE 149
Query: 289 IDPKHLK----FGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFI 342
I H+ ++ +G++G ++R T + + A K + + ++ +E+
Sbjct: 150 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQT 207
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
M +RH +V A + ++ EFMSGG +++ + ++ V KG
Sbjct: 208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 267
Query: 403 MNYLHQNNIIHRDLKAANLLM--DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEV 460
+ ++H+NN +H DLK N++ + +K+ DFG+ + TGT + APEV
Sbjct: 268 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 327
Query: 461 IEHKPYDHKADVFSFGIVLWELLTGKLP 488
E KP + D++S G++ + LL+G P
Sbjct: 328 AEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-34
Identities = 59/247 (23%), Positives = 106/247 (42%), Gaps = 13/247 (5%)
Query: 255 SHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC 314
H S P + M E + G + SG +G +Y G
Sbjct: 6 HHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRV 65
Query: 315 S--QDVAIKVLKPERINS----DMQKEFAQEVFIMRKVRHK--NVVQFIGACTKPPSLCI 366
S VAIK ++ +RI+ EV +++KV V++ + +P S +
Sbjct: 66 SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL 125
Query: 367 VTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE 425
+ E ++D++ + +G + V + + + H ++HRD+K N+L+D
Sbjct: 126 ILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL 184
Query: 426 NEV-VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSFGIVLWELL 483
N +K+ DFG + + V T GT + PE I + Y A V+S GI+L++++
Sbjct: 185 NRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 243
Query: 484 TGKLPYE 490
G +P+E
Sbjct: 244 CGDIPFE 250
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 50/204 (24%), Positives = 96/204 (47%), Gaps = 11/204 (5%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQK----EFAQEVFIMRKVRH 348
G ++ SG + + + S A K +K R S + + +EV I+++++H
Sbjct: 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
NV+ + ++ E ++GG ++D+L + K + + G+ YLH
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHS 132
Query: 409 NNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 464
I H DLK N+++ +K+ DFG+A GT ++APE++ ++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 465 PYDHKADVFSFGIVLWELLTGKLP 488
P +AD++S G++ + LL+G P
Sbjct: 193 PLGLEADMWSIGVITYILLSGASP 216
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 41/198 (20%), Positives = 93/198 (46%), Gaps = 6/198 (3%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
++ SG++G ++R + + K + + E+ IM ++ H ++
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPKLI 111
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
A + ++ EF+SGG ++D + ++ +G+ ++H+++I+
Sbjct: 112 NLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIV 171
Query: 413 HRDLKAANLLM--DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 470
H D+K N++ + VK+ DFG+A ++ T T + APE+++ +P
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYT 231
Query: 471 DVFSFGIVLWELLTGKLP 488
D+++ G++ + LL+G P
Sbjct: 232 DMWAIGVLGYVLLSGLSP 249
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 52/232 (22%), Positives = 100/232 (43%), Gaps = 40/232 (17%)
Query: 292 KHLKFGSKVASGSYGDL-YRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHK 349
+ + GS G + ++G++ + VA+K R+ D E+ ++ + H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVK-----RMLIDFCDIALMEIKLLTESDDHP 69
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYL------HKLKGVFKLPSLLKVAIDVSKGM 403
NV+++ + T L I E ++ D + + + K + + + ++ G+
Sbjct: 70 NVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 404 NYLHQNNIIHRDLKAANLLMD-------------ENEVVKVADFGVARV-----KAQSGV 445
+LH IIHRDLK N+L+ EN + ++DFG+ + +
Sbjct: 129 AHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 446 MTAETGTYRWMAPEVIE-------HKPYDHKADVFSFGIVLWELLT-GKLPY 489
+ +GT W APE++E + D+FS G V + +L+ GK P+
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 47/194 (24%), Positives = 93/194 (47%), Gaps = 13/194 (6%)
Query: 302 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGAC 358
GS+ + + Q A+K+ I+ M+ +E+ ++ H N+V+
Sbjct: 21 EGSFSICRKCVHKKSNQAFAVKI-----ISKRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 359 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 418
+V E ++GG +++ + K K F + + ++++H ++HRDLK
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKP 134
Query: 419 ANLLM---DENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 474
NLL ++N +K+ DFG AR + + T + APE++ YD D++S
Sbjct: 135 ENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWS 194
Query: 475 FGIVLWELLTGKLP 488
G++L+ +L+G++P
Sbjct: 195 LGVILYTMLSGQVP 208
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 51/209 (24%), Positives = 88/209 (42%), Gaps = 15/209 (7%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS----DMQKEFAQEVFIMRKVR- 347
+ G + G +G ++ G + VAIKV+ R+ EV ++ KV
Sbjct: 34 RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGA 93
Query: 348 ---HKNVVQFIGACTKPPSLCIVTEF-MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
H V++ + +V E + ++DY+ + KG V +
Sbjct: 94 GGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAI 152
Query: 404 NYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE 462
+ H ++HRD+K N+L+D K+ DFG + T GT + PE I
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL-HDEPYTDFDGTRVYSPPEWIS 211
Query: 463 HKPYD-HKADVFSFGIVLWELLTGKLPYE 490
Y A V+S GI+L++++ G +P+E
Sbjct: 212 RHQYHALPATVWSLGILLYDMVCGDIPFE 240
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-32
Identities = 51/247 (20%), Positives = 106/247 (42%), Gaps = 14/247 (5%)
Query: 254 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSK--------VASGSY 305
S+ + + + + P D + K S + G +
Sbjct: 43 WSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRF 102
Query: 306 GDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363
G +++ + +A K++K + ++E E+ +M ++ H N++Q A
Sbjct: 103 GQVHKCEETATGLKLAAKIIKTRGMKD--KEEVKNEISVMNQLDHANLIQLYDAFESKND 160
Query: 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
+ +V E++ GG ++D + + + +G+ ++HQ I+H DLK N+L
Sbjct: 161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILC 220
Query: 424 --DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWE 481
+ + +K+ DFG+AR + GT ++APEV+ + D++S G++ +
Sbjct: 221 VNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYM 280
Query: 482 LLTGKLP 488
LL+G P
Sbjct: 281 LLSGLSP 287
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 53/202 (26%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRK-VRHKNV 351
+ + GSY R + + + A+K++ +++ +E+ I+ + +H N+
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKII------DKSKRDPTEEIEILLRYGQHPNI 78
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
+ + +VTE M GG + D + + + F V ++K + YLH +
Sbjct: 79 ITLKDVYDDGKYVYVVTELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 412 IHRDLKAANLLM----DENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPY 466
+HRDLK +N+L E +++ DFG A+ ++A++G++ T ++APEV+E + Y
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY 197
Query: 467 DHKADVFSFGIVLWELLTGKLP 488
D D++S G++L+ +LTG P
Sbjct: 198 DAACDIWSLGVLLYTMLTGYTP 219
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 43/113 (38%), Positives = 62/113 (54%), Gaps = 4/113 (3%)
Query: 381 HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440
K L L+ + V+KGM +L IHRDL A N+L+ E VVK+ DFG+AR
Sbjct: 184 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243
Query: 441 AQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
+ + +WMAPE I + Y ++DV+SFG++LWE+ + G PY
Sbjct: 244 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 296
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 2e-20
Identities = 39/156 (25%), Positives = 61/156 (39%), Gaps = 15/156 (9%)
Query: 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-------VAIKVLKPERINSDMQKEF 336
WE LK G + G++G + D VA+K+LK E +
Sbjct: 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRAL 72
Query: 337 AQEVFIMRKV-RHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK 394
E+ I+ + H NVV +GACTKP L ++ EF G++ YL + F
Sbjct: 73 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKG 132
Query: 395 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK 430
+G +Y+ I DLK + ++
Sbjct: 133 A--RFRQGKDYV---GAIPVDLKRRLDSITSSQSSA 163
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-30
Identities = 43/210 (20%), Positives = 81/210 (38%), Gaps = 19/210 (9%)
Query: 297 GSKVASGSYGDLYRGT---YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 353
+A G G +Y + V +K L +++ Q E + +V H ++VQ
Sbjct: 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 354 FI-----GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
P IV E++ G S+ + + +++ ++YLH
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSYLHS 200
Query: 409 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 468
+++ DLK N+++ E + +K+ D G G + GT + APE++ P
Sbjct: 201 IGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFGYL---YGTPGFQAPEIVRTGP-TV 255
Query: 469 KADVFSFGIVLWELLTGKLPY--EYLTPLQ 496
D+++ G L L Y+ L
Sbjct: 256 ATDIYTVGRTLAALTLDLPTRNGRYVDGLP 285
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 5e-30
Identities = 34/246 (13%), Positives = 76/246 (30%), Gaps = 49/246 (19%)
Query: 291 PKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVL-KPERINSDMQKEFAQEVFIMRKVR 347
P+ L G+ + T + + V ER S+ K+ +EV +R +R
Sbjct: 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131
Query: 348 -------------------------HKNVVQFIGACTKPPSLCIVTEFM----SGGSVYD 378
K +++ L + + + +
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191
Query: 379 YLHKLKGVFKLPSL---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435
L K L++ + V + + LH ++H L+ ++++D+ V + F
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFE 251
Query: 436 VARVKAQSGVMTAETGTYRWMAPEVI-----------EHKPYDHKADVFSFGIVLWELLT 484
+ G + + + PE+ D ++ G+V++ +
Sbjct: 252 HLV---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
Query: 485 GKLPYE 490
LP
Sbjct: 309 ADLPIT 314
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-29
Identities = 49/174 (28%), Positives = 95/174 (54%), Gaps = 2/174 (1%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A K L+ +RI + A E I+ KV + VV A +LC+V M+GG +
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 272
Query: 378 DYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
+++ + + F + A ++ G+ LH+ I++RDLK N+L+D++ ++++D G+
Sbjct: 273 FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL 332
Query: 437 ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490
A + + GT +MAPEV++++ Y D ++ G +L+E++ G+ P++
Sbjct: 333 AVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 386
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-29
Identities = 53/178 (29%), Positives = 95/178 (53%), Gaps = 7/178 (3%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A K L +R+ + A E I+ KV + +V A LC+V M+GG +
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIR 273
Query: 378 DYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 434
+++ + F+ P + + G+ +LHQ NII+RDLK N+L+D++ V+++D
Sbjct: 274 YHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDL 333
Query: 435 GVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490
G+A V+ ++G + GT +MAPE++ + YD D F+ G+ L+E++ + P+
Sbjct: 334 GLA-VELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFR 390
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 60/265 (22%), Positives = 113/265 (42%), Gaps = 39/265 (14%)
Query: 256 HRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS 315
H S E G + Y + TD +++ + L G G G + +
Sbjct: 5 HHHHSSGLEVLFQGPEPKKYAV------TDDYQLSKQVL--GL----GVNGKVLECFHRR 52
Query: 316 --QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGAC----TKPPSLCIVT 368
Q A+K+L + QEV + ++V + L I+
Sbjct: 53 TGQKCALKLL-------YDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM 105
Query: 369 EFMSGGSVYDYLHKLKGVFKLP-----SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
E M GG ++ + + +G +++ D+ + +LH +NI HRD+K NLL
Sbjct: 106 ECMEGGELFSRIQE-RGDQAFTEREAAEIMR---DIGTAIQFLHSHNIAHRDVKPENLLY 161
Query: 424 ---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLW 480
+++ V+K+ DFG A+ + + T ++APEV+ + YD D++S G++++
Sbjct: 162 TSKEKDAVLKLTDFGFAK-ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMY 220
Query: 481 ELLTGKLPYEYLTPLQAAVGVVQKV 505
LL G P+ T + G+ +++
Sbjct: 221 ILLCGFPPFYSNTGQAISPGMKRRI 245
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 56/250 (22%), Positives = 101/250 (40%), Gaps = 26/250 (10%)
Query: 254 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 313
P+ P ++P + P I + + G G + +
Sbjct: 24 PTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFN 83
Query: 314 CS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGAC----TKPPSLCI 366
+ A+K+L D K +EV + + + ++V+ + L I
Sbjct: 84 KRTQEKFALKML------QDCPKAR-REVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136
Query: 367 VTEFMSGGSVYDYLHKLKGVFKLP-----SLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 421
V E + GG ++ + +G ++K + + + YLH NI HRD+K NL
Sbjct: 137 VMECLDGGELFSRIQD-RGDQAFTEREASEIMK---SIGEAIQYLHSINIAHRDVKPENL 192
Query: 422 LM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV 478
L N ++K+ DFG A+ +T T ++APEV+ + YD D++S G++
Sbjct: 193 LYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 252
Query: 479 LWELLTGKLP 488
++ LL G P
Sbjct: 253 MYILLCGYPP 262
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 48/195 (24%), Positives = 93/195 (47%), Gaps = 11/195 (5%)
Query: 303 GSYGDLY----RGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGA 357
GS+ + T S++ AIK+L+ I + + + E +M ++ H V+
Sbjct: 41 GSFSTVVLARELAT--SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT 98
Query: 358 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 417
L + G + Y+ K G F ++ + YLH IIHRDLK
Sbjct: 99 FQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLK 157
Query: 418 AANLLMDENEVVKVADFGVA-RVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFS 474
N+L++E+ +++ DFG A + +S A + GT ++++PE++ K +D+++
Sbjct: 158 PENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWA 217
Query: 475 FGIVLWELLTGKLPY 489
G ++++L+ G P+
Sbjct: 218 LGCIIYQLVAGLPPF 232
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-29
Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 302 SGSYGDLYRGTYCS--QDVAIKVL--KPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIG 356
G++ + Q+ A+K++ +P I S + +EV ++ + + H+NV++ I
Sbjct: 23 EGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF----REVEMLYQCQGHRNVLELIE 78
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ +V E M GGS+ ++HK + F V DV+ +++LH I HRDL
Sbjct: 79 FFEEEDRFYLVFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDL 137
Query: 417 KAANLLM---DENEVVKVADFGVARV--------KAQSGVMTAETGTYRWMAPEVIE--- 462
K N+L ++ VK+ DF + + + G+ +MAPEV+E
Sbjct: 138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197
Query: 463 --HKPYDHKADVFSFGIVLWELLTGKLP 488
YD + D++S G++L+ LL+G P
Sbjct: 198 EEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 55/190 (28%), Positives = 95/190 (50%), Gaps = 6/190 (3%)
Query: 303 GSYG--DLYRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQFIGACT 359
GS+G L + A+K+L +++ Q E E I++ V +V+ +
Sbjct: 52 GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
+L +V E+++GG ++ +L + G F P A + YLH ++I+RDLK
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 420 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 479
NLL+D+ ++V DFG A K G GT +APE+I K Y+ D ++ G+++
Sbjct: 171 NLLIDQQGYIQVTDFGFA--KRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLI 228
Query: 480 WELLTGKLPY 489
+E+ G P+
Sbjct: 229 YEMAAGYPPF 238
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 32/260 (12%), Positives = 81/260 (31%), Gaps = 44/260 (16%)
Query: 291 PKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVL-KPERINSDMQKEFAQEVFIMRK-- 345
P+ L G+ + T + + V ER S+ K+ +EV +R
Sbjct: 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 136
Query: 346 --------------------VRHKNVVQFIGACTKPPSLCIVTEF-------MSGGSVYD 378
V+ + I + +++ F + + +
Sbjct: 137 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 196
Query: 379 YLHKLKGVFKLPSL---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435
L K L++ + V + + LH ++H L+ ++++D+ V + F
Sbjct: 197 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFE 256
Query: 436 VARVKAQSGVMTAETGTY---RWMAPEVIEHKP-----YDHKADVFSFGIVLWELLTGKL 487
+ + ++ + A ++ D ++ G+ ++ + L
Sbjct: 257 HLV-RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 488 PYEYLTPLQAAVGVVQKVHH 507
P L + + + +
Sbjct: 316 PNTDDAALGGSEWIFRSCKN 335
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 48/175 (27%), Positives = 91/175 (52%), Gaps = 5/175 (2%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A+K+L+ E I + + E +++ RH + A LC V E+ +GG ++
Sbjct: 34 AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF 93
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437
+L + + VF ++ + YLH ++++RD+K NL++D++ +K+ DFG+
Sbjct: 94 FHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC 152
Query: 438 RVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490
+ G T GT ++APEV+E Y D + G+V++E++ G+LP+
Sbjct: 153 KEGISDGATMK-TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 52/174 (29%), Positives = 95/174 (54%), Gaps = 4/174 (2%)
Query: 319 AIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYD 378
A+KVLK + + E I+ +V H +V+ A L ++ +F+ GG ++
Sbjct: 56 AMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFT 115
Query: 379 YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 438
L K + +F + +++ +++LH II+RDLK N+L+DE +K+ DFG+++
Sbjct: 116 RLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK 174
Query: 439 VKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490
+ GT +MAPEV+ + + AD +SFG++++E+LTG LP++
Sbjct: 175 ESIDHEKKAY-SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ 227
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 48/201 (23%), Positives = 94/201 (46%), Gaps = 10/201 (4%)
Query: 319 AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A+K + ++ + +E+ IM+ + H +V + + +V + + GG +
Sbjct: 44 AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLR 103
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437
+L + FK ++ ++ ++YL IIHRD+K N+L+DE+ V + DF +A
Sbjct: 104 YHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA 162
Query: 438 RVKAQSGVMTAETGTYRWMAPEVIEHKP---YDHKADVFSFGIVLWELLTGKLPYEYLTP 494
+ + +T GT +MAPE+ + Y D +S G+ +ELL G+ PY +
Sbjct: 163 AMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS 222
Query: 495 LQAAVGVVQKVHHSFLEQRLR 515
+++ H+F +
Sbjct: 223 -----TSSKEIVHTFETTVVT 238
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 57/194 (29%), Positives = 96/194 (49%), Gaps = 9/194 (4%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
V GSYG + + + VAIK + ++K +E+ +++++RH+N+V +
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
C K +V EF+ ++ D L + K + G+ + H +NIIHRD+
Sbjct: 92 VCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDI 150
Query: 417 KAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGT--YRWMAPEVI-EHKPYDHKADV 472
K N+L+ ++ VVK+ DFG AR A V E T YR APE++ Y DV
Sbjct: 151 KPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR--APELLVGDVKYGKAVDV 208
Query: 473 FSFGIVLWELLTGK 486
++ G ++ E+ G+
Sbjct: 209 WAIGCLVTEMFMGE 222
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 50/202 (24%), Positives = 102/202 (50%), Gaps = 7/202 (3%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376
A+KV+K E +N D ++ Q E + + H +V L V E+++GG +
Sbjct: 38 AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 97
Query: 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
++ + + + ++S +NYLH+ II+RDLK N+L+D +K+ D+G+
Sbjct: 98 MFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 156
Query: 437 ARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494
+ + G T+ T GT ++APE++ + Y D ++ G++++E++ G+ P++ +
Sbjct: 157 CKEGLRPGDTTS-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 215
Query: 495 LQAAVGV-VQKVHHSFLEQRLR 515
+ LE+++R
Sbjct: 216 SDNPDQNTEDYLFQVILEKQIR 237
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 36/209 (17%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQ--------EVFIMRKVRH 348
+ G + +Y+ +Q VAIK +I + E E+ +++++ H
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIK-----KIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS-------K 401
N++ + A ++ +V +FM L+ + K SL+ + +
Sbjct: 72 PNIIGLLDAFGHKSNISLVFDFME--------TDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 402 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT--YRWMAP 458
G+ YLHQ+ I+HRDLK NLL+DEN V+K+ADFG+A+ + T + T YR AP
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYR--AP 181
Query: 459 EVIEH-KPYDHKADVFSFGIVLWELLTGK 486
E++ + Y D+++ G +L ELL
Sbjct: 182 ELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 24/201 (11%)
Query: 299 KVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKNVV 352
K+ G+YG +Y+ + A+K +I + + E +E+ I+++++H N+V
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALK-----KIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
+ L +V E + D L +G + + + + G+ Y H
Sbjct: 64 KLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 410 NIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGT--YRWMAPEVI-EHKP 465
++HRDLK NLL++ +K+ADFG+AR T E T YR AP+V+ K
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR--APDVLMGSKK 177
Query: 466 YDHKADVFSFGIVLWELLTGK 486
Y D++S G + E++ G
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGT 198
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 57/176 (32%), Positives = 89/176 (50%), Gaps = 6/176 (3%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376
A+KVLK + I D E E I+ H + Q P L V EF++GG +
Sbjct: 52 AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL 111
Query: 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
++ K F A ++ + +LH II+RDLK N+L+D K+ADFG+
Sbjct: 112 MFHIQK-SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGM 170
Query: 437 ARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490
+ +GV TA T GT ++APE+++ Y D ++ G++L+E+L G P+E
Sbjct: 171 CKEGICNGVTTA-TFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 37/214 (17%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKE-F----AQEVFIMRKVRHKNV 351
K+ G++G++++ Q VA+K ++ + +KE F +E+ I++ ++H+NV
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKILQLLKHENV 78
Query: 352 VQFIGACT--------KPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVS 400
V I C S+ +V +F +D L + F L + +V +
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLVKFTLSEIKRVMQMLL 134
Query: 401 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-----VKAQSGVMTAETGT--Y 453
G+ Y+H+N I+HRD+KAAN+L+ + V+K+ADFG+AR +Q T T Y
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 194
Query: 454 RWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 486
R PE++ + Y D++ G ++ E+ T
Sbjct: 195 R--PPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-27
Identities = 55/176 (31%), Positives = 93/176 (52%), Gaps = 7/176 (3%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKN---VVQFIGACTKPPSLCIVTEFMSGG 374
A+K L +RI + A E ++ V + +V A P L + + M+GG
Sbjct: 218 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277
Query: 375 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 434
++ +L + GVF + A ++ G+ ++H +++RDLK AN+L+DE+ V+++D
Sbjct: 278 DLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDL 336
Query: 435 GVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPY 489
G+A A GT+ +MAPEV++ YD AD FS G +L++LL G P+
Sbjct: 337 GLA-CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 55/177 (31%), Positives = 97/177 (54%), Gaps = 8/177 (4%)
Query: 319 AIKVLKPERINSDMQKEFAQ---EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 375
A+KVLK I + K+ A E I+ +V+H +V I A L ++ E++SGG
Sbjct: 49 AMKVLKKAMIVRN-AKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGE 107
Query: 376 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435
++ L + +G+F + ++S + +LHQ II+RDLK N++++ VK+ DFG
Sbjct: 108 LFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFG 166
Query: 436 VARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490
+ + G +T T GT +MAPE++ ++ D +S G +++++LTG P+
Sbjct: 167 LCKESIHDGTVT-HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFT 222
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 58/172 (33%), Positives = 92/172 (53%), Gaps = 4/172 (2%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A+KVLK E + Q E E ++ V H +++ G + ++ +++ GG ++
Sbjct: 35 AMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELF 94
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437
L K F P A +V + YLH +II+RDLK N+L+D+N +K+ DFG A
Sbjct: 95 SLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA 153
Query: 438 RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489
K V GT ++APEV+ KPY+ D +SFGI+++E+L G P+
Sbjct: 154 --KYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-27
Identities = 63/267 (23%), Positives = 126/267 (47%), Gaps = 18/267 (6%)
Query: 232 EETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDP 291
EE E+ A++ L++Q + S +++G + L P +
Sbjct: 94 EEREEWTTAIQTVADGLKKQ-AAAEMDFRSGSPSDNSGAEEMEVSLAKPKH-----RVTM 147
Query: 292 KHLKFGSKVASGSYGDLY----RGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKV 346
++ + G++G + + T + A+K+LK E I + + E +++
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKAT--GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 205
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
RH + + LC V E+ +GG ++ +L + + VF ++ ++YL
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYL 264
Query: 407 H-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEH 463
H + N+++RDLK NL++D++ +K+ DFG+ + + G T GT ++APEV+E
Sbjct: 265 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK-TFCGTPEYLAPEVLED 323
Query: 464 KPYDHKADVFSFGIVLWELLTGKLPYE 490
Y D + G+V++E++ G+LP+
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCGRLPFY 350
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 53/194 (27%), Positives = 97/194 (50%), Gaps = 9/194 (4%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ GSYG +++ Q VAIK + ++K +E+ ++++++H N+V +
Sbjct: 10 KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ L +V E+ +V L + + + + + +N+ H++N IHRD+
Sbjct: 70 VFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDV 128
Query: 417 KAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGT--YRWMAPEVIEH-KPYDHKADV 472
K N+L+ ++ V+K+ DFG AR+ S E T YR +PE++ Y DV
Sbjct: 129 KPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR--SPELLVGDTQYGPPVDV 186
Query: 473 FSFGIVLWELLTGK 486
++ G V ELL+G
Sbjct: 187 WAIGCVFAELLSGV 200
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-27
Identities = 60/250 (24%), Positives = 116/250 (46%), Gaps = 12/250 (4%)
Query: 249 ERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDL 308
+ + + + + ++ + + F + GS+G +
Sbjct: 298 GNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKV 357
Query: 309 ----YRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKV-RHKNVVQFIGACTKPP 362
+GT + A+K+LK + + D E E ++ + + Q
Sbjct: 358 MLSERKGT--DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415
Query: 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 422
L V E+++GG + ++ + G FK P + A +++ G+ +L II+RDLK N++
Sbjct: 416 RLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM 474
Query: 423 MDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLW 480
+D +K+ADFG+ + GV T T GT ++APE+I ++PY D ++FG++L+
Sbjct: 475 LDSEGHIKIADFGMCKENIWDGVTTK-TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLY 533
Query: 481 ELLTGKLPYE 490
E+L G+ P+E
Sbjct: 534 EMLAGQAPFE 543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 46/186 (24%), Positives = 95/186 (51%), Gaps = 6/186 (3%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376
A++V+K E +N D ++ Q E + + H +V L V E+++GG +
Sbjct: 81 AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 140
Query: 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
++ + + + ++S +NYLH+ II+RDLK N+L+D +K+ D+G+
Sbjct: 141 MFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 199
Query: 437 ARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494
+ + G T+ T GT ++APE++ + Y D ++ G++++E++ G+ P++ +
Sbjct: 200 CKEGLRPGDTTS-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 258
Query: 495 LQAAVG 500
Sbjct: 259 SDNPDQ 264
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 28/203 (13%)
Query: 299 KVASGSYGDLYRG---TYCSQDVAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKN 350
KV G+YG +Y+ + VA+K RI D + E +E+ +++++ H N
Sbjct: 28 KVGEGTYGVVYKAKDSQ--GRIVALK-----RIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 351 VVQFIGACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
+V I L +V EFM D L + K + + + +G+ + H
Sbjct: 81 IVSLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT--YRWMAPEVI-EH 463
Q+ I+HRDLK NLL++ + +K+ADFG+AR T E T YR AP+V+
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR--APDVLMGS 194
Query: 464 KPYDHKADVFSFGIVLWELLTGK 486
K Y D++S G + E++TGK
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGK 217
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-27
Identities = 54/176 (30%), Positives = 96/176 (54%), Gaps = 6/176 (3%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376
A+K+LK + + D E E ++ + + Q L V E+++GG +
Sbjct: 49 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 108
Query: 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
++ + G FK P + A +++ G+ +L II+RDLK N+++D +K+ADFG+
Sbjct: 109 MYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM 167
Query: 437 ARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490
+ GV T T GT ++APE+I ++PY D ++FG++L+E+L G+ P+E
Sbjct: 168 CKENIWDGVTTK-TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 25/205 (12%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKNV 351
K+ G+YG +++ + VA+K R+ D E +E+ ++++++HKN+
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALK-----RVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
V+ L +V EF D Y G + + KG+ + H
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 409 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT--YRWMAPEVI-EHK 464
N++HRDLK NLL++ N +K+A+FG+AR +AE T YR P+V+ K
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR--PPDVLFGAK 177
Query: 465 PYDHKADVFSFGIVLWELLTGKLPY 489
Y D++S G + EL P
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPL 202
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 8/177 (4%)
Query: 319 AIKVLKPERINSDMQKEFAQ---EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 375
AIK LK + + D E V H + +L V E+++GG
Sbjct: 46 AIKALKKDVVLMDDDVECTMVEKRVL-SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGD 104
Query: 376 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435
+ ++ F L A ++ G+ +LH I++RDLK N+L+D++ +K+ADFG
Sbjct: 105 LMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG 163
Query: 436 VARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490
+ + T T GT ++APE++ + Y+H D +SFG++L+E+L G+ P+
Sbjct: 164 MCKENMLGDAKTN-TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH 219
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 35/212 (16%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQ--------EVFIMRKVR- 347
++ G+YG +Y+ + VA+K + EV ++R++
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALK-----SVRVPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 348 --HKNVVQFIGACT-----KPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLK-VA 396
H NVV+ + C + + +V E + D YL K +K +
Sbjct: 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETIKDLM 126
Query: 397 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT--YR 454
+G+++LH N I+HRDLK N+L+ VK+ADFG+AR+ + +T T YR
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYR 186
Query: 455 WMAPEVIEHKPYDHKADVFSFGIVLWELLTGK 486
APEV+ Y D++S G + E+ K
Sbjct: 187 --APEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 41/179 (22%), Positives = 84/179 (46%), Gaps = 8/179 (4%)
Query: 319 AIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A+K+L + + F +E ++ K + A +L +V ++ GG +
Sbjct: 103 AMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLL 162
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437
L K + ++ ++ +HQ + +HRD+K N+LMD N +++ADFG
Sbjct: 163 TLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC 222
Query: 438 RVKAQSGVMTAET--GTYRWMAPEVIEHKP-----YDHKADVFSFGIVLWELLTGKLPY 489
+ G + + GT +++PE+++ Y + D +S G+ ++E+L G+ P+
Sbjct: 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 52/203 (25%), Positives = 98/203 (48%), Gaps = 28/203 (13%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKE------FAQEVFIMRKVRHKN 350
K+ G+Y +Y+G VA+K ++ ++ E +EV +++ ++H N
Sbjct: 9 KLGEGTYATVYKGKSKLTDNLVALKEIR-------LEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 351 VVQFIGACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
+V SL +V E++ D YL + + ++ + +G+ Y H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGT--YRWMAPEVI-EH 463
+ ++HRDLK NLL++E +K+ADFG+AR K+ + E T YR P+++
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYR--PPDILLGS 175
Query: 464 KPYDHKADVFSFGIVLWELLTGK 486
Y + D++ G + +E+ TG+
Sbjct: 176 TDYSTQIDMWGVGCIFYEMATGR 198
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 49/253 (19%), Positives = 90/253 (35%), Gaps = 57/253 (22%)
Query: 269 GMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS------QDVAIKV 322
GM++ + + + ++SGSYG C+ VAIK
Sbjct: 1 GMQAKGEAAMRDLIAE-LHAMQSPY-TVQRFISSGSYG-----AVCAGVDSEGIPVAIKR 53
Query: 323 LKPERINSDMQKEF-----AQ----EVFIMRKVRHKNVVQFIGACTKPPSLC------IV 367
+ + + E+ ++ H N++ + +V
Sbjct: 54 VFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG-LRDIFVHFEEPAMHKLYLV 112
Query: 368 TEFMSGGSVYDYLHKL--KGVFKLPS---------LLKVAIDVSKGMNYLHQNNIIHRDL 416
TE M D L ++ + +L G++ LH+ ++HRDL
Sbjct: 113 TELMR----TD-LAQVIHDQRIVISPQHIQYFMYHILL-------GLHVLHEAGVVHRDL 160
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT--YRWMAPEVI-EHKPYDHKADVF 473
N+L+ +N + + DF +AR T YR APE++ + K + D++
Sbjct: 161 HPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYR--APELVMQFKGFTKLVDMW 218
Query: 474 SFGIVLWELLTGK 486
S G V+ E+ K
Sbjct: 219 SAGCVMAEMFNRK 231
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 39/211 (18%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKNV 351
K+ +G+Y +Y+G + VA+K +K + +E +E+ +M++++H+N+
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLD------SEEGTPSTAIREISLMKELKHENI 65
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS----------- 400
V+ L +V EFM + LK ++ +
Sbjct: 66 VRLYDVIHTENKLTLVFEFMD--------NDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 401 -KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGT--YRWM 456
+G+ + H+N I+HRDLK NLL+++ +K+ DFG+AR ++E T YR
Sbjct: 118 LQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYR-- 175
Query: 457 APEVI-EHKPYDHKADVFSFGIVLWELLTGK 486
AP+V+ + Y D++S G +L E++TGK
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 33/210 (15%)
Query: 299 KVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFA-----QEVFIMRKVR--- 347
++ G+YG +++ VA+K R+ +E +EV ++R +
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALK-----RVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 348 HKNVVQFI-----GACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLK-VAID 398
H NVV+ + L +V E + D YL K+ +K +
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT--YRWM 456
+ +G+++LH + ++HRDLK N+L+ + +K+ADFG+AR+ + +T+ T YR
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYR-- 186
Query: 457 APEVIEHKPYDHKADVFSFGIVLWELLTGK 486
APEV+ Y D++S G + E+ K
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 51/176 (28%), Positives = 94/176 (53%), Gaps = 6/176 (3%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIM-RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376
A+KVL+ + I +++ E ++ + V+H +V + L V ++++GG +
Sbjct: 67 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 126
Query: 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
+ +L + + F P A +++ + YLH NI++RDLK N+L+D + + DFG+
Sbjct: 127 FYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGL 185
Query: 437 ARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490
+ + T+ T GT ++APEV+ +PYD D + G VL+E+L G P+
Sbjct: 186 CKENIEHNSTTS-TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY 240
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 38/201 (18%), Positives = 85/201 (42%), Gaps = 16/201 (7%)
Query: 303 GSYGDLY----RGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGA 357
G++ ++ + T Q A+K++ + + + E ++ + + Q A
Sbjct: 72 GAFSEVAVVKMKQT--GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129
Query: 358 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 417
L +V E+ GG + L K ++ ++ +H+ +HRD+K
Sbjct: 130 FQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIK 189
Query: 418 AANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIE-------HKPYDH 468
N+L+D +++ADFG G + + GT +++PE+++ Y
Sbjct: 190 PDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGP 249
Query: 469 KADVFSFGIVLWELLTGKLPY 489
+ D ++ G+ +E+ G+ P+
Sbjct: 250 ECDWWALGVFAYEMFYGQTPF 270
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 67/255 (26%), Positives = 112/255 (43%), Gaps = 43/255 (16%)
Query: 256 HRSSSPTSEPEDTGMKSHPYHLKIP-NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC 314
S++P + + + +K+ +DG + + + + +GS+G +++
Sbjct: 4 TMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNC-KVIGNGSFGVVFQAKLV 62
Query: 315 -SQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPS-------LC 365
S +VAIK ++ D K F E+ IMR V+H NVV + A L
Sbjct: 63 ESDEVAIK-----KVLQD--KRFKNRELQIMRIVKHPNVVD-LKAFFYSNGDKKDEVFLN 114
Query: 366 IVTEFMSGGSVYDYL-HKLKGVFKLPS---------LLKVAIDVSKGMNYLHQNNIIHRD 415
+V E++ +VY H K +P LL+ + Y+H I HRD
Sbjct: 115 LVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLR-------SLAYIHSIGICHRD 166
Query: 416 LKAANLLMDENE-VVKVADFGVARVKAQSGVMTAE--TGTYRWMAPEVI-EHKPYDHKAD 471
+K NLL+D V+K+ DFG A++ + + YR APE+I Y D
Sbjct: 167 IKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR--APELIFGATNYTTNID 224
Query: 472 VFSFGIVLWELLTGK 486
++S G V+ EL+ G+
Sbjct: 225 IWSTGCVMAELMQGQ 239
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 57/221 (25%), Positives = 101/221 (45%), Gaps = 37/221 (16%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQ----E 339
+ + ++ + + SG+ G + ++VAIK K R + + A+ E
Sbjct: 57 TFTVLKRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQN--QTHAKRAYRE 111
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLL 393
+ +M+ V HKN++ + T +L +V E M + L ++ + L
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD----AN-LCQV-----IQMEL 161
Query: 394 K------VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT 447
+ + G+ +LH IIHRDLK +N+++ + +K+ DFG+AR S +MT
Sbjct: 162 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 221
Query: 448 AETGT--YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK 486
T YR APEVI Y D++S G ++ E++ K
Sbjct: 222 PYVVTRYYR--APEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 40/211 (18%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
+ +GS+G +Y+ C + VAIK ++ D + + +E+ IMRK+ H N+V+ +
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIK-----KVLQDKRFKN-RELQIMRKLDHCNIVR-LR 113
Query: 357 ACTKPPS-------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS--------- 400
L +V +++ + V + S K + V
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVP--------ETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 401 -KGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVKAQSGVMTAETGT--YRWM 456
+ + Y+H I HRD+K NLL+D + V+K+ DFG A+ + + + YR
Sbjct: 166 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR-- 223
Query: 457 APEVI-EHKPYDHKADVFSFGIVLWELLTGK 486
APE+I Y DV+S G VL ELL G+
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 45/218 (20%), Positives = 98/218 (44%), Gaps = 33/218 (15%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIM 343
W + K+ G Y +++ + + V +K+LKP + +K+ +E+ I+
Sbjct: 31 EWGN-QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKIL 84
Query: 344 RKVR-HKNVVQ----FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI- 397
+R N++ ++ P+L + + D +L +L I
Sbjct: 85 ENLRGGPNIITLADIVKDPVSRTPAL-VFEHVNN----TD-FKQL-----YQTLTDYDIR 133
Query: 398 ----DVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSGVMTAETGT 452
++ K ++Y H I+HRD+K N+++D E+ +++ D+G+A +
Sbjct: 134 FYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS 193
Query: 453 YRWM-APEVI-EHKPYDHKADVFSFGIVLWELLTGKLP 488
R+ PE++ +++ YD+ D++S G +L ++ K P
Sbjct: 194 -RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 45/225 (20%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQ----E 339
+ + ++ + + SG+ G + ++VAIK K R + + A+ E
Sbjct: 20 TFTVLKRY-QNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQN--QTHAKRAYRE 74
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLP--- 390
+ +M+ V HKN++ + T SL IV E M + L + V ++
Sbjct: 75 LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----AN-LCQ---VIQMELDH 126
Query: 391 --------SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442
+L G+ +LH IIHRDLK +N+++ + +K+ DFG+AR
Sbjct: 127 ERMSYLLYQMLC-------GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179
Query: 443 SGVMTAETGTYRWM-APEVIEHKPYDHKADVFSFGIVLWELLTGK 486
S +MT T R+ APEVI Y D++S G ++ E++ G
Sbjct: 180 SFMMTPYVVT-RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 45/220 (20%), Positives = 98/220 (44%), Gaps = 43/220 (19%)
Query: 298 SKVASGSYG------DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---- 347
K+ G + D+ T+ VA+K+++ + + E+ ++++V
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTH----VAMKIVRG---DKVYTEAAEDEIKLLQRVNDADN 77
Query: 348 -------HKNVVQ------FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLL 393
++++ G + +V E + G ++ + K + L +
Sbjct: 78 TKEDSMGANHILKLLDHFNHKGPNGVH--VVMVFEVL-GENLLALIKKYEHRGIPLIYVK 134
Query: 394 KVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENE------VVKVADFGVARVKAQSGVM 446
+++ + G++Y+H+ IIH D+K N+LM+ + +K+AD G A +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 194
Query: 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK 486
+ +T YR +PEV+ P+ AD++S +++EL+TG
Sbjct: 195 SIQTREYR--SPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 69/220 (31%), Positives = 102/220 (46%), Gaps = 35/220 (15%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQ----E 339
WE+ + V SG+YG + VAIK K R + FA+ E
Sbjct: 20 AWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK--KLYRPFQS--ELFAKRAYRE 74
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLL 393
+ +++ +RH+NV+ + T +L +V FM D L K + K L
Sbjct: 75 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG----TD-LGK---LMKHEKLG 126
Query: 394 KVAID-----VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448
+ I + KG+ Y+H IIHRDLK NL ++E+ +K+ DFG+AR MT
Sbjct: 127 EDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ--ADSEMTG 184
Query: 449 ETGTYRWM-APEVI-EHKPYDHKADVFSFGIVLWELLTGK 486
T RW APEVI Y D++S G ++ E++TGK
Sbjct: 185 YVVT-RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 62/221 (28%), Positives = 107/221 (48%), Gaps = 33/221 (14%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 343
V+++ P++ S + G+YG + VAIK + P + Q+ +E+ I+
Sbjct: 22 VFDVGPRY-TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKIL 79
Query: 344 RKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 397
+ RH+N++ P++ IV + M D L+K + K L I
Sbjct: 80 LRFRHENIIGINDIIR-APTIEQMKDVYIVQDLME----TD-LYK---LLKTQHLSNDHI 130
Query: 398 D-----VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTA 448
+ +G+ Y+H N++HRDLK +NLL++ +K+ DFG+ARV +G +T
Sbjct: 131 CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 449 ETGT--YRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 486
T YR APE++ K Y D++S G +L E+L+ +
Sbjct: 191 YVATRWYR--APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 54/252 (21%), Positives = 109/252 (43%), Gaps = 19/252 (7%)
Query: 254 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYG------- 306
+S + + + L+ N ++ ++ + + +G+YG
Sbjct: 16 GGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRK 75
Query: 307 DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQ---EVFIMRKVRHKN-VVQFIGACTKPP 362
T + A+KVLK I K E ++ +R +V A
Sbjct: 76 ISGHDT--GKLYAMKVLKKATIVQK-AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132
Query: 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 422
L ++ ++++GG ++ +L + + F + ++ + +LH+ II+RD+K N+L
Sbjct: 133 KLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENIL 191
Query: 423 MDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVI--EHKPYDHKADVFSFGIV 478
+D N V + DFG+++ A GT +MAP+++ +D D +S G++
Sbjct: 192 LDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVL 251
Query: 479 LWELLTGKLPYE 490
++ELLTG P+
Sbjct: 252 MYELLTGASPFT 263
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 48/178 (26%), Positives = 83/178 (46%), Gaps = 9/178 (5%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A+K+L + F E IM VVQ A L +V E+M GG +
Sbjct: 98 AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV 157
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437
+ + +V ++ +H IHRD+K N+L+D++ +K+ADFG
Sbjct: 158 NLMSNYD--VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 215
Query: 438 RVKAQSGVMTAET--GTYRWMAPEVIEHKP----YDHKADVFSFGIVLWELLTGKLPY 489
+ G++ +T GT +++PEV++ + Y + D +S G+ L+E+L G P+
Sbjct: 216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 37/210 (17%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKNV 351
K+ G+YG++Y+ + VAIK RI + ++E +EV ++++++H+N+
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIK-----RIRLEHEEEGVPGTAIREVSLLKELQHRNI 95
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS------KGMNY 405
++ L ++ E+ + LK + + + S G+N+
Sbjct: 96 IELKSVIHHNHRLHLIFEYAE--------NDLKKYMDKNPDVSMRVIKSFLYQLINGVNF 147
Query: 406 LHQNNIIHRDLKAANLLMDENE-----VVKVADFGVARVKA-QSGVMTAETGT--YRWMA 457
H +HRDLK NLL+ ++ V+K+ DFG+AR T E T YR
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR--P 205
Query: 458 PEVI-EHKPYDHKADVFSFGIVLWELLTGK 486
PE++ + Y D++S + E+L
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 68/216 (31%), Positives = 107/216 (49%), Gaps = 28/216 (12%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQ----E 339
WE+ PK + V SG+YG + + VAIK K R + FA+ E
Sbjct: 19 AWEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK--KLSRPFQS--EIFAKRAYRE 73
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLL 393
+ +++ ++H+NV+ + T SL +V FM D L K+ G+ +
Sbjct: 74 LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ----TD-LQKIMGLKFSEEKI 128
Query: 394 KVAI-DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 452
+ + + KG+ Y+H ++HRDLK NL ++E+ +K+ DFG+AR MT T
Sbjct: 129 QYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH--ADAEMTGYVVT 186
Query: 453 YRW-MAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 486
RW APEVI Y+ D++S G ++ E+LTGK
Sbjct: 187 -RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 48/218 (22%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA----QEVFIMRKVRHKNVV 352
G++G + G S VAIK ++ D F Q + + + H N+V
Sbjct: 30 MAGQGTFGTVQLGKEKSTGMSVAIK-----KVIQD--PRFRNRELQIMQDLAVLHHPNIV 82
Query: 353 QFIGACTKPPS--------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS---- 400
Q + + L +V E++ D LH+ + +VA
Sbjct: 83 Q-LQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHR---CCRNYYRRQVAPPPILIKV 133
Query: 401 ------KGMNYLHQN--NIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSGVMTAETG 451
+ + LH N+ HRD+K N+L++ + +K+ DFG A+ + S A
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC 193
Query: 452 T--YRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 486
+ YR APE+I ++ Y D++S G + E++ G+
Sbjct: 194 SRYYR--APELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 8e-23
Identities = 54/223 (24%), Positives = 99/223 (44%), Gaps = 44/223 (19%)
Query: 295 KFGSKVASGSYGDLYRG----TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN 350
G KV G+YG +Y+ +D A+K ++ I+ +E + ++R+++H N
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPN 79
Query: 351 VVQFIGACT--KPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSK---- 401
V+ + ++ ++ +D + + +++ + K
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 402 ----GMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVAR-----VKAQSGVMTA 448
G++YLH N ++HRDLK AN+L+ E VK+AD G AR +K + +
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD-LDP 194
Query: 449 ETGT--YRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGK 486
T YR APE++ H Y D+++ G + ELLT +
Sbjct: 195 VVVTFWYR--APELLLGARH--YTKAIDIWAIGCIFAELLTSE 233
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 8e-23
Identities = 46/208 (22%), Positives = 81/208 (38%), Gaps = 47/208 (22%)
Query: 296 FGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVV 352
+ G G + + + A+K+L D K +EV + + + ++V
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKML------QDCPK-ARREVELHWRASQCPHIV 74
Query: 353 QFIGAC----TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP-----SLLKVAIDVSKGM 403
+ + L IV E + GG ++ + +G ++K + + +
Sbjct: 75 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMK---SIGEAI 130
Query: 404 NYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEV 460
YLH NI HRD+K NLL N ++K+ DFG A E
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKET 170
Query: 461 IEHKPYDHKADVFSFGIVLWELLTGKLP 488
+ YD D++S G++++ LL G P
Sbjct: 171 T-GEKYDKSCDMWSLGVIMYILLCGYPP 197
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 66/233 (28%), Positives = 99/233 (42%), Gaps = 50/233 (21%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQ 338
V+ I + S + G+YG CS + VAIK ++P + +
Sbjct: 6 VYNISSDF-QLKSLLGEGAYG-----VVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-R 58
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSL 392
E+ I++ +H+N++ I +P S I+ E M D LH+ V L
Sbjct: 59 EIKILKHFKHENIIT-IFNIQRPDSFENFNEVYIIQELMQ----TD-LHR---VISTQML 109
Query: 393 LKVAI-----DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-------- 439
I + + LH +N+IHRDLK +NLL++ N +KV DFG+AR+
Sbjct: 110 SDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169
Query: 440 ---KAQSGVMTAETGT--YRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 486
Q M T YR APEV+ Y DV+S G +L EL +
Sbjct: 170 SEPTGQQSGMVEFVATRWYR--APEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 65/220 (29%), Positives = 108/220 (49%), Gaps = 35/220 (15%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQ----E 339
+WE+ ++ + S V SG+YG + T VA+K K R A+ E
Sbjct: 24 IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQS--IIHAKRTYRE 78
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLL 393
+ +++ ++H+NV+ + T SL +VT M D L+ + K L
Sbjct: 79 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG----AD-LNN---IVKCQKLT 130
Query: 394 KVAID-----VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448
+ + +G+ Y+H +IIHRDLK +NL ++E+ +K+ DFG+AR + MT
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH--TADEMTG 188
Query: 449 ETGTYRW-MAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 486
T RW APE++ Y+ D++S G ++ ELLTG+
Sbjct: 189 YVAT-RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-20
Identities = 21/213 (9%), Positives = 58/213 (27%), Gaps = 32/213 (15%)
Query: 297 GSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQ 353
++ T + VA+ + P+ + D+ +E + ++ V +
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
+ +V E++ GGS+ + ++ ++ + H+ +
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVAD---TSPSPVGAIRAMQSLAAAADAAHRAGVAL 152
Query: 414 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 473
+ + + + V +A + + D+
Sbjct: 153 SIDHPSRVRVSIDGDVVLAYPATMP--------------------------DANPQDDIR 186
Query: 474 SFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVH 506
G L+ LL + P +
Sbjct: 187 GIGASLYALLVNRWPLPEAGVRSGLAPAERDTA 219
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 1e-20
Identities = 56/188 (29%), Positives = 92/188 (48%), Gaps = 31/188 (16%)
Query: 316 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK------NVVQFIGACTKPPSLCIVTE 369
Q VA+K+++ ++ A+E+ I+ +R + NV+ + T +C+ E
Sbjct: 123 QHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFE 179
Query: 370 FMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427
+S ++Y+ + +K +G F LP + K A + + ++ LH+N IIH DLK N+L+ +
Sbjct: 180 LLSM-NLYELIKKNKFQG-FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQG 237
Query: 428 --VVKVADFGVARVKAQSGVMTAETGT-------YRWMAPEVIEHKPYDHKADVFSFGIV 478
+KV DFG S + YR APEVI Y D++S G +
Sbjct: 238 RSGIKVIDFG-------SSCYEHQRVYTYIQSRFYR--APEVILGARYGMPIDMWSLGCI 288
Query: 479 LWELLTGK 486
L ELLTG
Sbjct: 289 LAELLTGY 296
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 56/235 (23%), Positives = 100/235 (42%), Gaps = 52/235 (22%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQ 338
+++ ++ + G G S + VAIK + ++ +
Sbjct: 6 GFDLGSRY-MDLKPLGCGGNG-----LVFSAVDNDCDKRVAIKKIVLTDP-QSVKHAL-R 57
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLC--------------IVTEFMSGGSVYDYLHKLK 384
E+ I+R++ H N+V+ S IV E+M D L
Sbjct: 58 EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME----TD-LAN-- 110
Query: 385 GVFKLPSLLKVAID-----VSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVAR 438
V + LL+ + +G+ Y+H N++HRDLK ANL ++ E+ V+K+ DFG+AR
Sbjct: 111 -VLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLAR 169
Query: 439 V----KAQSGVMTAETGT--YRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 486
+ + G ++ T YR +P ++ Y D+++ G + E+LTGK
Sbjct: 170 IMDPHYSHKGHLSEGLVTKWYR--SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 2e-20
Identities = 68/296 (22%), Positives = 111/296 (37%), Gaps = 68/296 (22%)
Query: 239 AALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGS 298
++ E + G S S + S +P +D W+I ++ +
Sbjct: 2 SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSD-WQIPDRY-EIRH 59
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKE-FAQ----EVFIMRKVRHKNV 351
+ +GSYG + + VAIK +I + + E+ I+ ++ H +V
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIK-----KILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 352 VQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI------DV 399
V+ + P + +V E D K +F+ P L ++
Sbjct: 115 VK-VLDIVIPKDVEKFDELYVVLEIAD----SD-FKK---LFRTPVYLTELHIKTLLYNL 165
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-------------------- 439
G+ Y+H I+HRDLK AN L++++ VKV DFG+AR
Sbjct: 166 LVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 440 --------KAQSGVMTAETGT--YRWMAPEVI-EHKPYDHKADVFSFGIVLWELLT 484
K +T T YR APE+I + Y DV+S G + ELL
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYR--APELILLQENYTEAIDVWSIGCIFAELLN 279
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 3e-20
Identities = 64/252 (25%), Positives = 100/252 (39%), Gaps = 60/252 (23%)
Query: 281 NDGTDVWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQ 338
G + + + GSYG +Y ++VAIK K R+ D +
Sbjct: 16 FQGIKNVHVPDNY-IIKHLIGRGSYGYVYLAYDKNTEKNVAIK--KVNRMFED--LIDCK 70
Query: 339 ----EVFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFK 388
E+ I+ +++ +++ P L IV E D L K +FK
Sbjct: 71 RILREITILNRLKSDYIIRLYDLI-IPDDLLKFDELYIVLEIAD----SD-LKK---LFK 121
Query: 389 LPSLLK------VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--- 439
P L + ++ G N++H++ IIHRDLK AN L++++ VKV DFG+AR
Sbjct: 122 TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181
Query: 440 --------------------KAQSGVMTAETGT--YRWMAPEVI-EHKPYDHKADVFSFG 476
K +T+ T YR APE+I + Y D++S G
Sbjct: 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYR--APELILLQENYTKSIDIWSTG 239
Query: 477 IVLWELLTGKLP 488
+ ELL
Sbjct: 240 CIFAELLNMLQS 251
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 4e-20
Identities = 46/243 (18%), Positives = 91/243 (37%), Gaps = 72/243 (29%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQ-- 353
+ +GS+G + + A+K ++ D + E+ IM+ + H N+++
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALK-----KVLQD--PRYKNRELDIMKVLDHVNIIKLV 66
Query: 354 ------------------------------FIGACTKPPS------LCIVTEFMSGGSVY 377
+ + L ++ E++ +++
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLH 125
Query: 378 DYL-HKLKGVFKLPS---------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-EN 426
L ++ +P L + + ++H I HRD+K NLL++ ++
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFR-------AVGFIHSLGICHRDIKPQNLLVNSKD 178
Query: 427 EVVKVADFGVARVKAQSGVMTAETGT--YRWMAPEVI-EHKPYDHKADVFSFGIVLWELL 483
+K+ DFG A+ S A + YR APE++ Y D++S G V EL+
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYICSRFYR--APELMLGATEYTPSIDLWSIGCVFGELI 236
Query: 484 TGK 486
GK
Sbjct: 237 LGK 239
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 66/245 (26%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQ- 338
+ K+ + K+ G+YG + VA+K K + AQ
Sbjct: 5 RHVLRKY-ELVKKLGKGAYG-----IVWKSIDRRTGEVVAVK--KIFDAFQN--STDAQR 54
Query: 339 ---EVFIMRKVR-HKNVVQFIGACTKPPS---LCIVTEFMSGGSVYDYLHKLKGVFKLPS 391
E+ I+ ++ H+N+V + + + + +V ++M D LH V +
Sbjct: 55 TFREIMILTELSGHENIVNLLNVL-RADNDRDVYLVFDYME----TD-LHA---VIRANI 105
Query: 392 LLKVAI-----DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV------- 439
L V + K + YLH ++HRD+K +N+L++ VKVADFG++R
Sbjct: 106 LEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165
Query: 440 ---------------KAQSGVMTAETGT--YRWMAPEVI-EHKPYDHKADVFSFGIVLWE 481
++T T YR APE++ Y D++S G +L E
Sbjct: 166 TNNIPLSINENTENFDDDQPILTDYVATRWYR--APEILLGSTKYTKGIDMWSLGCILGE 223
Query: 482 LLTGK 486
+L GK
Sbjct: 224 ILCGK 228
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 49/183 (26%), Positives = 81/183 (44%), Gaps = 19/183 (10%)
Query: 316 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH------KNVVQFIGACTKPPSLCIVTE 369
+ VAIK++K + EV ++ + +V LC+V E
Sbjct: 80 EWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE 136
Query: 370 FMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQN--NIIHRDLKAANLLM-- 423
+S ++YD L +G L K A + + +L +IIH DLK N+L+
Sbjct: 137 MLSY-NLYDLLRNTNFRG-VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN 194
Query: 424 DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELL 483
+ +K+ DFG + Q ++ YR +PEV+ PYD D++S G +L E+
Sbjct: 195 PKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR--SPEVLLGMPYDLAIDMWSLGCILVEMH 252
Query: 484 TGK 486
TG+
Sbjct: 253 TGE 255
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 51/206 (24%), Positives = 82/206 (39%), Gaps = 48/206 (23%)
Query: 315 SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK------NVVQFIGACTKPPSLCIVT 368
+ VA+K++K + E+ ++ + VQ + +CIV
Sbjct: 40 GRHVAVKIVKN---VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVF 96
Query: 369 EFMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
E + G S YD++ + F+L + K+A + K +N+LH N + H DLK N+L ++
Sbjct: 97 ELL-GLSTYDFIKENGFLP-FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQS 154
Query: 427 EV-------------------VKVADFGVARVKAQSGVMTAETGT-------YRWMAPEV 460
+ +KV DFG S E + YR APEV
Sbjct: 155 DYTEAYNPKIKRDERTLINPDIKVVDFG-------SATYDDEHHSTLVSTRHYR--APEV 205
Query: 461 IEHKPYDHKADVFSFGIVLWELLTGK 486
I + DV+S G +L E G
Sbjct: 206 ILALGWSQPCDVWSIGCILIEYYLGF 231
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 49/206 (23%), Positives = 85/206 (41%), Gaps = 50/206 (24%)
Query: 316 QDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHK------NVVQFIGACTKPPSLCIVT 368
VA+K+++ N +E A+ E+ +++K++ K V +CI
Sbjct: 46 SQVALKIIR----NVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAF 101
Query: 369 EFMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
E + G + +++L + + + LP + +A + + +LH+N + H DLK N+L +
Sbjct: 102 ELL-GKNTFEFLKENNFQP-YPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNS 159
Query: 427 EV-------------------VKVADFGVARVKAQSGVMTAETGT-------YRWMAPEV 460
E ++VADFG S E T YR PEV
Sbjct: 160 EFETLYNEHKSCEEKSVKNTSIRVADFG-------SATFDHEHHTTIVATRHYR--PPEV 210
Query: 461 IEHKPYDHKADVFSFGIVLWELLTGK 486
I + DV+S G +L+E G
Sbjct: 211 ILELGWAQPCDVWSIGCILFEYYRGF 236
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 52/211 (24%), Positives = 93/211 (44%), Gaps = 55/211 (26%)
Query: 316 QDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRH-----KNVVQFIGACTKPPSLCIVTE 369
+ A+KV++ N A+ E I++K+++ N+V++ G +C++ E
Sbjct: 61 KYYAVKVVR----NIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE 116
Query: 370 FMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427
+ G S+Y+ + + G F + + I++ K +NYL + ++ H DLK N+L+D+
Sbjct: 117 PL-GPSLYEIITRNNYNG-FHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPY 174
Query: 428 V-------------------------VKVADFGVARVKAQSGVMTAETGT-------YRW 455
+K+ DFG ++ YR
Sbjct: 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-------CATFKSDYHGSIINTRQYR- 226
Query: 456 MAPEVIEHKPYDHKADVFSFGIVLWELLTGK 486
APEVI + +D +D++SFG VL EL TG
Sbjct: 227 -APEVILNLGWDVSSDMWSFGCVLAELYTGS 256
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 25/213 (11%)
Query: 293 HLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-K 349
+ G K+ SGS+GD+Y GT + ++VAIK+ E + + + E I + ++
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQ-LHIESKIYKMMQGGV 65
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
+ + +V E + G S+ D + F L ++L +A + + Y+H
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124
Query: 410 NIIHRDLKAANLLM---DENEVVKVADFGVAR--VKAQSGVMTAE------TGTYRWM-- 456
N IHRD+K N LM + +V + DFG+A+ A++ TGT R+
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184
Query: 457 -APEVIEHKPYDHKADVFSFGIVLWELLTGKLP 488
IE D D+ S G VL G LP
Sbjct: 185 NTHLGIEQSRRD---DLESLGYVLMYFNLGSLP 214
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 51/214 (23%), Positives = 94/214 (43%), Gaps = 25/214 (11%)
Query: 293 HLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-K 349
+ + G K+ G++G+L G + VAIK+ E + S + E +++
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL---EPMKSRAPQLH-LEYRFYKQLGSGD 65
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
+ Q +V E + G S+ D F L ++L +AI + M Y+H
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124
Query: 410 NIIHRDLKAANLLM-----DENEVVKVADFGVAR--VKAQSG--VMTAE----TGTYRWM 456
N+I+RD+K N L+ +V+ + DF +A+ + ++ + E TGT R+M
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM 184
Query: 457 APEVIEHKPYDH--KADVFSFGIVLWELLTGKLP 488
+ + H + + D+ + G + L G LP
Sbjct: 185 S--INTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 46/214 (21%), Positives = 86/214 (40%), Gaps = 25/214 (11%)
Query: 293 HLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-K 349
H K G ++ GS+G ++ GT Q VAIK E SD + E + +
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF---EPRRSDAP-QLRDEYRTYKLLAGCT 66
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
+ + +V + + G S+ D L F + ++ A + + +H+
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125
Query: 410 NIIHRDLKAANLLM-----DENEVVKVADFGVAR--VKAQSGVMTAE------TGTYRWM 456
++++RD+K N L+ ++ V DFG+ + + +GT R+M
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 185
Query: 457 APEVIEHKPYDH--KADVFSFGIVLWELLTGKLP 488
+ + H + + D+ + G V L G LP
Sbjct: 186 S--INTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 55/274 (20%), Positives = 93/274 (33%), Gaps = 47/274 (17%)
Query: 253 WPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGT 312
H SS E+ +S L+ GT + + + K S + G LY
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAA 62
Query: 313 ----------YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362
Q ++K+ + + + E F R + V P
Sbjct: 63 PTSTLTCDSGPQKQKFSLKL---DAKDGRLFNEQN---FFQRAAKPLQV-NKWKKLYSTP 115
Query: 363 SLCIVTEFMSGGSVYDY-----------LHKL-----KGVFKLPSLLKVAIDVSKGMNYL 406
L I T G Y L K V S+L+VA + + +L
Sbjct: 116 LLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFL 175
Query: 407 HQNNIIHRDLKAANLLMDENEVVKV--ADFGVAR--------VKAQSGVMTAETGTYRWM 456
H+N +H ++ A N+ +D + +V A +G A V G + G ++
Sbjct: 176 HENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFI 235
Query: 457 APEVIEHKPYDH--KADVFSFGIVLWELLTGKLP 488
+ + HK ++D+ S G + + L G LP
Sbjct: 236 S--MDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 54/258 (20%), Positives = 95/258 (36%), Gaps = 71/258 (27%)
Query: 298 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-------- 347
K+ G + ++ + VA+KV+K + E+ +++ VR
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMKVVK---SAEHYTETALDEIRLLKSVRNSDPNDPN 99
Query: 348 HKNVVQFIGACT-KPPS---LCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKG 402
+ VVQ + + +C+V E + G + ++ K LP + K+ V +G
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG 158
Query: 403 MNYLH-QNNIIHRDLKAANLLM-------------------------------------- 423
++YLH + IIH D+K N+L+
Sbjct: 159 LDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 424 -----------DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADV 472
E VK+AD G A + +T YR + EV+ Y+ AD+
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYR--SLEVLIGSGYNTPADI 276
Query: 473 FSFGIVLWELLTGKLPYE 490
+S + +EL TG +E
Sbjct: 277 WSTACMAFELATGDYLFE 294
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 60/277 (21%), Positives = 107/277 (38%), Gaps = 42/277 (15%)
Query: 255 SHRSSSPTSEPEDTGMKSHPYHLKIP-NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 313
H SS + Y +P +G + +++ G K+ SG +G +Y
Sbjct: 4 HHHHSSGVDLGTENL-----YFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFP 58
Query: 314 --CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371
+ A V+K E + E+ ++V K+ ++ + L I +
Sbjct: 59 TNKPEKDARHVVKVEYQENGPLF---SELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115
Query: 372 SGGSVY---DY--------------LHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
SG + + Y + G FK ++L++ I + + Y+H+N +H
Sbjct: 116 SGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHG 175
Query: 415 DLKAANLLMDENEVVKV--ADFGVARVKAQSGVM--------TAETGTYRWMAPEVIEHK 464
D+KAANLL+ +V AD+G++ +G GT + + + HK
Sbjct: 176 DIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTS--LDAHK 233
Query: 465 PYDH--KADVFSFGIVLWELLTGKLPYEYLTPLQAAV 499
++DV G + L GKLP+E AV
Sbjct: 234 GVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 41/228 (17%), Positives = 82/228 (35%), Gaps = 35/228 (15%)
Query: 295 KFGSKVASGSYGDLYRGT-YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 353
K G + G +G +Y S+ V ++ E+ ++ +Q
Sbjct: 38 KVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQ 97
Query: 354 FIGACTKPPSLCI-------------------VTEFMSGGSVYDYLHKLKGVFKLPSLLK 394
K L + + + G + F ++L+
Sbjct: 98 KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQ 156
Query: 395 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKV--ADFGVARVKAQSGVMTAE--- 449
+++ + + Y+H++ +H D+KA+NLL++ +V D+G+A GV A
Sbjct: 157 LSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAAD 216
Query: 450 -----TGTYRWMAPEVIEHKPYDH--KADVFSFGIVLWELLTGKLPYE 490
GT + + + H + D+ G + + LTG LP+E
Sbjct: 217 PKRCHDGTIEFTS--IDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE 262
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 25/213 (11%)
Query: 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HK 349
+ G K+ SGS+G++Y GT +++VAIK+ E + + + E I R ++
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHP-QLLYESKIYRILQGGT 63
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
+ + +V + + G S+ D + L ++L +A + + ++H
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
Query: 410 NIIHRDLKAANLLMDENE---VVKVADFGVAR--VKAQSGVMTAE------TGTYRWM-- 456
+ +HRD+K N LM V + DFG+A+ + TGT R+
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASV 182
Query: 457 -APEVIEHKPYDHKADVFSFGIVLWELLTGKLP 488
IE D D+ S G VL L G LP
Sbjct: 183 NTHLGIEQSRRD---DLESLGYVLMYFLRGSLP 212
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.4 bits (161), Expect = 4e-12
Identities = 33/186 (17%), Positives = 63/186 (33%), Gaps = 48/186 (25%)
Query: 299 KVASGSYGDLYRGTYCSQDVAIKVL---KPERINSDMQK---EFAQEVFIMRKV------ 346
K+ G +G++++ VAIK++ P+ +N QK E E+ I +++
Sbjct: 27 KIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 347 ---RHKNVVQFIGAC----TKPPSLC--------------------------IVTEFMSG 373
R + + + PP L IV EF G
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVA 432
G D + L + + ++ + + HRDL N+L+ + + K+
Sbjct: 147 GI--DLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLH 204
Query: 433 DFGVAR 438
+
Sbjct: 205 YTLNGK 210
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.3 bits (140), Expect = 4e-09
Identities = 88/550 (16%), Positives = 164/550 (29%), Gaps = 151/550 (27%)
Query: 23 SPPPQHQSR------QHRQKLGVY---NEVL----GRLKESNNDEAIQPRFDDELWTHF- 68
S + +Q+ V EVL L E QP ++
Sbjct: 57 SKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQR 116
Query: 69 NRL---PTRYALDVNVERAEDVL-MHKRLLHLAHDPRNRPAIEVRLVQVHPV--SDRNS- 121
+RL +A NV R + L + + LL L RPA + V + V S +
Sbjct: 117 DRLYNDNQVFA-KYNVSRLQPYLKLRQALLEL------RPA---KNVLIDGVLGSGKTWV 166
Query: 122 AVSSLLDSEVPAQRQSIHPPPAF----GSSPNLEALAIEANN-SHNLDGDNSVHANVQFS 176
A+ L +V Q F + + E + + +D + + ++ S
Sbjct: 167 ALDVCLSYKV----QCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSD-HSS 221
Query: 177 RPMHEITFSTDDKPKLLSQL---TAL--LADIGLNIQEAHAFS--------TVDGYSLDV 223
I + +LL L L ++ N + +AF+ T D
Sbjct: 222 NIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQ-NAKAWNAFNLSCKILLTTRFKQVTDF 280
Query: 224 FVVDGWPYEETEQLRAAL-EKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKI--- 279
+ + L EV L + + R P P + + ++P L I
Sbjct: 281 LSAATTTHISLDHHSMTLTPDEVKSLLLK-YLDCR---PQDLPREV-LTTNPRRLSIIAE 335
Query: 280 -PNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQ 338
DG W+ + KH+ K+ + + ++ VL+P + +K F
Sbjct: 336 SIRDGLATWD-NWKHVNC-DKLTT------------IIESSLNVLEPA----EYRKMF-D 376
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 396
+ + + P+ L ++ + V ++KL SL++
Sbjct: 377 RLSVFPP----SA--------HIPTILLSLIWFDVIKSDVMVVVNKLHK----YSLVE-- 418
Query: 397 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK----VADFGVARVKAQSGVMTAETGT 452
+ + I+ +LK ENE V + + + ++
Sbjct: 419 KQPKESTISIPS---IYLELKVKL----ENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQ 471
Query: 453 YRWMAPEVIEHKPYDH-----KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHH 507
Y H + H + + +L
Sbjct: 472 Y------FYSHIGH-HLKNIEHPERMTL-----------FRMVFLD-------------F 500
Query: 508 SFLEQRLRKS 517
FLEQ++R
Sbjct: 501 RFLEQKIRHD 510
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 3e-07
Identities = 79/538 (14%), Positives = 147/538 (27%), Gaps = 201/538 (37%)
Query: 22 SSPPPQHQSRQHRQKL------GVY-----------NEVLGRLKESNNDEAIQPRFDDEL 64
S P + RQ +L + +V +Q + D ++
Sbjct: 132 SRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVC-------LSYKVQCKMDFKI 184
Query: 65 -WTHFNRLPTRYALDVNVERAEDVL-MHKRLLHLA---------HDPRNRPAIEV----- 108
W + N E VL M ++LL+ H + I
Sbjct: 185 FWLNLK----------NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAEL 234
Query: 109 -RLVQVHP----------VSD-----------------RNSAVSSLLDSEVPAQRQSIHP 140
RL++ P V + R V+ L + H
Sbjct: 235 RRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHH 294
Query: 141 PPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTAL- 199
L + D P+ +
Sbjct: 295 SMTLTPDEVKSLLLKYLDCR-------------------------PQDLPREVLTTNPRR 329
Query: 200 LADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLKLE----RQGW-- 253
L+ I +I++ A D W + ++L +E + LE R+ +
Sbjct: 330 LSIIAESIRDGLATW------------DNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDR 377
Query: 254 ----------PSHR-----SSSPTSEPEDTGMKSHPYHL--KIPNDGTDVWEIDPKHLKF 296
P+ S+ K H Y L K P + T I +L+
Sbjct: 378 LSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKEST--ISIPSIYLEL 435
Query: 297 GSKVAS---------GSYGDLYRGTYCSQDVAIKV------------LKPERINSDMQKE 335
K+ + Y ++ + + S D+ LK + +
Sbjct: 436 KVKLENEYALHRSIVDHY-NIPKT-FDSDDLIPPYLDQYFYSHIGHHLKNIE-HPERMTL 492
Query: 336 FAQEV----FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--- 388
F F+ +K+RH + A GS+ + L +LK +K
Sbjct: 493 FRMVFLDFRFLEQKIRHDST-----AWNAS------------GSILNTLQQLK-FYKPYI 534
Query: 389 ---LPSLLKVAIDVSKGMNYLHQ--NNII---HRDLKAANLLMDENEVVKVADFGVAR 438
P ++ + +++L + N+I + DL L+ ++ + + A V R
Sbjct: 535 CDNDPKYERLVNAI---LDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAHKQVQR 589
|
| >1u8s_A Glycine cleavage system transcriptional repressor, putative; structural genomics, protein structure initiative (PSI), domain swapping; 2.45A {Vibrio cholerae} SCOP: d.58.18.5 d.58.18.5 Length = 192 | Back alignment and structure |
|---|
Score = 39.7 bits (92), Expect = 8e-04
Identities = 11/84 (13%), Positives = 27/84 (32%), Gaps = 2/84 (2%)
Query: 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAAL 241
IT D+P + +++ L+ G NI ++ ++L + + ++ L
Sbjct: 9 ITAVGTDRPGICNEVVRLVTQAGCNIIDSRIAMFGKEFTLLMLI--SGSPSNITRVETTL 66
Query: 242 EKEVLKLERQGWPSHRSSSPTSEP 265
+ + S
Sbjct: 67 PLLGQQHDLITMMKRTSPHDHQTH 90
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 518 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.7 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.34 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.17 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.16 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.14 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.85 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.62 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.5 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.47 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.36 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.24 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.21 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.17 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.86 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.7 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.5 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.49 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.47 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.28 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.14 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.11 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.96 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.71 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.69 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.69 | |
| 1u8s_A | 192 | Glycine cleavage system transcriptional repressor, | 96.63 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.27 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.93 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.88 | |
| 2nyi_A | 195 | Unknown protein; protein structure initiative, PSI | 95.86 | |
| 1zpv_A | 91 | ACT domain protein; structural genomics, PSI, prot | 95.79 | |
| 2ko1_A | 88 | CTR148A, GTP pyrophosphokinase; homodimer, alpha+b | 94.66 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.39 | |
| 2f1f_A | 164 | Acetolactate synthase isozyme III small subunit; f | 93.16 | |
| 2nyi_A | 195 | Unknown protein; protein structure initiative, PSI | 91.91 | |
| 2pc6_A | 165 | Probable acetolactate synthase isozyme III (small; | 91.7 | |
| 1u8s_A | 192 | Glycine cleavage system transcriptional repressor, | 90.28 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 90.05 | |
| 3nrb_A | 287 | Formyltetrahydrofolate deformylase; N-terminal ACT | 84.32 | |
| 3n0v_A | 286 | Formyltetrahydrofolate deformylase; formyl transfe | 84.29 | |
| 2fgc_A | 193 | Acetolactate synthase, small subunit; regulatory s | 83.42 | |
| 3obi_A | 288 | Formyltetrahydrofolate deformylase; structural gen | 83.12 | |
| 3lou_A | 292 | Formyltetrahydrofolate deformylase; structural gen | 82.25 | |
| 3p96_A | 415 | Phosphoserine phosphatase SERB; ssgcid, structural | 81.33 | |
| 3o1l_A | 302 | Formyltetrahydrofolate deformylase; structural gen | 80.46 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.19 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-52 Score=420.68 Aligned_cols=223 Identities=39% Similarity=0.727 Sum_probs=194.0
Q ss_pred CCCCceeeCCCCeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC
Q 010078 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (518)
Q Consensus 282 ~~~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~ 361 (518)
+....|+|+.++++++++||+|+||+||+|++.+ .||||+++.........+.|.+|+.+|++++|||||++++++.+
T Consensus 26 ~~~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~- 103 (307)
T 3omv_A 26 DSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK- 103 (307)
T ss_dssp ---CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred CCCcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-
Confidence 3456899999999999999999999999998765 69999998776677778899999999999999999999999875
Q ss_pred CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
+.+|||||||+||+|.++++...+.+++..+..|+.||+.||.|||+++||||||||+|||++.++.+||+|||+++...
T Consensus 104 ~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 104 DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 56899999999999999998877889999999999999999999999999999999999999999999999999998654
Q ss_pred cC---CccccCCCCCcccCchhccC---CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcC
Q 010078 442 QS---GVMTAETGTYRWMAPEVIEH---KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVH 506 (518)
Q Consensus 442 ~~---~~~~~~~gt~~y~APEvl~~---~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~ 506 (518)
.. ......+||+.|||||++.+ .+|+.++|||||||+||||+||+.||.+.+..+.+..++.++.
T Consensus 184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~ 254 (307)
T 3omv_A 184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGY 254 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTC
T ss_pred cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC
Confidence 32 23455689999999999953 4699999999999999999999999999887777776666554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=413.50 Aligned_cols=224 Identities=31% Similarity=0.536 Sum_probs=190.6
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeec
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~-------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~ 357 (518)
..+.|+.+++.+.++||+|+||+||+|++. ++.||||+++.. .....++|.+|+.+|++++|||||+++|+
T Consensus 34 ~~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~ 111 (329)
T 4aoj_A 34 CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGV 111 (329)
T ss_dssp CSCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 356788899999999999999999999874 467999999853 45567889999999999999999999999
Q ss_pred ccCCCCcceeeeecCCCchhHHHhhhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 010078 358 CTKPPSLCIVTEFMSGGSVYDYLHKLK--------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423 (518)
Q Consensus 358 ~~~~~~~~lV~Ey~~ggsL~~~l~~~~--------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILi 423 (518)
|.+...+|||||||++|+|.+++++.. +++++..++.|+.||+.||.|||+++||||||||+|||+
T Consensus 112 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl 191 (329)
T 4aoj_A 112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 191 (329)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE
Confidence 999999999999999999999997632 458999999999999999999999999999999999999
Q ss_pred cCCCcEEEEeeCcceecccCC---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 010078 424 DENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 499 (518)
Q Consensus 424 d~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~ 499 (518)
+.++.+||+|||+++...... ......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+.+.
T Consensus 192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999999998654332 2234579999999999999999999999999999999999 999999999988887
Q ss_pred HhhhhcCchhHH
Q 010078 500 GVVQKVHHSFLE 511 (518)
Q Consensus 500 ~iv~~~~rp~ip 511 (518)
.+.+ +.++.+|
T Consensus 272 ~i~~-g~~~~~p 282 (329)
T 4aoj_A 272 CITQ-GRELERP 282 (329)
T ss_dssp HHHH-TCCCCCC
T ss_pred HHHc-CCCCCCc
Confidence 7654 4444433
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=417.61 Aligned_cols=218 Identities=26% Similarity=0.469 Sum_probs=192.1
Q ss_pred CCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCccee
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV 367 (518)
..++|+++++||+|+||+||+|++. ++.||||+++.........+.+.+|+.+|++|+|||||++++++.+++.+|||
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 3578999999999999999999874 78899999988777777778899999999999999999999999999999999
Q ss_pred eeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-c
Q 010078 368 TEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-V 445 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~ 445 (518)
||||+||+|.+++.... ..+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+++...... .
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 181 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence 99999999999997643 457899999999999999999999999999999999999999999999999998765432 2
Q ss_pred cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCc
Q 010078 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 446 ~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
.+..+||+.|||||++.+..|+.++||||||||||||+||+.||.+.+..+.+..+++...+
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~ 243 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP 243 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC
T ss_pred ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC
Confidence 34567999999999999999999999999999999999999999999999999888775543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=410.03 Aligned_cols=220 Identities=29% Similarity=0.543 Sum_probs=192.5
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecc
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~-------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~ 358 (518)
.+.|+.++|.+.++||+|+||.||+|++. +..||||+++.. .....++|.+|+.+|++++|||||+++|+|
T Consensus 7 ~~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 84 (299)
T 4asz_A 7 VQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVC 84 (299)
T ss_dssp CCBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hcccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 34688889999999999999999999864 467999999853 455678899999999999999999999999
Q ss_pred cCCCCcceeeeecCCCchhHHHhhhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCC
Q 010078 359 TKPPSLCIVTEFMSGGSVYDYLHKLK------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426 (518)
Q Consensus 359 ~~~~~~~lV~Ey~~ggsL~~~l~~~~------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~ 426 (518)
.+++.+|||||||+||+|.+++++.. ..+++..++.|+.||+.||.|||+++||||||||+|||++.+
T Consensus 85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 85 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC
Confidence 99999999999999999999997632 468999999999999999999999999999999999999999
Q ss_pred CcEEEEeeCcceecccCCcc---ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhh
Q 010078 427 EVVKVADFGVARVKAQSGVM---TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 427 ~~vkL~DFGla~~~~~~~~~---~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv 502 (518)
+.+||+|||+++........ ....||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.++.+....+.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99999999999865443222 23458999999999999999999999999999999999 999999999988888766
Q ss_pred hhcCch
Q 010078 503 QKVHHS 508 (518)
Q Consensus 503 ~~~~rp 508 (518)
+ +.++
T Consensus 245 ~-~~~~ 249 (299)
T 4asz_A 245 Q-GRVL 249 (299)
T ss_dssp H-TCCC
T ss_pred c-CCCC
Confidence 5 4443
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=408.68 Aligned_cols=215 Identities=23% Similarity=0.434 Sum_probs=192.8
Q ss_pred CCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcce
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~l 366 (518)
..++|++++.||+|+||+||+++.. ++.||||++++... .....+.+.+|+.+|++++|||||++++++.++..+||
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 3467999999999999999999874 67899999975422 12235678999999999999999999999999999999
Q ss_pred eeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC---
Q 010078 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--- 443 (518)
Q Consensus 367 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~--- 443 (518)
|||||+||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 110 vmEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 9999999999999987 578999999999999999999999999999999999999999999999999999876432
Q ss_pred CccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 444 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 444 ~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
......+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..+....|++..
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~ 250 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE 250 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 23456689999999999999999999999999999999999999999999988888877654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-50 Score=406.94 Aligned_cols=218 Identities=28% Similarity=0.556 Sum_probs=192.4
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecc
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~-------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~ 358 (518)
.++++.+++++.++||+|+||+||+|++. ++.||||+++... .....++|.+|+.+|++++|||||+++|+|
T Consensus 20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 45788889999999999999999999873 4679999998643 334457899999999999999999999999
Q ss_pred cCCCCcceeeeecCCCchhHHHhhh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 010078 359 TKPPSLCIVTEFMSGGSVYDYLHKL---------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423 (518)
Q Consensus 359 ~~~~~~~lV~Ey~~ggsL~~~l~~~---------------~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILi 423 (518)
..++.+|||||||++|+|.++|... ...+++..++.|+.||+.||.|||+++||||||||+|||+
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 9999999999999999999999653 2458999999999999999999999999999999999999
Q ss_pred cCCCcEEEEeeCcceecccCC---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 010078 424 DENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 499 (518)
Q Consensus 424 d~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~ 499 (518)
+.++.+||+|||+++...... ......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+.+.
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999998654322 3345679999999999999999999999999999999999 899999999988887
Q ss_pred Hhhhh
Q 010078 500 GVVQK 504 (518)
Q Consensus 500 ~iv~~ 504 (518)
.+.++
T Consensus 259 ~i~~~ 263 (308)
T 4gt4_A 259 MIRNR 263 (308)
T ss_dssp HHHTT
T ss_pred HHHcC
Confidence 76553
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=410.40 Aligned_cols=217 Identities=27% Similarity=0.444 Sum_probs=187.6
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEE-----CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~-----~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
.+++++|++++.||+|+||+||+++. .++.||||+++...........+.+|+.+|++++|||||++++++.+++
T Consensus 20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG 99 (304)
T ss_dssp CCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred cCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 56678999999999999999999986 3467999999765433333346888999999999999999999999999
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
.+|||||||+||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEEEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 99999999999999999987 57899999999999999999999999999999999999999999999999999986543
Q ss_pred -CCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 443 -SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 443 -~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
.......+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+..+....|++..
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~ 242 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK 242 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC
Confidence 334556789999999999999999999999999999999999999999999998888877643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=407.32 Aligned_cols=209 Identities=29% Similarity=0.475 Sum_probs=189.7
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
+.|++.++||+|+||.||+|++. ++.||||+++...... .+.+.+|+.+|++++|||||+++++|.+++.+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 56999999999999999999984 6889999997543322 3568899999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-Ccccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~-~~~~~ 448 (518)
||+||+|.+++.+ +.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+++..... ...+.
T Consensus 152 y~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 229 (346)
T 4fih_A 152 FLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 229 (346)
T ss_dssp CCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred CCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence 9999999999975 57999999999999999999999999999999999999999999999999999876544 34567
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
.+||+.|||||++.+.+|+.++||||||||+|||++|+.||.+.++.+....|.+.
T Consensus 230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~ 285 (346)
T 4fih_A 230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN 285 (346)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC
Confidence 79999999999999999999999999999999999999999999998888876654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=391.47 Aligned_cols=211 Identities=26% Similarity=0.503 Sum_probs=173.6
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
++|++++.||+|+||.||+|++ +++.||||+++..... ......+.+|+.+|++++|||||++++++..++.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999986 4788999999765433 334567999999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcccc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~ 448 (518)
||+ +|+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus 93 Ey~-~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 170 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT 170 (275)
T ss_dssp ECC-CEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred eCC-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCC
Confidence 999 7899999977 67899999999999999999999999999999999999999999999999999987766666667
Q ss_pred CCCCCcccCchhccCCCC-ChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 449 ETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~-s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
.+||+.|||||++.+..| +.++|||||||++|+|+||+.||.+.+..+....+.+.
T Consensus 171 ~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~ 227 (275)
T 3hyh_A 171 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG 227 (275)
T ss_dssp ----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred eeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC
Confidence 899999999999999887 57999999999999999999999998887777776554
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=391.97 Aligned_cols=211 Identities=30% Similarity=0.540 Sum_probs=184.2
Q ss_pred eeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC----CCCccee
Q 010078 294 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK----PPSLCIV 367 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~----~~~~~lV 367 (518)
|++.++||+|+||.||+|.+. +..||+|++..........+.|.+|+.+|++++|||||+++++|.. ...+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 578889999999999999985 5679999998776677777889999999999999999999998854 3458999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEc-CCCcEEEEeeCcceecccCC
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~g--IiHrDLKp~NILid-~~~~vkL~DFGla~~~~~~~ 444 (518)
||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++| ||||||||+|||++ .+|.+||+|||+++.... .
T Consensus 108 mEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-~ 185 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-S 185 (290)
T ss_dssp EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-T
T ss_pred EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-C
Confidence 999999999999987 578999999999999999999999998 99999999999998 478999999999986443 3
Q ss_pred ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCc
Q 010078 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 445 ~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
.....+||+.|||||++.+ +|+.++|||||||+||||+||+.||.+.+....+...+..+.+
T Consensus 186 ~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~ 247 (290)
T 3fpq_A 186 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 247 (290)
T ss_dssp SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC
T ss_pred ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC
Confidence 4556789999999999875 5999999999999999999999999877665555555554444
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-49 Score=403.51 Aligned_cols=210 Identities=25% Similarity=0.378 Sum_probs=184.2
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
......|++.++||+|+||.||+|++. ++.||||+++.+.. +.+|+.+|++++|||||++++++.+.+.+|
T Consensus 54 ~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ 126 (336)
T 4g3f_A 54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVN 126 (336)
T ss_dssp CBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEE
T ss_pred hcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 445567999999999999999999975 68899999986533 246999999999999999999999999999
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC-cEEEEeeCcceecccCC
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSG 444 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~-~vkL~DFGla~~~~~~~ 444 (518)
||||||+||+|.+++++ .+.+++..++.++.||+.||+|||++|||||||||+||||+.+| .+||+|||+++......
T Consensus 127 ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp EEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred EEEeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999999999987 57899999999999999999999999999999999999999987 69999999998765432
Q ss_pred c------cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 445 V------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 445 ~------~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
. ....+||+.|||||++.+.+|+.++|||||||+||||+||+.||.+.+..+....|....
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~ 272 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP 272 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC
Confidence 1 123479999999999999999999999999999999999999999888777777766543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=407.78 Aligned_cols=227 Identities=32% Similarity=0.575 Sum_probs=198.1
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC-CcceEEee
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFIG 356 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~H-pnIv~l~g 356 (518)
+.|+|+.++|+++++||+|+||+||+|++.+ +.||||+++... .....+.|.+|+.+|++++| ||||+++|
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 4799999999999999999999999998754 469999998653 34456789999999999976 89999999
Q ss_pred cccCC-CCcceeeeecCCCchhHHHhhhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 010078 357 ACTKP-PSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420 (518)
Q Consensus 357 ~~~~~-~~~~lV~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~N 420 (518)
+|..+ ..+|||||||++|+|.++|++.. ..+++..++.++.||+.||.|||+++||||||||+|
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N 215 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 215 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence 98764 56899999999999999997632 347899999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEeeCcceecccCC---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 010078 421 LLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ 496 (518)
Q Consensus 421 ILid~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q 496 (518)
||++.++.+||+|||+++...... ......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~ 295 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 295 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999998654432 2234568999999999999999999999999999999998 999999988777
Q ss_pred HHHHhhhhcCchhHHH
Q 010078 497 AAVGVVQKVHHSFLEQ 512 (518)
Q Consensus 497 ~~~~iv~~~~rp~ip~ 512 (518)
.+..++..+.++.+|.
T Consensus 296 ~~~~~i~~g~~~~~p~ 311 (353)
T 4ase_A 296 EFCRRLKEGTRMRAPD 311 (353)
T ss_dssp HHHHHHHHTCCCCCCT
T ss_pred HHHHHHHcCCCCCCCc
Confidence 7777788887766554
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=409.46 Aligned_cols=209 Identities=29% Similarity=0.475 Sum_probs=189.9
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
+.|++.++||+|+||.||+|++. ++.||||++....... .+.+.+|+.+|++++|||||+++++|...+.+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 56999999999999999999985 6889999997553322 3568899999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-Ccccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~-~~~~~ 448 (518)
||+||+|.+++.. +.+++..+..|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+++..... .....
T Consensus 229 y~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 306 (423)
T 4fie_A 229 FLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 306 (423)
T ss_dssp CCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred CCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence 9999999999965 57999999999999999999999999999999999999999999999999999876543 34566
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
.+||+.|||||++.+..|+.++||||||||+|||++|+.||.+.++.+.+..|...
T Consensus 307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~ 362 (423)
T 4fie_A 307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN 362 (423)
T ss_dssp CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC
Confidence 78999999999999999999999999999999999999999999999888877654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=387.50 Aligned_cols=213 Identities=24% Similarity=0.361 Sum_probs=188.0
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC------CCC
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK------PPS 363 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~------~~~ 363 (518)
++|+++++||+|+||.||+|++. ++.||||+++.........+.+.+|+.+|++++|||||++++++.. ...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999874 7889999998776666667889999999999999999999998653 357
Q ss_pred cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC
Q 010078 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~ 443 (518)
+|||||||+ |+|.+++.+ .+.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+++.....
T Consensus 134 ~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 899999995 689999976 678999999999999999999999999999999999999999999999999999865332
Q ss_pred -----CccccCCCCCcccCchhccCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcC
Q 010078 444 -----GVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVH 506 (518)
Q Consensus 444 -----~~~~~~~gt~~y~APEvl~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~ 506 (518)
......+||+.|||||++.+. .|+.++||||+|||+|||++|+.||.+.+..+.+..|++...
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g 280 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLG 280 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC
Confidence 234567899999999998775 569999999999999999999999999999888888776443
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=379.82 Aligned_cols=217 Identities=26% Similarity=0.492 Sum_probs=175.7
Q ss_pred CCeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC----Cccee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP----SLCIV 367 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~----~~~lV 367 (518)
++|.+.++||+|+||+||+|+++++.||||+++.. ......+..|+..+.+++|||||+++++|..+. .+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 46889999999999999999999999999999753 221223345666677899999999999997654 47999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN--------NIIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~--------gIiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
||||+||+|.++++. ..+++..+.+++.|++.||.|||++ +||||||||+|||++.++.+||+|||+++.
T Consensus 80 ~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999999976 5689999999999999999999987 999999999999999999999999999987
Q ss_pred cccCCc-----cccCCCCCcccCchhccCC------CCChhhHHHHHHHHHHHHHcCCCCC----------CCC-----C
Q 010078 440 KAQSGV-----MTAETGTYRWMAPEVIEHK------PYDHKADVFSFGIVLWELLTGKLPY----------EYL-----T 493 (518)
Q Consensus 440 ~~~~~~-----~~~~~gt~~y~APEvl~~~------~~s~ksDVwSlGviL~eLltG~~Pf----------~~~-----~ 493 (518)
...... ....+||+.|||||++.+. .|+.++|||||||+||||+||..|| ... .
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 654332 2235799999999999764 4678999999999999999996654 332 2
Q ss_pred HHHHHHHhhhhcCchhHHHH
Q 010078 494 PLQAAVGVVQKVHHSFLEQR 513 (518)
Q Consensus 494 ~~q~~~~iv~~~~rp~ip~~ 513 (518)
..+....++.++.||.+|..
T Consensus 238 ~~~~~~~~~~~~~rp~~p~~ 257 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPNIPNR 257 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGG
T ss_pred HHHHHHHHhcccCCCCCCcc
Confidence 34455556677777766643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=372.42 Aligned_cols=196 Identities=26% Similarity=0.467 Sum_probs=161.2
Q ss_pred CeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC--------
Q 010078 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-------- 362 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~-------- 362 (518)
+|++++.||+|+||.||+|++. ++.||||+++... .....+.+.+|+.+|++++|||||++++++...+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 5899999999999999999875 7889999987543 3445678999999999999999999999986443
Q ss_pred ----CcceeeeecCCCchhHHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCc
Q 010078 363 ----SLCIVTEFMSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436 (518)
Q Consensus 363 ----~~~lV~Ey~~ggsL~~~l~~~~--~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGl 436 (518)
.+|||||||+||+|.+++.... ...+...++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 3689999999999999997632 1245567889999999999999999999999999999999999999999999
Q ss_pred ceecccCC-------------ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCC
Q 010078 437 ARVKAQSG-------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL 492 (518)
Q Consensus 437 a~~~~~~~-------------~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (518)
++...... ..+..+||+.|||||++.+.+|+.++|||||||++|||++ ||...
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~ 230 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ 230 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence 98654322 1234579999999999999999999999999999999996 88754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=392.02 Aligned_cols=213 Identities=24% Similarity=0.392 Sum_probs=194.8
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|++++.||+|+||.||+++.. ++.||||+++... ....+.+.+|+.+|+.++|||||++++++.+...+|||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 57999999999999999999874 6789999987542 3345678899999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCC--CcEEEEeeCcceecccCCccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN--EVVKVADFGVARVKAQSGVMT 447 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~--~~vkL~DFGla~~~~~~~~~~ 447 (518)
||+||+|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.........
T Consensus 235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~ 314 (573)
T 3uto_A 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314 (573)
T ss_dssp CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence 999999999997766789999999999999999999999999999999999999854 899999999999887776677
Q ss_pred cCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcC
Q 010078 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVH 506 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~ 506 (518)
..+||+.|||||++.+.+|+.++|||||||+||||++|+.||.+.+..+.+..|.....
T Consensus 315 ~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~ 373 (573)
T 3uto_A 315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW 373 (573)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC
T ss_pred eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCC
Confidence 78999999999999999999999999999999999999999999999998888776543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=365.88 Aligned_cols=204 Identities=23% Similarity=0.397 Sum_probs=174.0
Q ss_pred CCeeeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEeecccCCCCcc
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~-----~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~~~~ 365 (518)
+.|+++++||+|+||.||+|+.. ++.||||++..... ..++.+|+.+|+.+ +||||+++++++...+++|
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 57999999999999999999863 46799999875421 35678899999998 5999999999999999999
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCC-CcEEEEeeCcceecccCC
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVKAQSG 444 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~-~~vkL~DFGla~~~~~~~ 444 (518)
+||||++|++|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+......
T Consensus 97 lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp EEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred EEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 9999999999999984 48999999999999999999999999999999999999876 799999999997543321
Q ss_pred -----------------------------ccccCCCCCcccCchhccCC-CCChhhHHHHHHHHHHHHHcCCCCCC-CCC
Q 010078 445 -----------------------------VMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYE-YLT 493 (518)
Q Consensus 445 -----------------------------~~~~~~gt~~y~APEvl~~~-~~s~ksDVwSlGviL~eLltG~~Pf~-~~~ 493 (518)
..+..+||+.|||||++.+. .|+.++||||+|||+|||+||+.||. +.+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 22345799999999999775 58999999999999999999999995 445
Q ss_pred HHHHHHHhhh
Q 010078 494 PLQAAVGVVQ 503 (518)
Q Consensus 494 ~~q~~~~iv~ 503 (518)
..+.+..|.+
T Consensus 253 ~~~~l~~I~~ 262 (361)
T 4f9c_A 253 DLTALAQIMT 262 (361)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 5666655544
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=388.02 Aligned_cols=202 Identities=27% Similarity=0.444 Sum_probs=176.2
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC----ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI----NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~----~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
+..++|++++.||+|+||.||+++. +++.||||++++... ..........++.+++.++|||||+++++|.+..
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 3456899999999999999999987 467899999975322 1222233344567777889999999999999999
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
.+|||||||+||+|.+++.+ .+.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+++....
T Consensus 266 ~lylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 99999999999999999987 67899999999999999999999999999999999999999999999999999987654
Q ss_pred CCccccCCCCCcccCchhcc-CCCCChhhHHHHHHHHHHHHHcCCCCCCCC
Q 010078 443 SGVMTAETGTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYL 492 (518)
Q Consensus 443 ~~~~~~~~gt~~y~APEvl~-~~~~s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (518)
. .....+||+.|||||++. +..|+.++||||||||||||++|+.||.+.
T Consensus 345 ~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~ 394 (689)
T 3v5w_A 345 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394 (689)
T ss_dssp C-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred C-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4 345679999999999996 468999999999999999999999999753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=346.39 Aligned_cols=225 Identities=43% Similarity=0.723 Sum_probs=190.7
Q ss_pred CCceeeCCCCeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCC
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~ 363 (518)
.+.+++...+|++.++||+|+||.||+|++.++.||||++..........+.+.+|+.+|++++||||+++++++.....
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 45778999999999999999999999999999999999998776667777889999999999999999999999999999
Q ss_pred cceeeeecCCCchhHHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 364 LCIVTEFMSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~--~~l~~~~i~~i~~qIa~aL~yLHs~g--IiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 999999999999999997632 23899999999999999999999999 99999999999999999999999999975
Q ss_pred cccCC-ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCch
Q 010078 440 KAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHS 508 (518)
Q Consensus 440 ~~~~~-~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp 508 (518)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...++.+....+.....+.
T Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 258 (309)
T 3p86_A 189 KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL 258 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC
T ss_pred ccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 44332 2345679999999999999999999999999999999999999999999988877765444443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=344.66 Aligned_cols=214 Identities=29% Similarity=0.518 Sum_probs=195.7
Q ss_pred CCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
..+|++.+.||+|+||.||+|++ +++.||||++..........+.+.+|+.+|+.++||||+++++++.....+|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35799999999999999999997 5788999999877667777788999999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcccc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~ 448 (518)
||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus 94 e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 172 (328)
T 3fe3_A 94 EYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA 172 (328)
T ss_dssp CCCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGT
T ss_pred ECCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcccc
Confidence 99999999999977 56799999999999999999999999999999999999999999999999999987766666777
Q ss_pred CCCCCcccCchhccCCCCC-hhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 449 ETGTYRWMAPEVIEHKPYD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s-~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
.+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 230 (328)
T 3fe3_A 173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 230 (328)
T ss_dssp TSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred ccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 8899999999999988875 89999999999999999999999998888777766543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=360.05 Aligned_cols=272 Identities=22% Similarity=0.361 Sum_probs=198.7
Q ss_pred CCChhhHHHHHHHHHHHHHHhhhcCCCCCCCCCCCCCCCCCCCCCCCCccccCCCCCCceeeCCCCeeeeeeeeecCceE
Q 010078 228 GWPYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGD 307 (518)
Q Consensus 228 gw~~e~~~~l~~~l~~~~~~~~~~~~~s~~sss~~s~~~~~~~~~~~~~~~~p~~~~~~~ei~~~~~~i~~~LG~G~fG~ 307 (518)
....++.++|..++...+..++.+........+.+..... ....... ......+.+..++|++.++||+|+||.
T Consensus 90 ~~~~ee~e~W~~ai~~~i~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~~~~y~~~~~lG~G~~g~ 163 (446)
T 4ejn_A 90 VETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNS-GAEEMEV-----SLAKPKHRVTMNEFEYLKLLGKGTFGK 163 (446)
T ss_dssp CSSHHHHHHHHHHHHHHCCC----------------------------------------CCCGGGEEEEEEEEEETTEE
T ss_pred cCCHHHHHHHHHHHHhhhhhhhcccccccccCCCCCcccc-ccccccc-----cccCcccCCChHHcEEeEEEeeCcCEE
Confidence 4668899999999999876555443222111111110000 0000000 011123456678899999999999999
Q ss_pred EEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecCCCchhHHHhhhc
Q 010078 308 LYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK 384 (518)
Q Consensus 308 Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~ 384 (518)
||++... ++.||||+++.... .......+.+|+.+++.++||||+++++++.....+|+||||++|++|.+++.. .
T Consensus 164 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~ 242 (446)
T 4ejn_A 164 VILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-E 242 (446)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHH-H
T ss_pred EEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHh-c
Confidence 9999874 67899999875422 233346788899999999999999999999999999999999999999999976 5
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEcCCCcEEEEeeCcceeccc-CCccccCCCCCcccCchhcc
Q 010078 385 GVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGTYRWMAPEVIE 462 (518)
Q Consensus 385 ~~l~~~~i~~i~~qIa~aL~yLHs-~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~-~~~~~~~~gt~~y~APEvl~ 462 (518)
+.+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.... .......+||+.|+|||++.
T Consensus 243 ~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~ 322 (446)
T 4ejn_A 243 RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE 322 (446)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcC
Confidence 679999999999999999999998 9999999999999999999999999999975333 23445678999999999999
Q ss_pred CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcC
Q 010078 463 HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVH 506 (518)
Q Consensus 463 ~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~ 506 (518)
+..|+.++|||||||++|||++|+.||.+.+..+....++....
T Consensus 323 ~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~ 366 (446)
T 4ejn_A 323 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI 366 (446)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC
Confidence 99999999999999999999999999999988877777665443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=345.16 Aligned_cols=215 Identities=23% Similarity=0.447 Sum_probs=189.8
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
+..++|++++.||+|+||.||+++.. ++.||||+++.... .......+.+|+.+|+.++||||+++++++.....+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 45578999999999999999999874 67899999875321 1223467889999999999999999999999999999
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc-CC
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SG 444 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~-~~ 444 (518)
+||||++||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.... ..
T Consensus 82 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 99999999999999976 56799999999999999999999999999999999999999999999999999986433 33
Q ss_pred ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 445 ~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....++..
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~ 220 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 220 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 455678999999999999999999999999999999999999999998887777766554
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=329.67 Aligned_cols=217 Identities=36% Similarity=0.713 Sum_probs=192.0
Q ss_pred CCceeeCCCCeeeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~-~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
+..|.++.++|++.++||+|+||.||++.+ .++.||+|+++...... +.+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 78 (269)
T 4hcu_A 2 SGKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQA 78 (269)
T ss_dssp ---CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 457999999999999999999999999998 56779999998654433 56899999999999999999999999999
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
..|+||||+++++|.+++....+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 99999999999999999987777899999999999999999999999999999999999999999999999999975543
Q ss_pred CC--ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 443 SG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 443 ~~--~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
.. ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~ 222 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 222 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Confidence 22 2233456778999999999999999999999999999999 9999999988877776544
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=346.63 Aligned_cols=217 Identities=25% Similarity=0.395 Sum_probs=185.0
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCcceEEeecccCCCC
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 363 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~~ 363 (518)
.+..++|++.+.||+|+||.||++++. ++.||||+++.... .......+.+|..+++.+ +||||+++++++.....
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 466688999999999999999999875 67899999875421 122345678899999988 69999999999999999
Q ss_pred cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC
Q 010078 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~ 443 (518)
+|+||||++||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 9999999999999999987 567999999999999999999999999999999999999999999999999999754332
Q ss_pred -CccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 444 -GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 444 -~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+++..
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~ 240 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE 240 (353)
T ss_dssp --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 23455689999999999999999999999999999999999999999999988888876643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=340.59 Aligned_cols=213 Identities=22% Similarity=0.428 Sum_probs=192.5
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|++.+.||+|+||.||++... ++.||+|+++.........+.+.+|+.++++++||||+++++++......|+|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 57999999999999999999874 6789999998776666667889999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC---cEEEEeeCcceecccCCcc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VVKVADFGVARVKAQSGVM 446 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~---~vkL~DFGla~~~~~~~~~ 446 (518)
|++|++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.........
T Consensus 109 ~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~ 187 (362)
T 2bdw_A 109 LVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 187 (362)
T ss_dssp CCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSC
T ss_pred cCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCccc
Confidence 9999999999976 56799999999999999999999999999999999999998654 5999999999877665555
Q ss_pred ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
....||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~ 246 (362)
T 2bdw_A 188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 246 (362)
T ss_dssp CCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred ccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence 66789999999999999999999999999999999999999999988877777665543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=336.10 Aligned_cols=216 Identities=26% Similarity=0.446 Sum_probs=181.3
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEE-----CCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhcCCCcceEEeecccC
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERIN--SDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~-----~~~~vAVKvlk~~~~~--~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~ 360 (518)
.+..++|++.+.||+|+||.||+++. .++.||+|+++..... ......+.+|+.+|++++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 56678999999999999999999987 4678999999865332 2334567889999999999999999999999
Q ss_pred CCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceec
Q 010078 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~ 440 (518)
...+|+||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred CCEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 9999999999999999999976 567899999999999999999999999999999999999999999999999999754
Q ss_pred ccC-CccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 441 AQS-GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 441 ~~~-~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+++.
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 236 (327)
T 3a62_A 172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC 236 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT
T ss_pred ccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC
Confidence 332 2344567999999999999999999999999999999999999999999888877776654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=330.56 Aligned_cols=216 Identities=25% Similarity=0.466 Sum_probs=186.3
Q ss_pred CCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcce
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~l 366 (518)
-.++|++.++||+|+||.||++.+. ++.||+|++.... ......+.+.+|+.++++++||||+++++++.....+|+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 3478999999999999999999874 6789999986543 345556789999999999999999999999999999999
Q ss_pred eeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC--
Q 010078 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-- 444 (518)
Q Consensus 367 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-- 444 (518)
||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 89 v~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp EEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred EEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 9999999999999977 5679999999999999999999999999999999999999999999999999997654332
Q ss_pred ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcC
Q 010078 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVH 506 (518)
Q Consensus 445 ~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~ 506 (518)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+.....++...
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 229 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV 229 (294)
T ss_dssp -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC
T ss_pred ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC
Confidence 22345689999999999999999999999999999999999999999998887777665443
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=348.66 Aligned_cols=223 Identities=32% Similarity=0.619 Sum_probs=194.3
Q ss_pred CCceeeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~ 361 (518)
.+.|+++.++|+++++||+|+||.||+|++. ++.||||+++.. ........|.+|+.+|++++||||+++++++...
T Consensus 106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 184 (377)
T 3cbl_A 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK 184 (377)
T ss_dssp CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence 3578999999999999999999999999985 678999998854 3445566789999999999999999999999999
Q ss_pred CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
..+|+||||+++++|.+++......++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 185 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 185 QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 99999999999999999998766679999999999999999999999999999999999999999999999999998644
Q ss_pred cCCcc---ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCch
Q 010078 442 QSGVM---TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHS 508 (518)
Q Consensus 442 ~~~~~---~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~rp 508 (518)
..... ....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.... +.++.++
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~-~~~~~~~ 334 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF-VEKGGRL 334 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHH-HHTTCCC
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCC
Confidence 32211 11234678999999998899999999999999999998 9999999988776655 4444443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=329.46 Aligned_cols=221 Identities=39% Similarity=0.761 Sum_probs=181.7
Q ss_pred CCCceeeCCCCeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 283 ~~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
+.+.++|..++|+++++||+|+||.||+|++.+ .||+|+++.........+.+.+|+.++++++||||+++++++. ..
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~ 92 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-AP 92 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CC
Confidence 456789999999999999999999999998755 5999999887777777788999999999999999999999654 56
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
..++||||++|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccc
Confidence 78999999999999999987677899999999999999999999999999999999999999999999999999975443
Q ss_pred ---CCccccCCCCCcccCchhcc---CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 443 ---SGVMTAETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 443 ---~~~~~~~~gt~~y~APEvl~---~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
........||+.|+|||++. +..++.++||||||+++|+|++|+.||......+.....+..+
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 241 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG 241 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHT
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhccc
Confidence 22334457899999999986 6778999999999999999999999999877666665555443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=330.68 Aligned_cols=210 Identities=28% Similarity=0.513 Sum_probs=187.1
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|++.++||+|+||.||+|.+ .++.||||++....... ...+.+|+.++++++||||+++++++...+.+|+|||
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 5789999999999999999975 56789999987543332 3568899999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-cccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~ 448 (518)
|++|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus 98 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 175 (297)
T 3fxz_A 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (297)
T ss_dssp CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred CCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCC
Confidence 9999999999976 468999999999999999999999999999999999999999999999999987655433 3445
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
..||+.|+|||++.+..|+.++|||||||++|+|++|+.||...++.+....+....
T Consensus 176 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 232 (297)
T 3fxz_A 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG 232 (297)
T ss_dssp CCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC
T ss_pred ccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 689999999999999999999999999999999999999999998887777665443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=356.64 Aligned_cols=218 Identities=20% Similarity=0.351 Sum_probs=190.7
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCc
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~ 364 (518)
.+..++|+++++||+|+||.||++++. ++.||||+++..... ......+.+|+.++..++||||++++++|.+...+
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 455678999999999999999999985 477999998742111 11123378899999999999999999999999999
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
|+|||||+||+|.+++.+..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence 99999999999999998767789999999999999999999999999999999999999999999999999997655443
Q ss_pred c--cccCCCCCcccCchhcc-----CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 445 V--MTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 445 ~--~~~~~gt~~y~APEvl~-----~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
. ....+||+.|+|||++. +..|+.++|||||||++|||++|+.||.+.+..+....++...
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 297 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 297 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc
Confidence 2 23468999999999986 5679999999999999999999999999999998888887643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=334.94 Aligned_cols=213 Identities=20% Similarity=0.342 Sum_probs=192.4
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|++++.||+|+||.||++++. ++.||+|+++.. ......+.+|+.+|+.++||||+++++++.....+|+|||
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 68999999999999999999985 678999998753 3345678899999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC--CCcEEEEeeCcceecccCCccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE--NEVVKVADFGVARVKAQSGVMT 447 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~--~~~vkL~DFGla~~~~~~~~~~ 447 (518)
|++|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.........
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 161 (321)
T 1tki_A 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccc
Confidence 99999999999875567999999999999999999999999999999999999987 7899999999998776665566
Q ss_pred cCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCc
Q 010078 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
...||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+++....
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 221 (321)
T 1tki_A 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT 221 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC
T ss_pred cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCC
Confidence 678999999999999999999999999999999999999999999988888777665443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=339.64 Aligned_cols=213 Identities=24% Similarity=0.440 Sum_probs=191.4
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCh----HHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
+.|++++.||+|+||.||+++.. ++.||+|+++...... .....+.+|+.+|++++||||+++++++.....+|
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 57999999999999999999985 6789999997654321 12467899999999999999999999999999999
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC----cEEEEeeCcceecc
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE----VVKVADFGVARVKA 441 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~----~vkL~DFGla~~~~ 441 (518)
+||||++|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 92 lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~ 170 (361)
T 2yab_A 92 LILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (361)
T ss_dssp EEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred EEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence 99999999999999976 56799999999999999999999999999999999999998777 79999999998776
Q ss_pred cCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 442 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 442 ~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
.........||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~ 234 (361)
T 2yab_A 171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVS 234 (361)
T ss_dssp TTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC
T ss_pred CCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Confidence 6655667789999999999999999999999999999999999999999998888877766543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=342.27 Aligned_cols=222 Identities=31% Similarity=0.612 Sum_probs=190.6
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEEC---------CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEE
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQF 354 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~---------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l 354 (518)
..|++..++|++++.||+|+||.||+|++. +..||||+++... .......+.+|+.+|+++ +||||+++
T Consensus 74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~ 152 (370)
T 2psq_A 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL 152 (370)
T ss_dssp TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCE
T ss_pred ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 357788899999999999999999999863 2359999998653 344567899999999999 89999999
Q ss_pred eecccCCCCcceeeeecCCCchhHHHhhhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 010078 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419 (518)
Q Consensus 355 ~g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~ 419 (518)
+++|.....+|+||||++||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 232 (370)
T 2psq_A 153 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 232 (370)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred EEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchh
Confidence 999999999999999999999999998643 24788999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEeeCcceecccCC---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 010078 420 NLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPL 495 (518)
Q Consensus 420 NILid~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~ 495 (518)
|||++.++.+||+|||+++...... ......+|+.|+|||++.+..|+.++|||||||++|||++ |+.||.+.+..
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9999999999999999998654432 2234467889999999999999999999999999999999 99999988765
Q ss_pred HHHHHhhhhcCch
Q 010078 496 QAAVGVVQKVHHS 508 (518)
Q Consensus 496 q~~~~iv~~~~rp 508 (518)
+.... +..+.++
T Consensus 313 ~~~~~-~~~~~~~ 324 (370)
T 2psq_A 313 ELFKL-LKEGHRM 324 (370)
T ss_dssp GHHHH-HHTTCCC
T ss_pred HHHHH-HhcCCCC
Confidence 55544 3344443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=337.23 Aligned_cols=213 Identities=27% Similarity=0.491 Sum_probs=189.6
Q ss_pred CCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcce
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~l 366 (518)
..++|++.+.||+|+||.||+++.. ++.||+|+++..... ......+.+|+.+++.++||||+++++++.....+|+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 4568999999999999999999874 678999998753211 1224567889999999999999999999999999999
Q ss_pred eeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcc
Q 010078 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 446 (518)
Q Consensus 367 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~ 446 (518)
||||++|++|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.... ..
T Consensus 84 v~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--~~ 160 (318)
T 1fot_A 84 IMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VT 160 (318)
T ss_dssp EECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--CB
T ss_pred EEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--cc
Confidence 9999999999999987 56799999999999999999999999999999999999999999999999999986543 23
Q ss_pred ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
...+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+..+....+++..
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 219 (318)
T 1fot_A 161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE 219 (318)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC
T ss_pred ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 45689999999999999999999999999999999999999999999888888877654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=325.46 Aligned_cols=219 Identities=36% Similarity=0.701 Sum_probs=191.1
Q ss_pred CCCceeeCCCCeeeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC
Q 010078 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (518)
Q Consensus 283 ~~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~ 361 (518)
+...|+++.++|++.++||+|+||.||++++.+ ..||+|+++...... +.+.+|+.++++++||||+++++++...
T Consensus 15 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 91 (283)
T 3gen_A 15 GYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91 (283)
T ss_dssp -CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence 345789999999999999999999999999865 479999998664443 5688999999999999999999999999
Q ss_pred CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
..+|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 99999999999999999998767789999999999999999999999999999999999999999999999999997554
Q ss_pred cCC--ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhh
Q 010078 442 QSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 442 ~~~--~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~ 504 (518)
... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+.+.
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~ 237 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 237 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT
T ss_pred ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc
Confidence 322 1223456788999999998999999999999999999998 99999999888777775543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=325.18 Aligned_cols=221 Identities=29% Similarity=0.544 Sum_probs=195.9
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC--CCc
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSL 364 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~--~~~ 364 (518)
+.++.++|++.++||+|+||.||+|++.++.||||+++.........+.+.+|+.++++++||||+++++++... ...
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 467788999999999999999999999999999999998776777778899999999999999999999999877 778
Q ss_pred ceeeeecCCCchhHHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 365 CIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~-~l~~~~i~~i~~qIa~aL~yLHs~g--IiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
++||||+++++|.+++..... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||++....
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999999987443 5899999999999999999999999 9999999999999999999999998875432
Q ss_pred cCCccccCCCCCcccCchhccCCCCCh---hhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCchhHH
Q 010078 442 QSGVMTAETGTYRWMAPEVIEHKPYDH---KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSFLE 511 (518)
Q Consensus 442 ~~~~~~~~~gt~~y~APEvl~~~~~s~---ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp~ip 511 (518)
. ....||+.|+|||++.+..++. ++||||||+++|+|++|+.||...+..+....+.....++.+|
T Consensus 165 ~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (271)
T 3kmu_A 165 S----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP 233 (271)
T ss_dssp C----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCC
T ss_pred c----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCC
Confidence 2 3457899999999998765544 8999999999999999999999999988888877776665444
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=344.62 Aligned_cols=217 Identities=26% Similarity=0.463 Sum_probs=183.2
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC-hHHHHHHHHHHHH-HHhcCCCcceEEeecccCCCC
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFI-MRKVRHKNVVQFIGACTKPPS 363 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~-~~~~~~~~~Ei~i-L~~L~HpnIv~l~g~~~~~~~ 363 (518)
.+..++|++.+.||+|+||.||++++. ++.||||+++..... ......+.+|..+ ++.++||||+++++++.....
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 345678999999999999999999985 567999999765432 2334556777776 577899999999999999999
Q ss_pred cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc-
Q 010078 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ- 442 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~- 442 (518)
+|+||||++||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 9999999999999999977 56789999999999999999999999999999999999999999999999999986333
Q ss_pred CCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 443 ~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
.......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....++...
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~ 255 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP 255 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc
Confidence 334556789999999999999999999999999999999999999999999888888877653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=352.38 Aligned_cols=217 Identities=36% Similarity=0.662 Sum_probs=189.2
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC-C
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-S 363 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~-~ 363 (518)
..|+++.++|++.++||+|+||.||+|++.++.||||+++... ..+.|.+|+.+|++++||||+++++++.... .
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 261 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 261 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence 4689999999999999999999999999999999999998653 2467899999999999999999999976654 7
Q ss_pred cceeeeecCCCchhHHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 364 LCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~~-~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
+|+||||+++|+|.+++..... .++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 8999999999999999987543 378999999999999999999999999999999999999999999999999985433
Q ss_pred CCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCch
Q 010078 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHS 508 (518)
Q Consensus 443 ~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~rp 508 (518)
. .....++..|+|||++.+..++.++|||||||+||||++ |+.||...+..+....+ .++.++
T Consensus 342 ~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-~~~~~~ 405 (450)
T 1k9a_A 342 T--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKM 405 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH-HTTCCC
T ss_pred c--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCC
Confidence 2 223367889999999999999999999999999999999 99999998876666554 445443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=335.34 Aligned_cols=218 Identities=34% Similarity=0.573 Sum_probs=190.4
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~-----~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~ 360 (518)
.+++..++|++.+.||+|+||.||+|.+. +..||||+++... .....+.+.+|+.++++++||||+++++++..
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 34678889999999999999999999974 3459999998643 44556789999999999999999999999999
Q ss_pred CCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceec
Q 010078 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~ 440 (518)
....|+||||++|++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999999999876778999999999999999999999999999999999999999999999999999865
Q ss_pred ccCC----ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhh
Q 010078 441 AQSG----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 441 ~~~~----~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~ 504 (518)
.... ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+...
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~ 270 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG 270 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC
Confidence 4432 1223356778999999999999999999999999999999 99999999888877775543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=338.69 Aligned_cols=216 Identities=24% Similarity=0.431 Sum_probs=187.7
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCcceEEeecccCCCC
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 363 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~~ 363 (518)
.+..++|++.+.||+|+||.||++++. ++.||||+++.... .......+..|..+++.+ +||||+++++++.....
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 456788999999999999999999985 67899999975321 112245677899999887 89999999999999999
Q ss_pred cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc-
Q 010078 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ- 442 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~- 442 (518)
+|+||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 93 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 9999999999999999986 56799999999999999999999999999999999999999999999999999975432
Q ss_pred CCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 443 ~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
.......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+...
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~ 233 (345)
T 1xjd_A 172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD 233 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC
Confidence 23445668999999999999999999999999999999999999999999888777776543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=340.39 Aligned_cols=217 Identities=24% Similarity=0.421 Sum_probs=189.1
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEECC--ceEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCcceEEeecccCCCC
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 363 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~~--~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~~ 363 (518)
.+..++|++.+.||+|+||.||+++..+ +.||||+++.... .......+..|..+|..+ +||||+++++++.....
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 4566889999999999999999999864 6799999875421 112245678899999988 79999999999999999
Q ss_pred cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc-
Q 010078 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ- 442 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~- 442 (518)
+|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 96 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 9999999999999999986 46799999999999999999999999999999999999999999999999999986433
Q ss_pred CCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 443 ~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
.......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+++..
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~ 237 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 237 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC
Confidence 234456689999999999999999999999999999999999999999999888877776543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=322.06 Aligned_cols=215 Identities=35% Similarity=0.627 Sum_probs=191.2
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEECCc-eEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCc
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~~-~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~ 364 (518)
.|++..++|++.+.||+|+||.||++++.+. .||+|+++...... ..+.+|+.++++++||||+++++++......
T Consensus 2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 4678889999999999999999999998654 79999998654433 5688999999999999999999999999999
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||+++......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99999999999999998866679999999999999999999999999999999999999999999999999998665443
Q ss_pred c--cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 445 V--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 445 ~--~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
. .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+.+
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~ 220 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ 220 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT
T ss_pred hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHc
Confidence 2 223345678999999999899999999999999999999 9999999888777766544
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=334.72 Aligned_cols=202 Identities=22% Similarity=0.429 Sum_probs=181.4
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCcceEEeecccCCCCc
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSL 364 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~~~ 364 (518)
+..++|++.+.||+|+||.||++++. ++.||||+++.... .......+.+|+.+++++ +||||+++++++.....+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 45578999999999999999999975 67899999986544 344566788999999988 799999999999999999
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc-C
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-S 443 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~-~ 443 (518)
|+||||++|++|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.... .
T Consensus 86 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 999999999999999976 56799999999999999999999999999999999999999999999999999985432 3
Q ss_pred CccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 444 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 444 ~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
......+||+.|+|||++.+..|+.++|||||||++|||++|+.||..
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 344566899999999999999999999999999999999999999975
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=343.89 Aligned_cols=204 Identities=22% Similarity=0.419 Sum_probs=179.7
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC-hHHHHHHHHHHHHHHhc-CCCcceEEeecccCCC
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPP 362 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~-~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~ 362 (518)
..+..++|+++++||+|+||.||+++.. ++.||||+++..... ......+.+|..+|+++ +||||+++++++....
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 3566788999999999999999999875 567999999865433 23345678899999887 7999999999999999
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc-
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA- 441 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~- 441 (518)
.+|+||||++||+|..++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 99999999999999999987 5679999999999999999999999999999999999999999999999999998633
Q ss_pred cCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 442 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 442 ~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
........+||+.|+|||++.+..|+.++|||||||++|||++|+.||..
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 33345567899999999999999999999999999999999999999964
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=329.25 Aligned_cols=204 Identities=35% Similarity=0.578 Sum_probs=182.6
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCc
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~ 364 (518)
+.+..++|+++++||+|+||.||++++. ++.||+|++.. ......+.+.+|+.++++++||||+++++++......
T Consensus 5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp EEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred eeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence 4567789999999999999999999985 67899998864 3456678899999999999999999999999999999
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
|+||||++|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 99999999999999998877889999999999999999999999999999999999999999999999999998654332
Q ss_pred cc---------------ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCC
Q 010078 445 VM---------------TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL 492 (518)
Q Consensus 445 ~~---------------~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (518)
.. ....||+.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence 11 1457999999999999999999999999999999999999998753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=328.40 Aligned_cols=214 Identities=26% Similarity=0.394 Sum_probs=183.8
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCccee
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~-~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV 367 (518)
.-.++|++.++||+|+||.||++++ .++.||+|+++...........+.+|+.++++++||||+++++++.....+|+|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 3457899999999999999999998 567899999987655555567889999999999999999999999999999999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-Ccc
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVM 446 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~-~~~ 446 (518)
|||++ ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ...
T Consensus 98 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 176 (311)
T 3niz_A 98 FEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY 176 (311)
T ss_dssp EECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC--
T ss_pred EcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccc
Confidence 99996 5899988876677999999999999999999999999999999999999999999999999999876433 234
Q ss_pred ccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 447 TAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+++
T Consensus 177 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 234 (311)
T 3niz_A 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFS 234 (311)
T ss_dssp -CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHH
T ss_pred cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 55678999999999876 5689999999999999999999999998877666666544
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=349.93 Aligned_cols=217 Identities=18% Similarity=0.317 Sum_probs=190.4
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCc
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~ 364 (518)
.+..++|++.+.||+|+||.||+++.. ++.||||+++.... .......+.+|..++..++||||+++++++.....+
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 455678999999999999999999984 78899999874221 111224478899999999999999999999999999
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
|+||||++||+|.+++.+....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 99999999999999998766689999999999999999999999999999999999999999999999999998765543
Q ss_pred c--cccCCCCCcccCchhcc-------CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 445 V--MTAETGTYRWMAPEVIE-------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 445 ~--~~~~~gt~~y~APEvl~-------~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
. ....+||+.|+|||++. ...|+.++|||||||++|||++|+.||.+.+..+....+++.
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~ 285 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY 285 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 3 23458999999999997 457899999999999999999999999999998888887753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=351.02 Aligned_cols=215 Identities=23% Similarity=0.356 Sum_probs=188.3
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCc
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~ 364 (518)
.+..++|++.++||+|+||.||++++. ++.||+|+++.... .......+.+|+.+++.++||||+++++++.+...+
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 455678999999999999999999985 57799999874211 011123478899999999999999999999999999
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 145 ~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp EEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 999999999999999975 568999999999999999999999999999999999999999999999999998765544
Q ss_pred c--cccCCCCCcccCchhccCCC----CChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 445 V--MTAETGTYRWMAPEVIEHKP----YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 445 ~--~~~~~gt~~y~APEvl~~~~----~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
. ....+||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+..+....+++.
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~ 288 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH 288 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhc
Confidence 2 33568999999999998765 889999999999999999999999999998888888764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=329.67 Aligned_cols=211 Identities=24% Similarity=0.431 Sum_probs=188.8
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCh----HHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
+.|++.+.||+|+||.||+++.. ++.||+|+++...... .....+.+|+.+|++++||||+++++++.....+|
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 56999999999999999999985 6789999987654321 12467899999999999999999999999999999
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC----cEEEEeeCcceecc
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE----VVKVADFGVARVKA 441 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~----~vkL~DFGla~~~~ 441 (518)
+||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 91 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 99999999999999976 56799999999999999999999999999999999999999887 89999999998776
Q ss_pred cCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 442 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 442 ~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
.........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 231 (326)
T 2y0a_A 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231 (326)
T ss_dssp TTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH
T ss_pred CCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHh
Confidence 55555667899999999999999999999999999999999999999999888777666544
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=342.69 Aligned_cols=205 Identities=24% Similarity=0.443 Sum_probs=183.4
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
.+.+..++|++.+.||+|+||.||++... ++.||+|+++.... .......+.+|+.+|+.++||||+++++++....
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 34677789999999999999999999875 56799999874321 1222467889999999999999999999999999
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
.+|+||||+.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999999999976 56799999999999999999999999999999999999999999999999999988766
Q ss_pred CCccccCCCCCcccCchhccC---CCCChhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 443 SGVMTAETGTYRWMAPEVIEH---KPYDHKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 443 ~~~~~~~~gt~~y~APEvl~~---~~~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
.......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||..
T Consensus 168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~ 219 (384)
T 4fr4_A 168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219 (384)
T ss_dssp TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCC
Confidence 666677889999999999964 4689999999999999999999999974
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=330.60 Aligned_cols=218 Identities=30% Similarity=0.575 Sum_probs=190.7
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecc
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~ 358 (518)
.+++..++|++.+.||+|+||.||+|++.+ +.||||+++... .......+.+|+.++++++||||+++++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 457778899999999999999999999864 679999998653 445567899999999999999999999999
Q ss_pred cCCCCcceeeeecCCCchhHHHhhhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 010078 359 TKPPSLCIVTEFMSGGSVYDYLHKLK-----------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415 (518)
Q Consensus 359 ~~~~~~~lV~Ey~~ggsL~~~l~~~~-----------------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrD 415 (518)
.....+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+|||
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 99999999999999999999997642 5689999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEEeeCcceecccCC---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCC
Q 010078 416 LKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEY 491 (518)
Q Consensus 416 LKp~NILid~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~ 491 (518)
|||+|||++.++.+||+|||+++...... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 99999999999999999999997543321 2234567889999999999999999999999999999999 9999999
Q ss_pred CCHHHHHHHhhhh
Q 010078 492 LTPLQAAVGVVQK 504 (518)
Q Consensus 492 ~~~~q~~~~iv~~ 504 (518)
.+..+....+.+.
T Consensus 280 ~~~~~~~~~~~~~ 292 (343)
T 1luf_A 280 MAHEEVIYYVRDG 292 (343)
T ss_dssp SCHHHHHHHHHTT
T ss_pred CChHHHHHHHhCC
Confidence 9887777665543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=318.37 Aligned_cols=214 Identities=22% Similarity=0.424 Sum_probs=193.7
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
.++|++.++||+|+||.||++.+. ++.||+|+++...........+.+|+.++++++||||+++++++......|+||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 368999999999999999999875 678999999877666666788999999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCc---EEEEeeCcceecccCCc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV---VKVADFGVARVKAQSGV 445 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~---vkL~DFGla~~~~~~~~ 445 (518)
||++|++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++. +||+|||++........
T Consensus 85 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 85 DLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp CCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 99999999999876 567999999999999999999999999999999999999986655 99999999987776666
Q ss_pred cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 446 ~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
.....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+....
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 223 (284)
T 3kk8_A 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 223 (284)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcc
Confidence 666789999999999999999999999999999999999999999988887777765543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=330.85 Aligned_cols=216 Identities=30% Similarity=0.488 Sum_probs=182.7
Q ss_pred CCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCc---
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL--- 364 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~--- 364 (518)
.++|++.+.||+|+||.||++++ .++.||||+++.... .......+.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999996 567899999987543 345567899999999999999999999998766554
Q ss_pred -ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC
Q 010078 365 -CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (518)
Q Consensus 365 -~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~ 443 (518)
|+||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 91 ~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred cEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 999999999999999976 567999999999999999999999999999999999999999999999999999765443
Q ss_pred C----ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCc
Q 010078 444 G----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 444 ~----~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
. ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.++.+....++.....
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 237 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI 237 (311)
T ss_dssp ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC
T ss_pred ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC
Confidence 2 223346899999999999999999999999999999999999999999988877776655443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=337.71 Aligned_cols=212 Identities=25% Similarity=0.406 Sum_probs=189.1
Q ss_pred CCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcce
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~l 366 (518)
..++|++++.||+|+||.||+++.. ++.||||+++.... .......+.+|+.+|+.++||||+++++++.....+|+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 3468999999999999999999984 67899999875321 11224678899999999999999999999999999999
Q ss_pred eeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcc
Q 010078 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 446 (518)
Q Consensus 367 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~ 446 (518)
||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... .
T Consensus 119 v~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~ 195 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--T 195 (350)
T ss_dssp EEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--B
T ss_pred EEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--c
Confidence 9999999999999987 467999999999999999999999999999999999999999999999999999865443 3
Q ss_pred ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
...+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.++.+....+++.
T Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~ 253 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC
Confidence 4567999999999999999999999999999999999999999999988888777654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=344.77 Aligned_cols=214 Identities=20% Similarity=0.382 Sum_probs=190.2
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|+++++||+|+||.||++.. .++.||+|++..........+.+.+|+.+|++++||||+++++++......|+|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 5799999999999999999987 57889999998776656666789999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc---CCCcEEEEeeCcceecccCC-c
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVADFGVARVKAQSG-V 445 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid---~~~~vkL~DFGla~~~~~~~-~ 445 (518)
|+.||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...... .
T Consensus 91 ~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~ 169 (444)
T 3soa_A 91 LVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169 (444)
T ss_dssp CCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB
T ss_pred eCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce
Confidence 9999999999987 56799999999999999999999999999999999999998 45789999999997655433 3
Q ss_pred cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcC
Q 010078 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVH 506 (518)
Q Consensus 446 ~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~ 506 (518)
.....||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 170 ~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~ 230 (444)
T 3soa_A 170 WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAY 230 (444)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC
T ss_pred eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC
Confidence 3456899999999999999999999999999999999999999999888887777665443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=324.71 Aligned_cols=211 Identities=23% Similarity=0.428 Sum_probs=182.8
Q ss_pred CCeeeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~-~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
++|++.++||+|+||.||+++.. ++.||+|+++...........+.+|+.++++++||||+++++++.....+|+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57999999999999999999985 67899999976544433346788999999999999999999999999999999999
Q ss_pred cCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-CccccC
Q 010078 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAE 449 (518)
Q Consensus 371 ~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~-~~~~~~ 449 (518)
+++ +|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ......
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccc
Confidence 965 999999876778999999999999999999999999999999999999999999999999999765432 233455
Q ss_pred CCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 450 TGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 450 ~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
.||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+++
T Consensus 161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 215 (288)
T 1ob3_A 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215 (288)
T ss_dssp -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 78999999999976 4589999999999999999999999999988877777654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=335.85 Aligned_cols=218 Identities=32% Similarity=0.614 Sum_probs=191.9
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEECC---------ceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEE
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQF 354 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~---------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l 354 (518)
..|++..++|.++++||+|+||.||+|++.+ ..||||+++... .......+.+|+.+++++ +||||+++
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~ 140 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL 140 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence 4688999999999999999999999998643 469999998653 445567899999999999 89999999
Q ss_pred eecccCCCCcceeeeecCCCchhHHHhhhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 010078 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419 (518)
Q Consensus 355 ~g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~ 419 (518)
++++......|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 220 (382)
T 3tt0_A 141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 220 (382)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence 999999999999999999999999998743 35899999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEeeCcceecccCC---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 010078 420 NLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPL 495 (518)
Q Consensus 420 NILid~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~ 495 (518)
|||++.++.+||+|||+++...... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999998654432 2334567889999999999999999999999999999999 99999998877
Q ss_pred HHHHHhhh
Q 010078 496 QAAVGVVQ 503 (518)
Q Consensus 496 q~~~~iv~ 503 (518)
+....+.+
T Consensus 301 ~~~~~~~~ 308 (382)
T 3tt0_A 301 ELFKLLKE 308 (382)
T ss_dssp HHHHHHHT
T ss_pred HHHHHHHc
Confidence 66655433
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=336.44 Aligned_cols=223 Identities=32% Similarity=0.594 Sum_probs=189.4
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEee
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG 356 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g 356 (518)
..|++..++|+++++||+|+||.||+|++.+ +.||||+++... .....+.+.+|+.+++++ +||||+++++
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 4789999999999999999999999998532 679999998643 344467899999999999 7899999999
Q ss_pred cccCCCC-cceeeeecCCCchhHHHhhhcC--------------------------------------------------
Q 010078 357 ACTKPPS-LCIVTEFMSGGSVYDYLHKLKG-------------------------------------------------- 385 (518)
Q Consensus 357 ~~~~~~~-~~lV~Ey~~ggsL~~~l~~~~~-------------------------------------------------- 385 (518)
++..... +++||||++||+|.+++.....
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 9877554 8999999999999999976432
Q ss_pred ---------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC---ccc
Q 010078 386 ---------------VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMT 447 (518)
Q Consensus 386 ---------------~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~---~~~ 447 (518)
.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 253 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcc
Confidence 18889999999999999999999999999999999999999999999999998654332 223
Q ss_pred cCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCch
Q 010078 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHS 508 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~rp 508 (518)
...||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+.....+..+.++
T Consensus 254 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 315 (359)
T 3vhe_A 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 315 (359)
T ss_dssp -CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC
T ss_pred ccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC
Confidence 4567889999999999999999999999999999998 999999877655555555554443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=334.27 Aligned_cols=202 Identities=19% Similarity=0.330 Sum_probs=179.1
Q ss_pred CCceeeCCCCeeeeeeeeecCceEEEEEE-------ECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC---CCcceE
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGT-------YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVVQ 353 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~-------~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~---HpnIv~ 353 (518)
...+++..++|.+.++||+|+||.||+|+ ..++.||||+++... ..++..|+.+++.++ |+||+.
T Consensus 57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~ 131 (365)
T 3e7e_A 57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMK 131 (365)
T ss_dssp SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhh
Confidence 35678889999999999999999999993 356789999998542 346778888888887 899999
Q ss_pred EeecccCCCCcceeeeecCCCchhHHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC----
Q 010078 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKL----KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---- 425 (518)
Q Consensus 354 l~g~~~~~~~~~lV~Ey~~ggsL~~~l~~~----~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~---- 425 (518)
+++++...+..|+||||++||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 132 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTC
T ss_pred hheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccC
Confidence 999999999999999999999999999752 456999999999999999999999999999999999999998
Q ss_pred -------CCcEEEEeeCcceecc---cCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCC
Q 010078 426 -------NEVVKVADFGVARVKA---QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490 (518)
Q Consensus 426 -------~~~vkL~DFGla~~~~---~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~ 490 (518)
++.+||+|||+++... ........+||+.|+|||++.+..|+.++|||||||++|||+||+.||.
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 286 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV 286 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence 8999999999997543 2334556789999999999999999999999999999999999999985
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=318.51 Aligned_cols=215 Identities=37% Similarity=0.727 Sum_probs=190.8
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCc
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~-~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~ 364 (518)
.|.++.++|++.+.||+|+||.||++.+ .++.||+|+++..... .+.+.+|+.++++++||||+++++++......
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence 5889999999999999999999999998 4567999999875443 25788999999999999999999999999999
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
|+||||+++++|.+++....+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 99999999999999998866789999999999999999999999999999999999999999999999999997553321
Q ss_pred --ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 445 --VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 445 --~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
......++..|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+..
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~ 220 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 220 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Confidence 1233456788999999998999999999999999999999 9999999888777666543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=320.06 Aligned_cols=218 Identities=35% Similarity=0.674 Sum_probs=180.2
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERIN--SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~--~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
+++.++|++.+.||+|+||.||+|.+.++.||||+++..... ....+.+.+|+.+++.++||||+++++++......|
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 567789999999999999999999999999999998754322 223467889999999999999999999999999999
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCcEEEcC--------CCcEEEEee
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN---IIHRDLKAANLLMDE--------NEVVKVADF 434 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~g---IiHrDLKp~NILid~--------~~~vkL~DF 434 (518)
+||||++|++|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+||
T Consensus 83 lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999999854 57999999999999999999999999 899999999999986 678999999
Q ss_pred CcceecccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCch
Q 010078 435 GVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHS 508 (518)
Q Consensus 435 Gla~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp 508 (518)
|+++...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+.....+.
T Consensus 161 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 233 (271)
T 3dtc_A 161 GLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL 233 (271)
T ss_dssp CC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCC
T ss_pred Cccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCC
Confidence 9997654432 234578999999999999999999999999999999999999999998888777766555443
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=319.93 Aligned_cols=211 Identities=23% Similarity=0.409 Sum_probs=185.0
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|++.++||+|+||.||+|++. ++.||||+++...........+.+|+.++++++||||+++++++.....+|+|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999984 6789999998776666667889999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-Ccccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~-~~~~~ 448 (518)
|+++ +|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .....
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCS
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccC
Confidence 9964 777777666788999999999999999999999999999999999999999999999999999866433 23455
Q ss_pred CCCCCcccCchhccCCC-CChhhHHHHHHHHHHHHHcCCCC-CCCCCHHHHHHHhhh
Q 010078 449 ETGTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELLTGKLP-YEYLTPLQAAVGVVQ 503 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~-~s~ksDVwSlGviL~eLltG~~P-f~~~~~~q~~~~iv~ 503 (518)
..||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+..+....+.+
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~ 217 (292)
T 3o0g_A 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHH
T ss_pred CccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 68899999999997765 89999999999999999987766 666677666666554
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=333.70 Aligned_cols=223 Identities=32% Similarity=0.581 Sum_probs=189.8
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEee
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG 356 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~-------~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g 356 (518)
..|++..++|++++.||+|+||.||+|++ .+..||||+++... .......+.+|+.+++++ +||||+++++
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 46899999999999999999999999997 23569999998543 233457799999999999 8999999999
Q ss_pred cccCCCCcceeeeecCCCchhHHHhhhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 010078 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKG----------------------VFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414 (518)
Q Consensus 357 ~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~----------------------~l~~~~i~~i~~qIa~aL~yLHs~gIiHr 414 (518)
++.....+|+||||+++++|.+++..... .+++..++.++.||+.||.|||++||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 99999999999999999999999976432 37889999999999999999999999999
Q ss_pred cCCCCcEEEcCCCcEEEEeeCcceecccCCc---cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCC
Q 010078 415 DLKAANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE 490 (518)
Q Consensus 415 DLKp~NILid~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~ 490 (518)
||||+|||++.++.+||+|||++........ .....+|+.|+|||++.+..++.++||||||+++|+|+| |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999976544322 223456788999999999999999999999999999998 999999
Q ss_pred CCCHHHHHHHhhhhcCch
Q 010078 491 YLTPLQAAVGVVQKVHHS 508 (518)
Q Consensus 491 ~~~~~q~~~~iv~~~~rp 508 (518)
+.+.......++..+.++
T Consensus 277 ~~~~~~~~~~~~~~~~~~ 294 (344)
T 1rjb_A 277 GIPVDANFYKLIQNGFKM 294 (344)
T ss_dssp TCCCSHHHHHHHHTTCCC
T ss_pred cCCcHHHHHHHHhcCCCC
Confidence 887666666666655443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=347.22 Aligned_cols=219 Identities=34% Similarity=0.639 Sum_probs=191.2
Q ss_pred CCceeeCCCCeeeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~-~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
.+.|++..++|++.++||+|+||.||+|++. +..||||+++..... .+.|.+|+.+|++++||||+++++++. ..
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 4679999999999999999999999999986 577999999865432 467999999999999999999999987 56
Q ss_pred CcceeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
.+|+||||+++|+|.+++.... ..++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 7899999999999999997543 368899999999999999999999999999999999999999999999999998654
Q ss_pred cCC--ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCc
Q 010078 442 QSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 442 ~~~--~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
... ......+|..|+|||++....++.++|||||||+||||+| |+.||.+.+..+....+.+ +.+
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~ 403 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYR 403 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH-TCC
T ss_pred CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCC
Confidence 321 1123346778999999998999999999999999999999 9999999998887776543 443
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=331.51 Aligned_cols=206 Identities=30% Similarity=0.500 Sum_probs=180.3
Q ss_pred CCCCceeeCCCCeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC
Q 010078 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (518)
Q Consensus 282 ~~~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~ 361 (518)
+++.+|.++.++|+++++||+|+||.||+|++.++.||||+++.. ......+..|+.++++++||||+++++++...
T Consensus 14 ~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (322)
T 3soc_A 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRG 90 (322)
T ss_dssp CCCCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred cCccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence 456688999999999999999999999999999999999999753 23345566799999999999999999998765
Q ss_pred CC----cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHC----------CceeccCCCCcEEEcCCC
Q 010078 362 PS----LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN----------NIIHRDLKAANLLMDENE 427 (518)
Q Consensus 362 ~~----~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~----------gIiHrDLKp~NILid~~~ 427 (518)
.. +|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 91 ~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~ 168 (322)
T 3soc_A 91 TSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL 168 (322)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred CCCCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence 43 6999999999999999976 5589999999999999999999999 999999999999999999
Q ss_pred cEEEEeeCcceecccCC---ccccCCCCCcccCchhccC-----CCCChhhHHHHHHHHHHHHHcCCCCCCCC
Q 010078 428 VVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEH-----KPYDHKADVFSFGIVLWELLTGKLPYEYL 492 (518)
Q Consensus 428 ~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APEvl~~-----~~~s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (518)
.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+.
T Consensus 169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 241 (322)
T 3soc_A 169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241 (322)
T ss_dssp CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 99999999997654432 2334579999999999987 35667899999999999999999999753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=320.83 Aligned_cols=217 Identities=30% Similarity=0.563 Sum_probs=178.2
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeeccc
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-----~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~ 359 (518)
..|++..++|++++.||+|+||.||+|.+.. ..||+|+++... .....+.+.+|+.++++++||||+++++++.
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 4678889999999999999999999998743 359999987542 3455678999999999999999999999985
Q ss_pred CCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
.+..|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 4578999999999999999987666799999999999999999999999999999999999999999999999999986
Q ss_pred cccCCc--cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 440 KAQSGV--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 440 ~~~~~~--~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
...... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+.+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~ 232 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 232 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHc
Confidence 544332 233456788999999999999999999999999999997 9999998877666555443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=336.48 Aligned_cols=211 Identities=20% Similarity=0.385 Sum_probs=189.4
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
+.|++.+.||+|+||.||+|... ++.||+|++.... ......+.+|+.+|++++||||+++++++.....+|+|||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 57999999999999999999874 6789999987542 3345678999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC--CCcEEEEeeCcceecccCCccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE--NEVVKVADFGVARVKAQSGVMT 447 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~--~~~vkL~DFGla~~~~~~~~~~ 447 (518)
|++|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.........
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 208 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 208 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCccee
Confidence 99999999999875667999999999999999999999999999999999999974 4679999999998776655556
Q ss_pred cCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~ 265 (387)
T 1kob_A 209 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC 265 (387)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC
T ss_pred eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 668999999999999999999999999999999999999999999888777776543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=323.63 Aligned_cols=223 Identities=30% Similarity=0.585 Sum_probs=192.7
Q ss_pred CCceeeCCCCeeeeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEe
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI 355 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~-------~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~ 355 (518)
...|++..++|++++.||+|+||.||+|++ .++.||||+++... .....+.+.+|+.+++++ +||||++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 93 (313)
T 1t46_A 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLL 93 (313)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence 457899999999999999999999999986 23679999998653 334567899999999999 899999999
Q ss_pred ecccCCCCcceeeeecCCCchhHHHhhhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 010078 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKG-----------------VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 418 (518)
Q Consensus 356 g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~-----------------~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp 418 (518)
+++......++||||+++++|.+++..... .+++..++.++.||+.||.|||++||+||||||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 173 (313)
T 1t46_A 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (313)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence 999999999999999999999999976432 489999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEEeeCcceecccCCc---cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCH
Q 010078 419 ANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTP 494 (518)
Q Consensus 419 ~NILid~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~ 494 (518)
+|||++.++.+||+|||+++....... .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+...
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 999999999999999999986554332 223456788999999999999999999999999999999 9999998776
Q ss_pred HHHHHHhhhhcCc
Q 010078 495 LQAAVGVVQKVHH 507 (518)
Q Consensus 495 ~q~~~~iv~~~~r 507 (518)
......++....+
T Consensus 254 ~~~~~~~~~~~~~ 266 (313)
T 1t46_A 254 DSKFYKMIKEGFR 266 (313)
T ss_dssp SHHHHHHHHHTCC
T ss_pred hhHHHHHhccCCC
Confidence 5555555554444
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=335.08 Aligned_cols=220 Identities=20% Similarity=0.355 Sum_probs=191.5
Q ss_pred ceeeCCCCeeeeeeeeec--CceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC
Q 010078 286 VWEIDPKHLKFGSKVASG--SYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G--~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~ 361 (518)
.+....++|+++++||+| +||.||++++. ++.||||+++...........+.+|+.++++++||||+++++++...
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 98 (389)
T 3gni_B 19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 98 (389)
T ss_dssp CCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence 455667899999999999 99999999985 77899999987766677778899999999999999999999999999
Q ss_pred CCcceeeeecCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceec
Q 010078 362 PSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~ 440 (518)
..+|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+...
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999999999764 356999999999999999999999999999999999999999999999999988643
Q ss_pred ccCC--------ccccCCCCCcccCchhccC--CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 441 AQSG--------VMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 441 ~~~~--------~~~~~~gt~~y~APEvl~~--~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
...+ ......||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+....++...
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 253 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 253 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence 3221 2233478999999999987 679999999999999999999999999888777766655433
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=332.40 Aligned_cols=214 Identities=23% Similarity=0.406 Sum_probs=177.0
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeecccCCC--Ccce
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPP--SLCI 366 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~--~~~l 366 (518)
++|+++++||+|+||.||+|.+. ++.||||++............+.+|+.+|+++. ||||+++++++...+ .+|+
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 68999999999999999999874 678999999866556666788899999999998 999999999986443 6899
Q ss_pred eeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc----
Q 010078 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ---- 442 (518)
Q Consensus 367 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~---- 442 (518)
|||||+ ++|..++.. +.++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 89 v~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred EecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence 999996 699999875 5789999999999999999999999999999999999999999999999999986432
Q ss_pred ------------------CCccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 443 ------------------SGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 443 ------------------~~~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
....+..+||+.|+|||++.+ ..|+.++||||||||+|||++|+.||.+.+..+.+..++.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 245 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 112344579999999999976 6799999999999999999999999999999888888775
Q ss_pred hcCch
Q 010078 504 KVHHS 508 (518)
Q Consensus 504 ~~~rp 508 (518)
....|
T Consensus 246 ~~~~p 250 (388)
T 3oz6_A 246 VIDFP 250 (388)
T ss_dssp HHCCC
T ss_pred hcCCC
Confidence 44433
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=342.42 Aligned_cols=213 Identities=25% Similarity=0.362 Sum_probs=182.8
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC------
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------ 362 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~------ 362 (518)
.++|+++++||+|+||.||++.+. ++.||||++..........+.+.+|+.+|+.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 378999999999999999999874 678999999876556666788999999999999999999999986654
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
.+|+||||+++ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 141 ~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred eEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 35999999965 5766664 3589999999999999999999999999999999999999999999999999987776
Q ss_pred CCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCc
Q 010078 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 443 ~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
....+...||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+++....
T Consensus 217 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~ 281 (464)
T 3ttj_A 217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 281 (464)
T ss_dssp CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 66667789999999999999999999999999999999999999999999998888887765443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=333.22 Aligned_cols=208 Identities=22% Similarity=0.389 Sum_probs=182.1
Q ss_pred eeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeecCC
Q 010078 296 FGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373 (518)
Q Consensus 296 i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (518)
..+.||+|+||.||+|+.. ++.||+|+++... ......+.+|+.+|++++||||+++++++.....+|+||||++|
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 3678999999999999874 6789999998643 34457899999999999999999999999999999999999999
Q ss_pred CchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE--cCCCcEEEEeeCcceecccCCccccCCC
Q 010078 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM--DENEVVKVADFGVARVKAQSGVMTAETG 451 (518)
Q Consensus 374 gsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILi--d~~~~vkL~DFGla~~~~~~~~~~~~~g 451 (518)
++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++............|
T Consensus 171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~g 250 (373)
T 2x4f_A 171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFG 250 (373)
T ss_dssp CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCS
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccC
Confidence 99999998766679999999999999999999999999999999999999 5678999999999987766655666789
Q ss_pred CCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 452 TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 452 t~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
|+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....++...
T Consensus 251 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~ 304 (373)
T 2x4f_A 251 TPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACR 304 (373)
T ss_dssp SCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC
T ss_pred CCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence 999999999999999999999999999999999999999999888887776543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=343.62 Aligned_cols=219 Identities=37% Similarity=0.647 Sum_probs=187.3
Q ss_pred CCceeeCCCCeeeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
.+.|++..++|++.++||+|+||.||+|++.+ ..||||+++..... .+.|.+|+.+|++++||||+++++++.. .
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 251 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence 46799999999999999999999999999876 56999999865433 3578999999999999999999999876 6
Q ss_pred CcceeeeecCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
.+|+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 789999999999999999753 3568999999999999999999999999999999999999999999999999998654
Q ss_pred cCC--ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCc
Q 010078 442 QSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 442 ~~~--~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
... ......++..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+. ++.+
T Consensus 332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~ 399 (452)
T 1fmk_A 332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYR 399 (452)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCC
T ss_pred CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCC
Confidence 332 1223356788999999999999999999999999999999 999999999888776654 3444
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=332.80 Aligned_cols=218 Identities=30% Similarity=0.543 Sum_probs=188.4
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeec
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~-------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~ 357 (518)
+.+++..++|+++++||+|+||.||+|++. ++.||||+++.. ........+.+|+.++++++||||++++++
T Consensus 64 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 142 (367)
T 3l9p_A 64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGV 142 (367)
T ss_dssp GSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred chhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 345777889999999999999999999854 356999998754 344556679999999999999999999999
Q ss_pred ccCCCCcceeeeecCCCchhHHHhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC---c
Q 010078 358 CTKPPSLCIVTEFMSGGSVYDYLHKLK------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---V 428 (518)
Q Consensus 358 ~~~~~~~~lV~Ey~~ggsL~~~l~~~~------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~---~ 428 (518)
+......|+||||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred EecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCce
Confidence 999999999999999999999998643 3588999999999999999999999999999999999999554 5
Q ss_pred EEEEeeCcceecccC---CccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 429 VKVADFGVARVKAQS---GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 429 vkL~DFGla~~~~~~---~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
+||+|||+++..... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||...+..+....+..
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~ 301 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 999999999754322 22334567899999999999999999999999999999998 9999999888777766554
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=327.04 Aligned_cols=204 Identities=26% Similarity=0.447 Sum_probs=178.8
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC--Cc
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP--SL 364 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~--~~ 364 (518)
+...+|++.++||+|+||.||+|++. ++.||||+++..... .....+.+|+.+|++++||||+++++++.... ..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 44578999999999999999999986 678999999854322 22466789999999999999999999887654 67
Q ss_pred ceeeeecCCCchhHHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE----cCCCcEEEEeeCcce
Q 010078 365 CIVTEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVAR 438 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~--~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILi----d~~~~vkL~DFGla~ 438 (518)
|+||||++|++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999999976433 38999999999999999999999999999999999999 778889999999998
Q ss_pred ecccCCccccCCCCCcccCchhcc--------CCCCChhhHHHHHHHHHHHHHcCCCCCCCCC
Q 010078 439 VKAQSGVMTAETGTYRWMAPEVIE--------HKPYDHKADVFSFGIVLWELLTGKLPYEYLT 493 (518)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~APEvl~--------~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~ 493 (518)
............||+.|+|||++. +..++.++|||||||++|||++|+.||....
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 227 (319)
T 4euu_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (319)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred ecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 877666666778999999999986 5789999999999999999999999997543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=341.54 Aligned_cols=205 Identities=26% Similarity=0.375 Sum_probs=165.2
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC---
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--- 360 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~--- 360 (518)
.|.+. ++|+++++||+|+||.||+|.+. ++.||||++..........+.+.+|+.+|++++||||+++++++..
T Consensus 48 ~~~~~-~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 126 (458)
T 3rp9_A 48 DWQIP-DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126 (458)
T ss_dssp SCCSC-TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred cCccC-CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence 44544 78999999999999999999764 6789999998765566667889999999999999999999999843
Q ss_pred --CCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcce
Q 010078 361 --PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (518)
Q Consensus 361 --~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~ 438 (518)
...+|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 127 EKFDELYVVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp TTCCCEEEEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred ccCceEEEEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccch
Confidence 35689999998 6799999976 5679999999999999999999999999999999999999999999999999998
Q ss_pred ecccCC----------------------------ccccCCCCCcccCchhc-cCCCCChhhHHHHHHHHHHHHHc-----
Q 010078 439 VKAQSG----------------------------VMTAETGTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLT----- 484 (518)
Q Consensus 439 ~~~~~~----------------------------~~~~~~gt~~y~APEvl-~~~~~s~ksDVwSlGviL~eLlt----- 484 (518)
...... ..+..+||+.|+|||++ .+..|+.++||||||||||||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 654221 23455789999999986 56679999999999999999999
Q ss_pred ------CCCCCCCCC
Q 010078 485 ------GKLPYEYLT 493 (518)
Q Consensus 485 ------G~~Pf~~~~ 493 (518)
|++||.+.+
T Consensus 285 ~~~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 285 VAYHADRGPLFPGSS 299 (458)
T ss_dssp CSSGGGCCCSCC---
T ss_pred ccccccccccCCCCc
Confidence 778887654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=333.82 Aligned_cols=217 Identities=32% Similarity=0.575 Sum_probs=179.8
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~-----~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~ 360 (518)
..+++..+|++.+.||+|+||.||+|++. +..||||+++... .....+.|.+|+.+|++++||||+++++++..
T Consensus 39 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp SCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred HhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 34677889999999999999999999864 4669999998643 45556789999999999999999999999999
Q ss_pred CCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceec
Q 010078 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~ 440 (518)
...+|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999999999886678999999999999999999999999999999999999999999999999999865
Q ss_pred ccCCc----cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 441 AQSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 441 ~~~~~----~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
..... .....++..|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+.+
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~ 265 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE 265 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHT
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 44321 112245678999999999999999999999999999998 9999999888776666543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=349.47 Aligned_cols=221 Identities=36% Similarity=0.665 Sum_probs=192.8
Q ss_pred CCceeeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~ 361 (518)
.+.|++...+|++.++||+|+||.||+|++. +..||||+++..... .+.|.+|+.+|++++||||++++++|...
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 288 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTRE 288 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 4679999999999999999999999999986 678999999865433 46799999999999999999999999999
Q ss_pred CCcceeeeecCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceec
Q 010078 362 PSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~ 440 (518)
..+|+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence 9999999999999999999864 345899999999999999999999999999999999999999999999999999876
Q ss_pred ccCCc--cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCch
Q 010078 441 AQSGV--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHS 508 (518)
Q Consensus 441 ~~~~~--~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~rp 508 (518)
..... .....++..|+|||++.+..++.++|||||||+||||+| |+.||.+.+..+.... +.++.+.
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~-~~~~~~~ 438 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-LEKDYRM 438 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-HHTTCCC
T ss_pred cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCC
Confidence 44321 123345678999999999999999999999999999999 9999999887665544 4444443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=320.83 Aligned_cols=214 Identities=26% Similarity=0.413 Sum_probs=178.5
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCh------------------------HHHHHHHHHHHH
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS------------------------DMQKEFAQEVFI 342 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~------------------------~~~~~~~~Ei~i 342 (518)
+..++|++.+.||+|+||.||+|+. .++.||||+++...... ...+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 3446899999999999999999987 46789999987543211 123568899999
Q ss_pred HHhcCCCcceEEeecccC--CCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 010078 343 MRKVRHKNVVQFIGACTK--PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420 (518)
Q Consensus 343 L~~L~HpnIv~l~g~~~~--~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~N 420 (518)
|++++||||+++++++.. ...+|+||||+++++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 999999999999999876 457899999999999998764 3579999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEeeCcceecccCC-ccccCCCCCcccCchhccCCC---CChhhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 010078 421 LLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKP---YDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 496 (518)
Q Consensus 421 ILid~~~~vkL~DFGla~~~~~~~-~~~~~~gt~~y~APEvl~~~~---~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q 496 (518)
||++.++.+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.......
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 247 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence 999999999999999998665432 344568999999999998765 4789999999999999999999999888766
Q ss_pred HHHHhhhh
Q 010078 497 AAVGVVQK 504 (518)
Q Consensus 497 ~~~~iv~~ 504 (518)
....+...
T Consensus 248 ~~~~~~~~ 255 (298)
T 2zv2_A 248 LHSKIKSQ 255 (298)
T ss_dssp HHHHHHHC
T ss_pred HHHHHhcc
Confidence 66555443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=322.85 Aligned_cols=212 Identities=25% Similarity=0.446 Sum_probs=189.4
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCh----HHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
+.|++++.||+|+||.||+++.. ++.||+|+++...... .....+.+|+.++++++||||+++++++.....+|
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 57999999999999999999974 6789999987653321 12567899999999999999999999999999999
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC----cEEEEeeCcceecc
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE----VVKVADFGVARVKA 441 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~----~vkL~DFGla~~~~ 441 (518)
+||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 92 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp EEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 99999999999999976 56789999999999999999999999999999999999999887 79999999998776
Q ss_pred cCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 442 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 442 ~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
.........||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+...
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 233 (321)
T 2a2a_A 171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233 (321)
T ss_dssp TTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred ccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 655556678999999999999999999999999999999999999999998887777665543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=330.61 Aligned_cols=211 Identities=27% Similarity=0.449 Sum_probs=180.3
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcce
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI---NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~---~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~l 366 (518)
+.|++.+.||+|+||.||+++.. ++.||||+++.... .....+.+.+|+.+++.++||||+++++++.....+|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 57999999999999999999874 68899999864211 11124678999999999999999999999999999999
Q ss_pred eeeecCCCchhHHHhhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCc---EEEEeeCcceec
Q 010078 367 VTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV---VKVADFGVARVK 440 (518)
Q Consensus 367 V~Ey~~ggsL~~~l~~~---~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~---vkL~DFGla~~~ 440 (518)
||||++|++|.+++.+. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 99999999999888653 235899999999999999999999999999999999999986654 999999999876
Q ss_pred ccCCc-cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 441 AQSGV-MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 441 ~~~~~-~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
..... .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+. ..+....+++
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~ 246 (351)
T 3c0i_A 184 GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIK 246 (351)
T ss_dssp CTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHH
T ss_pred cCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHc
Confidence 55432 34567999999999999999999999999999999999999999874 3444444444
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=322.22 Aligned_cols=215 Identities=29% Similarity=0.579 Sum_probs=188.1
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeec
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~-------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~ 357 (518)
..|++..++|++++.||+|+||.||+++.. ++.||||+++... .....+.+.+|+.++++++||||++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 467888999999999999999999999862 2679999998543 45556789999999999999999999999
Q ss_pred ccCCCCcceeeeecCCCchhHHHhhhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 010078 358 CTKPPSLCIVTEFMSGGSVYDYLHKLK-----------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414 (518)
Q Consensus 358 ~~~~~~~~lV~Ey~~ggsL~~~l~~~~-----------------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHr 414 (518)
+......|+||||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 999999999999999999999997643 237889999999999999999999999999
Q ss_pred cCCCCcEEEcCCCcEEEEeeCcceecccCCc---cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCC
Q 010078 415 DLKAANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE 490 (518)
Q Consensus 415 DLKp~NILid~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~ 490 (518)
||||+|||++.++.+||+|||+++....... .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999986544322 233456788999999999999999999999999999999 999999
Q ss_pred CCCHHHHHHH
Q 010078 491 YLTPLQAAVG 500 (518)
Q Consensus 491 ~~~~~q~~~~ 500 (518)
+.+..+....
T Consensus 255 ~~~~~~~~~~ 264 (314)
T 2ivs_A 255 GIPPERLFNL 264 (314)
T ss_dssp TCCGGGHHHH
T ss_pred CCCHHHHHHH
Confidence 8877555444
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=324.32 Aligned_cols=219 Identities=27% Similarity=0.498 Sum_probs=173.3
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEECCc-----eEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~~-----~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~ 360 (518)
.+.+..++|++++.||+|+||.||+|++... .||||+++.........+.+.+|+.++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 4577888999999999999999999986542 69999998766556667889999999999999999999999877
Q ss_pred CCCc------ceeeeecCCCchhHHHhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcE
Q 010078 361 PPSL------CIVTEFMSGGSVYDYLHKLK-----GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVV 429 (518)
Q Consensus 361 ~~~~------~lV~Ey~~ggsL~~~l~~~~-----~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~v 429 (518)
.... ++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence 6655 99999999999999996532 258999999999999999999999999999999999999999999
Q ss_pred EEEeeCcceecccCCc---cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhh
Q 010078 430 KVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 430 kL~DFGla~~~~~~~~---~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~ 504 (518)
||+|||+++....... .....+++.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+....+...
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~ 255 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG 255 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence 9999999976544322 223456788999999999999999999999999999999 99999988877666665543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=321.39 Aligned_cols=221 Identities=29% Similarity=0.545 Sum_probs=192.4
Q ss_pred CCceeeCCCCeeeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEee
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~-------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g 356 (518)
.+.|++..++|++.+.||+|+||.||+|++. ++.||||+++... .......+.+|+.++++++||||+++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 3578999999999999999999999999865 4679999987543 3444567999999999999999999999
Q ss_pred cccCCCCcceeeeecCCCchhHHHhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC
Q 010078 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLK---------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427 (518)
Q Consensus 357 ~~~~~~~~~lV~Ey~~ggsL~~~l~~~~---------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~ 427 (518)
++......|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence 9999999999999999999999997632 4578999999999999999999999999999999999999999
Q ss_pred cEEEEeeCcceecccCC---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 428 VVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 428 ~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
.+||+|||+++...... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+....+.+
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 255 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence 99999999997554332 1223456889999999999999999999999999999999 8999999988877777655
Q ss_pred hc
Q 010078 504 KV 505 (518)
Q Consensus 504 ~~ 505 (518)
..
T Consensus 256 ~~ 257 (322)
T 1p4o_A 256 GG 257 (322)
T ss_dssp TC
T ss_pred CC
Confidence 43
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=317.49 Aligned_cols=211 Identities=23% Similarity=0.360 Sum_probs=182.3
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|+++++||+|+||.||++++. ++.||||++..........+.+.+|+.++++++||||+++++++......++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57999999999999999999985 6789999998776666667788999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-cccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~ 448 (518)
|+++++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 83 ~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (311)
T 4agu_A 83 YCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD 161 (311)
T ss_dssp CCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred eCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCC
Confidence 9999999988865 5679999999999999999999999999999999999999999999999999998765332 3345
Q ss_pred CCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 449 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 449 ~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
..||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....+.+
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 217 (311)
T 4agu_A 162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRK 217 (311)
T ss_dssp ----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 678999999999876 6789999999999999999999999999988777666543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=324.97 Aligned_cols=199 Identities=24% Similarity=0.370 Sum_probs=177.0
Q ss_pred CCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEeecccCCCCcce
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCI 366 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~~~~l 366 (518)
-.++|++.+.||+|+||.||+|+. .++.||||++...... ..+.+|+.+++++ +||||+++++++......|+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 347899999999999999999995 5788999998754322 3578899999999 89999999999999888999
Q ss_pred eeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCc-----EEEEeeCcceecc
Q 010078 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV-----VKVADFGVARVKA 441 (518)
Q Consensus 367 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~-----vkL~DFGla~~~~ 441 (518)
||||+ +++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99999 99999999876678999999999999999999999999999999999999998887 9999999998654
Q ss_pred cCCc--------cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCC
Q 010078 442 QSGV--------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 493 (518)
Q Consensus 442 ~~~~--------~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~ 493 (518)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~ 221 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK 221 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc
Confidence 4321 245679999999999999999999999999999999999999998743
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=314.68 Aligned_cols=215 Identities=32% Similarity=0.622 Sum_probs=188.1
Q ss_pred CCceeeCCCCeeeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
.+.|++..++|++++.||+|+||.||+|.+.+ ..||+|+++..... .+.+.+|+.++++++||||+++++++.. +
T Consensus 5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 80 (279)
T 1qpc_A 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (279)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred hhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC-C
Confidence 35799999999999999999999999999865 57999999865433 3578899999999999999999999874 5
Q ss_pred CcceeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 6899999999999999997543 368999999999999999999999999999999999999999999999999998765
Q ss_pred cCCc--cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhh
Q 010078 442 QSGV--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 442 ~~~~--~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv 502 (518)
.... .....++..|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+....+.
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 224 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh
Confidence 4332 223456788999999998899999999999999999999 999999988877666544
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=318.90 Aligned_cols=203 Identities=32% Similarity=0.581 Sum_probs=175.3
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEE------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~------~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~ 360 (518)
.++..++|++.++||+|+||.||++++ .++.||||+++.. .....+.+.+|+.++++++||||+++++++..
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 466778999999999999999999986 4678999998854 45556789999999999999999999998754
Q ss_pred --CCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcce
Q 010078 361 --PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (518)
Q Consensus 361 --~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~ 438 (518)
...+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 356899999999999999998866679999999999999999999999999999999999999999999999999998
Q ss_pred ecccCC----ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 439 VKAQSG----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 439 ~~~~~~----~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
...... ......++..|+|||++.+..++.++||||||+++|+|+||..||..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 654432 22234567789999999999999999999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=321.93 Aligned_cols=217 Identities=33% Similarity=0.591 Sum_probs=185.2
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEECC------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeeccc
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~ 359 (518)
.+++...+|++.+.||+|+||.||+|.+.. ..||||+++... .......+.+|+.++++++||||+++++++.
T Consensus 38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 357888999999999999999999998743 249999998643 4455678999999999999999999999999
Q ss_pred CCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
.....++||||+++++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999999999987667899999999999999999999999999999999999999999999999999976
Q ss_pred cccCC----ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 440 KAQSG----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 440 ~~~~~----~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
..... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+.+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~ 265 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 265 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHC
Confidence 54332 1123346788999999999999999999999999999999 9999999888777666544
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=317.59 Aligned_cols=219 Identities=27% Similarity=0.407 Sum_probs=173.0
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCc
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~ 364 (518)
+++..++|++.++||+|+||.||+++. .++.||||+++...........+.++..+++.++||||+++++++......
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 567788999999999999999999998 678899999986644444445555666678889999999999999999999
Q ss_pred ceeeeecCCCchhHHHhh---hcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEcCCCcEEEEeeCcceec
Q 010078 365 CIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~---~~~~l~~~~i~~i~~qIa~aL~yLHs~-gIiHrDLKp~NILid~~~~vkL~DFGla~~~ 440 (518)
|+||||++ ++|.+++.. ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99999996 588887754 356799999999999999999999998 9999999999999999999999999999876
Q ss_pred ccCCccccCCCCCcccCchhc----cCCCCChhhHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHhhhhcC
Q 010078 441 AQSGVMTAETGTYRWMAPEVI----EHKPYDHKADVFSFGIVLWELLTGKLPYEY-LTPLQAAVGVVQKVH 506 (518)
Q Consensus 441 ~~~~~~~~~~gt~~y~APEvl----~~~~~s~ksDVwSlGviL~eLltG~~Pf~~-~~~~q~~~~iv~~~~ 506 (518)
..........||+.|+|||++ .+..++.++||||||+++|+|++|+.||.. ..+.+.....+....
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (290)
T 3fme_A 161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS 231 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC
T ss_pred cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC
Confidence 665555566899999999996 567799999999999999999999999986 455555555554443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=328.28 Aligned_cols=201 Identities=27% Similarity=0.482 Sum_probs=163.8
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
.+.|++.++||+|+||.||+|++. ++.||||+++... ..+.+.+|+.+|++++||||+++++++.....+|+||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 467999999999999999999985 5679999998542 2356888999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC---CCcEEEEeeCcceecccCCc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVKAQSGV 445 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~---~~~vkL~DFGla~~~~~~~~ 445 (518)
||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.......
T Consensus 128 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 206 (349)
T 2w4o_A 128 ELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206 (349)
T ss_dssp CCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred EeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence 99999999999976 567999999999999999999999999999999999999975 88999999999987665555
Q ss_pred cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 010078 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 496 (518)
Q Consensus 446 ~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q 496 (518)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 257 (349)
T 2w4o_A 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ 257 (349)
T ss_dssp ------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH
T ss_pred cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH
Confidence 556789999999999999999999999999999999999999998766554
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=330.53 Aligned_cols=216 Identities=19% Similarity=0.308 Sum_probs=176.3
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHH---------HHHHHHHHHHHHhcCCCc
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDM---------QKEFAQEVFIMRKVRHKN 350 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~~-------~~~vAVKvlk~~~~~~~~---------~~~~~~Ei~iL~~L~Hpn 350 (518)
.++..++|+++++||+|+||.||+|.+. ++.||||++......... ...+.+|+..++.++|||
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~ 109 (364)
T 3op5_A 30 TDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLG 109 (364)
T ss_dssp ECTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred eccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence 3466789999999999999999999874 367999998754311100 012445667778889999
Q ss_pred ceEEeecccCC----CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc--
Q 010078 351 VVQFIGACTKP----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-- 424 (518)
Q Consensus 351 Iv~l~g~~~~~----~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid-- 424 (518)
|+++++++... ...|+||||+ |++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS
T ss_pred CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC
Confidence 99999998664 3479999999 9999999988667899999999999999999999999999999999999999
Q ss_pred CCCcEEEEeeCcceecccCCc--------cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 010078 425 ENEVVKVADFGVARVKAQSGV--------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 496 (518)
Q Consensus 425 ~~~~vkL~DFGla~~~~~~~~--------~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q 496 (518)
.++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 889999999999976543321 123459999999999999999999999999999999999999998644333
Q ss_pred HHHHhhh
Q 010078 497 AAVGVVQ 503 (518)
Q Consensus 497 ~~~~iv~ 503 (518)
.......
T Consensus 269 ~~~~~~~ 275 (364)
T 3op5_A 269 KYVRDSK 275 (364)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 3333333
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=322.18 Aligned_cols=211 Identities=26% Similarity=0.441 Sum_probs=170.4
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
.++|++.++||+|+||.||+|... ++.||+|+++.... ......+.+|+.++++++||||+++++++.....+|+||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 357899999999999999999864 67899999875432 222356889999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC
Q 010078 369 EFMSGGSVYDYLHKLK-----GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~-----~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~ 443 (518)
||++ ++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 9997 59999987643 45899999999999999999999999999999999999999999999999999865433
Q ss_pred -CccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 444 -GVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 444 -~~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+++
T Consensus 162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 223 (317)
T 2pmi_A 162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFD 223 (317)
T ss_dssp CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 23445678999999999976 4689999999999999999999999999988877776654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=311.40 Aligned_cols=210 Identities=24% Similarity=0.443 Sum_probs=187.8
Q ss_pred CCeeeeeeeeecCceEEEEEEECC--ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~~--~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|++.++||+|+||.||+|.+.+ ..||+|++....... .+.+.+|+.++++++||||+++++++......|+|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 579999999999999999999864 578999987643322 4678999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---cCCCcEEEEeeCcceecccCCcc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVM 446 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILi---d~~~~vkL~DFGla~~~~~~~~~ 446 (518)
|+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++.........
T Consensus 87 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~ 165 (277)
T 3f3z_A 87 LCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM 165 (277)
T ss_dssp CCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCB
T ss_pred ccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccch
Confidence 9999999999976 5679999999999999999999999999999999999999 78889999999999877666666
Q ss_pred ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
....||+.|+|||++.+. ++.++||||||+++|+|++|+.||...+..+....+.+..
T Consensus 166 ~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 223 (277)
T 3f3z_A 166 RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGT 223 (277)
T ss_dssp CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence 677899999999998765 9999999999999999999999999988888777765543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=320.72 Aligned_cols=207 Identities=29% Similarity=0.460 Sum_probs=184.3
Q ss_pred CeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
.|...++||+|+||.||+|+.. ++.||||+++..... ..+.+.+|+.++++++||||+++++++......|+||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 3677789999999999999874 788999999765332 246788999999999999999999999988999999999
Q ss_pred cCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-ccccC
Q 010078 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAE 449 (518)
Q Consensus 371 ~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~~ 449 (518)
++|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .....
T Consensus 124 ~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 201 (321)
T 2c30_A 124 LQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 201 (321)
T ss_dssp CCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred CCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence 999999999865 569999999999999999999999999999999999999999999999999998655432 33456
Q ss_pred CCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 450 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 450 ~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
.||+.|+|||++.+..++.++||||||+++|+|++|+.||...++.+....+..
T Consensus 202 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 255 (321)
T 2c30_A 202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD 255 (321)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred cCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 799999999999999999999999999999999999999999988877766544
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=323.16 Aligned_cols=223 Identities=30% Similarity=0.576 Sum_probs=191.6
Q ss_pred CCceeeCCCCeeeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEe
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI 355 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~ 355 (518)
...|++..++|++++.||+|+||.||+|++.+ ..||+|+++... .......+.+|+.+++++ +||||++++
T Consensus 38 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 116 (333)
T 2i1m_A 38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLL 116 (333)
T ss_dssp CGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 34689999999999999999999999999753 369999998653 344567899999999999 899999999
Q ss_pred ecccCCCCcceeeeecCCCchhHHHhhh-------------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 010078 356 GACTKPPSLCIVTEFMSGGSVYDYLHKL-------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 422 (518)
Q Consensus 356 g~~~~~~~~~lV~Ey~~ggsL~~~l~~~-------------~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NIL 422 (518)
+++.....+|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL 196 (333)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCE
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEE
Confidence 9999999999999999999999999753 245789999999999999999999999999999999999
Q ss_pred EcCCCcEEEEeeCcceecccCCc---cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 010078 423 MDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAA 498 (518)
Q Consensus 423 id~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~ 498 (518)
++.++.+||+|||+++....... .....+|+.|+|||++.+..++.++||||||+++|+|+| |..||.+.......
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 99999999999999986544322 223456788999999999999999999999999999999 99999987665555
Q ss_pred HHhhhhcCc
Q 010078 499 VGVVQKVHH 507 (518)
Q Consensus 499 ~~iv~~~~r 507 (518)
..++..+.+
T Consensus 277 ~~~~~~~~~ 285 (333)
T 2i1m_A 277 YKLVKDGYQ 285 (333)
T ss_dssp HHHHHHTCC
T ss_pred HHHHhcCCC
Confidence 555554443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=317.17 Aligned_cols=216 Identities=29% Similarity=0.564 Sum_probs=188.1
Q ss_pred ceeeCCCCeeeee-eeeecCceEEEEEEE----CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC
Q 010078 286 VWEIDPKHLKFGS-KVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (518)
Q Consensus 286 ~~ei~~~~~~i~~-~LG~G~fG~Vy~g~~----~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~ 360 (518)
.|.+..++|.+.+ .||+|+||.||+|++ .+..||||+++... .....+.+.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~- 80 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ- 80 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-
Confidence 4677888898887 999999999999986 45679999998653 4455678999999999999999999999994
Q ss_pred CCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceec
Q 010078 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~ 440 (518)
....++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 45689999999999999999876677999999999999999999999999999999999999999999999999999866
Q ss_pred ccCCc----cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 441 AQSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 441 ~~~~~----~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
..... .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~ 228 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc
Confidence 44322 223356889999999998899999999999999999998 9999999887766655443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=323.15 Aligned_cols=201 Identities=23% Similarity=0.285 Sum_probs=173.6
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEeecccCCCCccee
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~~~~lV 367 (518)
.++|++.++||+|+||.||+|.+. ++.||||++............+..|+..+.++ +||||++++++|.....+|+|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367999999999999999999985 77899999887655555555666677666665 899999999999999999999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccc
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT 447 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~ 447 (518)
|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 214 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE 214 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCc
Confidence 9999 779999998877789999999999999999999999999999999999999999999999999998776665566
Q ss_pred cCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCC
Q 010078 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 493 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~ 493 (518)
...||+.|+|||++.+ .++.++|||||||++|||++|..||....
T Consensus 215 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~ 259 (311)
T 3p1a_A 215 VQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE 259 (311)
T ss_dssp CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH
T ss_pred ccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 6789999999999886 69999999999999999999976665533
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=326.71 Aligned_cols=215 Identities=28% Similarity=0.434 Sum_probs=184.4
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
..|++. +.|++.+.||+|+||.||+|.+ +++.||||++..........+.+.+|+.+|+.++||||+++++++....
T Consensus 19 ~~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 97 (367)
T 1cm8_A 19 TAWEVR-AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 97 (367)
T ss_dssp SEECCB-SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred ceeeec-ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence 356664 7899999999999999999987 4688999999776556666788999999999999999999999987653
Q ss_pred ------CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCc
Q 010078 363 ------SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436 (518)
Q Consensus 363 ------~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGl 436 (518)
.+|+||||+ +++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 98 TLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 8899999976 5789999999999999999999999999999999999999999999999999
Q ss_pred ceecccCCccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 437 ARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 437 a~~~~~~~~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
++.... ..+...+|+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+..+++..
T Consensus 175 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~ 242 (367)
T 1cm8_A 175 ARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 242 (367)
T ss_dssp CEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred cccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 986543 3456688999999999877 789999999999999999999999999999888887776543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=342.22 Aligned_cols=213 Identities=28% Similarity=0.490 Sum_probs=184.2
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
+.|+++++||+|+||.||+++.. +..||||+++...........+.+|+.+|+.++||||+++++++.....+|+|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 46999999999999999999984 6789999998654433335678999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCC---CcEEEEeeCcceecccCCcc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN---EVVKVADFGVARVKAQSGVM 446 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~---~~vkL~DFGla~~~~~~~~~ 446 (518)
|++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||+++........
T Consensus 117 ~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~ 195 (494)
T 3lij_A 117 CYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM 195 (494)
T ss_dssp CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCB
T ss_pred cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccc
Confidence 9999999999876 5679999999999999999999999999999999999999764 45999999999887766666
Q ss_pred ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcC
Q 010078 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVH 506 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~ 506 (518)
....||+.|+|||++. ..|+.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 196 ~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 254 (494)
T 3lij_A 196 KERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKY 254 (494)
T ss_dssp CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred cccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 6778999999999986 4699999999999999999999999999998888777665443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=329.54 Aligned_cols=199 Identities=31% Similarity=0.575 Sum_probs=178.1
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
++|++.+.||+|+||.||+|.+ .++.||||++...... ......+.+|+.+++.++||||+++++++.....+|+||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999997 5678999998743211 112356889999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcccc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~ 448 (518)
||+ +|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 89 E~~-~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~ 166 (336)
T 3h4j_B 89 EYA-GGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT 166 (336)
T ss_dssp CCC-CEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCC
T ss_pred ECC-CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCccccc
Confidence 999 7899999876 56799999999999999999999999999999999999999999999999999987766666667
Q ss_pred CCCCCcccCchhccCCCC-ChhhHHHHHHHHHHHHHcCCCCCCCC
Q 010078 449 ETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYL 492 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~-s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (518)
.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...
T Consensus 167 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 211 (336)
T 3h4j_B 167 SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211 (336)
T ss_dssp CTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred ccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence 789999999999998876 78999999999999999999999764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=322.70 Aligned_cols=217 Identities=31% Similarity=0.618 Sum_probs=189.5
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEEC---------CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEE
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQF 354 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~---------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l 354 (518)
..|++..++|++++.||+|+||.||+|++. +..||||+++... .......+.+|+.+++++ +||||+++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence 568999999999999999999999999864 3569999998653 445567899999999999 89999999
Q ss_pred eecccCCCCcceeeeecCCCchhHHHhhhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 010078 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419 (518)
Q Consensus 355 ~g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~ 419 (518)
++++.....+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 186 (334)
T 2pvf_A 107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 186 (334)
T ss_dssp EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence 999999999999999999999999997643 24889999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEeeCcceecccCCc---cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 010078 420 NLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPL 495 (518)
Q Consensus 420 NILid~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~ 495 (518)
|||++.++.+||+|||+++....... .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 99999999999999999986554322 233456788999999998899999999999999999999 99999998876
Q ss_pred HHHHHhh
Q 010078 496 QAAVGVV 502 (518)
Q Consensus 496 q~~~~iv 502 (518)
+....+.
T Consensus 267 ~~~~~~~ 273 (334)
T 2pvf_A 267 ELFKLLK 273 (334)
T ss_dssp HHHHHHH
T ss_pred HHHHHHh
Confidence 6655543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=321.25 Aligned_cols=210 Identities=26% Similarity=0.430 Sum_probs=185.2
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-----CCcceEEeecccC
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-----HKNVVQFIGACTK 360 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-----HpnIv~l~g~~~~ 360 (518)
.+-.++|++.++||+|+||.||+|++ .++.||||+++.. ......+..|+.+++.+. ||||+++++++..
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 44567999999999999999999998 5678999999742 444567888999999997 9999999999999
Q ss_pred CCCcceeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC--------------
Q 010078 361 PPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-------------- 425 (518)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~-------------- 425 (518)
...+|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 108 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 108 YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence 89999999999 999999997643 35899999999999999999999999999999999999975
Q ss_pred -----------CCcEEEEeeCcceecccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 426 -----------NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 426 -----------~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
++.+||+|||+++..... .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||...+.
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 264 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEH 264 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcH
Confidence 789999999999865432 3456789999999999999999999999999999999999999999888
Q ss_pred HHHHHHhhh
Q 010078 495 LQAAVGVVQ 503 (518)
Q Consensus 495 ~q~~~~iv~ 503 (518)
.+....+..
T Consensus 265 ~~~~~~~~~ 273 (360)
T 3llt_A 265 MEHLAMMES 273 (360)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 776666443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=330.35 Aligned_cols=202 Identities=30% Similarity=0.495 Sum_probs=167.5
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcce
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~l 366 (518)
...++|++.++||+|+||.||+++. .++.||||++...... ...+.+|+.++++++||||+++++++.....+|+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 4567899999999999999999998 4678999999764332 2457899999999999999999999999999999
Q ss_pred eeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCc--EEEEeeCcceecccCC
Q 010078 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV--VKVADFGVARVKAQSG 444 (518)
Q Consensus 367 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~--vkL~DFGla~~~~~~~ 444 (518)
||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 94 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 94 IMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 9999999999999976 567999999999999999999999999999999999999987765 9999999998655555
Q ss_pred ccccCCCCCcccCchhccCCCCChh-hHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 445 VMTAETGTYRWMAPEVIEHKPYDHK-ADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 445 ~~~~~~gt~~y~APEvl~~~~~s~k-sDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+...
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (361)
T 3uc3_A 173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223 (361)
T ss_dssp --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----
T ss_pred CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc
Confidence 5566789999999999988888766 8999999999999999999987544
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=318.83 Aligned_cols=216 Identities=29% Similarity=0.550 Sum_probs=183.6
Q ss_pred CceeeCCCCeeeee-eeeecCceEEEEEEEC----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeeccc
Q 010078 285 DVWEIDPKHLKFGS-KVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (518)
Q Consensus 285 ~~~ei~~~~~~i~~-~LG~G~fG~Vy~g~~~----~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~ 359 (518)
..+.++..+|++.+ .||+|+||.||+|.+. ++.||||+++.........+.+.+|+.+++.++||||+++++++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 35677888999998 9999999999999653 46799999987655556678899999999999999999999999
Q ss_pred CCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
.....|+||||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCCCcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 45678999999999999999987 56799999999999999999999999999999999999999999999999999986
Q ss_pred cccCCc----cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhh
Q 010078 440 KAQSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 440 ~~~~~~----~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv 502 (518)
...... .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~ 234 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 544332 223356788999999999899999999999999999999 999999988876655543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=325.15 Aligned_cols=212 Identities=26% Similarity=0.374 Sum_probs=177.4
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC------
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------ 362 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~------ 362 (518)
.++|++.+.||+|+||.||+|... ++.||||+++...........+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 368999999999999999999874 678999999876556666788999999999999999999999987654
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
.+|+||||++ ++|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 104 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred ceEEEEEcCC-CCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 5799999996 57888874 4589999999999999999999999999999999999999999999999999987665
Q ss_pred CCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcC
Q 010078 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVH 506 (518)
Q Consensus 443 ~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~ 506 (518)
........||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+++...
T Consensus 180 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 243 (371)
T 2xrw_A 180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 243 (371)
T ss_dssp ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CC
T ss_pred ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 5455667899999999999999999999999999999999999999999999888888776443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=348.45 Aligned_cols=219 Identities=37% Similarity=0.647 Sum_probs=191.3
Q ss_pred CCceeeCCCCeeeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
.+.|++..++|++.++||+|+||.||+|++.+ ..||||+++..... .+.|.+|+.+|++++|+||+++++++.. .
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 46799999999999999999999999999876 56999999875433 3579999999999999999999999876 6
Q ss_pred CcceeeeecCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
.+||||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 789999999999999999753 3568999999999999999999999999999999999999999999999999997654
Q ss_pred cCC--ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCc
Q 010078 442 QSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 442 ~~~--~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
... ......++..|+|||++.+..++.++|||||||+||||++ |+.||.+.+..+....+. ++.+
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~ 482 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYR 482 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH-TTCC
T ss_pred CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCC
Confidence 321 1123346788999999999999999999999999999999 999999999887776644 4444
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.99 Aligned_cols=215 Identities=26% Similarity=0.545 Sum_probs=190.2
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
+...+|.+++.||+|+||.||+|+.. ++.||||+++..... ......+.+|+.+|+.++||||+++++++.....+|
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34468999999999999999999874 788999998753211 123467889999999999999999999999999999
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 445 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~ 445 (518)
+||||++|++|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 93 lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 93 MVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171 (476)
T ss_dssp EEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence 99999999999999976 56799999999999999999999999999999999999999999999999999987766655
Q ss_pred cccCCCCCcccCchhccCCCC-ChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 446 MTAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 446 ~~~~~gt~~y~APEvl~~~~~-s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+..+....+...
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 231 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG 231 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC
Confidence 667789999999999998876 68999999999999999999999988777766665543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=310.29 Aligned_cols=211 Identities=26% Similarity=0.492 Sum_probs=183.2
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCh----HHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
++|++++.||+|+||.||+++.. ++.||+|+++...... .....+.+|+.++++++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46899999999999999999985 6789999987654322 12567899999999999999999999999999999
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC----cEEEEeeCcceecc
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE----VVKVADFGVARVKA 441 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~----~vkL~DFGla~~~~ 441 (518)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++....
T Consensus 85 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 99999999999999976 56799999999999999999999999999999999999998877 89999999998766
Q ss_pred cCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 442 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 442 ~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
.........||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+..
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 225 (283)
T 3bhy_A 164 AGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISA 225 (283)
T ss_dssp --------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred CCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHh
Confidence 55555566799999999999999999999999999999999999999999888776666443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=355.12 Aligned_cols=219 Identities=24% Similarity=0.407 Sum_probs=190.1
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCcceEEeecccCC
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKP 361 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~ 361 (518)
...+..++|++++.||+|+||.||++++. ++.||||+++.... .......+..|..+|..+ +||||+++++++...
T Consensus 335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~ 414 (674)
T 3pfq_A 335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 414 (674)
T ss_dssp -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence 34567789999999999999999999985 46799999875321 112245678899999987 699999999999999
Q ss_pred CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
..+||||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++...
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred CEEEEEEeCcCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 999999999999999999987 5679999999999999999999999999999999999999999999999999998643
Q ss_pred c-CCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 442 Q-SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 442 ~-~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
. .......+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+....|++..
T Consensus 494 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~ 558 (674)
T 3pfq_A 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 558 (674)
T ss_dssp CTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC
T ss_pred cCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC
Confidence 3 334556789999999999999999999999999999999999999999999988888887654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=323.64 Aligned_cols=201 Identities=29% Similarity=0.531 Sum_probs=175.3
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|+++++||+|+||.||++.+. ++.||||++..... ....+.+.+|+.+++.++||||+++++++......|+|||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 67999999999999999999875 67899999875432 2234668899999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC---cc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VM 446 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~---~~ 446 (518)
|++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 86 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 164 (323)
T 3tki_A 86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (323)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred cCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence 9999999999976 5569999999999999999999999999999999999999999999999999997654322 23
Q ss_pred ccCCCCCcccCchhccCCCC-ChhhHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 447 TAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~~~-s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 45679999999999988776 7789999999999999999999987554
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=340.96 Aligned_cols=214 Identities=28% Similarity=0.493 Sum_probs=186.6
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|++.++||+|+||.||+++.. ++.||||+++...........+.+|+.+|++++||||+++++++.....+|+|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 67999999999999999999974 7789999986433222235678999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc---CCCcEEEEeeCcceecccCCcc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVADFGVARVKAQSGVM 446 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid---~~~~vkL~DFGla~~~~~~~~~ 446 (518)
|+.|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++........
T Consensus 102 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 180 (486)
T 3mwu_A 102 LYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180 (486)
T ss_dssp CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCcc
Confidence 9999999999976 46799999999999999999999999999999999999995 4567999999999876666566
Q ss_pred ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCc
Q 010078 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
....||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 181 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 240 (486)
T 3mwu_A 181 KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA 240 (486)
T ss_dssp -CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred CCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence 67789999999999976 4999999999999999999999999999998888776665433
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=311.53 Aligned_cols=214 Identities=28% Similarity=0.552 Sum_probs=183.2
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeeccc
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-----~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~ 359 (518)
..|.+..++|++.+.||+|+||.||+|++.+ ..||+|+++... .....+.+.+|+.++++++||||+++++++.
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 83 (281)
T 3cc6_A 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE 83 (281)
T ss_dssp CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred ccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence 4567888999999999999999999998743 249999988653 3455678999999999999999999999987
Q ss_pred CCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
. ...|+||||+++++|.+++......++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 84 ~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 84 E-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred C-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 5 457899999999999999988677799999999999999999999999999999999999999999999999999976
Q ss_pred cccCC--ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 010078 440 KAQSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVG 500 (518)
Q Consensus 440 ~~~~~--~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~ 500 (518)
..... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~ 226 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV 226 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH
Confidence 54432 2234456789999999999999999999999999999998 9999987666554443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=319.81 Aligned_cols=215 Identities=24% Similarity=0.417 Sum_probs=181.5
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC---hHHHHHHHHHHHHHHhcC---CCcceEEeecccC
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN---SDMQKEFAQEVFIMRKVR---HKNVVQFIGACTK 360 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~---~~~~~~~~~Ei~iL~~L~---HpnIv~l~g~~~~ 360 (518)
+..++|++.++||+|+||.||+|++ .++.||||+++..... ......+.+|+.+++.++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3457899999999999999999995 5678999998743211 111235666777777665 9999999999866
Q ss_pred CC-----CcceeeeecCCCchhHHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEee
Q 010078 361 PP-----SLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 434 (518)
Q Consensus 361 ~~-----~~~lV~Ey~~ggsL~~~l~~~~~-~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DF 434 (518)
.. .+++||||+. ++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 54 4799999995 699999977433 3899999999999999999999999999999999999999999999999
Q ss_pred CcceecccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 435 GVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 435 Gla~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
|+++............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+++.
T Consensus 165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (308)
T 3g33_A 165 GLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234 (308)
T ss_dssp SCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 9998776665666778999999999999999999999999999999999999999999998888777653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=337.68 Aligned_cols=213 Identities=25% Similarity=0.490 Sum_probs=186.3
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCh-----------HHHHHHHHHHHHHHhcCCCcceEEeecc
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS-----------DMQKEFAQEVFIMRKVRHKNVVQFIGAC 358 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~-----------~~~~~~~~Ei~iL~~L~HpnIv~l~g~~ 358 (518)
+.|+++++||+|+||.||+++.. ++.||||+++...... ...+.+.+|+.+|++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 67999999999999999999974 5789999987653321 2346789999999999999999999999
Q ss_pred cCCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC---cEEEEeeC
Q 010078 359 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VVKVADFG 435 (518)
Q Consensus 359 ~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~---~vkL~DFG 435 (518)
.....+|+||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 194 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG 194 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred EcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence 999999999999999999999976 56799999999999999999999999999999999999998776 69999999
Q ss_pred cceecccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcC
Q 010078 436 VARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVH 506 (518)
Q Consensus 436 la~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~ 506 (518)
+++............||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+..+....+.+...
T Consensus 195 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 264 (504)
T 3q5i_A 195 LSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY 264 (504)
T ss_dssp TCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred CCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence 9988776666677789999999999874 699999999999999999999999999998888877665443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.05 Aligned_cols=213 Identities=25% Similarity=0.421 Sum_probs=188.8
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCccee
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV 367 (518)
..+|.+++.||+|+||.||++.+. ++.||+|++..... .......+.+|+.+++.++||||+++++++.....+|+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467999999999999999999985 56799999875533 345567889999999999999999999999999999999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-cc
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VM 446 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~ 446 (518)
|||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 120 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 198 (335)
T 2owb_A 120 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 198 (335)
T ss_dssp ECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred EecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccc
Confidence 999999999999876 5679999999999999999999999999999999999999999999999999998665332 34
Q ss_pred ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
....||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+...
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 256 (335)
T 2owb_A 199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN 256 (335)
T ss_dssp CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT
T ss_pred cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC
Confidence 4567999999999999999999999999999999999999999998877766665443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=326.31 Aligned_cols=211 Identities=33% Similarity=0.489 Sum_probs=186.4
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
+.|++.+.||+|+||.||+|+. .++.||||+++..... ....+.+.+|+.+|++++||||+++++++......|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4589999999999999999986 5778999999765433 344577999999999999999999999999989999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcccc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~ 448 (518)
||+. |+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ...
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---~~~ 209 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANS 209 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCC
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC---CCc
Confidence 9996 689998877678899999999999999999999999999999999999999999999999999976543 234
Q ss_pred CCCCCcccCchhcc---CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcC
Q 010078 449 ETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVH 506 (518)
Q Consensus 449 ~~gt~~y~APEvl~---~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~ 506 (518)
..||+.|+|||++. +..++.++|||||||++|||++|+.||...+..+....+.+...
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~ 270 (348)
T 1u5q_A 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES 270 (348)
T ss_dssp CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Confidence 57999999999984 57799999999999999999999999999988887777665543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=313.74 Aligned_cols=217 Identities=29% Similarity=0.597 Sum_probs=182.0
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHH-----HHHHHHHHHHHhcCCCcceEEeecccC
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQ-----KEFAQEVFIMRKVRHKNVVQFIGACTK 360 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~-----~~~~~Ei~iL~~L~HpnIv~l~g~~~~ 360 (518)
.+..++|++.+.||+|+||.||+|++ .++.||+|++.......... +.+.+|+.++++++||||+++++++..
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 45668899999999999999999998 46789999987654332211 678999999999999999999999976
Q ss_pred CCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEcCCCc-----EEEEe
Q 010078 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEV-----VKVAD 433 (518)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~g--IiHrDLKp~NILid~~~~-----vkL~D 433 (518)
.. ++||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++. +||+|
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 54 7999999999999999876778999999999999999999999999 999999999999988776 99999
Q ss_pred eCcceecccCCccccCCCCCcccCchhc--cCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHhhhhcCch
Q 010078 434 FGVARVKAQSGVMTAETGTYRWMAPEVI--EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP--LQAAVGVVQKVHHS 508 (518)
Q Consensus 434 FGla~~~~~~~~~~~~~gt~~y~APEvl--~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~--~q~~~~iv~~~~rp 508 (518)
||+++.... ......||+.|+|||++ ....++.++|||||||++|+|++|+.||...+. ......+.....++
T Consensus 173 fg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 249 (287)
T 4f0f_A 173 FGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249 (287)
T ss_dssp CTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCC
T ss_pred CCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCC
Confidence 999974433 34456799999999998 456689999999999999999999999987543 32244444444443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=324.91 Aligned_cols=212 Identities=29% Similarity=0.557 Sum_probs=178.6
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEECC--ce----EEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS--QD----VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~~--~~----vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~ 361 (518)
.+..++|++.++||+|+||.||+|++.. +. |++|++..... ......+.+|+.++++++||||+++++++. .
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G 86 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence 4566889999999999999999998743 33 78887754322 222345778999999999999999999886 4
Q ss_pred CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
...++||||+.+++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 56899999999999999998766789999999999999999999999999999999999999999999999999998654
Q ss_pred cCC---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHh
Q 010078 442 QSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 501 (518)
Q Consensus 442 ~~~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~i 501 (518)
... ......+|..|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+....+
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 230 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH
Confidence 432 2334567889999999999999999999999999999999 99999987766555443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=320.16 Aligned_cols=222 Identities=32% Similarity=0.594 Sum_probs=187.8
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEee
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG 356 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~-------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g 356 (518)
..|++..++|++++.||+|+||.||+|++. ++.||||+++... .......+.+|+.+++++ +||||+++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 467888999999999999999999999853 3679999998653 344557899999999999 6899999999
Q ss_pred cccCCC-CcceeeeecCCCchhHHHhhhcCC---------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 010078 357 ACTKPP-SLCIVTEFMSGGSVYDYLHKLKGV---------------FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420 (518)
Q Consensus 357 ~~~~~~-~~~lV~Ey~~ggsL~~~l~~~~~~---------------l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~N 420 (518)
++.... .+++||||+++++|.+++...... +++..++.++.||+.||.|||++||+||||||+|
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N 178 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence 987654 489999999999999999764322 7899999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEeeCcceecccCCc---cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 010078 421 LLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ 496 (518)
Q Consensus 421 ILid~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q 496 (518)
|+++.++.+||+|||+++....... .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+
T Consensus 179 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 258 (316)
T 2xir_A 179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258 (316)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred EEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence 9999999999999999976543321 223457889999999999999999999999999999998 999998876555
Q ss_pred HHHHhhhhcCc
Q 010078 497 AAVGVVQKVHH 507 (518)
Q Consensus 497 ~~~~iv~~~~r 507 (518)
.....+..+.+
T Consensus 259 ~~~~~~~~~~~ 269 (316)
T 2xir_A 259 EFCRRLKEGTR 269 (316)
T ss_dssp HHHHHHHHTCC
T ss_pred HHHHHhccCcc
Confidence 55554544433
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=317.42 Aligned_cols=214 Identities=37% Similarity=0.682 Sum_probs=188.7
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
+.|++..++|++.++||+|+||.||+|.+. +..||+|+++... ...+.+.+|+.++++++||||+++++++....
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 578999999999999999999999999986 6789999997542 33567899999999999999999999999999
Q ss_pred CcceeeeecCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
.+|+||||++|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999999999999999764 3458999999999999999999999999999999999999999999999999997655
Q ss_pred cCCc--cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHh
Q 010078 442 QSGV--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 501 (518)
Q Consensus 442 ~~~~--~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~i 501 (518)
.... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~ 225 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 4332 223356788999999999999999999999999999999 99999987766555443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=344.39 Aligned_cols=215 Identities=25% Similarity=0.406 Sum_probs=185.1
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
+..++|++.+.||+|+||.||+++.. ++.||||+++..... ......+.+|+.+|++++||||+++++++.....+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 44578999999999999999999984 688999998753221 122456889999999999999999999999999999
Q ss_pred eeeeecCCCchhHHHhhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 366 IVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~---~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
+||||++||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999999998764 34699999999999999999999999999999999999999999999999999987654
Q ss_pred CCc-cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHhhh
Q 010078 443 SGV-MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL----TPLQAAVGVVQ 503 (518)
Q Consensus 443 ~~~-~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~----~~~q~~~~iv~ 503 (518)
... ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||... ...+....++.
T Consensus 342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~ 407 (543)
T 3c4z_A 342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE 407 (543)
T ss_dssp TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH
T ss_pred CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh
Confidence 433 33458999999999999999999999999999999999999999875 33444444443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=313.38 Aligned_cols=212 Identities=36% Similarity=0.677 Sum_probs=177.9
Q ss_pred CCceeeCCCCeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC-C
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-P 362 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~-~ 362 (518)
...|.++.++|++.+.||+|+||.||++++.++.||||+++... ..+.+.+|+.++++++||||+++++++... .
T Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 88 (278)
T ss_dssp --CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred hccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence 34688899999999999999999999999999999999988543 346789999999999999999999986544 5
Q ss_pred CcceeeeecCCCchhHHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~-~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
.+|+||||+++++|.+++..... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 78999999999999999976432 37899999999999999999999999999999999999999999999999987544
Q ss_pred cCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHh
Q 010078 442 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 501 (518)
Q Consensus 442 ~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~i 501 (518)
.. .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+
T Consensus 169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~ 227 (278)
T 1byg_A 169 ST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 227 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH
T ss_pred cc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 33 233467889999999999999999999999999999998 99999987765555443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=311.18 Aligned_cols=212 Identities=22% Similarity=0.322 Sum_probs=183.1
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEeecccCCCCc
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSL 364 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~~~ 364 (518)
.+..++|++++.||+|+||.||+|+. .++.||||+++..... ..+.+|+.+++.+ +|+|++++++++......
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 45567899999999999999999995 5788999998754322 3577899999999 699999999999988899
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCc-----EEEEeeCccee
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV-----VKVADFGVARV 439 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~-----vkL~DFGla~~ 439 (518)
|+||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9999999 99999999876667999999999999999999999999999999999999987765 99999999986
Q ss_pred cccCCc--------cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHhhhh
Q 010078 440 KAQSGV--------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL---TPLQAAVGVVQK 504 (518)
Q Consensus 440 ~~~~~~--------~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~---~~~q~~~~iv~~ 504 (518)
...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+. ...+....+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 654321 23457999999999999999999999999999999999999999874 445555554443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=322.10 Aligned_cols=216 Identities=22% Similarity=0.436 Sum_probs=189.9
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC--C----hHHHHHHHHHHHHHHhc-CCCcceEEeecccCCC
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI--N----SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPP 362 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~--~----~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~ 362 (518)
++|++.+.||+|+||.||+|++. ++.||||+++.... . ....+.+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 56999999999999999999984 78899999876532 1 12345688999999999 7999999999999989
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
..|+||||++|++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 99999999999999999976 56799999999999999999999999999999999999999999999999999987766
Q ss_pred CCccccCCCCCcccCchhcc------CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCch
Q 010078 443 SGVMTAETGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHS 508 (518)
Q Consensus 443 ~~~~~~~~gt~~y~APEvl~------~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp 508 (518)
........||+.|+|||++. ...++.++|||||||++|+|++|+.||...+..+....+.......
T Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 324 (365)
T 2y7j_A 253 GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF 324 (365)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 55566778999999999985 3468999999999999999999999999988887777766554443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=312.24 Aligned_cols=205 Identities=19% Similarity=0.388 Sum_probs=178.8
Q ss_pred CCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeecccC--CCCc
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTK--PPSL 364 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~--~~~~ 364 (518)
..++|+++++||+|+||.||+|.. .++.||||+++... ...+.+|+.++++++ ||||+++++++.. ....
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 347899999999999999999986 56789999997532 367889999999998 9999999999887 5678
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC-cEEEEeeCcceecccC
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQS 443 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~-~vkL~DFGla~~~~~~ 443 (518)
++||||+.+++|.+++.. +++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 109 ~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp EEEEECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred EEEEeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 999999999999998854 88999999999999999999999999999999999999776 8999999999877666
Q ss_pred CccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHhhh
Q 010078 444 GVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYE-YLTPLQAAVGVVQ 503 (518)
Q Consensus 444 ~~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~-~~~~~q~~~~iv~ 503 (518)
.......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+.+
T Consensus 185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~ 246 (330)
T 3nsz_A 185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 246 (330)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHH
T ss_pred CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHH
Confidence 66667789999999999977 679999999999999999999999994 4455555554444
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=309.53 Aligned_cols=212 Identities=25% Similarity=0.422 Sum_probs=188.1
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCccee
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV 367 (518)
.++|++++.||+|+||.||++... ++.||+|++..... .......+.+|+.++++++||||+++++++......++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 367999999999999999999985 57799999876533 345567889999999999999999999999999999999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-cc
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VM 446 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~ 446 (518)
|||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 94 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 172 (294)
T 2rku_A 94 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 172 (294)
T ss_dssp EECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcccc
Confidence 999999999999876 5679999999999999999999999999999999999999999999999999998654332 34
Q ss_pred ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+..
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 229 (294)
T 2rku_A 173 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK 229 (294)
T ss_dssp CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh
Confidence 456789999999999999999999999999999999999999999887776666544
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=315.45 Aligned_cols=198 Identities=26% Similarity=0.453 Sum_probs=168.8
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC-------
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------- 362 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~------- 362 (518)
++|++.+.||+|+||.||+|++. ++.||||+++... .....+.+.+|+.+|++++||||++++++|....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 46899999999999999999984 7889999997654 3344678999999999999999999999875433
Q ss_pred --------------------------------------------------CcceeeeecCCCchhHHHhhhc--CCCCHH
Q 010078 363 --------------------------------------------------SLCIVTEFMSGGSVYDYLHKLK--GVFKLP 390 (518)
Q Consensus 363 --------------------------------------------------~~~lV~Ey~~ggsL~~~l~~~~--~~l~~~ 390 (518)
.+|+||||++|++|.+++.... ...+..
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 2789999999999999997632 235566
Q ss_pred HHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-------------ccccCCCCCcccC
Q 010078 391 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-------------VMTAETGTYRWMA 457 (518)
Q Consensus 391 ~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-------------~~~~~~gt~~y~A 457 (518)
.++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ......||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 789999999999999999999999999999999999999999999998665432 2234579999999
Q ss_pred chhccCCCCChhhHHHHHHHHHHHHHcCCCCCC
Q 010078 458 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490 (518)
Q Consensus 458 PEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~ 490 (518)
||++.+..++.++|||||||++|+|++|..|+.
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 999999999999999999999999999987753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=321.74 Aligned_cols=211 Identities=24% Similarity=0.423 Sum_probs=177.3
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|+++++||+|+||.||+|+.. ++.||||+++.... ......+.+|+.+|++++||||+++++++.....+|+|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 57999999999999999999985 67899999875432 1112245679999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-cccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~ 448 (518)
|++ ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 159 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN 159 (324)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccccc
Confidence 996 69999998867779999999999999999999999999999999999999999999999999997654332 3345
Q ss_pred CCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 449 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 449 ~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
..||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.+.
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 216 (324)
T 3mtl_A 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRI 216 (324)
T ss_dssp ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 578999999999876 67899999999999999999999999999988877776653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=321.78 Aligned_cols=212 Identities=22% Similarity=0.407 Sum_probs=176.0
Q ss_pred CCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
.++|++.++||+|+||.||++.. .++.||||+++...........+.+|+.++++++||||+++++++.....+|+||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 46799999999999999999986 4678999999876555555677889999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc-----CCCcEEEEeeCcceecccC
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-----ENEVVKVADFGVARVKAQS 443 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid-----~~~~vkL~DFGla~~~~~~ 443 (518)
||++ ++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.....
T Consensus 113 e~~~-~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 113 EYAE-NDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp ECCS-EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred ecCC-CCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 9996 599999977 56799999999999999999999999999999999999994 4556999999999765432
Q ss_pred -CccccCCCCCcccCchhccCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 444 -GVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 444 -~~~~~~~gt~~y~APEvl~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+++.
T Consensus 191 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 253 (329)
T 3gbz_A 191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEV 253 (329)
T ss_dssp ---------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHH
Confidence 234456789999999999874 5899999999999999999999999999998888877654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=316.00 Aligned_cols=221 Identities=28% Similarity=0.495 Sum_probs=180.5
Q ss_pred CCCceeeCCCCeeeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeec
Q 010078 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357 (518)
Q Consensus 283 ~~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-----~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~ 357 (518)
....+.++.++|++++.||+|+||.||+|++.. ..||+|+++...........+.+|+.++++++||||++++++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 345678888999999999999999999998643 369999998776666667889999999999999999999999
Q ss_pred ccCCC-----CcceeeeecCCCchhHHHhh-----hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC
Q 010078 358 CTKPP-----SLCIVTEFMSGGSVYDYLHK-----LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427 (518)
Q Consensus 358 ~~~~~-----~~~lV~Ey~~ggsL~~~l~~-----~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~ 427 (518)
+.... ..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC
Confidence 87654 34999999999999999853 235689999999999999999999999999999999999999999
Q ss_pred cEEEEeeCcceecccCC---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 428 VVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 428 ~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
.+||+|||+++...... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+..
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 264 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc
Confidence 99999999997654332 2233457889999999999999999999999999999999 9999998877666655444
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=317.90 Aligned_cols=217 Identities=25% Similarity=0.390 Sum_probs=187.2
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCC
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~ 363 (518)
.+....++|++.+.||+|+||.||++++. ++.||||++..........+.+.+|+.++++++||||+++++++.....
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 98 (331)
T 4aaa_A 19 LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR 98 (331)
T ss_dssp CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE
Confidence 34455688999999999999999999985 6789999998776666667788999999999999999999999999999
Q ss_pred cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC
Q 010078 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~ 443 (518)
.|+||||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 99 ~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp EEEEEECCSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEEEecCCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999999888887654 567999999999999999999999999999999999999999999999999999765443
Q ss_pred -CccccCCCCCcccCchhccCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 444 -GVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 444 -~~~~~~~gt~~y~APEvl~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....++.
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 239 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMM 239 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 234456789999999999775 789999999999999999999999999998887777654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=320.85 Aligned_cols=215 Identities=21% Similarity=0.365 Sum_probs=180.4
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC--CcceEEeecccCCC
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGACTKPP 362 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~-~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~H--pnIv~l~g~~~~~~ 362 (518)
...+..+.|++.++||+|+||.||++... ++.||||+++...........+.+|+.+|++++| +||+++++++....
T Consensus 3 ~i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 3 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp CEESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred eeeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 34677789999999999999999999864 5679999998776677777889999999999986 99999999999999
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
.+|+|||+ .+++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus 83 ~~~lv~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 83 YIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEEEECC-CSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEEEEEeC-CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99999995 58899999987 56799999999999999999999999999999999999997 67899999999986543
Q ss_pred CC---ccccCCCCCcccCchhccC-----------CCCChhhHHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHhhh
Q 010078 443 SG---VMTAETGTYRWMAPEVIEH-----------KPYDHKADVFSFGIVLWELLTGKLPYEYL-TPLQAAVGVVQ 503 (518)
Q Consensus 443 ~~---~~~~~~gt~~y~APEvl~~-----------~~~s~ksDVwSlGviL~eLltG~~Pf~~~-~~~q~~~~iv~ 503 (518)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||... ........++.
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 235 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 235 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc
Confidence 32 2335579999999999864 67899999999999999999999999874 33444444443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=311.84 Aligned_cols=209 Identities=23% Similarity=0.419 Sum_probs=177.1
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
+.|.+.++||+|+||.||+++.. +..||+|++...... .....+.+|+.+|++++||||+++++++......|+|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 57999999999999999999874 678999998765432 224678899999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---cCCCcEEEEeeCcceecccC
Q 010078 370 FMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQS 443 (518)
Q Consensus 370 y~~ggsL~~~l~~~---~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILi---d~~~~vkL~DFGla~~~~~~ 443 (518)
|+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence 99999999998643 3679999999999999999999999999999999999999 45678999999999876655
Q ss_pred CccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 010078 444 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 444 ~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv 502 (518)
.......||+.|+|||++. ..++.++||||||+++|+|++|+.||.+.+..+....+.
T Consensus 181 ~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~ 238 (285)
T 3is5_A 181 EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT 238 (285)
T ss_dssp ------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhc
Confidence 5556678999999999986 468999999999999999999999999887766655543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=338.25 Aligned_cols=215 Identities=26% Similarity=0.471 Sum_probs=191.2
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCccee
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV 367 (518)
.++|++.++||+|+||.||+++.. ++.||||++...... ......+.+|+.+|++++||||+++++++.....+|+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367999999999999999999874 678999998755332 23356789999999999999999999999999999999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---cCCCcEEEEeeCcceecccCC
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILi---d~~~~vkL~DFGla~~~~~~~ 444 (518)
|||+.|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 105 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 183 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183 (484)
T ss_dssp ECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC
T ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc
Confidence 999999999999976 5679999999999999999999999999999999999999 567899999999998776665
Q ss_pred ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCc
Q 010078 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 445 ~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
......||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+..+....+.+....
T Consensus 184 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 245 (484)
T 3nyv_A 184 KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT 245 (484)
T ss_dssp SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC
Confidence 6666789999999999976 6999999999999999999999999999998888887665443
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=312.00 Aligned_cols=206 Identities=28% Similarity=0.491 Sum_probs=178.9
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEECC---------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecc
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~~---------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~ 358 (518)
++..++|++.+.||+|+||.||+|++.. ..||+|+++... ....+.+.+|+.++++++||||+++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 5677899999999999999999998643 459999987542 33457799999999999999999999999
Q ss_pred cCCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCc--------EE
Q 010078 359 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV--------VK 430 (518)
Q Consensus 359 ~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~--------vk 430 (518)
......|+||||++|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++. +|
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999999999886666999999999999999999999999999999999999998886 99
Q ss_pred EEeeCcceecccCCccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 010078 431 VADFGVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAA 498 (518)
Q Consensus 431 L~DFGla~~~~~~~~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~ 498 (518)
|+|||++...... ....+|+.|+|||++.+ ..++.++||||||+++|+|++ |..||.........
T Consensus 162 l~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~ 228 (289)
T 4fvq_A 162 LSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL 228 (289)
T ss_dssp ECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred eccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH
Confidence 9999998644322 23457889999999987 779999999999999999999 56777766664443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=322.61 Aligned_cols=216 Identities=27% Similarity=0.463 Sum_probs=181.6
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCC---CChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcce
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPER---INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~---~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~l 366 (518)
++|++++.||+|+||.||++.+. +..||+|+++... ........+.+|+.++++++||||+++++++......|+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 78999999999999999999874 5679999986532 133445789999999999999999999999999999999
Q ss_pred eeeecCCCchhHHHhhh---------------------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Q 010078 367 VTEFMSGGSVYDYLHKL---------------------------------------KGVFKLPSLLKVAIDVSKGMNYLH 407 (518)
Q Consensus 367 V~Ey~~ggsL~~~l~~~---------------------------------------~~~l~~~~i~~i~~qIa~aL~yLH 407 (518)
||||++|++|.+++... ...+++..++.++.||+.||.|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 99999999999998521 112356778899999999999999
Q ss_pred HCCceeccCCCCcEEEcCCC--cEEEEeeCcceecccCC-----ccccCCCCCcccCchhccC--CCCChhhHHHHHHHH
Q 010078 408 QNNIIHRDLKAANLLMDENE--VVKVADFGVARVKAQSG-----VMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIV 478 (518)
Q Consensus 408 s~gIiHrDLKp~NILid~~~--~vkL~DFGla~~~~~~~-----~~~~~~gt~~y~APEvl~~--~~~s~ksDVwSlGvi 478 (518)
++||+||||||+|||++.++ .+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||+
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 265 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence 99999999999999998776 89999999998653321 2345679999999999965 678999999999999
Q ss_pred HHHHHcCCCCCCCCCHHHHHHHhhhhcCc
Q 010078 479 LWELLTGKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 479 L~eLltG~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
+|+|++|+.||.+.+..+....++.....
T Consensus 266 l~el~~g~~pf~~~~~~~~~~~~~~~~~~ 294 (345)
T 3hko_A 266 LHLLLMGAVPFPGVNDADTISQVLNKKLC 294 (345)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred HHHHHHCCCCCCCCChHHHHHHHHhcccc
Confidence 99999999999999998888887766543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=348.53 Aligned_cols=221 Identities=27% Similarity=0.536 Sum_probs=185.7
Q ss_pred CceeeCCCCeeeee-eeeecCceEEEEEEEC----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeeccc
Q 010078 285 DVWEIDPKHLKFGS-KVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (518)
Q Consensus 285 ~~~ei~~~~~~i~~-~LG~G~fG~Vy~g~~~----~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~ 359 (518)
..|.+..+.+.+.+ +||+|+||.||+|.+. +..||||+++.... ....+.|.+|+.+|++++||||+++++++.
T Consensus 328 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 406 (613)
T 2ozo_A 328 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQ 406 (613)
T ss_dssp CCSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS-STTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEec
Confidence 35677778888877 8999999999999873 35699999986532 334578999999999999999999999997
Q ss_pred CCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
. +.+|+||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 407 ~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 407 A-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA 485 (613)
T ss_dssp S-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred c-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence 6 569999999999999999987667799999999999999999999999999999999999999999999999999986
Q ss_pred cccCCc----cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCch
Q 010078 440 KAQSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHS 508 (518)
Q Consensus 440 ~~~~~~----~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~rp 508 (518)
...... .....+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+.+..+....+. ++.++
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~ 558 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRM 558 (613)
T ss_dssp CC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-TTCCC
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCC
Confidence 543221 122345689999999999999999999999999999998 999999998877766644 44443
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=324.59 Aligned_cols=215 Identities=27% Similarity=0.443 Sum_probs=172.2
Q ss_pred CCceeeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~ 361 (518)
...|++. ++|++.+.||+|+||.||+|.+ .++.||||++..........+.+.+|+.+|+.++||||+++++++...
T Consensus 22 ~~~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 100 (367)
T 2fst_X 22 KTIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 100 (367)
T ss_dssp TEEEEEE-TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred CcccCCC-CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 3467776 7899999999999999999986 467899999987655666678899999999999999999999988654
Q ss_pred ------CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeC
Q 010078 362 ------PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435 (518)
Q Consensus 362 ------~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFG 435 (518)
..+|+||||+ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 101 ~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 101 RSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp SSGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--
T ss_pred CccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecc
Confidence 5679999999 8899999865 579999999999999999999999999999999999999999999999999
Q ss_pred cceecccCCccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 436 VARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 436 la~~~~~~~~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
+++.... ..+...||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+..+++.
T Consensus 178 ~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~ 245 (367)
T 2fst_X 178 LARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 245 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 9976543 2455689999999999977 67999999999999999999999999999988887776654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=346.07 Aligned_cols=205 Identities=24% Similarity=0.443 Sum_probs=182.5
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
+..++|++.+.||+|+||.||+++. +++.||||+++.... .......+.+|+.+|++++||||+++++++.....+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 4557899999999999999999998 478899999875321 1122456889999999999999999999999999999
Q ss_pred eeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 366 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
+||||++||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 9999999999999997643 349999999999999999999999999999999999999999999999999998776655
Q ss_pred ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCC
Q 010078 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 493 (518)
Q Consensus 445 ~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~ 493 (518)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+
T Consensus 341 ~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 5566789999999999999999999999999999999999999998753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=320.75 Aligned_cols=211 Identities=31% Similarity=0.602 Sum_probs=176.7
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEEC--Cc----eEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~----~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~ 361 (518)
.+..++|++.++||+|+||.||+|++. ++ +||+|.++... .....+.+.+|+.++++++||||++++++|...
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 456688999999999999999999874 33 35888776432 233457899999999999999999999999875
Q ss_pred CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
..++|+||+.+|+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 90 -~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp -SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred -CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 4789999999999999998877889999999999999999999999999999999999999999999999999998654
Q ss_pred cCCc---cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 010078 442 QSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVG 500 (518)
Q Consensus 442 ~~~~---~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~ 500 (518)
.... .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+....
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 231 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHH
Confidence 4322 223456789999999999999999999999999999999 9999998776554443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=313.03 Aligned_cols=213 Identities=24% Similarity=0.425 Sum_probs=183.7
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecc--cCCCCcce
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC--TKPPSLCI 366 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~--~~~~~~~l 366 (518)
.++|++.+.||+|+||.||++... ++.||+|+++.........+.+.+|+.++++++||||+++++++ .....+|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 367999999999999999999984 67899999987766666778899999999999999999999987 34567899
Q ss_pred eeeecCCCchhHHHhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCcEEEcCCCcEEEEeeCcce
Q 010078 367 VTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNN-----IIHRDLKAANLLMDENEVVKVADFGVAR 438 (518)
Q Consensus 367 V~Ey~~ggsL~~~l~~~~---~~l~~~~i~~i~~qIa~aL~yLHs~g-----IiHrDLKp~NILid~~~~vkL~DFGla~ 438 (518)
||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999997542 34899999999999999999999999 9999999999999999999999999987
Q ss_pred ecccCC-ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 439 VKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 439 ~~~~~~-~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+.+
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~ 230 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh
Confidence 654332 22345689999999999999999999999999999999999999999888766666444
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=307.69 Aligned_cols=201 Identities=22% Similarity=0.360 Sum_probs=176.1
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
++|++.+.||+|+||.||++.+. ++.||||+++...........+.+|+.++..+ +||||+++++++.....+|+||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999985 78899999987665566677899999999999 8999999999999999999999
Q ss_pred eecCCCchhHHHhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCC-------------------
Q 010078 369 EFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN------------------- 426 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~---~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~------------------- 426 (518)
||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 9999999999997642 668999999999999999999999999999999999999844
Q ss_pred CcEEEEeeCcceecccCCccccCCCCCcccCchhccCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCHH
Q 010078 427 EVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPL 495 (518)
Q Consensus 427 ~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APEvl~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~ 495 (518)
..+||+|||.+...... ....||+.|+|||++.+. .++.++|||||||++|+|++|..|+......
T Consensus 171 ~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~ 237 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW 237 (289)
T ss_dssp CCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH
T ss_pred eEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH
Confidence 47999999999866543 234689999999999776 6678999999999999999999877655443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=314.33 Aligned_cols=202 Identities=32% Similarity=0.563 Sum_probs=175.4
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEE------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~------~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~ 361 (518)
.+....|++.++||+|+||.||++++ .++.||+|+++.... ......+.+|+.++++++||||+++++++...
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 45667899999999999999999985 467899999986532 22346789999999999999999999998776
Q ss_pred --CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 362 --PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 362 --~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
..+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence 668999999999999999987777899999999999999999999999999999999999999999999999999987
Q ss_pred cccCC----ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCC
Q 010078 440 KAQSG----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490 (518)
Q Consensus 440 ~~~~~----~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~ 490 (518)
..... ......+|..|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 65443 2234467888999999999999999999999999999999998764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=308.59 Aligned_cols=214 Identities=25% Similarity=0.405 Sum_probs=188.9
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC---C----hHHHHHHHHHHHHHHhcC-CCcceEEeecccC
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI---N----SDMQKEFAQEVFIMRKVR-HKNVVQFIGACTK 360 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~---~----~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~ 360 (518)
.++|++.+.||+|+||.||+++.. ++.||||+++.... . ......+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 478999999999999999999984 57899999976532 1 233467889999999996 9999999999999
Q ss_pred CCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceec
Q 010078 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~ 440 (518)
....|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 9999999999999999999976 567999999999999999999999999999999999999999999999999999877
Q ss_pred ccCCccccCCCCCcccCchhcc------CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 441 AQSGVMTAETGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 441 ~~~~~~~~~~gt~~y~APEvl~------~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
..........||+.|+|||++. ...++.++||||||+++|+|++|+.||...+..+....+....
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 245 (298)
T 1phk_A 175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 245 (298)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred CCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCC
Confidence 6655556678999999999984 5678999999999999999999999999988877776665543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=315.58 Aligned_cols=197 Identities=37% Similarity=0.711 Sum_probs=169.1
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCccee
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV 367 (518)
.++.++|++.+.||+|+||.||++++.++.||||+++.. ...+.+.+|+.++++++||||+++++++.+ ..|+|
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv 77 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLV 77 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEE
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEE
Confidence 466788999999999999999999999999999998743 335779999999999999999999999874 48999
Q ss_pred eeecCCCchhHHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCCCcEEEcCCCc-EEEEeeCcceecc
Q 010078 368 TEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLHQ---NNIIHRDLKAANLLMDENEV-VKVADFGVARVKA 441 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~--~l~~~~i~~i~~qIa~aL~yLHs---~gIiHrDLKp~NILid~~~~-vkL~DFGla~~~~ 441 (518)
|||++|++|.+++..... .++...++.++.||++||.|||+ +||+||||||+|||++.++. +||+|||++....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 999999999999976432 47889999999999999999999 89999999999999998886 7999999997543
Q ss_pred cCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCC
Q 010078 442 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL 492 (518)
Q Consensus 442 ~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (518)
.. .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 158 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 158 TH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred cc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 32 33456899999999999999999999999999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=320.14 Aligned_cols=212 Identities=26% Similarity=0.416 Sum_probs=183.5
Q ss_pred CCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC-------
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------- 361 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~------- 361 (518)
.++|+++++||+|+||.||+|+. .++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36899999999999999999997 467899999876655444456788999999999999999999988663
Q ss_pred -CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceec
Q 010078 362 -PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 362 -~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~ 440 (518)
..+|+||||++ ++|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 45799999996 5888888776678999999999999999999999999999999999999999999999999999865
Q ss_pred cc-----CCccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 441 AQ-----SGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 441 ~~-----~~~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
.. ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.+
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 243 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 42 223345678999999999876 5689999999999999999999999999988777666544
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=317.48 Aligned_cols=205 Identities=30% Similarity=0.533 Sum_probs=179.4
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcce
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~-~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~l 366 (518)
+...++|++.+.||+|+||.||+|++. ++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..|+
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 334578999999999999999999974 6789999987653 3345779999999999999999999999999999999
Q ss_pred eeeecCCCchhHHHhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC
Q 010078 367 VTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (518)
Q Consensus 367 V~Ey~~ggsL~~~l~~~~---~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~ 443 (518)
||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999999996532 35899999999999999999999999999999999999999999999999999764332
Q ss_pred C---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 444 G---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 444 ~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....+
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~ 246 (321)
T 2qkw_B 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246 (321)
T ss_dssp SCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS
T ss_pred cccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc
Confidence 1 22344689999999999988999999999999999999999999976443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=325.57 Aligned_cols=198 Identities=25% Similarity=0.368 Sum_probs=170.5
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC--
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-- 361 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~-- 361 (518)
.|.+. ++|++++.||+|+||.||+|.+. ++.||||+++.........+.+.+|+.+|++++||||+++++++...
T Consensus 21 ~~~i~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 99 (432)
T 3n9x_A 21 NVHVP-DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL 99 (432)
T ss_dssp GCCCC-TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred cceec-CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC
Confidence 44554 78999999999999999999874 57799999987655666678899999999999999999999998766
Q ss_pred ---CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcce
Q 010078 362 ---PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (518)
Q Consensus 362 ---~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~ 438 (518)
..+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 100 ~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 100 LKFDELYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred CcCCeEEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 56899999995 699999976 5679999999999999999999999999999999999999999999999999998
Q ss_pred ecccCC-----------------------ccccCCCCCcccCchhc-cCCCCChhhHHHHHHHHHHHHHcCC
Q 010078 439 VKAQSG-----------------------VMTAETGTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 486 (518)
Q Consensus 439 ~~~~~~-----------------------~~~~~~gt~~y~APEvl-~~~~~s~ksDVwSlGviL~eLltG~ 486 (518)
...... ..+..+||+.|+|||++ ....|+.++||||||||+|||++|.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~ 249 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTC
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcc
Confidence 654332 23567899999999986 5667999999999999999999843
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=322.64 Aligned_cols=215 Identities=22% Similarity=0.340 Sum_probs=181.4
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC----
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK---- 360 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~---- 360 (518)
++...++|+++++||+|+||.||+|+. +++.||||++..... ...+|+.+|+.++||||+++++++..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 345668899999999999999999987 568899999875432 12369999999999999999998733
Q ss_pred ----------------------------------CCCcceeeeecCCCchhHHHhh---hcCCCCHHHHHHHHHHHHHHH
Q 010078 361 ----------------------------------PPSLCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGM 403 (518)
Q Consensus 361 ----------------------------------~~~~~lV~Ey~~ggsL~~~l~~---~~~~l~~~~i~~i~~qIa~aL 403 (518)
...+++||||++ ++|.+.+.. ....+++..++.++.||+.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 334789999997 588777753 256799999999999999999
Q ss_pred HHHHHCCceeccCCCCcEEEc-CCCcEEEEeeCcceecccCCccccCCCCCcccCchhccCC-CCChhhHHHHHHHHHHH
Q 010078 404 NYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWE 481 (518)
Q Consensus 404 ~yLHs~gIiHrDLKp~NILid-~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APEvl~~~-~~s~ksDVwSlGviL~e 481 (518)
.|||++||+||||||+|||++ .++.+||+|||+++............+|+.|+|||++.+. .|+.++|||||||++|+
T Consensus 155 ~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 155 GFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp HHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred HHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence 999999999999999999998 6889999999999877666666677899999999998775 49999999999999999
Q ss_pred HHcCCCCCCCCCHHHHHHHhhhhcCch
Q 010078 482 LLTGKLPYEYLTPLQAAVGVVQKVHHS 508 (518)
Q Consensus 482 LltG~~Pf~~~~~~q~~~~iv~~~~rp 508 (518)
|++|+.||.+.+..+.+..+++....|
T Consensus 235 ll~g~~pf~~~~~~~~~~~i~~~~g~p 261 (383)
T 3eb0_A 235 LILGKPLFSGETSIDQLVRIIQIMGTP 261 (383)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 999999999999999888887654443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=319.07 Aligned_cols=213 Identities=25% Similarity=0.377 Sum_probs=180.7
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCh---HHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS---DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~---~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
.++|++++.||+|+||.||+|++. ++.||||+++...... .....+.+|+.++++++||||+++++++......+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 467999999999999999999874 6789999987543221 12346889999999999999999999999999999
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-C
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-G 444 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~-~ 444 (518)
+||||+++ +|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 167 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence 99999965 899999876667999999999999999999999999999999999999999999999999999865433 2
Q ss_pred ccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 445 VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 445 ~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+++.
T Consensus 168 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~ 228 (346)
T 1ua2_A 168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET 228 (346)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Confidence 3455689999999999965 45899999999999999999999999999998888887764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=309.24 Aligned_cols=214 Identities=26% Similarity=0.537 Sum_probs=177.4
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCc
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~ 364 (518)
.+..++|++++.||+|+||.||+|++. ++.||||+++.... .......+.+|+.+++.++||||+++++++......
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 344578999999999999999999975 78899999875321 112245788999999999999999999999999999
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
|+||||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 87 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 999999999999999976 4678999999999999999999999999999999999999999999999999998766554
Q ss_pred ccccCCCCCcccCchhccCCCC-ChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 010078 445 VMTAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 445 ~~~~~~gt~~y~APEvl~~~~~-s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv 502 (518)
......+|+.|+|||++.+..+ +.++||||||+++|+|++|+.||...+..+....+.
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 224 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR 224 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh
Confidence 4556678999999999988776 689999999999999999999999887766655543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=309.79 Aligned_cols=214 Identities=25% Similarity=0.466 Sum_probs=186.7
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCc
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~ 364 (518)
.+..++|++.+.||+|+||.||+++.. ++.||||++...... ......+.+|+.++++++||||+++++++.....+
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 345578999999999999999999985 567999998643211 11245788999999999999999999999999999
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
|+||||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 90 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp EEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 999999999999999987 467999999999999999999999999999999999999999999999999998755432
Q ss_pred ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 445 ~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+..
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 226 (284)
T 2vgo_A 168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN 226 (284)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc
Confidence 23456789999999999999999999999999999999999999998887776666554
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=325.03 Aligned_cols=199 Identities=23% Similarity=0.446 Sum_probs=178.2
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChH------HHHHHHHHHHHHHhcCCCcceEEeecccCCCC
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSD------MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~ 363 (518)
++|++.++||+|+||.||+|.+ .++.||||+++....... ....+.+|+.+|++++||||+++++++.....
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 5799999999999999999986 467899999986543221 23457789999999999999999999999999
Q ss_pred cceeeeecCCC-chhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 364 LCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 364 ~~lV~Ey~~gg-sL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
+++||||+.+| +|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 182 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence 99999999766 99999976 56799999999999999999999999999999999999999999999999999987766
Q ss_pred CCccccCCCCCcccCchhccCCCC-ChhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 443 SGVMTAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 443 ~~~~~~~~gt~~y~APEvl~~~~~-s~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..
T Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 183 GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 666666789999999999988887 8899999999999999999999975
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=310.01 Aligned_cols=213 Identities=27% Similarity=0.473 Sum_probs=182.0
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
...++|++++.||+|+||.||++.+. ++.||+|++...... ......+.+|+.++++++||||+++++++......+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 34468999999999999999999885 456999998643211 122456889999999999999999999999999999
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 445 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~ 445 (518)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... .
T Consensus 86 lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-~ 163 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-R 163 (279)
T ss_dssp EEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-c
Confidence 99999999999999977 467999999999999999999999999999999999999999999999999988644332 3
Q ss_pred cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 446 ~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
.....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+..
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 221 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 221 (279)
T ss_dssp ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh
Confidence 3455789999999999999999999999999999999999999999888776665443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=306.94 Aligned_cols=215 Identities=30% Similarity=0.540 Sum_probs=183.5
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC----C
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK----P 361 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~----~ 361 (518)
..+...|++.++||+|+||.||+|.+. +..||+|+++.........+.+.+|+.++++++||||+++++++.. .
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence 344567899999999999999999885 4679999998776677777889999999999999999999998754 3
Q ss_pred CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEc-CCCcEEEEeeCcce
Q 010078 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMD-ENEVVKVADFGVAR 438 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~g--IiHrDLKp~NILid-~~~~vkL~DFGla~ 438 (518)
..+|+||||+++++|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred ceEEEEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 458999999999999999976 467899999999999999999999999 99999999999998 78999999999997
Q ss_pred ecccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 439 VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
..... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||............+..+
T Consensus 181 ~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 245 (290)
T 1t4h_A 181 LKRAS-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG 245 (290)
T ss_dssp GCCTT-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT
T ss_pred ccccc-ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhcc
Confidence 54433 3445679999999998875 59999999999999999999999998855544444434333
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=317.20 Aligned_cols=190 Identities=24% Similarity=0.497 Sum_probs=151.6
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeecccCCCCcceeeeecCCC
Q 010078 298 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSGG 374 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~~~~lV~Ey~~gg 374 (518)
++||+|+||.||++.+. ++.||||++... ....+.+|+.+++.+. ||||+++++++......|+||||++|+
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 68999999999999985 678999998743 2456788999999998 999999999999999999999999999
Q ss_pred chhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC---cEEEEeeCcceecccCC-ccccCC
Q 010078 375 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VVKVADFGVARVKAQSG-VMTAET 450 (518)
Q Consensus 375 sL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~---~vkL~DFGla~~~~~~~-~~~~~~ 450 (518)
+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...... ......
T Consensus 92 ~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 170 (325)
T 3kn6_A 92 ELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC 170 (325)
T ss_dssp BHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccC
Confidence 99999987 57799999999999999999999999999999999999998765 89999999998654432 345567
Q ss_pred CCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCC
Q 010078 451 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 493 (518)
Q Consensus 451 gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~ 493 (518)
||+.|+|||++.+..|+.++|||||||++|+|++|+.||...+
T Consensus 171 ~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp -------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred CCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 8999999999999999999999999999999999999998643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=327.74 Aligned_cols=195 Identities=25% Similarity=0.428 Sum_probs=161.9
Q ss_pred CCeeee-eeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHH-hcCCCcceEEeecccC----CCC
Q 010078 292 KHLKFG-SKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMR-KVRHKNVVQFIGACTK----PPS 363 (518)
Q Consensus 292 ~~~~i~-~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~-~L~HpnIv~l~g~~~~----~~~ 363 (518)
++|.+. +.||+|+||.||++.+. ++.||||+++.. ..+.+|+.++. ..+||||+++++++.. ...
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 456665 78999999999999875 678999998742 35677888874 4579999999998754 566
Q ss_pred cceeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC---CCcEEEEeeCccee
Q 010078 364 LCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARV 439 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~---~~~vkL~DFGla~~ 439 (518)
+|+||||++||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 899999999999999997643 35999999999999999999999999999999999999997 78999999999987
Q ss_pred cccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCC
Q 010078 440 KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 493 (518)
Q Consensus 440 ~~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~ 493 (518)
..........+||+.|+|||++.+..|+.++||||||||+|+|++|+.||....
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 267 (400)
T 1nxk_A 214 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_dssp CC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred cCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 666555667789999999999999999999999999999999999999997654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=311.55 Aligned_cols=196 Identities=31% Similarity=0.606 Sum_probs=168.6
Q ss_pred CCCCeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHh--cCCCcceEEeecccC----CCC
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK--VRHKNVVQFIGACTK----PPS 363 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~--L~HpnIv~l~g~~~~----~~~ 363 (518)
-.++|++.++||+|+||.||+|++.++.||||++... ....+..|.+++.. ++||||+++++++.. ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 4478999999999999999999999999999998743 23456667777776 789999999998543 345
Q ss_pred cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCcEEEcCCCcEEEEeeC
Q 010078 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH--------QNNIIHRDLKAANLLMDENEVVKVADFG 435 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLH--------s~gIiHrDLKp~NILid~~~~vkL~DFG 435 (518)
+|+||||+++++|.++++. ..+++..++.++.||+.||.||| ++||+||||||+|||++.++.+||+|||
T Consensus 81 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp EEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred eEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCC
Confidence 8999999999999999954 57899999999999999999999 9999999999999999999999999999
Q ss_pred cceecccCCc-----cccCCCCCcccCchhccCC------CCChhhHHHHHHHHHHHHHcC----------CCCCCCC
Q 010078 436 VARVKAQSGV-----MTAETGTYRWMAPEVIEHK------PYDHKADVFSFGIVLWELLTG----------KLPYEYL 492 (518)
Q Consensus 436 la~~~~~~~~-----~~~~~gt~~y~APEvl~~~------~~s~ksDVwSlGviL~eLltG----------~~Pf~~~ 492 (518)
+++....... .....||+.|+|||++.+. .++.++|||||||++|||++| +.||...
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 9976554332 2234799999999999876 456799999999999999999 8899653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=312.95 Aligned_cols=220 Identities=34% Similarity=0.621 Sum_probs=180.7
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEECC---c--eEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccC
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS---Q--DVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~---~--~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~ 360 (518)
..+..++|++.++||+|+||.||+|++.. + .||||+++.... .....+.+.+|+.++++++||||+++++++..
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 46677899999999999999999998632 2 589999876543 33456789999999999999999999999887
Q ss_pred CCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceec
Q 010078 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~ 440 (518)
.. .++||||+++++|.+++....+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 54 89999999999999999886678999999999999999999999999999999999999999999999999999866
Q ss_pred ccCCc----cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCc
Q 010078 441 AQSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 441 ~~~~~----~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
..... .....+|..|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+.....+
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~ 243 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER 243 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCC
Confidence 54332 223457788999999999899999999999999999999 99999999988887776654433
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=312.55 Aligned_cols=208 Identities=26% Similarity=0.449 Sum_probs=159.4
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
++|++.+.||+|+||.||+|+. .++.||||++..... .......+.+|+.++++++||||+++++++......|+||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5799999999999999999997 578899999864321 1122467889999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-ccc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT 447 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~ 447 (518)
||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 170 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY 170 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-------
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcce
Confidence 9999999999998766789999999999999999999999999999999999999999999999999998654322 233
Q ss_pred cCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 010078 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV 499 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~ 499 (518)
...||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+...
T Consensus 171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 222 (278)
T 3cok_A 171 TLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN 222 (278)
T ss_dssp ---------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----
T ss_pred eccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH
Confidence 4578999999999999999999999999999999999999998765443333
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=311.09 Aligned_cols=209 Identities=28% Similarity=0.528 Sum_probs=182.9
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|++.+.||+|+||.||+++.. ++.||+|+++.... .....+.+|+.++++++||||+++++++.....+|+|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 57899999999999999999974 78899999985432 223568899999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---cCCCcEEEEeeCcceecccCCcc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVM 446 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILi---d~~~~vkL~DFGla~~~~~~~~~ 446 (518)
|++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.++|+|||+++.... ...
T Consensus 87 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-~~~ 164 (304)
T 2jam_A 87 LVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-GIM 164 (304)
T ss_dssp CCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-BTT
T ss_pred cCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-Ccc
Confidence 9999999999976 5679999999999999999999999999999999999999 7788999999999875433 233
Q ss_pred ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+.+.
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 222 (304)
T 2jam_A 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG 222 (304)
T ss_dssp HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHC
T ss_pred ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC
Confidence 4456899999999999999999999999999999999999999998887776665544
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=323.96 Aligned_cols=216 Identities=20% Similarity=0.355 Sum_probs=181.9
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC--CCcceEEeecccCCC
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR--HKNVVQFIGACTKPP 362 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~-~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~--HpnIv~l~g~~~~~~ 362 (518)
...+....|++++.||+|+||.||++... ++.||||+++...........+.+|+.+|++++ ||||+++++++....
T Consensus 50 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 50 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp CEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred cccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 44566678999999999999999999864 677999999877666677788999999999997 599999999999989
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
.+|+|||+ .+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus 130 ~~~lv~E~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 130 YIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EEEEEEEC-CSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred EEEEEEec-CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99999995 58899999987 56789999999999999999999999999999999999996 58899999999986543
Q ss_pred CC---ccccCCCCCcccCchhccC-----------CCCChhhHHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHhhhh
Q 010078 443 SG---VMTAETGTYRWMAPEVIEH-----------KPYDHKADVFSFGIVLWELLTGKLPYEYLT-PLQAAVGVVQK 504 (518)
Q Consensus 443 ~~---~~~~~~gt~~y~APEvl~~-----------~~~s~ksDVwSlGviL~eLltG~~Pf~~~~-~~q~~~~iv~~ 504 (518)
.. ......||+.|+|||++.+ ..|+.++||||||||+|||++|+.||.... ....+..++..
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~ 283 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 283 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc
Confidence 32 2345679999999999865 468999999999999999999999998753 44455554443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=349.10 Aligned_cols=221 Identities=29% Similarity=0.538 Sum_probs=186.2
Q ss_pred CceeeCCCCeeeee-eeeecCceEEEEEEEC----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeeccc
Q 010078 285 DVWEIDPKHLKFGS-KVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (518)
Q Consensus 285 ~~~ei~~~~~~i~~-~LG~G~fG~Vy~g~~~----~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~ 359 (518)
..|.++...+.+.. +||+|+||.||+|.+. ++.||||+++.........+++.+|+.+|++++||||+++++++.
T Consensus 361 ~~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 440 (635)
T 4fl3_A 361 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE 440 (635)
T ss_dssp SSSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 35677777777654 8999999999999763 467999999876655666788999999999999999999999996
Q ss_pred CCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
. ..+++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 441 ~-~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 518 (635)
T 4fl3_A 441 A-ESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 518 (635)
T ss_dssp S-SSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHH
T ss_pred c-CCEEEEEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccc
Confidence 5 468999999999999999976 56799999999999999999999999999999999999999999999999999976
Q ss_pred cccCC----ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCch
Q 010078 440 KAQSG----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHS 508 (518)
Q Consensus 440 ~~~~~----~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~rp 508 (518)
..... ......+|+.|+|||++.+..|+.++|||||||++|||++ |+.||.+.+..+....+. ++.++
T Consensus 519 ~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~ 591 (635)
T 4fl3_A 519 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERM 591 (635)
T ss_dssp TTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCC
T ss_pred cccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCC
Confidence 54332 2233456788999999999999999999999999999998 999999998877666644 44443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=309.78 Aligned_cols=211 Identities=33% Similarity=0.498 Sum_probs=181.1
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
....+.|++.+.||+|+||.||+|.+. ++.||||+++.... ...+.+|+.++++++||||+++++++.....+|
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 445678999999999999999999985 68899999976432 356889999999999999999999999888999
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG- 444 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~- 444 (518)
+||||+++++|.+++......+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.......
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 9999999999999998667789999999999999999999999999999999999999999999999999997654432
Q ss_pred ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 010078 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 445 ~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv 502 (518)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+.
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 238 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP 238 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh
Confidence 2345578999999999999999999999999999999999999999988876665543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=318.37 Aligned_cols=215 Identities=33% Similarity=0.580 Sum_probs=181.8
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEEC--Cce--EEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEeecccCCC
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQD--VAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPP 362 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~--vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~ 362 (518)
.++.++|++.+.||+|+||.||++++. +.. +++|+++... .......+.+|+.+++++ +||||+++++++....
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 356689999999999999999999864 443 5999887532 333456789999999999 8999999999999999
Q ss_pred CcceeeeecCCCchhHHHhhhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~ 427 (518)
.+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999997643 3689999999999999999999999999999999999999999
Q ss_pred cEEEEeeCcceecccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 428 VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 428 ~vkL~DFGla~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
.+||+|||+++............+++.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+....+.+
T Consensus 180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~ 256 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 256 (327)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc
Confidence 999999999975443333445567889999999999999999999999999999998 9999999988777666544
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=321.87 Aligned_cols=205 Identities=26% Similarity=0.497 Sum_probs=176.4
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
++|++.+.||+|+||.||++... ++.||||+++..... +.+|+.++.++ +||||+++++++.....+|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 57999999999999999999985 678999999765322 34688888888 6999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCC----CcEEEEeeCcceecccC-
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN----EVVKVADFGVARVKAQS- 443 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~----~~vkL~DFGla~~~~~~- 443 (518)
||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+..+ +.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 96 ELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp CCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred eCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 99999999999976 5679999999999999999999999999999999999998543 35999999999865443
Q ss_pred CccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHhhh
Q 010078 444 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY---LTPLQAAVGVVQ 503 (518)
Q Consensus 444 ~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~---~~~~q~~~~iv~ 503 (518)
......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.. .+..+....+..
T Consensus 175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~ 237 (342)
T 2qr7_A 175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS 237 (342)
T ss_dssp CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH
T ss_pred CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc
Confidence 344566899999999999988899999999999999999999999985 345555544433
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=317.13 Aligned_cols=221 Identities=23% Similarity=0.324 Sum_probs=181.0
Q ss_pred CCCCeeeeeeeeecCceEEEEEEE-CCceEEEEEecCCCC---------ChHHHHHHHHHHHHHHhcCCCcceEEeeccc
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERI---------NSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~-~~~~vAVKvlk~~~~---------~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~ 359 (518)
-.++|++++.||+|+||.||+|.. .++.||||++..... .....+.+.+|+.++++++||||+++++++.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 347899999999999999999976 467899999865322 2234578999999999999999999999883
Q ss_pred -----CCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEee
Q 010078 360 -----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 434 (518)
Q Consensus 360 -----~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DF 434 (518)
....+|+||||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence 3345799999996 6899998876678999999999999999999999999999999999999999999999999
Q ss_pred CcceecccCCccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCchhHH
Q 010078 435 GVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSFLE 511 (518)
Q Consensus 435 Gla~~~~~~~~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp~ip 511 (518)
|+++............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+++....+...
T Consensus 179 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 256 (362)
T 3pg1_A 179 NLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256 (362)
T ss_dssp TC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred CcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChH
Confidence 99986665555566789999999999877 779999999999999999999999999999988888887766555443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=331.00 Aligned_cols=215 Identities=24% Similarity=0.436 Sum_probs=170.5
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC------hHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN------SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~------~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
.++|.+.++||+|+||.||+|... ++.||||++...... ......+.+|+.+|++++||||+++++++.. .
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 368999999999999999999874 578999998754321 1223358899999999999999999999865 4
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC---cEEEEeeCccee
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VVKVADFGVARV 439 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~---~vkL~DFGla~~ 439 (518)
.+|+||||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred ceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 58999999999999999876 56799999999999999999999999999999999999997544 599999999987
Q ss_pred cccCCccccCCCCCcccCchhcc---CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCc
Q 010078 440 KAQSGVMTAETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 440 ~~~~~~~~~~~gt~~y~APEvl~---~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
...........||+.|+|||++. ...|+.++|||||||++|+|++|+.||............+..+..
T Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~ 362 (419)
T 3i6u_A 292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362 (419)
T ss_dssp CC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC
T ss_pred cCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC
Confidence 76655566778999999999985 367889999999999999999999999875443333333333433
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.90 Aligned_cols=203 Identities=30% Similarity=0.535 Sum_probs=179.3
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEE------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeeccc--
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT-- 359 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~------~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~-- 359 (518)
-++.++|++.++||+|+||.||++++ .++.||||+++.. .....+.+.+|+.++++++||||+++++++.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 36678999999999999999999985 4577999999864 4555677999999999999999999999875
Q ss_pred CCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
....+|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence 44558999999999999999987667799999999999999999999999999999999999999999999999999986
Q ss_pred cccCC----ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCC
Q 010078 440 KAQSG----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL 492 (518)
Q Consensus 440 ~~~~~----~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (518)
..... ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 233 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP 233 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccc
Confidence 65433 223346788899999999999999999999999999999999998653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=315.29 Aligned_cols=210 Identities=27% Similarity=0.477 Sum_probs=162.9
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeecc---
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGAC--- 358 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~--- 358 (518)
..+++...+|++.++||+|+||.||++++ .++.||||++... .......+.+|+.+++++. ||||+++++++
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 56788889999999999999999999998 6788999988644 3445677899999999996 99999999988
Q ss_pred -----cCCCCcceeeeecCCCchhHHHhh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEcCCCcE
Q 010078 359 -----TKPPSLCIVTEFMSGGSVYDYLHK--LKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVV 429 (518)
Q Consensus 359 -----~~~~~~~lV~Ey~~ggsL~~~l~~--~~~~l~~~~i~~i~~qIa~aL~yLHs~g--IiHrDLKp~NILid~~~~v 429 (518)
.....+++||||+ +|+|.+++.. ..+.+++..++.++.||+.||.|||++| |+||||||+|||++.++.+
T Consensus 99 ~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TTTSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred ccccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence 3344579999999 4799999865 2456999999999999999999999999 9999999999999999999
Q ss_pred EEEeeCcceecccCCcc-------------ccCCCCCcccCchhc---cCCCCChhhHHHHHHHHHHHHHcCCCCCCCCC
Q 010078 430 KVADFGVARVKAQSGVM-------------TAETGTYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 493 (518)
Q Consensus 430 kL~DFGla~~~~~~~~~-------------~~~~gt~~y~APEvl---~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~ 493 (518)
||+|||+++........ ....||+.|+|||++ .+..++.++|||||||++|+|++|+.||....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 99999999765443211 134689999999998 57789999999999999999999999998765
Q ss_pred HHHH
Q 010078 494 PLQA 497 (518)
Q Consensus 494 ~~q~ 497 (518)
..+.
T Consensus 258 ~~~~ 261 (337)
T 3ll6_A 258 KLRI 261 (337)
T ss_dssp ----
T ss_pred HHHh
Confidence 5443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=308.66 Aligned_cols=211 Identities=32% Similarity=0.564 Sum_probs=178.1
Q ss_pred CCeeeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecc-cCCCCcc
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC-TKPPSLC 365 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~~-----~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~-~~~~~~~ 365 (518)
..|++.++||+|+||.||+|++.. ..+|+|+++.. ........+.+|+.++++++||||+++++++ ......|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 468899999999999999998643 24899988753 2445567899999999999999999999985 4556789
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG- 444 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~- 444 (518)
+||||+++++|.+++......++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 9999999999999998766778999999999999999999999999999999999999999999999999997554322
Q ss_pred ----ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 445 ----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 445 ----~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
......+|+.|+|||++.+..++.++||||||+++|+|++ |.+||...+..+....+.+
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~ 247 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHT
T ss_pred hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhc
Confidence 2234457789999999999999999999999999999999 7788887766555555443
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=328.15 Aligned_cols=214 Identities=25% Similarity=0.428 Sum_probs=181.7
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC--Cc
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP--SL 364 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~--~~ 364 (518)
+...+|++.++||+|+||.||+|.+. ++.||||+++..... .....+.+|+.+|++++||||+++++++.... ..
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 44578999999999999999999986 678999999854322 22466789999999999999999999987654 67
Q ss_pred ceeeeecCCCchhHHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE----cCCCcEEEEeeCcce
Q 010078 365 CIVTEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVAR 438 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~--~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILi----d~~~~vkL~DFGla~ 438 (518)
|+||||++|++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999999976432 38999999999999999999999999999999999999 777889999999998
Q ss_pred ecccCCccccCCCCCcccCchhccC--------CCCChhhHHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHhhh
Q 010078 439 VKAQSGVMTAETGTYRWMAPEVIEH--------KPYDHKADVFSFGIVLWELLTGKLPYEYL----TPLQAAVGVVQ 503 (518)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~APEvl~~--------~~~s~ksDVwSlGviL~eLltG~~Pf~~~----~~~q~~~~iv~ 503 (518)
............||+.|+|||++.+ ..++.++|||||||++|||++|+.||... ...+....++.
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp ECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred EccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 7766555566789999999999865 56788999999999999999999999743 23444555444
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=315.42 Aligned_cols=212 Identities=22% Similarity=0.419 Sum_probs=182.8
Q ss_pred CCeeee-eeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeecccCCCCccee
Q 010078 292 KHLKFG-SKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 292 ~~~~i~-~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~~~~lV 367 (518)
+.|.+. ++||+|+||.||++... ++.||+|+++...........+.+|+.+++.+. ||||+++++++.....+|+|
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 456666 88999999999999875 788999999876555555678999999999996 69999999999999999999
Q ss_pred eeecCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC---CCcEEEEeeCcceecccC
Q 010078 368 TEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVKAQS 443 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~---~~~vkL~DFGla~~~~~~ 443 (518)
|||++|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.....
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 9999999999998543 467999999999999999999999999999999999999987 789999999999877665
Q ss_pred CccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 444 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 444 ~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+.+
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 247 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ 247 (327)
T ss_dssp ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHh
Confidence 555667899999999999999999999999999999999999999999888777766554
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=325.88 Aligned_cols=206 Identities=27% Similarity=0.381 Sum_probs=175.6
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC------CCC
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK------PPS 363 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~------~~~ 363 (518)
..|++.+.||+|+||.||+|++. ++.||||++..... .+.+|+.+|++++||||+++++++.. ...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 46999999999999999999984 68899999875421 23469999999999999999998732 223
Q ss_pred cceeeeecCCCchhHHHhh---hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCC-CcEEEEeeCccee
Q 010078 364 LCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARV 439 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~---~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~-~~vkL~DFGla~~ 439 (518)
+++||||+++ +|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 6799999965 67666543 35679999999999999999999999999999999999999965 5789999999987
Q ss_pred cccCCccccCCCCCcccCchhccCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 440 KAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 440 ~~~~~~~~~~~gt~~y~APEvl~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
...........||+.|+|||++.+. .|+.++||||||||+|||++|+.||.+.+..+.+..+++.
T Consensus 207 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~ 272 (420)
T 1j1b_A 207 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 272 (420)
T ss_dssp CCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred cccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 6655555667899999999999764 7999999999999999999999999999988888877764
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=328.02 Aligned_cols=203 Identities=23% Similarity=0.420 Sum_probs=174.3
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEE-----CCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhc-CCCcceEEeeccc
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACT 359 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~-----~~~~vAVKvlk~~~~--~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~ 359 (518)
.+..++|++.++||+|+||.||+++. .++.||||+++.... .......+.+|+.+|+++ +||||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 45567899999999999999999987 568899999875321 112234567799999999 5999999999999
Q ss_pred CCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
....+|+||||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eCceEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 98899999999999999999986 46799999999999999999999999999999999999999999999999999986
Q ss_pred cccCC--ccccCCCCCcccCchhccC--CCCChhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 440 KAQSG--VMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 440 ~~~~~--~~~~~~gt~~y~APEvl~~--~~~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 264 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 264 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSC
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCcc
Confidence 54322 2334579999999999985 4578999999999999999999999974
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=321.78 Aligned_cols=218 Identities=32% Similarity=0.631 Sum_probs=186.6
Q ss_pred CCceeeCCCCeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCC
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~ 363 (518)
...|++..++|++++.||+|+||.||+|++.+ .+|+|+++.........+.+.+|+.++++++||||+++++++.....
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 35789999999999999999999999999865 59999998655444444567889999999999999999999999999
Q ss_pred cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc-
Q 010078 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ- 442 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~- 442 (518)
+++||||++|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 9999999999999999987666799999999999999999999999999999999999998 67999999999865422
Q ss_pred -----CCccccCCCCCcccCchhccC---------CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 443 -----SGVMTAETGTYRWMAPEVIEH---------KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 443 -----~~~~~~~~gt~~y~APEvl~~---------~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+..+....+..
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 257 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT 257 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHT
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc
Confidence 122334568999999999864 4589999999999999999999999999888777666443
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=307.28 Aligned_cols=209 Identities=34% Similarity=0.576 Sum_probs=185.6
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
.+.|++.++||+|+||.||+|+.. ++.||||+++..... ...+.+.+|+.++++++||||+++++++.....+|+||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 356999999999999999999874 678999999765432 33577999999999999999999999999888999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-ccc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT 447 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~ 447 (518)
||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus 100 e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 177 (303)
T 3a7i_A 100 EYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 177 (303)
T ss_dssp ECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBC
T ss_pred EeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccC
Confidence 99999999999964 679999999999999999999999999999999999999999999999999997655433 234
Q ss_pred cCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 010078 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv 502 (518)
...||+.|+|||++.+..++.++||||||+++|+|++|+.||....+.+....+.
T Consensus 178 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 232 (303)
T 3a7i_A 178 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP 232 (303)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred ccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh
Confidence 5678999999999999999999999999999999999999999988877665543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=310.72 Aligned_cols=212 Identities=30% Similarity=0.520 Sum_probs=181.0
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
.+.|++.+.||+|+||.||+|++. ++.||+|++.... ......+.+|+.++++++||||+++++++.....+|+||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 367999999999999999999985 6789999987543 223567899999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-Cccc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMT 447 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~-~~~~ 447 (518)
||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ....
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 175 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD 175 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC--
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccc
Confidence 999999999999876778999999999999999999999999999999999999999999999999987532211 1223
Q ss_pred cCCCCCcccCchhc-----cCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 448 AETGTYRWMAPEVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 448 ~~~gt~~y~APEvl-----~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
...||+.|+|||++ .+..++.++||||||+++|+|++|+.||...+..+....+...
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (302)
T 2j7t_A 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS 237 (302)
T ss_dssp ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc
Confidence 45789999999998 4678999999999999999999999999999888777765543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=315.53 Aligned_cols=201 Identities=26% Similarity=0.474 Sum_probs=171.3
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC------hHHHHHHHHHHHHHHhcCCCcceEEeecccCCCC
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN------SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~------~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~ 363 (518)
++|++.+.||+|+||.||+|++. ++.||||+++..... ......+.+|+.+|++++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 57999999999999999999874 578999998754321 122345889999999999999999999987654
Q ss_pred cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCc---EEEEeeCcceec
Q 010078 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV---VKVADFGVARVK 440 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~---vkL~DFGla~~~ 440 (518)
+|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 89 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 8999999999999999976 567999999999999999999999999999999999999987664 999999999876
Q ss_pred ccCCccccCCCCCcccCchhcc---CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 441 AQSGVMTAETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 441 ~~~~~~~~~~gt~~y~APEvl~---~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
..........||+.|+|||++. ...++.++|||||||++|+|++|+.||.....
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (322)
T 2ycf_A 168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224 (322)
T ss_dssp CCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred ccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence 6554445567999999999973 56789999999999999999999999976544
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=332.18 Aligned_cols=204 Identities=15% Similarity=0.218 Sum_probs=164.9
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CChHHHHHHHHHH---HHHHhcCCCcceEEee-----
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER-INSDMQKEFAQEV---FIMRKVRHKNVVQFIG----- 356 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~-~~~~~~~~~~~Ei---~iL~~L~HpnIv~l~g----- 356 (518)
....++|++.+.||+|+||.||+|++ .++.||||+++... ......+.+.+|+ .+|++++||||+++++
T Consensus 69 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 69 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148 (377)
T ss_dssp SCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred CCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence 34457899999999999999999985 47899999987542 2344567899999 5555567999999984
Q ss_pred --cccCCC-----------------CcceeeeecCCCchhHHHhhhcCCCCH-------HHHHHHHHHHHHHHHHHHHCC
Q 010078 357 --ACTKPP-----------------SLCIVTEFMSGGSVYDYLHKLKGVFKL-------PSLLKVAIDVSKGMNYLHQNN 410 (518)
Q Consensus 357 --~~~~~~-----------------~~~lV~Ey~~ggsL~~~l~~~~~~l~~-------~~i~~i~~qIa~aL~yLHs~g 410 (518)
++...+ ..|+||||+ +|+|.+++... +.+++ ..++.++.||+.||.|||++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 226 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL-LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 226 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH-HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc-cccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 433332 378999999 68999999864 23444 778889999999999999999
Q ss_pred ceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccccCCCCCcccCchhccCC-----------CCChhhHHHHHHHHH
Q 010078 411 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-----------PYDHKADVFSFGIVL 479 (518)
Q Consensus 411 IiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APEvl~~~-----------~~s~ksDVwSlGviL 479 (518)
|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .|+.++|||||||++
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 99999999999999999999999999985432 3445577 999999999887 899999999999999
Q ss_pred HHHHcCCCCCCCCCHHH
Q 010078 480 WELLTGKLPYEYLTPLQ 496 (518)
Q Consensus 480 ~eLltG~~Pf~~~~~~q 496 (518)
|||++|+.||...+..+
T Consensus 304 ~elltg~~Pf~~~~~~~ 320 (377)
T 3byv_A 304 YWIWCADLPITKDAALG 320 (377)
T ss_dssp HHHHHSSCCC------C
T ss_pred HHHHHCCCCCccccccc
Confidence 99999999998765433
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=316.75 Aligned_cols=216 Identities=28% Similarity=0.455 Sum_probs=186.7
Q ss_pred CCCceeeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC
Q 010078 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (518)
Q Consensus 283 ~~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~ 360 (518)
....|++. ++|.+.+.||+|+||.||+|.+. ++.||||+++...........+.+|+.+++.++||||+++++++..
T Consensus 34 ~~~~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 112 (371)
T 4exu_A 34 NKTAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTP 112 (371)
T ss_dssp TTEEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred ccceeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheec
Confidence 34567776 78999999999999999999874 6789999998776666667889999999999999999999999987
Q ss_pred CCCc------ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEee
Q 010078 361 PPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 434 (518)
Q Consensus 361 ~~~~------~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DF 434 (518)
.... |+||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 113 ~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Df 188 (371)
T 4exu_A 113 ASSLRNFYDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDF 188 (371)
T ss_dssp CSSSTTCCCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECST
T ss_pred cCCcccceeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEec
Confidence 7655 99999995 68888773 45999999999999999999999999999999999999999999999999
Q ss_pred CcceecccCCccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 435 GVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 435 Gla~~~~~~~~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
|+++.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+++..
T Consensus 189 g~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 258 (371)
T 4exu_A 189 GLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 258 (371)
T ss_dssp TCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred Cccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99975543 2445678999999999977 789999999999999999999999999999988888876543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=312.51 Aligned_cols=205 Identities=21% Similarity=0.358 Sum_probs=171.5
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCccee
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV 367 (518)
.++|++.+.||+|+||.||+++.. ++.||||+++.... .......+.+|+.++++++||||+++++++.....+|+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999874 67899999876533 344567899999999999999999999999998999999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC--c
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--V 445 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~--~ 445 (518)
|||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 113 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 191 (309)
T 2h34_A 113 MRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ 191 (309)
T ss_dssp EECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence 999999999999986 4679999999999999999999999999999999999999999999999999987654432 2
Q ss_pred cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 010078 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 496 (518)
Q Consensus 446 ~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q 496 (518)
.....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+...
T Consensus 192 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 242 (309)
T 2h34_A 192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV 242 (309)
T ss_dssp -----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH
T ss_pred ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH
Confidence 334578999999999999999999999999999999999999999876543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=322.16 Aligned_cols=203 Identities=23% Similarity=0.362 Sum_probs=168.2
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCChH---------HHHHHHHHHHHHHhcCCCcce
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSD---------MQKEFAQEVFIMRKVRHKNVV 352 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~~-----~~~vAVKvlk~~~~~~~---------~~~~~~~Ei~iL~~L~HpnIv 352 (518)
..+..++|++++.||+|+||.||+|.+. +..+|||++........ ....+.+|+.+++.++||||+
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~ 111 (345)
T 2v62_A 32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP 111 (345)
T ss_dssp ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence 3456789999999999999999999984 46799999876532110 112466788999999999999
Q ss_pred EEeecccC----CCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC-
Q 010078 353 QFIGACTK----PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE- 427 (518)
Q Consensus 353 ~l~g~~~~----~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~- 427 (518)
++++++.. ...+|+||||+ |++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ-NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBG-GGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSST
T ss_pred eeecccccccCCCcEEEEEEecc-CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCC
Confidence 99999876 67789999999 9999999976 34899999999999999999999999999999999999999877
Q ss_pred -cEEEEeeCcceecccCC--------ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 428 -VVKVADFGVARVKAQSG--------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 428 -~vkL~DFGla~~~~~~~--------~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 99999999997654321 12455799999999999999999999999999999999999999965
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=313.37 Aligned_cols=217 Identities=29% Similarity=0.545 Sum_probs=183.1
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecc
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~-------~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~ 358 (518)
..++..++|++++.||+|+||.||+|++ .+..||||++... ........+.+|+.++++++||||+++++++
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (327)
T 2yfx_A 24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVS 102 (327)
T ss_dssp SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence 4467788999999999999999999984 3457999999744 2445567899999999999999999999999
Q ss_pred cCCCCcceeeeecCCCchhHHHhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC---CCcE
Q 010078 359 TKPPSLCIVTEFMSGGSVYDYLHKLK------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVV 429 (518)
Q Consensus 359 ~~~~~~~lV~Ey~~ggsL~~~l~~~~------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~---~~~v 429 (518)
......|+||||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++. +..+
T Consensus 103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence 99999999999999999999998743 34889999999999999999999999999999999999984 4469
Q ss_pred EEEeeCcceecccCC---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 430 KVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 430 kL~DFGla~~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
||+|||+++...... ......+|+.|+|||++.+..++.++||||||+++|+|+| |+.||...+..+....+..
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 260 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence 999999987543322 2234467889999999999999999999999999999998 9999998887766655443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=318.52 Aligned_cols=208 Identities=27% Similarity=0.450 Sum_probs=184.1
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
++..++|++.++||+|+||.||++++. ++.||+|+++... .......+.+|+.++++++||||+++++++.....+|
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence 566678999999999999999999986 6789999998653 4555678999999999999999999999999999999
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~-gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
+||||++|++|.+++.. .+.+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++.....
T Consensus 108 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp EEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEEECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 99999999999999977 56799999999999999999999996 9999999999999999999999999998654332
Q ss_pred ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 010078 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA 498 (518)
Q Consensus 445 ~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~ 498 (518)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+..
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 239 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 239 (360)
T ss_dssp C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHH
T ss_pred cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 234457899999999999999999999999999999999999999987775543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=314.94 Aligned_cols=211 Identities=31% Similarity=0.604 Sum_probs=175.4
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEEC--Cce----EEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQD----VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~----vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~ 361 (518)
.+..++|++.++||+|+||.||+|.+. ++. |++|.++... .......+.+|+.++++++||||+++++++...
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 466789999999999999999999874 343 5777766433 223357799999999999999999999999865
Q ss_pred CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
..++|++|+.+++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 90 -~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp -SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred -CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 4889999999999999998877889999999999999999999999999999999999999999999999999998654
Q ss_pred cCC---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 010078 442 QSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVG 500 (518)
Q Consensus 442 ~~~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~ 500 (518)
... ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+....
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~ 231 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Confidence 332 2223456788999999999999999999999999999999 9999998776555444
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=306.96 Aligned_cols=208 Identities=31% Similarity=0.563 Sum_probs=176.6
Q ss_pred CeeeeeeeeecCceEEEEEEECC--c---eEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCc-ce
Q 010078 293 HLKFGSKVASGSYGDLYRGTYCS--Q---DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL-CI 366 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~~~--~---~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~-~l 366 (518)
.|+++++||+|+||.||+|++.. + .||+|+++.. ......+.+.+|+.++++++||||+++++++...... ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 45667999999999999998632 2 5999998753 2345567899999999999999999999999766655 99
Q ss_pred eeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC---
Q 010078 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--- 443 (518)
Q Consensus 367 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~--- 443 (518)
||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 180 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence 99999999999999876778999999999999999999999999999999999999999999999999999754332
Q ss_pred --CccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHh
Q 010078 444 --GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 501 (518)
Q Consensus 444 --~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~i 501 (518)
.......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||...++.+....+
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~ 241 (298)
T 3pls_A 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL 241 (298)
T ss_dssp CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHH
T ss_pred ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHh
Confidence 12234467889999999999999999999999999999999 55667666665544443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=311.60 Aligned_cols=213 Identities=24% Similarity=0.448 Sum_probs=182.8
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC---CceEEEEEecCCCCChHHHHHHHHHHHHHHhc---CCCcceEEeeccc-----
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV---RHKNVVQFIGACT----- 359 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~---~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L---~HpnIv~l~g~~~----- 359 (518)
.++|++.+.||+|+||.||++.+. ++.||+|+++...........+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 368999999999999999999873 57799999875433322223466777777766 8999999999986
Q ss_pred CCCCcceeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcce
Q 010078 360 KPPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (518)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~ 438 (518)
....+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 5567899999996 69999997643 348999999999999999999999999999999999999999999999999998
Q ss_pred ecccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 439 VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
............||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+++.
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (326)
T 1blx_A 169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234 (326)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred cccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 765544555678999999999999999999999999999999999999999999988887777653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=311.27 Aligned_cols=214 Identities=33% Similarity=0.552 Sum_probs=177.3
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEeecccC----
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTK---- 360 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~---- 360 (518)
....++|++.+.||+|+||.||+|++ .++.||||++...... ...+.+|+.+++++ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 34457899999999999999999998 5788999998754332 35788999999999 79999999999865
Q ss_pred --CCCcceeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcc
Q 010078 361 --PPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437 (518)
Q Consensus 361 --~~~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla 437 (518)
...+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 456899999999999999997643 57899999999999999999999999999999999999999999999999998
Q ss_pred eecccC-CccccCCCCCcccCchhcc-----CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 438 RVKAQS-GVMTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 438 ~~~~~~-~~~~~~~gt~~y~APEvl~-----~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
...... .......||+.|+|||++. +..++.++|||||||++|+|++|+.||....+.+....+...
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 249 (326)
T 2x7f_A 177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 249 (326)
T ss_dssp C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Confidence 765432 2234457899999999987 567899999999999999999999999998887776665543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=323.49 Aligned_cols=209 Identities=31% Similarity=0.563 Sum_probs=170.3
Q ss_pred CeeeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeeccc-CCCCcce
Q 010078 293 HLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT-KPPSLCI 366 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~~~-----~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~-~~~~~~l 366 (518)
.|++.+.||+|+||.||+|++.. ..||+|+++... .......|.+|+.++++++||||+++++++. .....|+
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 47788999999999999998632 348999987532 3455678999999999999999999999865 4567899
Q ss_pred eeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC--
Q 010078 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-- 444 (518)
Q Consensus 367 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-- 444 (518)
||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 248 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence 999999999999998766778999999999999999999999999999999999999999999999999997553322
Q ss_pred ---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhh
Q 010078 445 ---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV 502 (518)
Q Consensus 445 ---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv 502 (518)
......+|+.|+|||++.+..++.++|||||||++|||+| |.+||...+..+....+.
T Consensus 249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~ 310 (373)
T 3c1x_A 249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 310 (373)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH
T ss_pred cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH
Confidence 1233456788999999999999999999999999999999 788998876655554443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=306.28 Aligned_cols=212 Identities=28% Similarity=0.501 Sum_probs=186.0
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|++.++||+|+||.||+++. .++.||||+++...........+.+|+.++++++||||+++++++.....+|+|||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 5799999999999999999998 47889999987654444445778999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCC---CcEEEEeeCcceecccCCcc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN---EVVKVADFGVARVKAQSGVM 446 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~---~~vkL~DFGla~~~~~~~~~ 446 (518)
|+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++.........
T Consensus 102 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~ 180 (287)
T 2wei_A 102 LYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180 (287)
T ss_dssp CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSC
T ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCcc
Confidence 9999999999876 4679999999999999999999999999999999999999754 46999999999866555444
Q ss_pred ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
....+|+.|+|||++.+. ++.++||||||+++|+|++|+.||...+..+....+....
T Consensus 181 ~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (287)
T 2wei_A 181 KDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK 238 (287)
T ss_dssp SCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred ccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 455688999999998765 8999999999999999999999999988877776655443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=308.65 Aligned_cols=200 Identities=34% Similarity=0.581 Sum_probs=175.3
Q ss_pred eeeeeeeeecCceEEEEEEECCceEEEEEecCCC--CChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeeec
Q 010078 294 LKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPER--INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~--~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey~ 371 (518)
+..+++||+|+||.||+|++.++.||||++.... ......+.+.+|+.++++++||||+++++++......|+||||+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 4456899999999999999999999999987543 23445678999999999999999999999999999999999999
Q ss_pred CCCchhHHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC---cc
Q 010078 372 SGGSVYDYLHKL--KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VM 446 (518)
Q Consensus 372 ~ggsL~~~l~~~--~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~---~~ 446 (518)
++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...... ..
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 192 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEEC
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccc
Confidence 999999999753 3458999999999999999999999999999999999999999999999999997654422 12
Q ss_pred ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.....
T Consensus 193 ~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 239 (307)
T 2nru_A 193 SRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE 239 (307)
T ss_dssp SSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred cccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence 34578999999999876 489999999999999999999999987543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=312.25 Aligned_cols=217 Identities=35% Similarity=0.588 Sum_probs=166.4
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCC
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~ 363 (518)
.|.+..++|++.+.||+|+||.||++.+ .++.||||++..... ......+.+|+.++++++||||+++++++...+.
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 4678889999999999999999999976 578899999875432 2335678899999999999999999999999999
Q ss_pred cceeeeecCCCchhHHHhh-------hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCc
Q 010078 364 LCIVTEFMSGGSVYDYLHK-------LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~-------~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGl 436 (518)
.|+||||++|++|.+++.. ..+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999999874 245689999999999999999999999999999999999999999999999999
Q ss_pred ceecccCC------ccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 437 ARVKAQSG------VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 437 a~~~~~~~------~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
+....... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+.....++
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 241 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ 241 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc
Confidence 87543321 1234578999999999876 5689999999999999999999999998776555544443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=302.26 Aligned_cols=201 Identities=29% Similarity=0.531 Sum_probs=177.6
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|++.+.||+|+||.||+++.. ++.||||+++.... ......+.+|+.+++.++||||+++++++......|+|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 46899999999999999999875 67899999875433 2345778999999999999999999999998889999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC---cc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VM 446 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~---~~ 446 (518)
|+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||.+....... ..
T Consensus 86 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 164 (276)
T 2yex_A 86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (276)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred ecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence 9999999999975 4578999999999999999999999999999999999999999999999999997654322 23
Q ss_pred ccCCCCCcccCchhccCCCC-ChhhHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 447 TAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~~~-s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...+.
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 213 (276)
T 2yex_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (276)
T ss_dssp CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence 45678999999999988775 7789999999999999999999987654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=304.81 Aligned_cols=194 Identities=27% Similarity=0.462 Sum_probs=173.6
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC---------
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--------- 360 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~--------- 360 (518)
.+|++.+.||+|+||.||++.+. ++.||+|+++... ..+.+|+.++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 56899999999999999999985 7889999987542 346789999999999999999998743
Q ss_pred -------CCCcceeeeecCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEE
Q 010078 361 -------PPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVA 432 (518)
Q Consensus 361 -------~~~~~lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~ 432 (518)
...+|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 34479999999999999999764 3579999999999999999999999999999999999999999999999
Q ss_pred eeCcceecccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 433 DFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 433 DFGla~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
|||+++............||+.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 223 (284)
T 2a19_B 165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE 223 (284)
T ss_dssp CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred cchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence 99999877665555667899999999999999999999999999999999999988753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=320.63 Aligned_cols=209 Identities=26% Similarity=0.372 Sum_probs=176.0
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC------C
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------S 363 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~-~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~------~ 363 (518)
..+|++.+.||+|+||.||+|++. +..||+|++...... ..+|+.+|+.++||||+++++++.... .
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 457999999999999999999984 456898877643221 236999999999999999999984433 3
Q ss_pred cceeeeecCCCchhHHHh--hhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc-CCCcEEEEeeCcceec
Q 010078 364 LCIVTEFMSGGSVYDYLH--KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARVK 440 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~--~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid-~~~~vkL~DFGla~~~ 440 (518)
+|+||||++++.+..... .....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 789999997644333322 2356799999999999999999999999999999999999999 7899999999999877
Q ss_pred ccCCccccCCCCCcccCchhccCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 441 AQSGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 441 ~~~~~~~~~~gt~~y~APEvl~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
..........||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+.+..+++..
T Consensus 193 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~ 258 (394)
T 4e7w_A 193 IAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVL 258 (394)
T ss_dssp CTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred cCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 666666677899999999998764 59999999999999999999999999999988888877643
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=315.52 Aligned_cols=204 Identities=32% Similarity=0.570 Sum_probs=178.1
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCc
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~-~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~ 364 (518)
.+.+..++|++.+.||+|+||.||+|+. .++.||||+++...... ....+.+|+.++++++||||+++++++......
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 102 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence 4567778999999999999999999986 46789999988653221 123688999999999999999999999999999
Q ss_pred ceeeeecCCCchhHHHhhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCcEEEcCCCcEEEEeeCcce
Q 010078 365 CIVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQN---NIIHRDLKAANLLMDENEVVKVADFGVAR 438 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~---~~l~~~~i~~i~~qIa~aL~yLHs~---gIiHrDLKp~NILid~~~~vkL~DFGla~ 438 (518)
++||||+++++|.+++.... ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence 99999999999999997642 3489999999999999999999999 99999999999999999999999999998
Q ss_pred ecccCC--ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCC
Q 010078 439 VKAQSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490 (518)
Q Consensus 439 ~~~~~~--~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~ 490 (518)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp ECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred ccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 664332 2344569999999999998899999999999999999999999995
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=306.36 Aligned_cols=202 Identities=22% Similarity=0.456 Sum_probs=167.0
Q ss_pred CCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCccee
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV 367 (518)
..+|++.++||+|+||.||+|.. .++.||||+++... ........+.+|+.++++++||||+++++++......++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35799999999999999999986 47889999998643 3455667899999999999999999999999998999999
Q ss_pred eeecCCCchhHHHhhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 368 TEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~---~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
|||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~ 190 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence 9999999999998642 4568999999999999999999999999999999999999999999999999987654432
Q ss_pred -ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCC
Q 010078 445 -VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL 492 (518)
Q Consensus 445 -~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (518)
......|++.|+|||++.+..++.++||||||+++|+|++|+.||.+.
T Consensus 191 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 191 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp --------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 233457899999999999999999999999999999999999999754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=312.96 Aligned_cols=209 Identities=25% Similarity=0.415 Sum_probs=181.2
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC-----CCc
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-----PSL 364 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~-----~~~ 364 (518)
.+|+++++||+|+||.||++... ++.||||+++... .......+.+|+.+|++++||||+++++++... ...
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 68999999999999999999874 6779999998532 445567899999999999999999999988654 368
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 106 ~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 99999995 699999865 569999999999999999999999999999999999999999999999999998654332
Q ss_pred ----ccccCCCCCcccCchhcc-CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 445 ----VMTAETGTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 445 ----~~~~~~gt~~y~APEvl~-~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
......||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.+..+....++..
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 247 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 247 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHH
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHH
Confidence 234458999999999865 456899999999999999999999999998887777776543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=312.25 Aligned_cols=210 Identities=31% Similarity=0.498 Sum_probs=160.2
Q ss_pred CCCceeeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHH-HHHhcCCCcceEEeeccc
Q 010078 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVF-IMRKVRHKNVVQFIGACT 359 (518)
Q Consensus 283 ~~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~-iL~~L~HpnIv~l~g~~~ 359 (518)
....|.+..++|++.+.||+|+||.||++... ++.||||+++.... ......+..|+. +++.++||||+++++++.
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~ 91 (327)
T 3aln_A 13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALF 91 (327)
T ss_dssp CCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred hHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence 34578999999999999999999999999985 78899999986533 333455566665 778889999999999999
Q ss_pred CCCCcceeeeecCCCchhHHHhh----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEcCCCcEEEEee
Q 010078 360 KPPSLCIVTEFMSGGSVYDYLHK----LKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADF 434 (518)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~l~~----~~~~l~~~~i~~i~~qIa~aL~yLHs~-gIiHrDLKp~NILid~~~~vkL~DF 434 (518)
..+..++||||+++ +|.+++.. ....+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+||
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Df 170 (327)
T 3aln_A 92 REGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDF 170 (327)
T ss_dssp CSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCC
T ss_pred eCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccC
Confidence 99999999999965 88887753 256789999999999999999999999 9999999999999999999999999
Q ss_pred CcceecccCCccccCCCCCcccCchhc----cCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 435 GVARVKAQSGVMTAETGTYRWMAPEVI----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 435 Gla~~~~~~~~~~~~~gt~~y~APEvl----~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
|+++............||+.|+|||++ .+..++.++||||||+++|+|++|+.||.....
T Consensus 171 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 234 (327)
T 3aln_A 171 GISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS 234 (327)
T ss_dssp SSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--
T ss_pred CCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcch
Confidence 999876555444555799999999998 566799999999999999999999999987543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=323.43 Aligned_cols=200 Identities=12% Similarity=0.168 Sum_probs=156.6
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC-hHHHHHHHHHHHHHHhc--CCCcceEEeeccc------
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKV--RHKNVVQFIGACT------ 359 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~-~~~~~~~~~Ei~iL~~L--~HpnIv~l~g~~~------ 359 (518)
...|++.++||+|+||.||+|++. ++.||||+++..... ......+.+|+.+++.+ +||||++++..+.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 456999999999999999999974 678999999876543 34456677886555555 5999888664332
Q ss_pred -CC-----------------CCcceeeeecCCCchhHHHhhhcCCCCHHHH------HHHHHHHHHHHHHHHHCCceecc
Q 010078 360 -KP-----------------PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL------LKVAIDVSKGMNYLHQNNIIHRD 415 (518)
Q Consensus 360 -~~-----------------~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i------~~i~~qIa~aL~yLHs~gIiHrD 415 (518)
.+ ..+|+||||++ ++|.+++......+....+ ..++.||+.||.|||++||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 11 23799999997 8999999876555666666 67889999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEEeeCcceecccCCccccCCCCCcccCchhccC--CCCChhhHHHHHHHHHHHHHcCCCCCCCCC
Q 010078 416 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLT 493 (518)
Q Consensus 416 LKp~NILid~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APEvl~~--~~~s~ksDVwSlGviL~eLltG~~Pf~~~~ 493 (518)
|||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..|+.++|||||||++|||++|+.||...+
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 297 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence 9999999999999999999999865432 224567799999999987 789999999999999999999999998763
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=320.02 Aligned_cols=209 Identities=27% Similarity=0.412 Sum_probs=183.9
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhc------CCCcceEEeecccCCC
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV------RHKNVVQFIGACTKPP 362 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L------~HpnIv~l~g~~~~~~ 362 (518)
..+|+++++||+|+||.||+|.+. ++.||||+++.. ......+.+|+.+++.+ +|+||+++++++....
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 467999999999999999999875 578999999753 34456788899998888 5679999999999989
Q ss_pred CcceeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCc--EEEEeeCccee
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV--VKVADFGVARV 439 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~--vkL~DFGla~~ 439 (518)
.+|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 9999999995 69999987643 35899999999999999999999999999999999999999887 99999999976
Q ss_pred cccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 440 KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 440 ~~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
.... .....||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..+++..
T Consensus 252 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~ 315 (429)
T 3kvw_A 252 EHQR--VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELL 315 (429)
T ss_dssp TTCC--CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred cCCc--ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 5432 345689999999999999999999999999999999999999999999988887776543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=309.62 Aligned_cols=206 Identities=22% Similarity=0.381 Sum_probs=176.1
Q ss_pred CCceeeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeeccc--
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT-- 359 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~-- 359 (518)
...+.++.++|++.+.||+|+||.||++.. .++.||||++... .......+.+|+.++++++||||+++++++.
T Consensus 21 g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (317)
T 2buj_A 21 GHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRE 98 (317)
T ss_dssp EEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred ccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec
Confidence 356788999999999999999999999996 5688999998653 3455678999999999999999999999886
Q ss_pred --CCCCcceeeeecCCCchhHHHhhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEee
Q 010078 360 --KPPSLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 434 (518)
Q Consensus 360 --~~~~~~lV~Ey~~ggsL~~~l~~~---~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DF 434 (518)
.....|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~df 178 (317)
T 2buj_A 99 RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDL 178 (317)
T ss_dssp ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEec
Confidence 344689999999999999999763 467999999999999999999999999999999999999999999999999
Q ss_pred CcceecccCC----------ccccCCCCCcccCchhccCCC---CChhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 435 GVARVKAQSG----------VMTAETGTYRWMAPEVIEHKP---YDHKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 435 Gla~~~~~~~----------~~~~~~gt~~y~APEvl~~~~---~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
|+++...... ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||..
T Consensus 179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 9987543211 112345799999999997654 78999999999999999999999953
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=309.70 Aligned_cols=215 Identities=28% Similarity=0.565 Sum_probs=181.2
Q ss_pred CCCeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHh--cCCCcceEEeecccCCC----Cc
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK--VRHKNVVQFIGACTKPP----SL 364 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~--L~HpnIv~l~g~~~~~~----~~ 364 (518)
.++|++.+.||+|+||.||+|++.++.||||+++.. ....+.+|+.+++. ++||||+++++++.... .+
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 368999999999999999999999999999998743 23567889999888 78999999999987765 78
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCcEEEcCCCcEEEEeeCc
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH--------QNNIIHRDLKAANLLMDENEVVKVADFGV 436 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLH--------s~gIiHrDLKp~NILid~~~~vkL~DFGl 436 (518)
|+||||+++++|.+++.+ ..+++..++.++.||+.||.||| ++||+||||||+|||++.++.+||+|||+
T Consensus 116 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 193 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193 (342)
T ss_dssp EEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCC
Confidence 999999999999999975 56899999999999999999999 89999999999999999999999999999
Q ss_pred ceecccCC-----ccccCCCCCcccCchhccCC------CCChhhHHHHHHHHHHHHHcC----------CCCCCCCC--
Q 010078 437 ARVKAQSG-----VMTAETGTYRWMAPEVIEHK------PYDHKADVFSFGIVLWELLTG----------KLPYEYLT-- 493 (518)
Q Consensus 437 a~~~~~~~-----~~~~~~gt~~y~APEvl~~~------~~s~ksDVwSlGviL~eLltG----------~~Pf~~~~-- 493 (518)
++...... ......||+.|+|||++.+. .++.++|||||||++|||+|| +.||....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 273 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence 98665443 22445799999999999776 334789999999999999999 88997653
Q ss_pred ---HHHHHHHhhhhcCchhHHH
Q 010078 494 ---PLQAAVGVVQKVHHSFLEQ 512 (518)
Q Consensus 494 ---~~q~~~~iv~~~~rp~ip~ 512 (518)
.......+..+..++.+|.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~ 295 (342)
T 1b6c_B 274 DPSVEEMRKVVCEQKLRPNIPN 295 (342)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCG
T ss_pred cccHHHHHHHHHHHHhCCCCcc
Confidence 2334444455556655543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=306.34 Aligned_cols=209 Identities=25% Similarity=0.361 Sum_probs=179.1
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC-----CC
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-----PS 363 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~-----~~ 363 (518)
.++|++.+.||+|+||.||+|++. ++.||||+++.. ........+.+|+.++++++||||+++++++... ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 378999999999999999999985 788999999753 2344567788999999999999999999987654 67
Q ss_pred cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC
Q 010078 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~ 443 (518)
.|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 899999995 699999875 57999999999999999999999999999999999999999999999999999865432
Q ss_pred C-----------ccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 444 G-----------VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 444 ~-----------~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 237 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 1 1223478999999998754 7899999999999999999999999999887766655543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=309.56 Aligned_cols=212 Identities=28% Similarity=0.465 Sum_probs=182.6
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
..|++. ++|.+.+.||+|+||.||+|.+. ++.||||++............+.+|+.++++++||||+++++++....
T Consensus 18 ~~~~l~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 96 (353)
T 3coi_A 18 TAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS 96 (353)
T ss_dssp EEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred cccccC-ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccc
Confidence 356665 68999999999999999999874 688999999876666666788999999999999999999999987765
Q ss_pred C------cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCc
Q 010078 363 S------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436 (518)
Q Consensus 363 ~------~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGl 436 (518)
. +|+||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 97 SLRNFYDFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp SGGGCCCCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred ccccceeEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeeccc
Confidence 4 499999996 68888874 3589999999999999999999999999999999999999999999999999
Q ss_pred ceecccCCccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 437 ARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 437 a~~~~~~~~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
++..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+++
T Consensus 173 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~ 238 (353)
T 3coi_A 173 ARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 238 (353)
T ss_dssp TTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHH
T ss_pred ccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9764432 345578999999999877 6789999999999999999999999999988877776654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=306.63 Aligned_cols=219 Identities=26% Similarity=0.459 Sum_probs=169.4
Q ss_pred CCceeeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~ 361 (518)
...|.+..++|++.+.||+|+||.||++.+. ++.||||+++.........+.+.++..+++.++||||+++++++...
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~ 96 (318)
T 2dyl_A 17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN 96 (318)
T ss_dssp SSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred chhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Confidence 4567888899999999999999999999984 78899999987654444445555666778889999999999999999
Q ss_pred CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEcCCCcEEEEeeCcceec
Q 010078 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~-gIiHrDLKp~NILid~~~~vkL~DFGla~~~ 440 (518)
..+|+||||+ ++.+..+.....+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 97 ~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 97 TDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp SEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred CcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 9999999999 6677766665567899999999999999999999995 9999999999999999999999999999766
Q ss_pred ccCCccccCCCCCcccCchhcc-----CCCCChhhHHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHhhh
Q 010078 441 AQSGVMTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYL-TPLQAAVGVVQ 503 (518)
Q Consensus 441 ~~~~~~~~~~gt~~y~APEvl~-----~~~~s~ksDVwSlGviL~eLltG~~Pf~~~-~~~q~~~~iv~ 503 (518)
..........||+.|+|||++. ...++.++||||||+++|+|++|+.||... +..+....+++
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 244 (318)
T 2dyl_A 176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ 244 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH
T ss_pred cCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc
Confidence 5554455667999999999994 567899999999999999999999999874 44455555444
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=302.27 Aligned_cols=196 Identities=29% Similarity=0.433 Sum_probs=171.6
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecc-cCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC-TKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~-~~~~~~~lV~ 368 (518)
++|++.+.||+|+||.||+|+. .++.||||++...... ..+.+|+.+++.++|++++..+..+ ......++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 6899999999999999999995 5788999998765433 3578899999999998876666554 5556679999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---cCCCcEEEEeeCcceecccCCc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGV 445 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILi---d~~~~vkL~DFGla~~~~~~~~ 445 (518)
||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 999 999999998767789999999999999999999999999999999999999 4788999999999986554322
Q ss_pred --------cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCC
Q 010078 446 --------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL 492 (518)
Q Consensus 446 --------~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (518)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 218 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Confidence 24557999999999999999999999999999999999999999874
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=307.33 Aligned_cols=199 Identities=28% Similarity=0.477 Sum_probs=168.2
Q ss_pred CCeeee-eeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEeecccCCCCccee
Q 010078 292 KHLKFG-SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 292 ~~~~i~-~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~~~~lV 367 (518)
+.|++. +.||+|+||.||+++. .++.||||+++.... .....+.+|+.+++++ +||||+++++++.....+|+|
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 567774 7899999999999986 578899999976532 2346788999999985 799999999999999999999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCc---EEEEeeCcceecccCC
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV---VKVADFGVARVKAQSG 444 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~---vkL~DFGla~~~~~~~ 444 (518)
|||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 90 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 168 (316)
T 2ac3_A 90 FEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168 (316)
T ss_dssp EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred EEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence 999999999999987 467999999999999999999999999999999999999988765 9999999987543221
Q ss_pred --------ccccCCCCCcccCchhccC-----CCCChhhHHHHHHHHHHHHHcCCCCCCCCC
Q 010078 445 --------VMTAETGTYRWMAPEVIEH-----KPYDHKADVFSFGIVLWELLTGKLPYEYLT 493 (518)
Q Consensus 445 --------~~~~~~gt~~y~APEvl~~-----~~~s~ksDVwSlGviL~eLltG~~Pf~~~~ 493 (518)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 1224469999999999875 568899999999999999999999998754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=303.72 Aligned_cols=207 Identities=25% Similarity=0.411 Sum_probs=180.9
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEE---CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCc------ceEEeeccc
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTY---CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN------VVQFIGACT 359 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~---~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~Hpn------Iv~l~g~~~ 359 (518)
+-.++|++.++||+|+||.||++.+ .++.||||+++.. ......+.+|+.+++.++|++ ++++++++.
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 3457899999999999999999987 4678999999743 344577889999999997664 999999999
Q ss_pred CCCCcceeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC-------------
Q 010078 360 KPPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE------------- 425 (518)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~------------- 425 (518)
..+.+|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 999999999999 899999997643 36889999999999999999999999999999999999987
Q ss_pred ------CCcEEEEeeCcceecccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 010078 426 ------NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV 499 (518)
Q Consensus 426 ------~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~ 499 (518)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+...
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 244 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred ccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 668999999999865432 345678999999999999999999999999999999999999999988876655
Q ss_pred Hh
Q 010078 500 GV 501 (518)
Q Consensus 500 ~i 501 (518)
.+
T Consensus 245 ~~ 246 (339)
T 1z57_A 245 MM 246 (339)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=319.60 Aligned_cols=198 Identities=21% Similarity=0.308 Sum_probs=170.9
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEEC----------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceE----
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYC----------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ---- 353 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~----------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~---- 353 (518)
....++|++.+.||+|+||.||+|++. ++.||||+++.. ..+.+|+.++++++||||++
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~ 110 (352)
T 2jii_A 38 DKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKK 110 (352)
T ss_dssp CTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHH
T ss_pred cccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhh
Confidence 344689999999999999999999874 578999998754 35788999999999999988
Q ss_pred -----------EeecccC-CCCcceeeeecCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 010078 354 -----------FIGACTK-PPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420 (518)
Q Consensus 354 -----------l~g~~~~-~~~~~lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~N 420 (518)
+++++.. ....|+||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 111 ~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N 189 (352)
T 2jii_A 111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN 189 (352)
T ss_dssp HTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred hccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence 4444443 56789999999 99999999874 3679999999999999999999999999999999999
Q ss_pred EEEcCCC--cEEEEeeCcceecccCC--------ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCC
Q 010078 421 LLMDENE--VVKVADFGVARVKAQSG--------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490 (518)
Q Consensus 421 ILid~~~--~vkL~DFGla~~~~~~~--------~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~ 490 (518)
||++.++ .+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 89999999997654322 1234479999999999999999999999999999999999999998
Q ss_pred CCC
Q 010078 491 YLT 493 (518)
Q Consensus 491 ~~~ 493 (518)
...
T Consensus 270 ~~~ 272 (352)
T 2jii_A 270 NCL 272 (352)
T ss_dssp GGT
T ss_pred cCC
Confidence 764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=301.73 Aligned_cols=209 Identities=25% Similarity=0.410 Sum_probs=174.1
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeeccc---------
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT--------- 359 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~--------- 359 (518)
.++|++.+.||+|+||.||+|.+. ++.||||++... .....+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 378999999999999999999986 678999998754 3555678999999999999999999998763
Q ss_pred -----CCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc-CCCcEEEEe
Q 010078 360 -----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVAD 433 (518)
Q Consensus 360 -----~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid-~~~~vkL~D 433 (518)
.....|+||||++ ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred cccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 3356799999996 699999964 6789999999999999999999999999999999999997 567999999
Q ss_pred eCcceecccC----CccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 434 FGVARVKAQS----GVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 434 FGla~~~~~~----~~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
||+++..... .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+++.
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999865432 22334567899999998865 78999999999999999999999999999988877776654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=308.03 Aligned_cols=202 Identities=32% Similarity=0.547 Sum_probs=175.7
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEE------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~------~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~ 361 (518)
.++...|+++++||+|+||.||++.+ .++.||||+++.. ........+.+|+.+|++++||||+++++++...
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 34545569999999999999999876 4677999999865 3445567899999999999999999999998764
Q ss_pred --CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 362 --PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 362 --~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
..+++||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred CCceEEEEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 567999999999999999976 4589999999999999999999999999999999999999999999999999987
Q ss_pred cccCCc----cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCC
Q 010078 440 KAQSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL 492 (518)
Q Consensus 440 ~~~~~~----~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (518)
...... .....+|..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 654332 23446788899999999999999999999999999999999999753
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=336.84 Aligned_cols=217 Identities=30% Similarity=0.564 Sum_probs=187.0
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeeccc
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-----~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~ 359 (518)
..+++..++|++++.||+|+||.||+|.+.. ..||||+++.. ........+.+|+.+|++++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 4678888999999999999999999998843 35899988754 24455678999999999999999999999985
Q ss_pred CCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
. +..|+||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 462 ~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 462 E-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred c-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 4 568999999999999999987666799999999999999999999999999999999999999999999999999986
Q ss_pred cccCCc--cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 010078 440 KAQSGV--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 440 ~~~~~~--~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~ 503 (518)
...... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+..
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~ 607 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 607 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Confidence 544332 223456789999999999999999999999999999997 9999999988877776554
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=315.35 Aligned_cols=213 Identities=22% Similarity=0.418 Sum_probs=184.2
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCCh---------------HHHHHHHHHHHHHHhcCCCcceE
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINS---------------DMQKEFAQEVFIMRKVRHKNVVQ 353 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~---------------~~~~~~~~Ei~iL~~L~HpnIv~ 353 (518)
+..++|++.+.||+|+||.||++++.++.||||++....... .....+.+|+.++++++||||++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 345789999999999999999999999999999987432111 11267899999999999999999
Q ss_pred EeecccCCCCcceeeeecCCCchhHH------Hhhh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEcC
Q 010078 354 FIGACTKPPSLCIVTEFMSGGSVYDY------LHKL-KGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDE 425 (518)
Q Consensus 354 l~g~~~~~~~~~lV~Ey~~ggsL~~~------l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs-~gIiHrDLKp~NILid~ 425 (518)
+++++.....+|+||||+++++|.++ +... ...+++..++.++.||+.||.|||+ +||+||||||+||+++.
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK 187 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence 99999999999999999999999998 5442 4679999999999999999999999 99999999999999999
Q ss_pred CCcEEEEeeCcceecccCCccccCCCCCcccCchhccCC-CCCh-hhHHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHhh
Q 010078 426 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDH-KADVFSFGIVLWELLTGKLPYEYLTP-LQAAVGVV 502 (518)
Q Consensus 426 ~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APEvl~~~-~~s~-ksDVwSlGviL~eLltG~~Pf~~~~~-~q~~~~iv 502 (518)
++.+||+|||.+...... ......||+.|+|||++.+. .++. ++||||||+++|+|++|+.||...+. .+....+.
T Consensus 188 ~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~ 266 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266 (348)
T ss_dssp TSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHT
T ss_pred CCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh
Confidence 999999999999865443 44566799999999999887 6776 99999999999999999999998776 44444433
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=310.99 Aligned_cols=197 Identities=28% Similarity=0.505 Sum_probs=163.1
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHH--HHhcCCCcceEEeecc-----
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFI--MRKVRHKNVVQFIGAC----- 358 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~i--L~~L~HpnIv~l~g~~----- 358 (518)
.+.++.++|++++.||+|+||.||+|++.++.||||+++... ...+..|..+ +..++||||+++++.+
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 81 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTA 81 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECT
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheeccccccc
Confidence 346778899999999999999999999999999999987432 2334444444 4558999999999743
Q ss_pred cCCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCcEEEcCCCcE
Q 010078 359 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN---------NIIHRDLKAANLLMDENEVV 429 (518)
Q Consensus 359 ~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~---------gIiHrDLKp~NILid~~~~v 429 (518)
.....+|+||||+++++|.+++.. ...++..++.++.||+.||.|||++ ||+||||||+|||++.++.+
T Consensus 82 ~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 82 DGRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp TSCEEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred CCCceEEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence 333457899999999999999976 4458889999999999999999999 99999999999999999999
Q ss_pred EEEeeCcceecccCC---------ccccCCCCCcccCchhccC-------CCCChhhHHHHHHHHHHHHHcCCCCC
Q 010078 430 KVADFGVARVKAQSG---------VMTAETGTYRWMAPEVIEH-------KPYDHKADVFSFGIVLWELLTGKLPY 489 (518)
Q Consensus 430 kL~DFGla~~~~~~~---------~~~~~~gt~~y~APEvl~~-------~~~s~ksDVwSlGviL~eLltG~~Pf 489 (518)
||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 999999998654321 2234579999999999987 45678999999999999999997665
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=306.04 Aligned_cols=194 Identities=34% Similarity=0.628 Sum_probs=165.0
Q ss_pred CCeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhc--CCCcceEEeecccCC----CCcc
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV--RHKNVVQFIGACTKP----PSLC 365 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L--~HpnIv~l~g~~~~~----~~~~ 365 (518)
++|++.++||+|+||.||+|++.++.||||++.... ...+..|..++..+ +||||+++++++... ..+|
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 111 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred cceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence 689999999999999999999999999999986431 23445555665554 899999999998766 6789
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCcEEEcCCCcEEEEeeCcc
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN--------NIIHRDLKAANLLMDENEVVKVADFGVA 437 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~--------gIiHrDLKp~NILid~~~~vkL~DFGla 437 (518)
+||||+++++|.+++.. ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 112 lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 189 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189 (337)
T ss_dssp EEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCc
Confidence 99999999999999965 4689999999999999999999999 9999999999999999999999999999
Q ss_pred eecccCCc-----cccCCCCCcccCchhccCCCCChh------hHHHHHHHHHHHHHcC----------CCCCCCC
Q 010078 438 RVKAQSGV-----MTAETGTYRWMAPEVIEHKPYDHK------ADVFSFGIVLWELLTG----------KLPYEYL 492 (518)
Q Consensus 438 ~~~~~~~~-----~~~~~gt~~y~APEvl~~~~~s~k------sDVwSlGviL~eLltG----------~~Pf~~~ 492 (518)
+....... .....||+.|+|||++.+..++.+ +|||||||++|||+|| +.||...
T Consensus 190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp EECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred eeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 76543321 124579999999999988766654 9999999999999999 7888654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=306.89 Aligned_cols=203 Identities=31% Similarity=0.573 Sum_probs=177.6
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEE------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~------~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~ 360 (518)
..+...+|+++++||+|+||.||++++ .++.||||+++.. .....+.+.+|+.++++++||||+++++++..
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 113 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 113 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence 355667899999999999999999985 4678999999864 34556789999999999999999999998866
Q ss_pred CC--CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcce
Q 010078 361 PP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (518)
Q Consensus 361 ~~--~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~ 438 (518)
.. .+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred cCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 44 7899999999999999998866779999999999999999999999999999999999999999999999999998
Q ss_pred ecccCCc----cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 439 VKAQSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 439 ~~~~~~~----~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
....... .....++..|+|||++.+..++.++||||||+++|+|+||..||..
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 7654332 2234567789999999998999999999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=311.01 Aligned_cols=197 Identities=27% Similarity=0.434 Sum_probs=172.0
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC--------CCcceEEeeccc-
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR--------HKNVVQFIGACT- 359 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~--------HpnIv~l~g~~~- 359 (518)
.++|++.++||+|+||.||+++.. ++.||||+++.. ......+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 478999999999999999999874 678999999743 445677899999999996 788999999886
Q ss_pred ---CCCCcceeeeecCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEcCCC-------
Q 010078 360 ---KPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENE------- 427 (518)
Q Consensus 360 ---~~~~~~lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~-gIiHrDLKp~NILid~~~------- 427 (518)
....+|+||||+ +++|.+++... .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 566789999999 66666666543 36799999999999999999999998 999999999999999775
Q ss_pred ------------------------------------------cEEEEeeCcceecccCCccccCCCCCcccCchhccCCC
Q 010078 428 ------------------------------------------VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKP 465 (518)
Q Consensus 428 ------------------------------------------~vkL~DFGla~~~~~~~~~~~~~gt~~y~APEvl~~~~ 465 (518)
.+||+|||+++..... .....||+.|+|||++.+..
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~ 269 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG 269 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSC
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCC
Confidence 7999999999866543 44567999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHcCCCCCCCCC
Q 010078 466 YDHKADVFSFGIVLWELLTGKLPYEYLT 493 (518)
Q Consensus 466 ~s~ksDVwSlGviL~eLltG~~Pf~~~~ 493 (518)
|+.++|||||||++|+|++|+.||...+
T Consensus 270 ~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 270 YNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred CCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 9999999999999999999999998654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=300.12 Aligned_cols=197 Identities=28% Similarity=0.431 Sum_probs=169.1
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecc-cCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC-TKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~-~~~~~~~lV~ 368 (518)
++|++.+.||+|+||.||+|+. .++.||||++...... ..+.+|+.+++.++|++++..++.+ ......++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 6799999999999999999995 5678999987654322 3578899999999988877766655 5566789999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---cCCCcEEEEeeCcceecccCCc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGV 445 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILi---d~~~~vkL~DFGla~~~~~~~~ 445 (518)
||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 999 999999998767789999999999999999999999999999999999999 7889999999999986554322
Q ss_pred --------cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCC
Q 010078 446 --------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 493 (518)
Q Consensus 446 --------~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~ 493 (518)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 234578999999999999999999999999999999999999998753
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=319.93 Aligned_cols=197 Identities=24% Similarity=0.464 Sum_probs=155.2
Q ss_pred Ceee-eeeeeecCceEEEEEEEC----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecc--cCCCCcc
Q 010078 293 HLKF-GSKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC--TKPPSLC 365 (518)
Q Consensus 293 ~~~i-~~~LG~G~fG~Vy~g~~~----~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~--~~~~~~~ 365 (518)
.|++ +++||+|+||.||+|++. ++.||||+++..... ..+.+|+.+|++++||||+++++++ .....+|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 3555 568999999999999965 567999999865433 3578899999999999999999998 4567789
Q ss_pred eeeeecCCCchhHHHhhhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE----cCCCcEEEEe
Q 010078 366 IVTEFMSGGSVYDYLHKLK--------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVAD 433 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~--------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILi----d~~~~vkL~D 433 (518)
+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9999995 58888875321 248999999999999999999999999999999999999 6778999999
Q ss_pred eCcceecccC----CccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 434 FGVARVKAQS----GVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 434 FGla~~~~~~----~~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
||+++..... .......||+.|+|||++.+ ..|+.++||||||||+|+|++|+.||.+...
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 9999865432 22345678999999999987 4599999999999999999999999976543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=309.07 Aligned_cols=214 Identities=20% Similarity=0.267 Sum_probs=170.2
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCC--
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-- 363 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~-- 363 (518)
....++|++.++||+|+||.||+|++. ++.||||++...... ...+.+++..++.++||||+++++++.....
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 344578999999999999999999975 678999988654322 2356678888999999999999999854332
Q ss_pred -----cceeeeecCCCchhHHHhh---hcCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCcEEEcC-CCcEEEE
Q 010078 364 -----LCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLH--QNNIIHRDLKAANLLMDE-NEVVKVA 432 (518)
Q Consensus 364 -----~~lV~Ey~~ggsL~~~l~~---~~~~l~~~~i~~i~~qIa~aL~yLH--s~gIiHrDLKp~NILid~-~~~vkL~ 432 (518)
+|+||||+++ +|...+.. ....+++..+..++.||+.||.||| ++||+||||||+|||++. ++.+||+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 7899999976 55544432 2567889999999999999999999 999999999999999997 8999999
Q ss_pred eeCcceecccCCccccCCCCCcccCchhccCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 433 DFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 433 DFGla~~~~~~~~~~~~~gt~~y~APEvl~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
|||+++............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+++..
T Consensus 175 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 248 (360)
T 3e3p_A 175 DFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248 (360)
T ss_dssp CCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred eCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence 99999877666666677899999999998665 48999999999999999999999999999988888876643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=301.13 Aligned_cols=211 Identities=23% Similarity=0.424 Sum_probs=176.2
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCcceEEeecc--cCCCCcc
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFIGAC--TKPPSLC 365 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~--~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~--~~~~~~~ 365 (518)
++|++++.||+|+||.||++.+ .++.||+|+++.... .......+.+|+.++++++||||+++++++ ......|
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 5799999999999999999987 457899999875421 123356799999999999999999999988 4556789
Q ss_pred eeeeecCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc--
Q 010078 366 IVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-- 442 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~-- 442 (518)
+||||++++ |.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 999999765 77777543 45689999999999999999999999999999999999999999999999999986543
Q ss_pred -CCccccCCCCCcccCchhccCCC--CChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 443 -SGVMTAETGTYRWMAPEVIEHKP--YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 443 -~~~~~~~~gt~~y~APEvl~~~~--~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
........||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...+..+....+.+
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~ 227 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK 227 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc
Confidence 22334557899999999997654 37899999999999999999999999887766655443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=301.37 Aligned_cols=206 Identities=30% Similarity=0.518 Sum_probs=173.4
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCc
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~ 364 (518)
+....+++.....||+|+||.||+|++ .++.||||+++... ....+.+.+|+.+++.++||||+++++++......
T Consensus 17 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 94 (295)
T 2clq_A 17 YDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFI 94 (295)
T ss_dssp EEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred ccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcE
Confidence 445555566667899999999999997 45779999987542 33457789999999999999999999999998899
Q ss_pred ceeeeecCCCchhHHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC-CCcEEEEeeCcceecc
Q 010078 365 CIVTEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVARVKA 441 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~--~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~-~~~vkL~DFGla~~~~ 441 (518)
++||||+++++|.+++....+ .+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++...
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174 (295)
T ss_dssp EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence 999999999999999986533 4568889999999999999999999999999999999987 8999999999998654
Q ss_pred cCC-ccccCCCCCcccCchhccCCC--CChhhHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 442 QSG-VMTAETGTYRWMAPEVIEHKP--YDHKADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 442 ~~~-~~~~~~gt~~y~APEvl~~~~--~s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
... ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||.....
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 230 (295)
T 2clq_A 175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 230 (295)
T ss_dssp C-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS
T ss_pred CCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc
Confidence 322 234557899999999997643 89999999999999999999999976543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=302.93 Aligned_cols=216 Identities=21% Similarity=0.360 Sum_probs=180.4
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC--CCcceEEeecccCC
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR--HKNVVQFIGACTKP 361 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~-~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~--HpnIv~l~g~~~~~ 361 (518)
....+..++|++.+.||+|+||.||++.+. ++.||||+++...........+.+|+.++++++ |+||+++++++...
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 456788889999999999999999999874 577999999877666777788999999999998 59999999999999
Q ss_pred CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
..+|+|||+ .+++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++...
T Consensus 101 ~~~~lv~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 101 QYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 177 (313)
T ss_dssp SEEEEEECC-CSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--
T ss_pred CEEEEEEec-CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccccc
Confidence 999999995 58899999987 56789999999999999999999999999999999999996 4899999999997654
Q ss_pred cCC---ccccCCCCCcccCchhccC-----------CCCChhhHHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHhhh
Q 010078 442 QSG---VMTAETGTYRWMAPEVIEH-----------KPYDHKADVFSFGIVLWELLTGKLPYEYLT-PLQAAVGVVQ 503 (518)
Q Consensus 442 ~~~---~~~~~~gt~~y~APEvl~~-----------~~~s~ksDVwSlGviL~eLltG~~Pf~~~~-~~q~~~~iv~ 503 (518)
... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.... .......++.
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 254 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 254 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh
Confidence 332 2234578999999999875 478999999999999999999999998753 3344444443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=307.49 Aligned_cols=209 Identities=25% Similarity=0.376 Sum_probs=182.3
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CC-----cceEEeecccCCC
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HK-----NVVQFIGACTKPP 362 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-Hp-----nIv~l~g~~~~~~ 362 (518)
.++|++.++||+|+||.||+|... ++.||||+++.. ......+..|+.+++.++ |+ +|+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 478999999999999999999875 677999999843 344567788999998886 55 4999999999889
Q ss_pred CcceeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCcEEEc--CCCcEEEEeeCcc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLH--QNNIIHRDLKAANLLMD--ENEVVKVADFGVA 437 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLH--s~gIiHrDLKp~NILid--~~~~vkL~DFGla 437 (518)
.+|+||||+. ++|.+++.... ..+++..++.++.||+.||.||| ++||+||||||+|||++ .++.+||+|||++
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 9999999995 59999997753 56899999999999999999999 57999999999999995 4778999999999
Q ss_pred eecccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 438 RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 438 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
+..... .....||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..+++..
T Consensus 209 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 274 (382)
T 2vx3_A 209 CQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVL 274 (382)
T ss_dssp EETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred eecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 866432 345689999999999999999999999999999999999999999999988888877643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=300.45 Aligned_cols=205 Identities=23% Similarity=0.439 Sum_probs=178.4
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--C-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCc------ceEEeecccCC
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--S-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN------VVQFIGACTKP 361 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~-~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~Hpn------Iv~l~g~~~~~ 361 (518)
.++|++.+.||+|+||.||++.+. + +.||+|+++.. ......+.+|+.++++++|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 478999999999999999999874 3 57999999743 345577889999999998766 89999999988
Q ss_pred CCcceeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE-----------------
Q 010078 362 PSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----------------- 423 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILi----------------- 423 (518)
..+|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccc
Confidence 9999999999 667777776543 569999999999999999999999999999999999999
Q ss_pred --cCCCcEEEEeeCcceecccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 010078 424 --DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV 501 (518)
Q Consensus 424 --d~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~i 501 (518)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 251 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMM 251 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 56789999999999864432 34567999999999999999999999999999999999999999998877665553
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=316.80 Aligned_cols=208 Identities=25% Similarity=0.380 Sum_probs=177.0
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC-CcceEEeecccCCCCccee
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~H-pnIv~l~g~~~~~~~~~lV 367 (518)
.++|+++++||+|+||.||+|++. ++.||||+++..... ..+.+|+.+++.++| ++|..+..++......|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 368999999999999999999974 788999998765433 347789999999987 5556666666777778999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---cCCCcEEEEeeCcceecccCC
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILi---d~~~~vkL~DFGla~~~~~~~ 444 (518)
|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++......
T Consensus 82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 9999 999999998777889999999999999999999999999999999999999 588999999999998665432
Q ss_pred c--------cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHhhh
Q 010078 445 V--------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP---LQAAVGVVQ 503 (518)
Q Consensus 445 ~--------~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~---~q~~~~iv~ 503 (518)
. .....||+.|+|||++.+..++.++||||||||||||++|+.||.+... .+.+..+.+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh
Confidence 2 1256799999999999999999999999999999999999999987543 444444433
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=294.09 Aligned_cols=194 Identities=27% Similarity=0.515 Sum_probs=163.2
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC---------
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--------- 360 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~--------- 360 (518)
++|++.+.||+|+||.||+|+. .++.||||+++.. ......+.+|+.++++++||||+++++++..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 4689999999999999999997 4678999998642 3446788999999999999999999998744
Q ss_pred ----CCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCc
Q 010078 361 ----PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436 (518)
Q Consensus 361 ----~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGl 436 (518)
...+|+||||++|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 3457999999999999999987666788899999999999999999999999999999999999999999999999
Q ss_pred ceecccC---------------CccccCCCCCcccCchhccCC-CCChhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 437 ARVKAQS---------------GVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 437 a~~~~~~---------------~~~~~~~gt~~y~APEvl~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
++..... .......||+.|+|||++.+. .++.++|||||||++|+|++ ||..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~ 230 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST 230 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence 8754321 123345689999999999765 78999999999999999998 5553
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=312.50 Aligned_cols=196 Identities=17% Similarity=0.259 Sum_probs=165.1
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEECCceEEEEEecCCCC------ChHHHHHHHHHHHHHHhcC---------CCcceE
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI------NSDMQKEFAQEVFIMRKVR---------HKNVVQ 353 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~------~~~~~~~~~~Ei~iL~~L~---------HpnIv~ 353 (518)
+..++|+++++||+|+||.||+|+++++.||||+++.... .....+.+.+|+.+|+.++ ||||++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 4557899999999999999999999999999999986532 2223467889999999886 555555
Q ss_pred Eee-----------------cccC-------------CCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHH
Q 010078 354 FIG-----------------ACTK-------------PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403 (518)
Q Consensus 354 l~g-----------------~~~~-------------~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL 403 (518)
+++ ++.. ...+|+||||+++|++.+.+.+ +.+++..++.++.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 554 4432 6789999999999987777743 6689999999999999999
Q ss_pred HHHH-HCCceeccCCCCcEEEcCCC--------------------cEEEEeeCcceecccCCccccCCCCCcccCchhcc
Q 010078 404 NYLH-QNNIIHRDLKAANLLMDENE--------------------VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE 462 (518)
Q Consensus 404 ~yLH-s~gIiHrDLKp~NILid~~~--------------------~vkL~DFGla~~~~~~~~~~~~~gt~~y~APEvl~ 462 (518)
.||| ++||+||||||+|||++.++ .+||+|||+++..... ...||+.|+|||++.
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGC
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhc
Confidence 9999 99999999999999999887 8999999999876543 347999999999998
Q ss_pred CCCCChhhHHHHHHHH-HHHHHcCCCCCCC
Q 010078 463 HKPYDHKADVFSFGIV-LWELLTGKLPYEY 491 (518)
Q Consensus 463 ~~~~s~ksDVwSlGvi-L~eLltG~~Pf~~ 491 (518)
+.. +.++|||||+++ .+++++|..||..
T Consensus 251 g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 251 GDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp CCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred CCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 776 999999998777 7788889999965
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=299.19 Aligned_cols=203 Identities=26% Similarity=0.443 Sum_probs=166.7
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCh----HHHHHHHHHHHHHHhc----CCCcceEEee
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS----DMQKEFAQEVFIMRKV----RHKNVVQFIG 356 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~----~~~~~~~~Ei~iL~~L----~HpnIv~l~g 356 (518)
.+.-.++|++++.||+|+||.||+|.+ .++.||||+++...... .....+.+|+.+++++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 344567899999999999999999987 46789999997654322 1233466799999999 8999999999
Q ss_pred cccCCCCcceeeee-cCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc-CCCcEEEEee
Q 010078 357 ACTKPPSLCIVTEF-MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADF 434 (518)
Q Consensus 357 ~~~~~~~~~lV~Ey-~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid-~~~~vkL~DF 434 (518)
++......++|||| +.+++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+||
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence 99999999999999 789999999987 56799999999999999999999999999999999999999 8899999999
Q ss_pred CcceecccCCccccCCCCCcccCchhccCCCCC-hhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 435 GVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 435 Gla~~~~~~~~~~~~~gt~~y~APEvl~~~~~s-~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
|+++..... ......||..|+|||++.+..+. .++||||||+++|+|++|+.||..
T Consensus 185 g~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 185 GSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp SSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred chhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 999866543 34456799999999999877664 589999999999999999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=302.35 Aligned_cols=198 Identities=24% Similarity=0.409 Sum_probs=144.6
Q ss_pred CCeeeee-eeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC----CCCc
Q 010078 292 KHLKFGS-KVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK----PPSL 364 (518)
Q Consensus 292 ~~~~i~~-~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~----~~~~ 364 (518)
++|.+.+ .||+|+||.||++.+. ++.||||++... ... ..+....++.++||||+++++++.. ...+
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKA---RQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 5688754 6999999999999986 788999998753 221 2223334677789999999998865 3458
Q ss_pred ceeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC---CCcEEEEeeCcceec
Q 010078 365 CIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVK 440 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~---~~~vkL~DFGla~~~ 440 (518)
|+||||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 99999999999999998643 36999999999999999999999999999999999999976 455999999999765
Q ss_pred ccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 010078 441 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 496 (518)
Q Consensus 441 ~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q 496 (518)
... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||...+...
T Consensus 182 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 236 (336)
T 3fhr_A 182 TQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQA 236 (336)
T ss_dssp -----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred ccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchh
Confidence 433 3345678999999999999999999999999999999999999997665433
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=300.73 Aligned_cols=200 Identities=21% Similarity=0.391 Sum_probs=171.5
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-----------CCcceEE
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-----------HKNVVQF 354 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-----------HpnIv~l 354 (518)
.+...+|++.++||+|+||.||+|++ .++.||||+++.. ......+.+|+.++++++ |+||+++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 45678999999999999999999996 5678999999743 344567889999999887 7899999
Q ss_pred eecccCCC----CcceeeeecCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEc----
Q 010078 355 IGACTKPP----SLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMD---- 424 (518)
Q Consensus 355 ~g~~~~~~----~~~lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~-gIiHrDLKp~NILid---- 424 (518)
++++.... .+++||||+ +++|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence 99886543 689999999 99999999764 34599999999999999999999998 999999999999995
Q ss_pred --CCCcEEEEeeCcceecccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCC
Q 010078 425 --ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 493 (518)
Q Consensus 425 --~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~ 493 (518)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 3448999999999866443 345579999999999999999999999999999999999999998654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=302.46 Aligned_cols=204 Identities=26% Similarity=0.469 Sum_probs=175.5
Q ss_pred eeeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCh----HHHHHHHHHHHHHHhcC--CCcceEEeecc
Q 010078 287 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVR--HKNVVQFIGAC 358 (518)
Q Consensus 287 ~ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~----~~~~~~~~Ei~iL~~L~--HpnIv~l~g~~ 358 (518)
.+.-.++|++++.||+|+||.||+|++ .++.||||+++...... .....+.+|+.++++++ |+||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 345568899999999999999999987 46789999987653321 12245678999999997 59999999999
Q ss_pred cCCCCcceeeeecCC-CchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc-CCCcEEEEeeCc
Q 010078 359 TKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGV 436 (518)
Q Consensus 359 ~~~~~~~lV~Ey~~g-gsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid-~~~~vkL~DFGl 436 (518)
......++||||+.+ ++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 999999999999976 899999977 56799999999999999999999999999999999999999 778999999999
Q ss_pred ceecccCCccccCCCCCcccCchhccCCCC-ChhhHHHHHHHHHHHHHcCCCCCCCC
Q 010078 437 ARVKAQSGVMTAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYL 492 (518)
Q Consensus 437 a~~~~~~~~~~~~~gt~~y~APEvl~~~~~-s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (518)
++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||...
T Consensus 197 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 197 GALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp CEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred ccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 9866543 3445679999999999987766 68899999999999999999999753
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=313.09 Aligned_cols=207 Identities=25% Similarity=0.402 Sum_probs=169.3
Q ss_pred CCceeeCCCCeeeeeeeeecCceE-EEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEeecccCC
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGD-LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKP 361 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~-Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~ 361 (518)
.+.+.+...+|.+.+.||+|+||. ||++...++.||||++..... ..+.+|+.+|+++ +||||+++++++...
T Consensus 16 ~~~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 90 (432)
T 3p23_A 16 TSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDR 90 (432)
T ss_dssp --CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEET
T ss_pred CCcEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 346778888999999999999998 667778899999999875432 2356799999999 799999999999998
Q ss_pred CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCC-----CcEEEEeeCc
Q 010078 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-----EVVKVADFGV 436 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~-----~~vkL~DFGl 436 (518)
...|+||||+. ++|.+++......+....++.++.||+.||.|||++||+||||||+|||++.+ ..+||+|||+
T Consensus 91 ~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 91 QFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp TEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred CEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 99999999995 69999998766566666778999999999999999999999999999999532 3588999999
Q ss_pred ceecccC----CccccCCCCCcccCchhcc---CCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 010078 437 ARVKAQS----GVMTAETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ 496 (518)
Q Consensus 437 a~~~~~~----~~~~~~~gt~~y~APEvl~---~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q 496 (518)
++..... .......||+.|+|||++. ...++.++|||||||++|||++ |..||......+
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~ 237 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ 237 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH
Confidence 9865433 2334567999999999997 4678889999999999999999 999997654433
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=321.12 Aligned_cols=194 Identities=20% Similarity=0.265 Sum_probs=168.1
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEEC---CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCC--
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-- 363 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~---~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~-- 363 (518)
+-.++|++.++||+|+||.||++.+. ++.||||++... ........+.+|+.++++++||||+++++++.....
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 33478999999999999999999874 678999998754 244556788999999999999999999999877665
Q ss_pred ---cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceec
Q 010078 364 ---LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 364 ---~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~ 440 (518)
.|+||||++|++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++..
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp CEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred CceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 6999999999999998754 78999999999999999999999999999999999999975 8999999999866
Q ss_pred ccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCC
Q 010078 441 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY 491 (518)
Q Consensus 441 ~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (518)
... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+
T Consensus 232 ~~~---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 232 NSF---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp TCC---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred ccC---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcc
Confidence 543 455799999999999765 48999999999999999999998864
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=319.90 Aligned_cols=202 Identities=29% Similarity=0.472 Sum_probs=177.5
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC------CCC
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK------PPS 363 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~------~~~ 363 (518)
++|++.++||+|+||.||+|.+ .++.||||+++.. ........+.+|+.++++++||||+++++++.. ...
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 6789999999999999999986 4678999998764 345556789999999999999999999998765 667
Q ss_pred cceeeeecCCCchhHHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCc---EEEEeeCcce
Q 010078 364 LCIVTEFMSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV---VKVADFGVAR 438 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~--~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~---vkL~DFGla~ 438 (518)
.|+||||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 899999999999999997643 25889999999999999999999999999999999999997764 9999999998
Q ss_pred ecccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 439 VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
............||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 173 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~ 228 (676)
T 3qa8_A 173 ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228 (676)
T ss_dssp BTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH
T ss_pred ccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc
Confidence 77666556667899999999999999999999999999999999999999976543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=302.56 Aligned_cols=197 Identities=24% Similarity=0.387 Sum_probs=157.3
Q ss_pred CCeeeeeeeeecCceEEE-EEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLY-RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy-~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
+.|.+.+.||+|+||+|| .+...++.||||++.... ...+.+|+.+|+++ +||||+++++++.....+|+|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 445667889999999996 455678999999987532 35678899999886 79999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCC------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCC-------------CcEE
Q 010078 370 FMSGGSVYDYLHKLKGV------FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-------------EVVK 430 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~------l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~-------------~~vk 430 (518)
|+. ++|.+++...... .++..++.++.||+.||.|||++||+||||||+|||++.+ +.+|
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 995 6999999763221 1222457799999999999999999999999999999754 4899
Q ss_pred EEeeCcceecccCC-----ccccCCCCCcccCchhccC-------CCCChhhHHHHHHHHHHHHHc-CCCCCCCCCH
Q 010078 431 VADFGVARVKAQSG-----VMTAETGTYRWMAPEVIEH-------KPYDHKADVFSFGIVLWELLT-GKLPYEYLTP 494 (518)
Q Consensus 431 L~DFGla~~~~~~~-----~~~~~~gt~~y~APEvl~~-------~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~ 494 (518)
|+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||.....
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 99999998765432 1234579999999999975 678999999999999999999 9999976543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=305.15 Aligned_cols=202 Identities=18% Similarity=0.229 Sum_probs=158.1
Q ss_pred CCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCC-CcceE------------
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRH-KNVVQ------------ 353 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~H-pnIv~------------ 353 (518)
....|++++.||+|+||.||+|++. ++.||||+++.... .....+.+.+|+.+++.++| +|...
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3456889999999999999999986 78999999884332 22335678999999999987 32111
Q ss_pred ---------EeecccC-----CCCcceeeeecCCCchhHHHhhh------cCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 010078 354 ---------FIGACTK-----PPSLCIVTEFMSGGSVYDYLHKL------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413 (518)
Q Consensus 354 ---------l~g~~~~-----~~~~~lV~Ey~~ggsL~~~l~~~------~~~l~~~~i~~i~~qIa~aL~yLHs~gIiH 413 (518)
+..++.. ...++++|+++ +++|.+++... ...+++..++.++.||+.||.|||++||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 1111111 12356777766 78999998532 344677788999999999999999999999
Q ss_pred ccCCCCcEEEcCCCcEEEEeeCcceecccCCccccCCCCCcccCchhc----------cCCCCChhhHHHHHHHHHHHHH
Q 010078 414 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI----------EHKPYDHKADVFSFGIVLWELL 483 (518)
Q Consensus 414 rDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APEvl----------~~~~~s~ksDVwSlGviL~eLl 483 (518)
|||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..|+.++|||||||++|||+
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 999999999999999999999998765443 455677 999999999 6667899999999999999999
Q ss_pred cCCCCCCCCCHH
Q 010078 484 TGKLPYEYLTPL 495 (518)
Q Consensus 484 tG~~Pf~~~~~~ 495 (518)
+|+.||...+..
T Consensus 312 tg~~Pf~~~~~~ 323 (413)
T 3dzo_A 312 CADLPNTDDAAL 323 (413)
T ss_dssp HSSCCCCTTGGG
T ss_pred HCCCCCCCcchh
Confidence 999999876543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=281.27 Aligned_cols=177 Identities=12% Similarity=0.170 Sum_probs=156.5
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
+-.++|++.+.||+|+||.||+|++. ++.||||+++..... ......+.+|+.++++++||||+++++++...+..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 44478999999999999999999986 688999999876543 455678999999999999999999999999989999
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 445 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~ 445 (518)
+||||++|++|.+++.. + .....+.+++.||+.||.|||++||+||||||+|||++.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred EEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 99999999999999954 3 4566788999999999999999999999999999999999999998543
Q ss_pred cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 446 ~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
|++ +++.++|||||||++|||+||+.||.+.+.
T Consensus 175 ---------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~ 207 (286)
T 3uqc_A 175 ---------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGV 207 (286)
T ss_dssp ---------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred ---------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 333 379999999999999999999999987654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=276.37 Aligned_cols=177 Identities=25% Similarity=0.449 Sum_probs=149.7
Q ss_pred CCeeee-eeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHH-HhcCCCcceEEeecccC----CCC
Q 010078 292 KHLKFG-SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIM-RKVRHKNVVQFIGACTK----PPS 363 (518)
Q Consensus 292 ~~~~i~-~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL-~~L~HpnIv~l~g~~~~----~~~ 363 (518)
++|.+. +.||+|+||.||++.. .++.||||+++.. ..+.+|+.++ +.++||||+++++++.. ...
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 456666 7899999999999987 4678999998742 3567788887 66689999999998865 667
Q ss_pred cceeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC---CCcEEEEeeCccee
Q 010078 364 LCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARV 439 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~---~~~vkL~DFGla~~ 439 (518)
+|+||||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 899999999999999998743 36999999999999999999999999999999999999998 78899999999864
Q ss_pred cccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 010078 440 KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 496 (518)
Q Consensus 440 ~~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q 496 (518)
.. +..++.++|||||||++|+|++|+.||......+
T Consensus 170 ~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 205 (299)
T 3m2w_A 170 TT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 205 (299)
T ss_dssp CT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----
T ss_pred cc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh
Confidence 32 2457889999999999999999999997665433
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-31 Score=291.90 Aligned_cols=183 Identities=14% Similarity=0.127 Sum_probs=131.2
Q ss_pred eeeecCceEEEEE--EECCceEEEEEecCCCCC--------hHHHHHHHHHHHHHHhc-CCCcceEEeecccCCCCccee
Q 010078 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERIN--------SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 299 ~LG~G~fG~Vy~g--~~~~~~vAVKvlk~~~~~--------~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~~~~lV 367 (518)
..+.|+.|.+..+ .+.++.+++|++...... ....++|.+|+.+|+++ .|+||+++++++.++..+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 3456666655544 356899999999765321 23346799999999999 599999999999999999999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-cc
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VM 446 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~ 446 (518)
|||++|++|.+++.. .++++.. +|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+++...... ..
T Consensus 321 MEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~ 396 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP 396 (569)
T ss_dssp EECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS
T ss_pred EecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc
Confidence 999999999999987 5667654 578999999999999999999999999999999999999999998665432 34
Q ss_pred ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCC
Q 010078 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK 486 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~ 486 (518)
...+||+.|||||++.+. +..++|+||+|+++++|+++.
T Consensus 397 ~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 397 TNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp HHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred cCceechhhccHHHhCCC-CCCcccccccccchhhhcccc
Confidence 556899999999999765 677899999999988765553
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=268.49 Aligned_cols=183 Identities=20% Similarity=0.259 Sum_probs=148.2
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCChH------HHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSD------MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 297 ~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
.+.||+|+||.||++++.++.+++|+......... ..+.+.+|+.+|++++||||+++..++......|+||||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~ 420 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSY 420 (540)
T ss_dssp -------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEEC
T ss_pred CCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEEC
Confidence 57899999999999999999999998765433211 235589999999999999999544444456678999999
Q ss_pred cCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc-----
Q 010078 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV----- 445 (518)
Q Consensus 371 ~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~----- 445 (518)
++|++|.+++.. +..++.||+.||.|||++||+||||||+|||++. .+||+|||+++.......
T Consensus 421 ~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~ 489 (540)
T 3en9_A 421 INGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDL 489 (540)
T ss_dssp CCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHH
T ss_pred CCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccch
Confidence 999999999865 5689999999999999999999999999999998 999999999987654321
Q ss_pred ---cccCCCCCcccCchhccC--CCCChhhHHHHHHHHHHHHHcCCCCCC
Q 010078 446 ---MTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYE 490 (518)
Q Consensus 446 ---~~~~~gt~~y~APEvl~~--~~~s~ksDVwSlGviL~eLltG~~Pf~ 490 (518)
.....||+.|||||++.. ..|+..+|+||..+-..+.+.++-+|.
T Consensus 490 ~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 490 IVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred hhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 135579999999999987 678888999999999988888888774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.6e-24 Score=214.80 Aligned_cols=146 Identities=14% Similarity=0.128 Sum_probs=116.7
Q ss_pred CCeeeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCh----------------HHHHHHHHHHHHHHhcCCCcceEE
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINS----------------DMQKEFAQEVFIMRKVRHKNVVQF 354 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~-~~~~vAVKvlk~~~~~~----------------~~~~~~~~Ei~iL~~L~HpnIv~l 354 (518)
..|.+++.||+|+||.||+|.+ .++.||||+++...... .....+.+|+.+|++++| +++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v 166 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAV 166 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSS
T ss_pred eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCc
Confidence 3467789999999999999998 46789999997543211 135678999999999994 555
Q ss_pred eecccCCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEee
Q 010078 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 434 (518)
Q Consensus 355 ~g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DF 434 (518)
++++. .+..|+||||++|++|.+ +.. .....++.||+.||.|||++||+||||||+|||++ ++.+||+||
T Consensus 167 ~~~~~-~~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 167 PKVYA-WEGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp CCEEE-EETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred CeEEe-ccceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence 55443 356799999999999998 421 23457999999999999999999999999999999 999999999
Q ss_pred CcceecccCCccccCCCCCcccCchhcc
Q 010078 435 GVARVKAQSGVMTAETGTYRWMAPEVIE 462 (518)
Q Consensus 435 Gla~~~~~~~~~~~~~gt~~y~APEvl~ 462 (518)
|+++. +..++|||++.
T Consensus 237 G~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 237 PQSVE------------VGEEGWREILE 252 (282)
T ss_dssp TTCEE------------TTSTTHHHHHH
T ss_pred CCCeE------------CCCCCHHHHHH
Confidence 99963 34578999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=2.3e-20 Score=184.37 Aligned_cols=137 Identities=16% Similarity=0.205 Sum_probs=107.5
Q ss_pred eeeeeeeeecCceEEEEEEE--CCce--EEEEEecCCCCCh----------------------HHHHHHHHHHHHHHhcC
Q 010078 294 LKFGSKVASGSYGDLYRGTY--CSQD--VAIKVLKPERINS----------------------DMQKEFAQEVFIMRKVR 347 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~--~~~~--vAVKvlk~~~~~~----------------------~~~~~~~~Ei~iL~~L~ 347 (518)
|.+.+.||+|+||.||+|.+ .++. ||||+++...... .....+.+|+.+|+.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999987 7888 9999986542110 11236788999999998
Q ss_pred CCcc--eEEeecccCCCCcceeeeecCC-C----chhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCC
Q 010078 348 HKNV--VQFIGACTKPPSLCIVTEFMSG-G----SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH-QNNIIHRDLKAA 419 (518)
Q Consensus 348 HpnI--v~l~g~~~~~~~~~lV~Ey~~g-g----sL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLH-s~gIiHrDLKp~ 419 (518)
|+++ +.+++. ...++||||+.+ | +|.++... .++..+..++.||+.+|.||| ++||+||||||+
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 8753 445543 357999999942 3 66665432 234567889999999999999 999999999999
Q ss_pred cEEEcCCCcEEEEeeCcceec
Q 010078 420 NLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 420 NILid~~~~vkL~DFGla~~~ 440 (518)
|||++. .++|+|||++...
T Consensus 201 NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 201 NIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SEEESS--SEEECCCTTCEET
T ss_pred HEEEcC--cEEEEECcccccC
Confidence 999998 8999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.70 E-value=6.3e-18 Score=176.31 Aligned_cols=136 Identities=16% Similarity=0.213 Sum_probs=98.6
Q ss_pred eeeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCC------------hHHHHH--------HHHHHHHHHhcCCCcc-
Q 010078 294 LKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERIN------------SDMQKE--------FAQEVFIMRKVRHKNV- 351 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~-~~~~vAVKvlk~~~~~------------~~~~~~--------~~~Ei~iL~~L~HpnI- 351 (518)
|.++++||+|+||.||+|.. .|+.||||+++..... ...... ...|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 78899999999999999986 5788999998743211 000111 2345666666654333
Q ss_pred -eEEeecccCCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC---
Q 010078 352 -VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE--- 427 (518)
Q Consensus 352 -v~l~g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~--- 427 (518)
...++. ...+|||||++|++|..+.. ......++.||+.+|.|||++|||||||||.|||++++|
T Consensus 177 vp~p~~~----~~~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 177 VPEPIAQ----SRHTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp CCCEEEE----ETTEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCeeeec----cCceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 222222 23479999999988876532 123457889999999999999999999999999998776
Q ss_pred -------cEEEEeeCcceec
Q 010078 428 -------VVKVADFGVARVK 440 (518)
Q Consensus 428 -------~vkL~DFGla~~~ 440 (518)
.+.|+||+.+-..
T Consensus 246 d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CTTSEEEEEEECCCTTCEET
T ss_pred cccccccceEEEEeCCcccC
Confidence 3899999987543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=2.1e-12 Score=126.38 Aligned_cols=139 Identities=12% Similarity=0.084 Sum_probs=110.6
Q ss_pred CeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeecccCCCCcceeeeec
Q 010078 293 HLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFM 371 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~~~~lV~Ey~ 371 (518)
.|++...++.|+++.||+....++.+++|+........ ...+.+|+.+++.+. +..++++++++...+..|+||||+
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 92 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred cceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence 46777788888999999998888899999987532111 235888999999985 667888998888777889999999
Q ss_pred CCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 010078 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ------------------------------------------- 408 (518)
Q Consensus 372 ~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs------------------------------------------- 408 (518)
+|.+|.+.+. +......++.+++.++..||+
T Consensus 93 ~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 93 DGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp SSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred CCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 9999887631 112234678899999999998
Q ss_pred ----------------CCceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 409 ----------------NNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 409 ----------------~gIiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4489999999999998766677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.17 E-value=8.8e-11 Score=120.47 Aligned_cols=140 Identities=15% Similarity=0.250 Sum_probs=106.9
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEec--CCCCChHHHHHHHHHHHHHHhcCC--CcceEEeecccCC---CCcceeee
Q 010078 297 GSKVASGSYGDLYRGTYCSQDVAIKVLK--PERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGACTKP---PSLCIVTE 369 (518)
Q Consensus 297 ~~~LG~G~fG~Vy~g~~~~~~vAVKvlk--~~~~~~~~~~~~~~Ei~iL~~L~H--pnIv~l~g~~~~~---~~~~lV~E 369 (518)
.+.|+.|.++.||+.+..+..+++|+.. ..... .....+.+|+.+++.+.. ..+++++.++.+. +..|+|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 4678999999999999888889999876 33211 123467889999999984 5578888888766 34789999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ----------------------------------------- 408 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs----------------------------------------- 408 (518)
|++|..+.+.. ...++......++.+++..|..||+
T Consensus 122 ~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 122 FVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp CCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred ecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 99998875421 2336777888899999999999997
Q ss_pred -----------------CCceeccCCCCcEEEcCCC--cEEEEeeCcceec
Q 010078 409 -----------------NNIIHRDLKAANLLMDENE--VVKVADFGVARVK 440 (518)
Q Consensus 409 -----------------~gIiHrDLKp~NILid~~~--~vkL~DFGla~~~ 440 (518)
..++|+|+++.|||++.++ .+.|+||+.+...
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 3689999999999999775 3699999998754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.16 E-value=6.7e-11 Score=114.42 Aligned_cols=132 Identities=12% Similarity=0.135 Sum_probs=96.2
Q ss_pred eeeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCc--ceEEeecccCCCCcceeeee
Q 010078 294 LKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--VVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~~-~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Iv~l~g~~~~~~~~~lV~Ey 370 (518)
+.+....+.|..+.||+.... +..+++|+..... ...+.+|+.+++.+.+.+ +.+++++....+..++||||
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp CEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 333333345667999999764 4679999976541 134778999999987544 55688888777788999999
Q ss_pred cCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCC----------------------------------------
Q 010078 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN---------------------------------------- 410 (518)
Q Consensus 371 ~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~g---------------------------------------- 410 (518)
++|.+|. ... .. ...++.+++..+..||+..
T Consensus 97 i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
T 1nd4_A 97 VPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 167 (264)
T ss_dssp CSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred cCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence 9998884 211 11 1245667777777777643
Q ss_pred ------------------ceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 411 ------------------IIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 411 ------------------IiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
++|+|++|.||+++.++.+.|+|||.+..
T Consensus 168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776677999998854
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.14 E-value=1.5e-10 Score=116.11 Aligned_cols=183 Identities=17% Similarity=0.196 Sum_probs=122.3
Q ss_pred eeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCc--ceEEeecccCCC---Ccceeeeec
Q 010078 298 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKN--VVQFIGACTKPP---SLCIVTEFM 371 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-Hpn--Iv~l~g~~~~~~---~~~lV~Ey~ 371 (518)
+.++.|.++.||+.. ..+++|+.... .....+.+|..+|+.+. +.. +..++....... ..|+||+++
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred EecCCCCcceEEEEC---CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 458999999999854 67999986532 34567889999999884 322 455655544333 348899999
Q ss_pred CCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 010078 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ------------------------------------------- 408 (518)
Q Consensus 372 ~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs------------------------------------------- 408 (518)
+|.+|.+... ..++......++.+++..+..||+
T Consensus 99 ~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 99 KGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 9998875432 235667777788888888888875
Q ss_pred ---------------CCceeccCCCCcEEEcC--CCcEEEEeeCcceecccCCccccCCCCCcccCchhcc----CCC-C
Q 010078 409 ---------------NNIIHRDLKAANLLMDE--NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE----HKP-Y 466 (518)
Q Consensus 409 ---------------~gIiHrDLKp~NILid~--~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APEvl~----~~~-~ 466 (518)
..++|+|++|.||+++. ++.+.|+||+.+.................-..|+... ..+ .
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~ 255 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK 255 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence 13799999999999998 5668899999987643321100000000001222211 100 1
Q ss_pred ---------ChhhHHHHHHHHHHHHHcCCCCCC
Q 010078 467 ---------DHKADVFSFGIVLWELLTGKLPYE 490 (518)
Q Consensus 467 ---------s~ksDVwSlGviL~eLltG~~Pf~ 490 (518)
....++|+++.++|.+.+|+.+|.
T Consensus 256 ~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 256 DIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 123689999999999999988763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=5.3e-07 Score=90.55 Aligned_cols=134 Identities=16% Similarity=0.170 Sum_probs=91.6
Q ss_pred eeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCC---cceEEeeccc-CCCCcceeeeecCC
Q 010078 298 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK---NVVQFIGACT-KPPSLCIVTEFMSG 373 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~Hp---nIv~l~g~~~-~~~~~~lV~Ey~~g 373 (518)
+.++.|....||+. +..+++|+-. .......+.+|..+|+.+.+. .+.+.+.++. ..+..++||||++|
T Consensus 25 ~~l~~G~~n~v~~v---g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 25 ESLGEGFRNYAILV---NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEECSSEEEEEE---TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eecCCCcceeEEEE---CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 46788999999987 7889999853 233456788999999999752 3556666553 34557899999999
Q ss_pred CchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------------
Q 010078 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ--------------------------------------------- 408 (518)
Q Consensus 374 gsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs--------------------------------------------- 408 (518)
.+|.+..- ..++......++.++...|..||+
T Consensus 98 ~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 98 QILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp EECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred eECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 88876311 112333333344444444444432
Q ss_pred ---------------CCceeccCCCCcEEEcC---CCc-EEEEeeCcceecc
Q 010078 409 ---------------NNIIHRDLKAANLLMDE---NEV-VKVADFGVARVKA 441 (518)
Q Consensus 409 ---------------~gIiHrDLKp~NILid~---~~~-vkL~DFGla~~~~ 441 (518)
..++|+|+++.||+++. ++. +.|+||+.+...+
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 24699999999999987 344 5899999887544
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=1e-06 Score=85.98 Aligned_cols=132 Identities=17% Similarity=0.236 Sum_probs=91.6
Q ss_pred eeeecCce-EEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeecccCCCCcceeeeecCCC
Q 010078 299 KVASGSYG-DLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSGG 374 (518)
Q Consensus 299 ~LG~G~fG-~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~~~~lV~Ey~~gg 374 (518)
.+..|..| .||+.... +..+++|+-... ....+.+|..+|+.+. +--+.++++++.+.+..++|||+++|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 45556665 58987653 457999986532 3456888999999886 333677888888888889999999998
Q ss_pred chhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------------
Q 010078 375 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ---------------------------------------------- 408 (518)
Q Consensus 375 sL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs---------------------------------------------- 408 (518)
++.+..... ......++.++...+..||+
T Consensus 106 ~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 106 TAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 877654321 11122333444444444442
Q ss_pred -----C-------CceeccCCCCcEEEcCCCcEEEEeeCcceec
Q 010078 409 -----N-------NIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 409 -----~-------gIiHrDLKp~NILid~~~~vkL~DFGla~~~ 440 (518)
. .++|+|+.+.|||++.++.+-|+||+.+...
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 1 2789999999999998877789999988643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=5.4e-07 Score=91.81 Aligned_cols=80 Identities=14% Similarity=0.083 Sum_probs=55.5
Q ss_pred eeeee-eecCceEEEEEEEC--------CceEEEEEecCCC---CChHHHHHHHHHHHHHHhcCC---CcceEEeecccC
Q 010078 296 FGSKV-ASGSYGDLYRGTYC--------SQDVAIKVLKPER---INSDMQKEFAQEVFIMRKVRH---KNVVQFIGACTK 360 (518)
Q Consensus 296 i~~~L-G~G~fG~Vy~g~~~--------~~~vAVKvlk~~~---~~~~~~~~~~~Ei~iL~~L~H---pnIv~l~g~~~~ 360 (518)
..+.| +.|..+.+|+.+.. +..+++|+..... ... ...+.+|+.+|+.+.. -.+.+++.++..
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~--~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP--TYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS--CCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc--hhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 34677 88889999998765 6789999865432 100 1346678888888753 346778877655
Q ss_pred C---CCcceeeeecCCCchh
Q 010078 361 P---PSLCIVTEFMSGGSVY 377 (518)
Q Consensus 361 ~---~~~~lV~Ey~~ggsL~ 377 (518)
. +..++||||++|.++.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 4 3468999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.24 E-value=5.8e-06 Score=82.92 Aligned_cols=136 Identities=18% Similarity=0.212 Sum_probs=80.4
Q ss_pred eeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC--CcceEEeecc------cCCCCcceeee
Q 010078 298 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGAC------TKPPSLCIVTE 369 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~H--pnIv~l~g~~------~~~~~~~lV~E 369 (518)
+.|+.|..+.||+....+..+++|+.... . ..+..|..+++.|.. -.+++++... ...+..+++|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGAVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEETTEEEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeCCCCEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 45666788999999887778999998752 1 233445566665542 1334444321 12345789999
Q ss_pred ecCCCchh--------------HHHhhhcCCC-------------CHHH-------------------------------
Q 010078 370 FMSGGSVY--------------DYLHKLKGVF-------------KLPS------------------------------- 391 (518)
Q Consensus 370 y~~ggsL~--------------~~l~~~~~~l-------------~~~~------------------------------- 391 (518)
|++|.++. ..++.....+ .+..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 1122211111 1110
Q ss_pred HHHHHHHHHHHHHHHH-------------HCCceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 392 LLKVAIDVSKGMNYLH-------------QNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 392 i~~i~~qIa~aL~yLH-------------s~gIiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
+..+..++..++.+|+ ...++|+|+++.|||++.++.+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1111122334566665 25799999999999998888999999998854
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=7.3e-06 Score=84.87 Aligned_cols=76 Identities=12% Similarity=-0.017 Sum_probs=49.5
Q ss_pred eeeeeecCceEEEEEEE--CCceEEEEEecCCCC--Ch---HHHHHHHHHHHHHHhcCC--C-cceEEeecccCCCCcce
Q 010078 297 GSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI--NS---DMQKEFAQEVFIMRKVRH--K-NVVQFIGACTKPPSLCI 366 (518)
Q Consensus 297 ~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~--~~---~~~~~~~~Ei~iL~~L~H--p-nIv~l~g~~~~~~~~~l 366 (518)
.+.||.|.++.||+++. .++.++||...+... .. .....+..|..+|+.+.. + .+.+++.+. ....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 35789999999999954 467899998654311 00 112356778888888753 3 344566543 345689
Q ss_pred eeeecCCC
Q 010078 367 VTEFMSGG 374 (518)
Q Consensus 367 V~Ey~~gg 374 (518)
||||++|.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999774
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.86 E-value=7.5e-05 Score=78.03 Aligned_cols=77 Identities=14% Similarity=0.148 Sum_probs=48.1
Q ss_pred HCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccccCC--CCCcccCchhccCC---CCChhhHHHHHHHHHHHH
Q 010078 408 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHK---PYDHKADVFSFGIVLWEL 482 (518)
Q Consensus 408 s~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~~~--gt~~y~APEvl~~~---~~s~ksDVwSlGviL~eL 482 (518)
...++|+|+++.|||++.++ ++|+||+.+............. -...|++|+..... .-....++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 46799999999999999877 9999999987544221100000 01345666554321 112235566777777877
Q ss_pred HcC
Q 010078 483 LTG 485 (518)
Q Consensus 483 ltG 485 (518)
+++
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 765
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00013 Score=73.70 Aligned_cols=75 Identities=16% Similarity=0.129 Sum_probs=60.1
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC---CCcceEEeecccCCCCcceeeeecCC
Q 010078 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVVQFIGACTKPPSLCIVTEFMSG 373 (518)
Q Consensus 297 ~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~---HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (518)
.+.|+.|.+..+|+.+..+..+++|+.... ....+..|...|+.|. ...+++++.++...+..++||||++|
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 467899999999999887888999987642 1456888999998885 25678888887777778999999998
Q ss_pred Cch
Q 010078 374 GSV 376 (518)
Q Consensus 374 gsL 376 (518)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.50 E-value=0.0004 Score=69.18 Aligned_cols=140 Identities=14% Similarity=0.143 Sum_probs=81.5
Q ss_pred eeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCc--ceEEeeccc------CCCCccee
Q 010078 296 FGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--VVQFIGACT------KPPSLCIV 367 (518)
Q Consensus 296 i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Iv~l~g~~~------~~~~~~lV 367 (518)
-.+.|+.|....+|+.+..+..+++|+...... ...+..|+.+++.+...+ +.+++.... ..+..+++
T Consensus 26 ~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTTKDPLILTLYEKRVE----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred EeeccCCCcccceEEEEeCCccEEEEEeCCCCC----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence 346788898999999988777899999875311 134556777777775322 334443211 12345789
Q ss_pred eeecCCCchhH-----------H---HhhhcCCC--------CHHHHHHH---------------HHHHHHHHHHHHH--
Q 010078 368 TEFMSGGSVYD-----------Y---LHKLKGVF--------KLPSLLKV---------------AIDVSKGMNYLHQ-- 408 (518)
Q Consensus 368 ~Ey~~ggsL~~-----------~---l~~~~~~l--------~~~~i~~i---------------~~qIa~aL~yLHs-- 408 (518)
|+|++|..+.. . ++.....+ ........ ...+...++.+..
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 99998865321 1 22211111 11111110 0113444555553
Q ss_pred -----CCceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 409 -----NNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 409 -----~gIiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
.+++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 182 ~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3689999999999999876668999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00028 Score=70.06 Aligned_cols=135 Identities=17% Similarity=0.197 Sum_probs=77.3
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcc-eEEeecccCCCCcceeeeec-CCC
Q 010078 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCIVTEFM-SGG 374 (518)
Q Consensus 297 ~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~g~~~~~~~~~lV~Ey~-~gg 374 (518)
.+.|+.|....+|+. ..+++|+....... .....+|+.+++.+...++ .++++.+. ..-++++||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCc
Confidence 467889999999998 77999987643111 1123457777777753222 46666543 3457899999 765
Q ss_pred chhHH------------------HhhhcCCC----CH-HHHHHHHH--------------HHHHHHHHH----HH----C
Q 010078 375 SVYDY------------------LHKLKGVF----KL-PSLLKVAI--------------DVSKGMNYL----HQ----N 409 (518)
Q Consensus 375 sL~~~------------------l~~~~~~l----~~-~~i~~i~~--------------qIa~aL~yL----Hs----~ 409 (518)
++... +|.....+ .. ..+..+.. .+...+..+ .. .
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 55321 11111111 11 11111111 111112222 11 2
Q ss_pred CceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 410 NIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 410 gIiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
.++|+|+.+.||+ ..++.+.|+||+.+....
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g~ 204 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGMND 204 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEEEC
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccCCC
Confidence 4899999999999 556678999999886543
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00031 Score=70.59 Aligned_cols=136 Identities=15% Similarity=0.108 Sum_probs=72.9
Q ss_pred eeeecCceE-EEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC--CcceEEeecccCCCCcceeeeecCCC
Q 010078 299 KVASGSYGD-LYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGACTKPPSLCIVTEFMSGG 374 (518)
Q Consensus 299 ~LG~G~fG~-Vy~g~~~-~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~H--pnIv~l~g~~~~~~~~~lV~Ey~~gg 374 (518)
.|+.|.... +|+.+.. +..+++|...+... ..+..|+.+++.+.. -.+.+++.+.... -+++||++.+.
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~-----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~ 97 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG-----GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDA 97 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT-----CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSC
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC-----ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCc
Confidence 455555444 6676653 66777776544310 223456777776652 2355677654433 37899999776
Q ss_pred chhHHHhhhc-------------------------CCCCHHHHHH--------HH------------HHHHHHHHHH---
Q 010078 375 SVYDYLHKLK-------------------------GVFKLPSLLK--------VA------------IDVSKGMNYL--- 406 (518)
Q Consensus 375 sL~~~l~~~~-------------------------~~l~~~~i~~--------i~------------~qIa~aL~yL--- 406 (518)
++.+++.... ..+....... +. ..+...+..+
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 6654432100 0122211100 00 1112223333
Q ss_pred ---HHCCceeccCCCCcEEEcCC----CcEEEEeeCcceecc
Q 010078 407 ---HQNNIIHRDLKAANLLMDEN----EVVKVADFGVARVKA 441 (518)
Q Consensus 407 ---Hs~gIiHrDLKp~NILid~~----~~vkL~DFGla~~~~ 441 (518)
+...++|+|+.+.|||++.+ +.+.|+||+.+....
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 12469999999999999874 689999999887544
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00068 Score=71.25 Aligned_cols=72 Identities=13% Similarity=0.245 Sum_probs=50.1
Q ss_pred eeeeeecCceEEEEEEEC---------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcc-eEEeecccCCCCcce
Q 010078 297 GSKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCI 366 (518)
Q Consensus 297 ~~~LG~G~fG~Vy~g~~~---------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~g~~~~~~~~~l 366 (518)
.+.|+.|....+|+.... +..+++|+..... . ...+..|..+++.+...++ +++++.+.. .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 357888999999999874 4679999985321 1 1345578888888864333 667776643 48
Q ss_pred eeeecCCCch
Q 010078 367 VTEFMSGGSV 376 (518)
Q Consensus 367 V~Ey~~ggsL 376 (518)
|+||++|.+|
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999987544
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0036 Score=61.51 Aligned_cols=78 Identities=14% Similarity=0.109 Sum_probs=55.1
Q ss_pred CCeeeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC---CcceEEeecccCCCCccee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH---KNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~-~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~H---pnIv~l~g~~~~~~~~~lV 367 (518)
.++.-.+.+|.|..+.||+.+. +|+.|++|+........ ...|..|...|+.|.. -.+++++++. .-++|
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv 88 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA 88 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence 3455567899999999999987 46889999865432221 2347789999998852 2345666543 24789
Q ss_pred eeecCCCc
Q 010078 368 TEFMSGGS 375 (518)
Q Consensus 368 ~Ey~~ggs 375 (518)
|||+.++.
T Consensus 89 ~e~l~~~~ 96 (288)
T 3f7w_A 89 MEWVDERP 96 (288)
T ss_dssp EECCCCCC
T ss_pred EEeecccC
Confidence 99998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0008 Score=68.70 Aligned_cols=73 Identities=11% Similarity=0.165 Sum_probs=45.0
Q ss_pred eeeeeecCceEEEEEEECC----------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCc-ceEEeecccCCCCcc
Q 010078 297 GSKVASGSYGDLYRGTYCS----------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN-VVQFIGACTKPPSLC 365 (518)
Q Consensus 297 ~~~LG~G~fG~Vy~g~~~~----------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Iv~l~g~~~~~~~~~ 365 (518)
.+.|+.|....+|+....+ ..+++|+..... .. ......|..+++.+...+ +.++++... -+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~--~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV--DE-LYNTISEFEVYKTMSKYKIAPQLLNTFN----GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG--GG-TSCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc--cc-eecHHHHHHHHHHHHhcCCCCceEEecC----Cc
Confidence 3567888899999998754 678889865421 11 112356888888876333 446665542 37
Q ss_pred eeeeecCCCch
Q 010078 366 IVTEFMSGGSV 376 (518)
Q Consensus 366 lV~Ey~~ggsL 376 (518)
+||||++|.++
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999988644
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0026 Score=65.80 Aligned_cols=135 Identities=13% Similarity=0.202 Sum_probs=81.3
Q ss_pred eeeeecCceEEEEEEEC---------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeecccCCCCccee
Q 010078 298 SKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~---------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~~~~lV 367 (518)
+.|.-|....+|+.+.. ++.+++|+.-... .....+.+|..+++.+. +.-..++++.+.. .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 46777888889998763 3678999853211 11345568999998886 3333667777654 389
Q ss_pred eeecCCCchhHH-----------------HhhhcC----CCC--HHHHHHHHHHHHH-------------------HHHH
Q 010078 368 TEFMSGGSVYDY-----------------LHKLKG----VFK--LPSLLKVAIDVSK-------------------GMNY 405 (518)
Q Consensus 368 ~Ey~~ggsL~~~-----------------l~~~~~----~l~--~~~i~~i~~qIa~-------------------aL~y 405 (518)
|||++|.+|..- ++.... ... ..++.++..++.. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 999998655311 121111 111 2445555544322 2333
Q ss_pred HH----H----CCceeccCCCCcEEEcCC----CcEEEEeeCccee
Q 010078 406 LH----Q----NNIIHRDLKAANLLMDEN----EVVKVADFGVARV 439 (518)
Q Consensus 406 LH----s----~gIiHrDLKp~NILid~~----~~vkL~DFGla~~ 439 (518)
|. . ..++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 33 2 248999999999999876 7899999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.71 E-value=0.01 Score=59.02 Aligned_cols=136 Identities=15% Similarity=0.147 Sum_probs=78.0
Q ss_pred eeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCc--ceEEeec-----ccCCCCcceeeee
Q 010078 299 KVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--VVQFIGA-----CTKPPSLCIVTEF 370 (518)
Q Consensus 299 ~LG~G~fG~Vy~g~~~-~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Iv~l~g~-----~~~~~~~~lV~Ey 370 (518)
.++ |....||+.... ++.+++|+..+..... ..+..|..+++.+.... +++++.. ....+..+++|+|
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 456 778889988754 4579999987543332 35666888888775322 3444443 0112334679999
Q ss_pred cCCCchh-----------HH---HhhhcC--------CCCHHHH----HHHH---------------HHHHHHHHHHH--
Q 010078 371 MSGGSVY-----------DY---LHKLKG--------VFKLPSL----LKVA---------------IDVSKGMNYLH-- 407 (518)
Q Consensus 371 ~~ggsL~-----------~~---l~~~~~--------~l~~~~i----~~i~---------------~qIa~aL~yLH-- 407 (518)
++|..+. .. ++.... ....... ..++ ..+-..++.+.
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 9885432 11 121110 1111111 0110 11111223332
Q ss_pred -----HCCceeccCCCCcEEEcCCCcEEEEeeCcceec
Q 010078 408 -----QNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 408 -----s~gIiHrDLKp~NILid~~~~vkL~DFGla~~~ 440 (518)
...++|+|+++.|||++ + .+.|+||+.+...
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 23589999999999999 4 8999999987644
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0029 Score=64.07 Aligned_cols=33 Identities=21% Similarity=0.412 Sum_probs=28.7
Q ss_pred CCceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 409 NNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 409 ~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
..++|+|+.+.||+++.++.+.|+||+.+....
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP 238 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence 368999999999999988889999999886543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0071 Score=64.09 Aligned_cols=73 Identities=19% Similarity=0.129 Sum_probs=48.9
Q ss_pred eeeeeecCceEEEEEEECC--ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcc-eEEeecccCCCCcceeeeecCC
Q 010078 297 GSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCIVTEFMSG 373 (518)
Q Consensus 297 ~~~LG~G~fG~Vy~g~~~~--~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~g~~~~~~~~~lV~Ey~~g 373 (518)
.+.|+.|-...+|+....+ ..+++|+....... .-...+|..+++.|...++ .++++.+.. .+||||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~---~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE---IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS---CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh---hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCC
Confidence 3578889999999999876 78999987542111 0112478889998875544 567777632 469999988
Q ss_pred Cch
Q 010078 374 GSV 376 (518)
Q Consensus 374 gsL 376 (518)
.+|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 554
|
| >1u8s_A Glycine cleavage system transcriptional repressor, putative; structural genomics, protein structure initiative (PSI), domain swapping; 2.45A {Vibrio cholerae} SCOP: d.58.18.5 d.58.18.5 | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0023 Score=59.57 Aligned_cols=64 Identities=17% Similarity=0.277 Sum_probs=53.3
Q ss_pred cceeeecCChhhHHHHHHHHHHhhcccceecccccCCCCceeeEEEEcCCChhhHHHHHHHHHHHH
Q 010078 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEV 245 (518)
Q Consensus 180 ~ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~dg~~ldv~vvdgw~~e~~~~l~~~l~~~~ 245 (518)
+.|++++.|+|+++++++.+|++.|+||.++..|.+.++|.+ .++|++ +.+..++|+++|.+..
T Consensus 7 ~~itv~~~DrpGiva~vt~~La~~g~NI~d~~~~~~~~~f~~-~~~v~~-~~~~~~~l~~~L~~~~ 70 (192)
T 1u8s_A 7 LVITAVGTDRPGICNEVVRLVTQAGCNIIDSRIAMFGKEFTL-LMLISG-SPSNITRVETTLPLLG 70 (192)
T ss_dssp EEEEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEETTEEEE-EEEEEE-CHHHHHHHHHHHHHHH
T ss_pred EEEEEEcCCCCcHHHHHHHHHHHCCCCEEeeeeeecCCceEE-EEEEec-CCCCHHHHHHHHHHHH
Confidence 579999999999999999999999999999999998888888 555654 2346677777777654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.93 E-value=0.032 Score=53.18 Aligned_cols=116 Identities=16% Similarity=0.140 Sum_probs=75.2
Q ss_pred CchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccccCCCC
Q 010078 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 452 (518)
Q Consensus 374 gsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLH-s~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~~~gt 452 (518)
.||.+.|...+.++++.++|.++.|.+.+|.-+- ++.-..+=+.|..|++..+|.|.+.+ ..+. ...
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~ 100 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGE 100 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------ccc
Confidence 4899999999999999999999999999987762 22222344567899999999887653 1110 112
Q ss_pred CcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCC---CCCCHHHHHHHhh
Q 010078 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY---EYLTPLQAAVGVV 502 (518)
Q Consensus 453 ~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf---~~~~~~q~~~~iv 502 (518)
..+.+||... ...+.+.=|||||+++|.-+- |-.+= .-..+++.+...+
T Consensus 101 ~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~eE~eLS~~LE~LL~~M 153 (229)
T 2yle_A 101 PPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENEERELSPPLEQLIDHM 153 (229)
T ss_dssp ------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTEEECCCHHHHHHHHHH
T ss_pred cCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcccchhhCHHHHHHHHHH
Confidence 3466888763 345788999999999999886 43322 2233455554444
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.88 E-value=0.013 Score=61.42 Aligned_cols=72 Identities=13% Similarity=0.164 Sum_probs=47.6
Q ss_pred eeeeecCceEEEEEEEC---------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC-CcceEEeecccCCCCccee
Q 010078 298 SKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 298 ~~LG~G~fG~Vy~g~~~---------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~H-pnIv~l~g~~~~~~~~~lV 367 (518)
+.|.-|....+|+.+.. ++.+++|+...... ..-...+|..+++.+.. .-..++++.+. -++|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~---~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I 148 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG---KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRI 148 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc---hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEE
Confidence 46777888999999876 57899998643211 11123468888887753 33456665443 3789
Q ss_pred eeecCCCch
Q 010078 368 TEFMSGGSV 376 (518)
Q Consensus 368 ~Ey~~ggsL 376 (518)
|||++|.+|
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999998664
|
| >2nyi_A Unknown protein; protein structure initiative, PSI, center for eukaryotic structural genomics, CESG, structural genomics; 1.80A {Galdieria sulphuraria} | Back alignment and structure |
|---|
Probab=95.86 E-value=0.0067 Score=56.70 Aligned_cols=47 Identities=11% Similarity=0.298 Sum_probs=43.2
Q ss_pred cceeeecCChhhHHHHHHHHHHhhcccceecccccCCCCceeeEEEEc
Q 010078 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVD 227 (518)
Q Consensus 180 ~ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~dg~~ldv~vvd 227 (518)
..|++++.|+|++.++++..|++.|+||.+|..|.+.++|.+ .+.|+
T Consensus 6 ~~ltv~~~DrpGiva~vs~~La~~g~NI~da~q~~~~~~f~m-~~~v~ 52 (195)
T 2nyi_A 6 FVVSVAGSDRVGIVHDFSWALKNISANVESSRMACLGGDFAM-IVLVS 52 (195)
T ss_dssp EEEEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEETTEEEE-EEEEE
T ss_pred EEEEEEeCCCCcHHHHHHHHHHHCCCCEEEEEeEEECCeEEE-EEEEE
Confidence 589999999999999999999999999999999999999999 45554
|
| >1zpv_A ACT domain protein; structural genomics, PSI, protein structure INIT midwest center for structural genomics, MCSG, unknown funct; 1.90A {Streptococcus pneumoniae} SCOP: d.58.18.7 | Back alignment and structure |
|---|
Probab=95.79 E-value=0.018 Score=46.37 Aligned_cols=67 Identities=22% Similarity=0.219 Sum_probs=53.6
Q ss_pred cceeeecCChhhHHHHHHHHHHhhcccceecccccCCCCceeeEEEEcCCChhhHHHHHHHHHHHHHH
Q 010078 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLK 247 (518)
Q Consensus 180 ~ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~dg~~ldv~vvdgw~~e~~~~l~~~l~~~~~~ 247 (518)
..|++...|+|++|+.++.+|++.|.||.....+... |...-.+.++....+..+++.++|++....
T Consensus 6 ~~l~v~~~DrpGila~vt~~la~~~~NI~~i~~~~~~-~~~~~~i~v~~~~~~~l~~l~~~L~~~~~~ 72 (91)
T 1zpv_A 6 AIITVVGKDKSGIVAGVSGKIAELGLNIDDISQTVLD-EYFTMMAVVSSDEKQDFTYLRNEFEAFGQT 72 (91)
T ss_dssp EEEEEEESCCTTHHHHHHHHHHHTTCEEEEEEEEEET-TEEEEEEEEEESSCCCHHHHHHHHHHHHHH
T ss_pred EEEEEEECCCCCHHHHHHHHHHHcCCCEEEEEeEEEc-CEEEEEEEEEeCCCCCHHHHHHHHHHHHHH
Confidence 5799999999999999999999999999998888765 666655666543356778888888765444
|
| >2ko1_A CTR148A, GTP pyrophosphokinase; homodimer, alpha+beta, transferase, structural genomics, PSI-2, protein structure initiative; NMR {Chlorobaculum tepidum} PDB: 3ibw_A | Back alignment and structure |
|---|
Probab=94.66 E-value=0.037 Score=43.93 Aligned_cols=62 Identities=16% Similarity=0.147 Sum_probs=45.3
Q ss_pred ccceeeecCChhhHHHHHHHHHHhhcccceecccccCCCCceeeEEEEcCCChhhHHHHHHHH
Q 010078 179 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAAL 241 (518)
Q Consensus 179 ~~ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~dg~~ldv~vvdgw~~e~~~~l~~~l 241 (518)
...|.+...|+|++|.+++.+|++.|.||......... +...-++.++.-..+..+++.++|
T Consensus 5 ~~~l~v~~~Dr~G~L~~I~~~la~~~inI~~i~~~~~~-~~~~~~i~v~~~~~~~l~~l~~~L 66 (88)
T 2ko1_A 5 LAGIRIVGEDKNGMTNQITGVISKFDTNIRTIVLNAKD-GIFTCNLMIFVKNTDKLTTLMDKL 66 (88)
T ss_dssp EEEEEEEEECCTTHHHHHHHHHTTSSSCEEEEEEEECS-SEEEEEEEEEESSHHHHHHHHHHH
T ss_pred EEEEEEEEECCCcHHHHHHHHHHHCCCCeEEEEEEEcC-CEEEEEEEEEECCHHHHHHHHHHH
Confidence 35788899999999999999999999999988876544 344455555554444445454444
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.39 E-value=0.06 Score=55.62 Aligned_cols=30 Identities=23% Similarity=0.462 Sum_probs=25.7
Q ss_pred ceeccCCCCcEEE------cCCCcEEEEeeCcceec
Q 010078 411 IIHRDLKAANLLM------DENEVVKVADFGVARVK 440 (518)
Q Consensus 411 IiHrDLKp~NILi------d~~~~vkL~DFGla~~~ 440 (518)
++|+|+.+.|||+ ++++.++++||..+...
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 6899999999999 45678999999998643
|
| >2f1f_A Acetolactate synthase isozyme III small subunit; ferredoxin fold, ACT domain, transferase; HET: P33 1PE; 1.75A {Escherichia coli} SCOP: d.58.18.6 d.58.18.6 | Back alignment and structure |
|---|
Probab=93.16 E-value=0.16 Score=46.05 Aligned_cols=63 Identities=22% Similarity=0.243 Sum_probs=50.9
Q ss_pred cceeeecCChhhHHHHHHHHHHhhcccceecccccCCC-CceeeEEEEcCCChhhHHHHHHHHHH
Q 010078 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSLDVFVVDGWPYEETEQLRAALEK 243 (518)
Q Consensus 180 ~ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~d-g~~ldv~vvdgw~~e~~~~l~~~l~~ 243 (518)
|.|.+-..|+|++|++++.++++-|.||.-..+..|.| |.+-=.|+|++ ..+..+++..++.+
T Consensus 4 ~~IsV~v~NrpGvLarIt~lfs~rg~NI~Sl~v~~t~d~~~sriti~V~~-d~~~leqI~kqL~K 67 (164)
T 2f1f_A 4 RILSVLLENESGALSRVIGLFSQRGYNIESLTVAPTDDPTLSRMTIQTVG-DEKVLEQIEKQLHK 67 (164)
T ss_dssp EEEEEEEECCTTHHHHHHHHHHTTTCCCSEEEEEECSCSSEEEEEEEEES-CHHHHHHHHHHHHH
T ss_pred EEEEEEEeCCCcHHHHHHHHHHHCCCCeeeceeeecCCCCEEEEEEEEec-cHHHHHHHHHHHcC
Confidence 78888899999999999999999999999988888775 88887888883 34445555555543
|
| >2nyi_A Unknown protein; protein structure initiative, PSI, center for eukaryotic structural genomics, CESG, structural genomics; 1.80A {Galdieria sulphuraria} | Back alignment and structure |
|---|
Probab=91.91 E-value=0.18 Score=46.78 Aligned_cols=69 Identities=19% Similarity=0.095 Sum_probs=48.9
Q ss_pred cccceeeecCChhhHHHHHHHHHHhhcccceecccccCC------CCceeeEEEEcCCChhhHHHHHHHHHHHHHHh
Q 010078 178 PMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTV------DGYSLDVFVVDGWPYEETEQLRAALEKEVLKL 248 (518)
Q Consensus 178 ~~~ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~------dg~~ldv~vvdgw~~e~~~~l~~~l~~~~~~~ 248 (518)
.-+-|++++.|+|+++..++.+|++.|+||.++..|..- +-|.+.+ .++.-.... ++|+++|.....++
T Consensus 92 ~~~iltv~g~DrpGiva~Vt~~La~~g~nI~~~~~~t~~~~~~~~~~F~m~~-~~~~~~~~~-~~l~~~l~~~a~~l 166 (195)
T 2nyi_A 92 REYELYVEGPDSEGIVEAVTAVLAKKGANIVELETETLPAPFAGFTLFRMGS-RVAFPFPLY-QEVVTALSRVEEEF 166 (195)
T ss_dssp EEEEEEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEEECSSTTCEEEEEEE-EEEEEGGGH-HHHHHHHHHHHHHH
T ss_pred cEEEEEEEeCCCcCHHHHHHHHHHHcCCCEEEceeeecccccCCCCeEEEEE-EEEcCCCcc-HHHHHHHHHHHHHc
Confidence 346799999999999999999999999999999998643 2222222 222112334 77888887655443
|
| >2pc6_A Probable acetolactate synthase isozyme III (small; regulatory subunit, structural genomi protein structure initiative; HET: MSE; 2.50A {Nitrosomonas europaea atcc 19718} SCOP: d.58.18.6 d.58.18.6 | Back alignment and structure |
|---|
Probab=91.70 E-value=0.29 Score=44.34 Aligned_cols=62 Identities=29% Similarity=0.402 Sum_probs=49.3
Q ss_pred cceeeecCChhhHHHHHHHHHHhhcccceecccccCCC-CceeeEEEEcCCChhhHHHHHHHHH
Q 010078 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSLDVFVVDGWPYEETEQLRAALE 242 (518)
Q Consensus 180 ~ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~d-g~~ldv~vvdgw~~e~~~~l~~~l~ 242 (518)
|.|.+-..|+|+.|++++.++++-|+||.-..+..|.| |.+-=.++|++ ..+..+++..++.
T Consensus 5 ~~IsV~veNrpGvL~rI~~lfs~rg~NI~Sl~v~~t~d~g~sritivV~~-d~~~leql~kQL~ 67 (165)
T 2pc6_A 5 HIISLLMENEAGALSRVAGLFSARGYNIESLSVAPTEDPTLSRMTLVTNG-PDEIVEQITKQLN 67 (165)
T ss_dssp EEEEEEEECSTTHHHHHHHHHHHHTCCCCEEEEEECSSTTEEEEEEEEEE-CHHHHHHHHHHHH
T ss_pred EEEEEEEeCCCcHHHHHHHHHHHCCCcEEEEEEEecCCCCEEEEEEEEec-cHHHHHHHHHHhc
Confidence 78888889999999999999999999999988887774 77777778873 3444445554444
|
| >1u8s_A Glycine cleavage system transcriptional repressor, putative; structural genomics, protein structure initiative (PSI), domain swapping; 2.45A {Vibrio cholerae} SCOP: d.58.18.5 d.58.18.5 | Back alignment and structure |
|---|
Probab=90.28 E-value=0.5 Score=43.42 Aligned_cols=70 Identities=16% Similarity=0.075 Sum_probs=49.8
Q ss_pred ccceeeecCChhhHHHHHHHHHHhhcccceecccccCC-------CCceeeEEEEcCCChhhHHHHHHHHHHHHHHh
Q 010078 179 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTV-------DGYSLDVFVVDGWPYEETEQLRAALEKEVLKL 248 (518)
Q Consensus 179 ~~ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~-------dg~~ldv~vvdgw~~e~~~~l~~~l~~~~~~~ 248 (518)
.+-|++.+.|+|+++..++.+|++.|+||.++..|+.- .+...--+.++.-.....++|+++|.....++
T Consensus 93 ~~~l~v~~~D~~Gil~~v~~~l~~~~~nI~~~~~~t~~~~~~~~~~~~F~~~~~~~~~~~~~~~~l~~~l~~~~~~~ 169 (192)
T 1u8s_A 93 TVEVYVESDDKLGLTEKFTQFFAQRQIGMASLSAQTISKDKLHSEQNQFHIAISARVDSGCNLMQLQEEFDALCTAL 169 (192)
T ss_dssp EEEEEEEESCCTTHHHHHHHHHHHTTCCEEEEEEEEEC--------CEEEEEEEEEECTTSCHHHHHHHHHHHHHHH
T ss_pred eEEEEEEeCCCccHHHHHHHHHHHcCCcHHHhhhhcccCCccCCCCCEEEEEEEEeCCCCCCHHHHHHHHHHHHHHh
Confidence 56899999999999999999999999999999998543 12211122233222336788888888755553
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=90.05 E-value=0.023 Score=60.16 Aligned_cols=60 Identities=8% Similarity=0.047 Sum_probs=16.3
Q ss_pred eeeeeeeecCceEEEEEEECC--ceEEE------EEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeec
Q 010078 295 KFGSKVASGSYGDLYRGTYCS--QDVAI------KVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357 (518)
Q Consensus 295 ~i~~~LG~G~fG~Vy~g~~~~--~~vAV------Kvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~ 357 (518)
.+.++|| ||.||+|.+++ .+||+ |..+......+....|.+|..+++.++|+|+++.+++
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f 212 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNF 212 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcce
Confidence 3445676 99999999875 47888 7766544455555678899999999999999998775
|
| >3nrb_A Formyltetrahydrofolate deformylase; N-terminal ACT domain, structural genomics, joint center for structural genomics, JCSG; HET: MSE FLC; 2.05A {Pseudomonas putida} | Back alignment and structure |
|---|
Probab=84.32 E-value=0.87 Score=44.96 Aligned_cols=63 Identities=22% Similarity=0.347 Sum_probs=45.4
Q ss_pred cceeeecCChhhHHHHHHHHHHhhcccceecccccCC-CCceeeEEEEcCCChhhHHHHHHHHHH
Q 010078 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTV-DGYSLDVFVVDGWPYEETEQLRAALEK 243 (518)
Q Consensus 180 ~ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~-dg~~ldv~vvdgw~~e~~~~l~~~l~~ 243 (518)
+=+|+++.|+|++..++|..|++.|.||.+...|.+. .|+..=...++. +....++|+++|+.
T Consensus 8 ~vLtv~c~Dr~GIVa~Vs~~La~~g~NI~d~~q~~d~~~g~Ffmr~~~~~-~~~~~~~L~~~f~~ 71 (287)
T 3nrb_A 8 YVLSLACQDAPGIVSEVSTFLFNNGANIVEAEQFNDEDSSKFFMRVSVEI-PVAGVNDFNSAFGK 71 (287)
T ss_dssp EEEEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEETTTTEEEEEEEEEC-CC---CHHHHHHHH
T ss_pred EEEEEECCCCCCHHHHHHHHHHHCCCCEEeeeeeecCCCCeEEEEEEEEc-CCCCHHHHHHHHHH
Confidence 3589999999999999999999999999999999533 554444444443 22234467777754
|
| >3n0v_A Formyltetrahydrofolate deformylase; formyl transferase, ACT domain, structural genomics, joint C structural genomics, JCSG; HET: MSE; 2.25A {Pseudomonas putida} | Back alignment and structure |
|---|
Probab=84.29 E-value=1.5 Score=43.27 Aligned_cols=66 Identities=15% Similarity=0.075 Sum_probs=48.6
Q ss_pred cceeeecCChhhHHHHHHHHHHhhcccceecccccC-CCCceeeEEEEcCCChhhHHHHHHHHHHHH
Q 010078 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFST-VDGYSLDVFVVDGWPYEETEQLRAALEKEV 245 (518)
Q Consensus 180 ~ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst-~dg~~ldv~vvdgw~~e~~~~l~~~l~~~~ 245 (518)
+-+|+++.|+|++..++|..|++.|.||.+...|.. ..|+..=...++.-.....++|+++|..-.
T Consensus 9 ~vLtv~c~DrpGIVa~Vs~~La~~g~NI~d~~q~~d~~~g~Ffmr~~~~~~~~~~~~~L~~~f~~la 75 (286)
T 3n0v_A 9 WILTADCPSMLGTVDVVTRYLFEQRCYVTEHHSFDDRQSGRFFIRVEFRQPDDFDEAGFRAGLAERS 75 (286)
T ss_dssp EEEEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEETTTTEEEEEEEEECCSSCCHHHHHHHHHHHH
T ss_pred EEEEEEeCCCCCHHHHHHHHHHHCCCCeeeeeeeccCCCCeeEEEEEEecCCCCCHHHHHHHHHHHH
Confidence 469999999999999999999999999999999942 234443344444322235677888886543
|
| >2fgc_A Acetolactate synthase, small subunit; regulatory subunit, structural genomi protein structure initiative; 2.30A {Thermotoga maritima} SCOP: d.58.18.6 d.58.18.6 | Back alignment and structure |
|---|
Probab=83.42 E-value=1.1 Score=41.44 Aligned_cols=62 Identities=24% Similarity=0.326 Sum_probs=48.6
Q ss_pred cceeeecCChhhHHHHHHHHHHhhcccceecccccCCC-CceeeEEEEcCCChhhHHHHHHHHH
Q 010078 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSLDVFVVDGWPYEETEQLRAALE 242 (518)
Q Consensus 180 ~ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~d-g~~ldv~vvdgw~~e~~~~l~~~l~ 242 (518)
|-|++-..|+|+.|++++.++++-|+||.--.+..|.| |.+-=.++|++- ....+++..++.
T Consensus 30 ~~LsVlVeN~pGvLaRItglfsrRG~NI~SLtV~~ted~gisRitIvV~g~-e~~ieqL~kQL~ 92 (193)
T 2fgc_A 30 HLVSMLVHNKPGVMRKVANLFARRGFNISSITVGESETPGLSRLVIMVKGD-DKTIEQIEKQAY 92 (193)
T ss_dssp EEEEEEEECCTTHHHHHHHHHHTTTCEEEEEEEEECSSTTEEEEEEEEEEC-TTHHHHHHHHHT
T ss_pred EEEEEEECCCChHHHHHHHHHHHCCceEEEEEeeccCCCCEEEEEEEEECC-HHHHHHHHHHhc
Confidence 78888888999999999999999999999888887766 777667788754 334455555444
|
| >3obi_A Formyltetrahydrofolate deformylase; structural genomics, joint center for structural genomics, J protein structure initiative; HET: MSE; 1.95A {Rhodopseudomonas palustris} | Back alignment and structure |
|---|
Probab=83.12 E-value=1.6 Score=43.07 Aligned_cols=67 Identities=21% Similarity=0.260 Sum_probs=50.1
Q ss_pred cceeeecCChhhHHHHHHHHHHhhcccceecccccCC-CCceeeEEEEcCCCh--hhHHHHHHHHHHHHHH
Q 010078 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTV-DGYSLDVFVVDGWPY--EETEQLRAALEKEVLK 247 (518)
Q Consensus 180 ~ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~-dg~~ldv~vvdgw~~--e~~~~l~~~l~~~~~~ 247 (518)
+-+|+++.|+|++..++|..|++.|.||.+...|.+. .|+..=...++ ++. ...++|+++|+.--.+
T Consensus 7 ~iLtv~g~DrpGIVa~Vs~~La~~g~NI~d~~q~~d~~~g~Ffmr~~~~-~~~~~~~~~~L~~~f~~la~~ 76 (288)
T 3obi_A 7 YVLTLSCPDRAGIVSAVSTFLFENGQNILDAQQYNDTESGHFFMRVVFN-AAAKVIPLASLRTGFGVIAAK 76 (288)
T ss_dssp EEEEEEEECCTTHHHHHHHHHHHTTEEEEEEEEEEETTTTEEEEEEEEE-ESSCCCCHHHHHHHHHHHHHH
T ss_pred EEEEEECCCCCCHHHHHHHHHHHCCCcEEeeeeeecCCCCceEEEEEEE-cCCCCCCHHHHHHHHHHHHHH
Confidence 4599999999999999999999999999999999543 55544444444 332 3577888888754333
|
| >3lou_A Formyltetrahydrofolate deformylase; structural genomics, JOI for structural genomics, JCSG, protein structure initiative hydrolase; HET: MSE; 1.90A {Burkholderia mallei} | Back alignment and structure |
|---|
Probab=82.25 E-value=1.7 Score=42.93 Aligned_cols=68 Identities=15% Similarity=0.139 Sum_probs=49.0
Q ss_pred cceeeecCChhhHHHHHHHHHHhhcccceeccccc-CCCCceeeEEEEcCC--C-hhhHHHHHHHHHHHHHH
Q 010078 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFS-TVDGYSLDVFVVDGW--P-YEETEQLRAALEKEVLK 247 (518)
Q Consensus 180 ~ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fs-t~dg~~ldv~vvdgw--~-~e~~~~l~~~l~~~~~~ 247 (518)
+-+|+++.|+|++..++|..|++-|.||.+...|. ...|+..=...++.- . ....++|+++|+.--.+
T Consensus 11 ~vLtv~c~Dr~GIVa~Vs~~La~~g~NI~d~~q~~d~~~g~Ffmr~~~~~~~~~~~~~~~~L~~~f~~la~~ 82 (292)
T 3lou_A 11 FVLTLSCPSAAGQVAAVVGLLDRHRCYVDELTVFDDDLSARFFVRCVFHATDDADALRVDALRREFEPIAER 82 (292)
T ss_dssp EEEEEEEESCSCHHHHHHHHHHHTTEEEEEEEEEEETTTTEEEEEEEEEECC----CCHHHHHHHHHHHHHH
T ss_pred EEEEEEcCCCCCHHHHHHHHHHHCCCCEEeeEEEecCCCCceEEEEEEEccCcccCCCHHHHHHHHHHHHHh
Confidence 45999999999999999999999999999999994 234444433444432 1 23567888888654433
|
| >3p96_A Phosphoserine phosphatase SERB; ssgcid, structural genomics, structural genomics center for infectious disease, hydrolas; 2.05A {Mycobacterium avium} | Back alignment and structure |
|---|
Probab=81.33 E-value=1.1 Score=46.25 Aligned_cols=66 Identities=23% Similarity=0.316 Sum_probs=48.0
Q ss_pred cceeeecCChhhHHHHHHHHHHhhcccceecccccCCCCceeeEEEEcCCChh--hHHHHHHHHHHHHHH
Q 010078 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYE--ETEQLRAALEKEVLK 247 (518)
Q Consensus 180 ~ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~dg~~ldv~vvdgw~~e--~~~~l~~~l~~~~~~ 247 (518)
.=||+++.|+|++.+.++..|++.|.||.+...+...+-|++-+. |+. +.. ..++|+++|...-.+
T Consensus 13 ~~lt~~g~Dr~Giv~~vs~~l~~~~~nI~d~~q~~~~~~f~~~~~-~~~-~~~~~~~~~l~~~l~~~~~~ 80 (415)
T 3p96_A 13 VLITVTGVDQPGVTATLFEVLSRHGVELLNVEQVVIRHRLTLGVL-VCC-PADVADGPALRHDVEAAIRK 80 (415)
T ss_dssp EEEEEEEECCTTHHHHHHHHHTTTTCEEEEEEEEEETTEEEEEEE-EEE-CHHHHTSHHHHHHHHHHHHH
T ss_pred EEEEEEcCCCCCHHHHHHHHHHHCCCCEEEeeeEEECCEeEEEEE-EEe-cCCcCCHHHHHHHHHHHHHH
Confidence 359999999999999999999999999999998865544444433 332 222 347788888764333
|
| >3o1l_A Formyltetrahydrofolate deformylase; structural genomics, joint center for structural genomics, J protein structure initiative; HET: MSE; 2.20A {Pseudomonas syringae PV} | Back alignment and structure |
|---|
Probab=80.46 E-value=2.5 Score=42.00 Aligned_cols=67 Identities=15% Similarity=0.182 Sum_probs=50.0
Q ss_pred cceeeecCChhhHHHHHHHHHHhhcccceecccccC-CCCceeeEEEEcCCCh--hhHHHHHHHHHHHHHH
Q 010078 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFST-VDGYSLDVFVVDGWPY--EETEQLRAALEKEVLK 247 (518)
Q Consensus 180 ~ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst-~dg~~ldv~vvdgw~~--e~~~~l~~~l~~~~~~ 247 (518)
+=+|+++.|+|++...+|..|++.|.||.+...|.. ..|+..=...++ ++. ...++|+++|+.--.+
T Consensus 23 ~iLtv~c~DrpGIVa~VS~~La~~g~NI~d~~q~~d~~~g~FfMr~~~~-~~~~~~~~~~L~~~l~~la~~ 92 (302)
T 3o1l_A 23 FRLVIACPDRVGIVAKVSNFLASHNGWITEASHHSDNLSGWFFMRHEIR-ADTLPFDLDGFREAFTPIAEE 92 (302)
T ss_dssp EEEEEEEECCTTHHHHHHHHHHHTTCCEEEEEEEEETTTTEEEEEEEEE-GGGSSSCHHHHHHHHHHHHHH
T ss_pred EEEEEECCCCCCHHHHHHHHHHHCCCCEEEeeEEecCCCCeEEEEEEEe-cCCCCCCHHHHHHHHHHHHHH
Confidence 359999999999999999999999999999999853 245544444444 322 3577888888754433
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.19 E-value=3.1 Score=39.19 Aligned_cols=115 Identities=10% Similarity=0.100 Sum_probs=73.6
Q ss_pred CCCcceEEeecccCCCCcceeeeecCCC-chhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC
Q 010078 347 RHKNVVQFIGACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE 425 (518)
Q Consensus 347 ~HpnIv~l~g~~~~~~~~~lV~Ey~~gg-sL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~ 425 (518)
.||++++. .+-...+.+.+.++.-+.+ ++.. ++ .++....++++.+|+....+++ .-+|--|.|+||+++.
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik----~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~~ 114 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK----SFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFTR 114 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG----GSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEECT
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH----hcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEcC
Confidence 57888765 3334444555555443322 2222 33 3678889999999988775443 3467789999999999
Q ss_pred CCcEEEEeeCcceecccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCC
Q 010078 426 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490 (518)
Q Consensus 426 ~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~ 490 (518)
++.+++.-.|+.... +|. .++...=+-.+=|++..+++++..|+
T Consensus 115 ~~~p~i~~RGik~~l----------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 115 DGLPIAKTRGLQNVV----------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp TSCEEESCCEETTTB----------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred CCCEEEEEccCccCC----------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999877654211 121 23333445566677888888887774
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 518 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-76 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-61 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-59 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-59 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-58 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-56 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-54 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-54 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-53 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-53 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-52 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-52 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-52 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-51 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-51 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-50 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-48 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-48 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-47 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-44 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-43 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-43 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-38 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-36 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-34 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-17 | |
| d1ygya3 | 78 | d.58.18.1 (A:452-529) Phosphoglycerate dehydrogena | 1e-04 | |
| d1u8sa1 | 86 | d.58.18.5 (A:2-87) putative transcriptional repres | 1e-04 | |
| d1sc6a3 | 84 | d.58.18.1 (A:327-410) Phosphoglycerate dehydrogena | 2e-04 | |
| d1y7pa2 | 77 | d.58.18.12 (A:2-78) Hypothetical protein AF1403, N | 4e-04 | |
| d1zpva1 | 83 | d.58.18.7 (A:1-83) UPF0237 protein SP0238 {Strepto | 8e-04 | |
| d2pc6a2 | 77 | d.58.18.6 (A:1-77) Acetolactate synthase small sub | 0.001 | |
| d2f06a1 | 71 | d.58.18.11 (A:71-141) Hypothetical protein BT0572 | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (609), Expect = 5e-76
Identities = 88/226 (38%), Positives = 139/226 (61%), Gaps = 8/226 (3%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMR 344
D WEI + G ++ SGS+G +Y+G + DVA+K+L + F EV ++R
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 404
K RH N++ F+G T P L IVT++ G S+Y +LH ++ F++ L+ +A ++GM+
Sbjct: 60 KTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ---SGVMTAETGTYRWMAPEVI 461
YLH +IIHRDLK+ N+ + E+ VK+ DFG+A VK++ S +G+ WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 462 EHK---PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504
+ PY ++DV++FGIVL+EL+TG+LPY + + +V +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 224
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 1e-64
Identities = 78/229 (34%), Positives = 122/229 (53%), Gaps = 9/229 (3%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
W ++ K LK + G +GD+ G Y VA+K +K N + F E +M ++
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 57
Query: 347 RHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMN 404
RH N+VQ +G + L IVTE+M+ GS+ DYL + + V LLK ++DV + M
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 464
YL NN +HRDL A N+L+ E+ V KV+DFG+ + + + +W APE + K
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREK 175
Query: 465 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHSFLEQ 512
+ K+DV+SFGI+LWE+ + G++PY + V + +
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG 224
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 1e-61
Identities = 56/206 (27%), Positives = 108/206 (52%), Gaps = 6/206 (2%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
E+ + S++ +G+ G +++ ++ +A K++ E I ++ + +E+ ++ +
Sbjct: 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHE 60
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 405
+V F GA + I E M GGS+ L K G L KV+I V KG+ Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTY 119
Query: 406 LHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 464
L + + I+HRD+K +N+L++ +K+ DFGV+ + + + GT +M+PE ++
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQGT 178
Query: 465 PYDHKADVFSFGIVLWELLTGKLPYE 490
Y ++D++S G+ L E+ G+ P
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIP 204
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 5e-61
Identities = 75/219 (34%), Positives = 126/219 (57%), Gaps = 7/219 (3%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
IDPK L F ++ +G +G + G + DVAIK++K ++ + EF +E +M +
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLS 57
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H+ +VQ G CTK + I+TE+M+ G + +YL +++ F+ LL++ DV + M YL
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMTAETGTYRWMAPEVIEHKP 465
+HRDL A N L+++ VVKV+DFG++R RW PEV+ +
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 466 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503
+ K+D+++FG+++WE+ + GK+PYE T + A + Q
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 216
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 5e-61
Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 7/213 (3%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS-DMQKEFAQEVFIM 343
W ++ + G + G +G++Y +A+KVL ++ ++ + +EV I
Sbjct: 3 WALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 60
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
+RH N+++ G + ++ E+ G+VY L K F +++ +
Sbjct: 61 SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANAL 119
Query: 404 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH 463
+Y H +IHRD+K NLL+ +K+ADFG + A S T GT ++ PE+IE
Sbjct: 120 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG 178
Query: 464 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 496
+ +D K D++S G++ +E L GK P+E T +
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 211
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 8e-60
Identities = 67/231 (29%), Positives = 121/231 (52%), Gaps = 11/231 (4%)
Query: 288 EIDPK-HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMR 344
+++P+ + ++ G++G +Y+ S A KV+ + + + +++ E+ I+
Sbjct: 7 DLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILA 64
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 404
H N+V+ + A +L I+ EF +GG+V + +L+ + V +N
Sbjct: 65 SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 124
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVI-- 461
YLH N IIHRDLKA N+L + +K+ADFGV+ ++ + GT WMAPEV+
Sbjct: 125 YLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184
Query: 462 ---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSF 509
+ +PYD+KADV+S GI L E+ + P+ L P++ + + + +
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL 235
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 2e-59
Identities = 65/225 (28%), Positives = 110/225 (48%), Gaps = 12/225 (5%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
D + LKF ++ GS+ +Y+G +VA L+ ++ ++ F +E +++ +
Sbjct: 6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL 65
Query: 347 RHKNVVQFIGACTKP----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
+H N+V+F + + +VTE M+ G++ YL + V K+ L + KG
Sbjct: 66 QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKG 124
Query: 403 MNYLHQNN--IIHRDLKAAN-LLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 459
+ +LH IIHRDLK N + VK+ D G+A +K ++ A GT +MAPE
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-RASFAKAVIGTPEFMAPE 183
Query: 460 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504
+ E K YD DV++FG+ + E+ T + PY V
Sbjct: 184 MYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 227
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 9e-59
Identities = 71/218 (32%), Positives = 126/218 (57%), Gaps = 9/218 (4%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIM 343
D WE+ + LK ++ +G +G+++ G Y VA+K LK ++ F E +M
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLM 62
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKG 402
++++H+ +V+ T+ P + I+TE+M GS+ D+L G+ + LL +A +++G
Sbjct: 63 KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGTYRWMAPEV 460
M ++ + N IHRDL+AAN+L+ + K+ADFG+AR+ + +W APE
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181
Query: 461 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 497
I + + K+DV+SFGI+L E++T G++PY +T +
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 219
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 2e-58
Identities = 83/217 (38%), Positives = 129/217 (59%), Gaps = 9/217 (4%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIM 343
D WEI + L+ K+ G +G+++ GT+ VAIK LKP ++ + F QE +M
Sbjct: 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVM 66
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 402
+K+RH+ +VQ ++ P + IVTE+MS GS+ D+L G +LP L+ +A ++ G
Sbjct: 67 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGTYRWMAPEV 460
M Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+ + +W APE
Sbjct: 126 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 185
Query: 461 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ 496
+ + K+DV+SFGI+L EL T G++PY + +
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 222
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 2e-58
Identities = 77/213 (36%), Positives = 127/213 (59%), Gaps = 7/213 (3%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
IDP L F ++ SG +G ++ G + ++D VAIK ++ ++ +++F +E +M K+
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLS 58
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H +VQ G C + +C+V EFM G + DYL +G+F +LL + +DV +GM YL
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKP 465
+ +IHRDL A N L+ EN+V+KV+DFG+ R ++ +W +PEV
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 466 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 497
Y K+DV+SFG+++WE+ + GK+PYE + +
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 211
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (488), Expect = 1e-57
Identities = 70/242 (28%), Positives = 113/242 (46%), Gaps = 11/242 (4%)
Query: 280 PNDGTDVWEIDPKHL-KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ-KE 335
P+ ++ DP+ L ++ GS+G +Y + VAIK + S+ + ++
Sbjct: 2 PDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61
Query: 336 FAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKV 395
+EV ++K+RH N +Q+ G + + +V E+ G + K + + V
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAV 120
Query: 396 AIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRW 455
+G+ YLH +N+IHRD+KA N+L+ E +VK+ DFG A + A + GT W
Sbjct: 121 THGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF---VGTPYW 177
Query: 456 MAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSFLEQ 512
MAPEVI YD K DV+S GI EL K P + + A + Q +
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG 237
Query: 513 RL 514
Sbjct: 238 HW 239
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 2e-56
Identities = 73/227 (32%), Positives = 120/227 (52%), Gaps = 12/227 (5%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINS-DMQKEFAQEVFI 342
I K L+ K+ GS+G + RG + + VA+K LKP+ ++ + +F +EV
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
M + H+N+++ G PP + +VTE GS+ D L K +G F L +L + A+ V++G
Sbjct: 65 MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYRWMAP 458
M YL IHRDL A NLL+ ++VK+ DFG+ R + + W AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 459 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQK 504
E ++ + + H +D + FG+ LWE+ T G+ P+ L Q + ++
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 230
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 3e-56
Identities = 73/252 (28%), Positives = 120/252 (47%), Gaps = 35/252 (13%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINSDMQKEFAQE 339
WE ++L+FG + SG++G + T S VA+K+LK E+ +S ++ E
Sbjct: 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSE 90
Query: 340 VFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK-------------- 384
+ +M ++ H+N+V +GACT + ++ E+ G + +YL +
Sbjct: 91 LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150
Query: 385 --------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
V LL A V+KGM +L + +HRDL A N+L+ +VVK+ DFG+
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 437 ARVKAQSGVMTAET---GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 492
AR +WMAPE + Y K+DV+S+GI+LWE+ + G PY +
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270
Query: 493 TPLQAAVGVVQK 504
++Q
Sbjct: 271 PVDANFYKLIQN 282
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 6e-56
Identities = 54/222 (24%), Positives = 106/222 (47%), Gaps = 13/222 (5%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ + +GSYG + S + + K L + ++ EV ++R+++H N+V
Sbjct: 7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66
Query: 353 QFIGACTKPPS--LCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLH 407
++ + L IV E+ GG + + K + +L+V ++ + H
Sbjct: 67 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126
Query: 408 Q-----NNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVI 461
+ + ++HRDLK AN+ +D + VK+ DFG+AR + + A GT +M+PE +
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 186
Query: 462 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503
Y+ K+D++S G +L+EL P+ + + A + +
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 228
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 186 bits (472), Expect = 1e-55
Identities = 77/225 (34%), Positives = 125/225 (55%), Gaps = 8/225 (3%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 342
D WE++ + K+ G YG++Y G + S VA+K LK + + +EF +E +
Sbjct: 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAV 66
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 401
M++++H N+VQ +G CT+ P I+TEFM+ G++ DYL + + LL +A +S
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 126
Query: 402 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMTAETGTYRWMAPE 459
M YL + N IHRDL A N L+ EN +VKVADFG++R+ +W APE
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186
Query: 460 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504
+ + + K+DV++FG++LWE+ T + L +++K
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 231
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 1e-55
Identities = 58/206 (28%), Positives = 106/206 (51%), Gaps = 8/206 (3%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ G+YG++ + VA+K++ +R D + +E+ I + + H+NVV
Sbjct: 8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVV 66
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
+F G + + E+ SGG ++D + P + + G+ YLH I
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGIT 125
Query: 413 HRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD-H 468
HRD+K NLL+DE + +K++DFG+A V + ++ GT ++APE+++ + +
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185
Query: 469 KADVFSFGIVLWELLTGKLPYEYLTP 494
DV+S GIVL +L G+LP++ +
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWDQPSD 211
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 1e-55
Identities = 61/219 (27%), Positives = 111/219 (50%), Gaps = 8/219 (3%)
Query: 290 DP-KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
DP K K+ G+ G +Y + Q+VAI+ + + ++ E+ +MR+
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMREN 74
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
++ N+V ++ + L +V E+++GGS+ D + + + V + + + +L
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFL 132
Query: 407 HQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKP 465
H N +IHRD+K+ N+L+ + VK+ DFG + + + GT WMAPEV+ K
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 466 YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504
Y K D++S GI+ E++ G+ PY PL+A +
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-55
Identities = 64/218 (29%), Positives = 113/218 (51%), Gaps = 12/218 (5%)
Query: 289 IDPKHLKFGSKV-ASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIM 343
+D K L K SG++G + +G Y + VA+K+LK E + ++ E E +M
Sbjct: 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
+++ + +V+ IG C S +V E G + YL + K +++++ VS GM
Sbjct: 63 QQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGM 120
Query: 404 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYRWMAPE 459
YL ++N +HRDL A N+L+ K++DFG+++ + T +W APE
Sbjct: 121 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 460 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ 496
I + + K+DV+SFG+++WE + G+ PY + +
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 218
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 183 bits (465), Expect = 2e-54
Identities = 77/244 (31%), Positives = 122/244 (50%), Gaps = 15/244 (6%)
Query: 274 PYHLKIPNDGTD--VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPE 326
P+ + PN+ EID +K + +G +G++ G VAIK LK
Sbjct: 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65
Query: 327 RINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV 386
+++F E IM + H NV+ G TK + I+TEFM GS+ +L + G
Sbjct: 66 Y-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ 124
Query: 387 FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 446
F + L+ + ++ GM YL N +HRDL A N+L++ N V KV+DFG++R
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184
Query: 447 TAET------GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 499
T RW APE I+++ + +DV+S+GIV+WE+++ G+ PY +T
Sbjct: 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVIN 244
Query: 500 GVVQ 503
+ Q
Sbjct: 245 AIEQ 248
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 183 bits (465), Expect = 8e-54
Identities = 53/218 (24%), Positives = 102/218 (46%), Gaps = 10/218 (4%)
Query: 287 WEIDPKHL----KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEV 340
EI H+ ++ +G++G ++R T + + A K + + ++ +E+
Sbjct: 17 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEI 74
Query: 341 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 400
M +RH +V A + ++ EFMSGG +++ + ++ V
Sbjct: 75 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 134
Query: 401 KGMNYLHQNNIIHRDLKAANLLM--DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAP 458
KG+ ++H+NN +H DLK N++ + +K+ DFG+ + TGT + AP
Sbjct: 135 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 194
Query: 459 EVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 496
EV E KP + D++S G++ + LL+G P+ +
Sbjct: 195 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 232
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 1e-53
Identities = 62/227 (27%), Positives = 113/227 (49%), Gaps = 12/227 (5%)
Query: 287 WEIDPKHLKFGS-KVASGSYGDLYRGTYCS----QDVAIKVLKPERINSDMQKEFAQEVF 341
+ +L ++ G++G + +G Y DVAIKVLK +E +E
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQ 61
Query: 342 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 401
IM ++ + +V+ IG C L +V E GG ++ +L + + ++ ++ VS
Sbjct: 62 IMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120
Query: 402 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYRWMA 457
GM YL + N +HRDL A N+L+ K++DFG+++ + +A +W A
Sbjct: 121 GMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 458 PEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503
PE I + + ++DV+S+G+ +WE L+ G+ PY+ + + + Q
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 227
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 2e-53
Identities = 67/219 (30%), Positives = 114/219 (52%), Gaps = 10/219 (4%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVF 341
+EI + ++ G + G +GD+++G Y S + VAIK K + ++++F QE
Sbjct: 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEAL 60
Query: 342 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 401
MR+ H ++V+ IG T+ P + I+ E + G + +L K L SL+ A +S
Sbjct: 61 TMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 402 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPE 459
+ YL +HRD+ A N+L+ N+ VK+ DFG++R S A +WMAPE
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 460 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 497
I + + +DV+ FG+ +WE+L G P++ +
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 218
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 2e-53
Identities = 67/228 (29%), Positives = 114/228 (50%), Gaps = 11/228 (4%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEV 340
EI P + + +G +G++Y+G + VAIK LK + +F E
Sbjct: 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEA 60
Query: 341 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 400
IM + H N+++ G +K + I+TE+M G++ +L + G F + L+ + ++
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 401 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYRWM 456
GM YL N +HRDL A N+L++ N V KV+DFG++RV + + RW
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 457 APEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504
APE I ++ + +DV+SFGIV+WE++T + + +
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 228
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 181 bits (459), Expect = 6e-53
Identities = 42/208 (20%), Positives = 98/208 (47%), Gaps = 6/208 (2%)
Query: 293 HLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN 350
+ ++ SG++G ++R + + K + + E+ IM ++ H
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPK 87
Query: 351 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 410
++ A + ++ EF+SGG ++D + ++ +G+ ++H+++
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 147
Query: 411 IIHRDLKAANLLMDENE--VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 468
I+H D+K N++ + + VK+ DFG+A ++ T T + APE+++ +P
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGF 207
Query: 469 KADVFSFGIVLWELLTGKLPYEYLTPLQ 496
D+++ G++ + LL+G P+ L+
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAGEDDLE 235
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 1e-52
Identities = 71/230 (30%), Positives = 115/230 (50%), Gaps = 22/230 (9%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS----QDVAIKVLKPERINSDMQKEFAQEVFIM 343
+D +KF + G++G + + D AIK +K + D ++FA E+ ++
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVL 64
Query: 344 RKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHK---------------LKGVF 387
K+ H N++ +GAC L + E+ G++ D+L K
Sbjct: 65 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 388 KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT 447
LL A DV++GM+YL Q IHRDL A N+L+ EN V K+ADFG++R + T
Sbjct: 125 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184
Query: 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ 496
RWMA E + + Y +DV+S+G++LWE+++ G PY +T +
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 234
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-52
Identities = 68/250 (27%), Positives = 112/250 (44%), Gaps = 31/250 (12%)
Query: 278 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINS 330
++P D WE L FG + +G++G + T VA+K+LKP +
Sbjct: 11 QLPYD--HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HL 67
Query: 331 DMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK----- 384
++ E+ ++ + H N+V +GACT ++TE+ G + ++L + +
Sbjct: 68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127
Query: 385 ------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVA 432
L LL + V+KGM +L N IHRDL A N+L+ + K+
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKIC 187
Query: 433 DFGVARVKAQSGVMTAET---GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489
DFG+AR + +WMAPE I + Y ++DV+S+GI LWEL +
Sbjct: 188 DFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
Query: 490 EYLTPLQAAV 499
P+ +
Sbjct: 248 YPGMPVDSKF 257
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 5e-52
Identities = 44/206 (21%), Positives = 89/206 (43%), Gaps = 7/206 (3%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ G +G ++R S + K +K + Q +E+ I+ RH+N++
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNIL 64
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
+ L ++ EF+SG +++ ++ ++ V + + +LH +NI
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 413 HRDLKAANLLMD--ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 470
H D++ N++ + +K+ +FG AR + APEV +H
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 471 DVFSFGIVLWELLTGKLPYEYLTPLQ 496
D++S G +++ LL+G P+ T Q
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQ 210
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 7e-52
Identities = 49/215 (22%), Positives = 97/215 (45%), Gaps = 7/215 (3%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSD-MQKEFAQEVFIMR 344
+ P+ KFG + GS+ + + ++ AIK+L+ I + +E +M
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 404
++ H V+ L + G + Y+ K G F ++ +
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALE 122
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVI 461
YLH IIHRDLK N+L++E+ +++ DFG A+V + + GT ++++PE++
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 462 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 496
K +D+++ G ++++L+ G P+
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 217
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 175 bits (445), Expect = 2e-51
Identities = 53/207 (25%), Positives = 104/207 (50%), Gaps = 7/207 (3%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
F + +G++ ++ + VAIK + + + + E+ ++ K++H N+V
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIV 70
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
L ++ + +SGG ++D + + KG + ++ V + YLH I+
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIV 129
Query: 413 HRDLKAANLL---MDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK 469
HRDLK NLL +DE+ + ++DFG+++++ V++ GT ++APEV+ KPY
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKA 189
Query: 470 ADVFSFGIVLWELLTGKLPYEYLTPLQ 496
D +S G++ + LL G P+ +
Sbjct: 190 VDCWSIGVIAYILLCGYPPFYDENDAK 216
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (440), Expect = 7e-51
Identities = 66/252 (26%), Positives = 118/252 (46%), Gaps = 35/252 (13%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQE 339
E ++++ + G++G +++ VA+K+LK E ++DMQ +F +E
Sbjct: 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQRE 66
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-------------- 385
+M + + N+V+ +G C +C++ E+M+ G + ++L +
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 386 ---------VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
L +A V+ GM YL + +HRDL N L+ EN VVK+ADFG+
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 437 ARVKAQSGVMTAET---GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKL-PYEYL 492
+R + A+ RWM PE I + Y ++DV+++G+VLWE+ + L PY +
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246
Query: 493 TPLQAAVGVVQK 504
+ V
Sbjct: 247 AHEEVIYYVRDG 258
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 170 bits (432), Expect = 7e-50
Identities = 54/218 (24%), Positives = 103/218 (47%), Gaps = 17/218 (7%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS-------DMQKEFAQEVFIMRK 345
+ + G + R + ++ A+K++ S ++++ +EV I+RK
Sbjct: 6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65
Query: 346 VR-HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 404
V H N++Q +V + M G ++DYL + K K+ + + +
Sbjct: 66 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVIC 124
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-- 462
LH+ NI+HRDLK N+L+D++ +K+ DFG + + GT ++APE+IE
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECS 184
Query: 463 ----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 496
H Y + D++S G++++ LL G P+ + +
Sbjct: 185 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 222
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 8e-50
Identities = 70/231 (30%), Positives = 108/231 (46%), Gaps = 15/231 (6%)
Query: 287 WEIDPKHLK--FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQE 339
I P L F + G +G +Y GT D A+K L + +F E
Sbjct: 20 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTE 78
Query: 340 VFIMRKVRHKNVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 398
IM+ H NV+ +G C + S +V +M G + +++ + L+ +
Sbjct: 79 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-----VMTAETGTY 453
V+KGM +L +HRDL A N ++DE VKVADFG+AR T
Sbjct: 139 VAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 198
Query: 454 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503
+WMA E ++ + + K+DV+SFG++LWEL+T G PY + V ++Q
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 1e-49
Identities = 51/207 (24%), Positives = 100/207 (48%), Gaps = 6/207 (2%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKN 350
+ GS+G ++ + Q AIK LK + + + D++ ++ + H
Sbjct: 5 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 64
Query: 351 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 410
+ +L V E+++GG + ++ F L A ++ G+ +LH
Sbjct: 65 LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 411 IIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPYDHK 469
I++RDLK N+L+D++ +K+ADFG+ + GT ++APE++ + Y+H
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS 183
Query: 470 ADVFSFGIVLWELLTGKLPYEYLTPLQ 496
D +SFG++L+E+L G+ P+ +
Sbjct: 184 VDWWSFGVLLYEMLIGQSPFHGQDEEE 210
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 8e-49
Identities = 56/228 (24%), Positives = 107/228 (46%), Gaps = 28/228 (12%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 351
+ + + G +G+++RG + ++VA+K+ + E++ +RH+N+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENI 59
Query: 352 VQFIGACTKP----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
+ FI A K L +V+++ GS++DYL++ + ++K+A+ + G+ +LH
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLH 117
Query: 408 Q--------NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-----VMTAETGTYR 454
I HRDLK+ N+L+ +N +AD G+A + GT R
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 455 WMAPEVIE------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 496
+MAPEV++ H +AD+++ G+V WE+ Q
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 167 bits (424), Expect = 9e-49
Identities = 68/229 (29%), Positives = 112/229 (48%), Gaps = 16/229 (6%)
Query: 291 PKHL----KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS-DMQKEFAQEVFIM 343
P HL + G + G +++ +DVA+KVL+ + F +E
Sbjct: 2 PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNA 61
Query: 344 RKVRHKNVVQFIGAC----TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
+ H +V P IV E++ G ++ D +H +G ++V D
Sbjct: 62 AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADA 120
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET----GTYRW 455
+ +N+ HQN IIHRD+K AN+++ VKV DFG+AR A SG +T GT ++
Sbjct: 121 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 456 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504
++PE D ++DV+S G VL+E+LTG+ P+ +P+ A V++
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE 229
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 1e-48
Identities = 65/240 (27%), Positives = 117/240 (48%), Gaps = 21/240 (8%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFA 337
D WE+ + + ++ GS+G +Y G VAIK + + + EF
Sbjct: 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE-RIEFL 71
Query: 338 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--------- 388
E +M++ +VV+ +G ++ ++ E M+ G + YL L+
Sbjct: 72 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131
Query: 389 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---V 445
L ++++A +++ GM YL+ N +HRDL A N ++ E+ VK+ DFG+ R ++
Sbjct: 132 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 191
Query: 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG-KLPYEYLTPLQAAVGVVQK 504
RWM+PE ++ + +DV+SFG+VLWE+ T + PY+ L+ Q V++
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 251
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 2e-48
Identities = 74/253 (29%), Positives = 117/253 (46%), Gaps = 28/253 (11%)
Query: 279 IPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-------VAIKVLKPERINSD 331
+P D WE LK G + G++G + D VA+K+LK +S+
Sbjct: 1 LPYD-ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE 59
Query: 332 MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHK-------- 382
+ ++ ++ H NVV +GACTKP L ++ EF G++ YL
Sbjct: 60 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 119
Query: 383 -------LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435
K L L+ + V+KGM +L IHRDL A N+L+ E VVK+ DFG
Sbjct: 120 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 179
Query: 436 VARVKAQSGVMTAET---GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG-KLPYEY 491
+AR + + +WMAPE I + Y ++DV+SFG++LWE+ + PY
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239
Query: 492 LTPLQAAVGVVQK 504
+ + +++
Sbjct: 240 VKIDEEFCRRLKE 252
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 3e-48
Identities = 73/247 (29%), Positives = 120/247 (48%), Gaps = 32/247 (12%)
Query: 279 IPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERIN 329
+P D WE+ L G + G++G + D VA+K+LK +
Sbjct: 2 LPED--PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE 59
Query: 330 SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH------- 381
D+ + E+ +M+ + +HKN++ +GACT+ L ++ E+ S G++ +YL
Sbjct: 60 KDL-SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 118
Query: 382 --------KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVAD 433
+ L+ A V++GM YL IHRDL A N+L+ E+ V+K+AD
Sbjct: 119 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 178
Query: 434 FGVARVKAQSGVMTA---ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489
FG+AR +WMAPE + + Y H++DV+SFG++LWE+ T G PY
Sbjct: 179 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238
Query: 490 EYLTPLQ 496
+ +
Sbjct: 239 PGVPVEE 245
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 3e-47
Identities = 66/218 (30%), Positives = 114/218 (52%), Gaps = 12/218 (5%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFI 342
+ K + SG++G +Y+G + + VAIK L+ E + KE E ++
Sbjct: 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYV 64
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
M V + +V + +G C ++ ++T+ M G + DY+ + K LL + ++KG
Sbjct: 65 MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPE 459
MNYL ++HRDL A N+L+ + VK+ DFG+A++ +WMA E
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 460 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ 496
I H+ Y H++DV+S+G+ +WEL+T G PY+ + +
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 2e-46
Identities = 52/212 (24%), Positives = 102/212 (48%), Gaps = 11/212 (5%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSD----MQKEFAQEVFIMRKVRH 348
G ++ SG + + + S A K +K R S +++ +EV I+++++H
Sbjct: 13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
NV+ + ++ E ++GG ++D+L + K + + G+ YLH
Sbjct: 73 PNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHS 131
Query: 409 NNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 464
I H DLK N+++ + V +K+ DFG+A GT ++APE++ ++
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 465 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 496
P +AD++S G++ + LL+G P+ T +
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQE 223
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 160 bits (405), Expect = 1e-45
Identities = 60/215 (27%), Positives = 107/215 (49%), Gaps = 6/215 (2%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRH 348
+ + + +GS+G ++ + A+KVLK E + Q E E ++ V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
+++ G + ++ +++ GG ++ L K F P A +V + YLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 409 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 468
+II+RDLK N+L+D+N +K+ DFG A+ V GT ++APEV+ KPY+
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTYTLCGTPDYIAPEVVSTKPYNK 180
Query: 469 KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503
D +SFGI+++E+L G P+ ++ ++
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 215
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 1e-44
Identities = 48/216 (22%), Positives = 100/216 (46%), Gaps = 11/216 (5%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS---QDVAIKVLKPERINSDMQKEFAQEVFIMRK--- 345
+ + +++ G+YG +++ + VA+K ++ + M +EV ++R
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 346 VRHKNVVQFIGACTKPPS-----LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 400
H NVV+ CT + L +V E + + ++ + +
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 401 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEV 460
+G+++LH + ++HRDLK N+L+ + +K+ADFG+AR+ + +T+ T + APEV
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 186
Query: 461 IEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 496
+ Y D++S G + E+ K + + +
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 222
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 158 bits (401), Expect = 1e-44
Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 9/207 (4%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQ----EVFIMRKVRH 348
+ G +G++Y + A+K L +RI + A + ++
Sbjct: 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
+V A P L + + M+GG ++ +L + GVF + A ++ G+ ++H
Sbjct: 67 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHN 125
Query: 409 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYD 467
+++RDLK AN+L+DE+ V+++D G+A ++ A GT+ +MAPEV++ YD
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYD 184
Query: 468 HKADVFSFGIVLWELLTGKLPYEYLTP 494
AD FS G +L++LL G P+
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPFRQHKT 211
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 1e-43
Identities = 53/206 (25%), Positives = 95/206 (46%), Gaps = 11/206 (5%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 347
+ G + SG +G +Y G S VAIK ++ +RI+ + EV +++KV
Sbjct: 7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 348 -HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
V++ + +P S ++ E +G + V + + +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 407 HQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKP 465
H ++HRD+K N+L+D N +K+ DFG + + V T GT + PE I +
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 185
Query: 466 Y-DHKADVFSFGIVLWELLTGKLPYE 490
Y A V+S GI+L++++ G +P+E
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPFE 211
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 2e-43
Identities = 51/221 (23%), Positives = 96/221 (43%), Gaps = 18/221 (8%)
Query: 302 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGAC 358
G G + + + A+K+L+ + +EV + + + ++V+ +
Sbjct: 22 LGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVY 74
Query: 359 ----TKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
L IV E + GG ++ + F ++ + + + YLH NI H
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 134
Query: 414 RDLKAANLLMD---ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 470
RD+K NLL N ++K+ DFG A+ +T T ++APEV+ + YD
Sbjct: 135 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSC 194
Query: 471 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSFLE 511
D++S G++++ LL G P+ L + G+ ++ E
Sbjct: 195 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 3e-42
Identities = 51/209 (24%), Positives = 101/209 (48%), Gaps = 5/209 (2%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRH 348
+ + G++G + + + A+K+L+ E I + D E +++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
+ A LC V E+ +GG ++ +L + + VF ++ + YLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHS 123
Query: 409 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYD 467
++++RD+K NL++D++ +K+ DFG+ + G M GT ++APEV+E Y
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 468 HKADVFSFGIVLWELLTGKLPYEYLTPLQ 496
D + G+V++E++ G+LP+ +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHER 212
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 4e-42
Identities = 53/202 (26%), Positives = 99/202 (49%), Gaps = 8/202 (3%)
Query: 302 SGSYGDLYRGTYCS--QDVAIKVLKPERI---NSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
G + +Y+ + Q VAIK +K + + +E+ +++++ H N++ +
Sbjct: 8 EGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLD 67
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
A ++ +V +FM + + V + + +G+ YLHQ+ I+HRDL
Sbjct: 68 AFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDL 126
Query: 417 KAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVI-EHKPYDHKADVFS 474
K NLL+DEN V+K+ADFG+A+ + + T + T + APE++ + Y D+++
Sbjct: 127 KPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWA 186
Query: 475 FGIVLWELLTGKLPYEYLTPLQ 496
G +L ELL + L
Sbjct: 187 VGCILAELLLRVPFLPGDSDLD 208
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (378), Expect = 5e-42
Identities = 54/226 (23%), Positives = 93/226 (41%), Gaps = 17/226 (7%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ G K+ SGS+GD+Y GT + ++VAIK+ + + E I + ++ +
Sbjct: 10 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGVGI 65
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
I C ++ + G S+ D + F L ++L +A + + Y+H N I
Sbjct: 66 PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI 125
Query: 413 HRDLKAANLLM---DENEVVKVADFGVARVKAQSGV--------MTAETGTYRWMAPEVI 461
HRD+K N LM + +V + DFG+A+ + TGT R+ +
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 462 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHH 507
+ D+ S G VL G LP++ L +
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 231
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 9e-42
Identities = 47/213 (22%), Positives = 97/213 (45%), Gaps = 4/213 (1%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ K+ G+YG +Y+ + VA+K ++ + + +E+ +++++ H N+V
Sbjct: 5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
+ + L +V EF+ LP + + +G+ + H + ++
Sbjct: 65 KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 413 HRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPY-DHKA 470
HRDLK NLL++ +K+ADFG+AR T E T + APE++ Y
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 471 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503
D++S G + E++T + + + + + +
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 217
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 4e-41
Identities = 53/222 (23%), Positives = 100/222 (45%), Gaps = 15/222 (6%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIM 343
V+++ P++ S + G+YG + VAIK + P + + +E+ I+
Sbjct: 3 VFDVGPRY-TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKIL 60
Query: 344 RKVRHKNVVQFIGACTKPP----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
+ RH+N++ P + + G +Y L + +
Sbjct: 61 LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQI 118
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYRW 455
+G+ Y+H N++HRDLK +NLL++ +K+ DFG+ARV +G +T T +
Sbjct: 119 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 456 MAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 496
APE++ + Y D++S G +L E+L+ + + L
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 146 bits (370), Expect = 6e-41
Identities = 47/205 (22%), Positives = 92/205 (44%), Gaps = 4/205 (1%)
Query: 295 KFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 353
K+ G+YG +Y+ + A+K ++ E+ + + +E+ I+++++H N+V+
Sbjct: 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
L +V E + L +G + + + + G+ Y H ++H
Sbjct: 65 LYDVIHTKKRLVLVFEHLDQDL-KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 414 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRW-MAPEVIE-HKPYDHKAD 471
RDLK NLL++ +K+ADFG+AR W AP+V+ K Y D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 472 VFSFGIVLWELLTGKLPYEYLTPLQ 496
++S G + E++ G + ++
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEAD 208
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 1e-40
Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 17/225 (7%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ +K+ G++G++++ + Q VA+K + E +E+ I++ ++H+NVV
Sbjct: 13 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 72
Query: 353 QFIGACTKPPS--------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 404
I C S + +V +F + L F L + +V + G+
Sbjct: 73 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLLNGLY 131
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-----KAQSGVMTAETGTYRWMAPE 459
Y+H+N I+HRD+KAAN+L+ + V+K+ADFG+AR +Q T T + PE
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 460 VI-EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503
++ + Y D++ G ++ E+ T + T + Q
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 144 bits (365), Expect = 3e-40
Identities = 44/240 (18%), Positives = 89/240 (37%), Gaps = 20/240 (8%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 349
H K G ++ GS+G ++ GT Q VAIK + E + +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP----RRSDAPQLRDEYRTYKLLAGC 60
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
+ + + ++ + G S+ D L F + ++ A + + +H+
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 410 NIIHRDLKAANLLMDE-----NEVVKVADFGVARVKAQSGV--------MTAETGTYRWM 456
++++RD+K N L+ ++ V DFG+ + +GT R+M
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 457 APEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSFLEQRLRK 516
+ + + D+ + G V L G LP++ L +++ LR+
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ-KYERIGEKKQSTPLRE 239
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-39
Identities = 50/226 (22%), Positives = 102/226 (45%), Gaps = 5/226 (2%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ K+ G+YG +++ + VA+K ++ + + + +E+ ++++++HKN+V
Sbjct: 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
+ L +V EF + G + + KG+ + H N++
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVL 123
Query: 413 HRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIE-HKPYDHKA 470
HRDLK NLL++ N +K+A+FG+AR +AE T + P+V+ K Y
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 471 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSFLEQRLRK 516
D++S G + EL P + + + ++ + E++
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 143 bits (360), Expect = 6e-39
Identities = 55/205 (26%), Positives = 100/205 (48%), Gaps = 6/205 (2%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNV 351
+ +GS+G + + A+K+L +++ Q E E I++ V +
Sbjct: 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
V+ + +L +V E+++GG ++ +L + G F P A + YLH ++
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 412 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKAD 471
I+RDLK NLL+D+ ++V DFG A+ G GT +APE+I K Y+ D
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWTLCGTPEALAPEIILSKGYNKAVD 220
Query: 472 VFSFGIVLWELLTGKLPYEYLTPLQ 496
++ G++++E+ G P+ P+Q
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQ 245
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-38
Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 11/221 (4%)
Query: 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEV 340
WE+ + V SG+YG + VAIK L + K +E+
Sbjct: 10 TKTAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYREL 68
Query: 341 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFM----SGGSVYDYLHKLKGVFKLPSLLKVA 396
+++ +RH+NV+ + T +L T+F G+ L K + +
Sbjct: 69 RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLV 127
Query: 397 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM 456
+ KG+ Y+H IIHRDLK NL ++E+ +K+ DFG+AR MT T +
Sbjct: 128 YQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRWYR 185
Query: 457 APEVI-EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 496
APEVI Y D++S G ++ E++TGK ++ L
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 226
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 3e-37
Identities = 54/222 (24%), Positives = 98/222 (44%), Gaps = 13/222 (5%)
Query: 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEV 340
G + + K + + SG+ G + ++VAIK L N K +E+
Sbjct: 9 GDSTFTV-LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67
Query: 341 FIMRKVRHKNVVQFIGACTKPPS------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK 394
+M+ V HKN++ + T + + +V E M ++ +
Sbjct: 68 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN----LCQVIQMELDHERMSY 123
Query: 395 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 454
+ + G+ +LH IIHRDLK +N+++ + +K+ DFG+AR S +MT T
Sbjct: 124 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 183
Query: 455 WMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 496
+ APEVI Y D++S G ++ E++ K+ + +
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 7e-37
Identities = 51/221 (23%), Positives = 95/221 (42%), Gaps = 18/221 (8%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ +GS+G +Y+ C + VAIK + ++ + +E+ IMRK+ H N+V
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIV 76
Query: 353 QFIGACTKPPS------LCIVTEFMSGGSVYDYLH--KLKGVFKLPSLLKVAIDVSKGMN 404
+ L +V +++ H + K + + + + +
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 405 YLHQNNIIHRDLKAANL-LMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAP-EVIE 462
Y+H I HRD+K NL L + V+K+ DFG A+ + + + + AP +
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 463 HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503
Y DV+S G VL ELL G+ + + + V +++
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 135 bits (340), Expect = 3e-36
Identities = 44/222 (19%), Positives = 102/222 (45%), Gaps = 24/222 (10%)
Query: 283 GTDVWEIDPKHLKFGS--------KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDM 332
+ W+ + +++G+ K+ G Y +++ + + V +K+LKP +
Sbjct: 18 PREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----- 72
Query: 333 QKEFAQEVFIMRKVR-HKNVVQFIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKL 389
+K+ +E+ I+ +R N++ P S +V E ++ +L
Sbjct: 73 KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD----FKQLYQTLTD 128
Query: 390 PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSGVMTA 448
+ ++ K ++Y H I+HRD+K N+++D E+ +++ D+G+A
Sbjct: 129 YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 188
Query: 449 ETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY 489
+ + PE+ ++++ YD+ D++S G +L ++ K P+
Sbjct: 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 6e-36
Identities = 53/244 (21%), Positives = 115/244 (47%), Gaps = 13/244 (5%)
Query: 277 LKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSD 331
L+ N ++ ++ + + +G+YG ++ S + A+KVLK I
Sbjct: 9 LRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK 68
Query: 332 MQ--KEFAQEVFIMRKVRHK-NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK 388
+ + E ++ +R +V A L ++ ++++GG ++ +L + + F
Sbjct: 69 AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-RERFT 127
Query: 389 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--VKAQSGVM 446
+ ++ + +LH+ II+RD+K N+L+D N V + DFG+++ V ++
Sbjct: 128 EHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA 187
Query: 447 TAETGTYRWMAPEVIEHKP--YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504
GT +MAP+++ +D D +S G++++ELLTG P+ + + ++
Sbjct: 188 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR 247
Query: 505 VHHS 508
+ S
Sbjct: 248 ILKS 251
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (326), Expect = 4e-34
Identities = 50/213 (23%), Positives = 98/213 (46%), Gaps = 11/213 (5%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFI 342
+WE+ P+ + S V SG+YG + VA+K L + K +E+ +
Sbjct: 12 TIWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 343 MRKVRHKNVVQFIGACTKPPSLC-----IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 397
++ ++H+NV+ + T SL + + G + + + + +
Sbjct: 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIY 128
Query: 398 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMA 457
+ +G+ Y+H +IIHRDLK +NL ++E+ +K+ DFG+AR + +
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTGYVATRWYRAP 187
Query: 458 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490
++ Y+ D++S G ++ ELLTG+ +
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 106 bits (264), Expect = 1e-25
Identities = 39/220 (17%), Positives = 90/220 (40%), Gaps = 29/220 (13%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
K+ G + ++ VA+K+++ +++ + E+ ++++V +
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNT 72
Query: 353 QFIGACTKPP---------------SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 397
+ + +V E + + L + +++
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 398 DVSKGMNYLH-QNNIIHRDLKAANLLMDENEV------VKVADFGVARVKAQSGVMTAET 450
+ G++Y+H + IIH D+K N+LM+ + +K+AD G A + +
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS--I 190
Query: 451 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490
T + +PEV+ P+ AD++S +++EL+TG +E
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 76.7 bits (188), Expect = 8e-17
Identities = 22/195 (11%), Positives = 58/195 (29%), Gaps = 32/195 (16%)
Query: 297 GSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQK--------EFAQEVFIMRKVR 347
G + G ++ + +K K + K F+ +
Sbjct: 5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 348 HKNVVQFIGACTKPP----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
+ + + G ++ E + +Y ++ + +V + + +
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV--------RVENPDEVLDMILEEV 116
Query: 404 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYRWMAPE 459
+ I+H DL N+L+ E + + DF + + + + +
Sbjct: 117 AKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRNIITYFS-- 173
Query: 460 VIEHKPYDHKADVFS 474
+ Y + D+ S
Sbjct: 174 ----RTYRTEKDINS 184
|
| >d1ygya3 d.58.18.1 (A:452-529) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 78 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 38.7 bits (90), Expect = 1e-04
Identities = 12/62 (19%), Positives = 23/62 (37%), Gaps = 2/62 (3%)
Query: 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSLDVFVVDGWP-YEETEQL 237
+ D+P L ++ LL G+NIQ A + + + +D + +
Sbjct: 4 INLIIHYVDRPGALGKIGTLLGTAGVNIQAAQLSEDAEGPGATILLRLDQDVPDDVRTAI 63
Query: 238 RA 239
A
Sbjct: 64 AA 65
|
| >d1u8sa1 d.58.18.5 (A:2-87) putative transcriptional repressor VC2159 {Vibrio cholerae [TaxId: 666]} Length = 86 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Glycine cleavage system transcriptional repressor domain: putative transcriptional repressor VC2159 species: Vibrio cholerae [TaxId: 666]
Score = 38.6 bits (90), Expect = 1e-04
Identities = 10/62 (16%), Positives = 22/62 (35%), Gaps = 2/62 (3%)
Query: 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAAL 241
IT D+P + +++ L+ G NI + + ++ G ++ L
Sbjct: 8 ITAVGTDRPGICNEVVRLVTQAGCNI-IDSRIAMFGKEFTLLMLISG-SPSNITRVETTL 65
Query: 242 EK 243
Sbjct: 66 PL 67
|
| >d1sc6a3 d.58.18.1 (A:327-410) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Escherichia coli [TaxId: 562]} Length = 84 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain species: Escherichia coli [TaxId: 562]
Score = 38.2 bits (89), Expect = 2e-04
Identities = 12/62 (19%), Positives = 29/62 (46%), Gaps = 2/62 (3%)
Query: 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSLDVFVVDGWPYEET-EQL 237
+ +++P +L+ L + A+ G+NI + ++ GY + D E+ + +
Sbjct: 12 RRLMHIHENRPGVLTALNKIFAEQGVNIAAQYLQTSAQMGYVVIDIEADEDVAEKALQAM 71
Query: 238 RA 239
+A
Sbjct: 72 KA 73
|
| >d1y7pa2 d.58.18.12 (A:2-78) Hypothetical protein AF1403, N-terminal domain {Archaeon Archaeoglobus fulgidus [TaxId: 2234]} Length = 77 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: AF1403 N-terminal domain-like domain: Hypothetical protein AF1403, N-terminal domain species: Archaeon Archaeoglobus fulgidus [TaxId: 2234]
Score = 36.7 bits (85), Expect = 4e-04
Identities = 13/73 (17%), Positives = 32/73 (43%), Gaps = 3/73 (4%)
Query: 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYE-ETEQLRAA 240
+ ++K +L LT ++A+ G NI A F G ++ + E++
Sbjct: 4 LRIIAENKIGVLRDLTTIIAEEGGNITFAQTFLIKHGEHEGKALIYFEIEGGDFEKILER 63
Query: 241 LEK--EVLKLERQ 251
++ ++++E +
Sbjct: 64 VKTFDYIIEIEEE 76
|
| >d1zpva1 d.58.18.7 (A:1-83) UPF0237 protein SP0238 {Streptococcus pneumoniae [TaxId: 1313]} Length = 83 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: SP0238-like domain: UPF0237 protein SP0238 species: Streptococcus pneumoniae [TaxId: 1313]
Score = 36.3 bits (84), Expect = 8e-04
Identities = 13/62 (20%), Positives = 27/62 (43%), Gaps = 1/62 (1%)
Query: 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAAL 241
IT DK +++ ++ +A++GLNI + + +++ V + LR
Sbjct: 5 ITVVGKDKSGIVAGVSGKIAELGLNIDDISQTVLDEYFTMMAVVSSDEKQDF-TYLRNEF 63
Query: 242 EK 243
E
Sbjct: 64 EA 65
|
| >d2pc6a2 d.58.18.6 (A:1-77) Acetolactate synthase small subunit, IlvH {Nitrosomonas europaea [TaxId: 915]} Length = 77 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: IlvH-like domain: Acetolactate synthase small subunit, IlvH species: Nitrosomonas europaea [TaxId: 915]
Score = 35.8 bits (83), Expect = 0.001
Identities = 23/73 (31%), Positives = 34/73 (46%), Gaps = 4/73 (5%)
Query: 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSLDVFVVDGWPYEETEQLR 238
H I+ +++ LS++ L + G NI+ T D S V +G P E EQ+
Sbjct: 3 HIISLLMENEAGALSRVAGLFSARGYNIESLSVAPTEDPTLSRMTLVTNG-PDEIVEQIT 61
Query: 239 AALEK--EVLKLE 249
L K EV+KL
Sbjct: 62 KQLNKLIEVVKLI 74
|
| >d2f06a1 d.58.18.11 (A:71-141) Hypothetical protein BT0572 {Bacteroides thetaiotaomicron [TaxId: 818]} Length = 71 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: BT0572-like domain: Hypothetical protein BT0572 species: Bacteroides thetaiotaomicron [TaxId: 818]
Score = 33.9 bits (78), Expect = 0.004
Identities = 9/63 (14%), Positives = 27/63 (42%), Gaps = 6/63 (9%)
Query: 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAAL 241
+ S + P L+++ L+ G+ I+ ++F+ + + V ++ L
Sbjct: 2 VGISCPNVPGALAKVLGFLSAEGVFIEYMYSFANNN-VANVVIRPS-----NMDKCIEVL 55
Query: 242 EKE 244
+++
Sbjct: 56 KEK 58
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 518 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.46 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.88 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.61 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.83 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.75 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.42 | |
| d1u8sa1 | 86 | putative transcriptional repressor VC2159 {Vibrio | 96.24 | |
| d1zpva1 | 83 | UPF0237 protein SP0238 {Streptococcus pneumoniae [ | 96.1 | |
| d1u8sa2 | 93 | putative transcriptional repressor VC2159 {Vibrio | 93.46 | |
| d1ygya3 | 78 | Phosphoglycerate dehydrogenase, regulatory (C-term | 91.5 | |
| d1sc6a3 | 84 | Phosphoglycerate dehydrogenase, regulatory (C-term | 91.25 | |
| d2f06a1 | 71 | Hypothetical protein BT0572 {Bacteroides thetaiota | 90.58 | |
| d1y7pa2 | 77 | Hypothetical protein AF1403, N-terminal domain {Ar | 89.68 | |
| d2f06a2 | 70 | Hypothetical protein BT0572 {Bacteroides thetaiota | 89.12 | |
| d2pc6a2 | 77 | Acetolactate synthase small subunit, IlvH {Nitroso | 83.18 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=401.23 Aligned_cols=220 Identities=40% Similarity=0.745 Sum_probs=192.9
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCc
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~ 364 (518)
|+|+|+.++|+++++||+|+||+||+|++.+ .||||+++.........+.|.+|+.+|++++|||||++++++.. +.+
T Consensus 1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~ 78 (276)
T d1uwha_ 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL 78 (276)
T ss_dssp CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEE
Confidence 5799999999999999999999999998654 69999998776667777899999999999999999999998865 568
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS- 443 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~- 443 (518)
|+||||++||+|.+++....+.+++..+..++.||++||+|||++|||||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999999999877778999999999999999999999999999999999999999999999999999865432
Q ss_pred --CccccCCCCCcccCchhccC---CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcC
Q 010078 444 --GVMTAETGTYRWMAPEVIEH---KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVH 506 (518)
Q Consensus 444 --~~~~~~~gt~~y~APEvl~~---~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~ 506 (518)
.......||+.|||||++.+ .+|+.++|||||||+||||+||+.||.+.++.+.+..++.++.
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~ 226 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY 226 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTS
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC
Confidence 23345679999999999864 4589999999999999999999999999888777777666654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-48 Score=388.37 Aligned_cols=225 Identities=34% Similarity=0.619 Sum_probs=193.1
Q ss_pred CCceeeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~ 361 (518)
.+.|+|+.++|++.++||+|+||+||+|++. ++.||||+++..... .++|.+|+.+|++++|||||+++++|...
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence 4679999999999999999999999999984 678999999865433 45799999999999999999999999999
Q ss_pred CCcceeeeecCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceec
Q 010078 362 PSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~ 440 (518)
+.+|+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeec
Confidence 9999999999999999999753 456899999999999999999999999999999999999999999999999999876
Q ss_pred ccCCc--cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCchhHH
Q 010078 441 AQSGV--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHSFLE 511 (518)
Q Consensus 441 ~~~~~--~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp~ip 511 (518)
..... .....||+.|||||++.+..|+.++|||||||++|||++|..||........+..++.++.++.+|
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~ 238 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP 238 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCC
Confidence 54432 233457889999999999999999999999999999999665554444444455556666665443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-48 Score=381.68 Aligned_cols=223 Identities=26% Similarity=0.475 Sum_probs=194.0
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
++|++++.||+|+||+||+|++. ++.||||+++.... .......+.+|+.+|++++||||+++++++.++..+|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 47999999999999999999985 67899999874322 1223467889999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcccc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~ 448 (518)
||++||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 86 Ey~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-~~~~ 163 (263)
T d2j4za1 86 EYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTT 163 (263)
T ss_dssp ECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-CCEE
T ss_pred eecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-cccc
Confidence 99999999999986 567999999999999999999999999999999999999999999999999999765543 3455
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCc--hhHHHHHhh
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHH--SFLEQRLRK 516 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~r--p~ip~~~~~ 516 (518)
..||+.|||||++.+.+|+.++|||||||+||||++|+.||.+.++.+....+.+.... ..+++.+++
T Consensus 164 ~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 233 (263)
T d2j4za1 164 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 233 (263)
T ss_dssp TTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHH
T ss_pred cCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHH
Confidence 68999999999999999999999999999999999999999999998888776654322 234444443
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=383.79 Aligned_cols=211 Identities=28% Similarity=0.511 Sum_probs=190.0
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|++.++||+|+||+||+|++. ++.||||+++...... .+.+.+|+.+|++++|||||++++++..++.+|+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 56999999999999999999864 7889999987543322 4678999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-cccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~ 448 (518)
|++||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...... ....
T Consensus 98 y~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 175 (293)
T d1yhwa1 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (293)
T ss_dssp CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred ecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence 9999999998865 579999999999999999999999999999999999999999999999999998765433 4456
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcC
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVH 506 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~ 506 (518)
.+||+.|||||++.+.+|+.++|||||||++|+|+||+.||.+.+..+....++....
T Consensus 176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~ 233 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT 233 (293)
T ss_dssp CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS
T ss_pred cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC
Confidence 6899999999999999999999999999999999999999999999888887776543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-48 Score=382.64 Aligned_cols=214 Identities=25% Similarity=0.425 Sum_probs=180.4
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC--CCCccee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPSLCIV 367 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~--~~~~~lV 367 (518)
++|++.+.||+|+||.||+|++. ++.||||+++.........+.+.+|+.+|++++|||||++++++.+ ...+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999874 6789999998877777777889999999999999999999998854 4568999
Q ss_pred eeecCCCchhHHHhhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 368 TEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNN-----IIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~---~~~l~~~~i~~i~~qIa~aL~yLHs~g-----IiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
|||++||+|.+++.+. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998643 467999999999999999999999876 99999999999999999999999999987
Q ss_pred cccCC-ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 440 KAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 440 ~~~~~-~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
..... ......||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..+....+.+..
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~ 230 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 230 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC
T ss_pred cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC
Confidence 55433 3456789999999999999999999999999999999999999999999988887766543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=379.90 Aligned_cols=223 Identities=31% Similarity=0.598 Sum_probs=192.1
Q ss_pred CCceeeCCCCeeeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 284 ~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
.+.|+|+.++|+++++||+|+||.||+|++.+ +.||||+++..... .+.|.+|+.+|++++|||||++++++.. +
T Consensus 5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~ 80 (272)
T d1qpca_ 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (272)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence 46899999999999999999999999999864 67999999865433 3579999999999999999999998865 5
Q ss_pred CcceeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
.+|+||||+++|+|.+++.... ..+++..++.++.||++||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence 6899999999999999876533 368999999999999999999999999999999999999999999999999998765
Q ss_pred cCC--ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCchhHH
Q 010078 442 QSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHSFLE 511 (518)
Q Consensus 442 ~~~--~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~rp~ip 511 (518)
... ......||+.|||||++.+..|+.++|||||||++|||+| |.+||...+..+.... +.++.++.+|
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~-i~~~~~~~~p 232 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERGYRMVRP 232 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCC
T ss_pred CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHH-HHhcCCCCCc
Confidence 543 2345578999999999999999999999999999999999 5666777777666665 4455555443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=384.01 Aligned_cols=215 Identities=23% Similarity=0.438 Sum_probs=188.8
Q ss_pred CCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcce
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~l 366 (518)
.+++|++++.||+|+||+||+|++. ++.||||+++.... .......+.+|+.+|++++||||+++++++.+...+|+
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 3467999999999999999999874 67899999875322 12234678999999999999999999999999999999
Q ss_pred eeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC--
Q 010078 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-- 444 (518)
Q Consensus 367 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-- 444 (518)
||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 86 vmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 9999999999999876 5789999999999999999999999999999999999999999999999999998765332
Q ss_pred -ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 445 -VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 445 -~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.++.+....+++..
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~ 226 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 226 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC
Confidence 3345679999999999999999999999999999999999999999999988888876643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=391.03 Aligned_cols=226 Identities=31% Similarity=0.562 Sum_probs=195.0
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEee
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG 356 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g 356 (518)
..|+++.++|+++++||+|+||+||+|++.+ ..||+|++.... .......+.+|+.+|+++ +|||||++++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 4699999999999999999999999998743 258999987543 233456789999999998 8999999999
Q ss_pred cccCCCCcceeeeecCCCchhHHHhhhc----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 010078 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLK----------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414 (518)
Q Consensus 357 ~~~~~~~~~lV~Ey~~ggsL~~~l~~~~----------------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHr 414 (518)
++...+.+|+|||||+||+|.++++... +.+++..++.++.||++||.|||++|||||
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR 188 (325)
T d1rjba_ 109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188 (325)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 9999999999999999999999997643 247888999999999999999999999999
Q ss_pred cCCCCcEEEcCCCcEEEEeeCcceecccCCc---cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCC
Q 010078 415 DLKAANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE 490 (518)
Q Consensus 415 DLKp~NILid~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~ 490 (518)
||||+|||++.++.+||+|||+++....... .....||+.|||||++.+..|+.++|||||||++|||+| |+.||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 9999999999999999999999986554432 224467999999999999999999999999999999998 899999
Q ss_pred CCCHHHHHHHhhhhcCchhHH
Q 010078 491 YLTPLQAAVGVVQKVHHSFLE 511 (518)
Q Consensus 491 ~~~~~q~~~~iv~~~~rp~ip 511 (518)
+.+..+.+..+++++.++..|
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~p 289 (325)
T d1rjba_ 269 GIPVDANFYKLIQNGFKMDQP 289 (325)
T ss_dssp TCCCSHHHHHHHHTTCCCCCC
T ss_pred CCCHHHHHHHHHhcCCCCCCC
Confidence 988888888888888776544
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-47 Score=375.57 Aligned_cols=218 Identities=35% Similarity=0.691 Sum_probs=182.8
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCccee
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~-~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV 367 (518)
|++++|+++++||+|+||.||+|.+. ++.||||+++..... .++|.+|+.++++++||||++++|+|..++.+|+|
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 67889999999999999999999985 567999999865433 35799999999999999999999999999999999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCc--
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-- 445 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~-- 445 (518)
|||+++|+|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.......
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 999999999999988777899999999999999999999999999999999999999999999999999986554332
Q ss_pred cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCchhH
Q 010078 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHSFL 510 (518)
Q Consensus 446 ~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~rp~i 510 (518)
.....||+.|+|||++.+..|+.++|||||||++|||+| |++||...+..+....+. .+.++..
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~ 223 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYK 223 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH-HTCCCCC
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHH-hcCCCCC
Confidence 234578999999999999999999999999999999999 678888887777766644 4554433
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.4e-47 Score=382.64 Aligned_cols=219 Identities=33% Similarity=0.572 Sum_probs=182.6
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEECC--c---eEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS--Q---DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~~--~---~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
+++.++|++.++||+|+||+||+|++.. + .||||++.... .....+.|.+|+.+|++++|||||+++++|..++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 5777899999999999999999998742 2 48888877543 4455678999999999999999999999999999
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
.+|+|||||+||+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 99999999999999999988777899999999999999999999999999999999999999999999999999986544
Q ss_pred CCc------cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCch
Q 010078 443 SGV------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHS 508 (518)
Q Consensus 443 ~~~------~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~rp 508 (518)
... .....||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+....+.+ +.++
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~-~~~~ 252 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-DYRL 252 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCC
Confidence 321 122357899999999999999999999999999999998 8999999999887777544 4443
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=382.40 Aligned_cols=212 Identities=31% Similarity=0.516 Sum_probs=188.7
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
+.|+++++||+|+||.||+|++. ++.||||+++... ....+.+.+|+.+|++++|||||++++++..++.+|+|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 45899999999999999999974 6789999987542 2335678999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-Ccccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~-~~~~~ 448 (518)
|++||+|.+++.+..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .....
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~ 169 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccc
Confidence 99999999998876778999999999999999999999999999999999999999999999999999765432 23345
Q ss_pred CCCCCcccCchhcc-----CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 449 ETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 449 ~~gt~~y~APEvl~-----~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
..||+.|||||++. +..|+.++|||||||++|||+||+.||.+.++.+.+..+.+..
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~ 231 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE 231 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC
T ss_pred cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC
Confidence 68999999999983 5668999999999999999999999999999988888877643
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=377.94 Aligned_cols=201 Identities=29% Similarity=0.531 Sum_probs=176.6
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|+++++||+|+||+||+|++. ++.||||+++.... .+..+.+.+|+.+|++++||||+++++++.+++.+|+|||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 57999999999999999999975 67899999876532 2334678999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC---cc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VM 446 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~---~~ 446 (518)
|++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 84 y~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~ 162 (271)
T d1nvra_ 84 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162 (271)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred ccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence 9999999999976 5679999999999999999999999999999999999999999999999999998754432 34
Q ss_pred ccCCCCCcccCchhccCCCC-ChhhHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 447 TAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~~~-s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
+..+||+.|||||++.+.++ +.++|||||||++|||+||+.||...+.
T Consensus 163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~ 211 (271)
T d1nvra_ 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 211 (271)
T ss_dssp CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST
T ss_pred cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh
Confidence 55689999999999988886 5789999999999999999999976544
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=372.63 Aligned_cols=213 Identities=30% Similarity=0.542 Sum_probs=183.2
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC----CCCcc
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK----PPSLC 365 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~----~~~~~ 365 (518)
..|++.++||+|+||+||+|++. ++.||+|+++.........+.|.+|+.+|++++|||||++++++.. ...+|
T Consensus 9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 34578889999999999999985 5679999998776667777889999999999999999999998753 34579
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEc-CCCcEEEEeeCcceeccc
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMD-ENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~g--IiHrDLKp~NILid-~~~~vkL~DFGla~~~~~ 442 (518)
+||||++||+|.+++.+ .+.+++..++.++.||+.||+|||++| |+||||||+|||++ +++.+||+|||+++....
T Consensus 89 ivmE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999999999977 567999999999999999999999998 99999999999996 578999999999986544
Q ss_pred CCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCc
Q 010078 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 443 ~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
. .....+||+.|||||++.+ +|+.++|||||||++|||++|+.||.+......+...+..+.+
T Consensus 168 ~-~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~ 230 (270)
T d1t4ha_ 168 S-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 230 (270)
T ss_dssp T-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC
T ss_pred C-ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC
Confidence 3 3456689999999999876 5999999999999999999999999877655555444444443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-47 Score=378.14 Aligned_cols=222 Identities=27% Similarity=0.541 Sum_probs=191.8
Q ss_pred eeeCCCCeeeee-eeeecCceEEEEEEEC----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC
Q 010078 287 WEIDPKHLKFGS-KVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (518)
Q Consensus 287 ~ei~~~~~~i~~-~LG~G~fG~Vy~g~~~----~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~ 361 (518)
|.+..++|.+.+ +||+|+||.||+|++. +..||||+++... .....++|.+|+.+|++++|||||++++++..
T Consensus 3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~- 80 (285)
T d1u59a_ 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 80 (285)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred eeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-
Confidence 456778888888 5999999999999764 3469999998653 45556789999999999999999999999875
Q ss_pred CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
+.+|+||||++||+|.+++...+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 46899999999999999987767789999999999999999999999999999999999999999999999999998765
Q ss_pred cCCc----cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCchhHH
Q 010078 442 QSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHSFLE 511 (518)
Q Consensus 442 ~~~~----~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~rp~ip 511 (518)
.... .....||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+.... +.++.++.+|
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~-i~~~~~~~~p 234 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-IEQGKRMECP 234 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH-HHTTCCCCCC
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCC
Confidence 4332 234468899999999999999999999999999999998 9999999988777666 4456665444
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.9e-47 Score=382.69 Aligned_cols=214 Identities=24% Similarity=0.485 Sum_probs=174.2
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
+.|++++.||+|+||+||+|++. ++.||||++....... ....+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 56999999999999999999875 6789999998654332 24568899999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc---CCCcEEEEeeCcceecccCCcc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVADFGVARVKAQSGVM 446 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid---~~~~vkL~DFGla~~~~~~~~~ 446 (518)
||+||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+. .++.+||+|||+++........
T Consensus 88 ~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~ 166 (307)
T d1a06a_ 88 LVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 166 (307)
T ss_dssp CCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred ccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCee
Confidence 9999999999976 67899999999999999999999999999999999999995 5789999999999877666666
Q ss_pred ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCc
Q 010078 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
...+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+++....
T Consensus 167 ~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~ 227 (307)
T d1a06a_ 167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE 227 (307)
T ss_dssp ------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCC
T ss_pred eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC
Confidence 6778999999999999999999999999999999999999999999998888887765543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=370.55 Aligned_cols=220 Identities=34% Similarity=0.664 Sum_probs=195.7
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCccee
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~-~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV 367 (518)
+++++|+++++||+|+||+||+|++. ++.||||+++..... .++|.+|+.++++++||||++++|+|.++..+++|
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred CChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence 46789999999999999999999985 457999999876544 35799999999999999999999999999999999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC--c
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--V 445 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~--~ 445 (518)
|||+++|+|.+++......+++..+++++.||++||.|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 99999999999988777889999999999999999999999999999999999999999999999999998654433 2
Q ss_pred cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCchhHHH
Q 010078 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHSFLEQ 512 (518)
Q Consensus 446 ~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~rp~ip~ 512 (518)
.....||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+.+..+....+.+ +.++.+|.
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~-~~~~~~p~ 224 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPH 224 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT-TCCCCCCT
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh-CCCCCCcc
Confidence 334678999999999999999999999999999999998 8999999999887777554 55655443
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.8e-46 Score=384.90 Aligned_cols=213 Identities=24% Similarity=0.392 Sum_probs=194.1
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|++++.||+|+||.||+|++. ++.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+.+|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 47999999999999999999874 7889999997542 3445778999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC--CCcEEEEeeCcceecccCCccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE--NEVVKVADFGVARVKAQSGVMT 447 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~--~~~vkL~DFGla~~~~~~~~~~ 447 (518)
||+||+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.........
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 183 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 183 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEE
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccc
Confidence 99999999999766778999999999999999999999999999999999999964 5789999999999877766667
Q ss_pred cCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcC
Q 010078 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVH 506 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~ 506 (518)
...||+.|||||++.+.+|+.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 184 ~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~ 242 (350)
T d1koaa2 184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW 242 (350)
T ss_dssp EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 78999999999999999999999999999999999999999999999888888776543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-47 Score=376.81 Aligned_cols=220 Identities=29% Similarity=0.540 Sum_probs=183.7
Q ss_pred eCCCCeeee-eeeeecCceEEEEEEECC----ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCC
Q 010078 289 IDPKHLKFG-SKVASGSYGDLYRGTYCS----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (518)
Q Consensus 289 i~~~~~~i~-~~LG~G~fG~Vy~g~~~~----~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~ 363 (518)
++.+.+.+. ++||+|+||.||+|.+.+ +.||||+++....+....++|.+|+.+|++++|||||+++++|.. +.
T Consensus 3 ld~~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~ 81 (277)
T d1xbba_ 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ES 81 (277)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SS
T ss_pred echhhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CC
Confidence 344455555 469999999999998643 469999998766566667889999999999999999999999865 46
Q ss_pred cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC
Q 010078 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~ 443 (518)
.|+||||+++|+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~lvmE~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~ 160 (277)
T d1xbba_ 82 WMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 160 (277)
T ss_dssp EEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEEEcCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccc
Confidence 7999999999999999976 567999999999999999999999999999999999999999999999999999865443
Q ss_pred Cc----cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCchhHH
Q 010078 444 GV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHSFLE 511 (518)
Q Consensus 444 ~~----~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~rp~ip 511 (518)
.. .....||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+.... +.++.++.+|
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~-i~~~~~~~~p 232 (277)
T d1xbba_ 161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-LEKGERMGCP 232 (277)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCC
T ss_pred ccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHH-HHcCCCCCCC
Confidence 21 233468999999999999999999999999999999998 9999999998776665 4456655544
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=383.67 Aligned_cols=215 Identities=23% Similarity=0.451 Sum_probs=191.8
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
|..++|++++.||+|+||.||+++. +++.||||+++.... .......+.+|+.+|++++||||+++++++.+...+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 4557899999999999999999997 468899999975422 1223567889999999999999999999999999999
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC-C
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-G 444 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~-~ 444 (518)
+|||||+||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..... .
T Consensus 82 iv~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred cceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 99999999999999987 678999999999999999999999999999999999999999999999999999865443 3
Q ss_pred ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 445 ~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
.....+||+.|||||++.+.+|+.++|||||||++|||++|+.||.+.+..+....+...
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~ 220 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 220 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC
Confidence 445678999999999999999999999999999999999999999999988777776543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.9e-46 Score=383.37 Aligned_cols=212 Identities=20% Similarity=0.380 Sum_probs=193.4
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
+.|+++++||+|+||.||+|++. ++.||||+++... ......+.+|+.+|++++|||||++++++.++..+|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 46999999999999999999974 6889999987643 3335678899999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc--CCCcEEEEeeCcceecccCCccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD--ENEVVKVADFGVARVKAQSGVMT 447 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid--~~~~vkL~DFGla~~~~~~~~~~ 447 (518)
||+||+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.........
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~ 186 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 186 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCcee
Confidence 9999999999877666799999999999999999999999999999999999998 56899999999999887776677
Q ss_pred cCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
...||+.|||||++.+..|+.++|||||||++|+|+||+.||.+.+..+.+..+.+..
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~ 244 (352)
T d1koba_ 187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD 244 (352)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC
T ss_pred eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 7889999999999999999999999999999999999999999999988888876644
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-46 Score=371.19 Aligned_cols=214 Identities=24% Similarity=0.415 Sum_probs=193.1
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCh----HHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
+.|++++.||+|+||+||+|++. ++.||||+++...... ...+.+.+|+.+|++++|||||++++++.+...+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 57999999999999999999975 6789999987543322 23577999999999999999999999999999999
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC----cEEEEeeCcceecc
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE----VVKVADFGVARVKA 441 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~----~vkL~DFGla~~~~ 441 (518)
||||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 90 iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 90 LILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 99999999999999977 56799999999999999999999999999999999999998776 59999999998877
Q ss_pred cCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcC
Q 010078 442 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVH 506 (518)
Q Consensus 442 ~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~ 506 (518)
.........||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.+...
T Consensus 169 ~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~ 233 (293)
T d1jksa_ 169 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 233 (293)
T ss_dssp TSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC
T ss_pred CCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC
Confidence 66666677899999999999999999999999999999999999999999999888888766443
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-47 Score=384.15 Aligned_cols=204 Identities=27% Similarity=0.462 Sum_probs=182.2
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcc
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~ 365 (518)
++..++|++.++||+|+||+||+|++. ++.||+|+++... .......+.+|+.+|++++|||||+++++|.++..+|
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 466788999999999999999999974 6789999998653 3444578999999999999999999999999999999
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs-~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
+||||++||+|.+++.+ .+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 iVmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp EEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 99999999999999987 5679999999999999999999997 59999999999999999999999999999865432
Q ss_pred ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 445 ~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
..+..+||+.|||||++.+.+|+.++|||||||++|||++|+.||.+.+.
T Consensus 159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 33456899999999999999999999999999999999999999987543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.4e-46 Score=380.14 Aligned_cols=222 Identities=26% Similarity=0.492 Sum_probs=195.1
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
++|+++++||+|+||+||+|++. ++.||||+++.... .....+.+.+|+.+|++++||||+++++++..+..+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999974 78899999875322 1223467899999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcccc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~ 448 (518)
||++||+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... ...
T Consensus 84 E~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~~~ 160 (316)
T d1fota_ 84 DYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYT 160 (316)
T ss_dssp CCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCC
T ss_pred eecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--ccc
Confidence 99999999999876 667899999999999999999999999999999999999999999999999999876543 445
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcC--chhHHHHHhh
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVH--HSFLEQRLRK 516 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~--rp~ip~~~~~ 516 (518)
.+||+.|||||++.+.+|+.++|||||||++|||+||+.||.+.++.+....+++... ++.+++.+++
T Consensus 161 ~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 230 (316)
T d1fota_ 161 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKD 230 (316)
T ss_dssp CCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred ccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 7899999999999999999999999999999999999999999999988888776443 2345555544
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=371.94 Aligned_cols=222 Identities=32% Similarity=0.555 Sum_probs=185.2
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEECC------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~~------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~ 361 (518)
||++++|++.+.||+|+||.||+|.+.+ ..||||+++... ......+|.+|+.+|++++|||||+++|++...
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 7888999999999999999999998753 359999997543 444566799999999999999999999999999
Q ss_pred CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
..+++||||+.++++.+++....+.+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence 99999999999999999998877889999999999999999999999999999999999999999999999999998654
Q ss_pred cCC----ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHhhhhcCchhHH
Q 010078 442 QSG----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG-KLPYEYLTPLQAAVGVVQKVHHSFLE 511 (518)
Q Consensus 442 ~~~----~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG-~~Pf~~~~~~q~~~~iv~~~~rp~ip 511 (518)
... ......||+.|||||++.+..|+.++|||||||++|||++| .+||...+..+.... +..+.++..|
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~-i~~~~~~~~~ 235 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA-INDGFRLPTP 235 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHTTCCCCCC
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHH-HhccCCCCCc
Confidence 332 22334689999999999999999999999999999999995 556666666665555 4555554433
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=371.83 Aligned_cols=220 Identities=30% Similarity=0.551 Sum_probs=183.1
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-----~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~ 360 (518)
+|+|+.++|++++.||+|+||.||+|++.. ..||||+++.. ......+.|.+|+.+|++++||||+++++++.+
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 79 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 79 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 589999999999999999999999998753 34788887653 245556789999999999999999999999964
Q ss_pred CCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceec
Q 010078 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~ 440 (518)
+.+|+||||+++|+|.+++....+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 80 -~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 80 -NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp -SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred -CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence 6789999999999999998877788999999999999999999999999999999999999999999999999999865
Q ss_pred ccCC--ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCch
Q 010078 441 AQSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHS 508 (518)
Q Consensus 441 ~~~~--~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~rp 508 (518)
.... ..+...||+.|+|||++.+..|+.++|||||||++|||+| |.+||.+.++.+....+.+ +.++
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~-~~~~ 228 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-GERL 228 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-TCCC
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCC
Confidence 4332 2344568999999999999999999999999999999998 8999999998888777655 4433
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-46 Score=377.76 Aligned_cols=212 Identities=31% Similarity=0.457 Sum_probs=188.3
Q ss_pred CeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
.|++.++||+|+||.||+|++. ++.||||+++..... ....+.+.+|+.+|++++|||||++++++..+..+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 5899999999999999999874 677999999865443 3445679999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCccccC
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 449 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~~ 449 (518)
||.||+|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ....
T Consensus 96 ~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---~~~~ 171 (309)
T d1u5ra_ 96 YCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSF 171 (309)
T ss_dssp CCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCCC
T ss_pred ecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---CCcc
Confidence 9999998776654 67899999999999999999999999999999999999999999999999999976543 3456
Q ss_pred CCCCcccCchhccC---CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCch
Q 010078 450 TGTYRWMAPEVIEH---KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHHS 508 (518)
Q Consensus 450 ~gt~~y~APEvl~~---~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~rp 508 (518)
.||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+.+..+....+++...++
T Consensus 172 ~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~ 233 (309)
T d1u5ra_ 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA 233 (309)
T ss_dssp CSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred ccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 79999999999854 468999999999999999999999999999999888887765543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=369.82 Aligned_cols=222 Identities=36% Similarity=0.620 Sum_probs=185.2
Q ss_pred CCCCceeeCCCCeeeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC
Q 010078 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (518)
Q Consensus 282 ~~~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~ 360 (518)
...+.|+|+.++|+++++||+|+||.||+|++.+ +.||||+++..... .+.|.+|+.+|++++|||||+++++|..
T Consensus 7 ~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~ 83 (285)
T d1fmka3 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE 83 (285)
T ss_dssp SSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec
Confidence 3567899999999999999999999999999865 57999999865443 3679999999999999999999999865
Q ss_pred CCCcceeeeecCCCchhHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 361 PPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
+.+++||||+++|+|..++... .+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 84 -~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 84 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 162 (285)
T ss_dssp -SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred -CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhh
Confidence 5689999999999999998653 45699999999999999999999999999999999999999999999999999986
Q ss_pred cccCC--ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHhhhhcCch
Q 010078 440 KAQSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG-KLPYEYLTPLQAAVGVVQKVHHS 508 (518)
Q Consensus 440 ~~~~~--~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG-~~Pf~~~~~~q~~~~iv~~~~rp 508 (518)
..... ......||+.|+|||++....++.++|||||||++|||+|| ++||.+....+....+. ++.++
T Consensus 163 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~-~~~~~ 233 (285)
T d1fmka3 163 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRM 233 (285)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCC
T ss_pred ccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCC
Confidence 54332 33446789999999999999999999999999999999995 56667766666665544 34443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.8e-45 Score=362.90 Aligned_cols=215 Identities=30% Similarity=0.491 Sum_probs=183.9
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCC----c
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS----L 364 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~----~ 364 (518)
++|++.+.||+|+||.||+|++. ++.||||+++.... +......|.+|+.+|++++||||+++++++..... +
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 57999999999999999999974 78899999987654 44556789999999999999999999998865443 7
Q ss_pred ceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC
Q 010078 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~ 444 (518)
|+||||++|++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.+.......
T Consensus 87 ~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 899999999999999876 5689999999999999999999999999999999999999999999999999987544322
Q ss_pred ----ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcCc
Q 010078 445 ----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVHH 507 (518)
Q Consensus 445 ----~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~r 507 (518)
.....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.++.+....+++....
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~ 232 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI 232 (277)
T ss_dssp -------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC
T ss_pred ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCC
Confidence 334557999999999999999999999999999999999999999999999888887776543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-46 Score=367.76 Aligned_cols=220 Identities=35% Similarity=0.644 Sum_probs=185.8
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC-CCCc
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-PPSL 364 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~-~~~~ 364 (518)
.|+|+.++|+++++||+|+||.||+|++.++.||||+++.+. ..+.|.+|+.+|++++||||++++|+|.+ ...+
T Consensus 1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (262)
T d1byga_ 1 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 76 (262)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred CCccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence 399999999999999999999999999999999999997543 24678999999999999999999998865 4568
Q ss_pred ceeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC
Q 010078 365 CIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~ 443 (518)
|+||||+++|+|.+++.+.. ..+++..+++++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence 99999999999999997643 35899999999999999999999999999999999999999999999999999865433
Q ss_pred CccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCchhHHH
Q 010078 444 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHSFLEQ 512 (518)
Q Consensus 444 ~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~rp~ip~ 512 (518)
.....+|..|+|||++.+..++.++|||||||++|||+| |++||...+..+....+ .++.++.+|.
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i-~~~~~~~~~~ 223 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDAPD 223 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH-TTTCCCCCCT
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCCCc
Confidence 334568899999999999999999999999999999998 89999998888777775 4455654444
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-45 Score=379.32 Aligned_cols=212 Identities=25% Similarity=0.402 Sum_probs=190.7
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 368 (518)
++|+++++||+|+||.||+|++. ++.||||+++.... .....+.+.+|+.+|+.++||||+++++++.....+++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999874 78899999874321 1223467889999999999999999999999999999999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCCcccc
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~~~~~ 448 (518)
||+.||+|..++.+ .+.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+++..... ...
T Consensus 121 e~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--~~~ 197 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWT 197 (350)
T ss_dssp ECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCC
T ss_pred ccccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--ccc
Confidence 99999999999977 568999999999999999999999999999999999999999999999999999876543 445
Q ss_pred CCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcC
Q 010078 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVH 506 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~ 506 (518)
..||+.|||||++.+..|+.++|||||||++|||+||+.||.+.++.+....+.....
T Consensus 198 ~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~ 255 (350)
T d1rdqe_ 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255 (350)
T ss_dssp CEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred ccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC
Confidence 6899999999999999999999999999999999999999999999888888776543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=366.57 Aligned_cols=223 Identities=33% Similarity=0.586 Sum_probs=186.3
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCcceEEeecccCC
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-----~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~ 361 (518)
-|+.++|++.+.||+|+||.||+|++.+ ..||||+++.... .....+.|.+|+.+|++++||||++++|+|.+
T Consensus 4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~- 82 (273)
T d1u46a_ 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT- 82 (273)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-
Confidence 4677889999999999999999998743 2589999876543 33456789999999999999999999999976
Q ss_pred CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
+.+++||||+++++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 46899999999999999998877889999999999999999999999999999999999999999999999999998765
Q ss_pred cCCc----cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCchhHH
Q 010078 442 QSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHSFLE 511 (518)
Q Consensus 442 ~~~~----~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~rp~ip 511 (518)
.... .....|+..|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+....+.+.+.++..|
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 237 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCC
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCc
Confidence 4432 223457889999999999999999999999999999998 899999999999999988887776443
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.6e-44 Score=357.55 Aligned_cols=214 Identities=25% Similarity=0.410 Sum_probs=191.8
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-------hHHHHHHHHHHHHHHhcC-CCcceEEeecccCC
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-------SDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKP 361 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~-------~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~ 361 (518)
++|++.+.||+|+||+||+|+. +++.||||+++..... ....+.+.+|+.+|++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6799999999999999999987 5688999998765432 123456889999999997 99999999999999
Q ss_pred CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecc
Q 010078 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~ 441 (518)
+.+|||||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 999999999999999999976 6789999999999999999999999999999999999999999999999999999877
Q ss_pred cCCccccCCCCCcccCchhcc------CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcC
Q 010078 442 QSGVMTAETGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVH 506 (518)
Q Consensus 442 ~~~~~~~~~gt~~y~APEvl~------~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~ 506 (518)
.....+...||+.|+|||.+. ...++.++||||+||++|||++|+.||.+.++......+++...
T Consensus 162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~ 232 (277)
T d1phka_ 162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 232 (277)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCC
Confidence 666667778999999999984 34678999999999999999999999999998888777776543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=367.13 Aligned_cols=212 Identities=25% Similarity=0.438 Sum_probs=186.1
Q ss_pred CCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHH-hcCCCcceEEeecccCCCCccee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMR-KVRHKNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~-~~~~~~~~~~Ei~iL~-~L~HpnIv~l~g~~~~~~~~~lV 367 (518)
++|++++.||+|+||+||+|++ +++.||||++++... .......+..|..++. .++||||+++++++.+...+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999998 578899999975321 1122345666666654 68999999999999999999999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc-CCcc
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVM 446 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~-~~~~ 446 (518)
||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ....
T Consensus 82 mEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~ 160 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 160 (320)
T ss_dssp EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred EeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence 999999999999986 67799999999999999999999999999999999999999999999999999986543 3345
Q ss_pred ccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 447 ~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
+...||+.|+|||++.+.+|+.++|||||||++|||+||+.||.+.++.+....+...
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~ 218 (320)
T d1xjda_ 161 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD 218 (320)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 5678999999999999999999999999999999999999999999998888776543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=365.55 Aligned_cols=212 Identities=20% Similarity=0.341 Sum_probs=191.7
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|++++.||+|+||.||+|.+. ++.||||+++... .....+.+|+.+|+.++||||+++++++.+...+|+|||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 57999999999999999999974 6789999998642 234568899999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCC--CcEEEEeeCcceecccCCccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN--EVVKVADFGVARVKAQSGVMT 447 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~--~~vkL~DFGla~~~~~~~~~~ 447 (518)
||+||+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.+ ..+||+|||+++.........
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~ 161 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCccc
Confidence 999999999998756679999999999999999999999999999999999999854 489999999998876666666
Q ss_pred cCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcC
Q 010078 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVH 506 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~ 506 (518)
...+|+.|+|||.+.+..|+.++|||||||++|+|++|+.||.+.+..+....|++...
T Consensus 162 ~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~ 220 (321)
T d1tkia_ 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY 220 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC
T ss_pred ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 67899999999999999999999999999999999999999999999888888776544
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-44 Score=363.79 Aligned_cols=224 Identities=29% Similarity=0.531 Sum_probs=192.7
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecc
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~ 358 (518)
.|++..++|+++++||+|+||+||+|++.+ +.||||+++.. ...+..++|.+|+.+|++++||||++++++|
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 467888899999999999999999999754 56999998754 3455677899999999999999999999999
Q ss_pred cCCCCcceeeeecCCCchhHHHhhhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 010078 359 TKPPSLCIVTEFMSGGSVYDYLHKLK-----------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415 (518)
Q Consensus 359 ~~~~~~~lV~Ey~~ggsL~~~l~~~~-----------------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrD 415 (518)
......+++|||+++|+|.+++.... ..+++..++.++.||+.||.|||+++|||||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 99999999999999999999996532 2478889999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEEeeCcceecccCC---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCC-CCCCC
Q 010078 416 LKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK-LPYEY 491 (518)
Q Consensus 416 LKp~NILid~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~-~Pf~~ 491 (518)
|||+|||++.++.+||+|||+++...... ......||+.|+|||++.+..|+.++|||||||++|||++|. .||.+
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 99999999999999999999997543322 233457889999999999999999999999999999999985 78999
Q ss_pred CCHHHHHHHhhhhcCchhHH
Q 010078 492 LTPLQAAVGVVQKVHHSFLE 511 (518)
Q Consensus 492 ~~~~q~~~~iv~~~~rp~ip 511 (518)
.+..+....+.+ +.++.+|
T Consensus 246 ~~~~e~~~~v~~-~~~~~~p 264 (301)
T d1lufa_ 246 MAHEEVIYYVRD-GNILACP 264 (301)
T ss_dssp SCHHHHHHHHHT-TCCCCCC
T ss_pred CCHHHHHHHHHc-CCCCCCC
Confidence 999888877554 4454433
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-45 Score=364.78 Aligned_cols=227 Identities=31% Similarity=0.561 Sum_probs=185.3
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEee
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG 356 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g 356 (518)
+.|+|+.++|+++++||+|+||.||+|++.+ +.||||+++... .....+.+.+|..++.++ +|+||+.+++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 5799999999999999999999999998743 469999987543 344456788888888777 5899999999
Q ss_pred cccCC-CCcceeeeecCCCchhHHHhhhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 010078 357 ACTKP-PSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420 (518)
Q Consensus 357 ~~~~~-~~~~lV~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~N 420 (518)
++... ..+++|||||++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~N 164 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 164 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccc
Confidence 87654 46899999999999999997532 347889999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEeeCcceecccCC---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcC-CCCCCCCCHHH
Q 010078 421 LLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG-KLPYEYLTPLQ 496 (518)
Q Consensus 421 ILid~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG-~~Pf~~~~~~q 496 (518)
||++.++.+||+|||+++...... ......||+.|||||++.+..|+.++|||||||++|||+|| ..||.+.+..+
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999998654332 23345799999999999999999999999999999999996 67899888777
Q ss_pred HHHHhhhhcCchhHHH
Q 010078 497 AAVGVVQKVHHSFLEQ 512 (518)
Q Consensus 497 ~~~~iv~~~~rp~ip~ 512 (518)
....++.++.++.+|.
T Consensus 245 ~~~~~~~~~~~~~~~~ 260 (299)
T d1ywna1 245 EFCRRLKEGTRMRAPD 260 (299)
T ss_dssp HHHHHHHHTCCCCCCT
T ss_pred HHHHHHhcCCCCCCCc
Confidence 7777787777765543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=360.74 Aligned_cols=225 Identities=32% Similarity=0.593 Sum_probs=190.4
Q ss_pred ceeeCCCCeeeeeeeeecCceEEEEEEECC---------ceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEe
Q 010078 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI 355 (518)
Q Consensus 286 ~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~---------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~ 355 (518)
.|+|+.++|+++++||+|+||.||+|++.+ ..||||+++... ......++.+|..++.++ +|||||+++
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 499999999999999999999999998643 359999998654 344567889999999888 799999999
Q ss_pred ecccCCCCcceeeeecCCCchhHHHhhhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 010078 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420 (518)
Q Consensus 356 g~~~~~~~~~lV~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~N 420 (518)
++|.++..+++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+++||||||||+|
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 99999999999999999999999997542 358999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEeeCcceecccCC---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 010078 421 LLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ 496 (518)
Q Consensus 421 ILid~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q 496 (518)
||++.++.+||+|||+++...... ......+|+.|+|||.+.+..|+.++|||||||++|||++ |+.||.+.+..+
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~ 245 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence 999999999999999998665433 2334578999999999999999999999999999999998 799999988876
Q ss_pred HHHHhhhhcCchhHHH
Q 010078 497 AAVGVVQKVHHSFLEQ 512 (518)
Q Consensus 497 ~~~~iv~~~~rp~ip~ 512 (518)
.... +..+.++..|.
T Consensus 246 ~~~~-i~~~~~~~~p~ 260 (299)
T d1fgka_ 246 LFKL-LKEGHRMDKPS 260 (299)
T ss_dssp HHHH-HHTTCCCCCCS
T ss_pred HHHH-HHcCCCCCCCc
Confidence 6554 55566665443
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=365.04 Aligned_cols=219 Identities=30% Similarity=0.593 Sum_probs=183.5
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEECC--c----eEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTYCS--Q----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~~~--~----~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
+..++|+++++||+|+||+||+|++.. + .||+|.++... .....++|.+|+.+|++++|||||+++++|.++
T Consensus 6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~- 83 (317)
T d1xkka_ 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 83 (317)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 345679999999999999999998753 2 58899887542 233457899999999999999999999999864
Q ss_pred CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceeccc
Q 010078 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~ 442 (518)
..+++|||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 57888999999999999988778899999999999999999999999999999999999999999999999999986544
Q ss_pred CCc---cccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhhcCchhH
Q 010078 443 SGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKVHHSFL 510 (518)
Q Consensus 443 ~~~---~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~q~~~~iv~~~~rp~i 510 (518)
... .....||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+.. .++.++.++..
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~-~~i~~~~~~~~ 234 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQ 234 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH-HHHHHTCCCCC
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH-HHHHcCCCCCC
Confidence 322 233468999999999999999999999999999999999 89999998776654 44555665443
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=358.87 Aligned_cols=225 Identities=29% Similarity=0.511 Sum_probs=195.9
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeec
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~-------~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~ 357 (518)
+.|+|+.++|+++++||+|+||.||+|++. ++.||||+++... .......|.+|+.++++++||||++++++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 579999999999999999999999999874 3579999998543 44556779999999999999999999999
Q ss_pred ccCCCCcceeeeecCCCchhHHHhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCc
Q 010078 358 CTKPPSLCIVTEFMSGGSVYDYLHKLK---------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428 (518)
Q Consensus 358 ~~~~~~~~lV~Ey~~ggsL~~~l~~~~---------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~ 428 (518)
|......++||||+++|+|.+++.... ..++...+.+++.|++.||.|||+++|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence 999999999999999999999986532 24688899999999999999999999999999999999999999
Q ss_pred EEEEeeCcceecccCC---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHhhhh
Q 010078 429 VKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG-KLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 429 vkL~DFGla~~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG-~~Pf~~~~~~q~~~~iv~~ 504 (518)
+||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||+|| +.||.+.+..+....+++
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~- 250 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME- 250 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT-
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-
Confidence 9999999998654432 22344689999999999999999999999999999999997 689999999988887665
Q ss_pred cCchhHH
Q 010078 505 VHHSFLE 511 (518)
Q Consensus 505 ~~rp~ip 511 (518)
+.++.+|
T Consensus 251 ~~~~~~p 257 (308)
T d1p4oa_ 251 GGLLDKP 257 (308)
T ss_dssp TCCCCCC
T ss_pred CCCCCCc
Confidence 4444443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-44 Score=360.93 Aligned_cols=227 Identities=30% Similarity=0.574 Sum_probs=199.3
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEee
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG 356 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~~-------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g 356 (518)
..|+++.++|+++++||+|+||.||+|++.+ +.||||+++... .......|.+|+.+++++ +|||||++++
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 3699999999999999999999999998733 469999998654 344567899999999999 6999999999
Q ss_pred cccCCCCcceeeeecCCCchhHHHhhhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 010078 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLK-----------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419 (518)
Q Consensus 357 ~~~~~~~~~lV~Ey~~ggsL~~~l~~~~-----------------~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~ 419 (518)
+|.....+|+|||||++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~ 174 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence 9999999999999999999999997532 25889999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEeeCcceecccCC---ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 010078 420 NLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPL 495 (518)
Q Consensus 420 NILid~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~ 495 (518)
|||++.++.+||+|||.++...... ......||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999998665432 2234578999999999999999999999999999999999 77888888887
Q ss_pred HHHHHhhhhcCchhHHH
Q 010078 496 QAAVGVVQKVHHSFLEQ 512 (518)
Q Consensus 496 q~~~~iv~~~~rp~ip~ 512 (518)
+.+..+++++.++..|.
T Consensus 255 ~~~~~~i~~~~~~~~~~ 271 (311)
T d1t46a_ 255 SKFYKMIKEGFRMLSPE 271 (311)
T ss_dssp HHHHHHHHHTCCCCCCT
T ss_pred HHHHHHHhcCCCCCCcc
Confidence 88888888888776553
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.2e-43 Score=365.08 Aligned_cols=203 Identities=27% Similarity=0.440 Sum_probs=175.5
Q ss_pred CCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC----ChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCC
Q 010078 290 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI----NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (518)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~----~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~ 363 (518)
..++|++++.||+|+||.||+|++. ++.||||++..... ..........++.+++.++|||||++++++...+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 4578999999999999999999984 68899999864322 11122233445777888889999999999999999
Q ss_pred cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC
Q 010078 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~ 443 (518)
+|+||||++||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 9999999999999999987 577899999999999999999999999999999999999999999999999999866543
Q ss_pred CccccCCCCCcccCchhcc-CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCH
Q 010078 444 GVMTAETGTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494 (518)
Q Consensus 444 ~~~~~~~gt~~y~APEvl~-~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (518)
......||+.|||||++. +..|+.++|||||||+||||+||+.||.+.+.
T Consensus 161 -~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 211 (364)
T d1omwa3 161 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211 (364)
T ss_dssp -CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS
T ss_pred -cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH
Confidence 345568999999999996 45799999999999999999999999986543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=355.51 Aligned_cols=208 Identities=25% Similarity=0.366 Sum_probs=176.6
Q ss_pred eeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCh---HHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 296 FGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS---DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 296 i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~---~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
.+++||+|+||+||+|++ +++.||||+++...... ...+.+.+|+.+|++++|||||++++++..++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 357899999999999986 46789999987653322 2235688999999999999999999999999999999999
Q ss_pred cCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-ccccC
Q 010078 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAE 449 (518)
Q Consensus 371 ~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~~ 449 (518)
+.|+++..+.. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .....
T Consensus 82 ~~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~ 160 (299)
T d1ua2a_ 82 METDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ 160 (299)
T ss_dssp CSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred hcchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccce
Confidence 98876665554 36779999999999999999999999999999999999999999999999999997655433 34456
Q ss_pred CCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 450 TGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 450 ~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
+||+.|+|||++.+ ..|+.++|||||||++|||+||+.||.+.+..+.+..+.+.
T Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~ 216 (299)
T d1ua2a_ 161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET 216 (299)
T ss_dssp CCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred ecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHh
Confidence 79999999999865 56899999999999999999999999999998888777653
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=356.18 Aligned_cols=213 Identities=23% Similarity=0.403 Sum_probs=184.7
Q ss_pred CCeeeeeeeeecCceEEEEEEEC---CceEEEEEecCCCCChHHHHHHHHHHHHHHhc---CCCcceEEeeccc-----C
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV---RHKNVVQFIGACT-----K 360 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~---~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L---~HpnIv~l~g~~~-----~ 360 (518)
++|+++++||+|+||+||+|++. ++.||||+++...........+.+|+.+|+.+ +||||++++++|. .
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 68999999999999999999874 45699999876544333334566777777766 7999999999884 3
Q ss_pred CCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceec
Q 010078 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~ 440 (518)
...+|++|||+.++.+..........+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~ 166 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 166 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence 34689999999888777666665677999999999999999999999999999999999999999999999999999877
Q ss_pred ccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 441 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 441 ~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
..........||+.|+|||++.+.+|+.++|||||||++|||++|+.||.+.++.+....+++.
T Consensus 167 ~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~ 230 (305)
T d1blxa_ 167 SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 230 (305)
T ss_dssp CGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred cccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence 6666677789999999999999999999999999999999999999999999998888777653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=355.08 Aligned_cols=211 Identities=22% Similarity=0.428 Sum_probs=180.7
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|+++++||+|+||.||+|++. ++.||||+++...........+.+|+.+|++++|||||++++++..+..+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 58999999999999999999975 6889999998665444445789999999999999999999999999999999999
Q ss_pred ecCCCchhHHH-hhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-ccc
Q 010078 370 FMSGGSVYDYL-HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT 447 (518)
Q Consensus 370 y~~ggsL~~~l-~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~ 447 (518)
|+.+ ++.+++ ......+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||.++...... ...
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~ 160 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 160 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTT
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccce
Confidence 9965 555554 4445679999999999999999999999999999999999999999999999999998665433 445
Q ss_pred cCCCCCcccCchhccCCC-CChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 448 AETGTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 448 ~~~gt~~y~APEvl~~~~-~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
...||+.|+|||++.... ++.++|+|||||++|+|++|+.||.+.+..+....+.+
T Consensus 161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~ 217 (298)
T d1gz8a_ 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 217 (298)
T ss_dssp CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHH
Confidence 568999999999987766 47899999999999999999999999998887777654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-44 Score=360.06 Aligned_cols=222 Identities=32% Similarity=0.527 Sum_probs=186.7
Q ss_pred eeCCCCeeeeeeeeecCceEEEEEEECC--c--eEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEeecccCCC
Q 010078 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS--Q--DVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPP 362 (518)
Q Consensus 288 ei~~~~~~i~~~LG~G~fG~Vy~g~~~~--~--~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~~~ 362 (518)
.|+.++|+++++||+|+||+||+|++.+ . .||||.++... .....+.|.+|+.+|+++ +|||||+++++|...+
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 4677899999999999999999998753 3 47788776432 233456799999999999 6999999999999999
Q ss_pred CcceeeeecCCCchhHHHhhh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC
Q 010078 363 SLCIVTEFMSGGSVYDYLHKL---------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427 (518)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~l~~~---------------~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~ 427 (518)
.+|+||||++||+|.++++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999999753 25689999999999999999999999999999999999999999
Q ss_pred cEEEEeeCcceecccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHhhhhcC
Q 010078 428 VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG-KLPYEYLTPLQAAVGVVQKVH 506 (518)
Q Consensus 428 ~vkL~DFGla~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG-~~Pf~~~~~~q~~~~iv~~~~ 506 (518)
.+||+|||+++............||+.|+|||.+.+..|+.++|||||||++|||++| .+||.+.+..+....+.+ +.
T Consensus 165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~-~~ 243 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GY 243 (309)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG-TC
T ss_pred ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh-cC
Confidence 9999999999866655455566789999999999999999999999999999999996 578999998888777554 45
Q ss_pred chhHH
Q 010078 507 HSFLE 511 (518)
Q Consensus 507 rp~ip 511 (518)
++.+|
T Consensus 244 ~~~~~ 248 (309)
T d1fvra_ 244 RLEKP 248 (309)
T ss_dssp CCCCC
T ss_pred CCCCC
Confidence 55433
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=361.56 Aligned_cols=198 Identities=26% Similarity=0.436 Sum_probs=173.0
Q ss_pred CCeeeee-eeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCcceEEeecccC----CCC
Q 010078 292 KHLKFGS-KVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTK----PPS 363 (518)
Q Consensus 292 ~~~~i~~-~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~g~~~~----~~~ 363 (518)
++|++.. .||+|+||.||+|++. ++.||||+++.. ..+.+|+.++.++ +|||||++++++.+ ...
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 4688765 5999999999999874 678999998742 4567899887654 79999999998854 456
Q ss_pred cceeeeecCCCchhHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC---CCcEEEEeeCccee
Q 010078 364 LCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARV 439 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~---~~~vkL~DFGla~~ 439 (518)
+|+|||||+||+|.+++.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++. .+.+||+|||+++.
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence 899999999999999997643 46999999999999999999999999999999999999985 46799999999998
Q ss_pred cccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 010078 440 KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 496 (518)
Q Consensus 440 ~~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q 496 (518)
...........||+.|||||++.+..|+.++|||||||+||+|+||+.||.+.+..+
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~ 220 (335)
T d2ozaa1 164 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 220 (335)
T ss_dssp CCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-
T ss_pred ccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH
Confidence 777767777899999999999999999999999999999999999999997765433
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.3e-42 Score=344.62 Aligned_cols=211 Identities=23% Similarity=0.394 Sum_probs=181.4
Q ss_pred CCeeeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~-~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~Ey 370 (518)
++|++.++||+|+||+||+|++. ++.||||+++.........+.+.+|+.+|++++||||+++++++...+..|++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 58999999999999999999875 57899999987654444457899999999999999999999999999999999999
Q ss_pred cCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-ccccC
Q 010078 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAE 449 (518)
Q Consensus 371 ~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~~ 449 (518)
+.++.+..+.. ..+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||.+....... .....
T Consensus 82 ~~~~~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (286)
T d1ob3a_ 82 LDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160 (286)
T ss_dssp CSEEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred ehhhhHHHHHh-hcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccccee
Confidence 97666555554 46789999999999999999999999999999999999999999999999999997654433 33455
Q ss_pred CCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 450 TGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 450 ~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
.+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+..+....+.+
T Consensus 161 ~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~ 215 (286)
T d1ob3a_ 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215 (286)
T ss_dssp -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 78999999999865 4579999999999999999999999999998887777654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=347.69 Aligned_cols=216 Identities=28% Similarity=0.429 Sum_probs=184.3
Q ss_pred CCCceeeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC
Q 010078 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (518)
Q Consensus 283 ~~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~ 360 (518)
+...|++. ++|+++++||+|+||.||+|++. ++.||||+++.........+.+.+|+.+|++++|||||+++++|..
T Consensus 10 ~~~~~~~~-~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~ 88 (346)
T d1cm8a_ 10 TKTAWEVR-AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTP 88 (346)
T ss_dssp SSSEECCB-SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECS
T ss_pred cCceeecC-CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEecc
Confidence 34568874 78999999999999999999975 7889999998776667777889999999999999999999999876
Q ss_pred CC------CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEee
Q 010078 361 PP------SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 434 (518)
Q Consensus 361 ~~------~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DF 434 (518)
.+ .+|+||||+ |.+|..+++. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Df 165 (346)
T d1cm8a_ 89 DETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDF 165 (346)
T ss_dssp CSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred CccccccceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccc
Confidence 54 479999999 7788887754 67999999999999999999999999999999999999999999999999
Q ss_pred CcceecccCCccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 435 GVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 435 Gla~~~~~~~~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
|+++.... ..+...||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+....+...
T Consensus 166 g~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~ 234 (346)
T d1cm8a_ 166 GLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 234 (346)
T ss_dssp TTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred cceeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhc
Confidence 99986544 3566789999999999876 45789999999999999999999999999888777665543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-42 Score=347.73 Aligned_cols=215 Identities=29% Similarity=0.510 Sum_probs=176.8
Q ss_pred eeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC-CCCcceee
Q 010078 295 KFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-PPSLCIVT 368 (518)
Q Consensus 295 ~i~~~LG~G~fG~Vy~g~~~~-----~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~-~~~~~lV~ 368 (518)
.+.++||+|+||+||+|++.. ..||||+++.. .+.....+|.+|+.+|++++||||++++|++.. +..+++||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 447889999999999999743 24899998743 355566889999999999999999999999764 45789999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC----
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---- 444 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~---- 444 (518)
|||++++|.+++......+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++......
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 9999999999998777778889999999999999999999999999999999999999999999999998654332
Q ss_pred -ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHhhhhcCchhHH
Q 010078 445 -VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY-LTPLQAAVGVVQKVHHSFLE 511 (518)
Q Consensus 445 -~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~-~~~~q~~~~iv~~~~rp~ip 511 (518)
......||+.|+|||.+.+..++.++||||||+++|||+||..||.. .+..+.... +..+.++..|
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~-i~~g~~~~~p 256 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-LLQGRRLLQP 256 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHH-HHTTCCCCCC
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHH-HHcCCCCCCc
Confidence 22234689999999999999999999999999999999997666654 444444444 3445555443
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=345.00 Aligned_cols=199 Identities=27% Similarity=0.497 Sum_probs=172.3
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCh----HHHHHHHHHHHHHHhcC--CCcceEEeecccCCCC
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVR--HKNVVQFIGACTKPPS 363 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~----~~~~~~~~Ei~iL~~L~--HpnIv~l~g~~~~~~~ 363 (518)
++|++++.||+|+||.||+|++. ++.||||+++...... ....++.+|+.+|++++ ||||+++++++..++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999974 6789999987543321 11234678999999997 8999999999999999
Q ss_pred cceeeeecCC-CchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCC-CcEEEEeeCcceecc
Q 010078 364 LCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVKA 441 (518)
Q Consensus 364 ~~lV~Ey~~g-gsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~-~~vkL~DFGla~~~~ 441 (518)
.|+||||+.+ +++.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 9999999976 578888876 5789999999999999999999999999999999999999854 799999999998654
Q ss_pred cCCccccCCCCCcccCchhccCCCC-ChhhHHHHHHHHHHHHHcCCCCCCCC
Q 010078 442 QSGVMTAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYL 492 (518)
Q Consensus 442 ~~~~~~~~~gt~~y~APEvl~~~~~-s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (518)
.. ..+...||+.|+|||++.+..+ +.++|||||||++|||+||+.||...
T Consensus 163 ~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 163 DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp SS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred cc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 43 4456789999999999987765 56789999999999999999999864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=343.47 Aligned_cols=193 Identities=28% Similarity=0.552 Sum_probs=162.1
Q ss_pred CCeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC----Cccee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP----SLCIV 367 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~----~~~lV 367 (518)
.+|.+.++||+|+||.||+|++.++.||||+++.. ......+..|+..+.+++||||++++++|.... .+|+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 46889999999999999999999999999998743 221122334555566789999999999987543 47899
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHH--------CCceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ--------NNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs--------~gIiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
||||++|+|.+++++ ..+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.
T Consensus 80 ~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 999999999999976 468899999999999999999996 5999999999999999999999999999987
Q ss_pred cccCC-----ccccCCCCCcccCchhccCCC------CChhhHHHHHHHHHHHHHcCCCCC
Q 010078 440 KAQSG-----VMTAETGTYRWMAPEVIEHKP------YDHKADVFSFGIVLWELLTGKLPY 489 (518)
Q Consensus 440 ~~~~~-----~~~~~~gt~~y~APEvl~~~~------~s~ksDVwSlGviL~eLltG~~Pf 489 (518)
..... ......||+.|||||++.+.. ++.++|||||||+||||+||..||
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~ 218 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 218 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCC
Confidence 65433 223457999999999987643 677999999999999999998776
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=340.39 Aligned_cols=217 Identities=24% Similarity=0.425 Sum_probs=180.5
Q ss_pred CceeeCCCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCC
Q 010078 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (518)
Q Consensus 285 ~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~ 362 (518)
..|++.. +|+++++||+|+||+||+|+.. ++.||||+++... .....+.+.+|+.+|++++||||+++++++....
T Consensus 2 ~~~~i~~-rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~ 79 (345)
T d1pmea_ 2 QVFDVGP-RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 79 (345)
T ss_dssp CCCCCCT-TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred CccCcCC-CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecc
Confidence 3566664 5999999999999999999874 7889999997543 4555678999999999999999999999986543
Q ss_pred ----CcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcce
Q 010078 363 ----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (518)
Q Consensus 363 ----~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~ 438 (518)
..+++++|+.|++|.+++.. +.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++
T Consensus 80 ~~~~~~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 80 IEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp TTTCCCEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ccccceEEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence 23455566779999999965 579999999999999999999999999999999999999999999999999997
Q ss_pred ecccCC----ccccCCCCCcccCchhc-cCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhc
Q 010078 439 VKAQSG----VMTAETGTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKV 505 (518)
Q Consensus 439 ~~~~~~----~~~~~~gt~~y~APEvl-~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~ 505 (518)
...... .....+||+.|+|||++ ....++.++||||+||++|+|++|+.||.+.+........+...
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~ 229 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 229 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhc
Confidence 654332 23455799999999998 45668999999999999999999999999988877766655433
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-41 Score=337.87 Aligned_cols=212 Identities=25% Similarity=0.387 Sum_probs=176.5
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC--------
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-------- 360 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~-------- 360 (518)
.++|+++++||+|+||+||+|++. ++.||||+++...........+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 378999999999999999999974 6789999987665544455778999999999999999999998744
Q ss_pred CCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceec
Q 010078 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~ 440 (518)
...+|+||||+.++.+..+ ......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~~~~~iv~e~~~~~~~~~~-~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp --CEEEEEECCCEEHHHHH-TCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEeccCCCccchh-hhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 3457999999976655544 444677999999999999999999999999999999999999999999999999999755
Q ss_pred ccCC-----ccccCCCCCcccCchhccCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 010078 441 AQSG-----VMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (518)
Q Consensus 441 ~~~~-----~~~~~~gt~~y~APEvl~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~ 503 (518)
.... .....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+.......+.+
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~ 236 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHH
Confidence 4321 22345799999999998765 689999999999999999999999999888777666544
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-40 Score=339.26 Aligned_cols=206 Identities=26% Similarity=0.362 Sum_probs=175.5
Q ss_pred CeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccC------CCCc
Q 010078 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK------PPSL 364 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~------~~~~ 364 (518)
+|+.+++||+|+||+||+|++. ++.||||+++..... +.+|+.+|++++||||++++++|.. ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 6889999999999999999984 678999999765322 3469999999999999999998743 2347
Q ss_pred ceeeeecCCCchhHHHh--hhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC-cEEEEeeCcceecc
Q 010078 365 CIVTEFMSGGSVYDYLH--KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKA 441 (518)
Q Consensus 365 ~lV~Ey~~ggsL~~~l~--~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~-~vkL~DFGla~~~~ 441 (518)
|+|||||+++.+..+.. .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 89999997654333332 2355799999999999999999999999999999999999999775 89999999998877
Q ss_pred cCCccccCCCCCcccCchhccC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhh
Q 010078 442 QSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504 (518)
Q Consensus 442 ~~~~~~~~~gt~~y~APEvl~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~ 504 (518)
.........||+.|+|||.+.+ ..|+.++|||||||++|||++|+.||...+..+.+..+++.
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~ 238 (350)
T d1q5ka_ 175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238 (350)
T ss_dssp TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHH
T ss_pred CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHH
Confidence 6666667789999999998765 57899999999999999999999999999988888777653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5e-40 Score=329.54 Aligned_cols=207 Identities=22% Similarity=0.323 Sum_probs=177.2
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC-CcceEEeecccCCCCccee
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFIGACTKPPSLCIV 367 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~H-pnIv~l~g~~~~~~~~~lV 367 (518)
.++|+++++||+|+||.||+|++. ++.||||+++..... ..+.+|+++++.+.| +|++.+++++......|+|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 468999999999999999999974 678999998654322 346778899999986 8999999999999999999
Q ss_pred eeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC-----CCcEEEEeeCcceeccc
Q 010078 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-----NEVVKVADFGVARVKAQ 442 (518)
Q Consensus 368 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~-----~~~vkL~DFGla~~~~~ 442 (518)
|||+ |++|.+++......++...+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 9999 78999999887778999999999999999999999999999999999999974 57899999999987543
Q ss_pred CC--------ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHhh
Q 010078 443 SG--------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL---TPLQAAVGVV 502 (518)
Q Consensus 443 ~~--------~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~---~~~q~~~~iv 502 (518)
.. ......||+.|||||++.+..++.++|||||||++|||+||+.||.+. +..+....+.
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~ 229 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHH
Confidence 21 223457999999999999999999999999999999999999999754 3444444443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-40 Score=326.56 Aligned_cols=209 Identities=23% Similarity=0.362 Sum_probs=182.3
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCCCCcceeee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 369 (518)
++|+++++||+|+||+||+|++. ++.||||+++...........+.+|+.+|++++||||+++++++.....+++||+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999974 5779999998776666677889999999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccCC-cccc
Q 010078 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (518)
Q Consensus 370 y~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~~-~~~~ 448 (518)
++.|++|..++.. .+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++...... ....
T Consensus 82 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~ 160 (292)
T d1unla_ 82 FCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160 (292)
T ss_dssp CCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCS
T ss_pred ecccccccccccc-ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcccee
Confidence 9999888887765 6788999999999999999999999999999999999999999999999999998765543 3344
Q ss_pred CCCCCcccCchhccCCC-CChhhHHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHh
Q 010078 449 ETGTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELLTGKLPYE-YLTPLQAAVGV 501 (518)
Q Consensus 449 ~~gt~~y~APEvl~~~~-~s~ksDVwSlGviL~eLltG~~Pf~-~~~~~q~~~~i 501 (518)
..+++.|+|||++.... ++.++|||||||++|||++|+.||. +.+..+....+
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~ 215 (292)
T d1unla_ 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHH
T ss_pred eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHH
Confidence 56778899999987665 6899999999999999999998864 44544444443
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-40 Score=338.03 Aligned_cols=220 Identities=25% Similarity=0.392 Sum_probs=187.0
Q ss_pred CCCCceeeCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeeccc
Q 010078 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (518)
Q Consensus 282 ~~~~~~ei~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~ 359 (518)
.+.+.|++. ++|+++++||+|+||+||+|.+ +++.||||+++....+....+.+.+|+.+|++++|||||++++++.
T Consensus 9 ~~~~~~~~~-~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~ 87 (348)
T d2gfsa1 9 LNKTIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 87 (348)
T ss_dssp CSSSEEEEE-TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cCCccccCC-CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 345679985 7899999999999999999986 4788999999877666666778999999999999999999999875
Q ss_pred CC-----CCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEee
Q 010078 360 KP-----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 434 (518)
Q Consensus 360 ~~-----~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DF 434 (518)
.. ...+++|+|+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++||
T Consensus 88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~df 165 (348)
T d2gfsa1 88 PARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDF 165 (348)
T ss_dssp SCSSTTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred eccccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccccccccc
Confidence 33 345677788889999999954 57999999999999999999999999999999999999999999999999
Q ss_pred CcceecccCCccccCCCCCcccCchhccCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcC
Q 010078 435 GVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVH 506 (518)
Q Consensus 435 Gla~~~~~~~~~~~~~gt~~y~APEvl~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~ 506 (518)
|++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+++...
T Consensus 166 g~a~~~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~ 236 (348)
T d2gfsa1 166 GLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 236 (348)
T ss_dssp ----CCTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred chhcccCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99865433 34556789999999987665 468999999999999999999999999998888777765443
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-40 Score=339.18 Aligned_cols=211 Identities=26% Similarity=0.370 Sum_probs=174.5
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcceEEeecccCC------CC
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------PS 363 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~g~~~~~------~~ 363 (518)
++|+++++||+|+||+||+|.+. ++.||||+++....+.....++.+|+.+|++++||||++++++|... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 56999999999999999999975 78899999987766777777899999999999999999999998543 56
Q ss_pred cceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceecccC
Q 010078 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (518)
Q Consensus 364 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~~~~ 443 (518)
+|+||||+.++ +.+.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||+++.....
T Consensus 97 ~~iv~Ey~~~~-l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEECCSEE-HHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eEEEEeccchH-HHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence 79999999654 44444 346899999999999999999999999999999999999999999999999999877776
Q ss_pred CccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhhcC
Q 010078 444 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKVH 506 (518)
Q Consensus 444 ~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~iv~~~~ 506 (518)
...+...+|+.|+|||++.+..+++++||||+||++|+|++|+.||.+.+.......++....
T Consensus 173 ~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~ 235 (355)
T d2b1pa1 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235 (355)
T ss_dssp --------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhcc
Confidence 666777899999999999999999999999999999999999999999988888777665443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9.8e-40 Score=331.67 Aligned_cols=202 Identities=19% Similarity=0.378 Sum_probs=174.3
Q ss_pred CCCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeecccC--CCCcc
Q 010078 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTK--PPSLC 365 (518)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~--~~~~~ 365 (518)
.++|+++++||+|+||+||+|++. ++.||||+++... .+.+.+|+.+|++++ ||||+++++++.. ...+|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 367999999999999999999974 7889999997542 356889999999996 9999999999864 45689
Q ss_pred eeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCC-cEEEEeeCcceecccCC
Q 010078 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSG 444 (518)
Q Consensus 366 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~-~vkL~DFGla~~~~~~~ 444 (518)
+||||+.+++|..+. +.+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+++......
T Consensus 109 ~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp EEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred EEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 999999999987764 4589999999999999999999999999999999999998655 69999999998777666
Q ss_pred ccccCCCCCcccCchhccCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHh
Q 010078 445 VMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLT-PLQAAVGV 501 (518)
Q Consensus 445 ~~~~~~gt~~y~APEvl~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~-~~q~~~~i 501 (518)
......+|+.|+|||.+.+. .|+.++||||+||++|+|++|+.||.... ..+....+
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i 243 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 243 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHH
T ss_pred cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHH
Confidence 66777899999999998765 57999999999999999999999997654 44444443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-41 Score=343.43 Aligned_cols=211 Identities=23% Similarity=0.397 Sum_probs=178.5
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEE-----CCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCC-CcceEEeecccC
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRH-KNVVQFIGACTK 360 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~-----~~~~vAVKvlk~~~~--~~~~~~~~~~Ei~iL~~L~H-pnIv~l~g~~~~ 360 (518)
+..++|+++++||+|+||+||+|.. +++.||||+++.... .....+.+.+|+.+|++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 3457899999999999999999986 356799999875432 12224568889999999987 899999999999
Q ss_pred CCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcceec
Q 010078 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (518)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla~~~ 440 (518)
...++++|||+.|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~-~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred CCceeeeeecccccHHHHHHHh-cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 9999999999999999999987 567788999999999999999999999999999999999999999999999999765
Q ss_pred ccC--CccccCCCCCcccCchhccCC--CCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 010078 441 AQS--GVMTAETGTYRWMAPEVIEHK--PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 500 (518)
Q Consensus 441 ~~~--~~~~~~~gt~~y~APEvl~~~--~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~~ 500 (518)
... .......|++.|+|||.+.+. .++.++|||||||+||+|++|+.||.+.+..+....
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~ 243 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE 243 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 432 233456799999999999764 478899999999999999999999987654433333
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-39 Score=327.28 Aligned_cols=203 Identities=27% Similarity=0.374 Sum_probs=168.5
Q ss_pred CCeeeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcce-EEeecccCCCCcceee
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV-QFIGACTKPPSLCIVT 368 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~--~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnIv-~l~g~~~~~~~~~lV~ 368 (518)
++|+++++||+|+||.||+|++. ++.||||+++..... .++..|+.+++.++|+|++ .+.+++......++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 46999999999999999999975 678999998765332 3477899999999877654 4555567777789999
Q ss_pred eecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcC---CCcEEEEeeCcceecccCC-
Q 010078 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVKAQSG- 444 (518)
Q Consensus 369 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~---~~~vkL~DFGla~~~~~~~- 444 (518)
||+ +++|.+.+....+.+++..+..++.|++.||+|||++||+||||||+|||++. +..++|+|||+++......
T Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 999 67787777776788999999999999999999999999999999999999864 4579999999998765432
Q ss_pred -------ccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 010078 445 -------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV 499 (518)
Q Consensus 445 -------~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~q~~~ 499 (518)
......||+.|||||++.+.+|+.++|||||||++|||+||+.||......+...
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~ 223 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ 223 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC------
T ss_pred ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH
Confidence 2234579999999999999999999999999999999999999998876654433
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-33 Score=288.22 Aligned_cols=200 Identities=21% Similarity=0.344 Sum_probs=160.1
Q ss_pred eCCCCeeeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-----------CCcceEEe
Q 010078 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-----------HKNVVQFI 355 (518)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-----------HpnIv~l~ 355 (518)
+...+|+++++||+|+||+||+|+. +++.||||+++.. ....+.+.+|+.+++.++ |+||++++
T Consensus 10 ~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~ 86 (362)
T d1q8ya_ 10 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86 (362)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred ccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence 3446799999999999999999987 4788999999854 333467788999998886 47799998
Q ss_pred ecccCC--CCcceeeeecCCCchhHH--HhhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEcCCC---
Q 010078 356 GACTKP--PSLCIVTEFMSGGSVYDY--LHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENE--- 427 (518)
Q Consensus 356 g~~~~~--~~~~lV~Ey~~ggsL~~~--l~~~~~~l~~~~i~~i~~qIa~aL~yLHs-~gIiHrDLKp~NILid~~~--- 427 (518)
+++... ...+++|+++..+..... .......+++..++.++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence 887543 345566666654433222 23335678999999999999999999998 8999999999999998665
Q ss_pred ---cEEEEeeCcceecccCCccccCCCCCcccCchhccCCCCChhhHHHHHHHHHHHHHcCCCCCCCCC
Q 010078 428 ---VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 493 (518)
Q Consensus 428 ---~vkL~DFGla~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~ 493 (518)
.++++|||.+...... .....||+.|+|||++....|+.++|+||+||++++|++|+.||....
T Consensus 167 ~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp TEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ccceeeEeecccccccccc--cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 3999999999765443 355679999999999999999999999999999999999999997543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=2.9e-24 Score=200.51 Aligned_cols=162 Identities=14% Similarity=0.149 Sum_probs=120.4
Q ss_pred eeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCC----------------hHHHHHHHHHHHHHHhcCCCcceEEeec
Q 010078 295 KFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERIN----------------SDMQKEFAQEVFIMRKVRHKNVVQFIGA 357 (518)
Q Consensus 295 ~i~~~LG~G~fG~Vy~g~~-~~~~vAVKvlk~~~~~----------------~~~~~~~~~Ei~iL~~L~HpnIv~l~g~ 357 (518)
.++++||+|+||.||+|+. +++.||||+++..... ......+..|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 5789999999999999986 5788999998743211 0112345568899999999999998876
Q ss_pred ccCCCCcceeeeecCCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcCCCcEEEEeeCcc
Q 010078 358 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437 (518)
Q Consensus 358 ~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLHs~gIiHrDLKp~NILid~~~~vkL~DFGla 437 (518)
.. .+++|||+++..+.+ ++......++.|++.++.|||++||+||||||+|||++++ .++|+|||++
T Consensus 83 ~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a 149 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQS 149 (191)
T ss_dssp ET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTC
T ss_pred cC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCc
Confidence 43 489999998765543 3444567899999999999999999999999999999965 4899999999
Q ss_pred eecccCCccccCCCCCcccCc------hhccCCCCChhhHHHHHHH
Q 010078 438 RVKAQSGVMTAETGTYRWMAP------EVIEHKPYDHKADVFSFGI 477 (518)
Q Consensus 438 ~~~~~~~~~~~~~gt~~y~AP------Evl~~~~~s~ksDVwSlGv 477 (518)
.....+... .|... +. ..+.|+.++|+||+.-
T Consensus 150 ~~~~~~~~~-------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 150 VEVGEEGWR-------EILERDVRNIITY-FSRTYRTEKDINSAID 187 (191)
T ss_dssp EETTSTTHH-------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHH
T ss_pred ccCCCCCcH-------HHHHHHHHHHHHH-HcCCCCCcccHHHHHH
Confidence 765433211 11111 11 1356788899999754
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.46 E-value=2.1e-07 Score=88.07 Aligned_cols=139 Identities=12% Similarity=0.085 Sum_probs=89.7
Q ss_pred CeeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCcceEEeecccCCCCcceeeeec
Q 010078 293 HLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFM 371 (518)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~g~~~~~~~~~lV~Ey~ 371 (518)
.+++.+..+-++.+.||+.+..++.+.+|+........ ...+.+|..+++.+. +--+.+++.++..++..++||+++
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l 92 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEec
Confidence 34544544434457899998888889999876442211 234677888888775 333567777777777889999999
Q ss_pred CCCchhHHHhhhcCCCCHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 010078 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH-------------------------------------------- 407 (518)
Q Consensus 372 ~ggsL~~~l~~~~~~l~~~~i~~i~~qIa~aL~yLH-------------------------------------------- 407 (518)
+|.++.+.... ... ...++.++.+.+..||
T Consensus 93 ~G~~~~~~~~~---~~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T d1j7la_ 93 DGVLCSEEYED---EQS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp SSEEHHHHTTT---CSC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSS
T ss_pred ccccccccccc---ccc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchH
Confidence 99877543211 001 1111222222222222
Q ss_pred ---------HC------CceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 408 ---------QN------NIIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 408 ---------s~------gIiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
+. .++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 167 ~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 21 278999999999999877778999998864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.88 E-value=1.8e-05 Score=73.81 Aligned_cols=136 Identities=13% Similarity=0.166 Sum_probs=83.3
Q ss_pred eeeecCc-eEEEEEEECCc-eEEEEEecCCCCChHHHHHHHHHHHHHHhcCCC--cceEEeecccCCCCcceeeeecCCC
Q 010078 299 KVASGSY-GDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK--NVVQFIGACTKPPSLCIVTEFMSGG 374 (518)
Q Consensus 299 ~LG~G~f-G~Vy~g~~~~~-~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIv~l~g~~~~~~~~~lV~Ey~~gg 374 (518)
.+..|.. +.||+.+..+. .+++|....... ..+..|...|+.+... .+.+++.++..++..++||++++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 4455554 57899887654 578888765432 2366778888777533 3567788777778889999999887
Q ss_pred chhHH--------------Hhhhc------CCC--CHHHHHHHH--------------------HHHHHHHHHHHHC---
Q 010078 375 SVYDY--------------LHKLK------GVF--KLPSLLKVA--------------------IDVSKGMNYLHQN--- 409 (518)
Q Consensus 375 sL~~~--------------l~~~~------~~l--~~~~i~~i~--------------------~qIa~aL~yLHs~--- 409 (518)
++.+. +.+.. ..+ .......-. ......+..+..+
T Consensus 92 ~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 171 (255)
T d1nd4a_ 92 DLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD 171 (255)
T ss_dssp ETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCS
T ss_pred ccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCc
Confidence 65431 11100 000 000000000 0112223334332
Q ss_pred ----CceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 410 ----NIIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 410 ----gIiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
.++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 172 ~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 172 GEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp SCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 379999999999999877778999998854
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.61 E-value=6.5e-05 Score=75.57 Aligned_cols=78 Identities=14% Similarity=0.042 Sum_probs=48.3
Q ss_pred eeeeeecCceEEEEEEE--CCceEEEEEecCCC-C----ChHHHHHHHHHHHHHHhcC-C--CcceEEeecccCCCCcce
Q 010078 297 GSKVASGSYGDLYRGTY--CSQDVAIKVLKPER-I----NSDMQKEFAQEVFIMRKVR-H--KNVVQFIGACTKPPSLCI 366 (518)
Q Consensus 297 ~~~LG~G~fG~Vy~g~~--~~~~vAVKvlk~~~-~----~~~~~~~~~~Ei~iL~~L~-H--pnIv~l~g~~~~~~~~~l 366 (518)
.+.||.|....||+.+. .++.+++|.-.+.. . ......+...|...|+.+. + ..+++++.+.. ...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~--~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT--EMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET--TTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC--CCCEE
Confidence 34689999999999874 35678999644311 0 0111223456777777664 2 34666776543 45689
Q ss_pred eeeecCCCch
Q 010078 367 VTEFMSGGSV 376 (518)
Q Consensus 367 V~Ey~~ggsL 376 (518)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999977543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.83 E-value=0.0014 Score=65.41 Aligned_cols=76 Identities=14% Similarity=0.301 Sum_probs=51.0
Q ss_pred CCeeeeeeeeecCceEEEEEEECC---------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCc-ceEEeecccCC
Q 010078 292 KHLKFGSKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN-VVQFIGACTKP 361 (518)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~g~~~~---------~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Iv~l~g~~~~~ 361 (518)
+.+++ +.|+-|-.-.+|+.+..+ +.|.+++.-.. .. .....+|..+++.+.-.+ ..++++++..
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~--~idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET--ESHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--ch--hhHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence 34444 578889999999998643 34777776421 11 234557888998886334 4578887753
Q ss_pred CCcceeeeecCCCch
Q 010078 362 PSLCIVTEFMSGGSV 376 (518)
Q Consensus 362 ~~~~lV~Ey~~ggsL 376 (518)
++||||++|.+|
T Consensus 117 ---g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ---GRLEEYIPSRPL 128 (395)
T ss_dssp ---EEEECCCCEEEC
T ss_pred ---ceEEEEeccccC
Confidence 789999987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.75 E-value=0.0021 Score=62.20 Aligned_cols=67 Identities=13% Similarity=0.140 Sum_probs=42.7
Q ss_pred ceEEEEEEE-CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcc--eEEeec-----ccCCCCcceeeeecCCC
Q 010078 305 YGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV--VQFIGA-----CTKPPSLCIVTEFMSGG 374 (518)
Q Consensus 305 fG~Vy~g~~-~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnI--v~l~g~-----~~~~~~~~lV~Ey~~gg 374 (518)
-..||+.+. .|+.|++|+.++...+. .++..|...+..|...++ +..+.. +......+.++++++|.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 367999976 57789999998765543 456778888888763332 111111 12233467788988764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.42 E-value=0.0049 Score=58.81 Aligned_cols=142 Identities=13% Similarity=0.079 Sum_probs=73.2
Q ss_pred eeeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcc--eEEeeccc------CCCCcc
Q 010078 294 LKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV--VQFIGACT------KPPSLC 365 (518)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~g~~~~~~vAVKvlk~~~~~~~~~~~~~~Ei~iL~~L~HpnI--v~l~g~~~------~~~~~~ 365 (518)
+.-.+.|..|.--+.|+.+..+..+++|+...... ..++..|+.+|..|...++ ...+.... .....+
T Consensus 20 ~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~----~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~ 95 (316)
T d2ppqa1 20 LTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVE----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 95 (316)
T ss_dssp EEEEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred ceEeecCCCCcccCeEEEEECCCcEEEEEcCCCCC----HHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccc
Confidence 44445677888888999998888899999865322 1334556777777753322 11111110 011223
Q ss_pred eeeeecCCCchhH--------------HHhhhcC--------CCC------------------HHHHHHHHHHHHHHHHH
Q 010078 366 IVTEFMSGGSVYD--------------YLHKLKG--------VFK------------------LPSLLKVAIDVSKGMNY 405 (518)
Q Consensus 366 lV~Ey~~ggsL~~--------------~l~~~~~--------~l~------------------~~~i~~i~~qIa~aL~y 405 (518)
.++.++.|..... .++.... ... .......+..+...+..
T Consensus 96 ~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 175 (316)
T d2ppqa1 96 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 175 (316)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred eeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhc
Confidence 3444554432111 0110000 000 01111222222222222
Q ss_pred HHH----CCceeccCCCCcEEEcCCCcEEEEeeCccee
Q 010078 406 LHQ----NNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (518)
Q Consensus 406 LHs----~gIiHrDLKp~NILid~~~~vkL~DFGla~~ 439 (518)
... .|+||+|+.++||+++.++..-|+||+.+..
T Consensus 176 ~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 176 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 222 4799999999999999888889999998863
|
| >d1u8sa1 d.58.18.5 (A:2-87) putative transcriptional repressor VC2159 {Vibrio cholerae [TaxId: 666]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Glycine cleavage system transcriptional repressor domain: putative transcriptional repressor VC2159 species: Vibrio cholerae [TaxId: 666]
Probab=96.24 E-value=0.003 Score=49.14 Aligned_cols=64 Identities=14% Similarity=0.126 Sum_probs=48.7
Q ss_pred eeeecCChhhHHHHHHHHHHhhcccceecccccCCCCceeeEEEEcCCChhhHHHHHHHHHHHHHH
Q 010078 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLK 247 (518)
Q Consensus 182 i~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~dg~~ldv~vvdgw~~e~~~~l~~~l~~~~~~ 247 (518)
||+...|+|+++.+++.+|++.|.||.+...+..- |...-.+.|. ++....++|+.+|++--.+
T Consensus 8 itv~G~DrpGiva~vt~~l~~~g~NI~d~~~~~~~-~~~~~~~~v~-~~~~~~~~l~~~L~~l~~~ 71 (86)
T d1u8sa1 8 ITAVGTDRPGICNEVVRLVTQAGCNIIDSRIAMFG-KEFTLLMLIS-GSPSNITRVETTLPLLGQQ 71 (86)
T ss_dssp EEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEET-TEEEEEEEEE-ECHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCChHHHHHHHHHHHCCCeEEEeEeEEEC-CeeEEEEEEE-cCcccHHHHHHHHHHHHHH
Confidence 78999999999999999999999999998776554 3444444444 5566677788777765444
|
| >d1zpva1 d.58.18.7 (A:1-83) UPF0237 protein SP0238 {Streptococcus pneumoniae [TaxId: 1313]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: SP0238-like domain: UPF0237 protein SP0238 species: Streptococcus pneumoniae [TaxId: 1313]
Probab=96.10 E-value=0.0049 Score=47.45 Aligned_cols=65 Identities=22% Similarity=0.285 Sum_probs=48.6
Q ss_pred eeeecCChhhHHHHHHHHHHhhcccceecccccCCCCceeeEEEEcCCChhhHHHHHHHHHHHHHH
Q 010078 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLK 247 (518)
Q Consensus 182 i~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~dg~~ldv~vvdgw~~e~~~~l~~~l~~~~~~ 247 (518)
||+++.|+|++++.+|.+|++.|.||.+...+...+-|.. .+.++.-.....++|+++|+....+
T Consensus 5 itv~g~DrpGiVa~vt~~l~~~g~NI~d~~q~~~~~~f~~-~~~v~~~~~~~~~~l~~~l~~la~~ 69 (83)
T d1zpva1 5 ITVVGKDKSGIVAGVSGKIAELGLNIDDISQTVLDEYFTM-MAVVSSDEKQDFTYLRNEFEAFGQT 69 (83)
T ss_dssp EEEEESCCTTHHHHHHHHHHHTTCEEEEEEEEEETTEEEE-EEEEEESSCCCHHHHHHHHHHHHHH
T ss_pred EEEEcCCCCCHHHHHHHHHHHCCCeEEEEEeEEeCCEEEE-EEEEEEecCCCHHHHHHHHHHHHHH
Confidence 7899999999999999999999999999988765544444 3444422233467788888765443
|
| >d1u8sa2 d.58.18.5 (A:88-180) putative transcriptional repressor VC2159 {Vibrio cholerae [TaxId: 666]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Glycine cleavage system transcriptional repressor domain: putative transcriptional repressor VC2159 species: Vibrio cholerae [TaxId: 666]
Probab=93.46 E-value=0.087 Score=40.98 Aligned_cols=68 Identities=16% Similarity=0.134 Sum_probs=45.8
Q ss_pred cceeeecCChhhHHHHHHHHHHhhcccceecccccCC---CC-----ceeeEEEEcCCChhhHHHHHHHHHHHHHHh
Q 010078 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTV---DG-----YSLDVFVVDGWPYEETEQLRAALEKEVLKL 248 (518)
Q Consensus 180 ~ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~---dg-----~~ldv~vvdgw~~e~~~~l~~~l~~~~~~~ 248 (518)
-+|++.+.|+|+++.++|..|++.|.||.+....... .+ |...+- +.--..-..++|+++|+.-...+
T Consensus 7 v~v~v~g~DrpGIV~~it~~la~~~~nI~~l~t~~~~a~~~~~~~~~f~~~~~-~~~p~~~~~~~l~~~l~~l~~~l 82 (93)
T d1u8sa2 7 VEVYVESDDKLGLTEKFTQFFAQRQIGMASLSAQTISKDKLHSEQNQFHIAIS-ARVDSGCNLMQLQEEFDALCTAL 82 (93)
T ss_dssp EEEEEEESCCTTHHHHHHHHHHHTTCCEEEEEEEEEC--------CEEEEEEE-EEECTTSCHHHHHHHHHHHHHHH
T ss_pred EEEEEEECCCCCHHHHHHHHHHHcCCCchhhhcccccccCCcccCccEEEEEE-EEcCccccHHHHHHHHHHHHHHc
Confidence 3889999999999999999999999999987654321 11 222221 22112334677888887655554
|
| >d1ygya3 d.58.18.1 (A:452-529) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=91.50 E-value=0.3 Score=36.57 Aligned_cols=53 Identities=21% Similarity=0.211 Sum_probs=43.6
Q ss_pred cceeeecCChhhHHHHHHHHHHhhcccceeccccc-CCCCceeeEEEEcCCChh
Q 010078 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFS-TVDGYSLDVFVVDGWPYE 232 (518)
Q Consensus 180 ~ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fs-t~dg~~ldv~vvdgw~~e 232 (518)
|=+.+.-.|+|+.+.+++++|++-|.||...+... ...|...-++.+|+-..+
T Consensus 4 ~~L~i~~~D~PGvi~~I~~~l~~~~iNI~~m~~~~~~~g~~a~~vi~vD~~~~~ 57 (78)
T d1ygya3 4 INLIIHYVDRPGALGKIGTLLGTAGVNIQAAQLSEDAEGPGATILLRLDQDVPD 57 (78)
T ss_dssp EEEEEEESCCTTHHHHHHHHHHHTTCCEEEEEEEECSSSSCEEEEEEESSCCCH
T ss_pred eEEEEEeCCcCCHHHHHHHHHHhcCcChhhheeeecCCCCeEEEEEEcCCCccH
Confidence 55677788999999999999999999999998865 455677778888875543
|
| >d1sc6a3 d.58.18.1 (A:327-410) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain species: Escherichia coli [TaxId: 562]
Probab=91.25 E-value=0.097 Score=39.94 Aligned_cols=46 Identities=20% Similarity=0.393 Sum_probs=38.0
Q ss_pred ccceeeecCChhhHHHHHHHHHHhhcccceecccccCCC-CceeeEE
Q 010078 179 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSLDVF 224 (518)
Q Consensus 179 ~~ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~d-g~~ldv~ 224 (518)
-|-+++.-.|+|+.|.+++++|++-|+||..-+.-+..+ ||.+=.+
T Consensus 11 ~~rl~i~~~d~PGvla~I~~~l~~~~iNI~~~~~~~~~~~~~a~~~i 57 (84)
T d1sc6a3 11 GRRLMHIHENRPGVLTALNKIFAEQGVNIAAQYLQTSAQMGYVVIDI 57 (84)
T ss_dssp SEEEEEEEESCTTHHHHHHHHHHHTTCEEEEEEEEECSSEEEEEEEE
T ss_pred CeEEEEEeCCcCCHHHHHHHHHHHcCCCHHHhccccCCCCcEEEEEE
Confidence 478999999999999999999999999999988777665 4444333
|
| >d2f06a1 d.58.18.11 (A:71-141) Hypothetical protein BT0572 {Bacteroides thetaiotaomicron [TaxId: 818]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: BT0572-like domain: Hypothetical protein BT0572 species: Bacteroides thetaiotaomicron [TaxId: 818]
Probab=90.58 E-value=0.24 Score=36.50 Aligned_cols=56 Identities=16% Similarity=0.223 Sum_probs=45.5
Q ss_pred eeeecCChhhHHHHHHHHHHhhcccceecccccCCCCceeeEEEEcCCChhhHHHHHHHHHH
Q 010078 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEK 243 (518)
Q Consensus 182 i~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~dg~~ldv~vvdgw~~e~~~~l~~~l~~ 243 (518)
|.+.-.|+|+-|.++..+|++-|.||.-..+|.+. ++..=+|.|| +.+..++.|++
T Consensus 2 iaV~v~d~pG~L~~v~~~L~~~~InI~~~y~~~~~-~~~~~vl~vd-----d~~~a~~~L~~ 57 (71)
T d2f06a1 2 VGISCPNVPGALAKVLGFLSAEGVFIEYMYSFANN-NVANVVIRPS-----NMDKCIEVLKE 57 (71)
T ss_dssp EEEEEESSTTHHHHHHHHHHHTTCCEEEEEEEEET-TEEEEEEEES-----CHHHHHHHHHH
T ss_pred EEEEecCCccHHHHHHHHHHHCCCCEEEEEEEcCC-CcEEEEEEEC-----CHHHHHHHHHH
Confidence 34556799999999999999999999999999986 6888888886 34555555554
|
| >d1y7pa2 d.58.18.12 (A:2-78) Hypothetical protein AF1403, N-terminal domain {Archaeon Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: AF1403 N-terminal domain-like domain: Hypothetical protein AF1403, N-terminal domain species: Archaeon Archaeoglobus fulgidus [TaxId: 2234]
Probab=89.68 E-value=0.059 Score=40.60 Aligned_cols=61 Identities=20% Similarity=0.189 Sum_probs=41.3
Q ss_pred ceeeecCChhhHHHHHHHHHHhhcccceecccccCCCCceeeEEEEc--CCChhhHHHHHHHHH
Q 010078 181 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVD--GWPYEETEQLRAALE 242 (518)
Q Consensus 181 ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~dg~~ldv~vvd--gw~~e~~~~l~~~l~ 242 (518)
.|.+-..|+|++|+.++.++++-|.||...+.+...+|..--.+.++ .... +.+.+.++|+
T Consensus 3 ~i~i~~~Dr~GlL~di~~~ia~~~~NI~~i~~~~~~~g~~~~~~~i~v~~~~~-~l~~ll~kL~ 65 (77)
T d1y7pa2 3 GLRIIAENKIGVLRDLTTIIAEEGGNITFAQTFLIKHGEHEGKALIYFEIEGG-DFEKILERVK 65 (77)
T ss_dssp EEEEEEECCTTHHHHHHHHCC----CEEEEEEEECCSSTTTTEEEEEEEECSS-CHHHHHHHHH
T ss_pred eEEEEEecCCChHHHHHHHHHHcCCCeEEEEeeccCCCeEEEEEEEEEEcCcc-cHHHHHHHHH
Confidence 47788899999999999999999999999999887887655444443 2211 3555555543
|
| >d2f06a2 d.58.18.11 (A:1-70) Hypothetical protein BT0572 {Bacteroides thetaiotaomicron [TaxId: 818]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: BT0572-like domain: Hypothetical protein BT0572 species: Bacteroides thetaiotaomicron [TaxId: 818]
Probab=89.12 E-value=0.48 Score=34.69 Aligned_cols=49 Identities=16% Similarity=0.271 Sum_probs=42.0
Q ss_pred ccceeeecCChhhHHHHHHHHHHhhcccceecccccCCCCceeeEEEEcC
Q 010078 179 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDG 228 (518)
Q Consensus 179 ~~ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~fst~dg~~ldv~vvdg 228 (518)
+|.|.+-..|||+.|.+++.+|++-|.||.--.++.|.+ +.+--++||.
T Consensus 3 ~~QisV~~eNkpG~L~~v~~~~~~~~inI~sl~v~~t~~-~~i~Riiv~~ 51 (70)
T d2f06a2 3 AKQLSIFLENKSGRLTEVTEVLAKENINLSALCIAENAD-FGILRGIVSD 51 (70)
T ss_dssp EEEEEEEECSSSSHHHHHHHHHHHTTCCEEEEEEEECSS-CEEEEEEESC
T ss_pred eEEEEEEEeCCCcHHHHHHHHHHHCCCCEEEEEEeecCC-CCEEEEEECC
Confidence 567888889999999999999999999999988888875 5666677773
|
| >d2pc6a2 d.58.18.6 (A:1-77) Acetolactate synthase small subunit, IlvH {Nitrosomonas europaea [TaxId: 915]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: IlvH-like domain: Acetolactate synthase small subunit, IlvH species: Nitrosomonas europaea [TaxId: 915]
Probab=83.18 E-value=1.5 Score=32.62 Aligned_cols=63 Identities=25% Similarity=0.305 Sum_probs=49.3
Q ss_pred cceeeecCChhhHHHHHHHHHHhhcccceecccc-cCCCCceeeEEEEcCCChhhHHHHHHHHHH
Q 010078 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAF-STVDGYSLDVFVVDGWPYEETEQLRAALEK 243 (518)
Q Consensus 180 ~ei~~s~~d~~~ll~~l~~~l~~~~~~i~~a~~f-st~dg~~ldv~vvdgw~~e~~~~l~~~l~~ 243 (518)
|-|.+-..|+|+.|.+++.+.+.=|+||.--.+- +-.+|.|-=.++|.|- .+..+++...|++
T Consensus 3 ~tisv~veN~pGvL~Ris~lF~rRg~NI~Sltv~~te~~~iSRmtivv~~~-~~~i~qi~kQL~K 66 (77)
T d2pc6a2 3 HIISLLMENEAGALSRVAGLFSARGYNIESLSVAPTEDPTLSRMTLVTNGP-DEIVEQITKQLNK 66 (77)
T ss_dssp EEEEEEEECSTTHHHHHHHHHHHHTCCCCEEEEEECSSTTEEEEEEEEEEC-HHHHHHHHHHHHH
T ss_pred EEEEEEEECCccHHHHHHHHHhccCcceEEEEEeccCCCCeEEEEEEEECC-HHHHHHHHHHHhC
Confidence 5567777899999999999999999999987775 4556777777787773 4566777666665
|